Citrus Sinensis ID: 038647
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 289 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 1.0 | 0.339 | 0.591 | 3e-92 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.899 | 0.306 | 0.596 | 1e-90 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.913 | 0.394 | 0.582 | 2e-89 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.885 | 0.408 | 0.595 | 6e-89 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.885 | 0.312 | 0.615 | 6e-88 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.885 | 0.382 | 0.596 | 8e-88 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 1.0 | 0.342 | 0.552 | 2e-87 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 1.0 | 0.341 | 0.542 | 6e-87 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.885 | 0.301 | 0.611 | 6e-87 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.996 | 0.338 | 0.554 | 7e-87 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function desciption |
|---|
Score = 338 bits (867), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 172/291 (59%), Positives = 211/291 (72%), Gaps = 2/291 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQGLEEFKNE++LIAKLQHRNLVRL G C+ EK+L+YEYMP+KSLD F+FD
Sbjct: 562 LSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRK 621
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
L W+MR I+ G+A+GLLYLH SRLR+IHRDLK SNILLD MNPKISDFG+AR+
Sbjct: 622 LCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARI 681
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FGG E +NT R+VGTYGYMSPEYAL GLFS KSDVFSFGV+V+ET+S K+N F+ +
Sbjct: 682 FGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEK 741
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
SL+LLGHAW+LW R EL+D LQ + +NV LLCVQE+ DRPTM V+
Sbjct: 742 SLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVF 801
Query: 240 ML-TNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
ML ++E LP+P QPAF R +S ++ + E C+ N LT++ D R
Sbjct: 802 MLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (853), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 155/260 (59%), Positives = 205/260 (78%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +SGQG++EFKNE++LIAKLQHRNLVRL GCC E EK+L+YEYMPNKSLD FLFD T
Sbjct: 559 LSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET 618
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K L+ W++R I+EG+A+GLLYLH SRLR+IHRDLK SN+LLD+ MNPKISDFG+AR+
Sbjct: 619 KQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI 678
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG++ ++NT R+VGTYGYMSPEYA+ GLFS+KSDV+SFGVL+LE +S K+N +++
Sbjct: 679 FGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH 738
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
+L+G+AW L+ GR+ EL+D ++ S R I+VA+LCVQ++AA+RP M V+ M
Sbjct: 739 GSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLM 798
Query: 241 LTNENVILPSPLQPAFSHVR 260
L ++ L +P QP F+ R
Sbjct: 799 LESDTATLAAPRQPTFTSTR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 328 bits (842), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 155/266 (58%), Positives = 201/266 (75%), Gaps = 2/266 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQG EFKNE++L+AKLQHRNLVRL G C++ E++L+YEY+PNKSLD FLFDP
Sbjct: 378 LSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPA 437
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G L W R +I+ GVA+G+LYLH SRL +IHRDLKASNILLD++MNPKI+DFG+AR+
Sbjct: 438 KKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 497
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FG D+ + NT RIVGTYGYMSPEYA+ G +S+KSDV+SFGVLVLE +S KKN+ FY TD
Sbjct: 498 FGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDG 557
Query: 181 L-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
L+ +AW LW++GR EL+D + + + R +++ LLCVQE+ A+RPT+ ++
Sbjct: 558 AHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVL 617
Query: 240 MLTNENVILPSPLQPA-FSHVRIAEN 264
MLT+ V LP P QP F RI ++
Sbjct: 618 MLTSNTVTLPVPRQPGLFFQSRIGKD 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 327 bits (838), Expect = 6e-89, Method: Compositional matrix adjust.
Identities = 153/257 (59%), Positives = 195/257 (75%), Gaps = 1/257 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQG EFKNE++++AKLQHRNLVRL G I GE+IL+YEYMPNKSLD FLFDP
Sbjct: 367 LSKSSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPA 426
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K L W R +++ G+A+G+LYLH SRL +IHRDLKASNILLD++MNPK++DFG+AR+
Sbjct: 427 KQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARI 486
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FG D+ Q NT RIVGT+GYM+PEYA+ G FS+KSDV+SFGVLVLE +S KKN FY TD
Sbjct: 487 FGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDG 546
Query: 181 L-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
L+ HAW LW++G A +L+D I+ ++ + R I++ LLCVQE+ A+RP + +
Sbjct: 547 AHDLVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFM 606
Query: 240 MLTNENVILPSPLQPAF 256
MLT+ V LP PLQP F
Sbjct: 607 MLTSNTVTLPVPLQPGF 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 324 bits (830), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 160/260 (61%), Positives = 199/260 (76%), Gaps = 4/260 (1%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQGL EFKNE +LIAKLQH NLV++ GCCIE EK+LIYEYM NKSLD FLFDP
Sbjct: 526 LSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPL 585
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ +L W +R RI+EG+ QGLLYLH YSRL+VIHRD+KASNILLD +MNPKISDFG+AR+
Sbjct: 586 RKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARI 645
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYN--T 178
FG +E ++NTKR+ GT+GYMSPEY GLFS KSDVFSFGVL+LE + +KN F++
Sbjct: 646 FGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLE 705
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDA-SYPMLNRYINVALLCVQENAADRPTMLEV 237
L L+ H WNL+ + + E++D L++ A YP + R + VALLCVQENA DRP+ML+V
Sbjct: 706 GPLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDV 765
Query: 238 ISMLTNE-NVILPSPLQPAF 256
+SM+ E N L P +PAF
Sbjct: 766 VSMIYGEGNNALSLPKEPAF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 154/258 (59%), Positives = 191/258 (74%), Gaps = 2/258 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQG EEFKNE +L++KLQH+NLVRL G C+E EKIL+YE++PNKSLD FLFDP
Sbjct: 375 LSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPA 434
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G L W R I+ G+A+G+LYLH SRL +IHRDLKASNILLD++MNPKI+DFG+AR+
Sbjct: 435 KQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 494
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FG D+ Q+NT+RI GT+GYMSPEYA+RG FS+KSDV+SFGVLVLE +S KKN+ FYN D
Sbjct: 495 FGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDD 554
Query: 180 -SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238
L+ HAW LW +G EL+D + R I++ALLCVQE+ ADRP + +I
Sbjct: 555 SGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAII 614
Query: 239 SMLTNENVILPSPLQPAF 256
MLT+ L P P F
Sbjct: 615 MMLTSSTTTLHVPRAPGF 632
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 163/295 (55%), Positives = 207/295 (70%), Gaps = 6/295 (2%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS S QG +EF NE+ LIAKLQH NLVRL GCC++ GEK+LIYEY+ N SLD LFD T
Sbjct: 549 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 608
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
++ L W+ R I+ G+A+GLLYLH SR R+IHRDLKASN+LLD NM PKISDFG+AR+
Sbjct: 609 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 668
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVL+LE +S K+N FYN++
Sbjct: 669 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 728
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDAS--YPM--LNRYINVALLCVQENAADRPTML 235
L LLG W W +G E++D I + S +P + R I + LLCVQE A DRP M
Sbjct: 729 DLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMS 788
Query: 236 EVISMLTNENVILPSPLQPAFSHVRIA-ENSSLPANCEVEACTVNCLTLSAMDAR 289
V+ ML +E +P P +P F R E S + + CTVN +TLS +DAR
Sbjct: 789 SVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 160/295 (54%), Positives = 208/295 (70%), Gaps = 6/295 (2%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS S QG +EF NE+ LIAKLQH NLVRL GCC++ GEK+LIYEY+ N SLD LFD T
Sbjct: 553 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 612
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
++ L W+ R I+ G+A+GLLYLH SR R+IHRDLKASN+LLD NM PKISDFG+AR+
Sbjct: 613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVL+LE +S K+N FYN++
Sbjct: 673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
Query: 180 SLTLLGHAWNLWNDGRAWELMDSI----LQNDASYPMLNRYINVALLCVQENAADRPTML 235
L LLG W W +G+ E++D I L ++ + R I + LLCVQE A DRP M
Sbjct: 733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792
Query: 236 EVISMLTNENVILPSPLQPAFSHVRIAENSSLPANCEV-EACTVNCLTLSAMDAR 289
V+ ML +E +P P +P F R + ++ + + CTVN +TLS +DAR
Sbjct: 793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 159/260 (61%), Positives = 197/260 (75%), Gaps = 4/260 (1%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQGL EFKNE MLIAKLQH NLV+L GCC+E EK+LIYEYMPNKSLD FLFDP
Sbjct: 557 LSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPL 616
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ +L W++R RI+EG+ QGLLYLH YSRL+VIHRD+KA NILLD +MNPKISDFG+AR+
Sbjct: 617 RKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARI 676
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FG E ++NTKR+ GT+GYMSPEY GLFS KSDVFSFGVL+LE + +KN F++
Sbjct: 677 FGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSE 736
Query: 181 --LTLLGHAWNLWNDGRAWELMDSILQNDA-SYPMLNRYINVALLCVQENAADRPTMLEV 237
L L+ H WNL+ + R E++D L + A P + R + VALLCVQ+NA DRP+ML+V
Sbjct: 737 GPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDV 796
Query: 238 ISMLTNE-NVILPSPLQPAF 256
+SM+ + N L P +PAF
Sbjct: 797 VSMIYGDGNNALSLPKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 7e-87, Method: Compositional matrix adjust.
Identities = 164/296 (55%), Positives = 213/296 (71%), Gaps = 8/296 (2%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS S QG +EFKNE+ LIA+LQH NLVRL CC++ GEK+LIYEY+ N SLD LFD +
Sbjct: 556 LSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKS 615
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ L W+MR I+ G+A+GLLYLH SR R+IHRDLKASNILLD M PKISDFG+AR+
Sbjct: 616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI 675
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FG DE ++NT+++VGTYGYMSPEYA+ G+FS+KSDVFSFGVL+LE +SSK+N FYN+D
Sbjct: 676 FGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDR 735
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDAS----YPMLNRYINVALLCVQENAADRPTML 235
L LLG W W +G+ E++D I+ + +S + +L R I + LLCVQE A DRPTM
Sbjct: 736 DLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMS 794
Query: 236 EVISMLTNENVILPSPLQPAFSHVR--IAENSSLPANCEVEACTVNCLTLSAMDAR 289
VI ML +E+ +P P P + R + +SS + E+ TVN +T+S +DAR
Sbjct: 795 LVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 289 | ||||||
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.996 | 0.416 | 0.688 | 1e-110 | |
| 224106535 | 333 | predicted protein [Populus trichocarpa] | 0.993 | 0.861 | 0.679 | 1e-109 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.993 | 0.331 | 0.681 | 1e-108 | |
| 224106539 | 846 | predicted protein [Populus trichocarpa] | 0.993 | 0.339 | 0.672 | 1e-108 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.993 | 0.450 | 0.681 | 1e-108 | |
| 302143119 | 547 | unnamed protein product [Vitis vinifera] | 0.993 | 0.524 | 0.671 | 1e-107 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.993 | 0.345 | 0.681 | 1e-106 | |
| 302143120 | 674 | unnamed protein product [Vitis vinifera] | 0.993 | 0.425 | 0.681 | 1e-106 | |
| 359493709 | 894 | PREDICTED: receptor-like serine/threonin | 0.944 | 0.305 | 0.708 | 1e-106 | |
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.889 | 0.129 | 0.731 | 1e-106 |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1035), Expect = e-110, Method: Compositional matrix adjust.
Identities = 199/289 (68%), Positives = 228/289 (78%), Gaps = 1/289 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQGLEE KNE +L+A+LQHRNLVRL GCCIE GEKILIYEYMPNKSLD FLFDP
Sbjct: 405 LSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPN 464
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G L W RV I+EG+AQGLLYLH YSRLR+IHRDLKASNILLD++MNPKISDFG+AR+
Sbjct: 465 KRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARM 524
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E +NT RIVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FYN+D+
Sbjct: 525 FGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDT 584
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L L+G+AW LW A LMD +L+ +S ML RYINV LLCV+E AADRPT+ EV+SM
Sbjct: 585 LNLIGYAWELWKSDMAINLMDPMLEGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVSM 644
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
LTNE +LPSP PAFS VR EN + E + N L++S M+AR
Sbjct: 645 LTNELAVLPSPKHPAFSTVRSMENPR-SSMSRPEIYSANGLSISVMEAR 692
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106535|ref|XP_002333668.1| predicted protein [Populus trichocarpa] gi|222837959|gb|EEE76324.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1030), Expect = e-109, Method: Compositional matrix adjust.
Identities = 197/290 (67%), Positives = 230/290 (79%), Gaps = 3/290 (1%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +SGQGLEEF+NE +LIAKLQHRNLVRL G CIE EK+LIYEYMPNKSLD FLFD
Sbjct: 46 LSERSGQGLEEFRNETILIAKLQHRNLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFDAN 105
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ +L W R+RI+EG+AQGLLYLH YSRLR+IHRDLK SNILLDS MNPKISDFG+AR+
Sbjct: 106 RGQILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARI 165
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E Q+NT RIVGTYGYMSPEYA+ GLFSIKSDVFSFGVLVLE +S KKN FY++ S
Sbjct: 166 FGGNETQANTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSGS 225
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLGHAW LWN +A +LMD IL + S L RYIN+ LLCVQE+ ADRPTM +VISM
Sbjct: 226 LNLLGHAWKLWNSNKALDLMDPILGDPPSTATLLRYINIGLLCVQESPADRPTMSDVISM 285
Query: 241 LTNENVILPSPLQPAFSHVR-IAENSSLPANCEVEACTVNCLTLSAMDAR 289
+ NE+V LP P QPAF R +AE SL + V +VN +T++ +DAR
Sbjct: 286 IVNEHVALPEPKQPAFVAGRNVAEPRSLMSFAGVP--SVNNVTITTIDAR 333
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1022), Expect = e-108, Method: Compositional matrix adjust.
Identities = 197/289 (68%), Positives = 232/289 (80%), Gaps = 2/289 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +SGQG EE KNE+MLIAKLQH+NLV+LFG CIE EKILIYEYMPNKSLD FLFDPT
Sbjct: 579 LSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPT 638
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G+L W+ RV I++GVAQGLLYLH YSRLR+IHRDLKASNILLD +MNP+ISDFG+AR+
Sbjct: 639 KHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI 698
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E ++ T IVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FY TDS
Sbjct: 699 FGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 757
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLG+AW+LW D R ELMD L+ +L RYIN+ LLCVQE+A DRPTM +V+SM
Sbjct: 758 LNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINIGLLCVQESADDRPTMSDVVSM 817
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
L NE+V LPSP QPAFS++R + N + + C++N +TLS M+AR
Sbjct: 818 LGNESVRLPSPKQPAFSNLRSGVEPHISQN-KPKICSLNGVTLSVMEAR 865
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106539|ref|XP_002333669.1| predicted protein [Populus trichocarpa] gi|222837960|gb|EEE76325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1021), Expect = e-108, Method: Compositional matrix adjust.
Identities = 195/290 (67%), Positives = 230/290 (79%), Gaps = 3/290 (1%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +SGQGLEEF+NE LIAKLQHRNLVRL G CIE EK+LIYEYMPNKSLD FLFD
Sbjct: 559 LSERSGQGLEEFRNETTLIAKLQHRNLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFDAN 618
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ +L W R+RI+EG+AQGLLYLH YSRLR+IHRDLK SNILLDS MNPKISDFG+AR+
Sbjct: 619 RGQILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARI 678
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E Q++T RIVGTYGYMSPEYA+ GLFSIKSDVFSFGVLVLE +S KKN FY++D+
Sbjct: 679 FGGNETQAHTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSDT 738
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLGHAW LWN +A +LMD IL + S L RYIN+ LLCVQE+ ADRPTM +VISM
Sbjct: 739 LHLLGHAWKLWNSNKALDLMDPILGDPPSTATLLRYINIGLLCVQESPADRPTMSDVISM 798
Query: 241 LTNENVILPSPLQPAFSHVR-IAENSSLPANCEVEACTVNCLTLSAMDAR 289
+ NE+V LP P QPAF R +AE L ++ V +VN +T++A+D R
Sbjct: 799 IANEHVALPEPKQPAFVACRNMAEQGPLMSSSGVP--SVNNMTITAIDGR 846
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1020), Expect = e-108, Method: Compositional matrix adjust.
Identities = 197/289 (68%), Positives = 232/289 (80%), Gaps = 2/289 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +SGQG EE KNE+MLIAKLQH+NLV+LFG CIE EKILIYEYMPNKSLD FLFDPT
Sbjct: 351 LSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPT 410
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G+L W+ RV I++GVAQGLLYLH YSRLR+IHRDLKASNILLD +MNP+ISDFG+AR+
Sbjct: 411 KHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI 470
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E ++ T IVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FY TDS
Sbjct: 471 FGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 529
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLG+AW+LW D R ELMD L+ +L RYIN+ LLCVQE+A DRPTM +V+SM
Sbjct: 530 LNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINIGLLCVQESADDRPTMSDVVSM 589
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
L NE+V LPSP QPAFS++R + N + + C++N +TLS M+AR
Sbjct: 590 LGNESVRLPSPKQPAFSNLRSGVEPHISQN-KPKICSLNGVTLSVMEAR 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143119|emb|CBI20414.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 393 bits (1010), Expect = e-107, Method: Compositional matrix adjust.
Identities = 194/289 (67%), Positives = 228/289 (78%), Gaps = 2/289 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +SGQG EE KNE MLIAKLQH+NLV+LFGCCIE EKILIYEYMPNKSLD FLFD
Sbjct: 261 LSKRSGQGWEELKNEAMLIAKLQHKNLVKLFGCCIEQDEKILIYEYMPNKSLDFFLFDSA 320
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
G+L WE RV I+EGVAQGLLYLH YSRLR+IHRDLKASNILLD ++NPKISDFG+AR+
Sbjct: 321 NHGILNWETRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDLNPKISDFGMARI 380
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FG +E ++ T IVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FY +DS
Sbjct: 381 FGSNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQSDS 439
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLG+AW+LW D R ELMD +L+ +L +YIN+ LLCVQE+A DRPTM +V+SM
Sbjct: 440 LNLLGYAWDLWKDSRGQELMDPVLEEALPRHILLKYINIGLLCVQESADDRPTMSDVVSM 499
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
L NE++ LPSP QPAFS++R + N E C++N +TLS M+AR
Sbjct: 500 LGNESLHLPSPKQPAFSNLRSGVEPHIFQN-RPEMCSLNSVTLSIMEAR 547
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1006), Expect = e-106, Method: Compositional matrix adjust.
Identities = 197/289 (68%), Positives = 226/289 (78%), Gaps = 2/289 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +S QG EE KNE MLIAKLQH+NLV++ G CIE EKILIYEYM NKSLD FLFDPT
Sbjct: 544 LSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPT 603
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G+L W+ RV I+EGVAQGLLYLH YSRLR+IHRDLKASNILLD +MNPKISDFG+AR+
Sbjct: 604 KHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARI 663
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E + T IVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FY TDS
Sbjct: 664 FGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 722
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLG+AW+LW D R ELMD L+ +L RYINV LLCVQE+A DRPTM +V+SM
Sbjct: 723 LNLLGYAWDLWKDSRGLELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTMSDVVSM 782
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
L NE+V LPSP QPAFS++R + N E C++N +TLS M+AR
Sbjct: 783 LGNESVRLPSPKQPAFSNLRSGVEPHISQN-RPEVCSLNGVTLSVMEAR 830
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1002), Expect = e-106, Method: Compositional matrix adjust.
Identities = 197/289 (68%), Positives = 226/289 (78%), Gaps = 2/289 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +S QG EE KNE MLIAKLQH+NLV++ G CIE EKILIYEYM NKSLD FLFDPT
Sbjct: 388 LSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPT 447
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G+L W+ RV I+EGVAQGLLYLH YSRLR+IHRDLKASNILLD +MNPKISDFG+AR+
Sbjct: 448 KHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARI 507
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E + T IVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FY TDS
Sbjct: 508 FGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 566
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLG+AW+LW D R ELMD L+ +L RYINV LLCVQE+A DRPTM +V+SM
Sbjct: 567 LNLLGYAWDLWKDSRGLELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTMSDVVSM 626
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
L NE+V LPSP QPAFS++R + N E C++N +TLS M+AR
Sbjct: 627 LGNESVRLPSPKQPAFSNLRSGVEPHISQN-RPEVCSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1002), Expect = e-106, Method: Compositional matrix adjust.
Identities = 194/274 (70%), Positives = 221/274 (80%), Gaps = 1/274 (0%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +S QG EE KNE MLIAKLQH+NLV++ G CIE EKILIYEYM NKSLD FLFDP
Sbjct: 548 LSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPA 607
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G+L WE RVRI+EGVAQGLLYLH YSRLRVIHRDLKASNILLD +MNPKISDFG+AR+
Sbjct: 608 KRGILNWETRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARI 667
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E ++ TK IVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FY TDS
Sbjct: 668 FGGNESKA-TKHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 726
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L LLG+AW+LW D R ELMD L+ +L RYINV LLCVQE+A DRPTM +V+SM
Sbjct: 727 LNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTMSDVVSM 786
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEVE 274
L NE+V LPSP QPAFS++R + SL +N ++E
Sbjct: 787 LGNESVRLPSPKQPAFSNLRSGTHKSLSSNPDLE 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 389 bits (999), Expect = e-106, Method: Compositional matrix adjust.
Identities = 188/257 (73%), Positives = 212/257 (82%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQGLEE KNE +L+A+LQHRNLVRL GCCIE GEKILIYEYMPNKSLD FLFDP
Sbjct: 822 LSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPN 881
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G L W RV I+EG+AQGLLYLH YSRLR+IHRDLKASNILLD++MNPKISDFG+AR+
Sbjct: 882 KRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARM 941
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG+E +NT RIVGTYGYMSPEYAL GLFS KSDVFSFGVL+LE LS KKN FYN+D+
Sbjct: 942 FGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDT 1001
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L L+G+AW LW A LMD +L+ +S ML RYINV LLCV+E AADRPT+ EV+SM
Sbjct: 1002 LNLIGYAWELWKSDMAINLMDPMLEGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVSM 1061
Query: 241 LTNENVILPSPLQPAFS 257
LTNE +LPSP PAFS
Sbjct: 1062 LTNELAVLPSPKHPAFS 1078
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 289 | ||||||
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.996 | 0.339 | 0.555 | 2.4e-83 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.899 | 0.306 | 0.596 | 6.4e-83 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 1.0 | 0.34 | 0.564 | 1.3e-82 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 1.0 | 0.342 | 0.552 | 2.5e-81 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 1.0 | 0.341 | 0.552 | 2.5e-81 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.996 | 0.338 | 0.554 | 2.5e-81 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.913 | 0.394 | 0.582 | 3.2e-81 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.885 | 0.382 | 0.596 | 1.2e-79 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.993 | 0.340 | 0.537 | 2.6e-79 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.972 | 0.349 | 0.561 | 1.1e-78 |
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 2.4e-83, P = 2.4e-83
Identities = 161/290 (55%), Positives = 216/290 (74%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L SGQGLEEFKNE++LIAKLQHRNLVRL GCCI EKIL+YEYMPNKSLD FLF+P
Sbjct: 560 LCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPE 619
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K LL W+ R I+EG+A+GLLYLH SRLRV+HRDLKASNILLD++M PKISDFG+AR+
Sbjct: 620 KQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARM 679
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFY-NTD 179
FGGD+ Q NT R+VGT+GYMSPEYA+ G+FS+KSDV+ FGVL+LE ++ K+ F+ + D
Sbjct: 680 FGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHED 739
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
SL + G+AW WN+ A EL+D +++ S + R I++ALLCVQ++A +RP + VI
Sbjct: 740 SLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVIL 799
Query: 240 MLTNENVILPSPLQPAFSHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
ML+N++ LP+P P +R E S ++ + + ++ +T++ + R
Sbjct: 800 MLSNDSSSLPNPRPPTLM-LRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 155/260 (59%), Positives = 205/260 (78%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +SGQG++EFKNE++LIAKLQHRNLVRL GCC E EK+L+YEYMPNKSLD FLFD T
Sbjct: 559 LSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET 618
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K L+ W++R I+EG+A+GLLYLH SRLR+IHRDLK SN+LLD+ MNPKISDFG+AR+
Sbjct: 619 KQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI 678
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FGG++ ++NT R+VGTYGYMSPEYA+ GLFS+KSDV+SFGVL+LE +S K+N +++
Sbjct: 679 FGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH 738
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
+L+G+AW L+ GR+ EL+D ++ S R I+VA+LCVQ++AA+RP M V+ M
Sbjct: 739 GSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLM 798
Query: 241 LTNENVILPSPLQPAFSHVR 260
L ++ L +P QP F+ R
Sbjct: 799 LESDTATLAAPRQPTFTSTR 818
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 828 (296.5 bits), Expect = 1.3e-82, P = 1.3e-82
Identities = 166/294 (56%), Positives = 212/294 (72%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQGL EFKNE MLIAKLQH NLV+L GCC+E EK+LIYEYMPNKSLD FLFDP
Sbjct: 557 LSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPL 616
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ +L W++R RI+EG+ QGLLYLH YSRL+VIHRD+KA NILLD +MNPKISDFG+AR+
Sbjct: 617 RKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARI 676
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FG E ++NTKR+ GT+GYMSPEY GLFS KSDVFSFGVL+LE + +KN F++
Sbjct: 677 FGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSE 736
Query: 181 --LTLLGHAWNLWNDGRAWELMDSILQNDA-SYPMLNRYINVALLCVQENAADRPTMLEV 237
L L+ H WNL+ + R E++D L + A P + R + VALLCVQ+NA DRP+ML+V
Sbjct: 737 GPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDV 796
Query: 238 ISMLTNE-NVILPSPLQPAFSHVRIAENSSLPANC-EVEACTVNCLTLSAMDAR 289
+SM+ + N L P +PAF + + E+E + N +T++ M+AR
Sbjct: 797 VSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 2.5e-81, P = 2.5e-81
Identities = 163/295 (55%), Positives = 207/295 (70%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS S QG +EF NE+ LIAKLQH NLVRL GCC++ GEK+LIYEY+ N SLD LFD T
Sbjct: 549 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 608
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
++ L W+ R I+ G+A+GLLYLH SR R+IHRDLKASN+LLD NM PKISDFG+AR+
Sbjct: 609 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 668
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVL+LE +S K+N FYN++
Sbjct: 669 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 728
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDAS--YPM--LNRYINVALLCVQENAADRPTML 235
L LLG W W +G E++D I + S +P + R I + LLCVQE A DRP M
Sbjct: 729 DLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMS 788
Query: 236 EVISMLTNENVILPSPLQPAFSHVRIA-ENSSLPANCEVEACTVNCLTLSAMDAR 289
V+ ML +E +P P +P F R E S + + CTVN +TLS +DAR
Sbjct: 789 SVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 2.5e-81, P = 2.5e-81
Identities = 163/295 (55%), Positives = 209/295 (70%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS S QG +EF NE+ LIAKLQH NLVRL GCC++ GEK+LIYEY+ N SLD LFD T
Sbjct: 553 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 612
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
++ L W+ R I+ G+A+GLLYLH SR R+IHRDLKASN+LLD NM PKISDFG+AR+
Sbjct: 613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FG +E ++NT+R+VGTYGYMSPEYA+ G+FS+KSDVFSFGVL+LE +S K+N FYN++
Sbjct: 673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDAS--YPM--LNRYINVALLCVQENAADRPTML 235
L LLG W W +G+ E++D I + S +P + R I + LLCVQE A DRP M
Sbjct: 733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792
Query: 236 EVISMLTNENVILPSPLQPAFSHVRIA-ENSSLPANCEVEACTVNCLTLSAMDAR 289
V+ ML +E +P P +P F R + E S + + CTVN +TLS +DAR
Sbjct: 793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 2.5e-81, P = 2.5e-81
Identities = 164/296 (55%), Positives = 213/296 (71%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS S QG +EFKNE+ LIA+LQH NLVRL CC++ GEK+LIYEY+ N SLD LFD +
Sbjct: 556 LSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKS 615
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ L W+MR I+ G+A+GLLYLH SR R+IHRDLKASNILLD M PKISDFG+AR+
Sbjct: 616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI 675
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD- 179
FG DE ++NT+++VGTYGYMSPEYA+ G+FS+KSDVFSFGVL+LE +SSK+N FYN+D
Sbjct: 676 FGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDR 735
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDAS----YPMLNRYINVALLCVQENAADRPTML 235
L LLG W W +G+ E++D I+ + +S + +L R I + LLCVQE A DRPTM
Sbjct: 736 DLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMS 794
Query: 236 EVISMLTNENVILPSPLQPAFSHVR--IAENSSLPANCEVEACTVNCLTLSAMDAR 289
VI ML +E+ +P P P + R + +SS + E+ TVN +T+S +DAR
Sbjct: 795 LVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 3.2e-81, P = 3.2e-81
Identities = 155/266 (58%), Positives = 201/266 (75%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQG EFKNE++L+AKLQHRNLVRL G C++ E++L+YEY+PNKSLD FLFDP
Sbjct: 378 LSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPA 437
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G L W R +I+ GVA+G+LYLH SRL +IHRDLKASNILLD++MNPKI+DFG+AR+
Sbjct: 438 KKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 497
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FG D+ + NT RIVGTYGYMSPEYA+ G +S+KSDV+SFGVLVLE +S KKN+ FY TD
Sbjct: 498 FGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDG 557
Query: 181 L-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
L+ +AW LW++GR EL+D + + + R +++ LLCVQE+ A+RPT+ ++
Sbjct: 558 AHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVL 617
Query: 240 MLTNENVILPSPLQPA-FSHVRIAEN 264
MLT+ V LP P QP F RI ++
Sbjct: 618 MLTSNTVTLPVPRQPGLFFQSRIGKD 643
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 154/258 (59%), Positives = 191/258 (74%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS SGQG EEFKNE +L++KLQH+NLVRL G C+E EKIL+YE++PNKSLD FLFDP
Sbjct: 375 LSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPA 434
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G L W R I+ G+A+G+LYLH SRL +IHRDLKASNILLD++MNPKI+DFG+AR+
Sbjct: 435 KQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 494
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
FG D+ Q+NT+RI GT+GYMSPEYA+RG FS+KSDV+SFGVLVLE +S KKN+ FYN D
Sbjct: 495 FGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDD 554
Query: 181 L--TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238
L+ HAW LW +G EL+D + R I++ALLCVQE+ ADRP + +I
Sbjct: 555 SGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAII 614
Query: 239 SMLTNENVILPSPLQPAF 256
MLT+ L P P F
Sbjct: 615 MMLTSSTTTLHVPRAPGF 632
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 2.6e-79, P = 2.6e-79
Identities = 156/290 (53%), Positives = 207/290 (71%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS +S QGLEEFKNE++LIAKLQHRNLVRL GCCIE EK+L+YEYMPNKSLD FLFD +
Sbjct: 555 LSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDES 614
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K G L W R ++ G+A+GLLYLH SRL++IHRDLKASNILLD+ MNPKISDFG+AR+
Sbjct: 615 KQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARI 674
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
F + +NT R+VGTYGYM+PEYA+ G+FS KSDV+SFGVL+LE +S +KN F TD
Sbjct: 675 FNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDH 734
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
+L+G+AW+LW+ G+ E++D I+++ R I+V +LC Q++ RP M V+ M
Sbjct: 735 GSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLM 794
Query: 241 LTNENVILPSPLQPAFSHVRIAENSSLPANCEV-EACTVNCLTLSAMDAR 289
L ++ LP P QP F H + + N + + +VN +T + + R
Sbjct: 795 LESQTSQLPPPRQPTF-H-SFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
Identities = 164/292 (56%), Positives = 210/292 (71%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LSS SGQG EEF NE++LI+KLQHRNLVR+ GCCIE EK+LIYE+M NKSLD FLFD
Sbjct: 521 LSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSR 580
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K + W R I++G+A+GLLYLHH SRLRVIHRDLK SNILLD MNPKISDFG+AR+
Sbjct: 581 KRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARM 640
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF-YNTD 179
+ G E Q NT+R+VGT GYMSPEYA G+FS KSD++SFGVL+LE +S +K + F Y +
Sbjct: 641 YQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVE 700
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPM-LNRYINVALLCVQENAADRPTMLEVI 238
TL+ +AW W++ R +L+D L D+ +P+ + R I + LLCVQ ADRP LE++
Sbjct: 701 GKTLIAYAWESWSEYRGIDLLDQDLA-DSCHPLEVGRCIQIGLLCVQHQPADRPNTLELL 759
Query: 239 SMLTNENVILPSPLQPAFS-HVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
+MLT + LPSP QP F+ H R ++ SL +N + TVN +T S + R
Sbjct: 760 AMLTTTSD-LPSPKQPTFAFHTR--DDESL-SN---DLITVNGMTQSVILGR 804
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 289 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 73/249 (29%), Positives = 106/249 (42%), Gaps = 37/249 (14%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
S Q +EEF E ++ KL H N+V+L G C E +++ EYMP L +L
Sbjct: 38 EDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP 97
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-L 120
L + +A+G+ YL IHRDL A N L+ N+ KISDFG++R L
Sbjct: 98 KE-LSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-------SKKNA 173
+ D + ++ +M+PE G F+ KSDV+SFGVL+ E + NA
Sbjct: 154 YDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA 211
Query: 174 HFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ-NDASYPMLNRYINVALLCVQENAADRP 232
L R + Y + L C E+ DRP
Sbjct: 212 EVLE-----------YLKKGYR----LPKPPNCPPELY-------KLMLQCWAEDPEDRP 249
Query: 233 TMLEVISML 241
T E++ +L
Sbjct: 250 TFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 72/249 (28%), Positives = 105/249 (42%), Gaps = 38/249 (15%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
S Q +EEF E ++ KL H N+V+L G C E ++ EYM L +L
Sbjct: 38 EDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP 97
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-L 120
L + +A+G+ YL IHRDL A N L+ N+ KISDFG++R L
Sbjct: 98 K--LSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 152
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-------SKKNA 173
+ D + ++ +M+PE G F+ KSDV+SFGVL+ E + N
Sbjct: 153 YDDDYYRKRGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 210
Query: 174 HFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ-NDASYPMLNRYINVALLCVQENAADRP 232
L N R + Y ++ L C E+ DRP
Sbjct: 211 EVLE-----------YLKNGYR----LPQPPNCPPELY-------DLMLQCWAEDPEDRP 248
Query: 233 TMLEVISML 241
T E++ +L
Sbjct: 249 TFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 7e-43
Identities = 65/165 (39%), Positives = 92/165 (55%), Gaps = 9/165 (5%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
S LEE E+ ++ KL H N+V+L+G + L+ EY SL L +
Sbjct: 29 EDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK 88
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLF 121
L + +RIL + +GL YLH +IHRDLK NILLDS N K++DFG+++L
Sbjct: 89 --LSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143
Query: 122 GGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLE 165
D+ T IVGT YM+PE L +G +S KSD++S GV++ E
Sbjct: 144 TSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 71/247 (28%), Positives = 112/247 (45%), Gaps = 39/247 (15%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL------FDPTKTG 63
++F E ++ KL H N+VRL G C E L+ EYM L +L F +
Sbjct: 41 KDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFG 122
L + + +A+G+ YL + +HRDL A N L+ ++ KISDFG++R ++
Sbjct: 101 TLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
D + T + +M+PE G+F+ KSDV+SFGVL+ E +
Sbjct: 158 DDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFT-------------- 202
Query: 183 LLGHA--WNLWNDGRAWELMDSI-----LQNDASYPMLNRYINVALLCVQENAADRPTML 235
LG L N+ E+++ + L P + + L C Q + DRPT
Sbjct: 203 -LGATPYPGLSNE----EVLEYLRKGYRLPKPEYCP--DELYELMLSCWQLDPEDRPTFS 255
Query: 236 EVISMLT 242
E++ L
Sbjct: 256 ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 57/165 (34%), Positives = 86/165 (52%), Gaps = 7/165 (4%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
S + EEF E ++ KL H N+VRL G C + ++ EYMP L FL
Sbjct: 41 SEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEK 98
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFGG 123
L + +++ +A+G+ YL +HRDL A N L+ N+ KISDFG++R ++
Sbjct: 99 LTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
D + + +M+PE G F+ KSDV+SFGVL+ E +
Sbjct: 156 DYYRKRGGGKL-PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 30/231 (12%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
E+ ++ +L H N+VRL + L+ EY L +L ++ G L + +I
Sbjct: 47 REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKI 103
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
+ +GL YLH +IHRDLK NILLD N KI+DFG+A+ S+
Sbjct: 104 ALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTF 158
Query: 134 VGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWN 192
VGT YM+PE L G + K DV+S GV++ E L+ F + L L
Sbjct: 159 VGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT--GKPPFSGENILDQL-------- 208
Query: 193 DGRAWELMDSILQNDASYPMLNRYINVALL------CVQENAADRPTMLEV 237
+L+ IL + C+ ++ + RPT E+
Sbjct: 209 -----QLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 52/157 (33%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E E+ ++ KL+H N+VRL+ + + L+ EY L L K G L +
Sbjct: 41 RERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSED 97
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
L + L YLH ++HRDLK NILLD + + K++DFG+AR E
Sbjct: 98 EARFYLRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK-- 152
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
VGT YM+PE L + D++S GV++ E
Sbjct: 153 -LTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-32
Identities = 60/177 (33%), Positives = 92/177 (51%), Gaps = 18/177 (10%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK-ILIY-EYMPNKSLDCFLFD 58
LS S + LE + E+ +++ LQH N+VR +G + + + I+ EY+ SL L
Sbjct: 35 LSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL-- 92
Query: 59 PTKTGLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKIS 113
K G L E +R ILEG L YLH ++HRD+K +NIL+DS+ K++
Sbjct: 93 -KKFGKLP-EPVIRKYTRQILEG----LAYLH---SNGIVHRDIKGANILVDSDGVVKLA 143
Query: 114 DFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
DFG A+ G E T + GT +M+PE + +D++S G V+E + K
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
E+ + + +V+ +G + GE ++ EYM SL L K G + + I
Sbjct: 48 RELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYI 104
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
+ +GL YLH + +IHRD+K SN+L++S KI+DFGI+++ Q NT
Sbjct: 105 ARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--F 160
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND 193
VGT YMSPE +S +D++S G+ +LE K +
Sbjct: 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK---------------FPFLPPGQ 205
Query: 194 GRAWELMDSI-------LQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
+ELM +I L + P +I+ C+Q++ RP+ E++
Sbjct: 206 PSFFELMQAICDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 63/159 (39%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFLFDPTKTGLLGWE 68
E F E ++ KL+H LV+L+ C E E I I EYM SL FL L
Sbjct: 46 EAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LP 103
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-- 126
V + +A+G+ YL IHRDL A NIL+ N+ KI+DFG+ARL DE
Sbjct: 104 QLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ K + + +PE A G F+IKSDV+SFG+L+ E
Sbjct: 161 REGAKFPI---KWTAPEAANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 73/239 (30%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
++F E ++ KL H NLV+L+G C + ++ EYM N L +L + G LG E
Sbjct: 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEW 101
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ + V + + YL IHRDL A N L+ + K+SDFG+AR D+ S+
Sbjct: 102 LLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158
Query: 130 TKRIVGT---YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGH 186
GT + PE FS KSDV+SFGVL+ E S K + ++S
Sbjct: 159 Q----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------ 208
Query: 187 AWNLWNDGRAWELMDSILQNDASY-PML--NRYINVALLCVQENAADRPTMLEVISMLT 242
E+++S+ Y P L + C E DRP +++S LT
Sbjct: 209 -----------EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI--LIYEYMPNKSLDCFLFDPT 60
S Q +F+ E+ ++ L H N+V+ G C + G + LI EY+P+ SL +L
Sbjct: 44 SGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QR 101
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ + + + +G+ YL R IHRDL A NIL++S KISDFG+A++
Sbjct: 102 HRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
Query: 121 F--GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
D + Y +PE FS SDV+SFGV + E +
Sbjct: 159 LPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-26
Identities = 60/168 (35%), Positives = 90/168 (53%), Gaps = 6/168 (3%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L S ++F+ E+ + +L+H++L+ LF C +I E M SL FL P
Sbjct: 38 LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+L + + VA+G+ YL IHRDL A NIL+ ++ K++DFG+ARL
Sbjct: 98 GQ-VLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
D S+ K+I Y + +PE A G FS KSDV+SFG+L+ E +
Sbjct: 154 IKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 70/249 (28%), Positives = 119/249 (47%), Gaps = 37/249 (14%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS+ S + E+ NE+ ++ KL H N+++ + E G+ ++ EY L +
Sbjct: 35 LSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK 94
Query: 61 KTGLLGWEMRVRILEGVAQ---GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI 117
K G E + IL+ Q L YLH SR +++HRD+K NI L SN K+ DFGI
Sbjct: 95 KEGKPFPEEQ--ILDWFVQLCLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGI 149
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYN 177
+++ + T +VGT Y+SPE ++ KSD++S G ++ E
Sbjct: 150 SKVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYE------------ 195
Query: 178 TDSLTLLGHAWNLWNDGRAW-ELMDSILQNDASYPML-NRY----INVALLCVQENAADR 231
L L H + +G EL IL+ YP + ++Y N+ +Q++ +R
Sbjct: 196 ---LCTLKHPF----EGENLLELALKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEER 246
Query: 232 PTMLEVISM 240
P++ +++
Sbjct: 247 PSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-----------FD 58
++F+ E L+ QH N+V+ +G C E I+++EYM + L+ FL
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
+ G L ++I +A G++YL + +HRDL N L+ ++ KI DFG++
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
Query: 119 RLFGGDELQSNTKRIVGT----YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAH 174
R D ++ R+ G +M PE + F+ +SDV+SFGV++ E + K
Sbjct: 170 R----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
Query: 175 F 175
+
Sbjct: 226 Y 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL---FDPTKTGLLGWEMRV 71
E+ ++ K +V +G +G+ + EYM SLD L +LG
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG----- 103
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTK 131
+I V +GL YLH + ++IHRD+K SNIL++S K+ DFG++ G + S K
Sbjct: 104 KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAK 157
Query: 132 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLW 191
VGT YM+PE +S+KSD++S G+ ++E L +
Sbjct: 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE---------------LATGRFPYPPE 202
Query: 192 NDGRA--WELMDSILQ-------NDASYPMLNRYINVALLCVQENAADRPT 233
ND +EL+ I+ + P ++N LC+ ++ +RP+
Sbjct: 203 NDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-25
Identities = 60/165 (36%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+F E ++ KL H LV+L+G C E L++E+M + L +L + G E
Sbjct: 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQET 101
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ + V +G+ YL + VIHRDL A N L+ N K+SDFG+ R D+ S+
Sbjct: 102 LLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158
Query: 130 TKRIVGT---YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171
T GT + SPE +S KSDV+SFGVL+ E S K
Sbjct: 159 T----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (253), Expect = 8e-25
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 17/241 (7%)
Query: 9 LEEFKNEMMLIAKLQH-RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGW 67
+E F E+ ++A L H N+V+L+ + G L+ EY+ SL+ L + G L
Sbjct: 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE 100
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMN-PKISDFGIARLFGGD-- 124
+ IL + L YLH +IHRD+K NILLD + K+ DFG+A+L
Sbjct: 101 SEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
Query: 125 --ELQSNTKRIVGTYGYMSPEYALRGLF---SIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
+ + VGT GYM+PE L S SD++S G+ + E L+ F
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP--PFEGEK 215
Query: 180 SLTLLGHAW-NLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238
+ + + + S L + ++ + ++ +R + +
Sbjct: 216 NSSATSQTLKIILELPT--PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 239 S 239
S
Sbjct: 274 S 274
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 1e-24
Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
L+ E+ L+ L+H N+V+ G +I EY N SL + K G
Sbjct: 43 LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPES 99
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ + V QGL YLH VIHRD+KA+NIL + K++DFG+A
Sbjct: 100 LVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ +VGT +M+PE S SD++S G V+E L+
Sbjct: 157 AS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 24/183 (13%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF----- 57
+ + +EF+ E L++ LQH N+V L G C + +++EY+ + L FL
Sbjct: 46 NAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPH 105
Query: 58 ---------DPTKTGLLGWEMRVRILEGVAQGLLYL--HHYSRLRVIHRDLKASNILLDS 106
+ K+ L + + I +A G+ YL HH+ +HRDL A N L+
Sbjct: 106 SDVGAESGDETVKSSLDCSDF-LHIAIQIAAGMEYLSSHHF-----VHRDLAARNCLVGE 159
Query: 107 NMNPKISDFGIARL-FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ KISDFG++R + D + +K ++ +M PE L G F+ +SD++SFGV++ E
Sbjct: 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWE 218
Query: 166 TLS 168
S
Sbjct: 219 IFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 5e-24
Identities = 51/173 (29%), Positives = 92/173 (53%), Gaps = 16/173 (9%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDP 59
S + +E +E ++A + H ++VRL G C+ ++ LI + MP L ++ +
Sbjct: 45 REETSPKANKEILDEAYVMASVDHPHVVRLLGICL--SSQVQLITQLMPLGCLLDYVRNH 102
Query: 60 TKT----GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDF 115
LL W +++ A+G+ YL R++HRDL A N+L+ + + KI+DF
Sbjct: 103 KDNIGSQYLLNWCVQI------AKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDF 153
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
G+A+L DE + + + +M+ E L +++ KSDV+S+GV V E ++
Sbjct: 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL----DCFLFDPTK 61
Q E NE++++ +H N+V + + E ++ EYM SL +
Sbjct: 56 KQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE 115
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
+ V QGL YLH VIHRD+K+ NILL + + K++DFG A
Sbjct: 116 ------PQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ +S +VGT +M+PE R + K D++S G++ +E
Sbjct: 167 T--KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 20/158 (12%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLD------CFLFDPTKTGLLGW 67
NE+ ++ K +H N+V+ +G ++ E ++ E+ SL ++
Sbjct: 46 NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY--- 102
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
+ + + +GL YLH +IHRD+KA+NILL S+ K+ DFG++
Sbjct: 103 -----VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDT 151
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+VGT +M+PE + K+D++S G+ +E
Sbjct: 152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-23
Identities = 56/162 (34%), Positives = 82/162 (50%), Gaps = 17/162 (10%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFLFDPTKTGLLGWE 68
++F E ++ KL+H L++L+ C E I I E M SL +L L
Sbjct: 46 KDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTELMKYGSLLEYLQG-GAGRALKLP 103
Query: 69 MRVRILEGVAQGLLYL--HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
+ + VA G+ YL +Y IHRDL A N+L+ N K++DFG+AR+ D
Sbjct: 104 QLIDMAAQVASGMAYLEAQNY-----IHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158
Query: 127 QSNTKRIVGT---YGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
++ G + +PE AL FSIKSDV+SFG+L+ E
Sbjct: 159 EARE----GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-22
Identities = 72/238 (30%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+F E ++ KL H LV+L+G C + ++ E+M N L +L + G L +M
Sbjct: 44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDM 101
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ + + V +G+ YL R IHRDL A N L+ S K+SDFG+ R DE S+
Sbjct: 102 LLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158
Query: 130 T--KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHA 187
+ K V + PE +S KSDV+SFGVL+ E + K F +
Sbjct: 159 SGAKFPV---KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP-FEKKSNY------ 208
Query: 188 WNLWNDGRAWELMDSILQNDASY-PML--NRYINVALLCVQENAADRPTMLEVISMLT 242
E+++ I + Y P L V C E RPT E++ +T
Sbjct: 209 ----------EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-22
Identities = 57/168 (33%), Positives = 89/168 (52%), Gaps = 14/168 (8%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP----TKTGLLG 66
EF E L++ H N+V+L G C+ + + +I E M L +L D LL
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT 104
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL-----DSNMNPKISDFGIAR-L 120
+ + I VA+G +YL ++ IHRDL A N L+ D++ KI DFG+AR +
Sbjct: 105 LKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ D + + ++ +M+PE L G F+ +SDV+SFGVL+ E L+
Sbjct: 162 YKSDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 54/154 (35%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 15 EMMLIAKLQHRNLVRLFGCCI-EHGEKILI-YEYMPNKSLDCFLFD-PTKTGLLGWEMRV 71
E+ + + +V+ +G + E I I EY SLD + G +G ++
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTK 131
+I E V +GL YLH SR ++IHRD+K SNILL K+ DFG++ G+ + S
Sbjct: 109 KIAESVLKGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAG 161
Query: 132 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
GT YM+PE +SI SDV+S G+ +LE
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-22
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 27 LVRLFGCCIEHGEKILIYEYMPNKSLDCFL--FDPTKTGLLGWEMRVRILEGVAQGLLYL 84
+V +G + + E+M SLD P +LG +I V +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144
Y+ R++HRD+K SNIL++S K+ DFG++ G+ + S VGT YMSPE
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173
Query: 145 ALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSIL 204
G +++KSDV+S G+ ++E K F N D L +L+ I+
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-------DLLQQIV 226
Query: 205 QNDASY-------PMLNRYINVALLCVQENAADRPT 233
Q L +++ C+ ++ +RPT
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-22
Identities = 72/243 (29%), Positives = 122/243 (50%), Gaps = 40/243 (16%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
++F +E ++ + H N++RL G + ++I EYM N +LD +L D G
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQ 108
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
V +L G+A G+ YL S + +HRDL A NIL++SN+ K+SDFG++R+ D +
Sbjct: 109 LVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165
Query: 130 TKRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
T T G + +PE F+ SDV+SFG+++ E +S + +
Sbjct: 166 T-----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY--------- 211
Query: 184 LGHAWNLWNDGRAWELMDSILQNDA---SYPM--LNRYINVALLCVQENAADRPTMLEVI 238
W++ N E+M +I ND PM + + L C Q++ A RP ++++
Sbjct: 212 ----WDMSNH----EVMKAI--NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
Query: 239 SML 241
++L
Sbjct: 262 NLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-22
Identities = 57/160 (35%), Positives = 87/160 (54%), Gaps = 9/160 (5%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70
+F E ++ + H N++RL G + ++I EYM N SLD FL + G
Sbjct: 51 DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQL 108
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
V +L G+A G+ YL S + +HRDL A NIL++SN+ K+SDFG++R E T
Sbjct: 109 VGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
Query: 131 K--RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
K +I + +PE F+ SDV+SFG+++ E +S
Sbjct: 166 KGGKI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 8e-22
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 44/208 (21%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEMRV 71
E +++++ H +V+L + EK+ L+ EY P L L
Sbjct: 41 LTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL-----------SKEG 88
Query: 72 RILEGVAQ--------GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
R E A+ L YLH L +I+RDLK NILLD++ + K++DFG+A+
Sbjct: 89 RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
+ ++NT GT Y++PE L + D +S GVL+ E L+ K FY D
Sbjct: 146 EGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK--PPFYAEDRK-- 199
Query: 184 LGHAWNLWNDGRAWELMDSILQNDASYP 211
E+ + IL++ +P
Sbjct: 200 --------------EIYEKILKDPLRFP 213
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-22
Identities = 67/248 (27%), Positives = 116/248 (46%), Gaps = 36/248 (14%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
SS+ + +E + E+ L+A+L H +++R+ G E L E+M S+ L +K
Sbjct: 40 SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SK 96
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN-MNPKISDFGIA-- 118
G + + E + +GL YLH ++IHRD+K +N+L+DS +I+DFG A
Sbjct: 97 YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153
Query: 119 ---RLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAH 174
+ G E Q +++GT +M+PE LRG + DV+S G +++E ++K
Sbjct: 154 LAAKGTGAGEFQG---QLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAKP--- 206
Query: 175 FYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPM---LNRYI-NVALLCVQENAAD 230
WN L+ I + + L+ + +V L C++ D
Sbjct: 207 ------------PWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPED 254
Query: 231 RPTMLEVI 238
RP E++
Sbjct: 255 RPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 39/248 (15%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFLFDP 59
S ++ + + + E+ L+ LQH +V+ +GC + E + I+ EYMP S+ D
Sbjct: 40 DSPETKKEVNALECEIQLLKNLQHERIVQYYGC-LRDDETLSIFMEYMPGGSVK----DQ 94
Query: 60 TKT-GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
K G L + + + +G+ YLH ++HRD+K +NIL DS N K+ DFG +
Sbjct: 95 LKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 151
Query: 119 -RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYN 177
RL + K + GT +MSPE + K+DV+S G V+E L+ K
Sbjct: 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP----- 206
Query: 178 TDSLTLLGHAWNLWNDGRAWELMDSILQ--NDASYPMLNRYINVAL-----LCVQENAAD 230
W + +E M +I + + P L +++ ENA
Sbjct: 207 -------------WAE---FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKK 250
Query: 231 RPTMLEVI 238
RP+ E++
Sbjct: 251 RPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-21
Identities = 54/168 (32%), Positives = 88/168 (52%), Gaps = 12/168 (7%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
LS + + EE +E ++AKL ++R + ++ G+ ++ EY N L L
Sbjct: 35 LSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR 94
Query: 61 KTGL---LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI 117
L W ++IL GL +LH +++HRD+K+ N+ LD+ N KI D G+
Sbjct: 95 GRPLPEDQVWRFFIQIL----LGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGV 147
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
A+L + +NT IVGT Y+SPE ++ KSDV++ GV++ E
Sbjct: 148 AKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-21
Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 30/241 (12%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFL--FD 58
+ +++ + E+ L++KLQH N+V+ G E + + I+ E +P SL L +
Sbjct: 39 GQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYIFLELVPGGSLAKLLKKYG 97
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
++ R +IL G+ YLH R +HRD+K +NIL+D+N K++DFG+A
Sbjct: 98 SFPEPVIRLYTR-QILLGLE----YLH--DR-NTVHRDIKGANILVDTNGVVKLADFGMA 149
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSSKKNAHFYN 177
+ S K G+ +M+PE + G + + +D++S G VLE + K
Sbjct: 150 KQV---VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS--- 203
Query: 178 TDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237
L + + + + D L ++A + L C+Q + + RPT E+
Sbjct: 204 --QLEGVAAVFKIGRSKELPPIPDH-LSDEAK--------DFILKCLQRDPSLRPTAAEL 252
Query: 238 I 238
+
Sbjct: 253 L 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-21
Identities = 62/164 (37%), Positives = 92/164 (56%), Gaps = 13/164 (7%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E F E ++ KL+H LV+L+ E E I ++ EYM SL FL L
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLP 102
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
V + +A G+ Y+ R+ +HRDL+A+NIL+ N+ K++DFG+ARL +E
Sbjct: 103 QLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157
Query: 129 NTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
T R + + +PE AL G F+IKSDV+SFG+L+ E L++K
Sbjct: 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE-LTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-21
Identities = 60/162 (37%), Positives = 90/162 (55%), Gaps = 12/162 (7%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFLFDPTKTGLLGWE 68
E F E L+ +LQH LVRL+ + E I I EYM N SL FL P L +
Sbjct: 46 EAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPEGIKLTINK 103
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-- 126
+ + + +A+G+ ++ R IHRDL+A+NIL+ + KI+DFG+ARL +E
Sbjct: 104 L-IDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ K + + +PE G F+IKSDV+SFG+L+ E ++
Sbjct: 160 REGAKFPI---KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-21
Identities = 72/238 (30%), Positives = 114/238 (47%), Gaps = 36/238 (15%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+EF E ++ KL H LV+L+G C + ++ EYM N L +L + ++
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL----REHGKRFQP 99
Query: 70 RVRILE---GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
++LE V +G+ YL + IHRDL A N L+D K+SDFG++R DE
Sbjct: 100 -SQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155
Query: 127 QSNTKRIVGT---YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAH--FYNTDSL 181
S+ VG+ + PE L FS KSDV++FGVL+ E S K + F N++++
Sbjct: 156 TSS----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211
Query: 182 TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
+ L+ A E + +I+ + C E A +RPT +++S
Sbjct: 212 EKVSQGLRLYRPHLASEKVYAIMYS----------------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-21
Identities = 69/246 (28%), Positives = 116/246 (47%), Gaps = 48/246 (19%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70
+F +E ++ + H N++ L G + +++ EYM N SLD FL G
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQL 108
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
V +L G+A G+ YL S + +HRDL A NIL++SN+ K+SDFG++R+ D + T
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 131 KRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLL 184
R G + +PE F+ SDV+S+G+++ E +S + +
Sbjct: 166 TR-----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---------- 210
Query: 185 GHAWNLWNDGRAWELMDSILQNDASY----PM-----LNRYINVALLCVQENAADRPTML 235
W + N D I + Y PM L++ + L C Q++ +RP
Sbjct: 211 ---WEMSNQ-------DVIKAIEEGYRLPAPMDCPAALHQLM---LDCWQKDRNERPKFE 257
Query: 236 EVISML 241
+++S+L
Sbjct: 258 QIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-21
Identities = 57/176 (32%), Positives = 87/176 (49%), Gaps = 14/176 (7%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD--- 58
S S Q +F E ++++K H+N+VRL G E + ++ E M L FL +
Sbjct: 46 ESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRP 105
Query: 59 -PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP----KIS 113
P + L + + VA+G YL IHRD+ A N LL P KI+
Sbjct: 106 RPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIA 161
Query: 114 DFGIAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
DFG+AR ++ + + ++ +M PE L G+F+ K+DV+SFGVL+ E S
Sbjct: 162 DFGMARDIYRASYYRKGGRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-21
Identities = 62/162 (38%), Positives = 91/162 (56%), Gaps = 12/162 (7%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E F E ++ KL+H LV+L+ E E I ++ EYM SL FL D L
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKDGEGRALKLPN 103
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ V + VA G+ Y+ R+ IHRDL+++NIL+ + KI+DFG+ARL +E
Sbjct: 104 L-VDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157
Query: 129 NTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
T R + + +PE AL G F+IKSDV+SFG+L+ E ++
Sbjct: 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 27/243 (11%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL------FDPTKT 62
EF+ E+ + KL H+N+VRL G C E +I EY L FL + K
Sbjct: 52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP 111
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
L + +V + +A G+ +L S R +HRDL A N L+ S K+S +++
Sbjct: 112 PPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
E ++ +++PE FS KSDV+SFGVL+ E + + + +D
Sbjct: 169 NSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDAS--YPMLNRYINVALLCVQENAADRPTMLEVISM 240
L N +A +L + + S Y ++ R C N DRP+ E++S
Sbjct: 228 L--------NRLQAGKLELPVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSA 272
Query: 241 LTN 243
L
Sbjct: 273 LGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-20
Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-----T 60
+ F E ++ L+H NLV+L G ++ ++ EYM SL +L T
Sbjct: 41 STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT 100
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
LG+ + V +G+ YL +HRDL A N+L+ ++ K+SDFG+A+
Sbjct: 101 LAQQLGFALDV------CEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK- 150
Query: 121 FGGDELQSNTKRIVGTY--GYMSPEYALR-GLFSIKSDVFSFGVLVLETLS 168
+++ + G + +PE ALR FS KSDV+SFG+L+ E S
Sbjct: 151 ------EASQGQDSGKLPVKWTAPE-ALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-20
Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 32/247 (12%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
G +EF E ++A+L H +VRL G C +L+ E P L +L +
Sbjct: 34 EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREI 92
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL-- 120
+ +++ + VA G+ YL +HRDL A N+LL + KISDFG++R
Sbjct: 93 PVS--DLKELAHQ-VAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG 146
Query: 121 FGGDELQSNT--KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS--SKKNAHFY 176
G D ++ T + + Y +PE G FS KSDV+S+GV + E S +K
Sbjct: 147 AGSDYYRATTAGRWPLKWY---APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203
Query: 177 NTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236
+ + +L L R E I Y ++ C + DRPT E
Sbjct: 204 GAEVIAMLESGERL---PRPEECPQEI------YSIMLS-------CWKYRPEDRPTFSE 247
Query: 237 VISMLTN 243
+ S
Sbjct: 248 LESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-20
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 28/193 (14%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF------------ 57
++F+ E L+ LQH ++V+ +G C + I+++EYM + L+ FL
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 58 DPTKT-GLLGWEMRVRILEGVAQGLLYL--HHYSRLRVIHRDLKASNILLDSNMNPKISD 114
P + G LG + I +A G++YL H+ +HRDL N L+ +N+ KI D
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGD 166
Query: 115 FGIARLFGGDELQSNTKRIVG----TYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
FG++R D ++ R+ G +M PE + F+ +SDV+SFGV++ E +
Sbjct: 167 FGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222
Query: 171 KNAHFYNTDSLTL 183
K F +++ +
Sbjct: 223 KQPWFQLSNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-20
Identities = 53/166 (31%), Positives = 90/166 (54%), Gaps = 10/166 (6%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
L+ E+ L+ +LQH N+V+ G ++ + EY+P S+ L G
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEET 106
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ + + +GL YLH +R +IHRD+K +NIL+D+ KISDFGI++ + L +
Sbjct: 107 LVRNFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST 163
Query: 129 --NTKR--IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
N R + G+ +M+PE + ++ K+D++S G LV+E L+ K
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 9e-20
Identities = 58/177 (32%), Positives = 83/177 (46%), Gaps = 13/177 (7%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCI-EHGEKILIY-EYMPNKSLDCFLFDPTKTGL-LGWEMR 70
+E+ ++ +L+H N+VR + I + + I EY L + K + E
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 71 VRILEGVAQGLLYLHH-----YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
RIL Q LL L+ V+HRDLK +NI LD+N N K+ DFG+A++ G D
Sbjct: 108 WRIL---TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD- 163
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
S K VGT YMSPE + KSD++S G L+ E + N L
Sbjct: 164 -SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL---FDPTKTGL 64
E+F E+ ++++L N+ RL G C +I EYM N L+ FL T
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 65 LG-----WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
+ + + +A G+ YL L +HRDL N L+ N KI+DFG++R
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 120 -LFGGD--ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
L+ D +Q R +M+ E L G F+ KSDV++FGV + E L+
Sbjct: 179 NLYSSDYYRVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 72/244 (29%), Positives = 117/244 (47%), Gaps = 25/244 (10%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL--FDPTKTGL---- 64
+F E+ ++++L+ N++RL CI +I EYM N L+ FL +P +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 65 --LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LF 121
+ + + + +A G+ YL S L +HRDL N L+ N KI+DFG++R L+
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 122 GGD--ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNT 178
GD +Q R V +MS E L G F+ SDV++FGV + E L+ K+ + +
Sbjct: 182 SGDYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238
D + + GR L L D+ Y ++ L C + NA +RP+ E+
Sbjct: 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM-------LSCWRRNAKERPSFQEIH 291
Query: 239 SMLT 242
+ L
Sbjct: 292 ATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 32/170 (18%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ KL+H N+VRL G+ +++EYM + D TGLL
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH---DL-------TGLL---DSPE 94
Query: 73 ILEGVAQ----------GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ +Q GL YLH ++HRD+K SNIL++++ K++DFG+AR +
Sbjct: 95 VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT 151
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLVLETLSSK 170
T R++ T Y PE L G + + D++S G ++ E K
Sbjct: 152 KRNSADYTNRVI-TLWYRPPELLL-GATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-19
Identities = 63/168 (37%), Positives = 92/168 (54%), Gaps = 18/168 (10%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTG---LL 65
E F E ++ KL+H LV L+ E E I ++ E+M SL FL K G L
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFMGKGSLLDFL----KEGDGKYL 99
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
V + +A G+ Y+ R+ IHRDL+A+NIL+ N+ KI+DFG+ARL +E
Sbjct: 100 KLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
Query: 126 LQSNTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171
T R + + +PE AL G F+IKSDV+SFG+L+ E ++ +
Sbjct: 157 Y---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-19
Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+EEF E ++ +++H NLV+L G C +I E+M +L +L + + +
Sbjct: 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAV 104
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-- 126
+ + + ++ + YL + IHRDL A N L+ N K++DFG++RL GD
Sbjct: 105 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ K + + +PE FSIKSDV++FGVL+ E
Sbjct: 162 HAGAKFPI---KWTAPESLAYNKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 68/237 (28%), Positives = 114/237 (48%), Gaps = 27/237 (11%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
++ F E L+ LQH LVRL+ + +I EYM SL FL + G +
Sbjct: 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLP 103
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ +A+G+ Y+ R IHRDL+A+N+L+ ++ KI+DFG+AR+ +E
Sbjct: 104 KLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-- 158
Query: 129 NTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAH--FYNTDSLTLL 184
T R + + +PE G F+IKSDV+SFG+L+ E ++ K + N+D ++ L
Sbjct: 159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
Query: 185 GHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241
+ + + + I++ C +E A +RPT + S+L
Sbjct: 218 QRGYRMPRMENCPDELYDIMK----------------TCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-19
Identities = 74/244 (30%), Positives = 112/244 (45%), Gaps = 41/244 (16%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
QS + ++ E+ + +L+H N + GC + L+ EY + D + + K
Sbjct: 54 QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKP 111
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L E+ I G QGL YLH + R IHRD+KA NILL K++DFG A
Sbjct: 112 LQEVEIAA-ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA----- 162
Query: 124 DELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
L S VGT +M+PE L G + K DV+S G+ +E L+ +K F N ++
Sbjct: 163 -SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-NMNA 219
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNR------YINVALLCVQENAADRPTM 234
++ L H I QND+ P L+ + N C+Q+ DRP+
Sbjct: 220 MSALYH----------------IAQNDS--PTLSSNDWSDYFRNFVDSCLQKIPQDRPSS 261
Query: 235 LEVI 238
E++
Sbjct: 262 EELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-19
Identities = 53/167 (31%), Positives = 88/167 (52%), Gaps = 8/167 (4%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
+ ++E + E+ +++ H N+V+ + + E L+ Y+ SL +
Sbjct: 37 EKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR 96
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI-ARLF 121
G L + +L+ V +GL YLH + IHRD+KA NILL + + KI+DFG+ A L
Sbjct: 97 GGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLA 153
Query: 122 -GGDELQSNTKRIVGTYGYMSPE--YALRGLFSIKSDVFSFGVLVLE 165
GGD + K VGT +M+PE + G + K+D++SFG+ +E
Sbjct: 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-19
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 21/178 (11%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFDP 59
S ++ + + + E+ L+ LQH +V+ +GC + EK L EYMP S+ D
Sbjct: 41 SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQ 96
Query: 60 TKT-GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
K G L + + + +G+ YLH ++HRD+K +NIL DS N K+ DFG +
Sbjct: 97 LKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 153
Query: 119 RLFGGDELQ------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ LQ + + + GT +MSPE + K+DV+S G V+E L+ K
Sbjct: 154 K-----RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 73/240 (30%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDPTKTGLLG- 66
+++F E ++ L H NL+RL+G + H ++ E P SL D L L
Sbjct: 40 MDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDR-LRKDALGHFLIS 97
Query: 67 --WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFG 122
+ V+I A G+ YL S+ R IHRDL A NILL S+ KI DFG+ R
Sbjct: 98 TLCDYAVQI----ANGMRYLE--SK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
D V + + +PE +LR FS SDV+ FGV + E + Y +
Sbjct: 151 EDHYVMEEHLKV-PFAWCAPE-SLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPW 201
Query: 182 TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241
L + L + E ++ + +A NV L C N ADRPT + L
Sbjct: 202 AGLSGSQILKKIDKEGERLE---RPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-19
Identities = 59/177 (33%), Positives = 90/177 (50%), Gaps = 26/177 (14%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF------------ 57
EEFK+E M+ ++LQH N+V L G + +I+ Y + L FL
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 58 -DPTKTGLLGWEMRVRILEGVAQGLLYL--HHYSRLRVIHRDLKASNILLDSNMNPKISD 114
D T L V I+ +A G+ +L HH V+H+DL N+L+ +N KISD
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISD 167
Query: 115 FGIAR-LFGGD--ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
G+ R ++ D +L N+ + +MSPE + G FSI SD++S+GV++ E S
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-19
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 1 LSSQSGQGLEE-FKNEMMLIAKLQHRNLVRLFGCCIEHGEKI--LIYEYMPNKSLDCFLF 57
L + GQ +K E+ ++ L H N+V+ GCC E G K LI EY+P SL +L
Sbjct: 41 LKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL- 99
Query: 58 DPTKTGLLGWEMRVRILEGVAQGLLYLH--HYSRLRVIHRDLKASNILLDSNMNPKISDF 115
P L + + + +G+ YLH HY IHRDL A N+LLD++ KI DF
Sbjct: 100 -PKHK--LNLAQLLLFAQQICEGMAYLHSQHY-----IHRDLAARNVLLDNDRLVKIGDF 151
Query: 116 GIARLF-GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAH 174
G+A+ G E + + + E FS SDV+SFGV + E L+ +
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
Query: 175 FYNTDSLTLLGHAWNLWNDGRAWELMD 201
++G R EL++
Sbjct: 212 SPPKKFEEMIGPKQGQMTVVRLIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL---------FDPT 60
++F+ E L+ LQH+++VR +G C E ++++EYM + L+ FL
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 61 K---TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI 117
+ G L + I +A G++YL + L +HRDL N L+ + KI DFG+
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGM 168
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFY- 176
+R + R + +M PE L F+ +SD++SFGV++ E + K +
Sbjct: 169 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
Query: 177 -NTDSL 181
NT+++
Sbjct: 229 SNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 8/161 (4%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70
+F +E ++ + H N++ L G + ++I E+M N +LD FL G
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQL 108
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
V +L G+A G+ YL S + +HRDL A NIL++SN+ K+SDFG++R D
Sbjct: 109 VGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 131 KRIVG---TYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+G + +PE F+ SDV+S+G+++ E +S
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 55/172 (31%), Positives = 93/172 (54%), Gaps = 22/172 (12%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL-IY-EYMPNKSLDCFLFDPTKTGLLG 66
++ ++E+ + L H N+V+ G E E+ L I+ EY+P S+ L +
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFE--- 106
Query: 67 WEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR----LF 121
E VR E V +GL YLH ++HRDLKA N+L+D++ KISDFGI++ ++
Sbjct: 107 -EQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162
Query: 122 GGDELQSNTKRIVGTYGYMSPE--YALRGLFSIKSDVFSFGVLVLETLSSKK 171
D+ S + G+ +M+PE ++ +S K D++S G +VLE + ++
Sbjct: 163 DNDQNMS----MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 54/166 (32%), Positives = 84/166 (50%), Gaps = 19/166 (11%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+F E ++ + H N+V+L G C++ ++ E +P SL FL +
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK------KNRL 90
Query: 70 RVRILEGV----AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD- 124
V+ L + A G+ YL S+ IHRDL A N L+ N KISDFG++R G
Sbjct: 91 TVKKLLQMSLDAAAGMEYLE--SK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147
Query: 125 -ELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLS 168
+ K+I + +PE AL G ++ +SDV+S+G+L+ ET S
Sbjct: 148 YTVSDGLKQI--PIKWTAPE-ALNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 51/158 (32%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70
EF +E +++A + H +LVRL G C+ + L+ + MP+ L ++ + +G ++
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLL 111
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
+ +A+G++YL R++HRDL A N+L+ S + KI+DFG+ARL GDE + N
Sbjct: 112 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
Query: 131 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+M+ E F+ +SDV+S+GV + E ++
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 7/157 (4%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
L+E E+ ++ + +V+ +G ++ + ++ EY S+ + T L E
Sbjct: 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEE 100
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ IL +GL YLH + IHRD+KA NILL+ K++DFG++ +
Sbjct: 101 IAA-ILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
NT ++GT +M+PE ++ K+D++S G+ +E
Sbjct: 157 NT--VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-18
Identities = 55/172 (31%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
+NE ++ L H N++ + +E +++ EY P +L ++ + LL +
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDT--- 102
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGGDELQSNTK 131
IL Q LL LHH ++HRDLK NILLD + M KI DFGI+++ +S
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAY 159
Query: 132 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
+VGT Y+SPE ++ KSD+++ G ++ E S K+ N +L L
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-18
Identities = 59/187 (31%), Positives = 94/187 (50%), Gaps = 35/187 (18%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIY-EYMPNKSLDCFLFDPTKTGLLG 66
++E +EM ++ L+H NLV+ +G +E H EK+ I+ EY +L+ L + G +
Sbjct: 43 IKEIADEMKVLELLKHPNLVKYYG--VEVHREKVYIFMEYCSGGTLEELL----EHGRIL 96
Query: 67 WEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
E +R +LEG+A YLH + ++HRD+K +NI LD N K+ DFG A
Sbjct: 97 DEHVIRVYTLQLLEGLA----YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK- 148
Query: 122 GGDELQSNTKRI-------VGTYGYMSPEYALRGLFSIK---SDVFSFGVLVLETLSSKK 171
L++NT + GT YM+PE G +D++S G +VLE + K+
Sbjct: 149 ----LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
Query: 172 NAHFYNT 178
+
Sbjct: 205 PWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-18
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 25/184 (13%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFL-- 56
L + + L +F+ E+ ++ LQH N+V+ G C G + L+ EY+P SL +L
Sbjct: 41 LQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK 100
Query: 57 ----FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKI 112
D K L + + +G+ YL R +HRDL NIL++S KI
Sbjct: 101 HRERLDHRKLLLYASQ--------ICKGMEYL---GSKRYVHRDLATRNILVESENRVKI 149
Query: 113 SDFGIARLFGGDELQSNTKRIVG---TYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS- 168
DFG+ ++ D+ + R G + Y +PE FS+ SDV+SFGV++ E +
Sbjct: 150 GDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY 207
Query: 169 SKKN 172
S K+
Sbjct: 208 SDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-18
Identities = 54/173 (31%), Positives = 88/173 (50%), Gaps = 15/173 (8%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
S+ Q L E E+ L + L+HRN+V+ G E+G + E +P SL L +K
Sbjct: 46 SRYVQPLHE---EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKW 100
Query: 63 GLLGWEMRVRILEG--VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFGIAR 119
G L + I + +GL YLH +++HRD+K N+L+++ KISDFG ++
Sbjct: 101 GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157
Query: 120 LFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVLETLSSK 170
G + T+ GT YM+PE +G + +D++S G ++E + K
Sbjct: 158 RLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-18
Identities = 56/151 (37%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E L++KL H +V+ +E +I EY + LDC L + TG E +V
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV--C 109
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
E Q LL +H+ + R++HRDLKA NI L +N+ KI DFG++RL G + T
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FT 166
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
GT YMSPE + KSD++S G ++ E
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 21/185 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L S ++F E L+ LQH ++V+ +G C+E I+++EYM + L+ FL
Sbjct: 43 LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 102
Query: 61 KTGLLGWE----------MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP 110
+L E + I + +A G++YL + +HRDL N L+ N+
Sbjct: 103 PDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLV 159
Query: 111 KISDFGIARLFGGDELQSNTKRIVG----TYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166
KI DFG++R D ++ R+ G +M PE + F+ +SDV+S GV++ E
Sbjct: 160 KIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
Query: 167 LSSKK 171
+ K
Sbjct: 216 FTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 11/173 (6%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFDP 59
S ++ + + + E+ L+ L+H +V+ +GC + EK L EYMP S+ D
Sbjct: 41 SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQ 96
Query: 60 TKT-GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
K G L + R + QG+ YLH ++HRD+K +NIL DS N K+ DFG +
Sbjct: 97 LKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 153
Query: 119 RLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ + + K + GT +MSPE + K+DV+S V+E L+ K
Sbjct: 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-17
Identities = 57/159 (35%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+ F E ++ KL H+NLVRL G + +G I++ E M +L FL + L+
Sbjct: 44 QAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRA-LVSVIQ 101
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
++ VA+G+ YL +++HRDL A NIL+ + K+SDFG+AR+ G N
Sbjct: 102 LLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDN 156
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+K V + +PE FS KSDV+S+GVL+ E S
Sbjct: 157 SKLPV---KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 24/184 (13%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
S +F+ E L+A+ H N+V+L G C L++EYM L+ FL +
Sbjct: 48 SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQ 107
Query: 65 -------------------LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD 105
L ++ I + VA G+ YL S + +HRDL N L+
Sbjct: 108 CSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVG 164
Query: 106 SNMNPKISDFGIAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164
NM KI+DFG++R ++ D +++ + +M PE ++ +SDV+++GV++
Sbjct: 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLW 223
Query: 165 ETLS 168
E S
Sbjct: 224 EIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 55/175 (31%), Positives = 88/175 (50%), Gaps = 21/175 (12%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF-----LFDPTKTGLL 65
+F E+ ++++L+ N++RL G C++ +I EYM N L+ F L D + G
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 66 G-----------WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
+ + + +A G+ YL S L +HRDL N L+ N+ KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 115 FGIAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
FG++R L+ GD + R V +M+ E L G F+ SDV++FGV + E L
Sbjct: 182 FGMSRNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-17
Identities = 62/245 (25%), Positives = 116/245 (47%), Gaps = 29/245 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L+ S + + NE+++++ LQH N++ + ++ ++ EY +L +
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR-Q 93
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K L EM + L + + Y+H ++HRD+K NI L K+ DFGI+++
Sbjct: 94 KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
G + + T +VGT YMSPE ++ KSD+++ G ++ E L+ K+ F T+
Sbjct: 151 LGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT--FDATNP 206
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVALLCVQENAADRPTMLE 236
L L+ I+Q + + P+++ Y I++ +Q++ RPT E
Sbjct: 207 L----------------NLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADE 249
Query: 237 VISML 241
V+
Sbjct: 250 VLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 18/172 (10%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK------ILIYEYMPNKSLDCFLFDPTKT 62
+EEF +E + H N+++L G C E ++I +M + L FL
Sbjct: 45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG 104
Query: 63 GL---LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
GL L + ++ + +A G+ YL S IHRDL A N +L +M ++DFG+++
Sbjct: 105 GLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
Query: 120 -LFGGDELQSN--TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++ GD + K V +++ E +++ KSDV++FGV + E +
Sbjct: 162 KIYSGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-17
Identities = 49/169 (28%), Positives = 89/169 (52%), Gaps = 16/169 (9%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+S + LE+F E+ ++++ +H N+V L+ + ++ E+ +LD + + G
Sbjct: 41 ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERG 99
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L ++R + + + L +LH +VIHRDLKA NILL + + K++DFG++
Sbjct: 100 LTEPQIRY-VCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NK 154
Query: 124 DELQSNTKR--IVGTYGYMSPEYALRGLFS-----IKSDVFSFGVLVLE 165
LQ KR +GT +M+PE F K+D++S G+ ++E
Sbjct: 155 STLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-17
Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+ F E ++ +L+H NLV+L G +E G ++ EYM SL +L ++ +LG +
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGD 102
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
++ V + + YL + +HRDL A N+L+ + K+SDFG+ + Q
Sbjct: 103 CLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD 157
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
K V + +PE FS KSDV+SFG+L+ E S
Sbjct: 158 TGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-17
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 22/234 (9%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP------TKTGL 64
+F E+ ++++L++ N++RL G C+ +I EYM N L+ FL T
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 65 LGWEMRVRILEGVAQ---GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-L 120
+ +L Q G+ YL + L +HRDL N L+ ++ KI+DFG++R L
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTD 179
+ GD + R V +M+ E L G F+ SDV++FGV + E + K+ + +D
Sbjct: 180 YSGDYYRIQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT 233
+ N GR L + L + ++ R C + DRPT
Sbjct: 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR-------CWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 37/242 (15%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
QS + ++ E+ + +++H N + GC + L+ EY + D L + K
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKP 121
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L E+ I G QGL YLH ++ +IHRD+KA NILL K++DFG A
Sbjct: 122 LQEVEIAA-ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA----- 172
Query: 124 DELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
+ S VGT +M+PE L G + K DV+S G+ +E +++ +N ++
Sbjct: 173 -SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNA 229
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDA----SYPMLNRYINVALLCVQENAADRPTMLE 236
++ L H I QN++ S + + N C+Q+ DRPT E
Sbjct: 230 MSALYH----------------IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEE 273
Query: 237 VI 238
++
Sbjct: 274 LL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 47/157 (29%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+E+ + E+ ++++ + R +G ++ + +I EY+ S D K G L
Sbjct: 46 IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEET 101
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
IL + +GL YLH R IHRD+KA+N+LL + K++DFG+A +++
Sbjct: 102 YIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
NT VGT +M+PE + + K+D++S G+ +E
Sbjct: 159 NT--FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 26/167 (15%)
Query: 23 QHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81
H +++L+ + E + + EY PN L ++ K G L + + L
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLAL 115
Query: 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL--------------- 126
YLH +IHRDLK NILLD +M+ KI+DFG A++ +
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 127 ---QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ VGT Y+SPE SD+++ G ++ + L+ K
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFL------FDP 59
Q +E + M+ + L H +VRL G C G + L+ + P SL + DP
Sbjct: 51 QTFQEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDP 108
Query: 60 TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
+ LL W +++ A+G+ YL + R++HR+L A NILL S+ +I+DFG+A
Sbjct: 109 QR--LLNWCVQI------AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157
Query: 120 LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
L D+ + +M+ E L G ++ +SDV+S+GV V E +S
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 69/242 (28%), Positives = 109/242 (45%), Gaps = 37/242 (15%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
Q+ + ++ E+ + +L+H N + GC ++ L+ EY + D L + K
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKP 117
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L E+ I G QGL YLH ++ IHRD+KA NILL K++DFG A
Sbjct: 118 LQEVEIAA-ITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSA----- 168
Query: 124 DELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
S VGT +M+PE L G + K DV+S G+ +E L+ +K F N ++
Sbjct: 169 -SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-NMNA 225
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYIN----VALLCVQENAADRPTMLE 236
++ L H I QND+ N + + C+Q+ +RP E
Sbjct: 226 MSALYH----------------IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAE 269
Query: 237 VI 238
++
Sbjct: 270 LL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 37/237 (15%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
QS + ++ E+ + KL+H N ++ GC + L+ EY + D L + K
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKP 111
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L E+ + G QGL YLH ++ +IHRD+KA NILL K+ DFG A +
Sbjct: 112 LQEVEIAA-VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM-- 165
Query: 124 DELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
+ VGT +M+PE L G + K DV+S G+ +E +++ +N ++
Sbjct: 166 ----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNA 219
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNR----YINVALLCVQENAADRPT 233
++ L H I QN++ + N C+Q+ DRPT
Sbjct: 220 MSALYH----------------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E +E+ +++ L H N+V L G C G ++I EY L FL ++ L +
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--- 125
+ + VA+G+ +L + IHRDL A N+LL KI DFG+AR D
Sbjct: 143 L-LSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++ N + V +M+PE +++ +SDV+S+G+L+ E S
Sbjct: 199 VKGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+E+ + E+ +++ + + + +G ++ + +I EY S D K G L
Sbjct: 43 IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDET 98
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
IL V GL YLH IHRD+KA+NILL + K++DFG++ +L S
Sbjct: 99 YIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTS 150
Query: 129 NTKR---IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ VGT +M+PE + + K+D++S G+ +E
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEMRV 71
E ++++ Q +V+L+ + + + L+ EY+P L L G L ++
Sbjct: 41 LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVAR 96
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN-- 129
+ + L YLH +IHRDLK NIL+DSN + K++DFG+++ G Q N
Sbjct: 97 IYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLN 152
Query: 130 -----TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
KRIVGT Y++PE L S D +S G ++ E L
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK-ILIYEYMPNKSLDCFLFDP-----TKTGLLGWE 68
E L+ L H+N++ + CIE GE ++Y YM +L FL L +
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFGGDE-- 125
V + +A G+ YLH + VIH+D+ A N ++D + KI+D ++R LF D
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
L N R V +M+ E + +S SDV+SFGVL+ E
Sbjct: 175 LGDNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 11/173 (6%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFDP 59
S ++ + + + E+ L+ L H +V+ +GC + E+ L E+MP S+ D
Sbjct: 41 SPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQ 96
Query: 60 TKT-GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
K+ G L + + + +G+ YLH ++HRD+K +NIL DS N K+ DFG +
Sbjct: 97 LKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGAS 153
Query: 119 RLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ L + K + GT +MSPE + K+D++S G V+E L+ K
Sbjct: 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 52/175 (29%), Positives = 90/175 (51%), Gaps = 30/175 (17%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK------ILIYEYMPNKSL---------- 52
+E+F +E + + + H N++RL G C++ E ++I +M + L
Sbjct: 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG 103
Query: 53 DCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKI 112
DC + PT +M V+ + +A G+ YL S IHRDL A N +L+ NMN +
Sbjct: 104 DCPQYLPT-------QMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCV 153
Query: 113 SDFGIA-RLFGGDELQSNTKRIVGT-YGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+DFG++ +++ GD + RI +++ E +++ KSDV+SFGV + E
Sbjct: 154 ADFGLSKKIYNGDYYRQG--RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 17/163 (10%)
Query: 9 LEEFKNEMMLIAKLQH---RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLL 65
+ + + E+ L+++L+ N+ + +G ++ +I EY S+ + K G +
Sbjct: 43 VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPI 98
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
+ I+ V L Y+H VIHRD+KA+NIL+ + N K+ DFG+A L
Sbjct: 99 AEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN--- 152
Query: 126 LQSNTKRI--VGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165
Q+++KR VGT +M+PE G + K+D++S G+ + E
Sbjct: 153 -QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 30/241 (12%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF----DPTKTGLLG 66
EF NE ++ + ++VRL G +++ E M L +L + LG
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114
Query: 67 WEMRVRILEGVAQ---GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFG 122
+ ++ A+ G+ YL + +HRDL A N ++ ++ KI DFG+ R ++
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE--TLSSKKNAHFYNTDS 180
D + K ++ +M+PE G+F+ KSDV+SFGV++ E TL+ + N +
Sbjct: 172 TDYYRKGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L + DG +L ++ +L + +C Q N RPT LE++S
Sbjct: 231 LKFVI-------DGGHLDLPEN-----CPDKLL----ELMRMCWQYNPKMRPTFLEIVSS 274
Query: 241 L 241
L
Sbjct: 275 L 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 53/167 (31%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L S S + E+ NE+ ++A + H N++ ++ + ++ EY P L +
Sbjct: 35 LGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRK 94
Query: 61 KTG-LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
K L+ + RI + +GL LH +++HRDLK++NILL +N KI D GI++
Sbjct: 95 KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISK 151
Query: 120 LFGGDELQSN-TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ L+ N K +GT YM+PE +S KSD++S G L+ E
Sbjct: 152 V-----LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-16
Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 9/139 (6%)
Query: 27 LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86
+V +G GE + E+M SLD L K G + + +I V +GL YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLR- 116
Query: 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL 146
+ +++HRD+K SNIL++S K+ DFG++ G + S VGT YMSPE
Sbjct: 117 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 171
Query: 147 RGLFSIKSDVFSFGVLVLE 165
++++SD++S G+ ++E
Sbjct: 172 GTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 28/183 (15%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG----- 63
L + +E L+ ++ H ++++L+G C + G +LI EY SL FL + K G
Sbjct: 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLG 106
Query: 64 ----------------LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107
L + +++G+ YL + ++++HRDL A N+L+
Sbjct: 107 SDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEG 163
Query: 108 MNPKISDFGIARLFGGDELQSNTKRIVG--TYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
KISDFG++R ++ S KR G +M+ E +++ +SDV+SFGVL+ E
Sbjct: 164 RKMKISDFGLSRDVYEED--SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 221
Query: 166 TLS 168
++
Sbjct: 222 IVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ GL +LH + R+++RDLK N+LLD + N +ISD G+A G K GT
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
GYM+PE ++ D F+ G + E ++ +
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 47/171 (27%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLD-------CFLFDPTKTGLLGW 67
E+ ++ + H N+V+ +GE ++ E+M SL+ FL D +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR------ 175
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
+IL G+A YLH R ++HRD+K SN+L++S N KI+DFG++R+
Sbjct: 176 ----QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 128 SNTKRIVGTYGYMSPE-------------YALRGLFSIKSDVFSFGVLVLE 165
N+ VGT YMSPE YA D++S GV +LE
Sbjct: 225 CNSS--VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 21 KLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80
KLQH N+V+L G C LI+EY+ K+L L + L WE R +I G+A+
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792
Query: 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYM 140
L +LH V+ +L I++D P + RL L ++TK + + Y+
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYV 845
Query: 141 SPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELM 200
+PE + KSD++ FG++++E L+ K A +++ A ++D +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905
Query: 201 DSILQNDASYPM--LNRYINVALLCVQENAADRPTMLEVISML 241
D ++ D S + +N+AL C + RP +V+ L
Sbjct: 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 52/166 (31%), Positives = 88/166 (53%), Gaps = 8/166 (4%)
Query: 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTG 63
G + + K E+ ++ L H N+V+ G C E G LI E++P+ SL +L P
Sbjct: 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN 104
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
+ + +++ + +G+ YL SR + +HRDL A N+L++S KI DFG+ +
Sbjct: 105 KINLKQQLKYAVQICKGMDYLG--SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161
Query: 124 DELQSNTKRIVGT-YGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
D+ K + + + +PE ++ F I SDV+SFGV + E L+
Sbjct: 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 57/178 (32%), Positives = 90/178 (50%), Gaps = 17/178 (9%)
Query: 5 SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL------- 56
+ + L + +EM L+ + +H+N++ L G C + G +I EY +L FL
Sbjct: 57 TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 57 ----FDPTKT--GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP 110
FD TK L ++ V VA+G+ YL SR R IHRDL A N+L+ +
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVM 173
Query: 111 KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
KI+DFG+AR + T +M+PE +++ +SDV+SFG+L+ E +
Sbjct: 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (184), Expect = 2e-15
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 25/165 (15%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFL------FDPTKTGLLG 66
E+ L+ +L+H N+V+L + H E+ L++EY + L +L P +
Sbjct: 48 EISLLKELKHPNIVKLL--DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIM 104
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
++ +L G+A Y H S R++HRDLK NIL++ + K++DFG+AR F G L
Sbjct: 105 YQ----LLRGLA----YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPL 152
Query: 127 QSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLETLSSK 170
++ T +V T Y +PE L S D++S G + E ++ K
Sbjct: 153 RTYTHEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 24/174 (13%)
Query: 11 EFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-------FDPT-- 60
+F E+ ++ KL H N++ L G C G + EY P +L FL DP
Sbjct: 48 DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107
Query: 61 ----KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG 116
L + ++ VA G+ YL S + IHRDL A N+L+ N+ KI+DFG
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG 164
Query: 117 IARLFGGDELQSNTKRIVGTYG--YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++R G+E+ K+ +G +M+ E +++ KSDV+SFGVL+ E +S
Sbjct: 165 LSR---GEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL---FDPTKTGLLGWEMRV 71
E+ L+ +LQH N+V L ++ LI+E+ L L D G V
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELV 103
Query: 72 R-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
+ L + QG+L+ H RV+HRDLK N+L+D+ K++DFG+AR F G ++ T
Sbjct: 104 KSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYT 159
Query: 131 KRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSSK 170
+V T Y +PE L +S D++S G + E + K
Sbjct: 160 HEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 30/240 (12%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGW 67
+E F E ++ LQH LV+L + E I +I E+M SL FL +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSLLDFL-KSDEGSKQPL 101
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
+ +A+G+ ++ + IHRDL+A+NIL+ +++ KI+DFG+AR+ +E
Sbjct: 102 PKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157
Query: 128 SNTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAH--FYNTDSLTL 183
T R + + +PE G F+IKSDV+SFG+L++E ++ + + N + +
Sbjct: 158 --TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215
Query: 184 LGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243
L + + + P N+ + C + +RPT + S+L +
Sbjct: 216 LERGYR--------------MPRPENCP--EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 25/152 (16%)
Query: 26 NLVRLFGCCIEHGEKILIYEYMPNKSLDCF---LFDPTKT---GLLGWEMRVRILEGVAQ 79
V +G G+ + E M + SLD F ++D T +LG +I + +
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVK 114
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI-VGTYG 138
L YLH S+L VIHRD+K SN+L++ N K+ DFGI+ G + S K I G
Sbjct: 115 ALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKP 168
Query: 139 YMSPE-----YALRGLFSIKSDVFSFGVLVLE 165
YM+PE +G + +KSDV+S G+ ++E
Sbjct: 169 YMAPERINPELNQKG-YDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-15
Identities = 37/95 (38%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L YLH +IHRD+K NILLD + I+DF IA D T GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171
GYM+PE R +S+ D +S GV E L K+
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-15
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
NE++++ QH N+V ++ + E ++ E++ +L D + E +
Sbjct: 65 NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATV 120
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKR- 132
V + L +LH VIHRD+K+ +ILL S+ K+SDFG F + +R
Sbjct: 121 CLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRK 173
Query: 133 -IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+VGT +M+PE R + + D++S G++V+E
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-15
Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 21/169 (12%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-------DCFLFDPTKT 62
E K E++L+AK++H N+V F E+G ++ EY L LF +
Sbjct: 44 EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ- 102
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLF 121
+L W ++ ++ GL ++H +++HRD+K+ NI L N M K+ DFGIAR
Sbjct: 103 -ILSWFVQ------ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ T VGT Y+SPE ++ K+D++S G ++ E + K
Sbjct: 153 NDSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-15
Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFD----PTK 61
+ +E+F E +++ H N++ L G C+ G +++ YM + L F+ PT
Sbjct: 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV 97
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
L+G+ ++V A+G+ YL + + +HRDL A N +LD + K++DFG+AR
Sbjct: 98 KDLIGFGLQV------AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148
Query: 122 GGDELQS--NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
E S N +M+ E F+ KSDV+SFGVL+ E ++
Sbjct: 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 37/93 (39%), Positives = 56/93 (60%)
Query: 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYG 138
Q LL +HH +IHRD+K++NILL SN K+ DFG ++++ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 139 YMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171
Y++PE R +S K+D+FS GVL+ E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-15
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 11 EFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-------FDPT-- 60
+F E+ ++ KL H N++ L G C G L EY P+ +L FL DP
Sbjct: 41 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100
Query: 61 ----KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG 116
L + + VA+G+ YL S+ + IHRDL A NIL+ N KI+DFG
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 157
Query: 117 IARLFGGDELQSNTKRIVGTYG--YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++R G E+ K+ +G +M+ E +++ SDV+S+GVL+ E +S
Sbjct: 158 LSR---GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-15
Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70
+F +E ++ + H N+V+L G C + ++ E +P FL K L +
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQL 95
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF-GGDELQSN 129
V+ A G+ YL + IHRDL A N L+ N KISDFG++R G S
Sbjct: 96 VKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
K+I + +PE G +S +SDV+S+G+L+ ET S
Sbjct: 153 LKQI--PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-15
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
Q E NE++++ QH+N+V ++ + E ++ E++ +L D L
Sbjct: 60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLN 115
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
E + E V Q L YLH VIHRD+K+ +ILL + K+SDFG D
Sbjct: 116 EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-- 170
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
K +VGT +M+PE R + + D++S G++V+E
Sbjct: 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 21/180 (11%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF------- 57
+ Q EF+ E L+A+L H N+V L G + +++EY+ L FL
Sbjct: 47 NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSD 106
Query: 58 -------DPTKTGLLGWEMRVRILEGVAQGLLYL-HHYSRLRVIHRDLKASNILLDSNMN 109
D T L + I +A G+ YL H+ +H+DL A NIL+ ++
Sbjct: 107 VGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF----FVHKDLAARNILIGEQLH 162
Query: 110 PKISDFGIAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
KISD G++R ++ D + K ++ +M PE + G FS SD++SFGV++ E S
Sbjct: 163 VKISDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 15 EMM-LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
EMM +I K H+N++ L G C + G ++ EY + +L FL G R
Sbjct: 67 EMMKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 74 LEG-------------VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
E VA+G+ +L + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ T +M+PE +++ +SDV+SFGVL+ E +
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 53/157 (33%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFL---FDPTKTGLLGWEM 69
E+ L+ +L H N+VRL + H E L++E+ LD L D + L +
Sbjct: 48 EISLLKELNHPNIVRLLD--VVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPL 100
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
L + QG+ Y H S RV+HRDLK N+L+D K++DFG+AR F G +++
Sbjct: 101 IKSYLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTY 156
Query: 130 TKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165
T +V T Y +PE L +S D++S G + E
Sbjct: 157 THEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 14/167 (8%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL--FDPTKTGLLGW 67
E+ + E+ L+ L+H N+V+ G C++ + E++P S+ L F P +
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK 106
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR---LFGGD 124
+ +IL+GVA YLH+ V+HRD+K +N++L N K+ DFG AR G
Sbjct: 107 YTK-QILDGVA----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 125 ELQSNT-KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
SN K + GT +M+PE + KSD++S G V E + K
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 12/159 (7%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ +L H N+V+L + H E L++E++ ++ L F+ D + + +
Sbjct: 49 EISLLKELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKS 104
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKR 132
L + QGL + H + RV+HRDLK N+L+++ K++DFG+AR F G +++ T
Sbjct: 105 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHE 160
Query: 133 IVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSSK 170
+V T Y +PE L +S D++S G + E ++ +
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 12 FKNEMMLIAKLQHRNLVRLF--GCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
F+ E L A+L H N+V L G G ++EY+P ++L L G L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL---AADGALPAGE 80
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGG--- 123
R++ V L H ++HRDLK NI++ + K+ DFGI L G
Sbjct: 81 TGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 124 -DELQ-SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSSK 170
D + T ++GT Y +PE LRG + SD++++G++ LE L+ +
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 48/176 (27%), Positives = 89/176 (50%), Gaps = 15/176 (8%)
Query: 2 SSQSGQGLEEFKNEMML--IAKLQHRNLVRLFGCCI-----EHGEKILIYEYMPNKSLDC 54
+ + G L + +L + +H N+VRLF C + L++E++ ++ L
Sbjct: 39 TGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTT 97
Query: 55 FLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
+L + G+ ++ + + + +GL +LH + RV+HRDLK NIL+ S+ K++D
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153
Query: 115 FGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
FG+AR++ Q +V T Y +PE L+ ++ D++S G + E K
Sbjct: 154 FGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ ++ + +V +G GE + E+M SLD L K G + ++ ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 109
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
V +GL YL + +++HRD+K SNIL++S K+ DFG++ G + S V
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
GT YMSPE +S++SD++S G+ ++E
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 43/121 (35%), Positives = 64/121 (52%), Gaps = 14/121 (11%)
Query: 45 EYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL 104
E+M SLD + P +LG RI V +GL YL L+++HRD+K SN+L+
Sbjct: 79 EFMDGGSLDVYRKIPEH--VLG-----RIAVAVVKGLTYLW---SLKILHRDVKPSNMLV 128
Query: 105 DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164
++ K+ DFG++ + S K VGT YM+PE + I SDV+S G+ +
Sbjct: 129 NTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 165 E 165
E
Sbjct: 185 E 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 25/166 (15%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMP---NKSLDC---FLFDPTKTGLLG 66
E+ L+ ++QH N+VRL + H EK L++EY+ K +D F +P
Sbjct: 51 EISLLKEMQHGNIVRLQD--VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL 108
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFGIARLFGGDE 125
+++ L G+A Y H + RV+HRDLK N+L+D N K++DFG+AR F G
Sbjct: 109 YQI----LRGIA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIP 156
Query: 126 LQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSK 170
+++ T +V T Y +PE L +S D++S G + E ++ K
Sbjct: 157 VRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-14
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 13 KNEMMLIAKLQHR----NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
++EMM A++ H+ +VR+ G C E +L+ E L+ FL K +
Sbjct: 39 RDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVS 95
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
V ++ V+ G+ YL + +HRDL A N+LL + KISDFG+++ G D+
Sbjct: 96 NVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SY 151
Query: 129 NTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
R G + + +PE FS +SDV+S+G+ + E S
Sbjct: 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-14
Identities = 46/172 (26%), Positives = 96/172 (55%), Gaps = 16/172 (9%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+ ++S + LE++ E+ ++A H +V+L G G+ ++ E+ P ++D + +
Sbjct: 45 IETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD 104
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ GL +++V I + + L YLH +++IHRDLKA N+LL + + K++DFG++
Sbjct: 105 R-GLTEPQIQV-ICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS-- 157
Query: 121 FGGDELQSNTKR--IVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLVLE 165
+++ +R +GT +M+PE + + K+D++S G+ ++E
Sbjct: 158 --AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 24/174 (13%)
Query: 11 EFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-------FDP--- 59
+F E+ ++ KL H N++ L G C G L EY P+ +L FL DP
Sbjct: 53 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 112
Query: 60 ---TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG 116
+ L + + VA+G+ YL S+ + IHRDL A NIL+ N KI+DFG
Sbjct: 113 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 169
Query: 117 IARLFGGDELQSNTKRIVGTYG--YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++R G E+ K+ +G +M+ E +++ SDV+S+GVL+ E +S
Sbjct: 170 LSR---GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 52/279 (18%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDPTKTG---LL 65
+E +E ++A + + ++ RL G C+ + LI + MP L D G LL
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
W +++ A+G+ YL R++HRDL A N+L+ + + KI+DFG+A+L G DE
Sbjct: 113 NWCVQI------AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLG 185
+ + + +M+ E L +++ +SDV+S+GV V E ++ +
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----------- 212
Query: 186 HAWNLWNDGRAWELMDSILQNDASYPM-----LNRYINVALLCVQENAADRPTMLEVISM 240
DG + SIL+ P ++ Y+ + + C +A RP E+I
Sbjct: 213 -------DGIPASEISSILEKGERLPQPPICTIDVYM-IMVKCWMIDADSRPKFRELIIE 264
Query: 241 LT--------------NENVILPSPLQPAFSHVRIAENS 265
+ +E + LPSP F + E
Sbjct: 265 FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 303
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-14
Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 11/158 (6%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKS-LDCFLFDPTKTGLLGW 67
+E+ + E+ ++++ + + +G ++ + +I EY+ S LD L +P G L
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDE 100
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
IL + +GL YLH + IHRD+KA+N+LL + K++DFG+A +++
Sbjct: 101 TQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
N VGT +M+PE + + K+D++S G+ +E
Sbjct: 158 RN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 42/157 (26%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+E+ + E+ ++++ + + +G ++ + +I EY+ S D + G
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEF 101
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+L+ + +GL YLH + IHRD+KA+N+LL + K++DFG+A +++
Sbjct: 102 QIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
NT VGT +M+PE + + K+D++S G+ +E
Sbjct: 159 NT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 37/259 (14%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF-------DPTKTG 63
EF NE ++ ++VRL G + +++ E M + L +L +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFG 122
+ +++ +A G+ YL+ + +HRDL A N ++ + KI DFG+ R ++
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE--TLSSKKNAHFYNTDS 180
D + K ++ M+PE G+F+ SD++SFGV++ E +L+ + N
Sbjct: 172 TDYYRKGGKGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
L + L E + +++ +C Q N RPT LE++++
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMR----------------MCWQFNPKMRPTFLEIVNL 274
Query: 241 LTNENVILPSPLQPAFSHV 259
L ++ L P+F V
Sbjct: 275 LKDD-------LHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 52/181 (28%), Positives = 91/181 (50%), Gaps = 17/181 (9%)
Query: 2 SSQSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL---- 56
S + + L + +EM ++ + +H+N++ L G C + G +I EY +L +L
Sbjct: 60 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 119
Query: 57 -------FDPTKT--GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107
++PT+ L ++ V VA+G+ YL + + IHRDL A N+L+ +
Sbjct: 120 PPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 176
Query: 108 MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
KI+DFG+AR + T +M+PE +++ +SDV+SFGVL+ E
Sbjct: 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 168 S 168
+
Sbjct: 237 T 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 50/174 (28%), Positives = 86/174 (49%), Gaps = 17/174 (9%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL----------- 56
L + +EM ++ + +H+N++ L G C + G +I EY +L +L
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 123
Query: 57 FDPTKTG--LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
+D + + ++ V VA+G+ YL + + IHRDL A N+L+ N KI+D
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 180
Query: 115 FGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
FG+AR + T +M+PE +++ +SDV+SFGVL+ E +
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 46/151 (30%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ ++ + +V +G GE + E+M SLD L + + + E+ ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVS 109
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
V +GL YL + +++HRD+K SNIL++S K+ DFG++ G + S V
Sbjct: 110 IAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
GT YMSPE +S++SD++S G+ ++E
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 37/94 (39%), Positives = 55/94 (58%), Gaps = 4/94 (4%)
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNTKRIVGT 136
AQ + L H + R+I+RDLK N+LLD++ N +ISD G+A L G QS TK GT
Sbjct: 104 AQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---QSKTKGYAGT 160
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
G+M+PE + D F+ GV + E ++++
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-13
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 24/166 (14%)
Query: 12 FKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRV 71
F E + + + H N+VRL G +++ EYM N +LD FL G L +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLM 110
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTK 131
+L G+A G+ YL S + +H+ L A +L++S++ KIS F LQ +
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--------RLQED-- 157
Query: 132 RIVGTYGYMS---------PEYALRGLFSIKSDVFSFGVLVLETLS 168
+ Y MS PE FS SDV+SFG+++ E +S
Sbjct: 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR-I 73
E+ L+ +L H N+++L G+ L++E+M + L + GL E ++
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM--DTDLYKLIKDRQRGLP--ESLIKSY 103
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
L + QGL + H ++HRDLK N+L+++ K++DFG+AR FG
Sbjct: 104 LYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHY 158
Query: 134 VGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLS 168
V T Y +PE L +S D++S G + E LS
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 46/136 (33%), Positives = 73/136 (53%), Gaps = 21/136 (15%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIE---HGEKI-LIYEYMPNKSLDCFLFD---PTKTGLLGW 67
E+ + QH +V+L ++ HG L+ EYMP+ L L D P +
Sbjct: 49 EIKALQACQHPYVVKL----LDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS 103
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
MR+ +L+GVA Y+H ++HRDLK +N+L+ ++ KI+DFG+ARLF +E +
Sbjct: 104 YMRM-LLKGVA----YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155
Query: 128 SNTKRIVGTYGYMSPE 143
+ + V T Y +PE
Sbjct: 156 LYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 51/163 (31%), Positives = 86/163 (52%), Gaps = 14/163 (8%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDPTKTG---LL 65
+E +E ++A + + RL G C+ + L+ + MP L D + + G LL
Sbjct: 54 KEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
W +++ A+G+ YL +R++HRDL A N+L+ S + KI+DFG+ARL DE
Sbjct: 113 NWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ + +M+ E L F+ +SDV+S+GV V E ++
Sbjct: 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 6/152 (3%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRV-RI 73
E+ L+ +L H N+++ IE+ E ++ E L + K L E + +
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
+ L ++H S+ R++HRD+K +N+ + + K+ D G+ R F +++
Sbjct: 112 FVQLCSALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
VGT YMSPE ++ KSD++S G L+ E
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 24/140 (17%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKIL-----IYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+ ++ KL+H N+V L +E +K +Y P D +GLL
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL-------SGLLENP- 108
Query: 70 RVR--------ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
V+ + + +G+ YLH ++HRD+KA+NIL+D+ KI+DFG+AR +
Sbjct: 109 SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 122 GGDELQSNTKRIVGTYGYMS 141
G GT Y +
Sbjct: 166 DGPPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 15 EMM-LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-----------FDPTK- 61
EMM +I K H+N++ L G C + G ++ EY +L +L FD K
Sbjct: 69 EMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 62 -TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
L ++ V VA+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ T +M+PE +++ +SDV+SFGVL+ E +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-13
Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 34/177 (19%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGC------CIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
EE K E ++ K H N+ +G + L+ E S+ D K
Sbjct: 47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVK- 101
Query: 63 GLLGWEMRVR------ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG 116
GL R++ IL +GL YLH +VIHRD+K NILL N K+ DFG
Sbjct: 102 GLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158
Query: 117 IARLFGGDELQS-NTKR--IVGTYGYMSPE-----YALRGLFSIKSDVFSFGVLVLE 165
++ +L S +R +GT +M+PE + +SDV+S G+ +E
Sbjct: 159 VSA-----QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-13
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLD---CFLFDPTKT 62
G E + E+ ++ + +H N+V FG + + ++ EY SL P
Sbjct: 41 GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE 100
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI-ARLF 121
+ + R +GL YLH IHRD+K +NILL + + K++DFG+ A+L
Sbjct: 101 LQIAYVCR-----ETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152
Query: 122 GGDELQSNTKR--IVGTYGYMSPEYA---LRGLFSIKSDVFSFGVLVLE 165
+ KR +GT +M+PE A +G + K D+++ G+ +E
Sbjct: 153 -----ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-13
Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 27 LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86
+V +G G + EYM SLD T + ++ RI V +GL +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK- 119
Query: 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY-- 144
+IHRD+K +N+L++ N K+ DFG++ G+ + S K +G YM+PE
Sbjct: 120 -EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIK 174
Query: 145 ----ALRGLFSIKSDVFSFGVLVLE 165
++++SDV+S G+ +LE
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70
+F E ++ + H N+VRL G C + ++ E + FL T+ L +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKEL 96
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
++++E A G+ YL IHRDL A N L+ KISDFG++R D + ++T
Sbjct: 97 IQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYAST 152
Query: 131 ---KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
K+I + +PE G +S +SDV+SFG+L+ E S
Sbjct: 153 GGMKQI--PVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 30/239 (12%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL--FDPTKTG----- 63
EF NE ++ + ++VRL G + ++I E M L +L P
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFG 122
+ +++ +A G+ YL+ + +HRDL A N ++ + KI DFG+ R ++
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE--TLSSKKNAHFYNTDS 180
D + K ++ +MSPE G+F+ SDV+SFGV++ E TL+ + N
Sbjct: 172 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
L + + +L + P + + +C Q N RP+ LE+IS
Sbjct: 231 LRFV--------------MEGGLLDKPDNCP--DMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 52/184 (28%), Positives = 92/184 (50%), Gaps = 8/184 (4%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+S S + EE + E+ +++ ++H N+V+ E+G ++ +Y D +
Sbjct: 35 ISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG--DLYKKINA 92
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ G+L E + IL+ Q L L H +++HRD+K+ NI L + K+ DFGIAR+
Sbjct: 93 QRGVLFPEDQ--ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV 150
Query: 121 FGGD-ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
EL + +GT Y+SPE ++ KSD+++ G ++ E + K N
Sbjct: 151 LNSTVEL---ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207
Query: 180 SLTL 183
+L L
Sbjct: 208 NLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 43/137 (31%), Positives = 68/137 (49%), Gaps = 27/137 (19%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIV 134
+A GL +LH +I+RDLK N++LD+ + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG 194
GT Y++PE + D ++FGVL+ E L+ + F D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--PPFDGEDED------------- 207
Query: 195 RAWELMDSILQNDASYP 211
EL SI++++ SYP
Sbjct: 208 ---ELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 27/137 (19%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIV 134
+ GL +LH +I+RDLK N+LLDS + KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG 194
GT Y++PE + D ++ GVL+ E L+ + + D
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------------- 202
Query: 195 RAWELMDSILQNDASYP 211
EL SIL+++ YP
Sbjct: 203 ---ELFQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 37/103 (35%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
E VR+ +A+ +L L H +L +I+RD+K NILLDS + ++DFG+++ F +E +
Sbjct: 104 ESEVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 128 SNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVLETLS 168
GT YM+PE G D +S GVL E L+
Sbjct: 162 -RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 34/235 (14%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL--------FDPTKTGLLG 66
E+ L+ +L H N+++ + IE E ++ E L + P KT
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--- 108
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
W+ V++ + H +SR RV+HRD+K +N+ + + K+ D G+ R F
Sbjct: 109 WKYFVQLCSALE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGH 186
+++ +VGT YMSPE ++ KSD++S G L+ E + + + FY G
Sbjct: 162 AAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--------GD 209
Query: 187 AWNLWNDGRAWELMD-SILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
NL++ + E D L +D L + +N +C+ + RP + V +
Sbjct: 210 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 13/138 (9%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKI--LIYEYMPNKSLDCFLFD-PTKTGLLGWEMRV 71
E+ L+ +L+H N+V L +EH +K L+++Y + F K + M
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP----KISDFGIARLFGGDELQ 127
+L + G+ YLH V+HRDLK +NIL+ KI D G+ARLF L+
Sbjct: 112 SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLK 167
Query: 128 S--NTKRIVGTYGYMSPE 143
+ +V T Y +PE
Sbjct: 168 PLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 35/171 (20%)
Query: 15 EMMLIAKLQHRNLVRL----FGC----------CIEHGEKILIYEYMPNKSLDCFLFDPT 60
E+ ++ KLQH N+V + G +EH K L+ E M FL
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQP----FLQSEV 108
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K +L ++L GVA +LH ++HRDLK SN+LL++ KI DFG+AR
Sbjct: 109 KCLML------QLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE 155
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSSK 170
+ G L+ T+ +V T Y +PE L +S D++S G + E L+ K
Sbjct: 156 Y-GSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFGGDELQSNTKRIVG 135
+A +L + +I+RDLK N+LLDSN K+ DFG A+ L G T G
Sbjct: 99 IACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTWTFCG 154
Query: 136 TYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
T Y++PE L + D +S G+L+ E L
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-12
Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF--GGDELQSNTKRIV 134
VA+G+ +L SR + IHRDL A NILL N KI DFG+AR D ++ R+
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+M+PE +++ +SDV+SFGVL+ E S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 7e-12
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
V L YLH L +++RDLK N+LLDS+ KI+DFG A+ ++ T + GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
Y++PE L + D ++ G+L+ E L
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 9/152 (5%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
NE++++ + +H N+V + E ++ EY+ SL + T+T + ++
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVC 121
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
E Q L +LH +VIHRD+K+ NILL + + K++DFG + QS +
Sbjct: 122 RE-CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 175
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
VGT +M+PE R + K D++S G++ +E
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 8e-12
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 26/157 (16%)
Query: 19 IAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT--GLLGWEMRVR-IL 74
+ KL H N+V+L E+ E ++EYM + L+ K G E +R I+
Sbjct: 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSII 105
Query: 75 EGVAQGLLYLHH--YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN--- 129
+ QGL ++H + HRDLK N+L+ KI+DFG+AR E++S
Sbjct: 106 YQILQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPY 155
Query: 130 TKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLE 165
T V T Y +PE LR +S D+++ G ++ E
Sbjct: 156 TD-YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 38/154 (24%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E ML+ + H +++R+ + ++ +P+ S D + + ++ L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
+ + +GL YLH R+IHRD+K NI ++ I D G A+ + +
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
GT +PE R ++ K+D++S G+++ E L+
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-11
Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 5 SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLF 57
+G EE K E+ ++ K HRN+ +G I+ + L+ E+ S+ L
Sbjct: 42 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLI 100
Query: 58 DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI 117
TK L E I + +GL +LH + +VIHRD+K N+LL N K+ DFG+
Sbjct: 101 KNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLVLE 165
+ + NT +GT +M+PE + KSD++S G+ +E
Sbjct: 158 SAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 56/234 (23%), Positives = 109/234 (46%), Gaps = 25/234 (10%)
Query: 14 NEMMLIAK-LQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDPTKTGLLGWEMRV 71
+E+ +I + L+H N+VR + +E+ ++ + + L + F K E
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTK 131
I + L YLH R++HRDL +NI+L + I+DFG+A+ + S
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKLT 171
Query: 132 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLW 191
+VGT Y PE + K+DV++FG ++ + FY+T+ L+L
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSL-------- 221
Query: 192 NDGRAWELMDSILQ--NDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243
A ++++++ + + Y +V C+ +A RP +++V +M+++
Sbjct: 222 ----ATKIVEAVYEPLPEGMYS--EDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 22/169 (13%)
Query: 15 EMMLIAKLQHRNLVRLFGCCI----------EHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
E+ ++ +L HRN+V L + G L++EYM D L ++GL
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGL 110
Query: 65 LGW-EMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ + E ++ ++ + +GL Y H + L HRD+K SNILL++ K++DFG+ARL+
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 123 GDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSSK 170
+E + T +++ T Y PE L + DV+S G ++ E + K
Sbjct: 168 SEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 9/87 (10%)
Query: 84 LHHYSR-LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTK-RIVGTYGYMS 141
L++ L++IHRD+K SNILLD N N K+ DFGI+ G + S K R G YM+
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMA 175
Query: 142 PEYAL---RGLFSIKSDVFSFGVLVLE 165
PE R + ++SDV+S G+ + E
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 6/162 (3%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+S +E+ + E +L+AK++H N+V G ++ EY L + +
Sbjct: 37 KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL-QRGK 95
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L + IL+ Q L + H RV+HRD+K+ NI L N K+ DFG ARL
Sbjct: 96 LFPEDT---ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ T VGT Y+ PE ++ KSD++S G ++ E
Sbjct: 153 PGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A+ L L H L +I+RDLK NILLD + K++DFG+++ E GT
Sbjct: 104 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 161
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
YM+PE R + +D +SFGVL+ E L+
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
NE++++ +L++ N+V + E ++ EY+ SL D + +
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAV 120
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
Q L +LH +VIHRD+K+ N+LL + + K++DFG + QS +
Sbjct: 121 CRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTM 175
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
VGT +M+PE R + K D++S G++ +E + +
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 31/151 (20%)
Query: 92 VIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNTKRIVGTYGYMSPEY----AL 146
VIHRD+K SNILLD++ N K+ DFGI+ RL + ++ T R G YM+PE
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERIDPPDP 191
Query: 147 RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQN 206
+ I++DV+S G+ ++E + + T+ +E++ ILQ
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----------------FEVLTKILQE 234
Query: 207 DASYPMLNR-----YINVALLCVQENAADRP 232
+ N + + LC+ ++ RP
Sbjct: 235 EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLL-----GWEM 69
E+ L+ +L H N+++ IE E ++ E L + K L W+
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
V++ V H +SR RV+HRD+K +N+ + + K+ D G+ R F ++
Sbjct: 112 FVQLCSAVE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ +VGT YMSPE ++ KSD++S G L+ E
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 15 EMMLIAKLQ---HRNLVRLFGCC----IEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLG 66
E+ L+ +L+ H N+VRL C + K+ L++E++ ++ L +L GL
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA 107
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
++ ++ +GL +LH ++HRDLK NIL+ S K++DFG+AR++
Sbjct: 108 ETIK-DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SC 160
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
Q +V T Y +PE L+ ++ D++S G + E K
Sbjct: 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 13/148 (8%)
Query: 23 QHRNLVRLFGCC----IEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV 77
+H N+VRL C + K+ L++E++ ++ L +L K GL ++ ++ +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQL 116
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTY 137
+G+ +LH + R++HRDLK NIL+ S+ KI+DFG+AR++ + +V T
Sbjct: 117 LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTL 170
Query: 138 GYMSPEYALRGLFSIKSDVFSFGVLVLE 165
Y +PE L+ ++ D++S G + E
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 9/164 (5%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
Q E NE++++ H N+V ++ + E ++ E++ +L D +
Sbjct: 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMN 116
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
E + V + L YLH+ VIHRD+K+ +ILL S+ K+SDFG +
Sbjct: 117 EEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-- 171
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
K +VGT +M+PE R + + D++S G++V+E + +
Sbjct: 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 10 EEFKNEMMLIAK----LQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLL 65
K+E++ A L + +VR+ G C E +L+ E L+ FL K +
Sbjct: 37 PALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHV 92
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
+ ++ V+ G+ YL + +HRDL A N+LL + KISDFG+++ G DE
Sbjct: 93 TEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
Query: 126 ----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+++ K V Y +PE FS KSDV+SFGVL+ E S
Sbjct: 150 NYYKAKTHGKWPVKWY---APECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDPTKT 62
+ G+ + E++++ +H N+V FG + + + E+ SL D + T
Sbjct: 45 EPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV----T 100
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
G L + QGL YLH + +HRD+K +NILL N + K++DFG++
Sbjct: 101 GPLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQIT 157
Query: 123 GDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLE 165
+ K +GT +M+PE A +G ++ D+++ G+ +E
Sbjct: 158 AT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 39/112 (34%), Positives = 62/112 (55%), Gaps = 12/112 (10%)
Query: 63 GLLGWEMRVRILEGVAQ---GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA- 118
G G EM R++ AQ G+L+LH + +++RD+K N+LLD N ++SD G+A
Sbjct: 88 GERGLEME-RVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAV 143
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
L G ++ T+R GT GYM+PE +S D F+ G + E ++ +
Sbjct: 144 ELKDG---KTITQR-AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 25/168 (14%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFL-----FDPTKT 62
+ NE ++ ++ H ++RLF EH ++ L + EY+P L +L F + T
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-T 102
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
GL V LE YLH +++RDLK NILLD + K++DFG A+
Sbjct: 103 GLFYASEIVCALE-------YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK--- 149
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+L+ T + GT Y++PE + D ++ G+L+ E L
Sbjct: 150 --KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTY 137
A+ +L L H V++RDLK +NILLD + + +ISD G+A F + ++ VGT+
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 159
Query: 138 GYMSPEYALRGL-FSIKSDVFSFGVLVLETL 167
GYM+PE +G+ + +D FS G ++ + L
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYG 138
+GL YLH ++HRD+K N+L++SN KI DFG+AR+ DE + T+ +V Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 139 YMSPEYALRGL--FSIKSDVFSFGVLVLETLSSK 170
Y +PE L G ++ D++S G + E L +
Sbjct: 170 YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
Q E NE++++ QH N+V ++ + E ++ E++ +L D +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMN 114
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
E + V + L LH VIHRD+K+ +ILL + K+SDFG E+
Sbjct: 115 EEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEV 170
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
K +VGT +M+PE R + + D++S G++V+E
Sbjct: 171 PRR-KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 40/94 (42%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF--GGDELQSNTKRIV 134
VA+G+ +L SR + IHRDL A NILL N KI DFG+AR D ++ R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+M+PE +++I+SDV+SFGVL+ E S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-11
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 7/129 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ ++ +L+H N+V L G L++EY+ L+ L + + GL +R +
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-SYI 106
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
+ Q + Y H +IHRD+K NIL+ + K+ DFG AR S V
Sbjct: 107 WQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP-ASPLTDYV 162
Query: 135 GTYGYMSPE 143
T Y +PE
Sbjct: 163 ATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 41/207 (19%)
Query: 17 MLIAKLQHRNLVRLFGCCIEHGEKIL-IYEYMPNKSL-----DCFLFDPTKTGLLGWEMR 70
+L +H L LF C + E + + EY+ L FD + E+
Sbjct: 48 VLALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII 106
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
GL +LH +I+RDLK N+LLD + + KI+DFG+ + E +++T
Sbjct: 107 C--------GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
Query: 131 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNL 190
GT Y++PE ++ D +SFGVL+ E L + H + D
Sbjct: 156 --FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----------- 202
Query: 191 WNDGRAWELMDSILQNDASYPMLNRYI 217
EL DSIL + +P R+I
Sbjct: 203 -------ELFDSILNDRPHFP---RWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 49/174 (28%)
Query: 15 EMMLIAKLQHRNLVRL---FGCCIEHGEKI-LIYEYMP--------NKSLDCFLFDP--T 60
E+ L+ +L+H N++ L FG H I L++E+M +KS+ + P
Sbjct: 52 EIKLLQELKHPNIIGLLDVFG----HKSNINLVFEFMETDLEKVIKDKSI---VLTPADI 104
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K+ +L L +GL YLH ++HRDLK +N+L+ S+ K++DFG+AR
Sbjct: 105 KSYML------MTL----RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151
Query: 121 FG--GDELQSNTKRIVGTYGYMSPEYALRGLFSIKS-----DVFSFGVLVLETL 167
FG ++ V T Y +PE LF + D++S G + E L
Sbjct: 152 FGSPNRKMTHQ----VVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 46/176 (26%), Positives = 89/176 (50%), Gaps = 24/176 (13%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+ ++S + LE++ E+ ++A H N+V+L ++ E+ ++D + +
Sbjct: 38 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 97
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ L ++RV + + + L YLH ++IHRDLKA NIL + + K++DFG++
Sbjct: 98 RP-LTEPQIRV-VCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS-- 150
Query: 121 FGGDELQSNTKRI------VGTYGYMSPEYALRGL-----FSIKSDVFSFGVLVLE 165
NT+ I +GT +M+PE + + K+DV+S G+ ++E
Sbjct: 151 ------AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ L+ L+H N++ L I E I Y + L L + L + L
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFL 114
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
+ +GL Y+H V+HRDLK SNIL++ N + KI DFG+AR+ V
Sbjct: 115 YQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYV 166
Query: 135 GTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSSK 170
T Y +PE L + ++ D++S G + E L K
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 51/189 (26%), Positives = 92/189 (48%), Gaps = 27/189 (14%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK------ILIYEYMPNKSLDCFLFDPTKT 62
+EEF E + + H N+++L G + K ++I +M + L FL ++
Sbjct: 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRI 103
Query: 63 G----LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
G L + VR + +A G+ YL S IHRDL A N +L+ NM ++DFG++
Sbjct: 104 GEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
Query: 119 R-LFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK---- 171
+ ++ GD + +K V +++ E +++ SDV++FGV + E ++ +
Sbjct: 161 KKIYSGDYYRQGCASKLPV---KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217
Query: 172 ---NAHFYN 177
N+ YN
Sbjct: 218 GVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE---LQSNTKRI 133
VAQG+ +L + IHRD+ A N+LL KI DFG+AR D ++ N +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKN 172
V +M+PE +++++SDV+S+G+L+ E S K+
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF--GGDELQSNTKRIV 134
VA+G+ +L SR + IHRDL A NILL N KI DFG+AR D ++ + R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+M+PE +++ +SDV+SFGVL+ E S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 13/166 (7%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDPTKT 62
+ G + E+ ++ + +H N+V FG + + + EY SL D + T
Sbjct: 45 EPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV----T 100
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
G L + QGL YLH ++ HRD+K +NILL N + K++DFG+A
Sbjct: 101 GPLSELQIAYVCRETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKIT 157
Query: 123 GDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLE 165
+ K +GT +M+PE A G ++ D+++ G+ +E
Sbjct: 158 AT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
NE++++ + ++ N+V + E ++ EY+ SL D + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAV 121
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
Q L +LH +VIHRD+K+ NILL + + K++DFG + QS +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 176
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
VGT +M+PE R + K D++S G++ +E + +
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIE-----HGEKI-LIYEYMPNKSLDCFLFDPTKT 62
EE K E+ ++ K HRN+ +G I+ H +++ L+ E+ S+ L TK
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKG 115
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
L + I + +GL +LH + +VIHRD+K N+LL N K+ DFG++
Sbjct: 116 NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
Query: 123 GDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLVLE 165
+ NT +GT +M+PE + +SD++S G+ +E
Sbjct: 173 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A GL +LH +I+RDLK N++LDS + KI+DFG+ + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D ++FGVL+ E L+ + A F D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDED--------------- 207
Query: 197 WELMDSILQNDASYP 211
EL SI++++ +YP
Sbjct: 208 -ELFQSIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ L+ +L+H N+VRL + +L++EYM +K L ++ G L
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFT 106
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT-KRI 133
+ +G+ + H RV+HRDLK N+L++ K++DFG+AR FG + NT
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNE 160
Query: 134 VGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSSK 170
V T Y +P+ L +S D++S G ++ E ++ +
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 41/126 (32%), Positives = 63/126 (50%), Gaps = 20/126 (15%)
Query: 54 CFLFDPTKTGLLGW-----------EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNI 102
CF+ D G L + EMR + +L L H V++RDLK +NI
Sbjct: 73 CFILDLMNGGDLHYHLSQHGVFSEKEMRFY----ATEIILGLEHMHNRFVVYRDLKPANI 128
Query: 103 LLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGV 161
LLD + + +ISD G+A F + ++ VGT+GYM+PE +G + +D FS G
Sbjct: 129 LLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTAYDSSADWFSLGC 184
Query: 162 LVLETL 167
++ + L
Sbjct: 185 MLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 21/164 (12%)
Query: 15 EMMLIAKLQHRNLVRLFGCCI-EHGEKI-LIYEYMPNKSLDC-----FLFDPTKTGLLGW 67
E+ L+ L+H N+V L + +H + I L+ EY C L D T
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY-------CEQDLASLLDNMPTPFSES 108
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
+++ +L+ + +GL YLH +IHRDLK SN+LL KI+DFG+AR + G +
Sbjct: 109 QVKCLMLQ-LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAK 163
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSK 170
T ++V T Y +PE L + D+++ G ++ E L+ K
Sbjct: 164 PMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNTKRIVGT 136
A+ L R R+++RDLK NILLD + +ISD G+A + G+ ++ VGT
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGT 164
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
GYM+PE ++ D + G L+ E + K
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 38/110 (34%), Positives = 66/110 (60%), Gaps = 10/110 (9%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ +L+H+N+VRL+ + H +K L++EY ++ L + FD G + E+
Sbjct: 49 EICLLKELKHKNIVRLYD--VLHSDKKLTLVFEYC-DQDLKKY-FDSCN-GDIDPEIVKS 103
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ + +GL + H + V+HRDLK N+L++ N K++DFG+AR FG
Sbjct: 104 FMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-10
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73
NE++++ + ++ N+V + E ++ EY+ SL D + +
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAV 120
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133
Q L +LH +VIHRD+K+ NILL + + K++DFG + QS +
Sbjct: 121 CRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 175
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
VGT +M+PE R + K D++S G++ +E + +
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
++ GL +LH R +I+RDLK N++LDS + KI+DFG+ + D + T+ GT
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGT 164
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D +++GVL+ E L+ + + D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----------------- 207
Query: 197 WELMDSILQNDASYP 211
EL SI++++ SYP
Sbjct: 208 -ELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 38/107 (35%), Positives = 59/107 (55%), Gaps = 14/107 (13%)
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
E VR G + +L L H +L +++RD+K NILLDS + ++DFG+++ F +E +
Sbjct: 104 EDEVRFYSG--EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-K 160
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKS------DVFSFGVLVLETLS 168
T GT YM+PE +RG K D +S G+L+ E L+
Sbjct: 161 ERTYSFCGTIEYMAPE-IIRG----KGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 34/84 (40%), Positives = 45/84 (53%), Gaps = 16/84 (19%)
Query: 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI-----VGTY 137
Y+H S VIHRDLK SNILL+S+ K++DFG+AR EL+ N + V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATR 176
Query: 138 GYMSPEYALRGLFSIKSDVFSFGV 161
Y +PE L S ++ GV
Sbjct: 177 WYRAPEILL------GSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-10
Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+F E ++ + H ++V+L G E+ I + E P L +L K L ++
Sbjct: 52 EKFLQEAYIMRQFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYL-QVNKYSL---DL 106
Query: 70 RVRILEG--VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
IL ++ L YL R +HRD+ A N+L+ S K+ DFG++R E +
Sbjct: 107 ASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDE 160
Query: 128 SNTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
S K G +M+PE F+ SDV+ FGV + E L
Sbjct: 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A L YLH ++HRDLK N+ L K+ D GIAR+ ++T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLL 184
YMSPE ++ KSDV++ G V E + K H +N + L
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 9e-10
Identities = 27/46 (58%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
GL YLH VIHRDLK SNIL++SN + KI DFG+AR DE
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
E V+I G + +L L H +L +I+RD+K NILLDSN + ++DFG+++ F DE++
Sbjct: 104 EQEVQIYSG--EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 128 SNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVLETLS 168
GT YM+P+ G D +S GVL+ E L+
Sbjct: 162 -RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 11/156 (7%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ ++ +L+H NLV L L++E++ + LD P L + L
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYL 106
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR-LFGGDELQSNTKRI 133
+ +G+ + H ++ +IHRD+K NIL+ + K+ DFG AR L E+ ++
Sbjct: 107 FQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---Y 160
Query: 134 VGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLS 168
V T Y +PE + + D+++ G LV E L+
Sbjct: 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE---LQSNTKRI 133
VA+G+ +L + IHRDL A NILL KI DFG+AR D ++ N +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
V +M+PE +++ +SDV+S+G+L+ E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 3/87 (3%)
Query: 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPE 143
L + R+++RDLK NILLD + + +ISD G+A + K VGT GYM+PE
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPE 171
Query: 144 YALRGLFSIKSDVFSFGVLVLETLSSK 170
++ D ++ G L+ E ++ +
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 16/142 (11%)
Query: 15 EMMLIAKLQHRNLVRLFGCC-----IEHGEKILIYEYMP--NKSLDCFLFDPTKTGLLGW 67
E+ ++ L+H N+V L C + K Y L L + L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS- 119
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG---GD 124
E++ ++++ + GL Y+H R +++HRD+KA+NIL+ + K++DFG+AR F
Sbjct: 120 EIK-KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 125 ELQSNTKRIVGTYGYMSPEYAL 146
+ T R+V T Y PE L
Sbjct: 176 KPNRYTNRVV-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 42/197 (21%)
Query: 23 QHRNLVRLFGCCIEHGEKIL-IYEYMPNKSL-----DCFLFDPTKTGLLGWEMRVRILEG 76
+H L L+ C + E + + EY+ L C FD + E
Sbjct: 54 EHPFLTHLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE-------- 104
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIV 134
+ GL +LH +++RDLK NILLD++ + KI+DFG+ + + G + T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG 194
GT Y++PE L ++ D +SFGVL+ E L + H ++ +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------------- 202
Query: 195 RAWELMDSILQNDASYP 211
EL SI ++ YP
Sbjct: 203 ---ELFQSIRMDNPCYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 2/92 (2%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
A+ L L + + VI+RDLK NILLD + + DFG+ +L D+ ++NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
Y++PE L ++ D ++ GVL+ E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 29/135 (21%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIVGTY 137
GL +LH +I+RDLK N++LD + + KI+DFG+ + +FG + GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTP 160
Query: 138 GYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE L+GL ++ D +SFGVL+ E L + H + D
Sbjct: 161 DYIAPE-ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----------------- 202
Query: 197 WELMDSILQNDASYP 211
EL +SI + YP
Sbjct: 203 -ELFESIRVDTPHYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 51/162 (31%)
Query: 42 LIYEYMPNKSLDCFLFDPTKTG--LLGWEMRVRILEG------VAQGLLYLHHYSRLRVI 93
L+ EYMP G L+ +R + +A+ +L L +L I
Sbjct: 78 LVMEYMP--------------GGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFI 123
Query: 94 HRDLKASNILLDSNMNPKISDFGIA--------RLFGGDELQSNTKR------------- 132
HRD+K NIL+D++ + K++DFG+ R + ++ + R
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 133 ------IVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETL 167
VGT Y++PE LRG + ++ D +S GV++ E L
Sbjct: 184 RVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 9/95 (9%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI---VGT 136
GL Y+H + V+HRDLK SN+LL++N + KI DFG+AR+ D +T + V T
Sbjct: 118 GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVAT 172
Query: 137 YGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSK 170
Y +PE L K+ D++S G ++ E LS++
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNT 130
R L A+ L L R ++RDLK NILLD + +ISD G+A ++ G+ ++
Sbjct: 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR- 161
Query: 131 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
VGT GYM+PE +++ D + G L+ E + +
Sbjct: 162 ---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 26/160 (16%)
Query: 22 LQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL--------FDPTKTGLLGWEMRVRI 73
L H N+++ G CIE +L+ E+ P L +L K L R+
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RM 105
Query: 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNTKR 132
VA GLL+LH + IH DL N L ++++ KI D+G+A + D +
Sbjct: 106 ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 133 IVGTYGYMSPEYA-------LRGLFSIKSDVFSFGVLVLE 165
V +++PE L + KS+++S GV + E
Sbjct: 163 AV-PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 27/138 (19%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIV 134
V L++LH + VI+RDLK NILLD+ + K++DFG+ + + G T
Sbjct: 105 VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFC 157
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG 194
GT Y++PE + D ++ GVL+ E ++ + N D
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------------- 202
Query: 195 RAWELMDSILQNDASYPM 212
+L +SIL +D YP+
Sbjct: 203 ---DLFESILHDDVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 11/92 (11%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
V G+ LH +IHRD+K N+L+D + K++DFG++R G E K+ VGT
Sbjct: 106 VVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156
Query: 137 YGYMSPEYALRGLFSIK-SDVFSFGVLVLETL 167
Y++PE + G+ K SD +S G ++ E L
Sbjct: 157 PDYLAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-09
Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 5/121 (4%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
S S Q +F E LQH NL++ G C E +L+ E+ P L +L K
Sbjct: 32 VSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRK 91
Query: 62 TGLLGWEMRV--RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
L+ + R+ +A GLL+LH + IH DL N LL +++ KI D+G++
Sbjct: 92 AELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148
Query: 120 L 120
Sbjct: 149 N 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-09
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIVGTYG 138
L L H + +I+RDLK NILLD+ + K++DFG+ + + G + T GT
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIE 165
Query: 139 YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
YM+PE +R D +S G L+ + L+
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-09
Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A+ +L L H + +++RDLK NILLD+ + + DFG+++ D +NT GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159
Query: 137 YGYMSPEYAL--RGLFSIKSDVFSFGVLVLE 165
Y++PE L +G ++ D +S GVLV E
Sbjct: 160 TEYLAPEVLLDEKG-YTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTG 63
EE + E ++ L H N+V+ +G + G+ L+ E S+ + G
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 64 L-LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
L M IL G GL +LH+ R+IHRD+K +NILL + K+ DFG++
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 123 GDELQSNTKRIVGTYGYMSPEY-----ALRGLFSIKSDVFSFGVLVLE 165
L+ NT VGT +M+PE + + DV+S G+ +E
Sbjct: 180 STRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 60/238 (25%), Positives = 94/238 (39%), Gaps = 46/238 (19%)
Query: 23 QHRNLVRLFGCCIEHGEKIL-IYEYMPNKSL-----DCFLFDPTKTGLLGWEMRVRILEG 76
H L +L+ CC + +++ + E++ L FD E R R
Sbjct: 54 NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---------EARARFYAA 103
Query: 77 -VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRI 133
+ L++LH +I+RDLK N+LLD + K++DFG+ + +F G T
Sbjct: 104 EITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTF 156
Query: 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND 193
GT Y++PE L+ D ++ GVL+ E L N D
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------------- 202
Query: 194 GRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNENVILPSP 251
+L ++IL ++ YP V +L + PTM L E IL P
Sbjct: 203 ----DLFEAILNDEVVYPTWLSQDAVDIL--KAFMTKNPTMRLGSLTLGGEEAILRHP 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 4 QSGQGLEEFKN----EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP 59
+ + EE K E+ ++ L+ N+V L G+ L++EY+ L+ L +
Sbjct: 35 KDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEE 92
Query: 60 TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
G+ ++R I Q + +H + ++HRD+K N+L+ N K+ DFG AR
Sbjct: 93 MPNGVPPEKVRSYIY----QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148
Query: 120 -LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
L G +N V T Y SPE L + D++S G ++ E
Sbjct: 149 NLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 12 FKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCF--------LFDPTKT 62
F+N+ AK +R LV + C+ H I L+ + P KSL+ F L D
Sbjct: 61 FQNQTH--AKRAYRELVLM--KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 63 GLLGWEM-RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
++ E+ R+ + Q L + H +IHRDLK SNI++ S+ KI DFG+AR
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
G + T +V Y Y +PE L + D++S G ++ E +
Sbjct: 177 GTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ F L+++L H++LV+L+G C+ E I++ EY+ LD FL
Sbjct: 40 SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNV 98
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNP----KISDFG 116
L W++ V + +A L YL +++H ++ NIL+ N K+SD G
Sbjct: 99 SLHWKLDV--AKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 117 IAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGLFS---IKSDVFSFGVLVLE------- 165
I + +E RI +++PE +R + I +D +SFG +LE
Sbjct: 154 IPITVLSREERVE---RI----PWIAPEC-IRNGQASLTIAADKWSFGTTLLEICSNGEE 205
Query: 166 ---TLSSKKNAHFYNT 178
TLSS + FY
Sbjct: 206 PLSTLSSSEKERFYQD 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 58/188 (30%), Positives = 88/188 (46%), Gaps = 23/188 (12%)
Query: 12 FKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCF--------LFDPTKT 62
F+N+ AK +R LV L C+ H I L+ + P KSL+ F L D
Sbjct: 58 FQNQTH--AKRAYRELVLL--KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLC 113
Query: 63 GLLGWEM-RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
++ E+ R+ + Q L + H +IHRDLK SNI++ S+ KI DFG+AR
Sbjct: 114 QVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
+ + T +V Y Y +PE L + D++S G ++ E + K + F TD +
Sbjct: 174 CTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELV--KGSVIFQGTDHI 228
Query: 182 TLLGHAWN 189
WN
Sbjct: 229 D----QWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYE---YMPNKSLDCFLFDPTKTGLLGW 67
+ +NE++ + +L H N++++ E+IL E YM + D L+ W
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 68 EMRV------RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
+ R I++ + + Y+H + +IHRD+K NI L+ + + DFG A F
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIH--DKK-LIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
E ++ VGT SPE + +D++S G+++L+ LS
Sbjct: 318 -EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 10 EEFKNEMMLIAKLQ-HRNLVRLFGCC----IEHGEKI-LIYEYMPNKSLDCFLFDPTKTG 63
EE + E ++ L H N+V+ +G +++G+++ L+ E S+ + K G
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 64 LLGWEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
E + IL GL +LH + IHRD+K +NILL + K+ DFG++
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175
Query: 123 GDELQSNTKRIVGTYGYMSPEY-----ALRGLFSIKSDVFSFGVLVLE 165
L+ NT VGT +M+PE L + + DV+S G+ +E
Sbjct: 176 STRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 12 FKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCF--------LFDPTKT 62
F+N+ AK +R LV + C+ H I L+ + P KSL+ F L D
Sbjct: 54 FQNQTH--AKRAYRELVLM--KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLC 109
Query: 63 GLLGWEM-RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
++ E+ R+ + Q L + H +IHRDLK SNI++ S+ KI DFG+AR
Sbjct: 110 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
G + T +V Y Y +PE L + D++S G ++ E + K
Sbjct: 170 GTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 30/85 (35%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNTKRIVGTYGYMSP 142
L R R+++RDLK NILLD + +ISD G+A ++ G+ ++ VGT GYM+P
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAP 170
Query: 143 EYALRGLFSIKSDVFSFGVLVLETL 167
E ++ D + G L+ E +
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 37/125 (29%), Positives = 59/125 (47%), Gaps = 4/125 (3%)
Query: 44 YEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNIL 103
Y+ + + L D GL ++ + VA+G+ +L + +HRDL A N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL-LSFTYQVARGMEFL---ASKNCVHRDLAARNVL 269
Query: 104 LDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163
L KI DFG+AR D + +M+PE L++ SDV+S+G+L+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
Query: 164 LETLS 168
E S
Sbjct: 330 WEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF--GGDELQSNTKRIVGTY 137
GL Y+H + V+HRDLK N+L++++ KI DFG+AR F E V T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 138 GYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSK 170
Y +PE L K+ DV+S G ++ E L K
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 2/156 (1%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
++E+ +A H +V+ F + +LI EY L+ + K L E V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKR 132
+L Q +L L +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 133 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
GT Y++PE R +S K+D++S GV++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG-IARLFGGDELQSNTKRIVG 135
+A+ +L + +L +HRD+K N+LLD N + +++DFG RL +QSN VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 136 TYGYMSPEY--AL---RGLFSIKSDVFSFGVLVLETL 167
T Y+SPE A+ +G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
GL Y+H + V+HRDLK SN+LL++N + KI DFG+AR ++ T+ +V T Y
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRWY 174
Query: 140 MSPEYALR-GLFSIKSDVFSFGVLVLETLSSK 170
+PE L ++ DV+S G + E L K
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 28/162 (17%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF--------LFDPTKTGLLG 66
E++L+ + H+N++ L + P KSL+ F L D ++
Sbjct: 65 ELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQ 112
Query: 67 WEM---RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
++ R+ L + Q L + H +IHRDLK SNI++ S+ KI DFG+AR G
Sbjct: 113 MDLDHERMSYL--LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ T +V Y Y +PE L + D++S G ++ E
Sbjct: 171 SFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 36/131 (27%), Positives = 56/131 (42%), Gaps = 18/131 (13%)
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKR 132
IL + GL LH + +HRDL +NI ++S KI+DFG+AR +G +
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 133 I------------VGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
V T Y +PE + + D++S G + E L+ K F +
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK--PLFPGEN 238
Query: 180 SLTLLGHAWNL 190
+ LG + L
Sbjct: 239 EIDQLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 16/131 (12%)
Query: 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSP 142
YLH +I+RDLK N+LLD+ + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 143 EYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYN-----TDSLTLLGH-AWNLWNDGRA 196
E D ++ GVL+ E ++ F++ L G + W DGRA
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG--YPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242
Query: 197 WELMDSILQND 207
+L+ +LQ D
Sbjct: 243 RDLVKGLLQTD 253
|
Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 58/243 (23%), Positives = 108/243 (44%), Gaps = 29/243 (11%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ +L+H N++ L + H ++ L+++Y + F + V+
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQ 104
Query: 73 ILEGVAQGLLY-----LHHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLFGG 123
+ G+ + LLY +H+ V+HRDLK +NIL+ KI+D G ARLF
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 124 D-ELQSNTKRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSK----------K 171
+ ++ +V T+ Y +PE L K+ D+++ G + E L+S+ K
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224
Query: 172 NAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNR--YINVALLCVQENAA 229
++ Y+ D L + + D + WE + + ++ R Y N +L+ E
Sbjct: 225 TSNPYHHDQLDRIFNVMGFPAD-KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 283
Query: 230 DRP 232
+P
Sbjct: 284 VKP 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 46/290 (15%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L S S + L+ + E++ +LQH N++ I E ++ M S + L
Sbjct: 35 LDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF 94
Query: 61 KTGLLGWEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
GL E+ + IL+ V L Y+H IHR +KAS+ILL + +S +
Sbjct: 95 PEGLP--ELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSV 149
Query: 120 -LFGGDELQ----SNTKRIVGTYGYMSPEY---ALRGLFSIKSDVFSFGVLVLETLSSKK 171
+ + Q K V ++SPE L+G ++ KSD++S G+ E L+
Sbjct: 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACE-LA--- 204
Query: 172 NAH--FYNTDSLTLL-----GHAWNLWNDGRAWELMDSILQNDASYPMLNRYINV----- 219
N H F + + +L G L + DS+ Q+ +S N +V
Sbjct: 205 NGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYT 264
Query: 220 ----------ALLCVQENAADRPTMLEVIS-----MLTNENVILPSPLQP 254
LC+Q + RP+ ++++ N L L+P
Sbjct: 265 RTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 19/114 (16%)
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE----- 125
+ I + + Y+H S+ V+HRDLK NILL I D+G A +E
Sbjct: 116 LSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 126 --------LQSN-TK--RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
S+ T +IVGT YM+PE L S +D+++ GV++ + L+
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 14/147 (9%)
Query: 68 EMRVRILEG-VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
E R R +A L YLH L +++RDLK NILLDS + ++DFG+ + E
Sbjct: 95 EPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEH 149
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL------SSKKNAHFYNTDS 180
T GT Y++PE + + D + G ++ E L S+ A Y+
Sbjct: 150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQND 207
L N+ N R L++ +LQ D
Sbjct: 210 NKPLQLKPNITNSAR--HLLEGLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ L+H N+V L I H +K L++EY+ +K L ++ D G + V+
Sbjct: 54 EVSLLKDLKHANIVTLHD--IVHTDKSLTLVFEYL-DKDLKQYMDD---CGNIMSMHNVK 107
Query: 73 I-LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT- 130
I L + +GL Y H R +V+HRDLK N+L++ K++DFG+AR + + T
Sbjct: 108 IFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTY 161
Query: 131 KRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSSK 170
V T Y P+ L +S + D++ G + E S +
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 10/86 (11%)
Query: 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPE 143
LH L IHRDLK N L+D++ + K++DFG+++ + + +VG+ YM+PE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPE 168
Query: 144 YALRGL-FSIKSDVFSFGVLVLETLS 168
LRG + D +S G ++ E L
Sbjct: 169 -VLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 13/117 (11%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E F ++++L H++LV +G C+ E I++ EY+ SLD +L + W++
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL 103
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL-----DSNMNP---KISDFGIA 118
V Q LH + H ++ A N+LL NP K+SD GI+
Sbjct: 104 EV-----AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTY 137
AQ +L + L +++RDLK N+LLD + K++DFG A++ + + T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192
Query: 138 GYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
Y++PE L +D ++ G+ + E L
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
V GL YLH ++++RDLK N+LLD+ KI+DFG+ + G T GT
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGT 164
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
+++PE ++ D + GVL+ E L
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG--DELQSNTKRIVGTY 137
GL Y+H + VIHRDLK SN+L++ + +I DFG+AR E + V T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 138 GYMSPEYALR-GLFSIKSDVFSFGVLVLETL 167
Y +PE L ++ D++S G + E L
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 17/141 (12%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A L YLH L +I+RDLK NILLDS + ++DFG+ + G E T GT
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLS------SKKNAHFYNTDSLTLLGHAWNL 190
Y++PE + + D + G ++ E L S+ A Y+ +L L
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD----NILNKPLRL 215
Query: 191 WND--GRAWELMDSILQNDAS 209
+ A L++ +LQ D +
Sbjct: 216 KPNISVSARHLLEGLLQKDRT 236
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 38/113 (33%), Positives = 55/113 (48%), Gaps = 8/113 (7%)
Query: 68 EMRVRILEG-VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
E R R VA + YLH L +I+RDLK NILLDS + ++DFG+ + G E
Sbjct: 95 EPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEP 149
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
+ T GT Y++PE + + D + G ++ E L FY+ D
Sbjct: 150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL--PPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD-ELQSNTKRIVG 135
+A+ +L +H +L +HRD+K N+LLD N + +++DFG D +QS+ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 136 TYGYMSPEY--ALR---GLFSIKSDVFSFGVLVLETL 167
T Y+SPE A+ G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 16/100 (16%)
Query: 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR---------LFGG----DELQ 127
L YLH+Y ++HRDLK N+L+ S + K++DFG+++ L+ G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
K++ GT Y++PE LR + D ++ G+++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 40/108 (37%), Positives = 61/108 (56%), Gaps = 12/108 (11%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ L+H N+V L I H EK L++EY+ +K L +L D G V+
Sbjct: 54 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFEYL-DKDLKQYLDD---CGNSINMHNVK 107
Query: 73 I-LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
+ L + +GL Y H R +V+HRDLK N+L++ K++DFG+AR
Sbjct: 108 LFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 11/97 (11%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIV 134
++ L YLH +I+RDLK N+LLDS + K++D+G+ + L GD T
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFC 157
Query: 135 GTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSK 170
GT Y++PE LRG + D ++ GVL+ E ++ +
Sbjct: 158 GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L YLH S V++RDLK N++LD + + KI+DFG+ + G + + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
Y++PE + D + GV++ E + + FYN D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
VA G+ +L + +HRDL A N+L+ KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLE--TLSSKK------NAHFYN 177
+M+PE L++ SDV+SFG+L+ E TL N FYN
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 9/114 (7%)
Query: 79 QGLLYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTY 137
+G+ + H + V+HRDLK N+L+D KI+D G+ R F ++S T IV T
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TL 175
Query: 138 GYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNL 190
Y +PE L +S D++S G + E S+K F L L H + L
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEM--SRKQPLFPGDSELQQLLHIFKL 227
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
GL Y+H +IHRDLK SNI ++ + KI DFG+AR DE+ V T Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWY 181
Query: 140 MSPEYAL-RGLFSIKSDVFSFGVLVLETLSSK 170
+PE L ++ D++S G ++ E L+ K
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPT-----KTGLLGW 67
E+ L+ +L+H N++ L + H ++ L+++Y + F K L
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLFGG 123
M +L + G+ YLH V+HRDLK +NIL+ KI+D G ARLF
Sbjct: 108 SMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 124 D-ELQSNTKRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSKKNAHFYNTD 179
+ ++ +V T+ Y +PE L K+ D+++ G + E L+S+ H D
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 8e-07
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 8/161 (4%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ ++ + HR ++ L + K + MP D F + ++G L E + I
Sbjct: 136 EIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
+ + L YLH +IHRD+K NI LD N + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
GT SPE + K+D++S G LVL +S K F
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAG-LVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ +GL Y+H +IHRDLK SN+ ++ + KI DFG+AR DE+ V T
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVAT 180
Query: 137 YGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSK 170
Y +PE L + ++ D++S G ++ E L+ +
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 12/98 (12%)
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIVG 135
A+ L L+ +I+RDLK N+LLD+ + K++D+G+ + + GD T G
Sbjct: 103 AEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCG 158
Query: 136 TYGYMSPEYALRGL---FSIKSDVFSFGVLVLETLSSK 170
T Y++PE LRG FS+ D ++ GVL+ E ++ +
Sbjct: 159 TPNYIAPE-ILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL-FGGDELQSNTKRIVGTY 137
+ L Y+H + V HRDLK NIL +++ KI DFG+AR+ F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 138 GYMSPEYALRGLFSIKS----DVFSFGVLVLETLSSK 170
Y +PE L G F K D++S G + E L+ K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 1e-06
Identities = 38/109 (34%), Positives = 51/109 (46%), Gaps = 22/109 (20%)
Query: 91 RVIHRDLKASNILLDS-------------NMN----PKISDFGIARLFGGDELQSNTKRI 133
RV+HRDLK NI L + N+N KI DFG+++ G ++S
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSC 201
Query: 134 VGTYGYMSPEYALRGLFSI--KSDVFSFGVLVLETLSSKKNAHFYNTDS 180
VGT Y SPE L S KSD+++ G ++ E S K H N S
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L YLH SR V++RD+K N++LD + + KI+DFG+ + D + K GT
Sbjct: 104 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
Y++PE + D + GV++ E + + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L YLH ++++RDLK N++LD + + KI+DFG+ + G + K GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
Y++PE + D + GV++ E + + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-06
Identities = 17/48 (35%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 243 NENVILPSPLQPAF-SHVRIAENSSLPANCEVEACTVNCLTLSAMDAR 289
+E +P P QP F E S + E+ TVN +T+S +DAR
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A L YLH + +++RDLK NILLDS + ++DFG+ + G T GT
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGT 159
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
Y++PE + + D + G ++ E L
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 40/109 (36%), Positives = 59/109 (54%), Gaps = 14/109 (12%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFDPTKTGLLGWEMR-V 71
E L+ L+H N+V L I H +K L ++EY+ + L ++ D GL M V
Sbjct: 53 EASLLKDLKHANIVTLHD--IIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGL---SMHNV 105
Query: 72 RI-LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
R+ L + +GL Y H RV+HRDLK N+L+ K++DFG+AR
Sbjct: 106 RLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 7/80 (8%)
Query: 93 IHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALR---- 147
IHRD+K N+LLD + + K++DFG + + + +T VGT Y+SPE
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGD 221
Query: 148 GLFSIKSDVFSFGVLVLETL 167
G + + D +S GV + E L
Sbjct: 222 GYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 34/170 (20%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF----LFDPTKTGLLGWEMR 70
E+ L+ ++H N++ L + P+ SLD F L P LG M+
Sbjct: 64 ELRLLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMK 111
Query: 71 V------RILEGVAQ---GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
RI V Q GL Y+H +IHRDLK N+ ++ + KI DFG+AR
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-- 166
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSK 170
+ S V T Y +PE L + ++ D++S G ++ E L+ K
Sbjct: 167 ---QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 31/167 (18%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIE--------HGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
E+ ++ +L+H NLV L IE H L++EY + L+ +P +
Sbjct: 50 EIRMLKQLKHPNLVNL----IEVFRRKRKLH----LVFEYCDHTVLNELEKNPRG---VP 98
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF--GGD 124
+ +I+ Q + + H + IHRD+K NIL+ K+ DFG AR+ GD
Sbjct: 99 EHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155
Query: 125 ELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLVLETLSS 169
+ V T Y +PE L G + DV++ G + E L+
Sbjct: 156 DYTD----YVATRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A+ +L +H ++ +HRD+K N+L+D + K++DFG A ++ N+K VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGT 166
Query: 137 YGYMSPEY------ALRGLFSIKSDVFSFGVLVLETL 167
Y++PE +G + ++ D +S GV+ E +
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 18/148 (12%)
Query: 42 LIYEYMPNKSLDCFLFDPTKTGLLGW---------EMRVRILEG-VAQGLLYLHHYSRLR 91
L Y + + L CF+ + G L + E R R + L YLH
Sbjct: 60 LKYSFQTHDRL-CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCD 115
Query: 92 VIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151
V++RDLK N++LD + + KI+DFG+ + G + K GT Y++PE +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 152 IKSDVFSFGVLVLETLSSKKNAHFYNTD 179
D + GV++ E + + FYN D
Sbjct: 174 RAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 11/94 (11%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR--LFGGDELQSNTKRIVGTY 137
L +LH +I+RDLK N+LLD++ + K++D+G+ + L GD T GT
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTP 160
Query: 138 GYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSK 170
Y++PE LRG + D ++ GVL+ E ++ +
Sbjct: 161 NYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E ++ + H ++++L G + LI +P D + + K + ++ + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
V + + YLH R+IHRD+KA NI ++ + + DFG A F D +
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
GT +PE R + D++S G+++ E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG-IARLFGGDELQSNTKRIVG 135
+A+ ++ + +L +HRD+K NIL+D N + +++DFG +L +QS+ VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 165
Query: 136 TYGYMSPEYAL-----RGLFSIKSDVFSFGVLVLETL 167
T Y+SPE +G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 25/165 (15%)
Query: 15 EMMLIAKLQHRNLVRL---FGCCIEHGEKILIYEYMPNKSLDC-----FLFDPTKTGLLG 66
E+ L+ +QH N++ L F + E Y MP D K L
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
++M GL Y+H +IHRDLK N+ ++ + KI DFG+AR
Sbjct: 124 YQM--------LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HA 167
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSK 170
+ V T Y +PE L + ++ D++S G ++ E L+ K
Sbjct: 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYG 138
+GL Y+H +IHRDLK SN+ ++ + +I DFG+AR DE+ V T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRW 180
Query: 139 YMSPEYALRGL-FSIKSDVFSFGVLVLETLSSK 170
Y +PE L + ++ D++S G ++ E L K
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E L+ L+H N+V L I H ++ L ++EYM + P GL + +R+
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLF 108
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT-K 131
+ + + +GL Y+H ++HRDLK N+L+ K++DFG+AR + S T
Sbjct: 109 MFQ-LLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYS 161
Query: 132 RIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETL 167
V T Y P+ L +S D++ G + +E L
Sbjct: 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 12/108 (11%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ L+H N+V L I H E+ L++EY+ + L +L G L V+
Sbjct: 53 EVSLLKNLKHANIVTLHD--IIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVK 106
Query: 73 I-LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
I + + +GL Y H +++HRDLK N+L++ K++DFG+AR
Sbjct: 107 IFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 18/161 (11%)
Query: 14 NEMMLIAKLQ-HRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTK--TGLLGWE 68
E+ + +L H N++RL + G L++E M D L++ K L E
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-E 99
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
RV+ + Q L L H R + HRD+K NIL+ + K++DFG R G
Sbjct: 100 KRVKSY--MYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPP 154
Query: 129 NTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLS 168
T+ I T Y +PE L G + K D+++ G + E LS
Sbjct: 155 YTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 21/53 (39%), Positives = 35/53 (66%), Gaps = 3/53 (5%)
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
EM V+ + VA L YLH + +IHRDLK N+L+ + + K++DFG++++
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 33/127 (25%), Positives = 54/127 (42%), Gaps = 36/127 (28%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG-------------------- 116
+A+ +L + +L IHRD+K N+LLD+ + K+SDFG
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 117 --------IARLFGGDELQSNTKR--------IVGTYGYMSPEYALRGLFSIKSDVFSFG 160
I++ KR VGT Y++PE L+ ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 161 VLVLETL 167
V++ E L
Sbjct: 227 VIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 41/177 (23%), Positives = 80/177 (45%), Gaps = 25/177 (14%)
Query: 22 LQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL------FDPTKTGLLGWEMRVRILE 75
LQH N+++ G C+E +L++EY L +L ++ LL R+
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMAC 106
Query: 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNTKRIV 134
+A G+ ++H + +H DL N L S++ K+ D+GI + D +++ + V
Sbjct: 107 EIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV 163
Query: 135 GTYGYMSPEYALR---GLFSIK----SDVFSFGVLVLETLSSKKN--AHFYNTDSLT 182
+++PE GL + + S+V++ GV + E + +H + + L
Sbjct: 164 -PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 27/174 (15%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKI--------------LIYEYMPNKSLDCFLFDPT 60
E+ +I +L H N+V+++ G + ++ EYM + L +
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVL 106
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIAR 119
+ G L E + + +GL Y+H + V+HRDLK +N+ +++ ++ KI DFG+AR
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
Query: 120 LFGGDELQSN--TKRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSK 170
+ ++ +V + Y SP L K+ D+++ G + E L+ K
Sbjct: 164 IVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 45/136 (33%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-------------RLFGG 123
+A+ +L + +L IHRD+K NIL+D + K+SDFG++ +L G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 124 DELQ------------------SNTKRI--------------VGTYGYMSPEYALRGLFS 151
+ S+ +I VGT Y++PE L+ +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 152 IKSDVFSFGVLVLETL 167
+ D +S G ++ E L
Sbjct: 227 QECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 18 LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV 77
L++++ H +L + G C+ E I++ E++ + LD L + W++ V + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVA--QQL 126
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNIL-----LDSNMNP--KISDFGIARLFGGDELQSNT 130
A L YL + ++H ++ A NIL L +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 131 KRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVLE 165
+RI +++PE + G S +D +SFG +LE
Sbjct: 182 ERI----PWIAPE-CVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E L+ L+H N+V L L++EY+ C D GL +++ +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDL--CQYMDKHPGGLHPENVKLFLF 110
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
+ + +GL Y+H + ++HRDLK N+L+ K++DFG+AR
Sbjct: 111 Q-LLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 51/244 (20%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK----ILIYEYMPNKSLDCFLFDPTKTGL 64
++ +NE+ + ++ N+++++G I+ + LI EY L L K
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKD 118
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
L ++ ++ + +GL L+ Y+ +++L + + L+ N KI G+ ++
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI---- 172
Query: 125 ELQSNTKRIVGTYGYMSPEYALRGLFS---IKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
L S + V Y S + L +FS IK D++S GV++ E + K F N +
Sbjct: 173 -LSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKDDIYSLGVVLWEIFTGK--IPFENLTTK 228
Query: 182 TLLGHAWNLWNDGRAWELMDSILQNDASYPM---LNRYI-NVALLCVQENAADRPTMLEV 237
E+ D I+ + S + I + C ++ RP + E+
Sbjct: 229 ----------------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
Query: 238 ISML 241
+ L
Sbjct: 273 LYNL 276
|
Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 8/108 (7%)
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTY 137
A+ +L L + IHRD+K N+LLD + + K++DFG + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 207
Query: 138 GYMSPEYALR----GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
Y+SPE G + + D +S GV + E L + FY DSL
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 12/107 (11%)
Query: 18 LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV 77
++ ++ H+++V L+G C+ E I++ E++ LD LF K+ +L + ++ + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL 114
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILL-----DSNMNP--KISDFGI 117
A L YL ++H ++ NILL D P K+SD GI
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 27 LVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFD---PTKTGLLGWEMRVRILEGVAQGL 81
+V+LF C +K L + EYMP L + + P K W A+ +
Sbjct: 105 VVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFY-----TAEVV 152
Query: 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDELQSNTKRIVGTYGYM 140
L L + +IHRD+K N+LLD + + K++DFG ++ ++ +T VGT Y+
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYI 210
Query: 141 SPEYALR----GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
SPE G + + D +S GV + E L + FY DSL
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 45/136 (33%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG-------------- 122
+A+ L + ++ IHRD+K NIL+D + + K++DFG+ F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 123 -------------------GDELQSNTKR------------IVGTYGYMSPEYALRGLFS 151
GD L++ +R +VGT Y++PE LR ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 152 IKSDVFSFGVLVLETL 167
D +S GV++ E L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 39/159 (24%)
Query: 42 LIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASN 101
LI E++P + L K L E + I E V L + +L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETV----LAIDSIHQLGFIHRDIKPDN 131
Query: 102 ILLDSNMNPKISDFGIA-----------------RLFGGDELQS-NTKR----------- 132
+LLDS + K+SDFG+ L Q+ N+KR
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 133 ----IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
VGT Y++PE ++ ++ D +S GV++ E L
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 17/150 (11%)
Query: 24 HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT-GLLGWEMRVR-ILEGVAQGL 81
+ N ++L+ +LI +Y+ D LFD K G L E V+ I+ + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLS-EAEVKKIIRQLVEAL 122
Query: 82 LYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFGIARLFGGDELQSNTKRIVGTYGYM 140
LH + +IH D+K N+L D + + D+G+ ++ G GT Y
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYF 173
Query: 141 SPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
SPE + + D ++ GVL E L+ K
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 45/182 (24%)
Query: 11 EFKN-EMMLIAKLQHRNLVRL----FGCCIEHGEKIL----IYEYMP------------- 48
++KN E++++ L H N++ L + C + EK + + E++P
Sbjct: 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163
Query: 49 NKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM 108
N +L FL L +++ + L Y+H S+ + HRDLK N+L+D N
Sbjct: 164 NHALPLFLVK-----LYSYQL--------CRALAYIH--SKF-ICHRDLKPQNLLIDPNT 207
Query: 109 NP-KISDFGIAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLE 165
+ K+ DFG A+ L G Q + I + Y +PE L ++ D++S G ++ E
Sbjct: 208 HTLKLCDFGSAKNLLAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAE 263
Query: 166 TL 167
+
Sbjct: 264 MI 265
|
Length = 440 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 38/132 (28%), Positives = 56/132 (42%), Gaps = 32/132 (24%)
Query: 64 LLGWEMR---------VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNP- 110
LL W M+ +I+ L Y H + L ++H DLK NIL+ D+ ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275
Query: 111 ------------KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158
+I D G DE S T IV T Y SPE L + +D++S
Sbjct: 276 TNRALPPDPCRVRICDLGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWS 330
Query: 159 FGVLVLETLSSK 170
G ++ E + K
Sbjct: 331 MGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 41/159 (25%), Positives = 63/159 (39%), Gaps = 39/159 (24%)
Query: 42 LIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASN 101
LI E++P + L K L + I E V L + +L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETV----LAIDAIHQLGFIHRDIKPDN 131
Query: 102 ILLDSNMNPKISDFGIA--------------------RLFGGDELQSNTK---------- 131
+LLD+ + K+SDFG+ F + S K
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 132 ---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
VGT Y++PE ++ ++ D +S GV++ E L
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 41/116 (35%)
Query: 93 IHRDLKASNILLDSNMNPKISDFGIARLF-----------GG----------DELQSNTK 131
IHRD+K NIL+D + + K++DFG+ F G +E +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 132 R--------------------IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
+VGT Y++PE LR ++ D +S GV++ E L
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 6e-04
Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 12/119 (10%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLV--RLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
S + + + E+ ++ L + L ++ G L+ E++ ++LD
Sbjct: 30 PSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSE---- 85
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
E + I E +A+ L LH L + H DL NIL+D I D+ A
Sbjct: 86 ------EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 32/124 (25%), Positives = 51/124 (41%), Gaps = 45/124 (36%)
Query: 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFG-------------------------- 122
++ IHRD+K NIL+D + + K++DFG+ F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 123 -------GDELQSNTKR------------IVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163
GD L+ +R +VGT Y++PE LR ++ D +S GV++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 164 LETL 167
E L
Sbjct: 239 YEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 29/181 (16%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L + + + L+ +NE++L +H N++ + +I +M S + L
Sbjct: 35 LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF 94
Query: 61 KTGLLGWEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
G+ E + IL G +GL YLH IHR++KAS+IL IS G+
Sbjct: 95 PEGMS--EALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVS 141
Query: 120 LFGGDELQS---NTKRIVGTYGY----------MSPEYALRGL--FSIKSDVFSFGVLVL 164
L G L S N ++ Y + +SPE + L +++KSD++S G+
Sbjct: 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITAC 201
Query: 165 E 165
E
Sbjct: 202 E 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 77 VAQGLL----YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKR 132
VA+ LL Y+H +IHRD+K N+L++ + + DFG A G
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 133 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166
I GT +PE ++ D++S G+++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 289 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.9 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.45 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.77 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.66 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.65 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.53 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.2 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.15 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.06 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.56 | |
| PLN02236 | 344 | choline kinase | 96.55 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.09 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.84 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 95.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.6 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.31 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.23 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.86 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.85 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.83 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.73 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.65 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.62 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.58 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.34 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.1 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 93.65 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.61 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=325.01 Aligned_cols=212 Identities=28% Similarity=0.444 Sum_probs=179.9
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe-EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE-KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+.-.+++.+|+++++.++||+||++||+|..++. ++++||||++|+|+.++. ..+.+++....+++.+|++||.|
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~Y 193 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSY 193 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999999994 999999999999999994 44789999999999999999999
Q ss_pred Hhc-CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 84 LHH-YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~-~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
||+ .+ |+||||||+|+|++..|.|||+|||.++...+. ...++.||..|||||.+.+..|+.++||||||++
T Consensus 194 Lh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLs 266 (364)
T KOG0581|consen 194 LHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLS 266 (364)
T ss_pred HhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHH
Confidence 996 55 999999999999999999999999999887544 3466789999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc---CCCCH-HHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ---NDASY-PMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
++|+.+|+.|+........... +++..+.. ...+. ..+.++.+++..||+.||.+|||+.|++
T Consensus 267 llE~a~GrfP~~~~~~~~~~~~-------------~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl 333 (364)
T KOG0581|consen 267 LLELAIGRFPYPPPNPPYLDIF-------------ELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLL 333 (364)
T ss_pred HHHHhhCCCCCCCcCCCCCCHH-------------HHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 9999999999887632211111 11222221 11122 3667899999999999999999999998
Q ss_pred H
Q 038647 239 S 239 (289)
Q Consensus 239 ~ 239 (289)
+
T Consensus 334 ~ 334 (364)
T KOG0581|consen 334 Q 334 (364)
T ss_pred c
Confidence 6
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=336.25 Aligned_cols=209 Identities=26% Similarity=0.388 Sum_probs=182.3
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
++.+.+...+||+|.++|+|||||+++++|++.+++|+|.|+|+.++|..+++ ..+.+++.+++.++.||+.||.||
T Consensus 58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYL 134 (592)
T KOG0575|consen 58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYL 134 (592)
T ss_pred CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHH
Confidence 45578889999999999999999999999999999999999999999999984 567899999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+|||||..|+|++++.+|||+|||+|....... ....+.+|||.|+|||++.+...+..+||||+|||+|
T Consensus 135 H~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmY 209 (592)
T KOG0575|consen 135 HSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMY 209 (592)
T ss_pred HhcC---ceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHH
Confidence 9988 9999999999999999999999999999876443 3456689999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCC--CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDA--SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.||+|++||...... +....+...++ +...+.+..+||.++|+.||.+|||+++|+.
T Consensus 210 tLL~G~PPFetk~vk------------------ety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 210 TLLVGRPPFETKTVK------------------ETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hhhhCCCCcccchHH------------------HHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999998753221 22222222222 2346678899999999999999999999996
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=326.16 Aligned_cols=233 Identities=40% Similarity=0.697 Sum_probs=201.3
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecC-eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.++|.+|+.+|.+++|||+|+++|||.+++ +.+|||||+++|+|++++...... .++|.++.+|+.++|.||+|||+.
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~ 193 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEG 193 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccC
Confidence 667999999999999999999999999999 599999999999999999764333 889999999999999999999997
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCC-CCcccccccc-cccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG-DELQSNTKRI-VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~-~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
...+|+||||||+|||+|++.++||+|||+++.... ... .... .||.+|+|||+...+..+.|+||||||+++.|
T Consensus 194 ~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllE 270 (361)
T KOG1187|consen 194 CPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLE 270 (361)
T ss_pred CCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHH
Confidence 777899999999999999999999999999966543 211 1112 79999999999999999999999999999999
Q ss_pred HHhCCCCcCCCC-CcchhHhHhHhhhhccCCcccccccccc-CCCCH-HHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 166 TLSSKKNAHFYN-TDSLTLLGHAWNLWNDGRAWELMDSILQ-NDASY-PMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 166 lltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|+||+.+..... .....+..|.+..+......+++++.+. +.... .....+..+...|++.+|.+||+|.+|+++|+
T Consensus 271 litgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 271 LITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 999998877644 3344477777888888889999999987 55543 56778899999999999999999999999996
Q ss_pred ccc
Q 038647 243 NEN 245 (289)
Q Consensus 243 ~~~ 245 (289)
...
T Consensus 351 ~~~ 353 (361)
T KOG1187|consen 351 GIL 353 (361)
T ss_pred hhc
Confidence 543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=323.47 Aligned_cols=219 Identities=29% Similarity=0.479 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecC-eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.++|.+|+.+|.+++|||||+++|++.+.. .+++||||+++|+|.+++... ....+++..++.|+.||+.||.|||++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~ 161 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE 161 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 679999999999999999999999999988 799999999999999999653 457899999999999999999999987
Q ss_pred CCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCcccccccccccccccChhhhh--cCCCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL--RGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~vl~ 164 (289)
+. ||||||||+|+|++.++ ++||+|||+++...... .......||+.|||||++. +..|+.|+||||||+++|
T Consensus 162 ~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlW 237 (362)
T KOG0192|consen 162 GP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLW 237 (362)
T ss_pred CC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHH
Confidence 63 99999999999999997 99999999998765432 2233367999999999999 569999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
||+||+.||....... ... .... ...+...+...+..+..++..||..||+.||++.+++..|+..
T Consensus 238 El~t~~~Pf~~~~~~~--~~~---~v~~---------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 238 ELLTGEIPFEDLAPVQ--VAS---AVVV---------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred HHHHCCCCCCCCCHHH--HHH---HHHh---------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 9999999988655411 111 1111 1111222223567889999999999999999999999999976
Q ss_pred cC
Q 038647 245 NV 246 (289)
Q Consensus 245 ~~ 246 (289)
..
T Consensus 304 ~~ 305 (362)
T KOG0192|consen 304 MS 305 (362)
T ss_pred HH
Confidence 43
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=318.87 Aligned_cols=203 Identities=26% Similarity=0.375 Sum_probs=172.3
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
...+|+++|++++|||||+++++|+..+..|+||||++||.|.+++ -.++.+.+..-..+++|++.|+.|||++|
T Consensus 222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~G-- 296 (475)
T KOG0615|consen 222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQG-- 296 (475)
T ss_pred hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHcC--
Confidence 3579999999999999999999999999999999999999999988 45677888889999999999999999998
Q ss_pred ceEeeccccCceEeCCC---CceEEcccccccccCCCCcccccccccccccccChhhhhcCCC---CCcccchhHHHHHH
Q 038647 91 RVIHRDLKASNILLDSN---MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF---SIKSDVFSFGVLVL 164 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~---~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslG~vl~ 164 (289)
|+||||||+|||+..+ -.+||+|||+|+..+.. ..+.+++||+.|.|||++.+..+ ..+.|+||+||++|
T Consensus 297 -I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLf 372 (475)
T KOG0615|consen 297 -IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLF 372 (475)
T ss_pred -cccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEE
Confidence 9999999999999766 67999999999987643 35678899999999999986543 34889999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCC------CCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND------ASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
-+++|.+||........ +.+++..+. .-..++++..++|.+||..||++|||+.|++
T Consensus 373 vcLsG~pPFS~~~~~~s-----------------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 373 VCLSGYPPFSEEYTDPS-----------------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred EEeccCCCcccccCCcc-----------------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 99999999875444321 112222222 2234678899999999999999999999998
Q ss_pred H
Q 038647 239 S 239 (289)
Q Consensus 239 ~ 239 (289)
+
T Consensus 436 ~ 436 (475)
T KOG0615|consen 436 N 436 (475)
T ss_pred c
Confidence 6
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=305.31 Aligned_cols=219 Identities=23% Similarity=0.340 Sum_probs=180.0
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeee-eEeecCe-EEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFG-CCIEHGE-KILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l 81 (289)
+.+..++...|+.+|++++|||||++++ .|.+++. ++||||||.+|+|.++++..+ ..+.+++..+++++.|++.||
T Consensus 58 d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL 137 (375)
T KOG0591|consen 58 DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRAL 137 (375)
T ss_pred cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHH
Confidence 4556788899999999999999999998 5655555 999999999999999987644 456899999999999999999
Q ss_pred HHHhcCCC-CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 82 LYLHHYSR-LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~-~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.++|.+-. ..|+||||||.|||++.+|.|||+|||+++.+.... ....+.+|||.||+||.+.+.+|+.|+||||+|
T Consensus 138 ~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslG 215 (375)
T KOG0591|consen 138 YHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLG 215 (375)
T ss_pred HHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHH
Confidence 99998321 249999999999999999999999999999876543 234567999999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCC----HHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDAS----YPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|++|||+.-++||.+.+-. ++-+.+.+++.+ ...+.++..+|..|+..||+.||+.-.
T Consensus 216 CllyEMcaL~~PF~g~n~~------------------~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~ 277 (375)
T KOG0591|consen 216 CLLYEMCALQSPFYGDNLL------------------SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVP 277 (375)
T ss_pred HHHHHHHhcCCCcccccHH------------------HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcch
Confidence 9999999999998755211 222233333332 447789999999999999999998555
Q ss_pred HHHHhhc
Q 038647 237 VISMLTN 243 (289)
Q Consensus 237 ll~~L~~ 243 (289)
+++.+..
T Consensus 278 ~v~di~~ 284 (375)
T KOG0591|consen 278 YVQDIQS 284 (375)
T ss_pred HHHHHHH
Confidence 5554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=315.63 Aligned_cols=218 Identities=33% Similarity=0.487 Sum_probs=182.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|+++|++++|+|||+++++|..++.+|||||||+.|+|.++|.. ...+.+...+.+.++.|||+|++||+++
T Consensus 244 ~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~ 322 (468)
T KOG0197|consen 244 SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK 322 (468)
T ss_pred ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999999999999999999999999999999999999965 3467889999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ +|||||.++||||+++..+||+|||+++......+....+ ..-+..|.|||.+....++.|+||||||++|+|++
T Consensus 323 ~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~f 398 (468)
T KOG0197|consen 323 N---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELF 398 (468)
T ss_pred C---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHh
Confidence 8 9999999999999999999999999999665554433222 23467899999999999999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
| |+.|++.....+. .+.+++..+-..+...+..+-+++..||+.+|++|||++.+...|+...
T Consensus 399 T~G~~py~~msn~ev---------------~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 399 TYGRVPYPGMSNEEV---------------LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ccCCCCCCCCCHHHH---------------HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 9 6666554433211 1222333333445556788999999999999999999999999888654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=301.67 Aligned_cols=165 Identities=28% Similarity=0.491 Sum_probs=149.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+...+.+..|+.+|+.++|||||.+++++..++.+|+|||||.||+|.+++. ..+.+++.++..++.||+.||++||
T Consensus 50 ~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~ 126 (429)
T KOG0595|consen 50 KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLH 126 (429)
T ss_pred HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456778899999999999999999999999999999999999999999994 4568999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCC------CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 86 HYSRLRVIHRDLKASNILLDSN------MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~------~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
+++ ||||||||+|||++.. -.+||+|||+++....+.. ..+.+|++-|||||++....|+.|+|+||+
T Consensus 127 ~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSi 200 (429)
T KOG0595|consen 127 ENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSI 200 (429)
T ss_pred HCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHH
Confidence 988 9999999999999765 4589999999998875443 445799999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCc
Q 038647 160 GVLVLETLSSKKNAHFYNTD 179 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~ 179 (289)
|+++|++++|..||...+..
T Consensus 201 G~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 201 GTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred HHHHHHHHhCCCCccccCHH
Confidence 99999999999998865443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=295.83 Aligned_cols=200 Identities=25% Similarity=0.345 Sum_probs=173.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+..++|..||.+++||+||+++..|++.+.+|+|+||+.||.|..+| +..+.+++..+.-++..|+.||.|||+
T Consensus 67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~ 143 (357)
T KOG0598|consen 67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHS 143 (357)
T ss_pred hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHh
Confidence 46778899999999999999999999999999999999999999999999 567889999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+| ||||||||+|||+|.+|+++|+|||+++...... ..+.+++||+.|||||++.+..|+..+|.||||+++|||
T Consensus 144 ~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeM 218 (357)
T KOG0598|consen 144 KG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEM 218 (357)
T ss_pred CC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHH
Confidence 98 9999999999999999999999999999654332 235568999999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCC---CCHHHHHHHHHHHHcccccCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND---ASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
++|.+||...+... ..+.+.... .+.-.+.+.++++..+|+.||++|.
T Consensus 219 L~G~pPF~~~~~~~------------------~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 219 LTGKPPFYAEDVKK------------------MYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hhCCCCCcCccHHH------------------HHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 99999987654332 112222221 2222557889999999999999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=298.57 Aligned_cols=215 Identities=26% Similarity=0.416 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecC--eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHG--EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
.+.+++|+++|++++|||||+++|...... .+++.|||+++|+|.+++... .+.+++..+..+..||++||+|||+
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs 135 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHS 135 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 677999999999999999999999855444 699999999999999999542 2279999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCC-CCceEEcccccccccCC-CCcccccccccccccccChhhhhcC-CCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGG-DELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl 163 (289)
+| |+||||||+|||++. ++.+||+|||++..... ...........||+.|||||++..+ ...+++|||||||++
T Consensus 136 ~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtV 212 (313)
T KOG0198|consen 136 KG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTV 212 (313)
T ss_pred CC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEE
Confidence 88 999999999999999 79999999999987653 1112224457899999999999953 334699999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
.||+||..|+....... ........... ....+...+.+..+++..|++.||++|||+.++++..
T Consensus 213 vEM~Tg~~PW~~~~~~~----~~~~~ig~~~~---------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 213 VEMLTGKPPWSEFFEEA----EALLLIGREDS---------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred EeccCCCCcchhhcchH----HHHHHHhccCC---------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 99999999976430000 00111111111 1133334667889999999999999999999999843
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=291.03 Aligned_cols=222 Identities=26% Similarity=0.393 Sum_probs=177.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.++.+.+|+..|+.++||||++++..|..+..+|+||.||.+|++.++++..-..+ +++..+..++++++.||.|||.+
T Consensus 67 ~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~ 145 (516)
T KOG0582|consen 67 DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN 145 (516)
T ss_pred hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc
Confidence 47899999999999999999999999999999999999999999999997644443 89999999999999999999999
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCC-cccc-cccccccccccChhhhhc--CCCCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE-LQSN-TKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~~~~-~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~vl 163 (289)
| .+|||||+.||||+.+|.|||+|||.+..+.... .... ..++.||+.|||||++.. ..|+.|+||||||+..
T Consensus 146 G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA 222 (516)
T KOG0582|consen 146 G---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITA 222 (516)
T ss_pred C---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHH
Confidence 8 9999999999999999999999999887664332 1222 267789999999999653 4799999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.||.+|..||.-...-...+. ..... .....-.....+........+.+++..||+.||.+|||+.++++
T Consensus 223 ~ELA~G~aPf~k~pPmkvLl~-----tLqn~-pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 223 CELAHGHAPFSKYPPMKVLLL-----TLQND-PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHhcCCCCcccCChHHHHHH-----HhcCC-CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 999999999875543322111 11111 11111111122222334568889999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=301.25 Aligned_cols=207 Identities=25% Similarity=0.351 Sum_probs=174.5
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|+.+++.++ ||||+++++++.....+|+|||||.||+|.+++. ..+++.+..+..++.|++.|+.|+|
T Consensus 61 ~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H 137 (370)
T KOG0583|consen 61 KLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCH 137 (370)
T ss_pred ccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHH
Confidence 34567778999999998 9999999999999999999999999999999994 4678999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCC-CceEEcccccccccCCCCcccccccccccccccChhhhhcCC-CC-CcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FS-IKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~-~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DiwslG~v 162 (289)
++| |+||||||+|+|++.+ +++||+|||++.... .......+.+|++.|+|||++.+.. |+ .++||||+|++
T Consensus 138 ~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GVi 212 (370)
T KOG0583|consen 138 SRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVI 212 (370)
T ss_pred hCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHH
Confidence 988 9999999999999999 999999999999773 1223456679999999999999877 85 88999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCC--CHHH-HHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDA--SYPM-LNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||.|++|..||...+..... ..+..+.. +... +.++.+++.+||..||.+|+|+.+++.
T Consensus 213 Ly~ml~G~~PF~d~~~~~l~------------------~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 213 LYVLLCGRLPFDDSNVPNLY------------------RKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHHhCCCCCCCccHHHHH------------------HHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 99999999998863221110 11111111 1112 678999999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=297.47 Aligned_cols=211 Identities=23% Similarity=0.327 Sum_probs=179.5
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.-++...+|-.+|.+| .||.|++++.-|++...+|+|+||+++|+|.++++ +-+.+++.....++.+|+.||+||
T Consensus 114 e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleyl 190 (604)
T KOG0592|consen 114 EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYL 190 (604)
T ss_pred hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHH
Confidence 34556677899999999 79999999999999999999999999999999994 457899999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc---------ccc--ccccccccccChhhhhcCCCCCc
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ---------SNT--KRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~---------~~~--~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
|++| ||||||||+|||++++++++|.|||.++.+...... ... .+++||-.|.+||++.....++.
T Consensus 191 H~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~ 267 (604)
T KOG0592|consen 191 HSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS 267 (604)
T ss_pred HhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc
Confidence 9988 999999999999999999999999999987543211 112 56899999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccc--cCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 154 SDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSIL--QNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 154 ~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
+|||+|||++|+|+.|.+||...+.... ++++. .-..+...++...+||.+.|..||.+|
T Consensus 268 sDiWAlGCilyQmlaG~PPFra~Neyli------------------FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~R 329 (604)
T KOG0592|consen 268 SDLWALGCILYQMLAGQPPFRAANEYLI------------------FQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDR 329 (604)
T ss_pred cchHHHHHHHHHHhcCCCCCccccHHHH------------------HHHHHHhcccCCCCCCHHHHHHHHHHHccCcccc
Confidence 9999999999999999999987665421 11111 113334455788999999999999999
Q ss_pred CCHHHHHHH
Q 038647 232 PTMLEVISM 240 (289)
Q Consensus 232 ps~~~ll~~ 240 (289)
+|..+|-+.
T Consensus 330 lt~~qIk~H 338 (604)
T KOG0592|consen 330 LTSQQIKAH 338 (604)
T ss_pred ccHHHHhhC
Confidence 999888763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=299.11 Aligned_cols=210 Identities=23% Similarity=0.364 Sum_probs=177.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+-+.+|+.+|+..+|+|||++++.|..++.+++||||++||+|.+.+.. ..+++.++..+|+++++||+|||.+
T Consensus 313 ~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~ 388 (550)
T KOG0578|consen 313 KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHAR 388 (550)
T ss_pred chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhc
Confidence 455677999999999999999999999999999999999999999998843 4589999999999999999999999
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
| |+|||||.+|||++.+|.+||+|||++..+..... ...+.+|||.|||||++....|.+|.||||||++++||+
T Consensus 389 g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMv 463 (550)
T KOG0578|consen 389 G---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMV 463 (550)
T ss_pred c---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHh
Confidence 8 99999999999999999999999999988765543 455678999999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
-|.+||-..+.-.. .+.....+.. .-......+..+.+++.+||..|+++|+++.|||+
T Consensus 464 eGEPPYlnE~PlrA-----lyLIa~ng~P--------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 464 EGEPPYLNENPLRA-----LYLIATNGTP--------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCCCccCCChHHH-----HHHHhhcCCC--------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 99999765332211 1111111111 11122335678999999999999999999999987
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=278.73 Aligned_cols=228 Identities=19% Similarity=0.260 Sum_probs=176.4
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+++...+-..||+++|++++|+|+|.++++|.....+++|+|||+..-|.++- . ....++.+.+.++++|++.|+.|
T Consensus 40 dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe-~--~p~G~~~~~vk~~l~Q~l~ai~~ 116 (396)
T KOG0593|consen 40 DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELE-R--YPNGVPSELVKKYLYQLLKAIHF 116 (396)
T ss_pred ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHH-h--ccCCCCHHHHHHHHHHHHHHhhh
Confidence 34445667789999999999999999999999999999999999886665543 2 23447888999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~v 162 (289)
+|+++ ++||||||+|||++.+|.+||+|||+|+..... .......+.|.+|.|||.+.+ ..|....||||+||+
T Consensus 117 cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv 191 (396)
T KOG0593|consen 117 CHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCV 191 (396)
T ss_pred hhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHH
Confidence 99988 999999999999999999999999999987632 223445678999999999997 789999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhH-hHh--------HhhhhccCCcccccc-cccc-----CCCCHHHHHHHHHHHHcccccC
Q 038647 163 VLETLSSKKNAHFYNTDSLTL-LGH--------AWNLWNDGRAWELMD-SILQ-----NDASYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~~l~~~ 227 (289)
+.||++|.+.|++.++-+... +.. ....|.......-+. +... ....+..+.-+.+++..||+.|
T Consensus 192 ~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~d 271 (396)
T KOG0593|consen 192 FAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMD 271 (396)
T ss_pred HHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCC
Confidence 999999999998876653322 111 112222222111100 0000 0111224457789999999999
Q ss_pred CCCCCCHHHHHH
Q 038647 228 AADRPTMLEVIS 239 (289)
Q Consensus 228 p~~Rps~~~ll~ 239 (289)
|++|++-++++.
T Consensus 272 P~~R~sc~qll~ 283 (396)
T KOG0593|consen 272 PDDRLSCEQLLH 283 (396)
T ss_pred ccccccHHHHhc
Confidence 999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=294.82 Aligned_cols=218 Identities=23% Similarity=0.262 Sum_probs=174.6
Q ss_pred HHHHHHhhCC-CCCceeeeeeEeecC-eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc
Q 038647 14 NEMMLIAKLQ-HRNLVRLFGCCIEHG-EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLR 91 (289)
Q Consensus 14 ~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 91 (289)
||++.|++++ |||||++.+++.+.+ .+|+|||||+. +|.++++++ +..+++..+..|++||++||+|+|.+|
T Consensus 57 REvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--- 130 (538)
T KOG0661|consen 57 REVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--- 130 (538)
T ss_pred HHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---
Confidence 7999999998 999999999999888 99999999966 899998764 678999999999999999999999998
Q ss_pred eEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHHhCC
Q 038647 92 VIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSSK 170 (289)
Q Consensus 92 ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~elltg~ 170 (289)
+.|||+||+|||+..+..+||+|||+||....... ....+.|.+|.|||++.. .-|+.+.|+|++|||++|+.+-+
T Consensus 131 fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr 207 (538)
T KOG0661|consen 131 FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR 207 (538)
T ss_pred cccccCChhheEecccceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998765432 334578999999999975 56899999999999999999999
Q ss_pred CCcCCCCCcch-hHhHhHhhhhccCCccc------ccccccc-------CCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 171 KNAHFYNTDSL-TLLGHAWNLWNDGRAWE------LMDSILQ-------NDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 171 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
+.|++.++-+. ..+....+........+ .+..... .......+.+..+++..|+++||++|||+.+
T Consensus 208 PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 208 PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred ccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence 99988765533 22222222211111111 1111111 1111225678899999999999999999999
Q ss_pred HHHH
Q 038647 237 VISM 240 (289)
Q Consensus 237 ll~~ 240 (289)
.++.
T Consensus 288 al~~ 291 (538)
T KOG0661|consen 288 ALQH 291 (538)
T ss_pred HhcC
Confidence 9884
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.43 Aligned_cols=206 Identities=24% Similarity=0.362 Sum_probs=177.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..-..+++|+-||+-+.|||++.++++++++.++|+|.||+++|.|.+++ ...+.+++..+++++.||+.|+.|+|.
T Consensus 54 s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~ 130 (786)
T KOG0588|consen 54 SQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHA 130 (786)
T ss_pred ccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhh
Confidence 34566789999999999999999999999999999999999999999998 456889999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~e 165 (289)
.+ |||||+||+|+|++..+++||+|||.|..-..+ ....+.||++.|+|||++.|.+| ..++||||.|||||.
T Consensus 131 ~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfA 204 (786)
T KOG0588|consen 131 FN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFA 204 (786)
T ss_pred hc---ceeccCCchhhhhhcccCEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHH
Confidence 88 999999999999999999999999999764443 33556799999999999999998 689999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCC--CCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND--ASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||||+.||+..+... ++.+..++. .+..++.+..+|+++|+..||++|.|++||++
T Consensus 205 LLtG~LPFdDdNir~------------------LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 205 LLTGKLPFDDDNIRV------------------LLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHhCCCCCCCccHHH------------------HHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 999999987433222 112222222 23446789999999999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=294.37 Aligned_cols=220 Identities=28% Similarity=0.389 Sum_probs=172.7
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeec-CeEEEEEeecCCCChhhhhcCCCC------------------------
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEH-GEKILIYEYMPNKSLDCFLFDPTK------------------------ 61 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------ 61 (289)
..+.+.+|+.+|+.+ +||||+++++++... +.+++||||+++|+|.+++.....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (338)
T cd05102 53 EHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132 (338)
T ss_pred HHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhc
Confidence 456799999999999 899999999988764 468999999999999988854211
Q ss_pred -----------------------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCC
Q 038647 62 -----------------------------------TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS 106 (289)
Q Consensus 62 -----------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~ 106 (289)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~ 209 (338)
T cd05102 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSE 209 (338)
T ss_pred cccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcC
Confidence 134778888999999999999999988 999999999999999
Q ss_pred CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhH
Q 038647 107 NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLG 185 (289)
Q Consensus 107 ~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 185 (289)
++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........ ..
T Consensus 210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~- 287 (338)
T cd05102 210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC- 287 (338)
T ss_pred CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH-
Confidence 99999999999986543222222233456778999999999999999999999999999997 9988875433211 10
Q ss_pred hHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 186 HAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
........ ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 288 ---~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 288 ---QRLKDGTR---------MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred ---HHHhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111110 011123346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=308.88 Aligned_cols=223 Identities=30% Similarity=0.432 Sum_probs=185.5
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-----------CCCCChHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-----------TGLLGWEMRVRI 73 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~ 73 (289)
+.++.++|+||+++|+.++|||||+++|+|.+++.+|+|+|||..|+|.+||..... .+.++..+.+.+
T Consensus 529 ~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~i 608 (774)
T KOG1026|consen 529 ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHI 608 (774)
T ss_pred cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHH
Confidence 445789999999999999999999999999999999999999999999999965321 223788899999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCc
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+.|||.|+.||-++. +|||||..+|+||+++..|||+|||+++..-..++....+...-+.+|||||.+....||.+
T Consensus 609 A~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte 685 (774)
T KOG1026|consen 609 ATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE 685 (774)
T ss_pred HHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch
Confidence 999999999999887 99999999999999999999999999998766665554545566889999999999999999
Q ss_pred ccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 154 SDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 154 ~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+|||||||+|||+++ |+-|+....+...-. ....+.. =+.+...+.++.+|+..||+.+|.+||
T Consensus 686 SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe------~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RP 750 (774)
T KOG1026|consen 686 SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE------CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRP 750 (774)
T ss_pred hhhhhhhhhhhhhhccccCcccccchHHHHH------HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCC
Confidence 999999999999998 666655544332111 1111111 123344567999999999999999999
Q ss_pred CHHHHHHHhhccc
Q 038647 233 TMLEVISMLTNEN 245 (289)
Q Consensus 233 s~~~ll~~L~~~~ 245 (289)
+++||-..|+...
T Consensus 751 sF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 751 SFKEIHSRLQAWA 763 (774)
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=286.15 Aligned_cols=212 Identities=19% Similarity=0.298 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+.|.+|+.+|++++||||+++++++.+ ....++||||+++|+|.+++. ..+.+++.....++.+++.||.||
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~l 138 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNL 138 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHH
Confidence 6788999999999999999999999877 457899999999999999994 345688899999999999999999
Q ss_pred hcC-CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc--CCCCCcccchhHHH
Q 038647 85 HHY-SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~-~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~ 161 (289)
|.. + ++||||||+||++++++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||
T Consensus 139 H~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv 210 (283)
T PHA02988 139 YKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210 (283)
T ss_pred HhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence 974 5 8899999999999999999999999988654321 12357889999999976 67999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
++|+|++|..||....... ..... ..... ....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 211 il~el~~g~~Pf~~~~~~~--~~~~i---~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 211 VLWEIFTGKIPFENLTTKE--IYDLI---INKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHHHHHHCCCCCCCCCHHH--HHHHH---HhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 9999999999987543221 11110 00000 0111223456899999999999999999999999999
Q ss_pred hccc
Q 038647 242 TNEN 245 (289)
Q Consensus 242 ~~~~ 245 (289)
+...
T Consensus 277 ~~~~ 280 (283)
T PHA02988 277 SLYK 280 (283)
T ss_pred HHHH
Confidence 8754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=272.34 Aligned_cols=196 Identities=27% Similarity=0.390 Sum_probs=172.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
.+++...+|..+|+.+.||+++++++.|.+.+++|+||||.+||.|..++ ++.+++++..++.++.+|+.||+|||+
T Consensus 86 KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~ 162 (355)
T KOG0616|consen 86 KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHS 162 (355)
T ss_pred HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHh
Confidence 35677889999999999999999999999999999999999999999999 567889999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ |++||+||+|||+|.+|.+||.|||+++.... .+.+.+|||.|+|||++...++..++|.||||+++|||
T Consensus 163 ~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEM 234 (355)
T KOG0616|consen 163 LD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEM 234 (355)
T ss_pred cC---eeeccCChHHeeeccCCcEEEEeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHH
Confidence 88 99999999999999999999999999998743 35668999999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCC--CCHHHHHHHHHHHHcccccCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND--ASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
+.|.+||...+.- .+.+.++.+. .+...+.++.+|+..+|+.|-.+|
T Consensus 235 laG~pPF~~~~~~------------------~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 235 LAGYPPFYDDNPI------------------QIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HcCCCCCcCCChH------------------HHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 9999998755431 2223333322 233456789999999999999998
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=285.25 Aligned_cols=209 Identities=22% Similarity=0.363 Sum_probs=181.9
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+++++-.+.+|++||+.++||||+.++.+|+..+.+.|||||..+|.|.+++ ..++.+++.....++.||+.|+.|
T Consensus 92 kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhY 168 (668)
T KOG0611|consen 92 KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHY 168 (668)
T ss_pred ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHH
Confidence 45677888999999999999999999999999999999999999999999999 677889999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~v 162 (289)
+|.++ ++|||||.+|||+|.|+++||+|||++..+.... ...+++|++-|.+||++++.+| .+..|-||||++
T Consensus 169 CHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvL 242 (668)
T KOG0611|consen 169 CHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVL 242 (668)
T ss_pred Hhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHH
Confidence 99887 9999999999999999999999999998876543 3556899999999999999998 699999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCC-CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDA-SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||.|+.|..||.+.+... ++.++.++.+ .++-+.+..-||++||..||++|.|+++|..
T Consensus 243 LYtLVyGtMPFDG~Dhk~------------------lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 243 LYTLVYGTMPFDGRDHKR------------------LVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHHhhcccccCCchHHH------------------HHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 999999999987654332 2222222222 2334457788999999999999999999976
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.72 Aligned_cols=228 Identities=25% Similarity=0.423 Sum_probs=174.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC----------------CCCCCChHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT----------------KTGLLGWEMR 70 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~ 70 (289)
...++|.+|+++|.+++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..+
T Consensus 61 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05096 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL 140 (304)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHH
Confidence 345689999999999999999999999999999999999999999998875321 1134677889
Q ss_pred HHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC
Q 038647 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF 150 (289)
Q Consensus 71 ~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 150 (289)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..+
T Consensus 141 ~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (304)
T cd05096 141 LHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217 (304)
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence 999999999999999988 99999999999999999999999999986544332222333456788999999998899
Q ss_pred CCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 151 SIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 151 ~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
+.++||||||+++|+|+++..+.++...............+....... ....+...+..+.+++.+||+.||++
T Consensus 218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchh
Confidence 999999999999999998654444433332222222211111110000 00111234568899999999999999
Q ss_pred CCCHHHHHHHhhc
Q 038647 231 RPTMLEVISMLTN 243 (289)
Q Consensus 231 Rps~~~ll~~L~~ 243 (289)
|||+.+|.+.|++
T Consensus 292 RPs~~~i~~~l~~ 304 (304)
T cd05096 292 RPSFSDIHAFLTE 304 (304)
T ss_pred CcCHHHHHHHHhC
Confidence 9999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=291.47 Aligned_cols=215 Identities=26% Similarity=0.367 Sum_probs=182.9
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe-EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE-KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+....+....|+.++++++|||||.+.+.|.+++. ++|||+||+||++.+.+.+.+ ...++++.+..|+.|++.|+.|
T Consensus 43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~y 121 (426)
T KOG0589|consen 43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNY 121 (426)
T ss_pred CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHH
Confidence 34455578899999999999999999999999888 999999999999999986533 5679999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
||++. |+|||||+.|||++.++.|+|+|||+++..+... ....+..||+.|++||++.+.+|..|+|||||||++
T Consensus 122 lH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~ 196 (426)
T KOG0589|consen 122 LHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCL 196 (426)
T ss_pred HHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchH
Confidence 99777 9999999999999999999999999999887654 234567899999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
|||++-+++|...+...... ++.... ....+...+.++..+|..||+.+|+.||++.+++..
T Consensus 197 yEm~~lk~aF~a~~m~~Li~--------------ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 197 YEMCTLKPAFKASNMSELIL--------------KINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhcccccCccchHHHHH--------------HHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999887655432211 111111 234445567899999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=284.26 Aligned_cols=227 Identities=21% Similarity=0.250 Sum_probs=176.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+.......|||.||++|+||||+++.+...+. ..+|||+|||+. +|.-++. ...-.+++.++..+++|++.||+|
T Consensus 157 ~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~ 233 (560)
T KOG0600|consen 157 EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEY 233 (560)
T ss_pred CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHH
Confidence 44566778999999999999999999999876 689999999966 7877774 234469999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~v 162 (289)
+|.+| |+|||||.+|||||.+|.+||+|||+|+.+....... ....+-|.+|.|||.+.|. .|+.+.|+||.|||
T Consensus 234 cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCI 309 (560)
T KOG0600|consen 234 CHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCI 309 (560)
T ss_pred HhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHH
Confidence 99988 9999999999999999999999999999876554332 4556789999999999975 79999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccc--------ccccccc-----CCCCHHHHHHHHHHHHcccccCCC
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWE--------LMDSILQ-----NDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+.||++|++.+++..+-.......-.........+. .++.... .+.....+....+|+..+|..||+
T Consensus 310 l~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~ 389 (560)
T KOG0600|consen 310 LAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD 389 (560)
T ss_pred HHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc
Confidence 999999999988766543322221111111111111 1111000 001122446778999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|.|+.++++
T Consensus 390 kR~tA~~aL~ 399 (560)
T KOG0600|consen 390 KRGTASSALQ 399 (560)
T ss_pred ccccHHHHhc
Confidence 9999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=295.40 Aligned_cols=226 Identities=26% Similarity=0.346 Sum_probs=182.9
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
..++++++|++|+++|++++|||||+++|+......+|+|||+|+||+|.++|.+.. +.++..++..++.+.+.||+|
T Consensus 200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~Y 277 (474)
T KOG0194|consen 200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEY 277 (474)
T ss_pred ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHH
Confidence 457789999999999999999999999999999999999999999999999996432 268999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
||+++ ++||||-.+|+|++.++.+||+|||+++........ .....-+.+|+|||.+....|+.++|||||||++
T Consensus 278 Lh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~ 352 (474)
T KOG0194|consen 278 LHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLL 352 (474)
T ss_pred HHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeE
Confidence 99988 999999999999999999999999998865421111 1112346799999999999999999999999999
Q ss_pred HHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 164 LETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 164 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
||+++ |..|++..... ...... .....+...+...+..+..++.+||..||++||+|.++.+.|+
T Consensus 353 ~Eif~~g~~Py~g~~~~--~v~~kI------------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 353 WEIFENGAEPYPGMKNY--EVKAKI------------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred EeeeccCCCCCCCCCHH--HHHHHH------------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 99999 67766544332 111111 0111112223345678888899999999999999999999999
Q ss_pred cccCCCCC
Q 038647 243 NENVILPS 250 (289)
Q Consensus 243 ~~~~~~~~ 250 (289)
........
T Consensus 419 ~~~~~~~~ 426 (474)
T KOG0194|consen 419 ALEKKKEA 426 (474)
T ss_pred HHHhcccc
Confidence 87655443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=290.17 Aligned_cols=209 Identities=26% Similarity=0.408 Sum_probs=175.3
Q ss_pred HHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceE
Q 038647 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVI 93 (289)
Q Consensus 14 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iv 93 (289)
.+|+=|++|+|+||+.+.|+|...--+|||||||..|-|...| +....+.......|..+||.|+.|||.+. ||
T Consensus 161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---II 234 (904)
T KOG4721|consen 161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---II 234 (904)
T ss_pred hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---Hh
Confidence 4788899999999999999999999999999999999999999 45667889999999999999999999887 99
Q ss_pred eeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCc
Q 038647 94 HRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNA 173 (289)
Q Consensus 94 H~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~ 173 (289)
|||||.-||||..+..|||+|||-++..... ...-.+.||..|||||++.+.+.+.|.|||||||||||||||..|+
T Consensus 235 HRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPY 311 (904)
T KOG4721|consen 235 HRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPY 311 (904)
T ss_pred hhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCc
Confidence 9999999999999999999999999876543 3345678999999999999999999999999999999999999987
Q ss_pred CCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 174 HFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
....... ..| ..+. ..+.-..+...++.+.-|+++||+..|..|||+++++..|+-..
T Consensus 312 kdVdssA-----IIw---GVGs------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 312 KDVDSSA-----IIW---GVGS------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cccchhe-----eEE---eccC------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 5332211 111 1111 11112223345677888999999999999999999999998654
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=280.41 Aligned_cols=223 Identities=26% Similarity=0.443 Sum_probs=178.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRVRIL 74 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~~~ 74 (289)
..+.|.+|++++++++|+||+++++++.+++..++||||+++++|.+++.... ..+.+++..++.++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 45789999999999999999999999999999999999999999999985422 12458899999999
Q ss_pred HHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcc
Q 038647 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKS 154 (289)
Q Consensus 75 ~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 154 (289)
.||+.||.|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++
T Consensus 130 ~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (291)
T cd05094 130 SQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206 (291)
T ss_pred HHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence 99999999999988 999999999999999999999999999765433322222334567889999999998999999
Q ss_pred cchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 155 DVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 155 DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
||||||+++|+|++ |..|+....... . .......... ......+..+.+++.+||+.||++|||
T Consensus 207 Di~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt 271 (291)
T cd05094 207 DVWSFGVILWEIFTYGKQPWFQLSNTE--V----IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLN 271 (291)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcC
Confidence 99999999999999 888875433221 1 1111111110 111123567899999999999999999
Q ss_pred HHHHHHHhhcccCCC
Q 038647 234 MLEVISMLTNENVIL 248 (289)
Q Consensus 234 ~~~ll~~L~~~~~~~ 248 (289)
+.+|++.|+......
T Consensus 272 ~~~v~~~l~~~~~~~ 286 (291)
T cd05094 272 IKEIYKILHALGKAT 286 (291)
T ss_pred HHHHHHHHHHHHhhc
Confidence 999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=300.09 Aligned_cols=215 Identities=21% Similarity=0.267 Sum_probs=174.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.....+.+|+.+|+.++|||||++++++.+++..|+||||+++|+|.+++.+. .....+++..+..++.||+.||.|||
T Consensus 107 ~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH 186 (478)
T PTZ00267 107 RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186 (478)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567888999999999999999999999999999999999999999887542 23456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+
T Consensus 187 ~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 263 (478)
T PTZ00267 187 SRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263 (478)
T ss_pred hCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHH
Confidence 888 99999999999999999999999999987654332223445579999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||....... .... ... +.. ...+...+..+.+++..||+.||++||++.+++.
T Consensus 264 l~tg~~Pf~~~~~~~--~~~~---~~~-~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 264 LLTLHRPFKGPSQRE--IMQQ---VLY-GKY---------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHhCCCCCCCCCHHH--HHHH---HHh-CCC---------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 999999986433211 1100 000 000 0112234568899999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=290.45 Aligned_cols=207 Identities=25% Similarity=0.384 Sum_probs=178.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+..++.+.+|++|++.++|||||.++++|++..++++|+|||.| +|..++ ...+.++++.+..++.|++.||.|||
T Consensus 42 ~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLh 117 (808)
T KOG0597|consen 42 EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLH 117 (808)
T ss_pred hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHH
Confidence 44677799999999999999999999999999999999999966 999999 56678999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+|||+||.|||++.++.+|++|||+++.+..+.. ......|||-|||||.+.+++|+..+|.||+||++||
T Consensus 118 s~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE 192 (808)
T KOG0597|consen 118 SNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYE 192 (808)
T ss_pred hcC---cccccCCcceeeecCCCceeechhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHH
Confidence 887 99999999999999999999999999998865432 3455689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCC--CCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND--ASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|++||...... .+.+.+.... .+...+..+..++...|..||.+|.|+.+++.
T Consensus 193 ~~~G~PPF~a~si~------------------~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 193 LYVGQPPFYARSIT------------------QLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhcCCCCchHHHHH------------------HHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 99999997643221 2222222222 22356778999999999999999999999985
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=279.69 Aligned_cols=218 Identities=27% Similarity=0.433 Sum_probs=175.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRVRIL 74 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~ 74 (289)
..++|.+|++++++++||||+++++++.+.+..+++|||+++++|.+++..... ...+++..+..++
T Consensus 51 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (283)
T cd05048 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHH
Confidence 456789999999999999999999999999999999999999999998854321 1457888999999
Q ss_pred HHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcc
Q 038647 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKS 154 (289)
Q Consensus 75 ~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 154 (289)
.|++.||.|||+++ ++||||||+||++++++.++|+|||+++...............+++.|+|||.+.+..++.++
T Consensus 131 ~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 207 (283)
T cd05048 131 IQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES 207 (283)
T ss_pred HHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhh
Confidence 99999999999988 999999999999999999999999999865433222223334567889999999988999999
Q ss_pred cchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 155 DVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 155 DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
|||||||++|+|++ |..||........ . ....... ....+...+.++.+++.+||+.||++||+
T Consensus 208 Dv~slG~il~el~~~g~~p~~~~~~~~~--~----~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~ 272 (283)
T cd05048 208 DIWSFGVVLWEIFSYGLQPYYGFSNQEV--I----EMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPR 272 (283)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHH--H----HHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcC
Confidence 99999999999998 8888764332211 1 1111111 11122345678999999999999999999
Q ss_pred HHHHHHHhhc
Q 038647 234 MLEVISMLTN 243 (289)
Q Consensus 234 ~~~ll~~L~~ 243 (289)
+.+|++.|+.
T Consensus 273 ~~~i~~~l~~ 282 (283)
T cd05048 273 FKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=290.03 Aligned_cols=219 Identities=26% Similarity=0.377 Sum_probs=172.7
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------------------
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK------------------------- 61 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------- 61 (289)
..+.+.+|+++|+.+ +||||+++++++.+++..++||||+++|+|.+++.....
T Consensus 81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (375)
T cd05104 81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM 160 (375)
T ss_pred HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence 456789999999999 899999999999999999999999999999988854211
Q ss_pred -----------------------------------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEe
Q 038647 62 -----------------------------------------------TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIH 94 (289)
Q Consensus 62 -----------------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH 94 (289)
...+++..+..++.||+.||.|||+++ ++|
T Consensus 161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH 237 (375)
T cd05104 161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIH 237 (375)
T ss_pred cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 124778889999999999999999988 999
Q ss_pred eccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh-CCCCc
Q 038647 95 RDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNA 173 (289)
Q Consensus 95 ~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt-g~~p~ 173 (289)
|||||+|||++.++.+||+|||+++...........+...++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 238 ~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~ 317 (375)
T cd05104 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317 (375)
T ss_pred cCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999986643322222223345678999999999999999999999999999998 77776
Q ss_pred CCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 174 HFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
........ ... ...... ....+...+.++.+++..||+.||++|||+.+|++.|++
T Consensus 318 ~~~~~~~~-~~~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 318 PGMPVDSK-FYK----MIKEGY---------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCchHH-HHH----HHHhCc---------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 54332211 111 111110 000111234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=290.91 Aligned_cols=220 Identities=27% Similarity=0.405 Sum_probs=173.5
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC--------------------------
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------------------- 60 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------- 60 (289)
..+.+.+|+.+++.+ +|+||+++++++.+++..++||||+++|+|.+++....
T Consensus 84 ~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (374)
T cd05106 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163 (374)
T ss_pred HHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchh
Confidence 456788999999999 89999999999999999999999999999998875321
Q ss_pred -----------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccc
Q 038647 61 -----------------------------------------KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKA 99 (289)
Q Consensus 61 -----------------------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp 99 (289)
....+++..+..++.||+.||.|||+++ ++||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp 240 (374)
T cd05106 164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAA 240 (374)
T ss_pred cccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCch
Confidence 1124778889999999999999999988 99999999
Q ss_pred CceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCC
Q 038647 100 SNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNT 178 (289)
Q Consensus 100 ~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~ 178 (289)
+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 241 ~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 241 RNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred heEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999999999999999986543322222222345678999999998899999999999999999997 9998865433
Q ss_pred cchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
... .. ...... .....+...+.++.+++..||+.||++|||+.+|++.|++.
T Consensus 321 ~~~-~~----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 321 NSK-FY----KMVKRG---------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cHH-HH----HHHHcc---------cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 211 10 001000 00011112346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=283.71 Aligned_cols=222 Identities=24% Similarity=0.342 Sum_probs=172.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|+++|++++||||+++++++.+++..++||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~ 121 (331)
T cd06649 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLRE 121 (331)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345789999999999999999999999999999999999999999999984 34568899999999999999999997
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ +|+||||||+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|
T Consensus 122 ~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el 195 (331)
T cd06649 122 KH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195 (331)
T ss_pred cC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHH
Confidence 53 3999999999999999999999999998765332 12335689999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhh-hcc-CC----------------------------cccccccccc----CCCCHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNL-WND-GR----------------------------AWELMDSILQ----NDASYPM 212 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~----------------------------~~~~~~~~~~----~~~~~~~ 212 (289)
++|+.||......... ...... ... .. .....+.+.. .......
T Consensus 196 ~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
T cd06649 196 AIGRYPIPPPDAKELE--AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVF 273 (331)
T ss_pred HhCCCCCCCCCHHHHH--HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccc
Confidence 9999998654322110 000000 000 00 0000000000 0011124
Q ss_pred HHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 213 LNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 213 ~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+.++.+++.+||+.||++|||++++++
T Consensus 274 ~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 274 TPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 568899999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=289.15 Aligned_cols=227 Identities=26% Similarity=0.412 Sum_probs=181.1
Q ss_pred CCcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 3 ~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.-++++.+.|++|+.++++-+|-||+-+.|+|..... .||+-+|+|.+|..++.. ....+...+.+.|+.||++|+.
T Consensus 426 ~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~ 502 (678)
T KOG0193|consen 426 DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMD 502 (678)
T ss_pred CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhh
Confidence 3456789999999999999999999999999998877 999999999999999864 3356889999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc---CCCCCcccchhH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSF 159 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Diwsl 159 (289)
|||.++ |||||||..|||+.++++|||+|||++.....-.-........|...|||||++.. .+|++++|||||
T Consensus 503 YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF 579 (678)
T KOG0193|consen 503 YLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF 579 (678)
T ss_pred hhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence 999998 99999999999999999999999999976533222222333457788999999974 579999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|+|||++|..|+.....++.. |..+......+.. ......++++.+|+..||.+++++||.+.+|+.
T Consensus 580 GiV~YELltg~lPysi~~~dqIi--------fmVGrG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 580 GIVWYELLTGELPYSIQNRDQII--------FMVGRGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hHHHHHHHhCcCCcCCCChhheE--------EEecccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 99999999999998833333221 1111110000100 111224568899999999999999999999999
Q ss_pred HhhcccC
Q 038647 240 MLTNENV 246 (289)
Q Consensus 240 ~L~~~~~ 246 (289)
.|+....
T Consensus 649 ~l~~l~~ 655 (678)
T KOG0193|consen 649 KLEELLP 655 (678)
T ss_pred HHHHhhh
Confidence 8887654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=286.54 Aligned_cols=209 Identities=19% Similarity=0.220 Sum_probs=171.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....++.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 37 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~ 113 (323)
T cd05571 37 DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHS 113 (323)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999999999999999999999999998884 34578999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+||+++.++.+||+|||+++..... ........|++.|+|||++.+..++.++|||||||++|+|
T Consensus 114 ~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 188 (323)
T cd05571 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred CC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhh
Confidence 88 999999999999999999999999998753221 1123345799999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
++|..||...+.... ... ..... ...+...+.++.+++.+||+.||++|| ++.++++
T Consensus 189 ltg~~Pf~~~~~~~~--~~~----~~~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 189 MCGRLPFYNQDHEKL--FEL----ILMEE----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred hcCCCCCCCCCHHHH--HHH----HHcCC----------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 999999864332111 100 00000 011223456889999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=257.78 Aligned_cols=223 Identities=22% Similarity=0.274 Sum_probs=174.6
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
....||++.|+.++|+||+.++++|.+.+.+.+|+||++. +|+..+++ +...++...+..|+.+++.|++|||.++
T Consensus 46 ~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~- 121 (318)
T KOG0659|consen 46 RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW- 121 (318)
T ss_pred HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh-
Confidence 4567999999999999999999999999999999999955 89999964 4467999999999999999999999998
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHHHh
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ellt 168 (289)
|+||||||.|+|++.+|.+||+|||+++.++...... ...+-|.+|.|||.+.|. .|+...|+||.||++.||+-
T Consensus 122 --IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll 197 (318)
T KOG0659|consen 122 --ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL 197 (318)
T ss_pred --hhcccCCccceEEcCCCcEEeecccchhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc
Confidence 9999999999999999999999999999887554332 223678999999999975 69999999999999999999
Q ss_pred CCCCcCCCCCcch-hHhHhHhhhhccCCccc--------ccccc---ccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 169 SKKNAHFYNTDSL-TLLGHAWNLWNDGRAWE--------LMDSI---LQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 169 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|.+.|++.++-+. ...-...+......+.+ .+... .........+.+..+++..+|..||.+|+|+.|
T Consensus 198 r~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 198 RVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred cCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 9887766554322 11111111111111111 01111 111123345567899999999999999999999
Q ss_pred HHHH
Q 038647 237 VISM 240 (289)
Q Consensus 237 ll~~ 240 (289)
++++
T Consensus 278 aL~~ 281 (318)
T KOG0659|consen 278 ALKH 281 (318)
T ss_pred Hhcc
Confidence 9864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=283.79 Aligned_cols=212 Identities=25% Similarity=0.368 Sum_probs=178.9
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+..+++.+.|+.+|.+++++||.++|+.+..+..++++||||.||++.+.+ +....+.+..+.-++.+++.||.||
T Consensus 51 ~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~yl 127 (467)
T KOG0201|consen 51 AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYL 127 (467)
T ss_pred cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhh
Confidence 4567889999999999999999999999999999999999999999999998 4555668888999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|.++ .+|||||+.|||+..+|.+||+|||++......... ..+++||+.|||||++.+..|+.|+||||||++.+
T Consensus 128 H~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITai 202 (467)
T KOG0201|consen 128 HSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAI 202 (467)
T ss_pred hhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHH
Confidence 9988 999999999999999999999999999887655433 36789999999999999989999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||.+|.+|+.....- ...-++-...........+..+.+++..||..||+.|||+.++++
T Consensus 203 Ela~GePP~s~~hPm---------------rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 203 ELAKGEPPHSKLHPM---------------RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHhcCCCCCcccCcc---------------eEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 999999996532221 111111111111222256678999999999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=278.89 Aligned_cols=214 Identities=24% Similarity=0.331 Sum_probs=168.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
-+++..+|+.||++++|||||+++.+..+ .+.+|||+|||..|.+...- .....++++++++++.+++.||+|||
T Consensus 151 ~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH 227 (576)
T KOG0585|consen 151 PIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH 227 (576)
T ss_pred cHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH
Confidence 35789999999999999999999999976 45899999999999875432 22333899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCC---CcccccccccccccccChhhhhcCC----CCCcccchh
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD---ELQSNTKRIVGTYGYMSPEYALRGL----FSIKSDVFS 158 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Diws 158 (289)
.+| |+||||||+|+|++++|.|||+|||.+.....+ ..........|||.|+|||.+.+.. .+.+.||||
T Consensus 228 ~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWa 304 (576)
T KOG0585|consen 228 YQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWA 304 (576)
T ss_pred hcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhh
Confidence 998 999999999999999999999999999876322 1122233468999999999998632 368899999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
+||+||.|+.|+.||.....-. .+ ..+...-+.-...+.+.+.+.+||.++|..||+.|.++.+|.
T Consensus 305 lGVTLYCllfG~~PF~~~~~~~---------l~-----~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 305 LGVTLYCLLFGQLPFFDDFELE---------LF-----DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred hhhhHHHhhhccCCcccchHHH---------HH-----HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 9999999999999976432111 00 011111222222334667899999999999999999999986
Q ss_pred HHh
Q 038647 239 SML 241 (289)
Q Consensus 239 ~~L 241 (289)
...
T Consensus 371 ~Hp 373 (576)
T KOG0585|consen 371 LHP 373 (576)
T ss_pred ecc
Confidence 543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=286.09 Aligned_cols=206 Identities=21% Similarity=0.259 Sum_probs=169.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 60 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~ 136 (329)
T PTZ00263 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHS 136 (329)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999884 34568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++..... .....|++.|+|||++.+..++.++|||||||++|+|
T Consensus 137 ~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 208 (329)
T PTZ00263 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208 (329)
T ss_pred CC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHH
Confidence 88 999999999999999999999999999865432 2235689999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
++|..||....... .. ........ ..+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 209 ltg~~pf~~~~~~~--~~----~~i~~~~~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 209 IAGYPPFFDDTPFR--IY----EKILAGRL----------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HcCCCCCCCCCHHH--HH----HHHhcCCc----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999986432211 10 00101000 011123457889999999999999996 677764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=278.79 Aligned_cols=218 Identities=33% Similarity=0.518 Sum_probs=168.5
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.+..+.|.+|++++++++||||+++++++.+.+..++|+||+++|+|.+++... ....+++..+..++.||+.||.||
T Consensus 41 ~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~L 119 (259)
T PF07714_consen 41 SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYL 119 (259)
T ss_dssp SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHH
T ss_pred ccccceeeeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence 3445899999999999999999999999999888899999999999999999653 245789999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ ++|+||+++||+++.++.+||+|||++................+...|+|||.+.+..++.++||||||+++|
T Consensus 120 h~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ 196 (259)
T PF07714_consen 120 HSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLY 196 (259)
T ss_dssp HHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHH
T ss_pred cccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9987 9999999999999999999999999998774333233333445678999999999988999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
|+++ |..|+..... ....... .... ........+..+.+++..||+.||++|||+.++++.|
T Consensus 197 ei~~~~~~p~~~~~~--~~~~~~~----~~~~---------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 197 EILTLGKFPFSDYDN--EEIIEKL----KQGQ---------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHTTSSGTTTTSCH--HHHHHHH----HTTE---------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccccccc--ccccccc----cccc---------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999 6677544322 1111111 1111 1111222456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=284.06 Aligned_cols=210 Identities=20% Similarity=0.238 Sum_probs=170.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 34 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH 110 (312)
T cd05585 34 RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ---REGRFDLSRARFYTAELLCALENLH 110 (312)
T ss_pred hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788899999999999999999999999999999999999999999884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 111 ~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~e 185 (312)
T cd05585 111 KFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYE 185 (312)
T ss_pred hCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHH
Confidence 988 9999999999999999999999999987543221 12334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC---HHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT---MLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 239 (289)
|++|..||....... ... ..... . ...+...+..+.+++.+||+.||++||+ +.++++
T Consensus 186 l~tg~~pf~~~~~~~--~~~---~~~~~-~----------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 186 MLTGLPPFYDENVNE--MYR---KILQE-P----------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHhCCCCcCCCCHHH--HHH---HHHcC-C----------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 999999986433211 100 00100 0 0112234567889999999999999985 566554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=281.52 Aligned_cols=205 Identities=22% Similarity=0.271 Sum_probs=169.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 120 (291)
T cd05612 44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSK 120 (291)
T ss_pred HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999999999999999999999999884 345688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+|||++.++.+||+|||+++..... .....|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 121 ~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 121 E---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192 (291)
T ss_pred C---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 8 999999999999999999999999998865332 22346899999999999989999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
+|..||....... .... ..... ...+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 193 ~g~~pf~~~~~~~--~~~~----i~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 193 VGYPPFFDDNPFG--IYEK----ILAGK----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred hCCCCCCCCCHHH--HHHH----HHhCC----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 9999986543211 1100 00000 0111223467889999999999999995 888775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=293.80 Aligned_cols=221 Identities=23% Similarity=0.264 Sum_probs=178.2
Q ss_pred cccCHHHHHHHHHHHhhCC-CCCceeeeeeEe-e------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCI-E------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEG 76 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 76 (289)
++++.+..++||++|+.|+ |+|||.+++... . .-+++|.||||.||.|-++++++...+ |++.++++|++|
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~d 152 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYD 152 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHH
Confidence 6778899999999999996 999999999432 1 135789999999999999997655544 999999999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-c------cccccccccccChhhhh---
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-N------TKRIVGTYGYMSPEYAL--- 146 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~------~~~~~g~~~y~aPE~~~--- 146 (289)
+++|+.+||.. +.+|+|||||-+||||+.+++.||||||.+.-.-...... . .-....|+.|.|||.+.
T Consensus 153 v~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys 231 (738)
T KOG1989|consen 153 VCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS 231 (738)
T ss_pred HHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc
Confidence 99999999998 4789999999999999999999999999986432211000 0 01123689999999986
Q ss_pred cCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHccccc
Q 038647 147 RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQE 226 (289)
Q Consensus 147 ~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 226 (289)
+.+.+.|+|||+|||+||.|+....||...+.- .++.....-...+.++..+.+||+.||+.
T Consensus 232 g~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~ 293 (738)
T KOG1989|consen 232 GLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQP 293 (738)
T ss_pred CCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------------------eEEeccccCCCCccHHHHHHHHHHHHhcc
Confidence 678899999999999999999999998754332 22222222233457889999999999999
Q ss_pred CCCCCCCHHHHHHHhhccc
Q 038647 227 NAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 227 ~p~~Rps~~~ll~~L~~~~ 245 (289)
||++||++.+++..+..+.
T Consensus 294 nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 294 NPDERPNIYQVLEEIFELA 312 (738)
T ss_pred CcccCCCHHHHHHHHHHHh
Confidence 9999999999998877643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=282.75 Aligned_cols=211 Identities=18% Similarity=0.205 Sum_probs=172.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+.....+.+|+++|+.++||||+++++++.+++..|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 36 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH 112 (328)
T cd05593 36 KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLH 112 (328)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999988884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 113 ~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~e 187 (328)
T cd05593 113 SGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187 (328)
T ss_pred hCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHH
Confidence 988 9999999999999999999999999987542221 12334578999999999999899999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVISM 240 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~ 240 (289)
|++|..||...+.... .. ...... ...+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 188 lltG~~Pf~~~~~~~~--~~----~~~~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 188 MMCGRLPFYNQDHEKL--FE----LILMED----------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HhhCCCCCCCCCHHHH--HH----HhccCC----------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 9999999864332211 00 000000 011223456889999999999999997 89998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=264.16 Aligned_cols=210 Identities=26% Similarity=0.384 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+.-.+|+.||+++ -||+|+++.++++.+..+++|+|.|+.|.|.+++ ...-.+++....+++.|+.+|++|||.+
T Consensus 66 ~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~ 142 (411)
T KOG0599|consen 66 REATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHAR 142 (411)
T ss_pred HHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHh
Confidence 34456799999999 4999999999999999999999999999999999 4556799999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh------cCCCCCcccchhHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL------RGLFSIKSDVFSFGV 161 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~ 161 (289)
+ ||||||||+|||++++.+++|+|||++.....+. .....+|||+|+|||.+. ...|+...|+|++|+
T Consensus 143 ~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GV 216 (411)
T KOG0599|consen 143 N---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGV 216 (411)
T ss_pred h---hhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHH
Confidence 8 9999999999999999999999999999876554 344579999999999996 356899999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|.|+.|.+||-. ..+...++.... +.. -...+.=.+++....++|.+||+.||.+|.|++|.++
T Consensus 217 ImyTLLaGcpPFwH--RkQmlMLR~Ime----Gky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 217 IMYTLLAGCPPFWH--RKQMLMLRMIME----GKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHcCCCchhH--HHHHHHHHHHHh----ccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 99999999998631 111111111111 100 0111222345678899999999999999999999986
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=276.88 Aligned_cols=223 Identities=26% Similarity=0.433 Sum_probs=176.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC----------CCCCCChHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT----------KTGLLGWEMRVRILE 75 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~~~ 75 (289)
....+.|.+|++++++++||||+++++++..++..++||||+++++|.+++.... ....+++..+..++.
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 127 (288)
T cd05093 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127 (288)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999885321 123589999999999
Q ss_pred HHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCccc
Q 038647 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 155 (289)
Q Consensus 76 ~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 155 (289)
|++.||.|||+++ ++||||||+||++++++.++|+|||+++...............++..|+|||++.+..++.++|
T Consensus 128 ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 204 (288)
T cd05093 128 QIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 204 (288)
T ss_pred HHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhh
Confidence 9999999999988 9999999999999999999999999998654332222222334577899999999889999999
Q ss_pred chhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 156 VFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 156 iwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|||||+++|+|++ |..||....... ... ........ ......+..+.+++.+||+.||.+|||+
T Consensus 205 iwslG~il~~l~t~g~~p~~~~~~~~--~~~----~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 269 (288)
T cd05093 205 VWSLGVVLWEIFTYGKQPWYQLSNNE--VIE----CITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNI 269 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9999999999998 888765433211 110 01111100 0111234578999999999999999999
Q ss_pred HHHHHHhhcccC
Q 038647 235 LEVISMLTNENV 246 (289)
Q Consensus 235 ~~ll~~L~~~~~ 246 (289)
.++++.|++...
T Consensus 270 ~~v~~~l~~~~~ 281 (288)
T cd05093 270 KEIHSLLQNLAK 281 (288)
T ss_pred HHHHHHHHHHHH
Confidence 999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=273.87 Aligned_cols=217 Identities=25% Similarity=0.432 Sum_probs=175.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-----------CCCCCChHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-----------KTGLLGWEMRVRILEG 76 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~~~ 76 (289)
..++|.+|+++|+.++|+||+++++++..+...++||||+++++|.+++.... ....+++..+..++.|
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 56899999999999999999999999999999999999999999999985422 2345788899999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccc
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
++.||.|||+++ ++||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++||
T Consensus 131 i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 207 (280)
T cd05049 131 IASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207 (280)
T ss_pred HHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence 999999999988 99999999999999999999999999976533322222233345788999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 157 FSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 157 wslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
||||+++|+|++ |..||....... ...... .+. ........+..+.+++.+||+.||++||++.
T Consensus 208 ~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 272 (280)
T cd05049 208 WSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIK 272 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 999999999998 988875433221 111110 000 0111123456889999999999999999999
Q ss_pred HHHHHhh
Q 038647 236 EVISMLT 242 (289)
Q Consensus 236 ~ll~~L~ 242 (289)
|+++.|+
T Consensus 273 eil~~l~ 279 (280)
T cd05049 273 DIHERLQ 279 (280)
T ss_pred HHHHHhh
Confidence 9999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=282.44 Aligned_cols=215 Identities=19% Similarity=0.293 Sum_probs=173.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+.+.+|+++++.++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~ 119 (333)
T cd05600 43 NEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE 119 (333)
T ss_pred hHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346778899999999999999999999999999999999999999999984 34568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+||+++.++.+||+|||+++.... ......|++.|+|||++.+..++.++|||||||++|+|
T Consensus 120 ~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 191 (333)
T cd05600 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEF 191 (333)
T ss_pred CC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhh
Confidence 88 99999999999999999999999999986533 23345789999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|..||...+...... .. ..+. ...............+.++.+++.+||..+|++||++.++++.
T Consensus 192 l~g~~pf~~~~~~~~~~--~i-~~~~-----~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 192 LCGFPPFSGSTPNETWE--NL-KYWK-----ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred hhCCCCCCCCCHHHHHH--HH-Hhcc-----ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 99999986543322110 00 0000 0000000111112346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.78 Aligned_cols=207 Identities=19% Similarity=0.237 Sum_probs=171.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++++.++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~ 149 (340)
T PTZ00426 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQS 149 (340)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999999999999999999999999984 34568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 150 ~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 221 (340)
T PTZ00426 150 LN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221 (340)
T ss_pred CC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHH
Confidence 88 999999999999999999999999999865322 2345789999999999998899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~ 240 (289)
++|..||...+... ... ...... . ..+...+..+.+++.+||+.||++|+ +++++++.
T Consensus 222 l~G~~Pf~~~~~~~--~~~----~i~~~~--------~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 222 LVGCPPFYANEPLL--IYQ----KILEGI--------I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred hcCCCCCCCCCHHH--HHH----HHhcCC--------C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999986543211 100 011100 0 11222346788999999999999995 89988763
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=276.57 Aligned_cols=227 Identities=19% Similarity=0.218 Sum_probs=171.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.+++.++||||+++++++.+++..|+||||++++++..+.. ....+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH 117 (287)
T cd07848 41 EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH 117 (287)
T ss_pred ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999987765542 2346889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++||||||+||+++.++.+||+|||+++....... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 118 ~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~e 193 (287)
T cd07848 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGE 193 (287)
T ss_pred HCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHH
Confidence 888 99999999999999999999999999987643221 12233568999999999998889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHh-Hh--------HhhhhccCCc-cccccccccC------CCCHHHHHHHHHHHHcccccCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLL-GH--------AWNLWNDGRA-WELMDSILQN------DASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~-~~--------~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
|++|+.||...+....... .. .+..+..... .......... ......+..+.+++.+||+.||+
T Consensus 194 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~ 273 (287)
T cd07848 194 LSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPT 273 (287)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcc
Confidence 9999999876443211100 00 0000000000 0000000000 00112456789999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||++++++
T Consensus 274 ~R~s~~~~l~ 283 (287)
T cd07848 274 DRYLTEQCLN 283 (287)
T ss_pred cCCCHHHHhc
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=282.05 Aligned_cols=209 Identities=20% Similarity=0.230 Sum_probs=170.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
.....+.+|+++++.++||||+++++++..++..|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||+
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~ 113 (323)
T cd05595 37 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHS 113 (323)
T ss_pred HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999999999999999999999988884 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|
T Consensus 114 ~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 188 (323)
T cd05595 114 RD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred CC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHH
Confidence 88 9999999999999999999999999987532221 122345689999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
++|..||...+..... .. .... . ...+...+..+.+++.+||+.||++|| ++.++++
T Consensus 189 l~g~~Pf~~~~~~~~~--~~---~~~~-~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 189 MCGRLPFYNQDHERLF--EL---ILME-E----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HhCCCCCCCCCHHHHH--HH---HhcC-C----------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 9999998644322111 00 0000 0 011223456889999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=277.45 Aligned_cols=215 Identities=20% Similarity=0.278 Sum_probs=173.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..+++....|-.+|...++|+||+++..|++.+++||||||++||++..+| ...+.++++.+..++.+++.|+..+|
T Consensus 182 ~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH 258 (550)
T KOG0605|consen 182 KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIH 258 (550)
T ss_pred hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHH
Confidence 467888999999999999999999999999999999999999999999999 55678999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCC----------------------CCccc---------------
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG----------------------DELQS--------------- 128 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~----------------------~~~~~--------------- 128 (289)
+.| ++||||||+|+|||..|++||+|||++.-... .+...
T Consensus 259 ~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (550)
T KOG0605|consen 259 QLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQ 335 (550)
T ss_pred HcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHH
Confidence 988 99999999999999999999999999854211 00000
Q ss_pred --------ccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccc
Q 038647 129 --------NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELM 200 (289)
Q Consensus 129 --------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (289)
...+.+|||.|+|||++.+..|+..+|.||||||+||||.|.+||...+....--....|.
T Consensus 336 ~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr----------- 404 (550)
T KOG0605|consen 336 TWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR----------- 404 (550)
T ss_pred HHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-----------
Confidence 0123469999999999999999999999999999999999999998766543211111111
Q ss_pred cccccCCCCHHHHHHHHHHHHcccccCCCCCCC---HHHHHH
Q 038647 201 DSILQNDASYPMLNRYINVALLCVQENAADRPT---MLEVIS 239 (289)
Q Consensus 201 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 239 (289)
..+.-......+.+..++|.+||. ||++|.- +.||-+
T Consensus 405 -~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 405 -ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred -hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 111122222334788999999999 9999975 555543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=274.39 Aligned_cols=230 Identities=27% Similarity=0.350 Sum_probs=173.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..+.|.+|+++|+.++||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH 124 (283)
T cd05080 49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLH 124 (283)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999988653 468999999999999998843 35899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ ++||||||+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||+++|
T Consensus 125 ~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~ 201 (283)
T cd05080 125 SQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201 (283)
T ss_pred HCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHH
Confidence 988 9999999999999999999999999998764332111 111223566799999998888999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+|++|..|+...................................+...+..+.+++..||+.+|++|||+.++++.|+..
T Consensus 202 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred HHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 99999988754432211111110000000011111111111112233457899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=271.64 Aligned_cols=215 Identities=27% Similarity=0.380 Sum_probs=171.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|+.++++++||||+++++++..++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~ 126 (266)
T cd05064 49 QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM 126 (266)
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4568999999999999999999999999999999999999999999988542 34688999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|||||||++|+++
T Consensus 127 ~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 202 (266)
T cd05064 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202 (266)
T ss_pred C---EeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHh
Confidence 8 99999999999999999999999998765432211 1111223567899999999999999999999999999977
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..||....... .... ..... ....+...+..+.+++..||+.+|++||++++|++.|..
T Consensus 203 ~~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 203 SYGERPYWDMSGQD--VIKA----VEDGF---------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred cCCCCCcCcCCHHH--HHHH----HHCCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 5 988876443221 1111 01100 011122345678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=303.69 Aligned_cols=223 Identities=29% Similarity=0.446 Sum_probs=183.4
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC----CCCCChHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK----TGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~ 79 (289)
.+.+.+.+|.+|..+|+.++|||||+++|++.+....++++|||++|+|..||++.+. ...+.....+.++.|||.
T Consensus 734 ~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~ 813 (1025)
T KOG1095|consen 734 SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAK 813 (1025)
T ss_pred CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhh
Confidence 4567899999999999999999999999999999999999999999999999976422 346888999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
|+.||++++ +|||||..+|+|+++...|||+|||+|+.....++........-+..|||||.+....++.|+|||||
T Consensus 814 G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsF 890 (1025)
T KOG1095|consen 814 GMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSF 890 (1025)
T ss_pred hhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhh
Confidence 999999888 99999999999999999999999999996554444443333345679999999999999999999999
Q ss_pred HHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 160 GVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 160 G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
||++||++| |..|++..+.... ... +..+. +-..+...+..+.+++..||+.+|++||++..|+
T Consensus 891 GVllWEifslG~~PY~~~~n~~v--~~~----~~~gg---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~ 955 (1025)
T KOG1095|consen 891 GVLLWEIFSLGATPYPSRSNFEV--LLD----VLEGG---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIV 955 (1025)
T ss_pred HHHHHHHHhCCCCCCCCcchHHH--HHH----HHhCC---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHH
Confidence 999999999 5666554333221 111 11111 1233444567888999999999999999999999
Q ss_pred HHhhcc
Q 038647 239 SMLTNE 244 (289)
Q Consensus 239 ~~L~~~ 244 (289)
+.+..+
T Consensus 956 ~q~~~i 961 (1025)
T KOG1095|consen 956 EQDPAI 961 (1025)
T ss_pred hhhhhh
Confidence 988764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=271.34 Aligned_cols=217 Identities=27% Similarity=0.406 Sum_probs=174.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|++++++++||||+++++++..++..++||||+++++|.+++... ....+++..+..++.|++.||.|||++
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~ 123 (263)
T cd05052 45 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK 123 (263)
T ss_pred HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999999999999999999999999999988542 234578899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||++++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 124 ~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 199 (263)
T cd05052 124 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 199 (263)
T ss_pred C---EeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 7 9999999999999999999999999998765432211 11223456899999999899999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+ |..|+....... . +...... .....+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 200 t~g~~p~~~~~~~~--~----~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 200 TYGMSPYPGIDLSQ--V----YELLEKG---------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred cCCCCCCCCCCHHH--H----HHHHHCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 8 888876433211 1 1111110 11122223457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=270.45 Aligned_cols=216 Identities=25% Similarity=0.329 Sum_probs=170.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+....|.+|++++++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~ 112 (252)
T cd05084 35 DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLES 112 (252)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4467899999999999999999999999999999999999999999998853 23458899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|++
T Consensus 113 ~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~ 189 (252)
T cd05084 113 KH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEA 189 (252)
T ss_pred CC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 88 999999999999999999999999998765432211111112234579999999988899999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
++ |..|+....... .. ...... .........+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 190 ~~~~~~p~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 190 FSLGAVPYANLSNQQ--TR----EAIEQG---------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HhCCCCCccccCHHH--HH----HHHHcC---------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 98 777765332211 00 001000 011112233568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=273.01 Aligned_cols=213 Identities=21% Similarity=0.241 Sum_probs=170.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|++++++++|+||+++++++.+++..++||||+++|+|..++... ....+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05631 43 GEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE 121 (285)
T ss_pred hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456889999999999999999999999999999999999999998877532 234688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+||++++++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|+
T Consensus 122 ~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 195 (285)
T cd05631 122 R---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI 195 (285)
T ss_pred C---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHH
Confidence 8 9999999999999999999999999998654322 123346899999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
+|..||.......... ........ .........+..+.+++.+||+.||++||+ ++++++
T Consensus 196 ~g~~pf~~~~~~~~~~--~~~~~~~~----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 196 QGQSPFRKRKERVKRE--EVDRRVKE----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hCCCCCCCCCcchhHH--HHHHHhhc----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 9999987544321110 00000000 001122234568899999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=276.26 Aligned_cols=220 Identities=26% Similarity=0.406 Sum_probs=175.4
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-------------CCCCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-------------TKTGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~ 72 (289)
+...++.+|+++++++ +|+||+++++++.+++..++||||+++|+|..++... ...+.+++..++.
T Consensus 57 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 136 (293)
T cd05053 57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136 (293)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence 4456789999999999 7999999999999999999999999999999988532 2235688999999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus 137 i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 213 (293)
T cd05053 137 FAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213 (293)
T ss_pred HHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence 9999999999999888 9999999999999999999999999998765433222222234567899999999889999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++|||||||++|++++ |..|+....... .. ....... ....+...+..+.+++.+||+.||++|
T Consensus 214 ~~Di~slG~il~el~~~g~~p~~~~~~~~--~~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 214 QSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF----KLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred ccceeehhhHHHHHhcCCCCCCCCCCHHH--HH----HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999999999999997 888765432211 11 1111111 011122335688899999999999999
Q ss_pred CCHHHHHHHhhcc
Q 038647 232 PTMLEVISMLTNE 244 (289)
Q Consensus 232 ps~~~ll~~L~~~ 244 (289)
||+.++++.|+..
T Consensus 279 ps~~eil~~l~~~ 291 (293)
T cd05053 279 PTFKQLVEDLDRM 291 (293)
T ss_pred cCHHHHHHHHHHh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=273.14 Aligned_cols=226 Identities=27% Similarity=0.416 Sum_probs=175.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC--------CCCCCChHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT--------KTGLLGWEMRVRILEGVA 78 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~~~i~ 78 (289)
...+.|.+|++++++++||||+++++++..++..++|+||+++++|.+++.... ....+++..++.++.|++
T Consensus 61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05051 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence 457789999999999999999999999999999999999999999999885432 123688999999999999
Q ss_pred HHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchh
Q 038647 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158 (289)
Q Consensus 79 ~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 158 (289)
.||.|||+.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||
T Consensus 141 ~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (296)
T cd05051 141 SGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217 (296)
T ss_pred HHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence 9999999888 9999999999999999999999999988654433333334445678899999999888999999999
Q ss_pred HHHHHHHHHh--CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 159 FGVLVLETLS--SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 159 lG~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
||+++|+|++ |..|+.. .............+........ .......+.++.+++.+||+.||++|||+.+
T Consensus 218 lG~~l~el~~~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 289 (296)
T cd05051 218 FGVTLWEILTLCREQPYEH--LTDQQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289 (296)
T ss_pred hHHHHHHHHhcCCCCCCCC--cChHHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence 9999999998 4444432 2222222222111111111000 0111223468999999999999999999999
Q ss_pred HHHHhhc
Q 038647 237 VISMLTN 243 (289)
Q Consensus 237 ll~~L~~ 243 (289)
|++.|++
T Consensus 290 l~~~L~~ 296 (296)
T cd05051 290 IHLFLQR 296 (296)
T ss_pred HHHHhcC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=280.54 Aligned_cols=208 Identities=25% Similarity=0.308 Sum_probs=169.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+.+|+.++||||+++++++.+++..|+||||+++|+|.+++. ..+.+.+..+..++.|++.||.|||++
T Consensus 43 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (323)
T cd05584 43 DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQ 119 (323)
T ss_pred hHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567899999999999999999999999999999999999999999884 345678889999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 120 ~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 194 (323)
T cd05584 120 G---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDML 194 (323)
T ss_pred C---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHh
Confidence 8 9999999999999999999999999987542221 1223356899999999999988999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
+|..||....... .. ..... .. ...+...+..+.+++.+||+.||++|| ++.++++
T Consensus 195 ~G~~pf~~~~~~~--~~---~~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 195 TGAPPFTAENRKK--TI---DKILK-GK----------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred cCCCCCCCCCHHH--HH---HHHHc-CC----------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 9999986543211 00 00010 00 011222356789999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=282.30 Aligned_cols=223 Identities=18% Similarity=0.211 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+.+|+++|++++||||+++++++..+...++|+|++. ++|..++. ....+++..++.++.||+.||.|||+++
T Consensus 127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~ 202 (391)
T PHA03212 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR 202 (391)
T ss_pred hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4567899999999999999999999999999999999995 67877774 3346889999999999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
|+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 203 ---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 278 (391)
T PHA03212 203 ---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278 (391)
T ss_pred ---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987543221 112234579999999999999999999999999999999999
Q ss_pred CCCCcCCCCCc-----chhHhHhHhhhhccC--C--------ccccc----cccccC-------CCCHHHHHHHHHHHHc
Q 038647 169 SKKNAHFYNTD-----SLTLLGHAWNLWNDG--R--------AWELM----DSILQN-------DASYPMLNRYINVALL 222 (289)
Q Consensus 169 g~~p~~~~~~~-----~~~~~~~~~~~~~~~--~--------~~~~~----~~~~~~-------~~~~~~~~~l~~li~~ 222 (289)
|..|+...... ............... . ..... ...... ......+.++.+++.+
T Consensus 279 g~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~ 358 (391)
T PHA03212 279 CHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICK 358 (391)
T ss_pred CCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHH
Confidence 99876432211 000000000000000 0 00000 000000 0011345688999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.||++|||++|+++
T Consensus 359 mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 359 MLAFDAHHRPSAEALLD 375 (391)
T ss_pred HhcCChhhCCCHHHHhc
Confidence 99999999999999985
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=284.63 Aligned_cols=221 Identities=25% Similarity=0.347 Sum_probs=174.8
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------------------
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK------------------------- 61 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------- 61 (289)
..+.|.+|+++|++++ ||||+++++++.+.+..|+|||||++|+|.+++.+...
T Consensus 83 ~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (400)
T cd05105 83 EKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADES 162 (400)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccc
Confidence 4578999999999996 99999999999999999999999999999988754210
Q ss_pred --------------------------------------------------------------------CCCCChHHHHHH
Q 038647 62 --------------------------------------------------------------------TGLLGWEMRVRI 73 (289)
Q Consensus 62 --------------------------------------------------------------------~~~~~~~~~~~~ 73 (289)
...+++..+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~ 242 (400)
T cd05105 163 TRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSF 242 (400)
T ss_pred ccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHH
Confidence 124778888999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCc
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.+
T Consensus 243 ~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 319 (400)
T cd05105 243 TYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319 (400)
T ss_pred HHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch
Confidence 999999999999888 99999999999999999999999999986543322222333456788999999999899999
Q ss_pred ccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 154 SDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 154 ~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+||||||+++|+|++ |..|+.......... ....... ........+..+.+++.+||+.||++||
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RP 385 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-----NKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRP 385 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcccchhHHHH-----HHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCc
Confidence 999999999999997 888876433221110 0011100 0111223456889999999999999999
Q ss_pred CHHHHHHHhhccc
Q 038647 233 TMLEVISMLTNEN 245 (289)
Q Consensus 233 s~~~ll~~L~~~~ 245 (289)
++.+|.+.|+...
T Consensus 386 t~~~l~~~l~~l~ 398 (400)
T cd05105 386 SFLHLSDIVESLL 398 (400)
T ss_pred CHHHHHHHHHHHc
Confidence 9999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=272.78 Aligned_cols=217 Identities=25% Similarity=0.402 Sum_probs=170.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------CCCCChHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------TGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~ 80 (289)
...+|.+|+.+++.++||||+++++++.++...++||||+++++|.+++..... ...+++..+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999998854221 2345778889999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+.+ ++||||||+||++++++.++|+|||+++...............++..|+|||++.+..++.++||||||
T Consensus 132 l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 208 (277)
T cd05062 132 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 208 (277)
T ss_pred HHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHH
Confidence 99999887 999999999999999999999999998765433222222223457789999999988999999999999
Q ss_pred HHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|+|++ |..|+...... ...... ...... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 209 ~~l~el~~~~~~p~~~~~~~--~~~~~~----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 209 VVLWEIATLAEQPYQGMSNE--QVLRFV----MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred HHHHHHHcCCCCCCCCCCHH--HHHHHH----HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999 67776543221 111110 010000 111123467899999999999999999999999
Q ss_pred Hhh
Q 038647 240 MLT 242 (289)
Q Consensus 240 ~L~ 242 (289)
.|+
T Consensus 274 ~l~ 276 (277)
T cd05062 274 SIK 276 (277)
T ss_pred Hhh
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=273.04 Aligned_cols=219 Identities=26% Similarity=0.405 Sum_probs=173.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--------------CCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--------------TGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~ 72 (289)
+..++|.+|+.++++++||||+++++++..++..|+||||+++++|.+++..... ...+++..+..
T Consensus 49 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (283)
T cd05090 49 QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHH
Confidence 3457899999999999999999999999999999999999999999998853211 23478888999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus 129 i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05090 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205 (283)
T ss_pred HHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc
Confidence 9999999999999988 9999999999999999999999999998764433222233344567899999999888999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++||||||+++|+|++ |..||...... .... ....... .......+..+.+++.+||+.||++|
T Consensus 206 ~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~----~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05090 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIE----MVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRR 270 (283)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999999999999998 88776543211 1111 0111110 01112234678899999999999999
Q ss_pred CCHHHHHHHhhc
Q 038647 232 PTMLEVISMLTN 243 (289)
Q Consensus 232 ps~~~ll~~L~~ 243 (289)
|++.+|++.|..
T Consensus 271 p~~~~i~~~l~~ 282 (283)
T cd05090 271 PRFKDIHTRLRS 282 (283)
T ss_pred cCHHHHHHHhhc
Confidence 999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=281.03 Aligned_cols=209 Identities=19% Similarity=0.203 Sum_probs=170.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....++.+|+++++.++||||+++++++.+++..|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||+
T Consensus 37 ~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~ 113 (325)
T cd05594 37 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHS 113 (325)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456778899999999999999999999999999999999999999988884 34568999999999999999999997
Q ss_pred -CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 -YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 -~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
.+ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 188 (325)
T cd05594 114 EKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 188 (325)
T ss_pred cCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeee
Confidence 66 9999999999999999999999999987532221 12234568999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
|++|..||.......... . ..... ...+...+.++.+++.+||+.||++|+ ++.++++
T Consensus 189 l~tG~~Pf~~~~~~~~~~--~----i~~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 189 MMCGRLPFYNQDHEKLFE--L----ILMEE----------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred eccCCCCCCCCCHHHHHH--H----HhcCC----------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 999999986543221100 0 00000 011122456788999999999999996 8999885
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=272.04 Aligned_cols=219 Identities=26% Similarity=0.435 Sum_probs=173.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC------------CCCCChHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK------------TGLLGWEMRVRI 73 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~ 73 (289)
....+.|.+|+++++.++|+||+++++++.+++..++||||+++++|.+++..... ...+++..+..+
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 127 (280)
T cd05092 48 ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127 (280)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998854221 135788999999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCc
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+.|++.||.|||+.+ ++||||||+|||+++++.++|+|||+++...............+++.|+|||.+.+..++.+
T Consensus 128 ~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 204 (280)
T cd05092 128 ASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 204 (280)
T ss_pred HHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch
Confidence 999999999999888 99999999999999999999999999876543322222223345678999999999899999
Q ss_pred ccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 154 SDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 154 ~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+|||||||++|+|++ |..||........ ... ..... ........+..+.+++.+||+.||++||
T Consensus 205 ~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~----~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp 269 (280)
T cd05092 205 SDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IEC----ITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRM 269 (280)
T ss_pred hhHHHHHHHHHHHHcCCCCCCccCCHHHH--HHH----HHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999999999999998 8887653322111 000 00000 0011123346788999999999999999
Q ss_pred CHHHHHHHhh
Q 038647 233 TMLEVISMLT 242 (289)
Q Consensus 233 s~~~ll~~L~ 242 (289)
++.+|++.|+
T Consensus 270 ~~~~l~~~l~ 279 (280)
T cd05092 270 VIKDIHSRLQ 279 (280)
T ss_pred CHHHHHHHHh
Confidence 9999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=255.25 Aligned_cols=214 Identities=22% Similarity=0.288 Sum_probs=172.3
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+..+.+++++|++|-+.++|||||++++.+.+....|+|+|++.|++|..-+- ..-..++..+-.++.||+++|.|+
T Consensus 50 ~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yC 126 (355)
T KOG0033|consen 50 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYC 126 (355)
T ss_pred ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34478999999999999999999999999999999999999999999955442 225678888999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|.++ |||||+||+|+++.. ..-+||+|||++...+.+ .....+.|||.|+|||++.+.+|+..+|||+.|+
T Consensus 127 H~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGV 200 (355)
T KOG0033|consen 127 HSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 200 (355)
T ss_pred HhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhH
Confidence 9888 999999999999954 445899999999988733 2234568999999999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+||-|+.|.+||-..+.... ...... +. -...+..-..+.++..+++++||..||.+|.|+.|.++
T Consensus 201 iLfiLL~G~~PF~~~~~~rl--ye~I~~----g~------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 201 ILYILLVGYPPFWDEDQHRL--YEQIKA----GA------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHhCCCCCCCccHHHH--HHHHhc----cc------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 99999999999765332211 111000 00 00011122345678899999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=285.02 Aligned_cols=203 Identities=24% Similarity=0.353 Sum_probs=176.3
Q ss_pred cccCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
..+.++..+.|.+|+...+ ||.++.++..|++.+++|+||||+.||++..+. ..+.+++..+..++..|+.||.|
T Consensus 408 ~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~f 483 (694)
T KOG0694|consen 408 QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQF 483 (694)
T ss_pred ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHH
Confidence 3467899999999999985 999999999999999999999999999965444 45789999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
||+++ |+|||||.+|||+|..|.+||+|||+++..... ...+.+++|||.|+|||++.+..|+.+.|.|||||++
T Consensus 484 LH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLl 558 (694)
T KOG0694|consen 484 LHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLL 558 (694)
T ss_pred HHhcC---ceeeecchhheEEcccCcEEecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHH
Confidence 99998 999999999999999999999999999976433 2357889999999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCC--CHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDA--SYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|||+.|+.||++.+.+. +.+.++..+. +.-.+.+..++++++|..||++|.-+
T Consensus 559 yeML~Gq~PF~gddEee------------------~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 559 YEMLVGESPFPGDDEEE------------------VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHcCCCCCCCCCHHH------------------HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 99999999998765542 3344444333 33467889999999999999999854
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=270.86 Aligned_cols=227 Identities=23% Similarity=0.391 Sum_probs=172.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC---------CCCCCChHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT---------KTGLLGWEMRVRILEGVA 78 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~~~i~ 78 (289)
..++|.+|++++++++|+|++++++++..++..++||||+++++|.+++.... ....+++..++.++.|++
T Consensus 60 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 139 (295)
T cd05097 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139 (295)
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHH
Confidence 45679999999999999999999999999999999999999999999885421 112467888999999999
Q ss_pred HHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchh
Q 038647 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158 (289)
Q Consensus 79 ~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 158 (289)
.||.|||+++ ++||||||+||+++.++.+||+|||++................++..|+|||++.+..++.++||||
T Consensus 140 ~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 140 SGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred HHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999988 9999999999999999999999999987654332222223334577899999999888999999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
||+++|+|+++..+.++...............+..... ..........+..+.+++.+||+.||++|||+.+|+
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 99999999985443333322222222111111111100 000111122346899999999999999999999999
Q ss_pred HHhhc
Q 038647 239 SMLTN 243 (289)
Q Consensus 239 ~~L~~ 243 (289)
+.|++
T Consensus 291 ~~l~~ 295 (295)
T cd05097 291 HFLRE 295 (295)
T ss_pred HHHhC
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=276.32 Aligned_cols=223 Identities=25% Similarity=0.371 Sum_probs=170.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|+++|++++||||++++++|.+++..++||||+++|+|.+++. ..+.+++..+..++.+++.||.|||+.
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~ 122 (333)
T cd06650 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREK 122 (333)
T ss_pred HHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 45679999999999999999999999999999999999999999999984 345688899999999999999999974
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ +++|+||||+|||++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|+
T Consensus 123 ~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 196 (333)
T cd06650 123 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196 (333)
T ss_pred C--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 2 3999999999999999999999999998755322 123346889999999999888999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhH-hh-hhcc-------------------CC-----ccccccccccCCC----CHHHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHA-WN-LWND-------------------GR-----AWELMDSILQNDA----SYPMLNRYI 217 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~-~~-~~~~-------------------~~-----~~~~~~~~~~~~~----~~~~~~~l~ 217 (289)
+|+.||.............. .. .... .. .....+....... ....+.++.
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd06650 197 IGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ 276 (333)
T ss_pred HCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHH
Confidence 99999875433211110000 00 0000 00 0000000000000 011346788
Q ss_pred HHHHcccccCCCCCCCHHHHHH
Q 038647 218 NVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 218 ~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++.+||+.||++|||+.|+++
T Consensus 277 ~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 277 DFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred HHHHHhccCCcccCcCHHHHhh
Confidence 9999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=272.95 Aligned_cols=220 Identities=25% Similarity=0.429 Sum_probs=174.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC---------------------CCCCCC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT---------------------KTGLLG 66 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~ 66 (289)
..+++.+|+.+++.++||||+++++.+..++..++|+||+.+++|.+++.... ....++
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 125 (290)
T cd05045 46 ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125 (290)
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccC
Confidence 45789999999999999999999999999999999999999999999875321 123578
Q ss_pred hHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh
Q 038647 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL 146 (289)
Q Consensus 67 ~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 146 (289)
+..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++...............++..|+|||.+.
T Consensus 126 ~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 8999999999999999999888 9999999999999999999999999998653322211222234567899999998
Q ss_pred cCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccc
Q 038647 147 RGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQ 225 (289)
Q Consensus 147 ~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 225 (289)
+..++.++||||||+++++|++ |..|+....... . +...... .........+.++.+++..||+
T Consensus 203 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~----~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~ 267 (290)
T cd05045 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--L----FNLLKTG---------YRMERPENCSEEMYNLMLTCWK 267 (290)
T ss_pred cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--H----HHHHhCC---------CCCCCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999998 888875432211 1 1111111 0111122344688899999999
Q ss_pred cCCCCCCCHHHHHHHhhccc
Q 038647 226 ENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 226 ~~p~~Rps~~~ll~~L~~~~ 245 (289)
.+|++||++.++++.|++..
T Consensus 268 ~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 268 QEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCcccCCCHHHHHHHHHHHH
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=270.31 Aligned_cols=218 Identities=26% Similarity=0.420 Sum_probs=174.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------CCCCChHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------TGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~ 79 (289)
.....+.+|+.+|+.++||||+++++++..+...++||||+++|+|.+++..... ...+++..+..++.|++.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999998854221 234788899999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||
T Consensus 131 ~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 131 GMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred HHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 999999888 99999999999999999999999999986644332222333456788999999988889999999999
Q ss_pred HHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 160 GVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 160 G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
|+++|++++ |..|+....... .... ....... ..+...+..+.+++.+||+.+|++|||+.+++
T Consensus 208 G~il~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 208 GVVLWEMATLAEQPYQGLSNEE--VLKF----VIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred HHHHHHhhccCCCCCccCCHHH--HHHH----HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 999999998 888875433221 1111 1111110 11112356889999999999999999999999
Q ss_pred HHhh
Q 038647 239 SMLT 242 (289)
Q Consensus 239 ~~L~ 242 (289)
+.|+
T Consensus 273 ~~l~ 276 (277)
T cd05032 273 SSLK 276 (277)
T ss_pred HHhc
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=266.14 Aligned_cols=214 Identities=30% Similarity=0.411 Sum_probs=170.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|+++|++++||||+++++++.+++..++||||+++|+|.+++... .+.+++..+..++.|++.||.|||++
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~ 119 (256)
T cd05114 42 SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN 119 (256)
T ss_pred cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3578999999999999999999999999999999999999999999988532 24588999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||+|+||+++.++.++|+|||.++......... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 120 ~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 120 S---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHH
Confidence 8 9999999999999999999999999988654332211 12223456899999999888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+ |+.|+....... ...... .... ...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 196 ~~g~~p~~~~~~~~--~~~~i~----~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 196 TEGKMPFEKKSNYE--VVEMIS----RGFR---------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred cCCCCCCCCCCHHH--HHHHHH----CCCC---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9 888875433211 111111 0000 0011112457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=268.68 Aligned_cols=218 Identities=30% Similarity=0.460 Sum_probs=174.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+.++++++||||+++++++.+++..++||||+++++|.+++.. ..+.+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 47 KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3467899999999999999999999999999999999999999999999854 23468899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ |+||||||+||++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|++
T Consensus 125 ~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred CC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 88 999999999999999999999999999876522211112223346789999999988999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++ |..|+....... .... ..... ........+..+.+++.+||+.+|++||++.+|++.|...
T Consensus 202 ~~~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 202 MSYGERPYWDMSNQD--VIKA----VEDGY---------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HccCCCCCCCCCHHH--HHHH----HHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 98 888864332111 1111 10000 0011123356789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=267.09 Aligned_cols=216 Identities=29% Similarity=0.437 Sum_probs=174.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~ 122 (261)
T cd05072 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK 122 (261)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4678999999999999999999999999999999999999999999988542 335678889999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 123 ~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 198 (261)
T cd05072 123 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198 (261)
T ss_pred C---eeccccchhhEEecCCCcEEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHH
Confidence 7 9999999999999999999999999998764432211 22234567899999999888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..||....... ..... .... ........+..+.+++.+||..+|++||+++++++.|+.
T Consensus 199 t~g~~p~~~~~~~~--~~~~~----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 199 TYGKIPYPGMSNSD--VMSAL----QRGY---------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ccCCCCCCCCCHHH--HHHHH----HcCC---------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 8 888876433221 11111 0000 001112244678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=269.37 Aligned_cols=225 Identities=26% Similarity=0.419 Sum_probs=172.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--------CCCCChHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--------TGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~ 79 (289)
..++|.+|+.+|+.++|+||+++++++.+++..++||||+++++|.+++..... ...+++..+..++.|++.
T Consensus 62 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05095 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence 457899999999999999999999999999999999999999999998854221 134777889999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+.+ ++||||||+||+++.++.++|+|||+++...........+...++..|+|||...+..++.++|||||
T Consensus 142 al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 142 GMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred HHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 999999988 99999999999999999999999999986543322222223344678999999988889999999999
Q ss_pred HHHHHHHHh--CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 160 GVLVLETLS--SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 160 G~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
||++|||++ |..|+..... ..........+..... .. ........+..+.+++.+||+.||++||++.+|
T Consensus 219 G~~l~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 290 (296)
T cd05095 219 GVTLWEILTLCKEQPYSQLSD--EQVIENTGEFFRDQGR-QV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290 (296)
T ss_pred HHHHHHHHHhCCCCCccccCh--HHHHHHHHHHHhhccc-cc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999999998 5555543222 2211111111111000 00 001112234688899999999999999999999
Q ss_pred HHHhhc
Q 038647 238 ISMLTN 243 (289)
Q Consensus 238 l~~L~~ 243 (289)
++.|++
T Consensus 291 ~~~l~~ 296 (296)
T cd05095 291 HATLLE 296 (296)
T ss_pred HHHHhC
Confidence 998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=267.41 Aligned_cols=215 Identities=30% Similarity=0.461 Sum_probs=175.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++... ....+++..+..++.|++.||.|||++
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~ 123 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ 123 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4678999999999999999999999999999999999999999999999653 335688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||+|+||+++.++.+||+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 124 ~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~ 198 (261)
T cd05148 124 N---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198 (261)
T ss_pred C---eeccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 8 999999999999999999999999999866433221 11234567899999999889999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..|+....... ...... .. .........+..+.+++.+||+.||.+|||+.++++.|++
T Consensus 199 ~~g~~p~~~~~~~~--~~~~~~----~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 199 TYGQVPYPGMNNHE--VYDQIT----AG---------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCcCCHHH--HHHHHH----hC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 8 788875433211 111110 00 0011122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=267.81 Aligned_cols=238 Identities=24% Similarity=0.269 Sum_probs=180.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEee-----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
-..++-.||+++|+.++|+||+.+.+++.. -+.+|+|+|+| +.+|.+.+ +.+..++.+.+..+++|++.||
T Consensus 63 ~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgL 138 (359)
T KOG0660|consen 63 IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGL 138 (359)
T ss_pred HHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhc
Confidence 356778899999999999999999999865 45799999999 66999999 4455599999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 160 (289)
+|+|+.+ ++||||||.|+|++.+..+||+|||+|+...........+..+.|.+|.|||++.. ..|+.+.||||.|
T Consensus 139 KyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvG 215 (359)
T KOG0660|consen 139 KYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVG 215 (359)
T ss_pred chhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhh
Confidence 9999988 99999999999999999999999999998865422333455678999999999875 5799999999999
Q ss_pred HHHHHHHhCCCCcCCCCCc-chhHhHhHhhhh--------ccCCccccccccccCCC------CHHHHHHHHHHHHcccc
Q 038647 161 VLVLETLSSKKNAHFYNTD-SLTLLGHAWNLW--------NDGRAWELMDSILQNDA------SYPMLNRYINVALLCVQ 225 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~ 225 (289)
|++.||++|++.|++.+.. +..++....+.. ........+.+...... .+......++++.+||.
T Consensus 216 CI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~ 295 (359)
T KOG0660|consen 216 CILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLV 295 (359)
T ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhc
Confidence 9999999999998876544 222222111111 11111112222211111 11234677899999999
Q ss_pred cCCCCCCCHHHHHH--HhhcccCCCCCC
Q 038647 226 ENAADRPTMLEVIS--MLTNENVILPSP 251 (289)
Q Consensus 226 ~~p~~Rps~~~ll~--~L~~~~~~~~~~ 251 (289)
.||.+|+|++|.++ .|.........|
T Consensus 296 fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 296 FDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred cCccccCCHHHHhcChhhhhhcCCccCC
Confidence 99999999999987 444443333333
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=273.23 Aligned_cols=209 Identities=23% Similarity=0.304 Sum_probs=167.0
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+..|..++... +||||+++++++..++..|+||||+++|+|..++. ..+.+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH 113 (316)
T cd05592 37 DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLH 113 (316)
T ss_pred hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456667788888765 89999999999999999999999999999998884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ |+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 188 (316)
T cd05592 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYE 188 (316)
T ss_pred HCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHH
Confidence 988 9999999999999999999999999997643222 22334578999999999999899999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH-HHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML-EVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~ll~ 239 (289)
|++|..||...+... .... .... ....+...+.++.+++.+||+.||++||++. ++++
T Consensus 189 ll~G~~Pf~~~~~~~--~~~~---i~~~-----------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 189 MLIGQSPFHGEDEDE--LFDS---ILND-----------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHhCCCCCCCCCHHH--HHHH---HHcC-----------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 999999987543221 1110 0000 0111222456788999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=268.61 Aligned_cols=215 Identities=20% Similarity=0.244 Sum_probs=171.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+..|+++++.++||||+++.+++.++...|+||||+++|+|..++.... ....+++..+..++.||+.||.|||+
T Consensus 36 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 115 (280)
T cd05608 36 GYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115 (280)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999999999999999999999999988774322 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+||+++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|
T Consensus 116 ~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el 190 (280)
T cd05608 116 RR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190 (280)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHH
Confidence 88 99999999999999999999999999976544322 12335689999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
++|+.||.......... ..... .... ........+..+.+++..||+.||++|| +++++++
T Consensus 191 ~~g~~pf~~~~~~~~~~--~~~~~--------~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 191 IAARGPFRARGEKVENK--ELKQR--------ILND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HhCCCCCCCCCcchhHH--HHHHh--------hccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 99999987543321110 00000 0000 0011223556889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=269.79 Aligned_cols=217 Identities=28% Similarity=0.398 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRVRILE 75 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~~~~ 75 (289)
.+.|.+|+.+++.++||||+++++++.+.+..++++||+.+++|.+++.... ....+++..+..++.
T Consensus 52 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (283)
T cd05091 52 REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131 (283)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999998874211 123578888999999
Q ss_pred HHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCccc
Q 038647 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 155 (289)
Q Consensus 76 ~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 155 (289)
|++.||.|||+++ ++||||||+||++++++.+||+|||+++...............+++.|+|||.+.+..++.++|
T Consensus 132 ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 208 (283)
T cd05091 132 QIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208 (283)
T ss_pred HHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchh
Confidence 9999999999888 9999999999999999999999999988664333222233345678899999999888999999
Q ss_pred chhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 156 VFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 156 iwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|||||+++|||++ |..|+...... ..... ...... .......+..+.+++..||+.+|++||++
T Consensus 209 v~slG~~l~el~~~g~~p~~~~~~~--~~~~~----i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 209 IWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEM----IRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH----HHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 9999999999998 77676543221 11111 111110 11122345678999999999999999999
Q ss_pred HHHHHHhhc
Q 038647 235 LEVISMLTN 243 (289)
Q Consensus 235 ~~ll~~L~~ 243 (289)
++|++.|+.
T Consensus 274 ~~i~~~l~~ 282 (283)
T cd05091 274 KDIHSRLRT 282 (283)
T ss_pred HHHHHHhhC
Confidence 999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=272.99 Aligned_cols=221 Identities=27% Similarity=0.409 Sum_probs=175.6
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~ 72 (289)
+..+++.+|+.+++.+ +||||+++++++...+..|+||||+++|+|.+++..... ...+++..+..
T Consensus 62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05101 62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141 (304)
T ss_pred HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence 4567899999999999 899999999999999999999999999999999865321 23577888999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus 142 ~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 218 (304)
T cd05101 142 CTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218 (304)
T ss_pred HHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence 9999999999999988 9999999999999999999999999998765433222223334567899999999888999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++||||||+++|++++ |..|+....... . ......... .......+..+.+++.+||+.+|++|
T Consensus 219 ~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~R 283 (304)
T cd05101 219 QSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L----FKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHR 283 (304)
T ss_pred hhhHHHHHHHHHHHHcCCCCCcccCCHHH--H----HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhC
Confidence 9999999999999998 666664332111 1 111111110 01122345688899999999999999
Q ss_pred CCHHHHHHHhhccc
Q 038647 232 PTMLEVISMLTNEN 245 (289)
Q Consensus 232 ps~~~ll~~L~~~~ 245 (289)
||+.++++.|+++.
T Consensus 284 ps~~e~l~~l~~~~ 297 (304)
T cd05101 284 PTFKQLVEDLDRIL 297 (304)
T ss_pred CCHHHHHHHHHHHH
Confidence 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=266.55 Aligned_cols=216 Identities=27% Similarity=0.362 Sum_probs=171.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+.+++.++||||+++++++. ++..++||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~ 113 (257)
T cd05116 38 ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEE 113 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999875 456789999999999999984 33568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++ ++||||||.||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||+++||
T Consensus 114 ~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 190 (257)
T cd05116 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190 (257)
T ss_pred CC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHH
Confidence 88 9999999999999999999999999998764332211 1112234578999999988889999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |..||....... ... ...... ....+...+.++.++|.+||+.||++||++.+|.+.|++.
T Consensus 191 l~t~g~~p~~~~~~~~--~~~----~i~~~~---------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 191 AFSYGQKPYKGMKGNE--VTQ----MIESGE---------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHhCCCCCCCCCCHHH--HHH----HHHCCC---------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 998 888876543221 111 111111 0111223456889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=271.13 Aligned_cols=218 Identities=27% Similarity=0.401 Sum_probs=173.8
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+
T Consensus 81 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~ 159 (302)
T cd05055 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS 159 (302)
T ss_pred HHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356799999999999 79999999999999999999999999999999885422 2348999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++||||||+++|+|
T Consensus 160 ~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el 236 (302)
T cd05055 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236 (302)
T ss_pred CC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHH
Confidence 88 999999999999999999999999999865433221122233467789999999998999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
++ |..|+........ ... ..... .........+..+.+++.+||..+|++|||+.++++.|+.
T Consensus 237 ~t~g~~p~~~~~~~~~-~~~----~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 237 FSLGSNPYPGMPVDSK-FYK----LIKEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HhCCCCCcCCCCchHH-HHH----HHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 98 8888754332211 100 11110 0001111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=273.42 Aligned_cols=209 Identities=22% Similarity=0.273 Sum_probs=169.9
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+..+.+.+|.++++.+ +||||+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH 113 (318)
T cd05570 37 DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH 113 (318)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567788999999988 69999999999999999999999999999988884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~ 188 (318)
T cd05570 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188 (318)
T ss_pred hCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHH
Confidence 888 9999999999999999999999999987532221 12233568999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH-----HHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM-----LEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~ 239 (289)
|++|..||....... .... ..... ...+...+..+.+++.+||+.||++||++ .++++
T Consensus 189 l~~G~~pf~~~~~~~--~~~~----i~~~~----------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 189 MLAGQSPFEGDDEDE--LFQS----ILEDE----------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HhhCCCCCCCCCHHH--HHHH----HHcCC----------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 999999986443211 1110 00000 01112345688999999999999999999 88765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=265.77 Aligned_cols=216 Identities=28% Similarity=0.409 Sum_probs=173.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|++++++++||||+++++++..++..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (261)
T cd05068 44 DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ 122 (261)
T ss_pred cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999999999999999999999999999985432 34688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||++++++.++|+|||+++......... ......+..|+|||.+.+..++.++||||||+++|+|+
T Consensus 123 ~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 198 (261)
T cd05068 123 N---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198 (261)
T ss_pred C---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999998765322111 11122345799999999889999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..|+...... ..... ..... ........+..+.+++.+||+.+|++||++.++++.|++
T Consensus 199 t~g~~p~~~~~~~--~~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 199 TYGRMPYPGMTNA--EVLQQ----VDQGY---------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred hcCCCCCCCCCHH--HHHHH----HHcCC---------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 9 88887543211 11111 10000 001122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=274.68 Aligned_cols=215 Identities=18% Similarity=0.272 Sum_probs=169.9
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+..+.+.+|..++..+ +||||+++++++.+++..|+||||+++|+|..++. ..+.+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH 113 (329)
T cd05588 37 EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLH 113 (329)
T ss_pred hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567788999999999 79999999999999999999999999999988873 3457899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|+
T Consensus 114 ~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 188 (329)
T cd05588 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 188 (329)
T ss_pred HCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHH
Confidence 988 9999999999999999999999999987532111 12334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcc---hhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC------HHH
Q 038647 166 TLSSKKNAHFYNTDS---LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT------MLE 236 (289)
Q Consensus 166 lltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~ 236 (289)
|++|+.||...+... ............... . ..+...+..+.+++.+||+.||++||+ +++
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~ 258 (329)
T cd05588 189 MMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRD 258 (329)
T ss_pred HHHCCCCcccccccccccccchHHHHHHHHcCC--------C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHH
Confidence 999999986433221 000011111111100 0 112234567889999999999999997 667
Q ss_pred HHH
Q 038647 237 VIS 239 (289)
Q Consensus 237 ll~ 239 (289)
+++
T Consensus 259 i~~ 261 (329)
T cd05588 259 IKS 261 (329)
T ss_pred Hhc
Confidence 764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=265.21 Aligned_cols=221 Identities=19% Similarity=0.306 Sum_probs=177.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...++|.+|+++++.++||||+++++++.+.+..++|+||+++++|.+++.... ....++++.+..++.|++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08228 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 445678999999999999999999999999999999999999999998875322 2345788999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 124 ~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~e 198 (267)
T cd08228 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred hCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHH
Confidence 888 99999999999999999999999999887643321 1223457889999999998889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++|+.|+............. ..... .........+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 199 l~~g~~p~~~~~~~~~~~~~~----~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 199 MAALQSPFYGDKMNLFSLCQK----IEQCD--------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HhcCCCCCccccccHHHHHHH----HhcCC--------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 999999975433222111111 00000 01111223456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=268.23 Aligned_cols=220 Identities=25% Similarity=0.414 Sum_probs=171.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCC---CCCCCCChHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDP---TKTGLLGWEMRVRILEG 76 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~ 76 (289)
....+.|.+|+.+++.++||||+++++++... ...++|+||+++|+|.+++... .....+++..+..++.|
T Consensus 41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 45578899999999999999999999987432 2578999999999998877321 12345889999999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccc
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
++.||.|||+++ |+||||||+||+++.++.++|+|||+++...............+++.|+|||...+..++.++||
T Consensus 121 i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 197 (272)
T cd05075 121 IASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV 197 (272)
T ss_pred HHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence 999999999988 99999999999999999999999999987654332222223345678999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 157 FSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 157 wslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
||||+++|+|++ |..||...... ... ......... ......+..+.+++.+||+.||++|||+.
T Consensus 198 ~slG~il~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 262 (272)
T cd05075 198 WSFGVTMWEIATRGQTPYPGVENS--EIY----DYLRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFE 262 (272)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 999999999999 77777543221 111 111111110 11123446789999999999999999999
Q ss_pred HHHHHhhc
Q 038647 236 EVISMLTN 243 (289)
Q Consensus 236 ~ll~~L~~ 243 (289)
+|++.|++
T Consensus 263 ~l~~~l~~ 270 (272)
T cd05075 263 TLRCELEK 270 (272)
T ss_pred HHHHHHHh
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=270.18 Aligned_cols=224 Identities=21% Similarity=0.237 Sum_probs=167.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|++++++++||||+++++++.+++..++||||+++ +|.+++.. ....+++..+..++.||+.||.|||++
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~ 122 (288)
T cd07871 46 APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKR 122 (288)
T ss_pred cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345788999999999999999999999999999999999975 88887743 234578889999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~el 166 (289)
+ |+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+ ..++.++||||+||++|+|
T Consensus 123 ~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l 197 (288)
T cd07871 123 K---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197 (288)
T ss_pred C---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987643222 11233467899999999875 5689999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhH------hhhhccCCcccccccccc----CC----CCHHHHHHHHHHHHcccccCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHA------WNLWNDGRAWELMDSILQ----ND----ASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~----~~----~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
++|..||...+.......... ...|.............. .. .......+..+++.+||+.||.+||
T Consensus 198 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~ 277 (288)
T cd07871 198 ATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI 277 (288)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC
Confidence 999999875443221110000 000111000000000000 00 0112345788999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
|++|+++
T Consensus 278 t~~~~l~ 284 (288)
T cd07871 278 SAEAALR 284 (288)
T ss_pred CHHHHhc
Confidence 9999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=275.87 Aligned_cols=203 Identities=21% Similarity=0.221 Sum_probs=162.3
Q ss_pred HHHHHHHHH-HHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMM-LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+++.+|.. +++.++||||+++++++.+++..|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||++
T Consensus 39 ~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 115 (323)
T cd05575 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSL 115 (323)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345555655 5678999999999999999999999999999999998884 345788999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 116 g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 190 (323)
T cd05575 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190 (323)
T ss_pred C---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhh
Confidence 8 9999999999999999999999999987542221 1233457899999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
+|..||...+.... .. .... .. .......+..+.+++.+||+.||++||+++
T Consensus 191 ~g~~pf~~~~~~~~--~~---~i~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 191 YGLPPFYSRDTAEM--YD---NILN-KP----------LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred cCCCCCCCCCHHHH--HH---HHHc-CC----------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 99999865432111 00 0000 00 011122356889999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=277.77 Aligned_cols=226 Identities=22% Similarity=0.242 Sum_probs=165.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
....++.+|+++|+.++||||+++++++... ...|+||||+. ++|.+++. ....+++..+..++.||+.||
T Consensus 41 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL 116 (338)
T cd07859 41 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRAL 116 (338)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999988643 35899999995 68888873 345689999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhc--CCCCCcccchh
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFS 158 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Diws 158 (289)
.|||+++ |+||||||+|||++.++.+||+|||+++....... ........|++.|+|||++.+ ..++.++||||
T Consensus 117 ~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwS 193 (338)
T cd07859 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 193 (338)
T ss_pred HHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHH
Confidence 9999988 99999999999999999999999999986432211 111234568999999999876 67899999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhH-hHhH--------hhhhccCCccccccccccCC------CCHHHHHHHHHHHHcc
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTL-LGHA--------WNLWNDGRAWELMDSILQND------ASYPMLNRYINVALLC 223 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~ 223 (289)
|||++|+|++|+.||.......... .... ...+........+....... .....+..+.+++.+|
T Consensus 194 lGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 273 (338)
T cd07859 194 IGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERL 273 (338)
T ss_pred HHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHH
Confidence 9999999999999986543221100 0000 00000000000000000000 0011245678999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|+.||++|||++++++
T Consensus 274 l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 274 LAFDPKDRPTAEEALA 289 (338)
T ss_pred cCcCcccCCCHHHHhc
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=274.06 Aligned_cols=210 Identities=20% Similarity=0.276 Sum_probs=166.0
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+..+.+.+|+.++.++ +||||+++++++.+++..|+||||+++|+|..++. ..+.+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH 113 (329)
T cd05618 37 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLH 113 (329)
T ss_pred hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456788999999887 79999999999999999999999999999988873 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 188 (329)
T cd05618 114 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 188 (329)
T ss_pred HCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHH
Confidence 988 9999999999999999999999999987532211 12234578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcch---hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 166 TLSSKKNAHFYNTDSL---TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 166 lltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|++|..||........ .............. ...+...+..+.+++.+||+.||++||++
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 189 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 9999999864322111 00111111111110 01222345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=265.19 Aligned_cols=217 Identities=29% Similarity=0.434 Sum_probs=176.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC------CCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK------TGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~~~i~~~l 81 (289)
..+++.+|+++++.++|+||+++++++.++...++||||+++++|.+++..... ...+++..++.++.|++.||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 478999999999999999999999999999999999999999999999865321 36789999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
.|||+++ ++|+||+|+||+++.++.++|+|||.++...............++..|+|||.+.+..++.++||||||+
T Consensus 119 ~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (262)
T cd00192 119 EYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195 (262)
T ss_pred HHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence 9999988 9999999999999999999999999998775443222233456788999999999888999999999999
Q ss_pred HHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|+|++ |..|+....... ... ..... .....+...+.++.+++.+||+.||++|||+.++++.
T Consensus 196 il~~l~~~g~~p~~~~~~~~--~~~----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 196 LLWEIFTLGATPYPGLSNEE--VLE----YLRKG---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHhcCCCCCCCCCHHH--HHH----HHHcC---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 9999999 588876542211 111 11100 0111122335789999999999999999999999988
Q ss_pred hh
Q 038647 241 LT 242 (289)
Q Consensus 241 L~ 242 (289)
|+
T Consensus 261 l~ 262 (262)
T cd00192 261 LE 262 (262)
T ss_pred hC
Confidence 74
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=272.98 Aligned_cols=222 Identities=26% Similarity=0.406 Sum_probs=175.1
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~ 72 (289)
...+++.+|+++++++ +||||+++++++.+++..++|+||+++|+|.+++.... ....+++..+..
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (334)
T cd05100 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138 (334)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3467899999999999 79999999999999999999999999999999986432 123577888999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus 139 ~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 139 CAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred HHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 9999999999999988 9999999999999999999999999998654332221122223456799999999999999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++||||||+++|+|++ |..|+....... .. ....... ........+..+.+++.+||+.+|++|
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~~~~~--~~----~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~R 280 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF----KLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQR 280 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 9999999999999998 777765432211 11 1111110 011122334678899999999999999
Q ss_pred CCHHHHHHHhhcccC
Q 038647 232 PTMLEVISMLTNENV 246 (289)
Q Consensus 232 ps~~~ll~~L~~~~~ 246 (289)
||+.++++.|+....
T Consensus 281 ps~~ell~~l~~~~~ 295 (334)
T cd05100 281 PTFKQLVEDLDRVLT 295 (334)
T ss_pred cCHHHHHHHHHHHhh
Confidence 999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=279.20 Aligned_cols=215 Identities=23% Similarity=0.265 Sum_probs=167.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+.+.+|++++++++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~ 119 (377)
T cd05629 43 DQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHK 119 (377)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456788999999999999999999999999999999999999999999884 34568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-------------c--------------------------
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-------------Q-------------------------- 127 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-------------~-------------------------- 127 (289)
.+ |+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 120 ~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (377)
T cd05629 120 LG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIAT 196 (377)
T ss_pred CC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 88 99999999999999999999999999864311000 0
Q ss_pred ------cccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccc
Q 038647 128 ------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMD 201 (289)
Q Consensus 128 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (289)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. ........
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~---~i~~~~~~----- 266 (377)
T cd05629 197 WKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET--YR---KIINWRET----- 266 (377)
T ss_pred hhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH--HH---HHHccCCc-----
Confidence 000124689999999999999999999999999999999999999865432211 00 00000000
Q ss_pred ccccCCCCHHHHHHHHHHHHcccccCCCCC---CCHHHHHHH
Q 038647 202 SILQNDASYPMLNRYINVALLCVQENAADR---PTMLEVISM 240 (289)
Q Consensus 202 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~ll~~ 240 (289)
..-......+..+.+++.+||. +|.+| +++.++++.
T Consensus 267 --~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 267 --LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred --cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 0000111234678899999997 77765 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=275.86 Aligned_cols=204 Identities=21% Similarity=0.272 Sum_probs=166.2
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|..++..+ +||||+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH 113 (320)
T cd05590 37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEITSALMFLH 113 (320)
T ss_pred cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567788899999887 69999999999999999999999999999998884 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 188 (320)
T cd05590 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYE 188 (320)
T ss_pred HCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHH
Confidence 988 9999999999999999999999999987542221 12334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|++|..||...+.... ... ..... ...+...+.++.+++.+||+.||++||++
T Consensus 189 l~~g~~Pf~~~~~~~~--~~~----i~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 189 MLCGHAPFEAENEDDL--FEA----ILNDE----------VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HhhCCCCCCCCCHHHH--HHH----HhcCC----------CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 9999999875432211 110 10000 01112245688999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=266.02 Aligned_cols=213 Identities=27% Similarity=0.380 Sum_probs=170.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++||||+++++++.+++..++|+||+++++|.+++. ..+.+++..+..++.|++.||.|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~ 123 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSN 123 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45789999999999999999999999999999999999999999999884 345688899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+ ++||||+|+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||+++|++
T Consensus 124 ~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 200 (263)
T cd06625 124 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200 (263)
T ss_pred C---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHH
Confidence 8 9999999999999999999999999987653321111 11234578899999999998899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|..||........ . ....... .....+...+..+.+++..||..+|++|||+.++++.
T Consensus 201 ~~g~~p~~~~~~~~~-~----~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 201 LTEKPPWAEFEAMAA-I----FKIATQP---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhCCCCccccchHHH-H----HHHhccC---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 999998754322111 0 0000000 0111222345678899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=265.18 Aligned_cols=219 Identities=30% Similarity=0.457 Sum_probs=174.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC----CCCCCChHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT----KTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.....|.+|+.+++.++||||+++++++..++..++||||+++++|.+++.... ....+++..+..++.|++.||.
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999885422 2245788999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCC-----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccch
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNM-----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~-----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
|||+.+ ++|+||+|+||+++.++ .++|+|||+++...............++..|+|||.+.+..++.++|||
T Consensus 121 ~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 197 (269)
T cd05044 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVW 197 (269)
T ss_pred HHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHH
Confidence 999887 99999999999999877 8999999999765443322223333457789999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||+++|+|++ |..|+....... .... ..... ........+..+.+++.+||..+|++||++.+
T Consensus 198 slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 198 SFGVLMWEILTLGQQPYPALNNQE--VLQH----VTAGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred HHHHHHHHHHHcCCCCCcccCHHH--HHHH----HhcCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 99999999998 888876432211 1111 00000 00112234578899999999999999999999
Q ss_pred HHHHhhc
Q 038647 237 VISMLTN 243 (289)
Q Consensus 237 ll~~L~~ 243 (289)
|++.|.+
T Consensus 263 i~~~l~~ 269 (269)
T cd05044 263 IQEILQN 269 (269)
T ss_pred HHHHHhC
Confidence 9998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=279.30 Aligned_cols=215 Identities=20% Similarity=0.331 Sum_probs=167.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+.+.+|+++|+.++||||+++++++.+++.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||.
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~ 119 (381)
T cd05626 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHK 119 (381)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456788999999999999999999999999999999999999999999884 34568889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc----------------------------------------
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL---------------------------------------- 126 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~---------------------------------------- 126 (289)
.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 120 ~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (381)
T cd05626 120 MG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRA 196 (381)
T ss_pred CC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccc
Confidence 88 99999999999999999999999999754310000
Q ss_pred -----ccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccc
Q 038647 127 -----QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMD 201 (289)
Q Consensus 127 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (289)
........||+.|+|||++.+..++.++|||||||++|||++|..||.............. +..
T Consensus 197 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~---~~~-------- 265 (381)
T cd05626 197 TKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN---WEN-------- 265 (381)
T ss_pred cccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc---ccc--------
Confidence 0001235799999999999998999999999999999999999999875443221110000 000
Q ss_pred ccccCCCCHHHHHHHHHHHHc--ccccCCCCCCCHHHHHH
Q 038647 202 SILQNDASYPMLNRYINVALL--CVQENAADRPTMLEVIS 239 (289)
Q Consensus 202 ~~~~~~~~~~~~~~l~~li~~--~l~~~p~~Rps~~~ll~ 239 (289)
..........+.++.+++.+ |+..+|..||++.++++
T Consensus 266 -~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 266 -TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred -ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 00011111244678888887 55666777999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=272.06 Aligned_cols=221 Identities=27% Similarity=0.408 Sum_probs=174.0
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~ 72 (289)
...+++.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++.... ....+++..+..
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (314)
T cd05099 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138 (314)
T ss_pred HHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHH
Confidence 3467889999999999 69999999999999999999999999999999985432 124588899999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.
T Consensus 139 ~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (314)
T cd05099 139 CAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215 (314)
T ss_pred HHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence 9999999999999888 9999999999999999999999999998664322211112223456799999999889999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++||||||+++|++++ |..||...... .... ....... .......+.++.+++.+||..||++|
T Consensus 216 ~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~R 280 (314)
T cd05099 216 QSDVWSFGILMWEIFTLGGSPYPGIPVE--ELFK----LLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQR 280 (314)
T ss_pred cchhhHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 9999999999999999 77776543221 1111 0111100 01122334678899999999999999
Q ss_pred CCHHHHHHHhhccc
Q 038647 232 PTMLEVISMLTNEN 245 (289)
Q Consensus 232 ps~~~ll~~L~~~~ 245 (289)
||+.++++.|....
T Consensus 281 ps~~~ll~~l~~~~ 294 (314)
T cd05099 281 PTFKQLVEALDKVL 294 (314)
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=273.99 Aligned_cols=220 Identities=29% Similarity=0.401 Sum_probs=172.2
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCC------------------------
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTK------------------------ 61 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------------------------ 61 (289)
..+.+.+|+.+++++ +|+||+++++++.. +..+++++||+++++|.+++.....
T Consensus 53 ~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (337)
T cd05054 53 EYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132 (337)
T ss_pred HHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccc
Confidence 456788999999999 89999999998864 4578999999999999988753211
Q ss_pred ----------------------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCC
Q 038647 62 ----------------------------------TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107 (289)
Q Consensus 62 ----------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~ 107 (289)
...+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~ 209 (337)
T cd05054 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSEN 209 (337)
T ss_pred cccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCC
Confidence 125788999999999999999999888 9999999999999999
Q ss_pred CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHh
Q 038647 108 MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGH 186 (289)
Q Consensus 108 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 186 (289)
+.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~-- 286 (337)
T cd05054 210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC-- 286 (337)
T ss_pred CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH--
Confidence 9999999999987643322222333456778999999999999999999999999999998 9888764322211 10
Q ss_pred HhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 187 AWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
....... ........+.++.+++.+||+.+|++||++.++++.|+..
T Consensus 287 --~~~~~~~---------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 287 --RRLKEGT---------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred --HHHhccC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111110 0011122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.91 Aligned_cols=215 Identities=22% Similarity=0.297 Sum_probs=173.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++..++||||+++++++.+++..|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~ 119 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK 119 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999999853 3678999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCC---------------------------cccccccccccccc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE---------------------------LQSNTKRIVGTYGY 139 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~---------------------------~~~~~~~~~g~~~y 139 (289)
.+ |+||||||+|||++.++.+||+|||++....... .........||+.|
T Consensus 120 ~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 196 (350)
T cd05573 120 LG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDY 196 (350)
T ss_pred CC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccc
Confidence 88 9999999999999999999999999998654332 00122345689999
Q ss_pred cChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHH
Q 038647 140 MSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINV 219 (289)
Q Consensus 140 ~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 219 (289)
+|||++.+..++.++|||||||++|+|++|+.||......... ....... ....-......+..+.++
T Consensus 197 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~-----~~i~~~~-------~~~~~p~~~~~~~~~~~l 264 (350)
T cd05573 197 IAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY-----NKIINWK-------ESLRFPPDPPVSPEAIDL 264 (350)
T ss_pred cCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH-----HHHhccC-------CcccCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999998754422110 0000000 000011111145788999
Q ss_pred HHcccccCCCCCCC-HHHHHHH
Q 038647 220 ALLCVQENAADRPT-MLEVISM 240 (289)
Q Consensus 220 i~~~l~~~p~~Rps-~~~ll~~ 240 (289)
+..||. ||.+||+ +.++++.
T Consensus 265 i~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 265 ICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHcc-ChhhcCCCHHHHhcC
Confidence 999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=265.29 Aligned_cols=221 Identities=24% Similarity=0.343 Sum_probs=165.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--CCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--TGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..+.|.+|+++++.++|+||+++++++.+....++||||+++|+|.+++..... ....++.....++.||+.||.|||
T Consensus 38 ~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 117 (269)
T cd05042 38 EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999865332 234567788899999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-------CCCCCcccchh
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-------GLFSIKSDVFS 158 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Diws 158 (289)
+++ |+||||||+|||++.++.+||+|||+++...............++..|+|||++.. ..++.++||||
T Consensus 118 ~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05042 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194 (269)
T ss_pred hcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence 888 99999999999999999999999999875433221111223345678999999753 35688999999
Q ss_pred HHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
|||++|+|++ |..|+....... .... ..... .... .........+..+.+++..|| .||++|||+++|
T Consensus 195 lG~~l~el~~~~~~p~~~~~~~~--~~~~---~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v 263 (269)
T cd05042 195 LGVTMWELFTAADQPYPDLSDEQ--VLKQ---VVREQ-DIKL----PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263 (269)
T ss_pred HHHHHHHHHhCCCCCCCcCCHHH--HHHH---Hhhcc-CccC----CCCcccccCCHHHHHHHHHHh-cCcccccCHHHH
Confidence 9999999999 666765432211 1111 01110 0011 111112234466778888898 599999999999
Q ss_pred HHHhh
Q 038647 238 ISMLT 242 (289)
Q Consensus 238 l~~L~ 242 (289)
++.|.
T Consensus 264 ~~~l~ 268 (269)
T cd05042 264 HELLT 268 (269)
T ss_pred HHHhc
Confidence 99873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=264.00 Aligned_cols=217 Identities=24% Similarity=0.365 Sum_probs=170.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.|.+|+.++++++||||+++++++.. ...++||||+++++|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~ 113 (257)
T cd05115 37 SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG 113 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345779999999999999999999998864 578999999999999998853 23568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++ ++||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+
T Consensus 114 ~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 190 (257)
T cd05115 114 KN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190 (257)
T ss_pred cC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHH
Confidence 88 9999999999999999999999999997553322111 1111223568999999998889999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+++ |..||....... .. ....... ....+...+.++.+++..||..+|++||++.+|.+.|+..
T Consensus 191 l~~~g~~p~~~~~~~~--~~----~~~~~~~---------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 191 AFSYGQKPYKKMKGPE--VM----SFIEQGK---------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HhcCCCCCcCcCCHHH--HH----HHHHCCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 996 888876433211 11 1111111 1111223356888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=278.46 Aligned_cols=205 Identities=25% Similarity=0.256 Sum_probs=166.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.||+.||.|||++
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~ 117 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL 117 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567889999999999999999999999999999999999999999884 345689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+..++.++|||||||++|+|+
T Consensus 118 ~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 192 (318)
T cd05582 118 G---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192 (318)
T ss_pred C---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeec
Confidence 8 9999999999999999999999999987653321 1223457899999999999988999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
+|..||....... .... .... . ...+...+..+.+++.+||+.||++||++.+
T Consensus 193 tg~~p~~~~~~~~--~~~~---i~~~---------~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 193 TGSLPFQGKDRKE--TMTM---ILKA---------K--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred cCCCCCCCCCHHH--HHHH---HHcC---------C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9999986433211 1110 0000 0 0111224567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.28 Aligned_cols=223 Identities=22% Similarity=0.246 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
...+.+|+.+++.++||||+++++++.++...++||||+. ++|.+++.. ..+.++++.+..++.|++.||.|||+++
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ 123 (303)
T cd07869 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY 123 (303)
T ss_pred chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567889999999999999999999999999999999996 567666643 2356888999999999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~ell 167 (289)
|+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 124 ---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 198 (303)
T cd07869 124 ---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198 (303)
T ss_pred ---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987543221 12233467899999999875 45899999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhh-------hccCCcccccc-cccc--CCCC-------HHHHHHHHHHHHcccccCCCC
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNL-------WNDGRAWELMD-SILQ--NDAS-------YPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~--~~~~-------~~~~~~l~~li~~~l~~~p~~ 230 (289)
+|..||.........+....... |.......... .... .... ...+..+.+++.+||+.||++
T Consensus 199 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~ 278 (303)
T cd07869 199 QGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKN 278 (303)
T ss_pred hCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchh
Confidence 99999876443222111111000 00000000000 0000 0000 012356789999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||+.++++
T Consensus 279 R~s~~~~l~ 287 (303)
T cd07869 279 RLSAQAALS 287 (303)
T ss_pred ccCHHHHhc
Confidence 999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=276.47 Aligned_cols=214 Identities=20% Similarity=0.295 Sum_probs=170.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++... .+.+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~ 120 (330)
T cd05601 43 ETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ 120 (330)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999999999999998542 3568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh------cCCCCCcccchhHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL------RGLFSIKSDVFSFG 160 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG 160 (289)
.+ |+||||||+|||++.++.+||+|||++......... ......||+.|+|||++. +..++.++||||||
T Consensus 121 ~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 196 (330)
T cd05601 121 MG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196 (330)
T ss_pred CC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeeccc
Confidence 88 999999999999999999999999999876433222 223346899999999987 45678999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+|++|..||........ . ...... .....-......+..+.+++..||+ +|++||++.++++
T Consensus 197 ~il~el~~g~~Pf~~~~~~~~--~---~~i~~~-------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 197 VIAYEMIYGRSPFHEGTSAKT--Y---NNIMNF-------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ceeeeeccCCCCCCCCCHHHH--H---HHHHcC-------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 999999999999864432111 0 011100 0001111112345678899999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=275.31 Aligned_cols=210 Identities=21% Similarity=0.261 Sum_probs=169.8
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+..+.+..|.++++.+ +||||+++++++.+++..|+||||+++|+|..++. ..+.+++..+..++.||+.||.||
T Consensus 36 ~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~L 112 (321)
T cd05591 36 DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFL 112 (321)
T ss_pred hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566788899999877 79999999999999999999999999999988884 345688999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|
T Consensus 113 H~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ 187 (321)
T cd05591 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMY 187 (321)
T ss_pred HHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHH
Confidence 9988 9999999999999999999999999987543221 1223456899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-------CHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-------TMLEV 237 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~~l 237 (289)
+|++|+.||...+.... ... .... . ...+...+.++.+++..||+.||++|| ++.++
T Consensus 188 el~tg~~Pf~~~~~~~~--~~~---i~~~-~----------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~ 251 (321)
T cd05591 188 EMMAGQPPFEADNEDDL--FES---ILHD-D----------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAI 251 (321)
T ss_pred HHhcCCCCCCCCCHHHH--HHH---HHcC-C----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHH
Confidence 99999999875432211 111 0100 0 001112346888999999999999999 78887
Q ss_pred HH
Q 038647 238 IS 239 (289)
Q Consensus 238 l~ 239 (289)
++
T Consensus 252 ~~ 253 (321)
T cd05591 252 KQ 253 (321)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=266.97 Aligned_cols=217 Identities=28% Similarity=0.405 Sum_probs=170.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC----CCCCChHHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK----TGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....|.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++..... ...+++..+..++.||+.||.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 52 DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 356799999999999999999999999999999999999999999998854321 2358889999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCC---ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNM---NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
||+++ ++||||||+||+++.++ .+||+|||+++................+..|+|||++.+..++.++||||||
T Consensus 132 LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 208 (277)
T cd05036 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFG 208 (277)
T ss_pred HHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHH
Confidence 99988 99999999999998654 5899999999876332222212222345689999999988999999999999
Q ss_pred HHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+|++ |..||....... .... ..... ....+...+..+.+++.+||+.+|++|||+.+|++
T Consensus 209 ~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 209 VLLWEIFSLGYMPYPGRTNQE--VMEF----VTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred HHHHHHHcCCCCCCCCCCHHH--HHHH----HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999997 888876433221 1111 11100 11112234568889999999999999999999999
Q ss_pred Hhh
Q 038647 240 MLT 242 (289)
Q Consensus 240 ~L~ 242 (289)
.|.
T Consensus 274 ~l~ 276 (277)
T cd05036 274 RIQ 276 (277)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=266.70 Aligned_cols=217 Identities=26% Similarity=0.342 Sum_probs=170.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++..|+.++++++||||+++++++.. ...++|+||+++|+|.+++.. ..+.+++..+..++.||+.||.|||++
T Consensus 52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T cd05111 52 TFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH 128 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678889999999999999999998764 467899999999999999853 234688999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||++
T Consensus 129 ~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~ 205 (279)
T cd05111 129 R---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205 (279)
T ss_pred C---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999998654332222233345677899999999889999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
+ |..|+........ . .....+.... .....+..+.+++..||..||++|||+.|+++.|....
T Consensus 206 t~g~~p~~~~~~~~~---~---~~~~~~~~~~---------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 206 SYGAEPYAGMRPHEV---P---DLLEKGERLA---------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred cCCCCCCCCCCHHHH---H---HHHHCCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 8 8888754322111 0 0111111000 01112346788999999999999999999999887744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=273.86 Aligned_cols=218 Identities=24% Similarity=0.386 Sum_probs=172.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+.+++.++||||+++++++..+ ..++|+||+++|+|.+++... ...+++..+..++.||+.||+|||+
T Consensus 51 ~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~ 127 (316)
T cd05108 51 KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE 127 (316)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh
Confidence 3467899999999999999999999998865 577999999999999988542 3457888999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|
T Consensus 128 ~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el 204 (316)
T cd05108 128 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204 (316)
T ss_pred cC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 88 999999999999999999999999999876543322222223346789999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..|+....... .. ....... ........+.++.+++..||+.||++||++.+++..|....
T Consensus 205 ~t~g~~p~~~~~~~~--~~----~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 205 MTFGSKPYDGIPASE--IS----SILEKGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HcCCCCCCCCCCHHH--HH----HHHhCCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 98 888875432211 10 0111110 00111123457889999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=269.07 Aligned_cols=234 Identities=24% Similarity=0.358 Sum_probs=172.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....++|.+|+++++.++||||+++++++.+. ...++||||+++++|.+++... ...+++..+..++.|++.||.|
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~ 124 (284)
T cd05079 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDY 124 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998875 5789999999999999988432 2357899999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
||+++ ++||||||+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.++||||||++
T Consensus 125 lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~i 201 (284)
T cd05079 125 LGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201 (284)
T ss_pred HHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhh
Confidence 99988 99999999999999999999999999987643221 111223456778999999998889999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+|+|++++.|...........................+............+..+.+++.+||+.||++|||+.++++.|+
T Consensus 202 l~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 202 LYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred hhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 99999987653221110000000000000000000000000011112234578999999999999999999999999987
Q ss_pred cc
Q 038647 243 NE 244 (289)
Q Consensus 243 ~~ 244 (289)
.+
T Consensus 282 ~~ 283 (284)
T cd05079 282 AI 283 (284)
T ss_pred hh
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=264.66 Aligned_cols=214 Identities=31% Similarity=0.464 Sum_probs=170.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|++++++++||||+++++++.+.+..|+||||+++++|.+++... .+.+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~ 119 (256)
T cd05059 42 SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESN 119 (256)
T ss_pred CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3467899999999999999999999999999999999999999999988532 24688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+++
T Consensus 120 ~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd05059 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C---cccccccHhhEEECCCCcEEECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHh
Confidence 8 9999999999999999999999999988654322111 11122345799999999989999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+ |..|+....... ..... ... .....+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus 196 ~~g~~p~~~~~~~~--~~~~~----~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 196 SEGKMPYERFSNSE--VVESV----SAG---------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred ccCCCCCCCCCHHH--HHHHH----HcC---------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 9 787775433221 11111 000 001111224568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=275.33 Aligned_cols=208 Identities=24% Similarity=0.362 Sum_probs=163.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|+++|+.++|+||+++++++.+++.+++||||+++|+|.... ...+..+..++.||+.||.|||++
T Consensus 115 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~ 187 (353)
T PLN00034 115 VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR 187 (353)
T ss_pred HHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4577899999999999999999999999999999999999999986432 345677889999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----CCCCCcccchhHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~v 162 (289)
+ |+||||||+|||++.++.+||+|||+++....... ......|+..|+|||++.. ...+.++|||||||+
T Consensus 188 ~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvi 262 (353)
T PLN00034 188 H---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262 (353)
T ss_pred C---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHH
Confidence 8 99999999999999999999999999986543211 1233468999999998853 234578999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|+.||.............. ... ..........+.++.+++.+||+.||++|||+.|+++
T Consensus 263 l~el~~g~~pf~~~~~~~~~~~~~~--~~~----------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 263 ILEFYLGRFPFGVGRQGDWASLMCA--ICM----------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHhCCCCCCCCCCccHHHHHHH--Hhc----------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999874332221111000 000 0001112234568999999999999999999999987
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=274.25 Aligned_cols=213 Identities=20% Similarity=0.236 Sum_probs=168.9
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+.+++.+ +||||+++++++.+++..++||||+++|+|.+++. ..+.++++.+..++.||+.||.|||+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~ 123 (332)
T cd05614 47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHK 123 (332)
T ss_pred HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999 59999999999999999999999999999999884 34568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
++ |+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 124 ~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 199 (332)
T cd05614 124 LG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199 (332)
T ss_pred CC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhh
Confidence 88 999999999999999999999999999865332211 22345789999999999865 47899999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
|++|..||.......... ........ .........+..+.+++.+||+.||++|| +++++++
T Consensus 200 lltg~~pf~~~~~~~~~~-~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 200 LLTGASPFTLEGERNTQS-EVSRRILK-----------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred hhcCCCCCCCCCCCCCHH-HHHHHHhc-----------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 999999986543321110 00000000 00111223456788999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=273.52 Aligned_cols=203 Identities=20% Similarity=0.212 Sum_probs=161.3
Q ss_pred HHHHHHHHH-HHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMM-LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+++.+|.. +++.++||||+++++++.+.+..|+||||+++|+|...+. ..+.+++..+..++.||+.||.|||++
T Consensus 39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~ 115 (321)
T cd05603 39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSL 115 (321)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 445556654 6788999999999999999999999999999999988773 345688889999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 116 ~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (321)
T cd05603 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190 (321)
T ss_pred C---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhh
Confidence 8 9999999999999999999999999987532221 1233457899999999999889999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
+|..||...+... .... .. ... ...+...+..+.+++.+||+.||++||++.
T Consensus 191 ~g~~pf~~~~~~~--~~~~---i~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 191 YGLPPFYSRDVSQ--MYDN---IL-HKP----------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cCCCCCCCCCHHH--HHHH---Hh-cCC----------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 9999986543211 1100 00 000 011122346788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=264.20 Aligned_cols=214 Identities=30% Similarity=0.436 Sum_probs=170.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|+.++++++||||+++++++.+++..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~ 119 (256)
T cd05113 42 SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK 119 (256)
T ss_pred cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3567999999999999999999999999999999999999999999988542 23688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||||.||+++.++.+||+|||.++......... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 120 ~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 120 Q---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred C---eeccccCcceEEEcCCCCEEECCCccceecCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHh
Confidence 8 9999999999999999999999999988654332211 11223567899999999888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+ |..|+........ ... ...... .......+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 196 ~~g~~p~~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 196 SLGKMPYERFNNSET--VEK----VSQGLR---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCCCcCcCCHHHH--HHH----HhcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 8 8888754432211 110 000000 0011123468899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=278.88 Aligned_cols=215 Identities=21% Similarity=0.323 Sum_probs=167.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|++++||||+++++.+.+++.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~ 119 (376)
T cd05598 43 NQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHK 119 (376)
T ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356778899999999999999999999999999999999999999999984 34568889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCC-----------------------------------------
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE----------------------------------------- 125 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~----------------------------------------- 125 (289)
++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 120 ~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (376)
T cd05598 120 MG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQH 196 (376)
T ss_pred CC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhc
Confidence 88 9999999999999999999999999975321000
Q ss_pred cccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc
Q 038647 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ 205 (289)
Q Consensus 126 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (289)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||............. .+.. ...
T Consensus 197 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~~~---------~~~ 264 (376)
T cd05598 197 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI---NWET---------TLH 264 (376)
T ss_pred ccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHh---ccCc---------ccc
Confidence 0000123479999999999999999999999999999999999999987654322111000 0000 000
Q ss_pred CCCCHHHHHHHHHHHHcccccCCCCCC---CHHHHHHH
Q 038647 206 NDASYPMLNRYINVALLCVQENAADRP---TMLEVISM 240 (289)
Q Consensus 206 ~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 240 (289)
.......+..+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 265 ~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 265 IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 0111123456778888876 5999999 89998863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.74 Aligned_cols=208 Identities=20% Similarity=0.266 Sum_probs=166.7
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+..|..++... +||||+++++++.+++.+|+||||+++|+|..++. ..+.+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH 113 (316)
T cd05620 37 DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLH 113 (316)
T ss_pred chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456677888888765 89999999999999999999999999999998884 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~e 188 (316)
T cd05620 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE 188 (316)
T ss_pred HCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHH
Confidence 988 9999999999999999999999999987532211 12234568999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH-HHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML-EVI 238 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~ll 238 (289)
|++|..||...+.. ..... .... ....+...+.++.+++.+||+.||++||++. +++
T Consensus 189 l~~g~~Pf~~~~~~--~~~~~----~~~~----------~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 189 MLIGQSPFHGDDED--ELFES----IRVD----------TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHhCCCCCCCCCHH--HHHHH----HHhC----------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 99999998644322 11111 0000 0011112446788999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=263.76 Aligned_cols=221 Identities=24% Similarity=0.346 Sum_probs=167.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--CCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--TGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....|.+|+.++++++||||+++++++.+....++||||+++|+|.+++..... ...+++..+..++.|++.||.|||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999864322 234667788899999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-------CCCCcccchh
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-------LFSIKSDVFS 158 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Diws 158 (289)
+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+. .++.++||||
T Consensus 118 ~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred HCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 888 999999999999999999999999998754433222222334567889999998642 3588999999
Q ss_pred HHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
||+++|+|++ |..||........ .... ... ...... ........+..+.+++..|| .+|++|||+++|
T Consensus 195 lG~~l~el~~~g~~p~~~~~~~~~--~~~~---~~~-~~~~~~----~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l 263 (269)
T cd05087 195 LGVTIWELFELGSQPYRHLSDEQV--LTYT---VRE-QQLKLP----KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV 263 (269)
T ss_pred HHHHHHHHHhCCCCCCCCCChHHH--HHHH---hhc-ccCCCC----CCccCCCCChHHHHHHHHHh-cCcccCCCHHHH
Confidence 9999999996 9988865433221 1110 000 000111 11111123456788999998 689999999999
Q ss_pred HHHhh
Q 038647 238 ISMLT 242 (289)
Q Consensus 238 l~~L~ 242 (289)
+..|+
T Consensus 264 ~~~l~ 268 (269)
T cd05087 264 HLLLS 268 (269)
T ss_pred HHHhc
Confidence 98875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=267.64 Aligned_cols=219 Identities=26% Similarity=0.417 Sum_probs=171.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------------CCCCCCh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------------KTGLLGW 67 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~ 67 (289)
+..++|.+|+.++++++||||+++++++.+++..++|+||+++|+|.+++.... ....+++
T Consensus 50 ~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 129 (288)
T cd05050 50 DMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129 (288)
T ss_pred HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCH
Confidence 346779999999999999999999999999999999999999999999986321 1134778
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc
Q 038647 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR 147 (289)
Q Consensus 68 ~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 147 (289)
..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++................+..|+|||.+.+
T Consensus 130 ~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 130 TEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY 206 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence 889999999999999999888 99999999999999999999999999886543322222222344667999999998
Q ss_pred CCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHccccc
Q 038647 148 GLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQE 226 (289)
Q Consensus 148 ~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 226 (289)
..++.++|||||||++|+|++ |..|+...... .... ........ ..+...+..+.+++.+||+.
T Consensus 207 ~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~ 271 (288)
T cd05050 207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--EVIY----YVRDGNVL---------SCPDNCPLELYNLMRLCWSK 271 (288)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHccc
Confidence 899999999999999999997 77676433221 1111 01111100 01112346889999999999
Q ss_pred CCCCCCCHHHHHHHhhc
Q 038647 227 NAADRPTMLEVISMLTN 243 (289)
Q Consensus 227 ~p~~Rps~~~ll~~L~~ 243 (289)
+|++|||+.|+++.|++
T Consensus 272 ~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 272 LPSDRPSFASINRILQR 288 (288)
T ss_pred CcccCCCHHHHHHHhhC
Confidence 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=265.56 Aligned_cols=220 Identities=23% Similarity=0.395 Sum_probs=172.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe------EEEEEeecCCCChhhhhcCCC---CCCCCChHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE------KILIYEYMPNKSLDCFLFDPT---KTGLLGWEMRVRILEGV 77 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i 77 (289)
...+.+.+|+++++.++||||+++++++.+... .++|+||+++|+|..++.... ....+++..+..++.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i 122 (273)
T cd05035 43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122 (273)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence 456789999999999999999999998876554 799999999999988874321 22468899999999999
Q ss_pred HHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccch
Q 038647 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 78 ~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
+.||.|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||
T Consensus 123 ~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~ 199 (273)
T cd05035 123 ALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 199 (273)
T ss_pred HHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchH
Confidence 99999999887 999999999999999999999999999876443322222223356789999999888899999999
Q ss_pred hHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||+++|||++ |..|+...... ....... .... ...+...+..+.+++.+||+.||++|||+.+
T Consensus 200 SlG~il~el~~~g~~p~~~~~~~--~~~~~~~----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 264 (273)
T cd05035 200 AFGVTMWEIATRGQTPYPGVENH--EIYDYLR----HGNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTK 264 (273)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH----cCCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999999999 77777543321 1111111 0100 1112234568899999999999999999999
Q ss_pred HHHHhhcc
Q 038647 237 VISMLTNE 244 (289)
Q Consensus 237 ll~~L~~~ 244 (289)
+++.|++.
T Consensus 265 ~~~~l~~~ 272 (273)
T cd05035 265 LREVLENI 272 (273)
T ss_pred HHHHHHhh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=277.41 Aligned_cols=209 Identities=23% Similarity=0.375 Sum_probs=172.6
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe--EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE--KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
++++..++|..|+.+|+.|+||||+++++++.+... +.+|+|++..|+|..|++ +.+......+..||.||+.||
T Consensus 80 q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL 156 (632)
T KOG0584|consen 80 QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGL 156 (632)
T ss_pred cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHh
Confidence 456678999999999999999999999999987654 889999999999999994 456678889999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.|||++ ..+|+|||||-+||||+. .|.|||+|+|+|....... .....|||.|||||... ..|+...||||||
T Consensus 157 ~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFG 230 (632)
T KOG0584|consen 157 VYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFG 230 (632)
T ss_pred hhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhh
Confidence 999998 478999999999999975 5889999999999875432 34468999999999986 8899999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHH----HHHHHHHHHcccccCCCCCCCHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPM----LNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
+.++||+|+..|+.-=.+ .+ ++.++...+..+... -+++.++|.+||.. .++|||+.|
T Consensus 231 MCmLEMvT~eYPYsEC~n-----~A------------QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~e 292 (632)
T KOG0584|consen 231 MCMLEMVTSEYPYSECTN-----PA------------QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKE 292 (632)
T ss_pred HHHHHHHhccCChhhhCC-----HH------------HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHH
Confidence 999999999998642111 11 222333333222221 14788999999999 999999999
Q ss_pred HHH
Q 038647 237 VIS 239 (289)
Q Consensus 237 ll~ 239 (289)
+|.
T Consensus 293 LL~ 295 (632)
T KOG0584|consen 293 LLK 295 (632)
T ss_pred Hhh
Confidence 996
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=274.52 Aligned_cols=208 Identities=19% Similarity=0.205 Sum_probs=164.3
Q ss_pred CHHHHHHHHH-HHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMM-LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|.. +++.++||||+++++++..++..|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||+
T Consensus 38 ~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~ 114 (325)
T cd05604 38 EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS 114 (325)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3455666665 4677899999999999999999999999999999988873 44578999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+| |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|
T Consensus 115 ~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 189 (325)
T cd05604 115 IN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189 (325)
T ss_pred CC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhh
Confidence 88 9999999999999999999999999987532211 123345789999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..||....... ... .... .. . ......+..+.+++.+||+.||.+||++++.++
T Consensus 190 ~~G~~pf~~~~~~~--~~~---~~~~-~~--------~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 190 LYGLPPFYCRDVAE--MYD---NILH-KP--------L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred hcCCCCCCCCCHHH--HHH---HHHc-CC--------c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 99999986543211 110 0000 00 0 011124467889999999999999998864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=262.28 Aligned_cols=217 Identities=28% Similarity=0.396 Sum_probs=173.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..++|.+|++++++++||||+++++++.+ ...++|+||+++++|.+++.+... ..+++..++.++.|++.||.|||+
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~ 115 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES 115 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh
Confidence 457789999999999999999999999988 889999999999999999865322 568999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++ ++|+||+|+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|+
T Consensus 116 ~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~e 192 (257)
T cd05040 116 KR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWE 192 (257)
T ss_pred CC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHH
Confidence 88 999999999999999999999999999876432211 11123456778999999999899999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|++ |..|+...+.... .... ..... ........+..+.+++..||+.+|++|||+.++++.|.
T Consensus 193 l~t~g~~p~~~~~~~~~--~~~~---~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 193 MFTYGEEPWAGLSGSQI--LKKI---DKEGE---------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHhCCCCCCCCCCHHHH--HHHH---HhcCC---------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 998 9988754332211 1110 00000 00111123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=266.40 Aligned_cols=217 Identities=19% Similarity=0.230 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+..|++++++++||||+++++++.++...|+||||+++++|..++... ....+++..+..++.|++.||.|||+.+
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ 115 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD 115 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445667999999999999999999999999999999999999998877542 2335788889999999999999999888
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
++||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++
T Consensus 116 ---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~ 189 (277)
T cd05607 116 ---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA 189 (277)
T ss_pred ---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHh
Confidence 9999999999999999999999999987654322 1223468899999999998889999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
|..||......... .......... . . .......+.++.+++.+||+.||++||+++|+++.+..
T Consensus 190 g~~p~~~~~~~~~~-~~~~~~~~~~-~--------~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 190 GRTPFKDHKEKVAK-EELKRRTLED-E--------V-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred CCCCCCCCcchhhH-HHHHHHhhcc-c--------c-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 99998643322110 0000000000 0 0 00111245678999999999999999999887654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=278.33 Aligned_cols=214 Identities=23% Similarity=0.281 Sum_probs=168.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|+.++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~ 119 (364)
T cd05599 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHK 119 (364)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999884 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc------------------------------------cc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS------------------------------------NT 130 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~------------------------------------~~ 130 (289)
++ |+||||||+|||++.++.++|+|||++.......... ..
T Consensus 120 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (364)
T cd05599 120 LG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA 196 (364)
T ss_pred CC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccc
Confidence 88 9999999999999999999999999987543211000 01
Q ss_pred ccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCH
Q 038647 131 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASY 210 (289)
Q Consensus 131 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (289)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. ....... ........
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~--~~---~i~~~~~-------~~~~~~~~ 264 (364)
T cd05599 197 YSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET--YR---KIINWKE-------TLQFPDEV 264 (364)
T ss_pred cccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH--HH---HHHcCCC-------ccCCCCCC
Confidence 124689999999999999999999999999999999999999865432211 00 0000000 00001111
Q ss_pred HHHHHHHHHHHcccccCCCCCCC---HHHHHH
Q 038647 211 PMLNRYINVALLCVQENAADRPT---MLEVIS 239 (289)
Q Consensus 211 ~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 239 (289)
..+..+.+++..|+. +|.+|++ +.++++
T Consensus 265 ~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 265 PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 345678899999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=270.57 Aligned_cols=221 Identities=27% Similarity=0.406 Sum_probs=173.7
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~ 72 (289)
...+++.+|+++++.+ +||||+++++++.+++..|+||||+++|+|.+++..... ...+++.+++.
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (307)
T cd05098 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144 (307)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3456788999999999 799999999999999999999999999999999865321 23578889999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.
T Consensus 145 ~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (307)
T cd05098 145 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221 (307)
T ss_pred HHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence 9999999999999888 9999999999999999999999999987654322111122223456899999999888999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++||||||+++|+|++ |..|+...... .... ...... ........+.++.+++..||+.+|++|
T Consensus 222 ~~DvwslG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R 286 (307)
T cd05098 222 QSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELFK----LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQR 286 (307)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHH----HHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhC
Confidence 9999999999999998 77776533211 1110 111110 111122345688899999999999999
Q ss_pred CCHHHHHHHhhccc
Q 038647 232 PTMLEVISMLTNEN 245 (289)
Q Consensus 232 ps~~~ll~~L~~~~ 245 (289)
||+.++++.|..+.
T Consensus 287 ps~~evl~~l~~~~ 300 (307)
T cd05098 287 PTFKQLVEDLDRIL 300 (307)
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=270.76 Aligned_cols=217 Identities=26% Similarity=0.390 Sum_probs=171.2
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~ 72 (289)
...+.|.+|++++.++ +||||+++++++.+++..|+||||+++++|.+++.... ....+++..+..
T Consensus 49 ~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 128 (303)
T cd05088 49 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128 (303)
T ss_pred HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHH
Confidence 4567889999999999 89999999999999999999999999999999885422 123678999999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...... ......++..|+|||.+.+..++.
T Consensus 129 ~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 202 (303)
T cd05088 129 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTT 202 (303)
T ss_pred HHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcc
Confidence 9999999999999888 9999999999999999999999999986432110 111123456799999998888999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++||||||+++|+|+| |..||....... .... .... .........+..+.+++.+||+.+|++|
T Consensus 203 ~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R 267 (303)
T cd05088 203 NSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK----LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYER 267 (303)
T ss_pred cccchhhhhHHHHHHhcCCCCcccCChHH--HHHH----HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999998 888875432211 1110 1000 0001111234578899999999999999
Q ss_pred CCHHHHHHHhhcc
Q 038647 232 PTMLEVISMLTNE 244 (289)
Q Consensus 232 ps~~~ll~~L~~~ 244 (289)
|++.++++.|.+.
T Consensus 268 p~~~~il~~l~~~ 280 (303)
T cd05088 268 PSFAQILVSLNRM 280 (303)
T ss_pred cCHHHHHHHHHHH
Confidence 9999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=262.00 Aligned_cols=213 Identities=26% Similarity=0.385 Sum_probs=174.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+++.+|+++++.++||||+++++++.+++..|+||||+++++|.+++... ....+++..++.++.+++.||.|||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH 118 (256)
T cd08529 40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH 118 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999988642 2356889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++|+||+|+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||||+++++
T Consensus 119 ~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 193 (256)
T cd08529 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193 (256)
T ss_pred HCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHH
Confidence 887 99999999999999999999999999886644321 1233467889999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..|+....... .... ..... ........+..+.+++.+||+.+|++||++.++++
T Consensus 194 l~~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 194 CCTGKHPFDANNQGA--LILK----IIRGV---------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHhCCCCCCCCCHHH--HHHH----HHcCC---------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 999999986544211 1100 00000 01111134568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=279.01 Aligned_cols=214 Identities=21% Similarity=0.318 Sum_probs=165.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++++.+++.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~ 119 (382)
T cd05625 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHK 119 (382)
T ss_pred HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356788999999999999999999999999999999999999999999884 33568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCC-----------------------------------------
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE----------------------------------------- 125 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~----------------------------------------- 125 (289)
++ |+||||||+|||++.++.+||+|||+++......
T Consensus 120 ~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (382)
T cd05625 120 MG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRA 196 (382)
T ss_pred CC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 88 9999999999999999999999999975321000
Q ss_pred ----cccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccc
Q 038647 126 ----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMD 201 (289)
Q Consensus 126 ----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (289)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..... .
T Consensus 197 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-----~i~~~-------~ 264 (382)
T cd05625 197 ARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQM-----KVINW-------Q 264 (382)
T ss_pred ccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHH-----HHHcc-------C
Confidence 0000123468999999999999999999999999999999999999987543221111 00000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHcccccCCCCCCC---HHHHHH
Q 038647 202 SILQNDASYPMLNRYINVALLCVQENAADRPT---MLEVIS 239 (289)
Q Consensus 202 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 239 (289)
...........+.+..+++.+|+ .+|++|++ +.++++
T Consensus 265 ~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 265 TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 00011111223467778887766 49999997 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=262.17 Aligned_cols=220 Identities=20% Similarity=0.316 Sum_probs=176.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..++|.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08229 45 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124 (267)
T ss_pred HHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45688999999999999999999999999999999999999999999875322 24568999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 125 ~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 125 RR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 88 99999999999999999999999999876543321 12234688899999999988899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++|..|+............. .. ............+..+.+++.+||+.||++|||+.+|++.+++.
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~----~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKK----IE--------QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HhCCCCcccccchHHHHhhh----hh--------cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 99999976433221111100 00 00001111123556899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=272.72 Aligned_cols=208 Identities=24% Similarity=0.313 Sum_probs=165.7
Q ss_pred cCHHHHHHHHHHH---hhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLI---AKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 7 ~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+..+.+.+|++++ +.++||||+++++++.+++..|+||||+++|+|..++. .+.+++..+..++.||+.||.|
T Consensus 41 ~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~ 116 (324)
T cd05589 41 DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQY 116 (324)
T ss_pred hHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHH
Confidence 3456777777665 56679999999999999999999999999999988773 2468999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
||+++ ++||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++
T Consensus 117 lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il 191 (324)
T cd05589 117 LHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI 191 (324)
T ss_pred HHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHH
Confidence 99988 9999999999999999999999999987532221 123345789999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVI 238 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll 238 (289)
|+|++|..||........ ... ... .. ...+...+..+.+++.+||+.||++|| ++.+++
T Consensus 192 ~el~~G~~pf~~~~~~~~--~~~---i~~-~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~ 255 (324)
T cd05589 192 YEMLVGESPFPGDDEEEV--FDS---IVN-DE----------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVK 255 (324)
T ss_pred HHHHhCCCCCCCCCHHHH--HHH---HHh-CC----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh
Confidence 999999999865432211 000 000 00 011223456788999999999999999 577776
Q ss_pred H
Q 038647 239 S 239 (289)
Q Consensus 239 ~ 239 (289)
+
T Consensus 256 ~ 256 (324)
T cd05589 256 K 256 (324)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=265.80 Aligned_cols=221 Identities=24% Similarity=0.331 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHhhC---CCCCceeeeeeEe-----ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKL---QHRNLVRLFGCCI-----EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|+.+++.+ +||||+++++++. .....++||||+. ++|.+++... ....+++..+..++.|++.|
T Consensus 45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~a 122 (290)
T cd07862 45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRG 122 (290)
T ss_pred hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHH
Confidence 45677788887776 6999999999985 3456899999996 5888888542 23458899999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+++ ++||||||+|||++.++.+||+|||+++..... .......|++.|+|||++.+..++.++||||||
T Consensus 123 L~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 196 (290)
T cd07862 123 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 196 (290)
T ss_pred HHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHH
Confidence 99999988 999999999999999999999999999865433 123345689999999999988999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhc---cCCccc---ccccccc--CC-----CCHHHHHHHHHHHHcccccC
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWN---DGRAWE---LMDSILQ--ND-----ASYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~--~~-----~~~~~~~~l~~li~~~l~~~ 227 (289)
|++|+|++|.+||........ ......... ...... ....... .. .....+..+.+++.+||+.|
T Consensus 197 ~il~el~~g~~~f~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 274 (290)
T cd07862 197 CIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 274 (290)
T ss_pred HHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccC
Confidence 999999999999876543211 111110000 000000 0000000 00 00123457789999999999
Q ss_pred CCCCCCHHHHHH
Q 038647 228 AADRPTMLEVIS 239 (289)
Q Consensus 228 p~~Rps~~~ll~ 239 (289)
|++|||+.++++
T Consensus 275 P~~R~s~~~~l~ 286 (290)
T cd07862 275 PAKRISAYSALS 286 (290)
T ss_pred chhcCCHHHHhc
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=262.27 Aligned_cols=215 Identities=29% Similarity=0.400 Sum_probs=170.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|+++++.++||||+++++++. .+..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||..
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~ 114 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESK 114 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 4568899999999999999999999876 4568999999999999999953 34688999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+ ++|+||||+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||+++|++
T Consensus 115 ~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~ 191 (257)
T cd05060 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191 (257)
T ss_pred C---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHH
Confidence 7 9999999999999999999999999998764332111 11112234679999999988999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++ |..||...... ...... .... ....+...+..+.+++.+||..+|++||++.+|++.|++.
T Consensus 192 ~~~g~~p~~~~~~~--~~~~~~----~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 192 FSYGAKPYGEMKGA--EVIAML----ESGE---------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HcCCCCCcccCCHH--HHHHHH----HcCC---------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 98 88887644321 111111 1110 0011222346788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=261.75 Aligned_cols=216 Identities=19% Similarity=0.221 Sum_probs=177.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+.+.+.+.|-+||+.++||.++.+|+.|+.+...|+|||||+||+|..++.+ +..+.++++.++.++..++.||+|||
T Consensus 118 rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLH 196 (459)
T KOG0610|consen 118 RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLH 196 (459)
T ss_pred hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHH
Confidence 44567788899999999999999999999999999999999999999887644 66788999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCC---------------------------------C-C------
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG---------------------------------D-E------ 125 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~---------------------------------~-~------ 125 (289)
..| ||+|||||+||||.++|++-|.||.++....- . .
T Consensus 197 mlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~ 273 (459)
T KOG0610|consen 197 MLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKD 273 (459)
T ss_pred hhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccc
Confidence 888 99999999999999999999999998765310 0 0
Q ss_pred --------------cccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhh
Q 038647 126 --------------LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLW 191 (289)
Q Consensus 126 --------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 191 (289)
......+++||-.|+|||++.+...+.+.|.|+||+++|||+.|..||.+.+......
T Consensus 274 ~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~-------- 345 (459)
T KOG0610|consen 274 ESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR-------- 345 (459)
T ss_pred ccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH--------
Confidence 0012345679999999999999999999999999999999999999998776543211
Q ss_pred ccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC----HHHHHH
Q 038647 192 NDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT----MLEVIS 239 (289)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~ll~ 239 (289)
.++.+-+.-......+..+.+||+++|..||.+|.- +.||-+
T Consensus 346 ------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 346 ------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 111111111222256678999999999999999998 666654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=264.70 Aligned_cols=217 Identities=26% Similarity=0.393 Sum_probs=170.1
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~ 72 (289)
...+.+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++.... ....+++.++..
T Consensus 37 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 116 (270)
T cd05047 37 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116 (270)
T ss_pred HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHH
Confidence 3456888999999999 79999999999999999999999999999999885422 123578899999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++...... ........+..|+|||++.+..++.
T Consensus 117 ~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~ 190 (270)
T cd05047 117 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTT 190 (270)
T ss_pred HHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCc
Confidence 9999999999999888 999999999999999999999999998632211 0111122356799999998888999
Q ss_pred cccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++||||||+++|+|++ |..||....... . ........ ........+..+.+++.+||+.||.+|
T Consensus 191 ~~Di~slG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (270)
T cd05047 191 NSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L----YEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYER 255 (270)
T ss_pred hhhHHHHHHHHHHHHcCCCCCccccCHHH--H----HHHHhCCC---------CCCCCCcCCHHHHHHHHHHcccChhhC
Confidence 9999999999999997 888875432111 1 11111100 001112234578899999999999999
Q ss_pred CCHHHHHHHhhcc
Q 038647 232 PTMLEVISMLTNE 244 (289)
Q Consensus 232 ps~~~ll~~L~~~ 244 (289)
||+.++++.|.+.
T Consensus 256 ps~~~il~~l~~~ 268 (270)
T cd05047 256 PSFAQILVSLNRM 268 (270)
T ss_pred CCHHHHHHHHHHh
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=249.49 Aligned_cols=226 Identities=21% Similarity=0.195 Sum_probs=176.7
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC-----eEEEEEeecCCCChhhhhcCCCC-CCCCChHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFLFDPTK-TGLLGWEMRVRILEGVA 78 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~ 78 (289)
+.++.+..++|++.-++++|||+++++++...+. ..|++++|...|+|.+.+...+. +..+++.++..|+.+|+
T Consensus 58 ~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic 137 (302)
T KOG2345|consen 58 SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGIC 137 (302)
T ss_pred chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHH
Confidence 4678899999999999999999999998876443 49999999999999998865443 34899999999999999
Q ss_pred HHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-------ccccccccccccccChhhhhc---C
Q 038647 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-------QSNTKRIVGTYGYMSPEYALR---G 148 (289)
Q Consensus 79 ~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~---~ 148 (289)
.||.+||+.. .++.||||||.||++.+.+.+++.|||.+....-... .........|..|.|||.+.- .
T Consensus 138 ~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ 216 (302)
T KOG2345|consen 138 RGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC 216 (302)
T ss_pred HHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc
Confidence 9999999875 4699999999999999999999999999886532110 011122356889999999973 4
Q ss_pred CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccc-ccccccCCCCHHHHHHHHHHHHcccccC
Q 038647 149 LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWEL-MDSILQNDASYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 149 ~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~ 227 (289)
..+.++|||||||++|.|+.|..||...-.. ++...-. ......-......++.+.++|.+|++.|
T Consensus 217 ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvd 283 (302)
T KOG2345|consen 217 TITERTDIWSLGCTLYAMMFGESPFERIYQQ-------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVD 283 (302)
T ss_pred ccccccchhhhhHHHHHHHHcCCcchHHhhc-------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCC
Confidence 5689999999999999999999998642211 1111111 1111111122237789999999999999
Q ss_pred CCCCCCHHHHHHHhhcc
Q 038647 228 AADRPTMLEVISMLTNE 244 (289)
Q Consensus 228 p~~Rps~~~ll~~L~~~ 244 (289)
|.+||++.+++..++..
T Consensus 284 P~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 284 PNQRPTIPELLSKLDDL 300 (302)
T ss_pred cccCCCHHHHHHHHHhh
Confidence 99999999999988754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=276.15 Aligned_cols=224 Identities=21% Similarity=0.265 Sum_probs=170.1
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
+.+.+|+++|+.++||||+++++++...+..|+|||++. ++|.+++ ...+.+++..+..++.||+.||.|||+++
T Consensus 131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g- 205 (392)
T PHA03207 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG- 205 (392)
T ss_pred ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 356789999999999999999999999999999999995 5787777 33467899999999999999999999988
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhC
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg 169 (289)
|+||||||+|||++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 206 --ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 283 (392)
T PHA03207 206 --IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283 (392)
T ss_pred --ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999999999876544333333456799999999999999999999999999999999999
Q ss_pred CCCcCCCCCcc-hhHhHhHhhhhccC-------Ccccc------ccccccCCCC-------HHHHHHHHHHHHcccccCC
Q 038647 170 KKNAHFYNTDS-LTLLGHAWNLWNDG-------RAWEL------MDSILQNDAS-------YPMLNRYINVALLCVQENA 228 (289)
Q Consensus 170 ~~p~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~------~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p 228 (289)
+.||....... ...+.......... ....+ .......... .....++.++|.+||..||
T Consensus 284 ~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 363 (392)
T PHA03207 284 NVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363 (392)
T ss_pred CCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh
Confidence 99986544321 11111111100000 00000 0000000000 1123567889999999999
Q ss_pred CCCCCHHHHHHH
Q 038647 229 ADRPTMLEVISM 240 (289)
Q Consensus 229 ~~Rps~~~ll~~ 240 (289)
++|||+.|++..
T Consensus 364 ~~Rpsa~e~l~~ 375 (392)
T PHA03207 364 EFRPSAQDILSL 375 (392)
T ss_pred hhCCCHHHHhhC
Confidence 999999999873
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=259.31 Aligned_cols=222 Identities=19% Similarity=0.314 Sum_probs=178.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+++.+|++++++++|+|++++++++.+++..++||||+++|+|..++.... ....++++.+..++.+++.||.|||
T Consensus 44 ~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 123 (267)
T cd08224 44 KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123 (267)
T ss_pred hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 357789999999999999999999999999999999999999999998885432 2456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++||||+|+||+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 124 ~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~ 198 (267)
T cd08224 124 SKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred hCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHH
Confidence 888 999999999999999999999999998765432211 223457889999999998889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
|++|..|+............. ..... .........+..+.+++.+||..+|++|||+.+|++.|+...
T Consensus 199 l~~g~~p~~~~~~~~~~~~~~----~~~~~--------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 199 MAALQSPFYGDKMNLYSLCKK----IEKCD--------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHCCCCcccCCccHHHHHhh----hhcCC--------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999875443221111100 00000 011111244568899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.07 Aligned_cols=214 Identities=20% Similarity=0.232 Sum_probs=169.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+
T Consensus 85 ~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~ 160 (370)
T cd05596 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS 160 (370)
T ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456688999999999999999999999999999999999999999998842 357888899999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC----CCCCcccchhHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVL 162 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~v 162 (289)
++ |+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 161 ~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvi 236 (370)
T cd05596 161 MG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred CC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHH
Confidence 88 999999999999999999999999999865432211 12345789999999998753 37899999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC--CCCHHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD--RPTMLEVISM 240 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~ 240 (289)
+|+|++|..||...+... .. ......... ..-......+..+.+++..||..+|.+ |+|+.++++.
T Consensus 237 lyelltG~~Pf~~~~~~~--~~---~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 237 LYEMLVGDTPFYADSLVG--TY---SKIMDHKNS-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHhCCCCcCCCCHHH--HH---HHHHcCCCc-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 999999999986543211 11 011111000 001111234578899999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=269.69 Aligned_cols=209 Identities=21% Similarity=0.267 Sum_probs=167.3
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+..|..++... +||||+++++++.+++.+|+||||+++|+|..++. ....+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH 113 (316)
T cd05619 37 DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLH 113 (316)
T ss_pred chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456677888888875 89999999999999999999999999999999884 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 188 (316)
T cd05619 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYE 188 (316)
T ss_pred hCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHH
Confidence 988 9999999999999999999999999987532221 12234568999999999999899999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH-HHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML-EVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~ll~ 239 (289)
|++|..||....... .... ..... ...+...+..+.+++.+||+.||++||++. ++++
T Consensus 189 l~~G~~pf~~~~~~~--~~~~----i~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 189 MLIGQSPFHGHDEEE--LFQS----IRMDN----------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHhCCCCCCCCCHHH--HHHH----HHhCC----------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 999999986543211 1110 00000 011112346788999999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=270.25 Aligned_cols=210 Identities=19% Similarity=0.264 Sum_probs=166.3
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+..+.+.+|+.++.++ +||||+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 37 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH 113 (327)
T cd05617 37 EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLH 113 (327)
T ss_pred hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567788999999999 69999999999999999999999999999988873 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 114 ~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~e 188 (327)
T cd05617 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 188 (327)
T ss_pred HCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHH
Confidence 988 9999999999999999999999999987532211 12334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcch-hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 166 TLSSKKNAHFYNTDSL-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 166 lltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|++|..||........ .............. ...+...+..+.+++.+||..||++|+++
T Consensus 189 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 189 MMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 9999999864332211 00011111111100 01122234678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=260.91 Aligned_cols=207 Identities=20% Similarity=0.336 Sum_probs=163.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.|.+|+.+++.++||||+++++++..+...++||||+++|+|..++.. ....+++..+..++.||+.||.|||+
T Consensus 46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~ 123 (262)
T cd05077 46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLED 123 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 3455788999999999999999999999999999999999999999888743 23568999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCc-------eEEcccccccccCCCCcccccccccccccccChhhhh-cCCCCCcccchh
Q 038647 87 YSRLRVIHRDLKASNILLDSNMN-------PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFS 158 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~-------vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Diws 158 (289)
++ ++||||||+|||++.++. ++++|||++...... ....++..|+|||.+. +..++.++||||
T Consensus 124 ~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diws 194 (262)
T cd05077 124 KD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWS 194 (262)
T ss_pred CC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHH
Confidence 88 999999999999987654 899999998754321 2235778899999987 467899999999
Q ss_pred HHHHHHHHH-hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETL-SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
||+++|+|+ +|..|+......... ..... . . ....+....+.+++.+||+.||++||++.+|
T Consensus 195 lG~~l~el~~~~~~p~~~~~~~~~~------~~~~~-~--------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~i 257 (262)
T cd05077 195 FGTTLWEICYNGEIPLKDKTLAEKE------RFYEG-Q--------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAI 257 (262)
T ss_pred HHHHHHHHHhCCCCCCCCcchhHHH------HHHhc-C--------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999998 477665432211110 00000 0 0 0111234678899999999999999999999
Q ss_pred HHHh
Q 038647 238 ISML 241 (289)
Q Consensus 238 l~~L 241 (289)
++.+
T Consensus 258 l~~~ 261 (262)
T cd05077 258 MRDI 261 (262)
T ss_pred HHhc
Confidence 9876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=253.58 Aligned_cols=220 Identities=21% Similarity=0.234 Sum_probs=169.3
Q ss_pred HHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 12 FKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 12 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
..|||.+|.+++|||||.+-.++.. -+.+|+|||||+. +|..++... ..++...++.-++.|++.|++|||.++
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w- 197 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW- 197 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce-
Confidence 4689999999999999999999874 3579999999965 888888532 257888999999999999999999988
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHHHh
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ellt 168 (289)
|+|||||++|+|++..|.+||+|||+||.++.. .......+-|.+|.|||.+.+. .|+...|+||+|||+.|+++
T Consensus 198 --ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~ 273 (419)
T KOG0663|consen 198 --ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT 273 (419)
T ss_pred --eEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence 999999999999999999999999999998754 2335556789999999999986 58999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhh------hccCCcccccccc---------ccCCCCHH-HHHHHHHHHHcccccCCCCCC
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNL------WNDGRAWELMDSI---------LQNDASYP-MLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~-~~~~l~~li~~~l~~~p~~Rp 232 (289)
+.+.|++.+.-+........-. |..-......+.. +...+... .++.-.+++..+|..||.+|.
T Consensus 274 ~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 274 QKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred cCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc
Confidence 9998887665433221111111 1111111111000 01111111 346678999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
|+.|.++
T Consensus 354 tA~~~L~ 360 (419)
T KOG0663|consen 354 TAEDGLK 360 (419)
T ss_pred cHHHhhc
Confidence 9999886
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=248.21 Aligned_cols=209 Identities=25% Similarity=0.324 Sum_probs=177.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+++.+|++|-+.++||||++++++|.+....|+++||.+.|++...|.. ...+.+++.....+..|++.||.|+|.
T Consensus 64 ~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~ 142 (281)
T KOG0580|consen 64 QVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHL 142 (281)
T ss_pred cchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhcc
Confidence 3457889999999999999999999999999999999999999999998854 245678999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+|+|++..+.+|++|||-+.... .....+.+||.-|.+||...+..++...|+|++|++.||+
T Consensus 143 k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yef 215 (281)
T KOG0580|consen 143 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEF 215 (281)
T ss_pred CC---cccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHH
Confidence 88 9999999999999999999999999887543 2345667999999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+.|.+||....... ... ++.+.. -..+..++....++|..|+..+|.+|.+..|+++
T Consensus 216 lvg~ppFes~~~~e-tYk-------------rI~k~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 216 LVGLPPFESQSHSE-TYK-------------RIRKVD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HhcCCchhhhhhHH-HHH-------------HHHHcc--ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 99999998665221 111 111111 1223456678999999999999999999999876
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=256.14 Aligned_cols=224 Identities=22% Similarity=0.281 Sum_probs=170.1
Q ss_pred HHHHHHHHHhhCCCCC-ceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCC-CCCChHHHHHHHHHHHHHHH
Q 038647 11 EFKNEMMLIAKLQHRN-LVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKT-GLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~l~ 82 (289)
...+|+.+|++++|+| ||.+++++.+.+ .+++|+||++ .+|..++...... ..++...+..++.||+.||+
T Consensus 56 taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~ 134 (323)
T KOG0594|consen 56 TAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLA 134 (323)
T ss_pred hhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHH
Confidence 4579999999999999 999999999877 8999999994 5899888653321 35667889999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGV 161 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~ 161 (289)
|||+++ |+||||||+||+++++|.+||+|||+++...-.. ......++|.+|.|||++.+. .|+...||||+||
T Consensus 135 ~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~Gc 209 (323)
T KOG0594|consen 135 FLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGC 209 (323)
T ss_pred HHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHH
Confidence 999988 9999999999999999999999999999765322 224456789999999999987 7999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccc------ccCCC-CHHH-------HHHHHHHHHcccccC
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSI------LQNDA-SYPM-------LNRYINVALLCVQEN 227 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~-------~~~l~~li~~~l~~~ 227 (289)
++.||+++++-|++....+........-.......+.-.... ..... .... .....+++.+||+.+
T Consensus 210 IfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~ 289 (323)
T KOG0594|consen 210 IFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYD 289 (323)
T ss_pred HHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccC
Confidence 999999999888876653322211111111111111111111 11111 1111 137789999999999
Q ss_pred CCCCCCHHHHHHH
Q 038647 228 AADRPTMLEVISM 240 (289)
Q Consensus 228 p~~Rps~~~ll~~ 240 (289)
|.+|.|++..++.
T Consensus 290 p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 290 PAKRISAKGALTH 302 (323)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=258.75 Aligned_cols=213 Identities=25% Similarity=0.340 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
...|.+|+++++.++||||+++++++...+..++||||+++++|.+++... ...+++..+..++.|++.+|.|+|+++
T Consensus 36 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ 113 (250)
T cd05085 36 KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN 113 (250)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 457889999999999999999999999999999999999999999988532 345789999999999999999999888
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
++||||+|+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|++++
T Consensus 114 ---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 114 ---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred ---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 999999999999999999999999998764332211 1122234567999999998889999999999999999998
Q ss_pred -CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 169 -SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 169 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|..||........ .. ...... ........+..+.+++.+||+.+|++||++.++++.|.
T Consensus 190 ~g~~p~~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 190 LGVCPYPGMTNQQA--RE----QVEKGY---------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCHHHH--HH----HHHcCC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 8888764432211 00 011110 11112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.99 Aligned_cols=216 Identities=21% Similarity=0.276 Sum_probs=165.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.++.+++||||+++++.+.++..+|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~ 119 (363)
T cd05628 43 EQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQ 119 (363)
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999999999999999999999999999984 34678999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc---------------------------------cccccc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ---------------------------------SNTKRI 133 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~---------------------------------~~~~~~ 133 (289)
++ |+||||||+|||++.++.+||+|||+++........ ......
T Consensus 120 ~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (363)
T cd05628 120 LG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFST 196 (363)
T ss_pred CC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence 88 999999999999999999999999998754321100 001234
Q ss_pred cccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHH
Q 038647 134 VGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPML 213 (289)
Q Consensus 134 ~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (289)
+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ....... ..-....+.+
T Consensus 197 ~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~--~~~---i~~~~~~-------~~~p~~~~~s 264 (363)
T cd05628 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET--YKK---VMNWKET-------LIFPPEVPIS 264 (363)
T ss_pred cCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHH--HHH---HHcCcCc-------ccCCCcCCCC
Confidence 799999999999999999999999999999999999999865432211 110 0000000 0001111234
Q ss_pred HHHHHHHHcccc--cCCCCCCCHHHHHHH
Q 038647 214 NRYINVALLCVQ--ENAADRPTMLEVISM 240 (289)
Q Consensus 214 ~~l~~li~~~l~--~~p~~Rps~~~ll~~ 240 (289)
.++.+++.+++. .++..||+++||++.
T Consensus 265 ~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 265 EKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 567777776443 234456899999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=264.70 Aligned_cols=222 Identities=23% Similarity=0.339 Sum_probs=175.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCCC-----CCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKT-----GLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~i~~ 79 (289)
....+.+.+|+.+++.++|+||+++++++.+ +...++++||+++++|.+++...... ..+++..++.++.|++.
T Consensus 49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 128 (280)
T cd05043 49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence 3457788999999999999999999998765 56789999999999999988653322 46889999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||
T Consensus 129 ~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 205 (280)
T cd05043 129 GMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF 205 (280)
T ss_pred HHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence 999999887 99999999999999999999999999986543332222223345678999999998889999999999
Q ss_pred HHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 160 GVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 160 G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
|+++|++++ |..|+..... ...... ...... .......+..+.+++.+||..||++|||+.+++
T Consensus 206 G~~l~el~~~g~~p~~~~~~--~~~~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 206 GVLLWELMTLGQTPYVEIDP--FEMAAY----LKDGYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLV 270 (280)
T ss_pred HHHHHHHhcCCCCCcCcCCH--HHHHHH----HHcCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 999999999 8888754322 111111 111100 001112346789999999999999999999999
Q ss_pred HHhhccc
Q 038647 239 SMLTNEN 245 (289)
Q Consensus 239 ~~L~~~~ 245 (289)
+.|....
T Consensus 271 ~~l~~~~ 277 (280)
T cd05043 271 QCLTDFH 277 (280)
T ss_pred HHHHHHH
Confidence 9998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=262.72 Aligned_cols=217 Identities=29% Similarity=0.490 Sum_probs=172.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|..|++++++++||||+++.+++.+.+..++||||+++++|.+++.. ..+.+++..+..++.|++.||.|||+.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~ 126 (268)
T cd05063 49 QRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDM 126 (268)
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467899999999999999999999999999999999999999999998853 235688999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccc-cccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN-TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+ ++||||||+||+++.++.++|+|||++........... ......+..|+|||.+.+..++.++||||||+++|++
T Consensus 127 ~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred C---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 8 99999999999999999999999999886643221111 1111234579999999988899999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++ |..|+...... ..... .... .........+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 204 l~~g~~p~~~~~~~--~~~~~----i~~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 204 MSFGERPYWDMSNH--EVMKA----INDG---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HhCCCCCCCcCCHH--HHHHH----HhcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 97 99887543321 11111 1110 01111123456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.67 Aligned_cols=218 Identities=21% Similarity=0.271 Sum_probs=173.4
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC--------eEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG--------EKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILE 75 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~ 75 (289)
+.+....+.+|+.+|..++|+||+++++.+...+ .+++||||+++|+|.+++.... ....+++..+..++.
T Consensus 71 ~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ 150 (496)
T PTZ00283 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150 (496)
T ss_pred CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHH
Confidence 3456778899999999999999999988876432 3689999999999999885432 345789999999999
Q ss_pred HHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCccc
Q 038647 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 155 (289)
Q Consensus 76 ~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 155 (289)
|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|
T Consensus 151 qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 151 QVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred HHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHH
Confidence 9999999999888 9999999999999999999999999998764332222334567999999999999999999999
Q ss_pred chhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 156 VFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
||||||++|+|++|..||....... .. ....... ....+...+..+.+++..||+.||++||++.
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~--~~----~~~~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ 292 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEE--VM----HKTLAGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHH--HH----HHHhcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence 9999999999999999986433211 10 0000000 0112233457899999999999999999999
Q ss_pred HHHHH
Q 038647 236 EVISM 240 (289)
Q Consensus 236 ~ll~~ 240 (289)
++++.
T Consensus 293 ell~~ 297 (496)
T PTZ00283 293 KLLNM 297 (496)
T ss_pred HHHhC
Confidence 99863
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=265.21 Aligned_cols=234 Identities=24% Similarity=0.350 Sum_probs=169.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....+.|.+|++++++++||||+++++++.. ....++|+||+++++|.+++.. ....+++..+..++.|++.||.|
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~ 123 (284)
T cd05081 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEY 123 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998753 3468999999999999999853 23458899999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
||+++ ++||||||+||++++++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||++
T Consensus 124 LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 200 (284)
T cd05081 124 LGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200 (284)
T ss_pred HHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHH
Confidence 99988 9999999999999999999999999998764322111 1111123456999999998889999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhh-hhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWN-LWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
++||++|..+................. ..........+............+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 201 l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 201 LYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 999999876543222110000000000 0000000000111111111223456899999999999999999999999998
Q ss_pred hcc
Q 038647 242 TNE 244 (289)
Q Consensus 242 ~~~ 244 (289)
+..
T Consensus 281 ~~~ 283 (284)
T cd05081 281 EAI 283 (284)
T ss_pred Hhc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=263.99 Aligned_cols=212 Identities=23% Similarity=0.237 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
...+.+|+.+++.++||||+++++.+.+++..++||||+++|+|..++... ....+++..+..++.|++.||.|||+.+
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER 122 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456788999999999999999999999999999999999999998887532 2346889999999999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
++||||||+||++++++.++|+|||+++....... .....|+..|+|||++.+..++.++||||+|+++|++++
T Consensus 123 ---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~ 196 (285)
T cd05605 123 ---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE 196 (285)
T ss_pred ---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHH
Confidence 99999999999999999999999999886543221 223468999999999998889999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
|..||......... ......... .........+..+.+++..||+.||++|| +++++++
T Consensus 197 g~~pf~~~~~~~~~--~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 197 GKSPFRQRKEKVKR--EEVERRVKE----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CCCCCCCCchhhHH--HHHHHHhhh----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 99998754322110 000000000 00112233566889999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=259.36 Aligned_cols=215 Identities=26% Similarity=0.369 Sum_probs=171.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|++++++++|+||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.+++.||.|||++
T Consensus 35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~ 112 (251)
T cd05041 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK 112 (251)
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999999999999999999999999999999999999988542 23578889999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 113 ~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~ 189 (251)
T cd05041 113 N---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF 189 (251)
T ss_pred C---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999998654322222112223456799999999889999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+ |..|+........ ... .... .....+...+..+.+++.+||..+|++|||+.||++.|+
T Consensus 190 t~~~~p~~~~~~~~~--~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 190 SLGDTPYPGMSNQQT--RER----IESG---------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hccCCCCccCCHHHH--HHH----HhcC---------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 9 7777654332111 000 1000 000112233568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=272.65 Aligned_cols=209 Identities=21% Similarity=0.230 Sum_probs=164.6
Q ss_pred HHHHHHHH-HHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 10 EEFKNEMM-LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 10 ~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
+.+..|.. +++.++||||+++++++.+++..|+||||+++|+|.+++. ..+.+.+..+..++.||+.||.|||++|
T Consensus 40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g 116 (325)
T cd05602 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN 116 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44455544 5678899999999999999999999999999999999884 3456788888999999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
|+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus 117 ---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (325)
T cd05602 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 191 (325)
T ss_pred ---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc
Confidence 9999999999999999999999999987542221 12334578999999999999999999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|..||...+... .... ... .. .......+..+.+++.+||+.||.+||++.+.+..+.
T Consensus 192 g~~pf~~~~~~~--~~~~---i~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 192 GLPPFYSRNTAE--MYDN---ILN-KP----------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCCCCCCCCHHH--HHHH---HHh-CC----------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 999986433221 1100 000 00 0112234568899999999999999998875444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=266.53 Aligned_cols=217 Identities=26% Similarity=0.381 Sum_probs=170.8
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRVRI 73 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~~ 73 (289)
..+.|.+|+++++++ +||||+++++++.+.+..++|+||+++++|.+++.... ....+++..++.+
T Consensus 45 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 124 (297)
T cd05089 45 DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124 (297)
T ss_pred HHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHH
Confidence 456899999999999 79999999999999999999999999999999885421 1235888999999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCc
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+.|++.||+|||+++ ++||||||+||+++.++.+||+|||++....... .......+..|+|||.+.+..++.+
T Consensus 125 ~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (297)
T cd05089 125 ASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTK 198 (297)
T ss_pred HHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCch
Confidence 999999999999888 9999999999999999999999999986432110 1111123457999999998889999
Q ss_pred ccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 154 SDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 154 ~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+|||||||++|+|++ |..||........ ....... .........+..+.+++.+||+.+|.+||
T Consensus 199 ~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 263 (297)
T cd05089 199 SDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERP 263 (297)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 999999999999997 8888754332211 0111000 00111123456789999999999999999
Q ss_pred CHHHHHHHhhccc
Q 038647 233 TMLEVISMLTNEN 245 (289)
Q Consensus 233 s~~~ll~~L~~~~ 245 (289)
|+.++++.|....
T Consensus 264 ~~~~i~~~l~~~~ 276 (297)
T cd05089 264 PFAQISVQLSRML 276 (297)
T ss_pred CHHHHHHHHHHHH
Confidence 9999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=274.64 Aligned_cols=220 Identities=24% Similarity=0.355 Sum_probs=172.9
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------------------
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK------------------------- 61 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------- 61 (289)
..+.+.+|+++|+++. ||||+++++++..++..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (401)
T cd05107 83 EKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLS 162 (401)
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccc
Confidence 3567999999999997 99999999999999999999999999999998854211
Q ss_pred ----------------------------------------------------------------------CCCCChHHHH
Q 038647 62 ----------------------------------------------------------------------TGLLGWEMRV 71 (289)
Q Consensus 62 ----------------------------------------------------------------------~~~~~~~~~~ 71 (289)
...+++..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 242 (401)
T cd05107 163 QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLV 242 (401)
T ss_pred ccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHH
Confidence 1236677788
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||+++...............++..|+|||.+.+..++
T Consensus 243 ~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 319 (401)
T cd05107 243 GFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT 319 (401)
T ss_pred HHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC
Confidence 99999999999999887 999999999999999999999999999865332211122234567889999999988899
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++||||||+++|||++ |..|+......... . .....+. ....+...+..+.+++.+||..+|++
T Consensus 320 ~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-~----~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~ 385 (401)
T cd05107 320 TLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-Y----NAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEI 385 (401)
T ss_pred cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-H----HHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhH
Confidence 99999999999999998 78887543322110 0 1011110 00112224568899999999999999
Q ss_pred CCCHHHHHHHhhcc
Q 038647 231 RPTMLEVISMLTNE 244 (289)
Q Consensus 231 Rps~~~ll~~L~~~ 244 (289)
||++++|++.|++.
T Consensus 386 RPs~~ell~~L~~~ 399 (401)
T cd05107 386 RPDFSQLVHLVGDL 399 (401)
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=258.70 Aligned_cols=212 Identities=28% Similarity=0.408 Sum_probs=168.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEe-ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.|.+|+.++++++|+|++++++++. +++..++|+||+++++|.+++... ....+++..+..++.|++.||.|||+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~ 120 (256)
T cd05082 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA 120 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4568999999999999999999999754 556799999999999999988542 23357889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.+||+|||+++...... ....++..|+|||++.+..++.++||||||+++|+|
T Consensus 121 ~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l 192 (256)
T cd05082 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred CC---EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHH
Confidence 88 9999999999999999999999999987643321 122345679999999988899999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
++ |..|+....... .... .... .........+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 193 ~~~g~~p~~~~~~~~--~~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 193 YSFGRVPYPRIPLKD--VVPR----VEKG---------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HhCCCCCCCCCCHHH--HHHH----HhcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 97 888875432211 1111 0000 0011112345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=262.63 Aligned_cols=218 Identities=26% Similarity=0.427 Sum_probs=171.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++|.+|+.++++++||||+++++++.++...++||||+++++|.+++... .+.+++..++.++.|++.||.|||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH 123 (269)
T cd05065 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS 123 (269)
T ss_pred HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999988542 356889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccccccccc---ccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV---GTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~---g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
+++ ++|+||||+||+++.++.++|+|||++................ .+..|+|||.+.+..++.++||||||++
T Consensus 124 ~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~ 200 (269)
T cd05065 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 200 (269)
T ss_pred HCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHH
Confidence 988 9999999999999999999999999987654322111111111 2457999999998899999999999999
Q ss_pred HHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 163 VLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 163 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
+||+++ |..||...... ....... .. .........+..+.+++..||+.+|++||++++|++.|
T Consensus 201 l~e~l~~g~~p~~~~~~~--~~~~~i~----~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 201 MWEVMSYGERPYWDMSNQ--DVINAIE----QD---------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred HHHHhcCCCCCCCCCCHH--HHHHHHH----cC---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999886 88887533221 1111110 00 00011123346788999999999999999999999998
Q ss_pred hc
Q 038647 242 TN 243 (289)
Q Consensus 242 ~~ 243 (289)
++
T Consensus 266 ~~ 267 (269)
T cd05065 266 DK 267 (269)
T ss_pred Hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=259.35 Aligned_cols=215 Identities=25% Similarity=0.389 Sum_probs=175.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+..+.+++.+|++++++++|+||+++++++.+++..++||||+++++|.+++.... ...+++..+..++.|++.||.||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~l 117 (256)
T cd08221 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYI 117 (256)
T ss_pred chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999999986432 35688999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+.+ ++|+||+|+||++++++.+||+|||++........ ......+++.|+|||.+.+..++.++|+||||++++
T Consensus 118 h~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~ 192 (256)
T cd08221 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLY 192 (256)
T ss_pred HhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHH
Confidence 9887 99999999999999999999999999986644331 223456889999999999888999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
+|++|..|+........ ..... .... .......+..+.+++.+||..+|++||++.++++.
T Consensus 193 ~l~~g~~~~~~~~~~~~-----~~~~~-~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 193 ELLTLKRTFDATNPLNL-----VVKIV-QGNY---------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHCCCCCCCCCHHHH-----HHHHH-cCCC---------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 99999998764322111 00000 1100 01112345688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=277.31 Aligned_cols=213 Identities=26% Similarity=0.449 Sum_probs=178.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCC--ChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLL--GWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~~l~~l 84 (289)
+..+-+..|+.+-++++|+|||+++|.+.+++++-|.||-++||+|..+++. ..+++ .+.++-.+.+||++||.||
T Consensus 614 r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYL 691 (1226)
T KOG4279|consen 614 REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYL 691 (1226)
T ss_pred hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhh
Confidence 3456678999999999999999999999999999999999999999999963 45666 7888999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcC--CCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~ 161 (289)
|++. |||||||-+|+|++. .|.+||+|||-++....- ...+.++.||..|||||++..+ .|..++|||||||
T Consensus 692 Hen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GC 766 (1226)
T KOG4279|consen 692 HENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGC 766 (1226)
T ss_pred hhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccc
Confidence 9887 999999999999974 688999999999876543 4456778999999999999865 5899999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+.||.||++||...+..+... |..+ . -......+.+.+.+...+|.+|+.+||.+||++.++++
T Consensus 767 T~vEMATGrPPF~ElgspqAAM-------FkVG----m--yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 767 TMVEMATGRPPFVELGSPQAAM-------FKVG----M--YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eeEeeccCCCCeeecCChhHhh-------hhhc----c--eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 9999999999987655443211 1100 0 11223455667788999999999999999999999986
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=262.07 Aligned_cols=219 Identities=21% Similarity=0.229 Sum_probs=166.3
Q ss_pred HHHHHHhhCCCCCceeeeeeEeecC-----eEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 14 NEMMLIAKLQHRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 14 ~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
+|+++|+.+.|||||++..+|.... ...+||||++. +|.+.+++.. .+..++.-.+.-+..||..||.|||+.
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~ 144 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH 144 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence 6999999999999999998886432 35689999976 7888886421 245677778899999999999999998
Q ss_pred CCCceEeeccccCceEeCCC-CceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~-~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
+ ||||||||+|+|+|.+ |.+||+|||.|+....+... .+...|..|.|||.+.+. .|+.+.||||.|||+.|
T Consensus 145 ~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 145 G---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred C---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 8 9999999999999976 88999999999987655433 345678899999999985 79999999999999999
Q ss_pred HHhCCCCcCCCCCcch-hHhHhHhhhhccC------------CccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 166 TLSSKKNAHFYNTDSL-TLLGHAWNLWNDG------------RAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 166 lltg~~p~~~~~~~~~-~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
|+.|++.|++.+..+. ..+....+..... ...++.............+.+..+++.++|+.+|.+|.
T Consensus 219 Ll~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~ 298 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL 298 (364)
T ss_pred HhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence 9999999887554322 1111111111110 01111111111113334567899999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
++.|++.
T Consensus 299 ~~~~~l~ 305 (364)
T KOG0658|consen 299 SALEALA 305 (364)
T ss_pred CHHHHhc
Confidence 9999885
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=264.21 Aligned_cols=219 Identities=25% Similarity=0.403 Sum_probs=171.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------CCCCChHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------TGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~ 80 (289)
...++.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++..... ...++...+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999864221 2345667888999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+++ ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||
T Consensus 132 l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG 208 (288)
T cd05061 132 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208 (288)
T ss_pred HHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHH
Confidence 99999988 999999999999999999999999998865433322222223456789999999988999999999999
Q ss_pred HHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+|++ |..|+....... .... ....... ......+..+.+++.+||+.||++|||+.++++
T Consensus 209 ~~l~el~~~~~~p~~~~~~~~--~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 209 VVLWEITSLAEQPYQGLSNEQ--VLKF----VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHH--HHHH----HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999998 677765322211 1111 0000000 011123468999999999999999999999999
Q ss_pred Hhhcc
Q 038647 240 MLTNE 244 (289)
Q Consensus 240 ~L~~~ 244 (289)
.|...
T Consensus 274 ~l~~~ 278 (288)
T cd05061 274 LLKDD 278 (288)
T ss_pred HHHhh
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=259.26 Aligned_cols=215 Identities=31% Similarity=0.460 Sum_probs=169.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|+.++++++|+|++++++++.+ +..++||||+++++|.+++... ....+++..+..++.+++.||.|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05070 44 SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM 121 (260)
T ss_pred CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45789999999999999999999998854 5689999999999999988542 234578999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||++++++.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 122 ~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05070 122 N---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred C---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHH
Confidence 8 9999999999999999999999999998654322111 11223456799999998888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..||...... ..... .... .........+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus 198 ~~g~~p~~~~~~~--~~~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 198 TKGRVPYPGMNNR--EVLEQ----VERG---------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred hcCCCCCCCCCHH--HHHHH----HHcC---------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9 78877543221 11111 1000 0011122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=263.42 Aligned_cols=211 Identities=21% Similarity=0.326 Sum_probs=170.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|||++++++.+..+...|+||||+++++|.+++.. ..+++.++..++.|++.||.|||+
T Consensus 59 ~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~ 134 (296)
T cd06654 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS 134 (296)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999998842 357888999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++||||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|
T Consensus 135 ~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l 209 (296)
T cd06654 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209 (296)
T ss_pred CC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHH
Confidence 88 99999999999999999999999999876533221 12234678899999999988899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..||.......... ....... .........+..+.+++.+||..||++||++.++++
T Consensus 210 ~~g~~pf~~~~~~~~~~-----~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 210 IEGEPPYLNENPLRALY-----LIATNGT--------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HhCCCCCCCCCHHHhHH-----HHhcCCC--------CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 99999986543221110 0010000 000112234567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=261.19 Aligned_cols=216 Identities=28% Similarity=0.465 Sum_probs=172.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|+.++++++||||+++++++.+++..++||||+++++|.+++.. ..+.+++.++..++.|++.||.|||++
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (267)
T cd05066 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDM 125 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467899999999999999999999999999999999999999999999853 234688899999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+ ++||||||+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus 126 ~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred C---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 8 9999999999999999999999999998764332111 11112235679999999988899999999999999998
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
++ |..|+....... ..... .... ........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 203 l~~g~~p~~~~~~~~--~~~~~----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 203 MSYGERPYWEMSNQD--VIKAI----EEGY---------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred hcCCCCCcccCCHHH--HHHHH----hCCC---------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 86 998875443221 11111 0000 001112235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=261.85 Aligned_cols=211 Identities=26% Similarity=0.437 Sum_probs=171.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++||||+++++++.+.+..++|+||+++++|.+++. ..+.+++..+..++.|++.||.|||+.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~ 125 (267)
T cd06628 49 MLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNR 125 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhc
Confidence 45788999999999999999999999999999999999999999999984 345688899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc----cccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+ ++||||+|+||++++++.++|+|||.++........ .......|+..|+|||.+.+..++.++|+||||+++
T Consensus 126 ~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il 202 (267)
T cd06628 126 G---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLV 202 (267)
T ss_pred C---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHH
Confidence 8 999999999999999999999999998876422111 111234578899999999988899999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||......... ..... ......+...+..+.+++.+||+.||++||++.++++
T Consensus 203 ~~l~~g~~p~~~~~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 203 VEMLTGKHPFPDCTQLQAI-----FKIGE----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHhhCCCCCCCccHHHHH-----HHHhc----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 9999999998653221110 00000 0111122334578899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=257.48 Aligned_cols=215 Identities=30% Similarity=0.446 Sum_probs=170.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|++++++++|+|++++++++.. +..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05069 44 MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM 121 (260)
T ss_pred cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45688999999999999999999998754 5688999999999999988542 234578899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||+|+||++++++.++|+|||+++........ ......++..|+|||...+..++.++||||||+++|+|+
T Consensus 122 ~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~ 197 (260)
T cd05069 122 N---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred C---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHH
Confidence 8 999999999999999999999999999765433211 112234567899999999888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..|+...... ...... .... ........+..+.+++.+||..||++||++++|++.|++
T Consensus 198 t~g~~p~~~~~~~--~~~~~~----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 198 TKGRVPYPGMVNR--EVLEQV----ERGY---------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred hCCCCCCCCCCHH--HHHHHH----HcCC---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9 88877543221 111111 0000 011122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=258.93 Aligned_cols=213 Identities=23% Similarity=0.307 Sum_probs=172.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|+||+++++++.+++.+|+||||+++++|.+++... ....++++.+..++.|++.||.|||+
T Consensus 40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~ 118 (255)
T cd08219 40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE 118 (255)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 35678899999999999999999999999999999999999999998887542 33467899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||||+||+++.++.++++|||.++....... ......|+..|+|||++.+..++.++|+||||+++|+|
T Consensus 119 ~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l 193 (255)
T cd08219 119 KR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193 (255)
T ss_pred CC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheeh
Confidence 88 99999999999999999999999999876543221 12234688899999999988899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|..||...+.... .. . ...... ...+...+..+.+++.+||+.||++||++.+++..
T Consensus 194 ~~g~~p~~~~~~~~~--~~---~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 194 CTLKHPFQANSWKNL--IL---K-VCQGSY---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hhccCCCCCCCHHHH--HH---H-HhcCCC---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999864322111 00 0 001110 01112244578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=267.21 Aligned_cols=228 Identities=18% Similarity=0.208 Sum_probs=167.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+++|+++++.++||||+++++++.+++..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~ 119 (327)
T cd08227 41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH 119 (327)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678889999999999999999999999999999999999999999885422 2358899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-----cccccccccccccChhhhhc--CCCCCcccchhH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSF 159 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Diwsl 159 (289)
++ |+||||||+||+++.++.+++.||+........... .......++..|+|||++.+ ..++.++|||||
T Consensus 120 ~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (327)
T cd08227 120 MG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196 (327)
T ss_pred CC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHH
Confidence 88 999999999999999999999999865443211100 01122346778999999976 468999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhc----c----------CCc-----ccc------------ccccccCCC
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWN----D----------GRA-----WEL------------MDSILQNDA 208 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~----------~~~-----~~~------------~~~~~~~~~ 208 (289)
||++|+|++|..||............ ...... . ... ... .........
T Consensus 197 G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (327)
T cd08227 197 GITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPY 275 (327)
T ss_pred HHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccc
Confidence 99999999999998643322110000 000000 0 000 000 000000011
Q ss_pred CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 209 SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 209 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.......+.+++.+||+.||++|||+.++++
T Consensus 276 ~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 276 NRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 1224567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=258.96 Aligned_cols=208 Identities=24% Similarity=0.383 Sum_probs=164.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.|.+|+.+++.++||||+++++++..++..++||||+++|+|..++... ...+++..+..++.||+.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (258)
T cd05078 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED 118 (258)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999998542 2357889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCc--------eEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccch
Q 038647 87 YSRLRVIHRDLKASNILLDSNMN--------PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVF 157 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~--------vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diw 157 (289)
++ |+||||||+||+++.++. ++++|||++...... ....++..|+|||++.+ ..++.++|||
T Consensus 119 ~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diw 189 (258)
T cd05078 119 KG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKW 189 (258)
T ss_pred CC---eecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHH
Confidence 88 999999999999987665 699999988654321 22457788999999986 4579999999
Q ss_pred hHHHHHHHHHhCC-CCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLSSK-KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||+++|+|++|. .|+....... .. . .... ....+.....++.+++.+||+.||++|||+++
T Consensus 190 slG~~l~~l~~g~~~~~~~~~~~~-~~-~----~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 252 (258)
T cd05078 190 SFGTTLWEIFSGGDKPLSALDSQK-KL-Q----FYED-----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRA 252 (258)
T ss_pred HHHHHHHHHHcCCCCChhhccHHH-HH-H----HHHc-----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHH
Confidence 9999999999995 4433221111 00 0 0000 01112223467899999999999999999999
Q ss_pred HHHHhh
Q 038647 237 VISMLT 242 (289)
Q Consensus 237 ll~~L~ 242 (289)
+++.|+
T Consensus 253 il~~l~ 258 (258)
T cd05078 253 IIRDLN 258 (258)
T ss_pred HHHhcC
Confidence 998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=265.20 Aligned_cols=221 Identities=26% Similarity=0.384 Sum_probs=169.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc-
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH- 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~- 86 (289)
..+++.+|++++++++||||+++++++.+++.+++||||+++++|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~ 118 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREK 118 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 35678899999999999999999999999999999999999999999984 33568899999999999999999997
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 119 ~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 119 HK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred CC---EEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHH
Confidence 45 999999999999999999999999998754322 12335688999999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCc--------------------ccccccccc----CCCCHHHHHHHHHHHHc
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRA--------------------WELMDSILQ----NDASYPMLNRYINVALL 222 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~----~~~~~~~~~~l~~li~~ 222 (289)
++|..|+.......... ........... .+..+.... .......+.++.+++.+
T Consensus 192 ~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 269 (308)
T cd06615 192 AIGRYPIPPPDAKELEA--MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK 269 (308)
T ss_pred HhCCCCCCCcchhhHHH--hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHH
Confidence 99999986443221100 00000000000 000000000 00011134578999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 038647 223 CVQENAADRPTMLEVISM 240 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~~ 240 (289)
||..||++|||+.++++.
T Consensus 270 ~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 270 CLKKNPKERADLKELTKH 287 (308)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=258.69 Aligned_cols=222 Identities=22% Similarity=0.325 Sum_probs=165.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.|.+|+.+++.++||||+++++++.+....|+||||+++|+|.+++.+.. .....++..+..++.||+.||.|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 346789999999999999999999999999999999999999999999886432 2234667778899999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-------CCCCCcccchh
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-------GLFSIKSDVFS 158 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Diws 158 (289)
+.+ ++||||||+|||++.++.++|+|||++................++..|+|||++.. ..++.++||||
T Consensus 117 ~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 KHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 887 99999999999999999999999999864322221222234467889999999853 24578999999
Q ss_pred HHHHHHHHHhC-CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETLSS-KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
||+++|+|+++ ..|+..... ........ . .......+.. ........+.+++..|| .+|++||++.+|
T Consensus 194 lG~~l~el~~~~~~p~~~~~~--~~~~~~~~---~-~~~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLSD--REVLNHVI---K-DQQVKLFKPQ----LELPYSERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCCH--HHHHHHHH---h-hcccccCCCc----cCCCCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence 99999999975 445533221 11111111 1 1111111111 11224467788999999 689999999999
Q ss_pred HHHhh
Q 038647 238 ISMLT 242 (289)
Q Consensus 238 l~~L~ 242 (289)
++.|.
T Consensus 263 ~~~l~ 267 (268)
T cd05086 263 HRLLT 267 (268)
T ss_pred HHHhc
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=266.43 Aligned_cols=210 Identities=23% Similarity=0.291 Sum_probs=178.0
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+++|+++. |||||.++++|++...+++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~ 153 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS 153 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh
Confidence 5678999999999998 999999999999999999999999999999988654 29999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCC----CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSN----MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~----~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
.| ++||||||+|+|+... +.+|++|||++..... .......+||+.|+|||++....|+..+||||+|++
T Consensus 154 ~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi 227 (382)
T KOG0032|consen 154 LG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVI 227 (382)
T ss_pred CC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHH
Confidence 88 9999999999999643 4799999999998765 334566799999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|.|++|.+||.......... . ... + +.......-..++..+.++|+.++..||.+|+|+.++++
T Consensus 228 ~yiLL~G~~PF~~~~~~~~~~-~----i~~-~------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 228 LYILLSGVPPFWGETEFEIFL-A----ILR-G------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHhhCCCCCcCCChhHHHH-H----HHc-C------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 999999999987665432221 0 000 0 002223334456788999999999999999999999998
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=262.30 Aligned_cols=218 Identities=24% Similarity=0.351 Sum_probs=171.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++.. ..+.+++..+..++.|++.||.|||+
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~ 127 (279)
T cd05109 51 KANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred HHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3467888999999999999999999998754 57899999999999998853 23468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||
T Consensus 128 ~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05109 128 VR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204 (279)
T ss_pred CC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 88 999999999999999999999999999876533221112222346789999999988999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..|+....... ... ...... ........+..+.+++.+||+.||++||++.++++.|....
T Consensus 205 ~t~g~~p~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 205 MTFGAKPYDGIPARE--IPD----LLEKGE---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HcCCCCCCCCCCHHH--HHH----HHHCCC---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 98 888765332211 111 111110 01111223467889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=266.13 Aligned_cols=213 Identities=20% Similarity=0.291 Sum_probs=179.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
...++..|++.|+.++|||||++|.+..+...+|+|.|+-.+|+|.+|+.+. ...+.++...+++.||+.|+.|+|+.
T Consensus 60 st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqL 137 (864)
T KOG4717|consen 60 STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQL 137 (864)
T ss_pred hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhh
Confidence 4457889999999999999999999999999999999999999999999754 34588999999999999999999988
Q ss_pred CCCceEeeccccCceEeC-CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC-CcccchhHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVLVLE 165 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~vl~e 165 (289)
+ +|||||||+|+.+- +-|-|||.|||++..+..+. ...+.+|+..|.|||++.+..|+ ++.||||||||||.
T Consensus 138 H---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyM 211 (864)
T KOG4717|consen 138 H---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYM 211 (864)
T ss_pred h---hhcccCCcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHH
Confidence 7 99999999998764 66889999999998876554 34567999999999999999885 78999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--Hhhc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--MLTN 243 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~L~~ 243 (289)
|+.|++||...++..-. ..+++.. ...+...+.++.+||..||..||.+|.|.++|.. +|+.
T Consensus 212 LVCGq~PFqeANDSETL--------------TmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 212 LVCGQPPFQEANDSETL--------------TMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred HHhCCCccccccchhhh--------------hhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 99999999866544211 1222222 2345567889999999999999999999999975 5554
Q ss_pred c
Q 038647 244 E 244 (289)
Q Consensus 244 ~ 244 (289)
.
T Consensus 276 ~ 276 (864)
T KOG4717|consen 276 G 276 (864)
T ss_pred C
Confidence 3
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=260.53 Aligned_cols=206 Identities=21% Similarity=0.314 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
...|.+|+.+++.++||||+++++++.++...++||||+++|+|..++.. ..+.+++..+..++.|++.||.|||+++
T Consensus 60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (274)
T cd05076 60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN 137 (274)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 46788999999999999999999999999999999999999999988853 3456889999999999999999999887
Q ss_pred CCceEeeccccCceEeCCCC-------ceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHH
Q 038647 89 RLRVIHRDLKASNILLDSNM-------NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFG 160 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~-------~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 160 (289)
++||||||+||+++..+ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||
T Consensus 138 ---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG 208 (274)
T cd05076 138 ---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFG 208 (274)
T ss_pred ---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHH
Confidence 99999999999997643 3799999987643221 12346778999998875 5689999999999
Q ss_pred HHHHHHH-hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETL-SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|+++ +|..|+........ ... ... .. ..+.+....+.+++.+||+.+|++|||+.+|++
T Consensus 209 ~~l~el~~~g~~p~~~~~~~~~--~~~----~~~---------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 209 TTLLEICFDGEVPLKERTPSEK--ERF----YEK---------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HHHHHHHhCCCCCccccChHHH--HHH----HHh---------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 9999995 68887754332211 000 000 00 011112347889999999999999999999998
Q ss_pred Hhh
Q 038647 240 MLT 242 (289)
Q Consensus 240 ~L~ 242 (289)
.|.
T Consensus 272 ~L~ 274 (274)
T cd05076 272 DLT 274 (274)
T ss_pred hhC
Confidence 773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=272.32 Aligned_cols=213 Identities=21% Similarity=0.232 Sum_probs=166.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~ 161 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM 161 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456688999999999999999999999999999999999999999998842 3578889999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC----CCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL----FSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~vl 163 (289)
+ |+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 162 ~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~il 237 (370)
T cd05621 162 G---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred C---eEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHH
Confidence 8 99999999999999999999999999987643221 1123457999999999997643 78999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC--CCCHHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD--RPTMLEVISM 240 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~ 240 (289)
|+|++|..||...+... .. ......... ..-......+..+.+++..||..++.+ |+++.++++.
T Consensus 238 yell~G~~Pf~~~~~~~--~~---~~i~~~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 238 FEMLVGDTPFYADSLVG--TY---SKIMDHKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHhCCCCCCCCCHHH--HH---HHHHhCCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 99999999986543211 10 111110000 001111234567888999999855543 8899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=264.62 Aligned_cols=232 Identities=26% Similarity=0.366 Sum_probs=173.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..+.|.+|+++++.++||||+++++++.. +...++||||+++++|.+++... ...+++..+..++.|++.||.|||
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH 126 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLG 126 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHH
Confidence 47789999999999999999999999887 56899999999999999998532 235889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ ++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++||||||++++
T Consensus 127 ~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~ 203 (284)
T cd05038 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLY 203 (284)
T ss_pred hCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhh
Confidence 988 999999999999999999999999999876532211 1111223456799999999889999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+|++|..|+..........................+............+.++.+++.+||+.+|++|||+.+|+++|+++
T Consensus 204 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 204 ELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred eeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 99999988654322211100000000000000001111111111223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.61 Aligned_cols=214 Identities=22% Similarity=0.343 Sum_probs=169.7
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++++.++||||+++++++..++..++|+||+++++|..++.. ....+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH 120 (282)
T cd06643 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLH 120 (282)
T ss_pred HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34577899999999999999999999999999999999999999999887743 2356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFG 160 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG 160 (289)
+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++. +..++.++||||||
T Consensus 121 ~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 195 (282)
T cd06643 121 ENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 195 (282)
T ss_pred HCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHH
Confidence 988 9999999999999999999999999987643221 1223346888999999984 45578899999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+|++|..||.......... . .... .... ...+...+..+.+++.+||+.||++||++.++++
T Consensus 196 vil~el~~g~~p~~~~~~~~~~~-~----~~~~-~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 196 ITLIEMAQIEPPHHELNPMRVLL-K----IAKS-EPPT-------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHccCCCCccccCHHHHHH-H----Hhhc-CCCC-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999876433211100 0 0000 0000 0111224568899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=261.72 Aligned_cols=226 Identities=24% Similarity=0.288 Sum_probs=168.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++||||+++++++.+++..|+||||++ ++|.+++........+++..++.++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 120 (285)
T cd07861 42 VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120 (285)
T ss_pred chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45778999999999999999999999999999999999997 57888775544446789999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~el 166 (289)
+ ++||||+|+||+++.++.++|+|||++....... .......+++.|+|||++.+. .++.++||||||+++|+|
T Consensus 121 ~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l 195 (285)
T cd07861 121 R---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195 (285)
T ss_pred C---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987653321 112233568899999998754 578999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhH--hH----hhhhccCCcccccccc----cc---CCCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLG--HA----WNLWNDGRAWELMDSI----LQ---NDASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
++|+.||............ .. ...|............ .. .......+.++.+++.+||+.||++|||
T Consensus 196 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 275 (285)
T cd07861 196 ATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275 (285)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC
Confidence 9999988654322111000 00 0000000000000000 00 0011124567889999999999999999
Q ss_pred HHHHHH
Q 038647 234 MLEVIS 239 (289)
Q Consensus 234 ~~~ll~ 239 (289)
+.+|++
T Consensus 276 ~~~ll~ 281 (285)
T cd07861 276 AKKALN 281 (285)
T ss_pred HHHHhc
Confidence 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.79 Aligned_cols=224 Identities=18% Similarity=0.237 Sum_probs=165.6
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
..+.+|+++|++++|+|||++++++..++..++|||++. ++|..++.. ....+++..+..++.||+.||.|||+++
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g- 280 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG- 280 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 457789999999999999999999999999999999995 678777743 2346899999999999999999999988
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhC
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg 169 (289)
|+||||||+|||++.++.++|+|||+++...............||..|+|||++.+..++.++|||||||++|||++|
T Consensus 281 --IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g 358 (461)
T PHA03211 281 --IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358 (461)
T ss_pred --EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHc
Confidence 999999999999999999999999999865433222222345689999999999999999999999999999999998
Q ss_pred CCCcCCCCCc------chhHhHhHhhh-hccCCccc-----ccccc-------ccCCCC-------HHHHHHHHHHHHcc
Q 038647 170 KKNAHFYNTD------SLTLLGHAWNL-WNDGRAWE-----LMDSI-------LQNDAS-------YPMLNRYINVALLC 223 (289)
Q Consensus 170 ~~p~~~~~~~------~~~~~~~~~~~-~~~~~~~~-----~~~~~-------~~~~~~-------~~~~~~l~~li~~~ 223 (289)
..++...... ...+....... ........ +.... ...... ......+.++|.+|
T Consensus 359 ~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 438 (461)
T PHA03211 359 TASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438 (461)
T ss_pred CCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHH
Confidence 8664332211 01111111000 00000000 00000 000000 01234678999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|+.||++|||+.|+++
T Consensus 439 L~~DP~~RPsa~elL~ 454 (461)
T PHA03211 439 LTFDGARRPSAAELLR 454 (461)
T ss_pred cccChhhCcCHHHHhh
Confidence 9999999999999987
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=268.59 Aligned_cols=204 Identities=23% Similarity=0.295 Sum_probs=164.3
Q ss_pred cCHHHHHHHHHHHhhCCC-CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQH-RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+..|++++..++| ++|+++++++.+++.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH 118 (324)
T cd05587 42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLH 118 (324)
T ss_pred hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788899999999975 568889999999999999999999999998884 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 119 ~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~e 193 (324)
T cd05587 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193 (324)
T ss_pred HCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHH
Confidence 988 9999999999999999999999999987532211 12334568999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|++|+.||....... ..... . ... ...+...+..+.+++.+||..||++|++.
T Consensus 194 lltG~~pf~~~~~~~--~~~~i---~-~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 194 MLAGQPPFDGEDEDE--LFQSI---M-EHN----------VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHhCCCCCCCCCHHH--HHHHH---H-cCC----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 999999986443211 11111 0 000 01122345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=258.94 Aligned_cols=212 Identities=26% Similarity=0.379 Sum_probs=172.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|+.+++.++|+||+++++++.+++..++||||+++++|.+++... ....+++..+..++.|++.||.|||++
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~ 121 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEK 121 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999999999999999999999999999998542 223689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||||+||+++.++.++|+|||.++....... ....+..|+|||.+.+..++.++||||||+++++++
T Consensus 122 ~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~ 193 (256)
T cd05039 122 N---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred C---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHH
Confidence 8 99999999999999999999999999987632211 223456799999998888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..|+....... .... ..... ........+..+.+++.+||..+|++|||+.++++.|++
T Consensus 194 ~~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 194 SFGRVPYPRIPLKD--VVPH----VEKGY---------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred hcCCCCCCCCCHHH--HHHH----HhcCC---------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 7 888875432221 1111 11110 011112335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=258.10 Aligned_cols=215 Identities=29% Similarity=0.433 Sum_probs=170.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|+++++.++||||+++++++.+ ...++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~ 121 (262)
T cd05071 44 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM 121 (262)
T ss_pred CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35689999999999999999999998754 5679999999999999998542 234578899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||++++++.++|+|||.++........ ......++..|+|||...+..++.++||||||+++|+|+
T Consensus 122 ~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ell 197 (262)
T cd05071 122 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 197 (262)
T ss_pred C---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence 8 999999999999999999999999999866433221 112234567899999999889999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..||....... .... ..... ........+..+.+++.+||+.||++||++.++++.|+.
T Consensus 198 t~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 198 TKGRVPYPGMVNRE--VLDQ----VERGY---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred cCCCCCCCCCChHH--HHHH----HhcCC---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 9 777765432211 1110 00000 001123455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=257.81 Aligned_cols=218 Identities=26% Similarity=0.365 Sum_probs=167.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEe-ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|+.+++.++||||+++++++. .++..++|+||+.+|+|.+++... ...+++..+..++.|++.||.|||
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH 115 (262)
T cd05058 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLA 115 (262)
T ss_pred HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999765 455689999999999999998532 234667778899999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+.+ ++||||||+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++
T Consensus 116 ~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 192 (262)
T cd05058 116 SKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192 (262)
T ss_pred hCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHH
Confidence 887 999999999999999999999999998765322111 111223456789999999988999999999999999
Q ss_pred HHHHhCC-CCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 164 LETLSSK-KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 164 ~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|+|++|. +|+.... ........ .... ........+..+.+++..||+.+|++||++.+|++.|+
T Consensus 193 ~el~~~~~~~~~~~~--~~~~~~~~---~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 193 WELMTRGAPPYPDVD--SFDITVYL---LQGR----------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred HHHHcCCCCCCCCCC--HHHHHHHH---hcCC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 9999965 4443221 11111111 1000 00011123467889999999999999999999999998
Q ss_pred cc
Q 038647 243 NE 244 (289)
Q Consensus 243 ~~ 244 (289)
+.
T Consensus 258 ~~ 259 (262)
T cd05058 258 QI 259 (262)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=255.77 Aligned_cols=211 Identities=21% Similarity=0.343 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+++.+|++++++++||||+++++++.++...|+++||+++++|.+++.. ....+++..+..++.|++.||.|||+.+
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~ 119 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK 119 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 67899999999999999999999999999999999999999999998853 2356899999999999999999999888
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 120 ---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~ 194 (256)
T cd06612 120 ---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194 (256)
T ss_pred ---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999887643321 1233457889999999999899999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|..|+........... .... ....-......+..+.+++.+||+.||++|||+.++++
T Consensus 195 g~~p~~~~~~~~~~~~------~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 195 GKPPYSDIHPMRAIFM------IPNK-------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCCCCcchhhhhhh------hccC-------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 9999865432211100 0000 00000112234567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=258.96 Aligned_cols=216 Identities=24% Similarity=0.374 Sum_probs=168.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~ 124 (267)
T cd06646 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHS 124 (267)
T ss_pred chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999884 34568899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl 163 (289)
.+ |+||||+|+||+++.++.++|+|||+++...... .......++..|+|||.+. ...++.++|+||||+++
T Consensus 125 ~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il 199 (267)
T cd06646 125 KG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199 (267)
T ss_pred CC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHH
Confidence 88 9999999999999999999999999998654321 1122346788999999985 34578899999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
|+|++|..|+.......... ..... ....... ......+..+.+++..||+.+|++|||++++++.|
T Consensus 200 ~el~~g~~p~~~~~~~~~~~------~~~~~---~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 200 IELAELQPPMFDLHPMRALF------LMSKS---NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHhCCCCccccchhhhhe------eeecC---CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999875332111100 00000 0000000 01123456889999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=255.95 Aligned_cols=216 Identities=30% Similarity=0.443 Sum_probs=171.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+.++++++|+||+++++++. .+..++||||+++++|.+++... ....+++.++..++.|++.||.|||+
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~ 120 (260)
T cd05067 43 MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER 120 (260)
T ss_pred CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 34578999999999999999999999874 45789999999999999988542 33568889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|++
T Consensus 121 ~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05067 121 KN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196 (260)
T ss_pred CC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHH
Confidence 88 999999999999999999999999999766432211 12223456789999999988899999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
++ |..||....... .... ..... ........+.++.+++.+||..+|++||+++++++.|+.
T Consensus 197 ~~~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 197 VTYGRIPYPGMTNPE--VIQN----LERGY---------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HhCCCCCCCCCChHH--HHHH----HHcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99 898876433211 1111 11100 001112234679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=267.23 Aligned_cols=204 Identities=24% Similarity=0.297 Sum_probs=164.8
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+..|..++..+ +|++|+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH 118 (323)
T cd05616 42 DDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLH 118 (323)
T ss_pred hHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456678889998888 58999999999999999999999999999998884 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 119 ~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 193 (323)
T cd05616 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193 (323)
T ss_pred HCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHH
Confidence 988 9999999999999999999999999987543221 12234568999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|++|..||........ ... ..... ...+...+.++.+++.+||+.||++|++.
T Consensus 194 lltg~~Pf~~~~~~~~--~~~----i~~~~----------~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 194 MLAGQAPFEGEDEDEL--FQS----IMEHN----------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhCCCCCCCCCHHHH--HHH----HHhCC----------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 9999999865432211 111 00000 01122345688999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=256.58 Aligned_cols=217 Identities=31% Similarity=0.459 Sum_probs=173.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|+.++++++|+||+++++++.++...++||||+++++|.+++... ....+++..+..++.+++.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~ 121 (261)
T cd05034 43 MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES 121 (261)
T ss_pred cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45678999999999999999999999999989999999999999999998542 23468899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||+|+||+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++|+||||+++|++
T Consensus 122 ~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l 197 (261)
T cd05034 122 RN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197 (261)
T ss_pred CC---cccCCcchheEEEcCCCCEEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHH
Confidence 88 9999999999999999999999999988664322111 1122345689999999988899999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
++ |+.||...... ........ . .....+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 198 ~t~g~~p~~~~~~~--~~~~~~~~----~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 198 VTYGRVPYPGMTNR--EVLEQVER----G---------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HhCCCCCCCCCCHH--HHHHHHHc----C---------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 98 88887543221 11111100 0 0001111235688999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=270.23 Aligned_cols=229 Identities=25% Similarity=0.410 Sum_probs=184.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..+..+|.+|+++|.+++|||||.++|+|..++.+++|+||+++|+|.+|+..... ..+.......+|.||+.|++||.
T Consensus 576 ~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLe 654 (807)
T KOG1094|consen 576 KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLE 654 (807)
T ss_pred hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHH
Confidence 44568999999999999999999999999999999999999999999999965322 22455667789999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ +|||||.+.|||++.++++||+|||.++..-.++.....+..+-+.+|||+|.+..+.++.++|+|+||+.+||
T Consensus 655 s~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 655 SLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 731 (807)
T ss_pred hhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence 877 99999999999999999999999999997766666666667778899999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+++-...-++....+..........+........+ ..+.-.+..+.+++..||..+-++|||++++...|.+.
T Consensus 732 ~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 98744333333333333333333344433332211 11223456888999999999999999999999887653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=264.94 Aligned_cols=165 Identities=28% Similarity=0.396 Sum_probs=134.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCC------CCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPT------KTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|+++|++++||||+++++++.. +...|+||||+. ++|.+++.... ....+++..+..++.||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 4567899999999999999999999854 457899999995 47777664211 12358889999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEe----CCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcC-CCCCcc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRG-LFSIKS 154 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill----~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~ 154 (289)
|.|||+++ |+||||||+|||+ +.++.+||+|||+++....... ........||+.|+|||++.+. .++.++
T Consensus 121 l~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07868 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchh
Confidence 99999988 9999999999999 4567899999999987643321 1223345789999999999874 589999
Q ss_pred cchhHHHHHHHHHhCCCCcCCCC
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYN 177 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~ 177 (289)
||||+||++|+|++|++||....
T Consensus 198 DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 198 DIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred hHHHHHHHHHHHHhCCCCccCCc
Confidence 99999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=272.28 Aligned_cols=215 Identities=21% Similarity=0.286 Sum_probs=166.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|+.++.+++||||+++++.+.+++.+|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 42 ~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH 118 (360)
T cd05627 42 KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIH 118 (360)
T ss_pred hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788899999999999999999999999999999999999999999984 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc---------------------------------ccccc
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ---------------------------------SNTKR 132 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~---------------------------------~~~~~ 132 (289)
+++ |+||||||+|||++.++.++|+|||+++........ .....
T Consensus 119 ~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (360)
T cd05627 119 QLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYS 195 (360)
T ss_pred HCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccc
Confidence 988 999999999999999999999999998754221100 00123
Q ss_pred ccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHH
Q 038647 133 IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPM 212 (289)
Q Consensus 133 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (289)
..||+.|+|||++.+..++.++|||||||++|+|++|..||......... .. ..... ....-......
T Consensus 196 ~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~--~~---i~~~~-------~~~~~p~~~~~ 263 (360)
T cd05627 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY--RK---VMNWK-------ETLVFPPEVPI 263 (360)
T ss_pred cCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH--HH---HHcCC-------CceecCCCCCC
Confidence 46899999999999999999999999999999999999998654322110 00 00000 00000111124
Q ss_pred HHHHHHHHHcccccCCCCCCC---HHHHHH
Q 038647 213 LNRYINVALLCVQENAADRPT---MLEVIS 239 (289)
Q Consensus 213 ~~~l~~li~~~l~~~p~~Rps---~~~ll~ 239 (289)
+.++.+++.+++. ||.+|++ +.++++
T Consensus 264 s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 264 SEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 5678888888764 9999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.71 Aligned_cols=218 Identities=27% Similarity=0.395 Sum_probs=172.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....++.+|+.++++++||||+++++++.. ...++|+||+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~ 127 (279)
T cd05057 51 KANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346788999999999999999999999987 788999999999999998853 23458999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+....++.++|+||||+++|++
T Consensus 128 ~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05057 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204 (279)
T ss_pred CC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHH
Confidence 87 999999999999999999999999999876533221111122235679999999888899999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..|+........ .. ...... ....+...+..+.+++.+||..||++||++.++++.|....
T Consensus 205 ~~~g~~p~~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 205 MTFGAKPYEGIPAVEI--PD----LLEKGE---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred hcCCCCCCCCCCHHHH--HH----HHhCCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 98 9988765432211 10 011000 00111123357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=257.71 Aligned_cols=212 Identities=22% Similarity=0.351 Sum_probs=167.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++|.+|++++++++||||+++++++..++..++||||+++++|..+. .+++..+..++.|++.||.|||
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH 112 (279)
T cd06619 40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW 112 (279)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH
Confidence 344578999999999999999999999999999999999999999986542 3678888999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++|+||||+||+++.++.++|+|||++...... ......|+..|+|||.+.+..++.++|+||||+++|+
T Consensus 113 ~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 185 (279)
T cd06619 113 SLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185 (279)
T ss_pred HCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHH
Confidence 988 999999999999999999999999999765332 1233578899999999999899999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhH-hHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLG-HAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||............ .......... .........+.++.+++.+||+.||++||+++++++
T Consensus 186 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 186 LALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred HHhCCCCchhhcccccccchHHHHHHHhccC--------CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 99999998643322111000 0000000000 000111223457899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.92 Aligned_cols=204 Identities=22% Similarity=0.305 Sum_probs=164.3
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+..|+.+++.+. |++|+++++++.+.+..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH 118 (323)
T cd05615 42 DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLH 118 (323)
T ss_pred hHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45667888999999885 6788899999999999999999999999999884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+
T Consensus 119 ~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~e 193 (323)
T cd05615 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYE 193 (323)
T ss_pred HCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHH
Confidence 988 9999999999999999999999999987543221 12234568999999999999899999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|++|..||....... ..... .. .. ...+...+..+.+++.+||+.||.+|++.
T Consensus 194 lltG~~pf~~~~~~~--~~~~i---~~-~~----------~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 194 MLAGQPPFDGEDEDE--LFQSI---ME-HN----------VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCCCCCCCCHHH--HHHHH---Hh-CC----------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 999999986543221 11110 00 00 01122345678899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=255.61 Aligned_cols=205 Identities=24% Similarity=0.408 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.|.+|+.+|+.++||||+++++++.. ...++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 6789999999999999999999999988 7789999999999999998542 226889999999999999999999888
Q ss_pred CCceEeeccccCceEeCCCC-------ceEEcccccccccCCCCcccccccccccccccChhhhhcC--CCCCcccchhH
Q 038647 89 RLRVIHRDLKASNILLDSNM-------NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSF 159 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~-------~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Diwsl 159 (289)
++||||||+||+++.++ .++|+|||++..... .....++..|+|||++.+. .++.++|||||
T Consensus 122 ---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 192 (259)
T cd05037 122 ---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSF 192 (259)
T ss_pred ---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHH
Confidence 99999999999999887 799999999886543 1223466789999999876 78999999999
Q ss_pred HHHHHHHHhC-CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 160 GVLVLETLSS-KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 160 G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
|+++|+|++| ..|+......... . .+.... ....+....+.+++.+||..+|.+|||+.+++
T Consensus 193 G~~~~~l~~~~~~p~~~~~~~~~~---~---~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 255 (259)
T cd05037 193 GTTLLEICSNGEEPLSTLSSSEKE---R---FYQDQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255 (259)
T ss_pred HHHHHHHHhCCCCCcccCCchhHH---H---HHhcCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHH
Confidence 9999999995 5555433211110 0 000000 00111126888999999999999999999999
Q ss_pred HHhh
Q 038647 239 SMLT 242 (289)
Q Consensus 239 ~~L~ 242 (289)
+.|+
T Consensus 256 ~~l~ 259 (259)
T cd05037 256 RDLN 259 (259)
T ss_pred HhcC
Confidence 8774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=255.06 Aligned_cols=215 Identities=27% Similarity=0.413 Sum_probs=171.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|+++++.++|+||+++++++.+ ...+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~ 121 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR 121 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999999887 7889999999999999998542 234678888999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+....++.++|+||||+++|+++
T Consensus 122 ~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05073 122 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 197 (260)
T ss_pred C---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHH
Confidence 7 999999999999999999999999998765432211 122234567799999999888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..||....... .... ..... ........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 198 t~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 198 TYGRIPYPGMSNPE--VIRA----LERGY---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred hcCCCCCCCCCHHH--HHHH----HhCCC---------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9 888876432211 1111 11110 001112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=258.06 Aligned_cols=217 Identities=28% Similarity=0.388 Sum_probs=171.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCC------CCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT------GLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~i~~~l 81 (289)
..+.|.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++...... ..+++..+..++.|++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999999999999998643322 2689999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
.|||+.+ ++||||||+||+++.++.++++|||++....... ........++..|+|||.+.+..++.++||||||+
T Consensus 131 ~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~ 206 (275)
T cd05046 131 DHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGV 206 (275)
T ss_pred HHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHH
Confidence 9999888 9999999999999999999999999987543221 11223335677899999999888999999999999
Q ss_pred HHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|++++ |..||....... .... ...... ........+..+.+++.+||+.+|++|||+.++++.
T Consensus 207 ~l~~l~~~~~~p~~~~~~~~--~~~~----~~~~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 207 LMWEVFTQGELPFYGLSDEE--VLNR----LQAGKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHhCCCCCccccchHH--HHHH----HHcCCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9999998 677764332211 1110 100000 001112345688999999999999999999999998
Q ss_pred hh
Q 038647 241 LT 242 (289)
Q Consensus 241 L~ 242 (289)
|.
T Consensus 273 l~ 274 (275)
T cd05046 273 LG 274 (275)
T ss_pred hc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=254.80 Aligned_cols=216 Identities=22% Similarity=0.342 Sum_probs=172.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|++++++++||||+++++++.+++..|++|||+++++|.+++.. ....+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh 118 (262)
T cd06613 41 GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLH 118 (262)
T ss_pred hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999999999999999999999998853 2256889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC---CCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG---LFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~v 162 (289)
+++ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||++
T Consensus 119 ~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~ 193 (262)
T cd06613 119 ETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGIT 193 (262)
T ss_pred hCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHH
Confidence 888 9999999999999999999999999987654321 112334678889999999876 78999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..|+.......... ... ... .. ..........+.++.+++.+||..+|.+|||+.+|+.
T Consensus 194 l~~~~tg~~p~~~~~~~~~~~-~~~-----~~~----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 194 AIELAELQPPMFDLHPMRALF-LIS-----KSN----FP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHhCCCCCCCCCHHHHHH-HHH-----hcc----CC-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999986543221111 000 000 00 0001122345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=257.45 Aligned_cols=213 Identities=25% Similarity=0.395 Sum_probs=170.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++|+||+++++++.+++..++|+||+++++|.+++. ..+.+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (265)
T cd06631 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNN 121 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45679999999999999999999999999999999999999999999984 334678999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCC----cccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+ ++|+||+|+||+++.++.++|+|||++....... .........++..|+|||.+.+..++.++|+||||+++
T Consensus 122 ~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~ 198 (265)
T cd06631 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTV 198 (265)
T ss_pred C---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHH
Confidence 7 9999999999999999999999999987653211 11112234678899999999988899999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||.......... ...... ..........+..+.+++.+||+.+|++||++.++++
T Consensus 199 ~~l~~g~~p~~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 199 FEMATGKPPLASMDRLAAMF-----YIGAHR--------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHhCCCccccCChHHHHH-----Hhhhcc--------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999986432211100 000000 0001112234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=254.72 Aligned_cols=214 Identities=31% Similarity=0.454 Sum_probs=169.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|++++++++|||++++++++......++|+||+++++|.+++.. ..+.++++.+..++.+++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (256)
T cd05112 42 SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESS 119 (256)
T ss_pred CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356899999999999999999999999999999999999999999998853 234578899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||||+||+++.++.++|+|||.++......... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 120 ~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987654322111 11223467899999999888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+ |..|+....... .... ..... .. ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 196 ~~g~~p~~~~~~~~--~~~~----~~~~~--~~-------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 196 SEGKTPYENRSNSE--VVET----INAGF--RL-------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred cCCCCCCCcCCHHH--HHHH----HhCCC--CC-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 8 888775432211 1110 00000 00 001112467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=255.40 Aligned_cols=212 Identities=26% Similarity=0.396 Sum_probs=164.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+..+.+.+|+.++++++||||+++++++.+ +...++++||+++++|.+++. ..+.+++.....++.|++.||.||
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~L 122 (266)
T cd06651 46 KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYL 122 (266)
T ss_pred HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999999999875 357899999999999999884 334588899999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCC-cccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE-LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
|+.+ ++||||+|+||+++.++.++|+|||+++...... .........++..|+|||.+.+..++.++||||||+++
T Consensus 123 H~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~ 199 (266)
T cd06651 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTV 199 (266)
T ss_pred HhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHH
Confidence 9887 9999999999999999999999999987653211 11112234578899999999988899999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||.......... ... ........+......+.+++ .||..+|++||+++||++
T Consensus 200 ~el~~g~~pf~~~~~~~~~~-----~~~---------~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 200 VEMLTEKPPWAEYEAMAAIF-----KIA---------TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHCCCCccccchHHHHH-----HHh---------cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 99999999976432111000 000 00001111223445667777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=256.00 Aligned_cols=213 Identities=23% Similarity=0.357 Sum_probs=167.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+.+++.++||||+++++++.+++..++|+||+++++|.+++. ..+.+++.++..++.|++.||.|||+.
T Consensus 49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~ 125 (267)
T cd06645 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSK 125 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999999999999999999999999884 345789999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl~ 164 (289)
+ ++|+||||+||+++.++.++|+|||++....... .......|+..|+|||.+. ...++.++|+|||||++|
T Consensus 126 ~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~ 200 (267)
T cd06645 126 G---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAI 200 (267)
T ss_pred C---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHH
Confidence 8 9999999999999999999999999987654321 1223456889999999985 456889999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..|+.......... .. ...... ..... .....+..+.+++.+||+.+|++||++.+|++
T Consensus 201 ~l~~~~~p~~~~~~~~~~~-~~----~~~~~~----~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 201 ELAELQPPMFDLHPMRALF-LM----TKSNFQ----PPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHhcCCCCcccccchhhHH-hh----hccCCC----CCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 9999999875433211110 00 000000 00000 01123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=256.92 Aligned_cols=218 Identities=22% Similarity=0.313 Sum_probs=172.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.|.+|+.++++++||||+++++++.+ +..++||||+++|+|.+++... ...+++..+..++.|++.||.|||
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH 124 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE 124 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999876 4578999999999999998542 235889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++||||||+||+++.++.++|+|||+++......... .....++..|+|||.+....++.++||||||+++|+
T Consensus 125 ~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 200 (270)
T cd05056 125 SKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 200 (270)
T ss_pred hCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHH
Confidence 888 9999999999999999999999999998654432211 112234568999999988889999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+++ |..||........ ... ....... ......+..+.+++.+|+..+|++|||+.++++.|++.
T Consensus 201 l~~~g~~pf~~~~~~~~--~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 201 ILMLGVKPFQGVKNNDV--IGR----IENGERL---------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HHHcCCCCCCCCCHHHH--HHH----HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 986 9988764432211 111 1111000 11123356889999999999999999999999999875
Q ss_pred c
Q 038647 245 N 245 (289)
Q Consensus 245 ~ 245 (289)
.
T Consensus 266 ~ 266 (270)
T cd05056 266 L 266 (270)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=258.42 Aligned_cols=209 Identities=23% Similarity=0.391 Sum_probs=169.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++++..++..|+|+||+++++|.+++. .+.+++..+..++.|++.|+.|||+
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~ 119 (277)
T cd06642 44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS 119 (277)
T ss_pred HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 346789999999999999999999999999999999999999999998883 2468889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||||+++|+|
T Consensus 120 ~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 194 (277)
T cd06642 120 ER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194 (277)
T ss_pred CC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHH
Confidence 88 99999999999999999999999999876543221 12234578899999999998899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..|+.......... ..... .........+..+.+++.+||+.+|++||++.++++
T Consensus 195 ~tg~~p~~~~~~~~~~~------~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 195 AKGEPPNSDLHPMRVLF------LIPKN---------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HhCCCCCcccchhhHHh------hhhcC---------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999875322111000 00000 001112234567889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=256.38 Aligned_cols=210 Identities=24% Similarity=0.391 Sum_probs=171.7
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++++.++|+||+++++++.++...|+|+||+++++|.+++.. ..+++..+..++.|++.||.|||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh 115 (274)
T cd06609 40 EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLH 115 (274)
T ss_pred chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999998843 27899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++||||+|+||++++++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+
T Consensus 116 ~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~ 190 (274)
T cd06609 116 EEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190 (274)
T ss_pred hCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHH
Confidence 888 9999999999999999999999999998765432 12233467889999999998889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHH-HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYP-MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..|+........ . . ..... ........ .+..+.+++..||..+|++|||++++++
T Consensus 191 l~tg~~p~~~~~~~~~--~---~-~~~~~---------~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 191 LAKGEPPLSDLHPMRV--L---F-LIPKN---------NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhCCCCcccCchHHH--H---H-Hhhhc---------CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 9999999864332110 0 0 00000 00011111 4567889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=255.85 Aligned_cols=211 Identities=22% Similarity=0.369 Sum_probs=172.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++++.++||||+++++++.++...++||||+++++|.+++.. +.+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh 118 (277)
T cd06640 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH 118 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998842 45788899999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 119 ~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~e 193 (277)
T cd06640 119 SEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193 (277)
T ss_pred hCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHH
Confidence 887 99999999999999999999999999976643321 1223457888999999998889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
|++|..|+.......... ..............+..+.+++.+||+.+|++||++.++++.
T Consensus 194 l~tg~~p~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 194 LAKGEPPNSDMHPMRVLF---------------LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHCCCCCCCcChHhHhh---------------hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 999999875432211000 000111122233466788999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=260.21 Aligned_cols=212 Identities=22% Similarity=0.339 Sum_probs=171.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.+++.++||||+++++++..++..|+|+||+++++|..++.. ..+++.++..++.+++.||.|||
T Consensus 57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH 132 (296)
T cd06655 57 QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLH 132 (296)
T ss_pred CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999998842 35889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+
T Consensus 133 ~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~ 207 (296)
T cd06655 133 ANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207 (296)
T ss_pred HCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHH
Confidence 988 99999999999999999999999999876543321 1223467889999999998889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||........... ...... . . -......+..+.+++.+||..||++||++.++++
T Consensus 208 lltg~~pf~~~~~~~~~~~-----~~~~~~-~-----~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 208 MVEGEPPYLNENPLRALYL-----IATNGT-P-----E--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHhCCCCCCCCCHHHHHHH-----HHhcCC-c-----c--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 9999999865433211110 000000 0 0 0111234467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.58 Aligned_cols=213 Identities=21% Similarity=0.222 Sum_probs=165.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~ 161 (371)
T cd05622 86 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM 161 (371)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 355688999999999999999999999999999999999999999998843 3478888999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC----CCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL----FSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~vl 163 (289)
+ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 162 ~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvil 237 (371)
T cd05622 162 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (371)
T ss_pred C---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHH
Confidence 8 99999999999999999999999999987643221 1223457999999999997543 78999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC--CCCHHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD--RPTMLEVISM 240 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~ 240 (289)
|+|++|..||...+... . .......... ..-......+..+.++|..||..++.+ |+++.++++.
T Consensus 238 yell~G~~Pf~~~~~~~--~---~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 238 YEMLVGDTPFYADSLVG--T---YSKIMNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHhCCCCCCCCCHHH--H---HHHHHcCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 99999999986543211 1 1111111000 000111234567889999999844433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.27 Aligned_cols=220 Identities=17% Similarity=0.216 Sum_probs=159.7
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeec--------CeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHH
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEH--------GEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l 81 (289)
...+|+.+|+.++||||+++++++... ..+++||||+++ +|.+++... .....+++..+..++.||+.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 456799999999999999999887432 257799999975 566655321 2346789999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Diwsl 159 (289)
.|||+++ |+||||||+|||++.++ .+||+|||+++...... ......|++.|+|||++.+. .++.++|||||
T Consensus 184 ~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 257 (440)
T PTZ00036 184 AYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSL 257 (440)
T ss_pred HHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence 9999988 99999999999998665 69999999998664322 12234679999999998764 68999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC---------------ccccccccccCCCCHHHHHHHHHHHHccc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR---------------AWELMDSILQNDASYPMLNRYINVALLCV 224 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l 224 (289)
||++|+|++|.+||.......... . ......... ........+....+...+.++.+++.+||
T Consensus 258 Gvil~elltG~~pf~~~~~~~~~~-~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L 335 (440)
T PTZ00036 258 GCIIAEMILGYPIFSGQSSVDQLV-R-IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFL 335 (440)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHH-H-HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHC
Confidence 999999999999987543321111 0 000000000 00000000000011123467899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 038647 225 QENAADRPTMLEVIS 239 (289)
Q Consensus 225 ~~~p~~Rps~~~ll~ 239 (289)
+.||.+|||+.|+++
T Consensus 336 ~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 336 KYEPLKRLNPIEALA 350 (440)
T ss_pred CCChhHCcCHHHHhC
Confidence 999999999999985
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.58 Aligned_cols=215 Identities=28% Similarity=0.426 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
..++.+|+.+++.++||||+++++++... ..++++||+++|+|.+++.. ....+++..+..++.|++.||.|||+++
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 129 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR 129 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 45788999999999999999999998754 46799999999999998853 2345788999999999999999999888
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|++++
T Consensus 130 ---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred ---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999987643322222222345678999999998899999999999999999997
Q ss_pred -CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 169 -SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 169 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|..|+....... ... ....... .......+..+.+++..||..+|++||++.++++.|...
T Consensus 207 ~g~~p~~~~~~~~--~~~----~~~~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 207 FGGKPYDGIPTRE--IPD----LLEKGER---------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCCCCCCCCCHHH--HHH----HHHCCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 888875432111 110 1111100 001112345788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=268.96 Aligned_cols=223 Identities=20% Similarity=0.257 Sum_probs=166.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecC-----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
...+++.+|+++|+.++||||+++++++...+ ..|+|+||+. ++|..++. ..+.+++..+..++.||+.||
T Consensus 41 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL 116 (372)
T cd07853 41 VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGL 116 (372)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999998776 7899999996 57777663 345789999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG 160 (289)
.|||+.+ ++||||||+|||++.++.+||+|||+++....... .......+++.|+|||++.+. .++.++||||||
T Consensus 117 ~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (372)
T cd07853 117 KYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG 192 (372)
T ss_pred HHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHH
Confidence 9999988 99999999999999999999999999986543221 112234578899999999874 579999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcc-----------ccccccccC-------CCCHHHHHHHHHHHHc
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAW-----------ELMDSILQN-------DASYPMLNRYINVALL 222 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-------~~~~~~~~~l~~li~~ 222 (289)
|++|+|++|+.||...+.... .............. .+....... ......+.++.+++.+
T Consensus 193 ~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (372)
T cd07853 193 CIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCR 270 (372)
T ss_pred HHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHH
Confidence 999999999999875443211 00000000000000 000000000 0111224678899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.||++|||+.++++
T Consensus 271 mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 271 MLVFDPDKRISAADALA 287 (372)
T ss_pred hCCCChhhCcCHHHHhc
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=257.52 Aligned_cols=213 Identities=23% Similarity=0.270 Sum_probs=169.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++|+|++++++.+.+++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05630 43 GESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE 121 (285)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456788999999999999999999999999999999999999999888542 223588899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 122 ~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 195 (285)
T cd05630 122 R---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195 (285)
T ss_pred C---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHH
Confidence 8 9999999999999999999999999987653222 122346899999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
+|..||......... ......... . ........+..+.+++..||+.||++||| ++|+++
T Consensus 196 ~g~~Pf~~~~~~~~~--~~~~~~~~~---------~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 196 AGQSPFQQRKKKIKR--EEVERLVKE---------V-QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hCCCCCCCCCccchH--HHHHhhhhh---------h-hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 999998653321110 000000000 0 00111223467889999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=260.40 Aligned_cols=212 Identities=23% Similarity=0.338 Sum_probs=170.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++.. +.+++..+..++.||+.||.|||+
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~ 136 (292)
T cd06658 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN 136 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4466789999999999999999999999999999999999999999988732 357889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++||||||+++|+|
T Consensus 137 ~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el 211 (292)
T cd06658 137 QG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211 (292)
T ss_pred CC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 88 9999999999999999999999999987653322 122335688999999999988899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|..|+....... ....... ....... .....+..+.+++..||..||++|||++++++.
T Consensus 212 ~~g~~p~~~~~~~~--~~~~~~~---------~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 212 IDGEPPYFNEPPLQ--AMRRIRD---------NLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhCCCCCCCCCHHH--HHHHHHh---------cCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 99999876432211 1000000 0001110 111234578899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=254.40 Aligned_cols=215 Identities=25% Similarity=0.421 Sum_probs=172.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|++++++++|+||+++++++.+++..++|+||+++++|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~ 122 (268)
T cd06630 46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHEN 122 (268)
T ss_pred HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999999999999999999999999999884 345688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCcc--cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+ ++|+||+|+||+++.++ .++|+|||.+......... .......++..|+|||.+.+..++.++|+||+|++++
T Consensus 123 ~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 199 (268)
T cd06630 123 Q---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVII 199 (268)
T ss_pred C---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHH
Confidence 8 99999999999998776 5899999998776433111 1122346788999999998888999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..|+.......... ... ...........+...+..+.+++.+||..+|++||++.++++
T Consensus 200 ~l~~g~~p~~~~~~~~~~~--~~~---------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 200 EMATAKPPWNAEKHSNHLA--LIF---------KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhCCCCCCCCCCcchHH--HHH---------HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 9999999876433221111 000 000111112333345678899999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=256.75 Aligned_cols=224 Identities=20% Similarity=0.250 Sum_probs=168.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++|||++++++++..++..++||||+++++|..+.. ....+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~ 119 (286)
T cd07847 43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKH 119 (286)
T ss_pred ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44678899999999999999999999999999999999999998887763 334689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~el 166 (289)
+ ++||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 120 ~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l 194 (286)
T cd07847 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAEL 194 (286)
T ss_pred C---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHH
Confidence 8 99999999999999999999999999987644321 1223457788999999876 4578999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHh-H--------hhhhccCCccc-cccccccCCC-----CHHHHHHHHHHHHcccccCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGH-A--------WNLWNDGRAWE-LMDSILQNDA-----SYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~-~--------~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++|..||............. . ...+....... .......... ....+..+.+++.+||+.+|++|
T Consensus 195 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd07847 195 LTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274 (286)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcccc
Confidence 99999987544321111000 0 00000000000 0000000000 01235678899999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
|++.+++.
T Consensus 275 p~~~eil~ 282 (286)
T cd07847 275 LSCEELLE 282 (286)
T ss_pred CCHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=253.95 Aligned_cols=211 Identities=27% Similarity=0.376 Sum_probs=168.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++|||++++++++..+ ..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~ 119 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK 119 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 346789999999999999999999998765 479999999999999998643 234578899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.++|+|||+++..... ......+..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 120 ~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 120 K---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred C---eeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 7 999999999999999999999999998754321 11123456799999998889999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+ |..|+....... .. ...... .........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 192 ~~g~~p~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 192 SYGRAPYPKMSLKE--VK----ECVEKG---------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred hCCCCCCccCCHHH--HH----HHHhCC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7 888876433211 11 011110 0111122345688899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=259.20 Aligned_cols=223 Identities=22% Similarity=0.289 Sum_probs=165.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++||||+++++++.+.+..++|+||+++ +|.+++.. ..+.+++..+..++.||+.||.|||+.
T Consensus 42 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~ 118 (284)
T cd07839 42 VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH 118 (284)
T ss_pred CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346788999999999999999999999999999999999975 67776642 245689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~el 166 (289)
+ ++||||||+||+++.++.++|+|||+++...... .......++..|+|||.+.+. .++.++|||||||++|+|
T Consensus 119 ~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 193 (284)
T cd07839 119 N---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193 (284)
T ss_pred C---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999988654322 112234578899999998764 479999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhc-----------cCCcccccccccc----CCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWN-----------DGRAWELMDSILQ----NDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++|..|+.......... ........ ............. .......+.++.+++.+||+.||.+|
T Consensus 194 ~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07839 194 ANAGRPLFPGNDVDDQL-KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQR 272 (284)
T ss_pred HhcCCCCcCCCCHHHHH-HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhc
Confidence 99998864333221111 10000000 0000000000000 01112245688899999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
||++++++
T Consensus 273 ~t~~~il~ 280 (284)
T cd07839 273 ISAEEALQ 280 (284)
T ss_pred CCHHHHhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=260.64 Aligned_cols=224 Identities=21% Similarity=0.271 Sum_probs=166.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|++++++++||||+++++++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 47 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~ 123 (309)
T cd07872 47 APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRR 123 (309)
T ss_pred cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678999999999999999999999999999999999975 77777643 234578889999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~el 166 (289)
+ |+||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 124 ~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 198 (309)
T cd07872 124 K---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198 (309)
T ss_pred C---eecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 8 99999999999999999999999999876433221 1223457889999999875 4689999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhH---------hHhhhhccCCccccccccccC-----CCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLG---------HAWNLWNDGRAWELMDSILQN-----DASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
++|+.||...+........ ..|..+.........+..... ......+.++.+++.+||+.||++||
T Consensus 199 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 278 (309)
T cd07872 199 ASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI 278 (309)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC
Confidence 9999998765433211100 000000000000000000000 00112456788999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
|+.|+++
T Consensus 279 t~~e~l~ 285 (309)
T cd07872 279 SAEEAMK 285 (309)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=253.63 Aligned_cols=213 Identities=24% Similarity=0.347 Sum_probs=170.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+.+.+|++++++++|+|++++++.+.. +..+|+||||+++++|.+++... ....+++.++..++.+++.||.+|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~l 118 (257)
T cd08223 40 RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYL 118 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999998864 44689999999999999988642 234689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+.+ ++||||+|+||+++.++.++|+|||++....... .......+++.|+|||++.+..++.++||||||++++
T Consensus 119 H~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 193 (257)
T cd08223 119 HEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVY 193 (257)
T ss_pred HhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHH
Confidence 9988 9999999999999999999999999988664322 1223446788999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||........ ...... .. . .......+..+.+++.+||+.||++||++.++++
T Consensus 194 ~l~~g~~~~~~~~~~~~-----~~~~~~-~~--------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 194 EMATLKHAFNAKDMNSL-----VYRIIE-GK--------L-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHcCCCCCCCCCHHHH-----HHHHHh-cC--------C-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 99999998764332111 000110 00 0 1122345578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=259.05 Aligned_cols=230 Identities=20% Similarity=0.237 Sum_probs=172.7
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.+..+.+.+|+++++.++|+||+++++++.+++..+++|||+++|+|.+++.... ...+++..+..++.|++.||.||
T Consensus 39 ~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~L 117 (314)
T cd08216 39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYI 117 (314)
T ss_pred chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHH
Confidence 45567899999999999999999999999999999999999999999999886432 24578899999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-----ccccccccccccccChhhhhc--CCCCCcccch
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-----QSNTKRIVGTYGYMSPEYALR--GLFSIKSDVF 157 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Diw 157 (289)
|+++ |+||||||+||+++.++.++|+|||.+........ ........++..|+|||++.+ ..++.++|+|
T Consensus 118 H~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diw 194 (314)
T cd08216 118 HSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194 (314)
T ss_pred HHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHH
Confidence 9988 99999999999999999999999998875532211 111223356778999999976 4588999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhh----hccC-------Cccc--------cccccccCCCCHHHHHHHHH
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNL----WNDG-------RAWE--------LMDSILQNDASYPMLNRYIN 218 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~-------~~~~--------~~~~~~~~~~~~~~~~~l~~ 218 (289)
|||+++|+|++|..||.......... ...... .... .... ................++.+
T Consensus 195 s~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (314)
T cd08216 195 SVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQ 273 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHH
Confidence 99999999999999987543221110 000000 0000 0000 00000111122334567889
Q ss_pred HHHcccccCCCCCCCHHHHHH
Q 038647 219 VALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 219 li~~~l~~~p~~Rps~~~ll~ 239 (289)
++..||+.||++|||+.++++
T Consensus 274 li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 274 FVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHHHhhcCCCcCcCHHHHhc
Confidence 999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=268.90 Aligned_cols=209 Identities=22% Similarity=0.262 Sum_probs=163.3
Q ss_pred CHHHHHHHHHHHhhC---CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL---QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+.+|..++... +||||+++++++.+++..|+||||+++|+|..++. ..+.+++..+..++.||+.||.||
T Consensus 36 ~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~L 112 (330)
T cd05586 36 EVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFSEDRAKFYIAELVLALEHL 112 (330)
T ss_pred HHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 344566677777766 69999999999999999999999999999998884 446689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl 163 (289)
|+++ |+||||||+|||++.++.++|+|||+++...... .......||+.|+|||++.+. .++.++|||||||++
T Consensus 113 H~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil 187 (330)
T cd05586 113 HKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187 (330)
T ss_pred HHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEE
Confidence 9988 9999999999999999999999999987542221 123345789999999999764 589999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC----CHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP----TMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~~ll~ 239 (289)
|+|++|..||....... .. ........ . ......+..+.+++.+||+.||++|| ++.++++
T Consensus 188 ~elltG~~Pf~~~~~~~--~~----~~i~~~~~-~--------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 188 FEMCCGWSPFYAEDTQQ--MY----RNIAFGKV-R--------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred EEeccCCCCCCCCCHHH--HH----HHHHcCCC-C--------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 99999999986433211 11 01100000 0 00112346788999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=260.74 Aligned_cols=165 Identities=28% Similarity=0.398 Sum_probs=134.4
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCC------CCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDP------TKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|+++|+.++||||+++++++.. +...++|+||+.+ +|.+++... .....+++..+..++.||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 4568899999999999999999999853 5678999999965 666665321 122358888999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEe----CCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcC-CCCCcc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRG-LFSIKS 154 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill----~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~ 154 (289)
|.|||+.+ ++||||||+||++ +.++.+||+|||+++....... ........+|+.|+|||++.+. .++.++
T Consensus 121 L~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07867 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHH
Confidence 99999988 9999999999999 5667899999999987643321 1123345689999999999764 589999
Q ss_pred cchhHHHHHHHHHhCCCCcCCCC
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYN 177 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~ 177 (289)
|||||||++|+|+||.+||....
T Consensus 198 DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 198 DIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHhHHHHHHHHHhCCCCccccc
Confidence 99999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=264.44 Aligned_cols=217 Identities=24% Similarity=0.322 Sum_probs=170.3
Q ss_pred CCcccCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 3 SQSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 3 ~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
+.+.+.++-|.+|+..|.+++ |.+||++++|-..++.+|+||||- .-+|..+|.++. ..++...++.++.||+.|+
T Consensus 397 ~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV 473 (677)
T KOG0596|consen 397 EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAV 473 (677)
T ss_pred hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHH
Confidence 345677889999999999995 999999999999999999999965 569999996533 2333347889999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-----------CC
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-----------LF 150 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~ 150 (289)
.++|++| |||.||||.|+|+ -.|.+||+|||+|..+..+...-.....+||+.||+||.+... ..
T Consensus 474 ~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki 549 (677)
T KOG0596|consen 474 KTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKI 549 (677)
T ss_pred HHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceee
Confidence 9999998 9999999999999 4578999999999998877766666778999999999998532 25
Q ss_pred CCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCC-CHHHHHHHHHHHHcccccCCC
Q 038647 151 SIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDA-SYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 151 ~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~ 229 (289)
+.++|||||||+||+|+.|+.||...... +..+. .+.+....-++ ..+...++.++++.||+.||.
T Consensus 550 ~r~SDvWSLGCILYqMvYgktPf~~~~n~--------~aKl~-----aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPk 616 (677)
T KOG0596|consen 550 SRKSDVWSLGCILYQMVYGKTPFGQIINQ--------IAKLH-----AITDPNHEIEFPDIPENDELIDVMKCCLARDPK 616 (677)
T ss_pred cCccchhhhhhHHHHHHhcCCchHHHHHH--------HHHHH-----hhcCCCccccccCCCCchHHHHHHHHHHhcCcc
Confidence 68899999999999999999998643211 11110 11111000000 011123489999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||..+||+
T Consensus 617 kR~si~eLLq 626 (677)
T KOG0596|consen 617 KRWSIPELLQ 626 (677)
T ss_pred cCCCcHHHhc
Confidence 9999999987
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=254.71 Aligned_cols=213 Identities=24% Similarity=0.373 Sum_probs=166.8
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
.....+..|+.+++++ +|+||+++++++... ...|+||||+++++|.+++... ....+++..+..++.|++.
T Consensus 44 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~ 122 (272)
T cd06637 44 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILR 122 (272)
T ss_pred ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHH
Confidence 3456889999999999 799999999998753 4689999999999999988642 2346889999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcc
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKS 154 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~ 154 (289)
||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||++. +..++.++
T Consensus 123 ~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~ 197 (272)
T cd06637 123 GLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKS 197 (272)
T ss_pred HHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchh
Confidence 999999988 9999999999999999999999999987653221 1233456889999999986 34578899
Q ss_pred cchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|||||||++|+|++|..|+.......... ..... ..........+..+.+++.+||..||.+|||+
T Consensus 198 Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 263 (272)
T cd06637 198 DLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPRN---------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT 263 (272)
T ss_pred hHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhcC---------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence 99999999999999999875432211110 00100 00111112244678999999999999999999
Q ss_pred HHHHH
Q 038647 235 LEVIS 239 (289)
Q Consensus 235 ~~ll~ 239 (289)
.++++
T Consensus 264 ~~il~ 268 (272)
T cd06637 264 EQLMK 268 (272)
T ss_pred HHHhh
Confidence 99975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=257.63 Aligned_cols=217 Identities=26% Similarity=0.383 Sum_probs=172.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+++.+|+++++.++||||+++++++...+.+++||||+++++|.+++. ..+.+++..+..++.+++.||.|||
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH 120 (284)
T cd06620 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLY 120 (284)
T ss_pred chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999998884 3456899999999999999999999
Q ss_pred c-CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 H-YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~-~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+ .+ ++||||+|+||+++.++.++|+|||++....... .....|+..|+|||++.+..++.++|||||||++|
T Consensus 121 ~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 193 (284)
T cd06620 121 NVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISII 193 (284)
T ss_pred HhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHH
Confidence 7 45 9999999999999999999999999986542221 22346889999999998888999999999999999
Q ss_pred HHHhCCCCcCCCCCcch------hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSL------TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 165 elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
++++|..||........ ........... ...........+..+.+++.+||+.||++|||+.|++
T Consensus 194 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~ 264 (284)
T cd06620 194 ELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ---------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264 (284)
T ss_pred HHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh---------ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 99999999875443210 00011110000 0000011112456789999999999999999999999
Q ss_pred HHh
Q 038647 239 SML 241 (289)
Q Consensus 239 ~~L 241 (289)
+..
T Consensus 265 ~~~ 267 (284)
T cd06620 265 AMP 267 (284)
T ss_pred cCc
Confidence 854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=252.52 Aligned_cols=214 Identities=31% Similarity=0.458 Sum_probs=170.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+..|+++++.++|+||+++++++.+.+..+++|||+++++|.+++..... ..+++..+..++.|++.||.+||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~ 122 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK 122 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC
Confidence 577999999999999999999999999999999999999999999999854221 2289999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||+|+||+++.++.++|+|||+++........... ...++..|+|||.+.+..++.++||||||+++++|+
T Consensus 123 ~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~ 198 (258)
T smart00219 123 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198 (258)
T ss_pred C---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence 8 999999999999999999999999999876544222211 223678999999998888999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
+ |..|+...... ..... ..... ........+.++.+++.+||..||++|||+.++++.|
T Consensus 199 ~~g~~p~~~~~~~--~~~~~----~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 199 TLGESPYPGMSNE--EVLEY----LKKGY---------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred hCCCCCCCCCCHH--HHHHH----HhcCC---------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 8 67766542211 11111 11111 0111122456889999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.19 Aligned_cols=216 Identities=18% Similarity=0.205 Sum_probs=165.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|+.++..++|+||+++++++.+++..|+||||+++|+|.+++.+ ....+++..+..++.||+.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~ 121 (332)
T cd05623 44 ETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQL 121 (332)
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345688999999999999999999999999999999999999999999853 234688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~v 162 (289)
+ |+||||||+|||++.++.+||+|||++........ .......||+.|+|||++. ...++.++|||||||+
T Consensus 122 ~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvi 197 (332)
T cd05623 122 H---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVC 197 (332)
T ss_pred C---eEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHH
Confidence 8 99999999999999999999999999876432221 1122346899999999986 3468899999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC--CCCHHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD--RPTMLEVISM 240 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~~ 240 (289)
+|+|++|+.||...+.... . ........... ........+..+.+++.+|+..++++ |+++.++++.
T Consensus 198 l~ell~g~~Pf~~~~~~~~--~---~~i~~~~~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 198 MYEMLYGETPFYAESLVET--Y---GKIMNHKERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHhcCCCCCCCCCHHHH--H---HHHhCCCcccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999864332111 1 11111100000 00111234567888999988654444 6899998864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=270.46 Aligned_cols=216 Identities=26% Similarity=0.395 Sum_probs=180.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+++|.+|+.+|+.++|||+|+++|+|..+-..|||+|||..|+|.++|+... ...++.-..+.++.||..|++||..+
T Consensus 306 eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk 384 (1157)
T KOG4278|consen 306 EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK 384 (1157)
T ss_pred hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh
Confidence 57899999999999999999999999999999999999999999999997633 34566667889999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ +|||||...|+|+.++..||++|||+++.+....+....+ .--+..|.|||.+.-..++.|+|||+|||+|||+.
T Consensus 385 n---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIA 460 (1157)
T KOG4278|consen 385 N---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIA 460 (1157)
T ss_pred h---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHH
Confidence 8 9999999999999999999999999999987665443222 22356899999999999999999999999999998
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
| |-.|+++.+..+. + .+++...+.+.+...++.+.+|++.||+++|.+||+++|+-+.++.
T Consensus 461 TYGMsPYPGidlSqV------Y---------~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 461 TYGMSPYPGIDLSQV------Y---------GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred hcCCCCCCCccHHHH------H---------HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 8 6677665433221 1 2333333444455567789999999999999999999999988774
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=256.88 Aligned_cols=215 Identities=22% Similarity=0.367 Sum_probs=168.8
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....+.+.+|+++++.++||||+++++++..++..++||||+++++|..++.+ ....+++..+..++.|++.||.||
T Consensus 49 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~l 126 (292)
T cd06644 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYL 126 (292)
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 344577899999999999999999999999999999999999999999887743 234688999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSF 159 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Diwsl 159 (289)
|+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++. ...++.++|||||
T Consensus 127 H~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 201 (292)
T cd06644 127 HSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201 (292)
T ss_pred hcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence 9887 9999999999999999999999999887543221 1123346788999999985 3457889999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||++|+|++|..|+........ . .... ..... ........+.++.+++.+||..||++||++.++++
T Consensus 202 G~il~el~~g~~p~~~~~~~~~-~----~~~~-~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 202 GITLIEMAQIEPPHHELNPMRV-L----LKIA-KSEPP-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHhcCCCCCccccHHHH-H----HHHh-cCCCc-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9999999999998764432111 0 0000 00000 00112234467889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.80 Aligned_cols=220 Identities=21% Similarity=0.216 Sum_probs=163.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+.+.+|+.+++.++||||+++++++...+ ..|+||||+.+ +|...+. ..+++..+..++.|++.
T Consensus 61 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~ 134 (359)
T cd07876 61 QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLC 134 (359)
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHH
Confidence 345678889999999999999999999986543 57999999976 4555542 24788889999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus 135 ~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 208 (359)
T cd07876 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208 (359)
T ss_pred HHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHH
Confidence 999999988 9999999999999999999999999997643221 1233468899999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhh-------------------hccCCc------ccccccccc---CCCCHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNL-------------------WNDGRA------WELMDSILQ---NDASYP 211 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~------~~~~~~~~~---~~~~~~ 211 (289)
||++|+|++|..||...+.... ....... ...... .+....... ......
T Consensus 209 G~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (359)
T cd07876 209 GCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKL 286 (359)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccc
Confidence 9999999999999875432110 0000000 000000 000000000 000111
Q ss_pred HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 212 MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
....+.+++.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 287 KTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred cchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 2456889999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=253.27 Aligned_cols=213 Identities=24% Similarity=0.418 Sum_probs=167.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCC--ChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLL--GWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~~l~~l 84 (289)
+..+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.+++... ...+ ++..+..++.|++.||.||
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~l 124 (268)
T cd06624 47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYL 124 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999988542 2334 7788889999999999999
Q ss_pred hcCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcCC--CCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~ 161 (289)
|+++ |+||||||+||+++. ++.++|+|||.+........ ......++..|+|||.+.+.. ++.++|+||||+
T Consensus 125 H~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGv 199 (268)
T cd06624 125 HDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGC 199 (268)
T ss_pred HHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHH
Confidence 9888 999999999999976 67899999999876543221 122345788999999987643 789999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..|+............. ... ......+.....++.+++.+||+.+|++|||+.+++.
T Consensus 200 vl~~l~~g~~p~~~~~~~~~~~~~~--~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 200 TIVEMATGKPPFIELGEPQAAMFKV--GMF-----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHhCCCCCccccChhhhHhhh--hhh-----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 9999999999876433221111000 000 0011122234567889999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=253.24 Aligned_cols=211 Identities=26% Similarity=0.389 Sum_probs=171.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
++..+.+.+|+++++.++|+||+++++++.++...++|+||+++++|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH 119 (258)
T cd06632 43 QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLH 119 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4467889999999999999999999999999999999999999999999984 3356889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC-CCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~vl~ 164 (289)
+.+ ++|+||+|+||+++.++.+||+|||++....... ......++..|+|||.+.... ++.++|+||||+++|
T Consensus 120 ~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~ 193 (258)
T cd06632 120 DRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVL 193 (258)
T ss_pred HCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHH
Confidence 888 9999999999999999999999999987654332 123456788999999998776 899999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||........ . ........ ...........+.+++.+||+.+|++||++.+++.
T Consensus 194 ~l~~g~~pf~~~~~~~~-~----~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 194 EMATGKPPWSQLEGVAA-V----FKIGRSKE---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhCCCCcccCcHHHH-H----HHHHhccc---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 99999999765431111 0 00000000 01112234567889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.76 Aligned_cols=222 Identities=27% Similarity=0.448 Sum_probs=183.8
Q ss_pred CCcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 3 ~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
+.++.+..+|..|+.||-+++||||+++.|++.....++||+|||++|+|+.||+++ .+.++..++.-+++.|+.|++
T Consensus 668 GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMk 745 (996)
T KOG0196|consen 668 GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMK 745 (996)
T ss_pred CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhH
Confidence 345678999999999999999999999999999999999999999999999999753 366999999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccc--cccccChhhhhcCCCCCcccchhHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVG--TYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
||-+.+ +|||||..+|||++.+..+|++|||++|....+. .....+..| +.+|.|||.+....+|.++||||||
T Consensus 746 YLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyG 821 (996)
T KOG0196|consen 746 YLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYG 821 (996)
T ss_pred HHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccc
Confidence 999887 9999999999999999999999999999775543 222222223 5689999999999999999999999
Q ss_pred HHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+||.++ |..|+=...+.+ ....++.-.+-..+.+.+..|-.|+..||+.|-.+||.+.+|+.
T Consensus 822 IVmWEVmSyGERPYWdmSNQd---------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 822 IVMWEVMSYGERPYWDMSNQD---------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred eEEEEecccCCCcccccchHH---------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 99999887 666643222111 11122222333455567789999999999999999999999999
Q ss_pred Hhhccc
Q 038647 240 MLTNEN 245 (289)
Q Consensus 240 ~L~~~~ 245 (289)
.|+..-
T Consensus 887 ~lDklI 892 (996)
T KOG0196|consen 887 TLDKLI 892 (996)
T ss_pred HHHHHh
Confidence 998743
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=255.91 Aligned_cols=214 Identities=23% Similarity=0.362 Sum_probs=169.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.|.+|++++++++||||+++++++.++...|+||||+++++|.+++.+ ....+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh 120 (280)
T cd06611 43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLH 120 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998853 2346899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFG 160 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG 160 (289)
+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+. +..++.++|+||||
T Consensus 121 ~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG 195 (280)
T cd06611 121 SHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG 195 (280)
T ss_pred HCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHH
Confidence 988 9999999999999999999999999887643221 1123346888999999985 34578899999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|+|++|..|+......... .. ....... . -..+...+..+.+++..||+.+|++||++.++++
T Consensus 196 ~il~~l~~g~~p~~~~~~~~~~-----~~-~~~~~~~-----~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 196 ITLIELAQMEPPHHELNPMRVL-----LK-ILKSEPP-----T--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHHhCCCCcccCCHHHHH-----HH-HhcCCCC-----C--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 9999999999997644321110 00 0000000 0 0011224467889999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=257.93 Aligned_cols=211 Identities=21% Similarity=0.323 Sum_probs=170.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~ 133 (297)
T cd06656 58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS 133 (297)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457789999999999999999999999999999999999999999998842 357888999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++||||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|++
T Consensus 134 ~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l 208 (297)
T cd06656 134 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208 (297)
T ss_pred CC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHH
Confidence 88 99999999999999999999999999876543321 12234678899999999998899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..||...+....... .... ...........+..+.+++.+||+.||++||+++++++
T Consensus 209 ~tg~~pf~~~~~~~~~~~-----~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 209 VEGEPPYLNENPLRALYL-----IATN--------GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HhCCCCCCCCCcchheee-----eccC--------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999864332111000 0000 00000112234467889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=255.75 Aligned_cols=213 Identities=23% Similarity=0.341 Sum_probs=169.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc-
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH- 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~- 86 (289)
..+++.+|+.++++++||||+++++.+..++..|+||||+++++|..++........+++..+..++.+++.||.|||+
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 121 (286)
T cd06622 42 KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121 (286)
T ss_pred HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 4578999999999999999999999999999999999999999999888543334578999999999999999999996
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC------CCCCcccchhHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG------LFSIKSDVFSFG 160 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG 160 (289)
.+ ++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|+||||
T Consensus 122 ~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 194 (286)
T cd06622 122 HN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194 (286)
T ss_pred CC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence 35 9999999999999999999999999987653221 2234578899999998654 358899999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+|++|..||........ ...... .. . ..........+.++.+++.+||+.+|++||++.++++
T Consensus 195 ~il~~l~~g~~pf~~~~~~~~--~~~~~~-~~--------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 195 LSILEMALGRYPYPPETYANI--FAQLSA-IV--------D-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHhCCCCCCCcchhhH--HHHHHH-Hh--------h-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 999999999999864332111 000000 00 0 0011222335678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=252.73 Aligned_cols=212 Identities=23% Similarity=0.306 Sum_probs=172.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++++.++||||+++++++.+++..++|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~ 111 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLHN 111 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 4557899999999999999999999999999999999999999999999843 3458899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus 112 ~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l 185 (262)
T cd05572 112 RG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYEL 185 (262)
T ss_pred CC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHH
Confidence 88 9999999999999999999999999998765432 22334678899999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
++|..|+.....+....... .. ........+...+..+.+++.+||+.||++||+ ++|+++
T Consensus 186 ~~g~~p~~~~~~~~~~~~~~---~~---------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 186 LTGRPPFGEDDEDPMEIYND---IL---------KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HhCCCCcCCCCCCHHHHHHH---Hh---------ccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99999987654322111110 00 000011112223568999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=253.57 Aligned_cols=217 Identities=23% Similarity=0.357 Sum_probs=171.9
Q ss_pred ccCHHHHHHHHHHHhh-CCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAK-LQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....+++..|+.++.+ ++||||+++++++.+++..++||||+++++|.+++... .....+++..++.++.|++.||.|
T Consensus 49 ~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 128 (269)
T cd08528 49 DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128 (269)
T ss_pred hHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 3456678889998875 69999999999999999999999999999998877431 234568899999999999999999
Q ss_pred Hhc-CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 84 LHH-YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~-~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
||+ .+ ++|+||+|+||+++.++.++|+|||.+....... ......|+..|+|||.+.+..++.++|+||||++
T Consensus 129 lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~l 202 (269)
T cd08528 129 LHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCI 202 (269)
T ss_pred hccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHH
Confidence 996 55 9999999999999999999999999998754432 2334568889999999998889999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+|+|++|..|+....... .... ...... .. ......+..+.+++.+||+.||++||++.|+.++++
T Consensus 203 l~~l~~g~~p~~~~~~~~--~~~~----~~~~~~----~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 203 LYQMCTLQPPFYSTNMLS--LATK----IVEAVY----EP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHhCCCcccccCHHH--HHHH----HhhccC----Cc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 999999999875432211 1000 000000 00 011123467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=258.66 Aligned_cols=216 Identities=19% Similarity=0.222 Sum_probs=165.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|+.+++.++|+||+++++++.+++++|+||||+++|+|.+++.+ ....+++..+..++.||+.||.|||++
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (331)
T cd05597 44 ETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQL 121 (331)
T ss_pred hHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456788999999999999999999999999999999999999999998853 234688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----CCCCCcccchhHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~v 162 (289)
+ |+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 122 ~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~ 197 (331)
T cd05597 122 G---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVC 197 (331)
T ss_pred C---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhH
Confidence 8 999999999999999999999999998765432211 1222468999999999973 457889999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCC--CCCCCHHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENA--ADRPTMLEVISM 240 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p--~~Rps~~~ll~~ 240 (289)
+|+|++|+.||........ . ............ .......+..+.+++.+|+..++ ..|+++.++++.
T Consensus 198 l~el~~g~~Pf~~~~~~~~--~---~~i~~~~~~~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 198 MYEMLYGETPFYAESLVET--Y---GKIMNHKEHFQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHhhCCCCCCCCCHHHH--H---HHHHcCCCcccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999864332111 0 011111100000 01111245678888888775433 347899998874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=253.23 Aligned_cols=214 Identities=26% Similarity=0.400 Sum_probs=171.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+++.+|++++++++||||+++++++..++..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~ 118 (265)
T cd06605 41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE 118 (265)
T ss_pred HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC
Confidence 456789999999999999999999999999999999999999999999985422 578899999999999999999998
Q ss_pred -CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 -YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 -~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
.+ ++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++||||||+++|+
T Consensus 119 ~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~ 191 (265)
T cd06605 119 KHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191 (265)
T ss_pred CCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence 77 9999999999999999999999999987553221 112567889999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHH-HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYP-MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..|+.................... . ....... .+..+.++|..||..||++|||+.+++.
T Consensus 192 l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 192 LATGRFPYPPENDPPDGIFELLQYIVNE-P---------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHhCCCCCCccccccccHHHHHHHHhcC-C---------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 9999999865432211111111100000 0 0011111 4567899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=263.32 Aligned_cols=221 Identities=28% Similarity=0.370 Sum_probs=169.0
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCC------------------------
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTK------------------------ 61 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------------------------ 61 (289)
..+.+.+|+.+|.++ +||||+++++++.. +...++||||+++|+|.+++.....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (343)
T cd05103 53 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132 (343)
T ss_pred HHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence 456788999999999 78999999998865 4568899999999999988753210
Q ss_pred ----------------------------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCc
Q 038647 62 ----------------------------------------TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASN 101 (289)
Q Consensus 62 ----------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~N 101 (289)
...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~N 209 (343)
T cd05103 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARN 209 (343)
T ss_pred hhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCe
Confidence 124677888999999999999999988 9999999999
Q ss_pred eEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcc
Q 038647 102 ILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDS 180 (289)
Q Consensus 102 ill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~ 180 (289)
|+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |..|+.......
T Consensus 210 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 289 (343)
T cd05103 210 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289 (343)
T ss_pred EEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH
Confidence 9999999999999999886533222122223345678999999998899999999999999999997 888875433221
Q ss_pred hhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
. ... ....... ...+...+..+.+++..||+.||++|||+.+|++.|+...
T Consensus 290 ~-~~~----~~~~~~~---------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 290 E-FCR----RLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred H-HHH----HHhccCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 100 0111100 0001112357889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=252.76 Aligned_cols=215 Identities=27% Similarity=0.379 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+.+|+.+++.++|||++++++++..++..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~ 128 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG 128 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 46788999999999999999999999999999999999999999999843 357889999999999999999999887
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC--CCCcccchhHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVLET 166 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~vl~el 166 (289)
++||||+|+||+++.++.++|+|||+++...............++..|+|||.+.... ++.++|+||||++++++
T Consensus 129 ---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 129 ---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred ---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHH
Confidence 9999999999999999999999999987654322122223345788999999988654 89999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..|+....... ............ .........++..+.+++.+||..+|++|||+.++++
T Consensus 206 ~~g~~p~~~~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 206 FAGRRPWSDEEAIA-----AMFKLGNKRSAP-----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HhCCCCCcCcchHH-----HHHHhhccccCC-----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 99999875322111 001111110000 0111112234578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=284.96 Aligned_cols=220 Identities=25% Similarity=0.344 Sum_probs=168.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
....+.|..|+.+|++++|||||+++++|.+ .+.+|+||||+++|+|.+++.... ..+.+++..++.|+.||+.||.
T Consensus 53 e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALa 132 (1021)
T PTZ00266 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132 (1021)
T ss_pred HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998854 457899999999999999885422 2357999999999999999999
Q ss_pred HHhcCCC----CceEeeccccCceEeCC-----------------CCceEEcccccccccCCCCcccccccccccccccC
Q 038647 83 YLHHYSR----LRVIHRDLKASNILLDS-----------------NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMS 141 (289)
Q Consensus 83 ~lH~~~~----~~ivH~dikp~Nill~~-----------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 141 (289)
|||..+. .+|+||||||+|||++. .+.+||+|||++....... ......||+.|+|
T Consensus 133 YLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmA 209 (1021)
T PTZ00266 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWS 209 (1021)
T ss_pred HHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccC
Confidence 9997431 23999999999999964 2348999999998654322 1234568999999
Q ss_pred hhhhhc--CCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHH
Q 038647 142 PEYALR--GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINV 219 (289)
Q Consensus 142 PE~~~~--~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 219 (289)
||++.+ ..++.++|||||||++|+|++|..||....... .+.. ...... .......+..+.+|
T Consensus 210 PEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~-qli~----~lk~~p----------~lpi~~~S~eL~dL 274 (1021)
T PTZ00266 210 PELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS-QLIS----ELKRGP----------DLPIKGKSKELNIL 274 (1021)
T ss_pred HHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-HHHH----HHhcCC----------CCCcCCCCHHHHHH
Confidence 999964 458999999999999999999999986433211 1111 111000 00011234678999
Q ss_pred HHcccccCCCCCCCHHHHHH--Hhhc
Q 038647 220 ALLCVQENAADRPTMLEVIS--MLTN 243 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~--~L~~ 243 (289)
|..||+.+|.+||++.+++. ++..
T Consensus 275 I~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 275 IKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHhcCChhHCcCHHHHhccHHHhh
Confidence 99999999999999999984 5543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.05 Aligned_cols=212 Identities=25% Similarity=0.344 Sum_probs=166.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+..+.+.+|+.++++++||||+++++++.+. ..+++||||+++++|.+++. ..+.+++..+..++.|++.||.||
T Consensus 46 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~l 122 (265)
T cd06652 46 KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYL 122 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999998763 56889999999999999884 334578888999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
|+++ ++|+||+|+||+++.++.++|+|||+++....... ........++..|+|||++.+..++.++||||||+++
T Consensus 123 H~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 199 (265)
T cd06652 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199 (265)
T ss_pred HhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHH
Confidence 9988 99999999999999999999999999876532211 1112334588899999999988899999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||........ .. ... ........+......+.+++.+|+. +|++||+++++++
T Consensus 200 ~el~~g~~p~~~~~~~~~-~~----~~~---------~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 200 VEMLTEKPPWAEFEAMAA-IF----KIA---------TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHhhCCCCCCccchHHH-HH----HHh---------cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 999999999754321110 00 000 0001112233455678899999984 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=282.21 Aligned_cols=221 Identities=22% Similarity=0.270 Sum_probs=170.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--------CCCCChHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--------TGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~ 79 (289)
..++|.+|++++++++||||+++++++.+++..|+||||++||+|.+++..... ....++..+..++.||+.
T Consensus 45 ~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~ 124 (932)
T PRK13184 45 LKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124 (932)
T ss_pred HHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHH
Confidence 456899999999999999999999999999999999999999999998853211 123456678899999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc----------------ccccccccccccccChh
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL----------------QSNTKRIVGTYGYMSPE 143 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~----------------~~~~~~~~g~~~y~aPE 143 (289)
||.|||+++ |+||||||+||+++.++.++|+|||+++....... ........||+.|+|||
T Consensus 125 AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE 201 (932)
T PRK13184 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201 (932)
T ss_pred HHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence 999999988 99999999999999999999999999986521100 00112346899999999
Q ss_pred hhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 144 YALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 144 ~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
++.+..++.++|||||||++|+|+||..||........... . ..............+..+.+++.+|
T Consensus 202 ~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~----~---------~i~~P~~~~p~~~iP~~L~~LI~rc 268 (932)
T PRK13184 202 RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR----D---------VILSPIEVAPYREIPPFLSQIAMKA 268 (932)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh----h---------hccChhhccccccCCHHHHHHHHHH
Confidence 99999999999999999999999999999865322111000 0 0000000001123456788999999
Q ss_pred cccCCCCCC-CHHHHHHHhhcc
Q 038647 224 VQENAADRP-TMLEVISMLTNE 244 (289)
Q Consensus 224 l~~~p~~Rp-s~~~ll~~L~~~ 244 (289)
|+.||++|| +++++++.|+..
T Consensus 269 L~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 269 LAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 999999996 677777777654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=274.75 Aligned_cols=227 Identities=19% Similarity=0.249 Sum_probs=162.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--CCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--TGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..++|++|+.+|++++||||+++++++.+.+..|+|++++. ++|..++..... ........+..++.||+.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999995 466666543211 222345667889999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||++||
T Consensus 285 ~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 360 (501)
T PHA03210 285 DKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360 (501)
T ss_pred hCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence 988 999999999999999999999999999876433221 1233578999999999999999999999999999999
Q ss_pred HHhCCCCcCC-CCCcchhHhHhHhhhhc--cCC-------ccccccccccCC---C------CHHHHHHHHHHHHccccc
Q 038647 166 TLSSKKNAHF-YNTDSLTLLGHAWNLWN--DGR-------AWELMDSILQND---A------SYPMLNRYINVALLCVQE 226 (289)
Q Consensus 166 lltg~~p~~~-~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~---~------~~~~~~~l~~li~~~l~~ 226 (289)
|++|..++.. ................. ... ....+....... . ....+..+.+++.+||+.
T Consensus 361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 9998754332 22221111111000000 000 000000000000 0 001234677889999999
Q ss_pred CCCCCCCHHHHHH
Q 038647 227 NAADRPTMLEVIS 239 (289)
Q Consensus 227 ~p~~Rps~~~ll~ 239 (289)
||.+|||+.|+++
T Consensus 441 DP~~Rpsa~elL~ 453 (501)
T PHA03210 441 DWHLRPGAAELLA 453 (501)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999986
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=259.29 Aligned_cols=214 Identities=22% Similarity=0.244 Sum_probs=170.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++++.++||||+++++.+.+++..|+||||+.+++|.+++.. .....+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 122 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLL 122 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHC
Confidence 567899999999999999999999999999999999999999999998853 2335689999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc---------------------------ccccccccccccc
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ---------------------------SNTKRIVGTYGYM 140 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~---------------------------~~~~~~~g~~~y~ 140 (289)
+ ++|+||||+||+++.++.++|+|||++......... .......|+..|+
T Consensus 123 ~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~ 199 (316)
T cd05574 123 G---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199 (316)
T ss_pred C---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCc
Confidence 8 999999999999999999999999998754322100 0112346788999
Q ss_pred ChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHH
Q 038647 141 SPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVA 220 (289)
Q Consensus 141 aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 220 (289)
|||++.+..++.++||||||+++|+|++|..||...+..... .... .....-......+..+.+++
T Consensus 200 aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-----~~~~---------~~~~~~~~~~~~~~~~~~li 265 (316)
T cd05574 200 APEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF-----SNIL---------KKEVTFPGSPPVSSSARDLI 265 (316)
T ss_pred CHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH-----HHHh---------cCCccCCCccccCHHHHHHH
Confidence 999999888999999999999999999999998654332110 0001 00000111112567899999
Q ss_pred HcccccCCCCCCC----HHHHHH
Q 038647 221 LLCVQENAADRPT----MLEVIS 239 (289)
Q Consensus 221 ~~~l~~~p~~Rps----~~~ll~ 239 (289)
.+||+.||++||| ++++++
T Consensus 266 ~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 266 RKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHccCCHhHCCCchhhHHHHHc
Confidence 9999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=254.44 Aligned_cols=211 Identities=27% Similarity=0.411 Sum_probs=167.5
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
...+|+.++++++||||+++++++.++...++||||+.+++|.+++. ..+.+++..+..++.|++.||.+||+.+
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~-- 118 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG-- 118 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhhhhcccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccc--
Confidence 34569999999999999999999999999999999999999999984 4567899999999999999999999988
Q ss_pred ceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-cCCCCCcccchhHHHHHHHHHhC
Q 038647 91 RVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~vl~elltg 169 (289)
++|+||||+||+++.++.++|+|||.+..... .........++..|+|||++. +..++.++||||||+++++|++|
T Consensus 119 -i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 119 -IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp -EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHS
T ss_pred -cccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999976411 122334456889999999998 78899999999999999999999
Q ss_pred CCCcCCCCCcch-hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 170 KKNAHFYNTDSL-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 170 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
..|+........ ......... .... ...........+.+++..||+.||++|||+.++++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 196 KLPFEESNSDDQLEIIEKILKR-------PLPS---SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SSSSTTSSHHHHHHHHHHHHHT-------HHHH---HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccccchhhhhhhhhcccc-------cccc---cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 998875521111 110000000 0000 00000011278999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=269.67 Aligned_cols=210 Identities=30% Similarity=0.394 Sum_probs=172.5
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
++.+-.+++.+|++.|++++|||+|.+.|+|..+...++||||| -|+-.+++. -..+++.+..+..++.+.+.||+|
T Consensus 65 Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaY 141 (948)
T KOG0577|consen 65 QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAY 141 (948)
T ss_pred ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999999999999999999999 557777663 245678899999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG 160 (289)
||+.+ .||||||..|||+++.|.|||+|||.+..... ..+++|||.|||||++. .+.|+-++||||||
T Consensus 142 LHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLG 212 (948)
T KOG0577|consen 142 LHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 212 (948)
T ss_pred HHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeecc
Confidence 99988 99999999999999999999999999976532 45689999999999996 56799999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++.||.-.++|+...+.-.. +-+.. ..-...-.....+..+..++..||+.-|.+|||.++++.
T Consensus 213 ITCIELAERkPPlFnMNAMSA--LYHIA------------QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 213 ITCIELAERKPPLFNMNAMSA--LYHIA------------QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred chhhhhhhcCCCccCchHHHH--HHHHH------------hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 999999999988654332111 11110 000111224567788999999999999999999998875
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.56 Aligned_cols=220 Identities=23% Similarity=0.333 Sum_probs=162.1
Q ss_pred HHHHHHHHHHhhC---CCCCceeeeeeEee-----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 10 EEFKNEMMLIAKL---QHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 10 ~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+.+|+.+++.+ +||||+++++++.. ....++||||+.+ +|..++... ....+++..+..++.|++.||
T Consensus 44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al 121 (288)
T cd07863 44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGL 121 (288)
T ss_pred hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHH
Confidence 4566788877766 69999999999864 3468999999975 788877542 234588999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
.|||+.+ ++||||||+||+++.++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||
T Consensus 122 ~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 195 (288)
T cd07863 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 195 (288)
T ss_pred HHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHH
Confidence 9999988 9999999999999999999999999998654322 122346788999999999889999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhc---cCCccc---ccccccc-------CCCCHHHHHHHHHHHHcccccCC
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWN---DGRAWE---LMDSILQ-------NDASYPMLNRYINVALLCVQENA 228 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p 228 (289)
++|+|++|.+||......... ........ ...... ....... .......+..+.+++.+||+.||
T Consensus 196 ~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 273 (288)
T cd07863 196 IFAEMFRRKPLFCGNSEADQL--GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNP 273 (288)
T ss_pred HHHHHHhCCcCcCCCCHHHHH--HHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCc
Confidence 999999999988654332111 00100000 000000 0000000 00112244678899999999999
Q ss_pred CCCCCHHHHHH
Q 038647 229 ADRPTMLEVIS 239 (289)
Q Consensus 229 ~~Rps~~~ll~ 239 (289)
++|||+.+++.
T Consensus 274 ~~R~t~~~~l~ 284 (288)
T cd07863 274 HKRISAFRALQ 284 (288)
T ss_pred ccCCCHHHHhc
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=259.17 Aligned_cols=218 Identities=20% Similarity=0.276 Sum_probs=169.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++++.++||||+++++.+.++++.++||||+++++|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~ 119 (305)
T cd05609 43 NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHN 119 (305)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346688899999999999999999999999999999999999999999984 34568999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-------------ccccccccccccccChhhhhcCCCCCc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-------------QSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
.+ ++||||||+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.+
T Consensus 120 ~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 196 (305)
T cd05609 120 YG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP 196 (305)
T ss_pred CC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCch
Confidence 87 99999999999999999999999999874211100 001112356788999999988889999
Q ss_pred ccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 154 SDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 154 ~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
+|+||||+++|++++|..||...... ...... . ... ..........+..+.+++.+||+.||++||+
T Consensus 197 ~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~~---~-~~~-------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 263 (305)
T cd05609 197 VDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQV---I-SDD-------IEWPEGDEALPADAQDLISRLLRQNPLERLG 263 (305)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---H-hcc-------cCCCCccccCCHHHHHHHHHHhccChhhccC
Confidence 99999999999999999997643221 111100 0 000 0000111134567899999999999999999
Q ss_pred HHHHHHHhhc
Q 038647 234 MLEVISMLTN 243 (289)
Q Consensus 234 ~~~ll~~L~~ 243 (289)
+.++.+.|+.
T Consensus 264 ~~~~~~ll~~ 273 (305)
T cd05609 264 TGGAFEVKQH 273 (305)
T ss_pred ccCHHHHHhC
Confidence 7666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=265.83 Aligned_cols=220 Identities=23% Similarity=0.233 Sum_probs=163.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+++.+|+.+++.++||||+++++++... ...|+||||+++ +|.+.+. ..+++..+..++.|++.|
T Consensus 58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~a 131 (355)
T cd07874 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCG 131 (355)
T ss_pred HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHH
Confidence 3467888999999999999999999998643 357999999966 5655552 247888899999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+++ |+||||||+|||++.++.+||+|||+++...... ......|+..|+|||++.+..++.++||||||
T Consensus 132 L~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG 205 (355)
T cd07874 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_pred HHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHH
Confidence 99999988 9999999999999999999999999998654321 12335689999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHh-----------------hhh-ccCCc------cccc-ccccc--CCCCHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAW-----------------NLW-NDGRA------WELM-DSILQ--NDASYPML 213 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~-----------------~~~-~~~~~------~~~~-~~~~~--~~~~~~~~ 213 (289)
|++|+|++|..||........ ...... ..+ ..... .... +.... ........
T Consensus 206 ~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (355)
T cd07874 206 CIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284 (355)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccc
Confidence 999999999999865432111 000000 000 00000 0000 00000 00111134
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 214 NRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 214 ~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
..+.+++.+||+.||++|||+.|+++
T Consensus 285 ~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 285 SQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 57789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=251.72 Aligned_cols=213 Identities=24% Similarity=0.380 Sum_probs=171.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.+..+.+.+|+++|++++|||++++++.+..++..++||||+++++|.+++.+. ....+++..+..++.+++.||.||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~l 117 (256)
T cd08220 39 TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHV 117 (256)
T ss_pred ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999998542 234578999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
|+++ ++|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++
T Consensus 118 h~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 191 (256)
T cd08220 118 HTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191 (256)
T ss_pred HhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHH
Confidence 9988 99999999999998654 579999999987643321 2234678899999999988899999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..|+...+.... ... ... .. ........+..+.+++..||+.||++|||+.++++
T Consensus 192 ~~l~~~~~~~~~~~~~~~--~~~---~~~-~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 192 YELASLKRAFEAANLPAL--VLK---IMS-GT---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHhCCCCcccCchHHH--HHH---HHh-cC---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 999999998754432211 100 000 00 00111224568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=250.70 Aligned_cols=219 Identities=26% Similarity=0.414 Sum_probs=174.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|+.++|+||+++++.+..++..++|+|++++++|.+++........+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 67889999999999999999999999999999999999999999999986533335689999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc--ccccccccccccChhhhhcC-CCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS--NTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ 164 (289)
+ ++||||+|+||++++++.++|+|||++.......... ......|+..|+|||++... .++.++|+||||++++
T Consensus 122 ~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~ 198 (267)
T cd06610 122 G---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI 198 (267)
T ss_pred C---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence 8 9999999999999999999999999988765432221 22334688899999999877 7899999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..|+........ ... .... .. ............+..+.+++..||+.||++||++.+|++
T Consensus 199 ~l~~g~~p~~~~~~~~~-~~~----~~~~-~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 199 ELATGAAPYSKYPPMKV-LML----TLQN-DP----PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHhCCCCccccChhhh-HHH----HhcC-CC----CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999764332111 000 0000 00 000000111244578899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.24 Aligned_cols=212 Identities=21% Similarity=0.215 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+.+|+++|+.++|+||+++++++.+++..++||||+++++|..++... ....+++..+..++.|++.||.|||+.+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 122 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN 122 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456788999999999999999999999999999999999999998887542 2346899999999999999999999888
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
|+||||||+||++++++.++|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 123 ---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 196 (285)
T cd05632 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196 (285)
T ss_pred ---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHh
Confidence 9999999999999999999999999987653221 1223468999999999998899999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
|..||.......... .......... .......+..+.+++..||+.||++||+ +.+++.
T Consensus 197 g~~P~~~~~~~~~~~--~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 197 GQSPFRGRKEKVKRE--EVDRRVLETE----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCCCCCCCCHHHHHH--HHHHhhhccc----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 999986543221100 0000000000 0111223457789999999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=257.20 Aligned_cols=212 Identities=25% Similarity=0.350 Sum_probs=170.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||+++++++..++..|+|+||+++++|..++. ...+++..+..++.|++.||.|||+
T Consensus 60 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~ 135 (297)
T cd06659 60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHS 135 (297)
T ss_pred chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345778999999999999999999999999999999999999999998773 2458899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++||||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|
T Consensus 136 ~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 210 (297)
T cd06659 136 QG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210 (297)
T ss_pred CC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 88 99999999999999999999999999875533221 12335688999999999988899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|..||........ ... ...... .........+..+.+++..||+.+|++||++.++++.
T Consensus 211 ~~g~~p~~~~~~~~~--~~~----~~~~~~-------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 211 VDGEPPYFSDSPVQA--MKR----LRDSPP-------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HhCCCCCCCCCHHHH--HHH----HhccCC-------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 999999864332111 100 000000 0000111234578899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=268.07 Aligned_cols=216 Identities=22% Similarity=0.361 Sum_probs=177.2
Q ss_pred CCcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 3 ~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+++..++|.-|++||..+.||+||++++.|...+.++++.|||.||.++.++-. -...+.+.++.-+|+|++.||.
T Consensus 67 tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn 144 (1187)
T KOG0579|consen 67 TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALN 144 (1187)
T ss_pred ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHH
Confidence 34677889999999999999999999999999999999999999999999887743 4567999999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccch
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVF 157 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Diw 157 (289)
|||+++ |+|||||..|||++-+|.++|+|||.+..... ......++.|||.|||||+.. ..+|+.++|||
T Consensus 145 ~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiW 219 (1187)
T KOG0579|consen 145 WLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIW 219 (1187)
T ss_pred HHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHH
Confidence 999888 99999999999999999999999999865322 233456789999999999885 46899999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc-CCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ-NDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||+.|.||..+.+|.+..+.-...+ ..- +.-.. --.+...+..+.+++..||..||+.||++.+
T Consensus 220 SlGITLIEMAqiEPPHhelnpMRVll-----Kia---------KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaq 285 (1187)
T KOG0579|consen 220 SLGITLIEMAQIEPPHHELNPMRVLL-----KIA---------KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQ 285 (1187)
T ss_pred hhhhHHHHHhccCCCccccchHHHHH-----HHh---------hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHH
Confidence 99999999999999865432211111 000 00000 0123346678899999999999999999999
Q ss_pred HHH
Q 038647 237 VIS 239 (289)
Q Consensus 237 ll~ 239 (289)
+++
T Consensus 286 ll~ 288 (1187)
T KOG0579|consen 286 LLK 288 (1187)
T ss_pred Hhh
Confidence 986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=251.36 Aligned_cols=212 Identities=23% Similarity=0.343 Sum_probs=170.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|+.++++++||||+++++++.+++..++|+||+++++|.+++... ....+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08218 41 KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD 119 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34568999999999999999999999999999999999999999999888532 22357889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++++|
T Consensus 120 ~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l 194 (256)
T cd08218 120 RK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194 (256)
T ss_pred CC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHH
Confidence 87 99999999999999999999999999976543221 12234578889999999988899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..|+........ . .... .+.. .......+.++.+++.+||+.+|++||++.+|++
T Consensus 195 ~~g~~~~~~~~~~~~--~---~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 195 CTLKHAFEAGNMKNL--V---LKII-RGSY---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HcCCCCccCCCHHHH--H---HHHh-cCCC---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 999998764322111 0 0000 0000 0112234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=251.87 Aligned_cols=221 Identities=21% Similarity=0.339 Sum_probs=169.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCC---CCCCCCChHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDP---TKTGLLGWEMRVRILEG 76 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~ 76 (289)
....+++.+|+++++.++||||+++++++...+ ..++++||+.+|+|..++... .....+++..+..++.|
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 121 (273)
T cd05074 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121 (273)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence 345678999999999999999999999886532 347889999999998876421 11235788899999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccc
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............+++.|++||.+.+..++.++||
T Consensus 122 i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi 198 (273)
T cd05074 122 IASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV 198 (273)
T ss_pred HHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhh
Confidence 999999999888 99999999999999999999999999986643322222223345678999999998899999999
Q ss_pred hhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 157 FSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 157 wslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
||||+++|+|++ |.+|+...... ....... .... .......+..+.+++.+||+.+|++|||+.
T Consensus 199 ~slG~il~el~~~g~~p~~~~~~~--~~~~~~~----~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~ 263 (273)
T cd05074 199 WAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI----KGNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQ 263 (273)
T ss_pred HHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH----cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999999999 77776543221 1111110 0000 011123446899999999999999999999
Q ss_pred HHHHHhhcc
Q 038647 236 EVISMLTNE 244 (289)
Q Consensus 236 ~ll~~L~~~ 244 (289)
++++.|++.
T Consensus 264 ~~~~~l~~~ 272 (273)
T cd05074 264 HLRDQLELI 272 (273)
T ss_pred HHHHHHHhh
Confidence 999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=264.15 Aligned_cols=220 Identities=21% Similarity=0.227 Sum_probs=163.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+.+.+|+.+++.++||||+++++++... ...|+||||+++ +|...+. ..+++..+..++.|++.
T Consensus 64 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~ 137 (364)
T cd07875 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLC 137 (364)
T ss_pred chhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHH
Confidence 34567888999999999999999999987543 357999999965 5666662 24778889999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+++ |+||||||+||+++.++.+||+|||+++...... ......++..|+|||++.+..++.++|||||
T Consensus 138 aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 211 (364)
T cd07875 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211 (364)
T ss_pred HHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhH
Confidence 999999988 9999999999999999999999999998654321 1233468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhc-------------------cCC-c-----ccccccccc---CCCCHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWN-------------------DGR-A-----WELMDSILQ---NDASYP 211 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~-~-----~~~~~~~~~---~~~~~~ 211 (289)
||++|+|++|+.||...+.... ......... ... . ......... ......
T Consensus 212 G~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (364)
T cd07875 212 GCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 289 (364)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccccccccc
Confidence 9999999999999865432211 000000000 000 0 000000000 000111
Q ss_pred HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 212 MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
....+.+++.+||+.||++|||+.++++
T Consensus 290 ~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 290 KASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred ccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 2357889999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=256.09 Aligned_cols=224 Identities=21% Similarity=0.249 Sum_probs=166.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+.+++.++||||+++++++.+++..++||||++ ++|..++.. ....+++..+..++.|++.||.|||+.
T Consensus 47 ~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~ 123 (301)
T cd07873 47 APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRR 123 (301)
T ss_pred chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567899999999999999999999999999999999997 588887753 234578899999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~el 166 (289)
+ ++|+||||+||+++.++.++|+|||++....... .......+++.|+|||++.+. .++.++||||||+++|+|
T Consensus 124 ~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el 198 (301)
T cd07873 124 K---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 198 (301)
T ss_pred C---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987643221 112233568899999998754 578999999999999999
Q ss_pred HhCCCCcCCCCCcchhHh-H--------hHhhhhccCCcccccc-ccccC----CCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLL-G--------HAWNLWNDGRAWELMD-SILQN----DASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
++|..||........... . ..|..+.......... ..... ......+..+.+++.+||+.||.+||
T Consensus 199 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~ 278 (301)
T cd07873 199 STGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278 (301)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 999999875443211000 0 0000000000000000 00000 01112345788999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
|+.|+++
T Consensus 279 t~~eil~ 285 (301)
T cd07873 279 SAEEAMK 285 (301)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=255.99 Aligned_cols=206 Identities=26% Similarity=0.342 Sum_probs=169.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|++++||||+++++++.+++..|+||||+++++|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~ 119 (290)
T cd05580 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHS 119 (290)
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999999984 34678999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++|+||+|+||+++.++.+||+|||++...... .....+++.|+|||.+.+...+.++||||||+++|+|
T Consensus 120 ~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 191 (290)
T cd05580 120 LD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEM 191 (290)
T ss_pred CC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHH
Confidence 88 999999999999999999999999998876433 2234688899999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
++|..|+....... ... ...... ...+...+..+.+++.+||..||.+|+ +++|+++
T Consensus 192 ~~g~~p~~~~~~~~--~~~----~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 192 LAGYPPFFDDNPIQ--IYE----KILEGK----------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HhCCCCCCCCCHHH--HHH----HHhcCC----------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 99999976543111 000 000000 011122356888999999999999999 6777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=265.48 Aligned_cols=205 Identities=25% Similarity=0.354 Sum_probs=176.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|+.++|||||+++.+......+|+||||+.+|.+.+++. +.+...+..+..++.|++.|++|||++
T Consensus 98 ~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k 174 (596)
T KOG0586|consen 98 KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSK 174 (596)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhc
Confidence 34668999999999999999999999999999999999999999999994 556677788999999999999999999
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~el 166 (289)
+ |||||||++|+|++.+.++||+|||++..+..+ ....+++|++.|+|||++.+..| .+++|+||+|+++|-|
T Consensus 175 ~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 175 N---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred c---eeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 8 999999999999999999999999999887633 34566899999999999998877 7999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCC--CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDA--SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+.|..||.+... .++....+.+.. +..++.++.++++++|-.+|.+|++..++..
T Consensus 249 V~GsLPFDG~~l------------------k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 249 VEGSLPFDGQNL------------------KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eecccccCCccc------------------ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 999999775432 222233333333 2335678999999999999999999999875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=257.78 Aligned_cols=229 Identities=20% Similarity=0.266 Sum_probs=167.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||++++++|..++..++|+||+.+++|.+++.... ...+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~ 119 (328)
T cd08226 41 EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ 119 (328)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346889999999999999999999999999999999999999999999886432 2358889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-----ccccccccccccChhhhhcC--CCCCcccchhH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-----NTKRIVGTYGYMSPEYALRG--LFSIKSDVFSF 159 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~--~~~~~~Diwsl 159 (289)
.+ ++||||||+||+++.++.++++||+.+.......... ......++..|+|||++.+. .++.++|||||
T Consensus 120 ~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (328)
T cd08226 120 NG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196 (328)
T ss_pred CC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence 88 9999999999999999999999998654332111000 01112345679999999763 57899999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc--------------------------CC-----ccccccccccCCC
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND--------------------------GR-----AWELMDSILQNDA 208 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~-----~~~~~~~~~~~~~ 208 (289)
||++|+|++|..||.................+.. .. .............
T Consensus 197 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (328)
T cd08226 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276 (328)
T ss_pred HHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchh
Confidence 9999999999999865432211100000000000 00 0000001111122
Q ss_pred CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 209 SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 209 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
....+..+.+++.+||+.||++|||+.++++
T Consensus 277 ~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 277 SKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2345678899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=261.20 Aligned_cols=154 Identities=23% Similarity=0.356 Sum_probs=133.3
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
....|+.++++++||||+++++++.+++..++|+||+. ++|.+++.. ....+++..+..++.||+.||.|||+++
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 177 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR-- 177 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 34579999999999999999999999999999999995 577777743 3456899999999999999999999988
Q ss_pred ceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCC
Q 038647 91 RVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~ 170 (289)
|+||||||+|||++.++.+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|+|+++.
T Consensus 178 -ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 178 -IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred -eecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcC
Confidence 999999999999999999999999998753221 1123356899999999999999999999999999999999876
Q ss_pred CCc
Q 038647 171 KNA 173 (289)
Q Consensus 171 ~p~ 173 (289)
.++
T Consensus 254 ~~~ 256 (357)
T PHA03209 254 STI 256 (357)
T ss_pred Ccc
Confidence 554
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=255.81 Aligned_cols=222 Identities=22% Similarity=0.273 Sum_probs=167.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++++.++||||+++++++.+++..|+|+||+++++|..+.. ....+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~ 119 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSH 119 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999999999999999999999988763 234589999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~el 166 (289)
+ ++||||+|+||++++++.++|+|||++....... .......++..|+|||.+.+ ..++.++||||||+++++|
T Consensus 120 ~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 194 (286)
T cd07846 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194 (286)
T ss_pred C---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHH
Confidence 7 9999999999999999999999999988654332 11223457889999999875 4578899999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhc-----------cCC------ccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWN-----------DGR------AWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
++|.+|+....... .. ........ ... .................+..+.+++.+||+.+|+
T Consensus 195 ~~g~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 272 (286)
T cd07846 195 LTGEPLFPGDSDID-QL-YHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPD 272 (286)
T ss_pred HcCCCCCCCCchHH-HH-HHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcc
Confidence 99998876433211 00 00000000 000 0000000000000123456789999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+||++.++++
T Consensus 273 ~Rp~~~~il~ 282 (286)
T cd07846 273 DRPSSSQLLH 282 (286)
T ss_pred cchhHHHHhc
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=253.71 Aligned_cols=227 Identities=20% Similarity=0.276 Sum_probs=170.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|++++++++|+||+++++++.+++..++||||++++.+..+.. ....+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH 117 (288)
T cd07833 41 EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCH 117 (288)
T ss_pred ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999887776653 3345889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ 164 (289)
+.+ ++|+||+|+||++++++.++|+|||++......... ......++..|+|||++.+. .++.++||||||+++|
T Consensus 118 ~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~ 193 (288)
T cd07833 118 SHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMA 193 (288)
T ss_pred HCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHH
Confidence 988 999999999999999999999999998876543321 22334678899999999887 8899999999999999
Q ss_pred HHHhCCCCcCCCCCcchhH-hHhHh--------hhhccCCcccc---cccc----ccCCCCHHHHHHHHHHHHcccccCC
Q 038647 165 ETLSSKKNAHFYNTDSLTL-LGHAW--------NLWNDGRAWEL---MDSI----LQNDASYPMLNRYINVALLCVQENA 228 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~---~~~~----~~~~~~~~~~~~l~~li~~~l~~~p 228 (289)
+|++|..|+.......... ..... ..+........ .... .........+..+.+++.+||..+|
T Consensus 194 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (288)
T cd07833 194 ELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDP 273 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCc
Confidence 9999998886543221100 00000 00000000000 0000 0001111235788999999999999
Q ss_pred CCCCCHHHHHH
Q 038647 229 ADRPTMLEVIS 239 (289)
Q Consensus 229 ~~Rps~~~ll~ 239 (289)
++|||++++++
T Consensus 274 ~~Rps~~~il~ 284 (288)
T cd07833 274 KERLTCDELLQ 284 (288)
T ss_pred hhcccHHHHhc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=248.15 Aligned_cols=212 Identities=21% Similarity=0.373 Sum_probs=176.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|+.||+++..|++|++||.+-.+..+++|||||..|++.++++. .++.+.++.+..++.+.+.||.|||.
T Consensus 70 sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~ 147 (502)
T KOG0574|consen 70 TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD 147 (502)
T ss_pred chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH
Confidence 3578899999999999999999999999999999999999999999999864 45679999999999999999999997
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.. -+|||||..|||++.+|..||+|||.+...... -....+..||+.|||||++....|+.++||||||+...||
T Consensus 148 ~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEM 222 (502)
T KOG0574|consen 148 LK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEM 222 (502)
T ss_pred HH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhh
Confidence 65 899999999999999999999999999866432 2334567899999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc--CCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ--NDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
.-|++|+.....-.. .| .+..... -..+...+.++-+++++||-.+|++|-|+.++++.
T Consensus 223 AEG~PPYsDIHPMRA--------IF-------MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 223 AEGRPPYSDIHPMRA--------IF-------MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hcCCCCcccccccce--------eE-------eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 999999753221100 00 0000011 11233467788999999999999999999998873
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=252.80 Aligned_cols=211 Identities=24% Similarity=0.336 Sum_probs=169.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.+++.. +.+++..+..++.|++.||.|||+
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~ 133 (285)
T cd06648 58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA 133 (285)
T ss_pred hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999999999999999999998843 468889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..++.++||||||+++|+|
T Consensus 134 ~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~el 208 (285)
T cd06648 134 QG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208 (285)
T ss_pred CC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHH
Confidence 88 99999999999999999999999998875533221 12334688899999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..|+...+... .... ...... ... ......+..+.+++.+||+.+|++||++.++++
T Consensus 209 l~g~~p~~~~~~~~--~~~~----~~~~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 209 VDGEPPYFNEPPLQ--AMKR----IRDNLP-----PKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HhCCCCCcCCCHHH--HHHH----HHhcCC-----CCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 99999875432211 1100 000000 000 011124468899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=263.20 Aligned_cols=217 Identities=22% Similarity=0.267 Sum_probs=162.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+.+.+|+++|++++||||+++++++... ...|++++++ +++|.+++. .+.+++..+..++.||+.||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL 131 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGL 131 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHH
Confidence 456788999999999999999999988643 3578999988 778988773 34689999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 160 (289)
.|||+++ |+||||||+||+++.++.+||+|||+++..... .....|++.|+|||++.+ ..++.++||||||
T Consensus 132 ~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 203 (343)
T cd07878 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 203 (343)
T ss_pred HHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHH
Confidence 9999988 999999999999999999999999999865432 233468999999999977 5689999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc-----------CCccccccccccCCC------CHHHHHHHHHHHHcc
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND-----------GRAWELMDSILQNDA------SYPMLNRYINVALLC 223 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~ 223 (289)
|++|+|++|..||........ .......... ............... .......+.+++.+|
T Consensus 204 ~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 281 (343)
T cd07878 204 CIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence 999999999999865432211 0000000000 000000000000000 001124578999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|+.||++|||+.++++
T Consensus 282 L~~dp~~R~s~~ell~ 297 (343)
T cd07878 282 LVLDSDKRISASEALA 297 (343)
T ss_pred cCCChhhCCCHHHHhc
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=253.27 Aligned_cols=212 Identities=24% Similarity=0.361 Sum_probs=165.4
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEee------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIE------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...++..|+.+++++ +|+||+++++++.. ++..|+||||+++|+|.+++... ....+++..+..++.|++.|
T Consensus 55 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~a 133 (282)
T cd06636 55 EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRG 133 (282)
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHH
Confidence 456788999999999 79999999999853 46789999999999999988542 23457888899999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCccc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSD 155 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~D 155 (289)
|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||.+. +..++.++|
T Consensus 134 l~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~D 208 (282)
T cd06636 134 LAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSD 208 (282)
T ss_pred HHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccc
Confidence 99999988 9999999999999999999999999987553211 1223356888999999986 346788999
Q ss_pred chhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 156 VFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
+|||||++|+|++|..||.......... ...............+..+.+++.+||+.||.+||++.
T Consensus 209 vwslG~~l~el~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 274 (282)
T cd06636 209 IWSLGITAIEMAEGAPPLCDMHPMRALF--------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTE 274 (282)
T ss_pred hhHHHHHHHHHHhCCCCccccCHHhhhh--------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHH
Confidence 9999999999999999875432211100 00001111111123456899999999999999999999
Q ss_pred HHHH
Q 038647 236 EVIS 239 (289)
Q Consensus 236 ~ll~ 239 (289)
||++
T Consensus 275 ell~ 278 (282)
T cd06636 275 QLLK 278 (282)
T ss_pred HHhc
Confidence 9975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=250.00 Aligned_cols=222 Identities=24% Similarity=0.345 Sum_probs=169.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+..+++.+|++++++++||||+++++++.+. +.+|+||||+++++|.+++... .....+++..+..++.|++.||.|
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999998653 4789999999999998876431 234568889999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
||+.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++
T Consensus 121 lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 193 (287)
T cd06621 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTL 193 (287)
T ss_pred HHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 99988 9999999999999999999999999987543221 1234567889999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..|+.............. ........... .... ......+..+.+++.+||+.+|++|||+.|+++
T Consensus 194 ~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 194 LEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPEL-KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchhh-ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 999999999876533111111100 00111011000 0000 111224568899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=263.10 Aligned_cols=217 Identities=23% Similarity=0.343 Sum_probs=180.9
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
..+..+.|..|..+|++++|||||+++|+|.+. ..++|||.++.|.|..++..++ ..++......+++||+.||.||
T Consensus 431 t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYL 507 (974)
T KOG4257|consen 431 TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYL 507 (974)
T ss_pred ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHH
Confidence 455688999999999999999999999999876 7899999999999999997533 4588889999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|++. +|||||..+|||+....-|||+|||+++.+....+.... ...-+..|||||.++-..++.++|||-|||.+|
T Consensus 508 eSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmW 583 (974)
T KOG4257|consen 508 ESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMW 583 (974)
T ss_pred Hhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHH
Confidence 9887 999999999999999999999999999998766544333 233467899999999999999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
|++. |..||..-.+.+ ....++...+-..++..+..+..++.+||+.+|.+||.+.++...|..
T Consensus 584 EIl~lGvkPfqgvkNsD---------------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 584 EILSLGVKPFQGVKNSD---------------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred HHHHhcCCccccccccc---------------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 9976 888876543322 112223333334455677888899999999999999999999887764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=289.85 Aligned_cols=214 Identities=24% Similarity=0.341 Sum_probs=175.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+...+|.++|..++|||+|+++|+-.+.+..+|.||||++|+|.+.+ ..++..++.....+..|++.|+.|||+
T Consensus 1276 k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~ 1352 (1509)
T KOG4645|consen 1276 KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHE 1352 (1509)
T ss_pred ccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHh
Confidence 45667789999999999999999999999999999999999999999999 455567777778899999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCC--cccccccccccccccChhhhhcC---CCCCcccchhHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--LQSNTKRIVGTYGYMSPEYALRG---LFSIKSDVFSFGV 161 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~ 161 (289)
+| ||||||||.|||++.+|.+|++|||.|....+.. .........||+.|||||++.+. ....++|||||||
T Consensus 1353 ~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1353 HG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred cC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence 99 9999999999999999999999999999876542 22334566899999999999864 3568899999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
|+.||+||+.|+...+.+..-.. ....++. ...+...+.+-.+++..||..||.+|.++.|+++.
T Consensus 1430 VVlEM~tGkrPW~~~dne~aIMy-----~V~~gh~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1430 VVLEMATGKRPWAELDNEWAIMY-----HVAAGHK---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred eEEEeecCCCchhhccchhHHHh-----HHhccCC---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999876555422111 1111111 12223366778899999999999999888888764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=256.06 Aligned_cols=215 Identities=18% Similarity=0.204 Sum_probs=165.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++..++|+||+++++++.+++..|+||||+++|+|.+++... ...+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 44 ETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3556888999999999999999999999999999999999999999998532 34688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----CCCCCcccchhHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~v 162 (289)
+ |+||||||+|||++.++.+||+|||+++........ ......|++.|+|||++.+ ..++.++||||||++
T Consensus 122 ~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvi 197 (331)
T cd05624 122 H---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 197 (331)
T ss_pred C---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehh
Confidence 8 999999999999999999999999999866433211 1223568999999999975 467899999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC--CCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD--RPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~ 239 (289)
+|+|++|+.||........ . ........... ........+..+.+++.+|+..++++ |++++++++
T Consensus 198 l~ell~g~~Pf~~~~~~~~--~---~~i~~~~~~~~------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 198 MYEMLYGETPFYAESLVET--Y---GKIMNHEERFQ------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred hhhhhhCCCCccCCCHHHH--H---HHHHcCCCccc------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 9999999999864332111 0 01111100000 00111124568889999998865544 468888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=249.73 Aligned_cols=214 Identities=26% Similarity=0.374 Sum_probs=166.6
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~ 79 (289)
..++|.+|+.+++++ +|+||+++++++.+.. ..++||||+++++|.+++.... ....+++..+..++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 457899999999999 7999999999997644 4899999999999998875422 2457899999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----CCCCCcc
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKS 154 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~ 154 (289)
||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.. ..++.++
T Consensus 125 al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 199 (275)
T cd06608 125 GLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARS 199 (275)
T ss_pred HHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccc
Confidence 999999888 9999999999999999999999999987654322 12233468889999999853 3468899
Q ss_pred cchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
||||||+++|++++|..||........ .. ... .... ..-......+..+.+++.+||..||++|||+
T Consensus 200 Dv~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~-~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~ 266 (275)
T cd06608 200 DVWSLGITAIELADGKPPLCDMHPMRA-LF----KIP-RNPP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFM 266 (275)
T ss_pred cHHHhHHHHHHHHhCCCCccccchHHH-HH----Hhh-ccCC-------CCCCchhhcCHHHHHHHHHHhhcChhhCcCH
Confidence 999999999999999999864321111 00 000 0000 0001112245688999999999999999999
Q ss_pred HHHHH
Q 038647 235 LEVIS 239 (289)
Q Consensus 235 ~~ll~ 239 (289)
.++++
T Consensus 267 ~~ll~ 271 (275)
T cd06608 267 EELLE 271 (275)
T ss_pred HHHhc
Confidence 99976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=250.28 Aligned_cols=210 Identities=24% Similarity=0.251 Sum_probs=171.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++.+.++...++|+||+.+++|.+++.. ...+++..+..++.|+++||.|||+
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~ 118 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS 118 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 4578999999999999999999999999999999999999999999999843 3578899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||+|+||++++++.++|+|||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|
T Consensus 119 ~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l 192 (258)
T cd05578 119 KG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYEC 192 (258)
T ss_pred CC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHH
Confidence 88 9999999999999999999999999988764332 12334578899999999988899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH--HHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM--LEVI 238 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~ll 238 (289)
++|..|+.......... ....... .....+...+..+.+++.+||+.||.+||++ .|++
T Consensus 193 ~~g~~p~~~~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 193 LRGKRPYRGHSRTIRDQ---IRAKQET----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HhCCCCCCCCCccHHHH---HHHHhcc----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 99999987554321111 0010000 1112222345789999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=249.15 Aligned_cols=213 Identities=21% Similarity=0.261 Sum_probs=168.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|++++||||+++++++...+..|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+.
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~ 114 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR 114 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45667889999999999999999999999999999999999999999885432 23688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 115 ~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~ 188 (277)
T cd05577 115 R---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188 (277)
T ss_pred C---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHh
Confidence 8 9999999999999999999999999987654321 122345778999999998888999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
+|+.||.......... ...... .. .........+..+.+++.+||+.||++|| ++.++++
T Consensus 189 ~g~~p~~~~~~~~~~~--~~~~~~--------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 189 AGRSPFRQRKEKVEKE--ELKRRT--------LE--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred hCCCCCCCCcccccHH--HHHhcc--------cc--ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 9999986544321100 000000 00 01111223456889999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=249.10 Aligned_cols=216 Identities=27% Similarity=0.399 Sum_probs=172.6
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l 81 (289)
+....+++.+|+++++.++||||+++++++.. +...+++|||+++++|.+++... .....+++..++.++.|++.||
T Consensus 39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l 118 (265)
T cd08217 39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118 (265)
T ss_pred CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999998754 45689999999999999888542 2245789999999999999999
Q ss_pred HHHh-----cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccc
Q 038647 82 LYLH-----HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 82 ~~lH-----~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
.||| +.+ ++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+
T Consensus 119 ~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv 193 (265)
T cd08217 119 YECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDI 193 (265)
T ss_pred HHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHH
Confidence 9999 666 999999999999999999999999999876543321 223468899999999998889999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
||||+++++|++|..|+...... .... ...... ........+..+.+++.+||+.+|++||++.+
T Consensus 194 ~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~~~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 194 WSLGCLIYELCALSPPFTARNQL--QLAS----KIKEGK---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred HHHHHHHHHHHHCCCcccCcCHH--HHHH----HHhcCC---------CCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 99999999999999998754311 1111 111111 11122234578899999999999999999999
Q ss_pred HHHH
Q 038647 237 VISM 240 (289)
Q Consensus 237 ll~~ 240 (289)
|++.
T Consensus 259 il~~ 262 (265)
T cd08217 259 LLQL 262 (265)
T ss_pred HhhC
Confidence 9863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=253.96 Aligned_cols=224 Identities=20% Similarity=0.259 Sum_probs=166.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++++.+++..++||||+. ++|..++... ....+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~ 118 (284)
T cd07860 41 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS 118 (284)
T ss_pred ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345689999999999999999999999999999999999996 5788877542 34568899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC-CCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~vl~e 165 (289)
.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.. ++.++||||||+++|+
T Consensus 119 ~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~ 193 (284)
T cd07860 119 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 193 (284)
T ss_pred CC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHH
Confidence 88 9999999999999999999999999987653321 1122234678899999887644 6889999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCC---------cc---ccccccccC---CCCHHHHHHHHHHHHcccccCCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGR---------AW---ELMDSILQN---DASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
|+||..||.......... .. ........ .. ......... .........+.+++.+||+.||++
T Consensus 194 l~tg~~p~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 271 (284)
T cd07860 194 MVTRRALFPGDSEIDQLF-RI-FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNK 271 (284)
T ss_pred HHHCCCCCCCCCHHHHHH-HH-HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCccc
Confidence 999999886543221111 00 00000000 00 000000000 001123457789999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||++++++
T Consensus 272 Rpt~~~~l~ 280 (284)
T cd07860 272 RISAKAALA 280 (284)
T ss_pred CCCHHHHhc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=247.63 Aligned_cols=215 Identities=25% Similarity=0.397 Sum_probs=170.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|+||+++++++.+.+..++|+||+++++|.+++. ....+++..+..++.+++.||.|||+
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 117 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHS 117 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999999999999999999999999999984 33457889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccc--cccccccccccChhhhhcCC---CCCcccchhHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN--TKRIVGTYGYMSPEYALRGL---FSIKSDVFSFGV 161 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~ 161 (289)
.+ ++|+||+|+||+++.++.+||+|||++........... .....++..|+|||.+.+.. ++.++||||||+
T Consensus 118 ~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194 (264)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence 88 99999999999999999999999999887643322111 22346788999999998766 899999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++++++|..||............ .. ..... .-......+..+.+++.+||+.+|++||++.+++.
T Consensus 195 il~~l~~g~~pf~~~~~~~~~~~~----~~-~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 195 VVLEMATGKRPWSELDNEFQIMFH----VG-AGHKP-------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHhCCCCccCCcchHHHHHH----Hh-cCCCC-------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 999999999998644322111100 00 00000 00011122567789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=248.70 Aligned_cols=212 Identities=27% Similarity=0.403 Sum_probs=173.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++|+||+++++++..++..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~ 117 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHT 117 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 3568899999999999999999999999999999999999999999999843 3678999999999999999999998
Q ss_pred -CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 -YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 -~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
.+ ++||||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 118 ~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 192 (264)
T cd06623 118 KRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLE 192 (264)
T ss_pred cCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHH
Confidence 87 999999999999999999999999998876443222 123457889999999998889999999999999999
Q ss_pred HHhCCCCcCCCCC-cchhHhHhHhhhhccCCccccccccccCCCCHH-HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNT-DSLTLLGHAWNLWNDGRAWELMDSILQNDASYP-MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..|+..... ......... . .. .. ...... .+..+.+++..||..+|++||++.++++
T Consensus 193 l~tg~~p~~~~~~~~~~~~~~~~---~-~~--------~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 193 CALGKFPFLPPGQPSFFELMQAI---C-DG--------PP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHhCCCCCccccccCHHHHHHHH---h-cC--------CC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 9999999865542 111111111 0 00 00 111122 4578999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=249.97 Aligned_cols=210 Identities=22% Similarity=0.367 Sum_probs=170.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.|.+|+.++++++||||+++++++.++...++||||+++++|..++. ...+++..+..++.+++.|+.+||+
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (277)
T cd06641 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS 119 (277)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc
Confidence 345789999999999999999999999999999999999999999998883 2468899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus 120 ~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l 194 (277)
T cd06641 120 EK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194 (277)
T ss_pred CC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 88 99999999999999999999999999876543221 12234678899999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|..|+......... .. ..... ........+..+.+++.+||+.+|++||++.++++.
T Consensus 195 ~~g~~p~~~~~~~~~~-----~~-~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 195 AKGEPPHSELHPMKVL-----FL-IPKNN---------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HcCCCCCCccchHHHH-----HH-HhcCC---------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999987543221100 00 00000 011122345678899999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=247.97 Aligned_cols=211 Identities=23% Similarity=0.402 Sum_probs=168.9
Q ss_pred ccCHHHHHHHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
....+++.+|+.++++++ |||++++++++.++...++||||+++++|.+++.. +.+++..+..++.|++.||.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~ 115 (277)
T cd06917 40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALK 115 (277)
T ss_pred chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHH
Confidence 445678999999999997 99999999999999999999999999999998842 36889999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGV 161 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~ 161 (289)
|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+ ..++.++|+||||+
T Consensus 116 ~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 190 (277)
T cd06917 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190 (277)
T ss_pred HHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHH
Confidence 999888 99999999999999999999999999987654331 1233468889999999875 45789999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..|+.......... ....... .... ....+.++.+++..||+.||++||++.+++.
T Consensus 191 ~l~~ll~g~~p~~~~~~~~~~~------~~~~~~~-----~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 191 TIYEMATGNPPYSDVDAFRAMM------LIPKSKP-----PRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHhCCCCCCCCChhhhhh------ccccCCC-----CCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 9999999999986432211000 0000000 0000 0114468889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=244.31 Aligned_cols=214 Identities=26% Similarity=0.398 Sum_probs=174.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
...+.+.+|+.++++++||||+++++.+.+. +..++|+||+++++|.+++.. ...+++..+..++.+++.||.||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~l 117 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYL 117 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999988 899999999999999999853 33789999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+.+ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+...+.++||||||++++
T Consensus 118 h~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~ 194 (260)
T cd06606 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVI 194 (260)
T ss_pred HHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHH
Confidence 9987 9999999999999999999999999998765543211123346788999999999888999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..|+........ ..+.... .......+...+..+.+++.+|++.||++||++.++++
T Consensus 195 ~l~~g~~p~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 195 EMATGKPPWSELGNPMA----ALYKIGS---------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHhCCCCCCCCCchHH----HHHhccc---------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 99999999876541111 1111100 00111122233578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=287.59 Aligned_cols=220 Identities=25% Similarity=0.411 Sum_probs=172.5
Q ss_pred HHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCce
Q 038647 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRV 92 (289)
Q Consensus 13 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 92 (289)
..|++++++++|||||++++++.+++..|+||||+++|+|.+++. .+++..+.+++.|++.||+|||.....+|
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 804 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAV 804 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 457999999999999999999999999999999999999999983 37899999999999999999995534459
Q ss_pred EeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCC
Q 038647 93 IHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKN 172 (289)
Q Consensus 93 vH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p 172 (289)
+||||||+||+++.++..++. |+....... .....++..|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred ecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 999999999999998887765 555433211 1123578899999999999999999999999999999999999
Q ss_pred cCCCCCcchhHhHhHhhhhccCCccccccccccC--CCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 173 AHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQN--DASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
+............+..............+..... ........++.+++.+||+.||++|||++|+++.|++..
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 8543333333333333333333333334443322 223445667889999999999999999999999998764
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=250.60 Aligned_cols=222 Identities=22% Similarity=0.249 Sum_probs=167.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++|+||+++++++.+++..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456788999999999999999999999999999999999 899999985322 3689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~el 166 (289)
+ ++|+||+|+||+++.++.++|+|||+++....... ......++..|+|||.+.+ ..++.++|||||||++++|
T Consensus 122 ~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~ 196 (298)
T cd07841 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196 (298)
T ss_pred C---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 8 99999999999999999999999999987644321 1222346778999999865 4678999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccC---------CccccccccccC-----CCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDG---------RAWELMDSILQN-----DASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
++|.+++....... ............ ............ ......+..+.+++.+||+.||++||
T Consensus 197 ~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 274 (298)
T cd07841 197 LLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI 274 (298)
T ss_pred HcCCccccCCccHH--HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc
Confidence 99977665433211 111111000000 000000000000 01122356888999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
|+.|+++
T Consensus 275 s~~e~l~ 281 (298)
T cd07841 275 TARQALE 281 (298)
T ss_pred CHHHHhh
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=249.78 Aligned_cols=212 Identities=24% Similarity=0.342 Sum_probs=170.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++++.++|+|++++++++..++..|+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~ 135 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ 135 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46788999999999999999999999999999999999999999999995422 3789999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 136 g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~ 210 (286)
T cd06614 136 N---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210 (286)
T ss_pred C---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHH
Confidence 7 99999999999999999999999998875543221 122345778999999999888999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|..|+.......... . ..... ..........+..+.+++.+||+.+|.+||++.+++.
T Consensus 211 ~g~~p~~~~~~~~~~~--~----~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 211 EGEPPYLREPPLRALF--L----ITTKG-------IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCCCCCCCCHHHHHH--H----HHhcC-------CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9999876432221110 0 00000 0000111124568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=253.50 Aligned_cols=208 Identities=29% Similarity=0.390 Sum_probs=164.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+++.+|+++++.++||||+++++++.+++..|+|+||+.+ ++.+++.. ....+++..+..++.|++.||.|||+
T Consensus 57 ~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~ 133 (307)
T cd06607 57 EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHS 133 (307)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999974 66665532 23468999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl 163 (289)
.+ ++||||+|+||+++.++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++
T Consensus 134 ~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 134 HE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred CC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 88 999999999999999999999999998754322 2245788999999884 35688999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
|+|++|..|+......... ..... . ..........+..+.+++.+||+.||++||++.+++..
T Consensus 205 ~el~tg~~p~~~~~~~~~~-----~~~~~-~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 205 IELAERKPPLFNMNAMSAL-----YHIAQ-N--------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHcCCCCCCCccHHHHH-----HHHhc-C--------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 9999999987543221110 00000 0 00011122345688999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=253.68 Aligned_cols=229 Identities=22% Similarity=0.255 Sum_probs=166.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCC-C-CCCCChHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPT-K-TGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~-~-~~~~~~~~~~~~~~~i~~~l~ 82 (289)
...+.+.+|+.+++.++||||+++++++.+. +..++||||+++ +|.+++.... . ...+++..+..++.|++.||.
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 122 (316)
T cd07842 44 GISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122 (316)
T ss_pred CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999988 889999999975 5666553222 2 236889999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCC----CCceEEcccccccccCCCCc-ccccccccccccccChhhhhcC-CCCCcccc
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDS----NMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRG-LFSIKSDV 156 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~----~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di 156 (289)
|||+.+ ++||||||+||+++. ++.+||+|||++........ ........++..|+|||++.+. .++.++||
T Consensus 123 ~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 199 (316)
T cd07842 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDI 199 (316)
T ss_pred HHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHH
Confidence 999888 999999999999999 89999999999886543221 1122334678899999988764 57999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcch-------hHhHhHhhhhcc-----------C-CccccccccccCCCC--------
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSL-------TLLGHAWNLWND-----------G-RAWELMDSILQNDAS-------- 209 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~-----------~-~~~~~~~~~~~~~~~-------- 209 (289)
||||+++++|++|+.||........ ............ . ......+........
T Consensus 200 ~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (316)
T cd07842 200 WAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWM 279 (316)
T ss_pred HHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHH
Confidence 9999999999999999876544320 000000000000 0 000000000000000
Q ss_pred ---HHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 210 ---YPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 210 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.....++.+++.+||+.||++|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 280 EKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 023356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=250.19 Aligned_cols=214 Identities=23% Similarity=0.324 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHhhC-CCCCceeeeeeEe-----ecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCI-----EHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 9 ~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l 81 (289)
.+++.+|+.+++.+ +||||+++++++. .++..++||||+++++|.+++... .....+++..+..++.|++.||
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 46788999999999 6999999999874 445789999999999999887532 2345688899999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----CCCCCcccc
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSIKSDV 156 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di 156 (289)
.|||+.+ ++||||||+||+++.++.++|+|||+++........ .....|+..|+|||++.. ..++.++||
T Consensus 138 ~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 212 (286)
T cd06638 138 QHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDV 212 (286)
T ss_pred HHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhh
Confidence 9999887 999999999999999999999999998866432211 223468899999999853 457899999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||||++|+|++|..|+........ .. . ......... ..+...+..+.+++.+||+.||++|||+.|
T Consensus 213 ~slGvi~~el~~g~~p~~~~~~~~~-~~----~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 279 (286)
T cd06638 213 WSLGITAIELGDGDPPLADLHPMRA-LF----K-IPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSD 279 (286)
T ss_pred hhHHHHHHHHhcCCCCCCCCchhHH-Hh----h-ccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHH
Confidence 9999999999999998764322111 00 0 000000000 001112457889999999999999999999
Q ss_pred HHHH
Q 038647 237 VISM 240 (289)
Q Consensus 237 ll~~ 240 (289)
+++.
T Consensus 280 ll~~ 283 (286)
T cd06638 280 LLQH 283 (286)
T ss_pred Hhhc
Confidence 9874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=247.43 Aligned_cols=212 Identities=25% Similarity=0.377 Sum_probs=170.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|+||+++++.+.+++..++|+||+++++|.+++... ....+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (257)
T cd08225 41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD 119 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999999999999988542 22357899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCc-eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMN-PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~-vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
.+ ++|+||+|+||++++++. ++|+|||.+........ ......|++.|+|||++.+..++.++|+||||+++++
T Consensus 120 ~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~ 194 (257)
T cd08225 120 RK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYE 194 (257)
T ss_pred CC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence 88 999999999999998864 69999999887643321 1223457889999999988889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|..|+........ ...... .. . .......+..+.+++.+||..+|++|||+.++++
T Consensus 195 l~~g~~p~~~~~~~~~-----~~~~~~-~~--------~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 195 LCTLKHPFEGNNLHQL-----VLKICQ-GY--------F-APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhCCCCCCCccHHHH-----HHHHhc-cc--------C-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9999998764332111 111000 00 0 1112234568999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=250.71 Aligned_cols=212 Identities=22% Similarity=0.340 Sum_probs=170.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||+++++++..++..|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||+
T Consensus 58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~ 133 (293)
T cd06647 58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS 133 (293)
T ss_pred hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3467889999999999999999999999999999999999999999998842 357888999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|++
T Consensus 134 ~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~l 208 (293)
T cd06647 134 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208 (293)
T ss_pred CC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHH
Confidence 88 99999999999999999999999998876543321 12334678899999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|..||........... ..... ...-......+..+.+++.+||+.+|++||++.+++..
T Consensus 209 l~g~~pf~~~~~~~~~~~-----~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 209 VEGEPPYLNENPLRALYL-----IATNG--------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HhCCCCCCCCChhhheee-----hhcCC--------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999865432211000 00000 00001122245678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=238.80 Aligned_cols=209 Identities=19% Similarity=0.214 Sum_probs=166.4
Q ss_pred HHHHHHHHHHhhC-CCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 10 ~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+|++.-=.. .|||||.++++++. ...+.+|||+++||.|...+.+. ....+++.++..++.||+.|+.||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHH
Confidence 4556888887666 49999999999874 34578999999999999988653 335699999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|+.+ |.||||||+|+|... |..+||+|||+++.... .....+.+-|+.|.|||++....|+..+|+||+||
T Consensus 178 H~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgV 251 (400)
T KOG0604|consen 178 HSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_pred Hhcc---hhhccCChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhH
Confidence 9887 999999999999964 55689999999987543 23345568899999999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCC------HHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDAS------YPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
++|-|+.|.+||......... . ....++..+.+. ..+++...++|+.+|+.+|.+|.|+.
T Consensus 252 imYIlLCGyPPFYS~hg~ais--p------------gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~ 317 (400)
T KOG0604|consen 252 IMYILLCGYPPFYSNHGLAIS--P------------GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIE 317 (400)
T ss_pred HHHHhhcCCCcccccCCccCC--h------------hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHH
Confidence 999999999998654432110 0 001111111111 23567889999999999999999999
Q ss_pred HHHH
Q 038647 236 EVIS 239 (289)
Q Consensus 236 ~ll~ 239 (289)
++++
T Consensus 318 ~~m~ 321 (400)
T KOG0604|consen 318 EVMD 321 (400)
T ss_pred Hhhc
Confidence 9986
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=250.14 Aligned_cols=216 Identities=24% Similarity=0.354 Sum_probs=171.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++.+.+++..|+|+||+++++|.+++.. .+.+++..+..++.|++.||.|||+
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~ 111 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEIVLALEYLHS 111 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4677899999999999999999999999999999999999999999998843 3468999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc------ccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL------QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.+ ++|+||+|+||+++.++.++|+|||++........ ........++..|+|||...+...+.++|+||||
T Consensus 112 ~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG 188 (265)
T cd05579 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLG 188 (265)
T ss_pred cC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHH
Confidence 88 99999999999999999999999999876533211 1122334578899999999988899999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++++++++|..|+........ ... ..... .........+..+.+++.+||+.+|++|||+..+.+.
T Consensus 189 ~~~~~l~~g~~p~~~~~~~~~--~~~----~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 189 CILYEFLVGIPPFHGETPEEI--FQN----ILNGK--------IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred HHHHHHHhCCCCCCCCCHHHH--HHH----HhcCC--------cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 999999999999764432211 000 00000 0000111135788999999999999999999666555
Q ss_pred hh
Q 038647 241 LT 242 (289)
Q Consensus 241 L~ 242 (289)
|+
T Consensus 255 l~ 256 (265)
T cd05579 255 KN 256 (265)
T ss_pred hc
Confidence 54
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.66 Aligned_cols=162 Identities=23% Similarity=0.314 Sum_probs=140.4
Q ss_pred CHHHHHHHHHHHhhCC-CC-----CceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQ-HR-----NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
-.++-..|+++|..++ |. |+|+++++|...+++|||+|.+ ..+|.++++.++.. .++...++.++.||+.||
T Consensus 225 f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L 302 (586)
T KOG0667|consen 225 FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTAL 302 (586)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHH
Confidence 3556678999999997 43 8999999999999999999999 55999999775544 488999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCC--CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSN--MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~--~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
..||+.+ ||||||||+|||+... ..|||+|||.+...... ..+...+..|.|||++.|.+|+.+.|||||
T Consensus 303 ~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSL 374 (586)
T KOG0667|consen 303 LFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSL 374 (586)
T ss_pred HHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeeh
Confidence 9999888 9999999999999643 36999999999865433 225677889999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCc
Q 038647 160 GVLVLETLSSKKNAHFYNTD 179 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~ 179 (289)
|||+.||++|.+.|++.+..
T Consensus 375 GCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 375 GCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred hhhHHhHhcCccccCCCCHH
Confidence 99999999998877776654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=249.47 Aligned_cols=224 Identities=21% Similarity=0.242 Sum_probs=169.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.++++++||||+++++++.++...++|+||+ +++|.+++... ...+++..+..++.||+.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~ 117 (286)
T cd07832 41 GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA 117 (286)
T ss_pred hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999999 99999988532 2568999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
.+ ++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++||||+|+++++
T Consensus 118 ~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 193 (286)
T cd07832 118 NG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAE 193 (286)
T ss_pred CC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHH
Confidence 88 99999999999999999999999999887644321 112334688899999998754 46899999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCC-----------cccccccccc-----CCCCHHHHHHHHHHHHcccccCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGR-----------AWELMDSILQ-----NDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
|++|.+++...... .............. .......... ..........+.+++.+||+.||+
T Consensus 194 l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 271 (286)
T cd07832 194 LLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPS 271 (286)
T ss_pred HHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChh
Confidence 99997766543321 11111111100000 0000000000 000112347889999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||++++++
T Consensus 272 ~R~~~~~~l~ 281 (286)
T cd07832 272 KRLSAAEALR 281 (286)
T ss_pred hCCCHHHHhh
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=247.87 Aligned_cols=207 Identities=22% Similarity=0.245 Sum_probs=162.1
Q ss_pred HHHHHHHHHHhh---CCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 10 EEFKNEMMLIAK---LQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 10 ~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+.+.+|..+++. .+||||+++++++.+++..++||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 39 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~ 115 (279)
T cd05633 39 TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN 115 (279)
T ss_pred HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 344555544443 479999999999999999999999999999998884 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~e 165 (289)
.+ ++||||||+||++++++.++|+|||++....... .....|+..|+|||.+.+ ..++.++|||||||++|+
T Consensus 116 ~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 188 (279)
T cd05633 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFK 188 (279)
T ss_pred CC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHH
Confidence 88 9999999999999999999999999987553321 123468999999999874 568999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
|++|..||............... . ......+...+.++.+++.+||..||++|| |++++++
T Consensus 189 l~~g~~pf~~~~~~~~~~~~~~~--~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 189 LLRGHSPFRQHKTKDKHEIDRMT--L-----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred HHhCCCCcCCCCCcCHHHHHHHh--h-----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 99999998654332211111100 0 001112233457889999999999999999 5998877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=249.43 Aligned_cols=221 Identities=22% Similarity=0.249 Sum_probs=163.1
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
..+.+|++++++++|+||+++++++.+++..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||+.+
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~- 123 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR- 123 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4577899999999999999999999999999999999975 898887532 236789999999999999999999888
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHHh
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~ellt 168 (289)
++||||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+ ..++.++||||+|+++|+|++
T Consensus 124 --i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 124 --VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred --eecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999875432211 1122346788999999875 458999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCc------------cccccccc------cCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRA------------WELMDSIL------QNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
|..||.......... ...+........ ........ ...........+.+++.+||+.+|++
T Consensus 200 g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 278 (291)
T cd07844 200 GRPLFPGSTDVEDQL-HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKK 278 (291)
T ss_pred CCCCCCCCccHHHHH-HHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccc
Confidence 999986544221111 111110000000 00000000 00000111257789999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||+.++++
T Consensus 279 Rps~~e~l~ 287 (291)
T cd07844 279 RISAAEAMK 287 (291)
T ss_pred ccCHHHHhc
Confidence 999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.49 Aligned_cols=223 Identities=21% Similarity=0.240 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+|+.++++++||||+++++++... +..|+|+||+++ +|.+++... ...+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~ 124 (293)
T cd07843 48 PITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD 124 (293)
T ss_pred hhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999877 899999999974 888877532 2368999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||||+++++
T Consensus 125 ~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHH
Confidence 88 9999999999999999999999999998765432 112234578899999998764 46899999999999999
Q ss_pred HHhCCCCcCCCCCcchhHh--H-------hHhhhhccCC------ccccccccccCCCCHH-HHHHHHHHHHcccccCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLL--G-------HAWNLWNDGR------AWELMDSILQNDASYP-MLNRYINVALLCVQENAA 229 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~--~-------~~~~~~~~~~------~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~ 229 (289)
|++|..||........... . ..|..+.... ................ .+..+.+++.+||+.||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 9999998875443211000 0 0000000000 0000000001111111 356788999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||+.|+++
T Consensus 280 ~R~t~~ell~ 289 (293)
T cd07843 280 KRISAEDALK 289 (293)
T ss_pred ccCCHHHHhc
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=241.70 Aligned_cols=211 Identities=25% Similarity=0.387 Sum_probs=171.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++++.++|+|++++++++..++..++++||+++++|.+++... ...+++..+..++.+++.||.+||..
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~ 117 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSN 117 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcC
Confidence 5678999999999999999999999999999999999999999999988542 25689999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++++|+
T Consensus 118 ~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~ 191 (253)
T cd05122 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191 (253)
T ss_pred C---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHH
Confidence 7 99999999999999999999999999887654321 23456788999999999888999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|..|+...+....... ......... ......+..+.+++..||+.||++|||+.++++
T Consensus 192 ~g~~p~~~~~~~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 192 EGKPPYSELPPMKALFK------IATNGPPGL-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred hCCCCCCCCchHHHHHH------HHhcCCCCc-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99998764432211110 000000000 001112567899999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=250.07 Aligned_cols=225 Identities=21% Similarity=0.249 Sum_probs=167.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++++.++|||++++++++.+++..|+||||++ ++|.+++.... ...+++..+..++.|++.||.|||+
T Consensus 40 ~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~ 117 (283)
T cd07835 40 GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS 117 (283)
T ss_pred cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999995 68988874322 2368999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
++ ++||||+|+||+++.++.++|+|||+++...... .......++..|+|||++.+. .++.++|+||||+++|+
T Consensus 118 ~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~ 192 (283)
T cd07835 118 HR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192 (283)
T ss_pred CC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHH
Confidence 87 9999999999999999999999999997653321 112223467889999988764 57999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccC--------Ccccccccc------ccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDG--------RAWELMDSI------LQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
|++|..||.......... .......... ......... .........+..+.+++.+||+.||++|
T Consensus 193 l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 271 (283)
T cd07835 193 MVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKR 271 (283)
T ss_pred HHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhC
Confidence 999999886543221110 0000000000 000000000 0011112244678899999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
||++++++
T Consensus 272 pt~~~il~ 279 (283)
T cd07835 272 ISAKAALQ 279 (283)
T ss_pred cCHHHHhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=250.34 Aligned_cols=211 Identities=29% Similarity=0.389 Sum_probs=166.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+++.+|+++++.++|||++++++++.+++..++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 67 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~ 143 (317)
T cd06635 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS 143 (317)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456899999999999999999999999999999999999975 67666632 24568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl 163 (289)
.+ ++||||+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.++|||||||++
T Consensus 144 ~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil 214 (317)
T cd06635 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214 (317)
T ss_pred CC---cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHH
Confidence 88 99999999999999999999999998875432 22345788999999984 45689999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
|+|++|..|+.......... . ... ...........+..+.+++.+||+.+|.+||++.++++.+-.
T Consensus 215 ~el~~g~~p~~~~~~~~~~~--~---~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 215 IELAERKPPLFNMNAMSALY--H---IAQ---------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHHhCCCCCCCccHHHHHH--H---HHh---------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 99999999875432111100 0 000 000111122345678999999999999999999999985543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.59 Aligned_cols=200 Identities=21% Similarity=0.210 Sum_probs=166.3
Q ss_pred HHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 11 EFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 11 ~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
+-.+|+.++... +||||+++++.+.++.+.|+|||.+.|+.+.+.+.. .+.+. ..+..|+.+|+.|+.|||++|
T Consensus 361 ~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g- 435 (612)
T KOG0603|consen 361 DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG- 435 (612)
T ss_pred ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC-
Confidence 345678777777 699999999999999999999999999988776632 22233 667789999999999999998
Q ss_pred CceEeeccccCceEe-CCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 90 LRVIHRDLKASNILL-DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 90 ~~ivH~dikp~Nill-~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
+|||||||+|||+ +..++++|+|||.++..... ..+.+-|..|.|||++....|++++|+||||++||+|++
T Consensus 436 --vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~ 508 (612)
T KOG0603|consen 436 --VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT 508 (612)
T ss_pred --eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh
Confidence 9999999999999 68999999999999876543 223456889999999999999999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+.|+...... .++...+..+.....++....+|+.+||+.||.+||++.++..
T Consensus 509 G~tp~~~~P~~-----------------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 509 GRTLFAAHPAG-----------------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CCCccccCCch-----------------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 99998754433 1233334444445667889999999999999999999999875
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=247.02 Aligned_cols=213 Identities=24% Similarity=0.330 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHhhC-CCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 9 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l 81 (289)
...+.+|+.+++++ +|||++++++++... +..++|+||+++++|.+++.... ....+++..++.++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 46788999999999 799999999998754 36899999999999998875322 345688999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-----CCCCcccc
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-----LFSIKSDV 156 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di 156 (289)
.|||+.+ ++||||||+||+++.++.++|+|||++......... .....|+..|+|||.+... .++.++||
T Consensus 142 ~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 216 (291)
T cd06639 142 QHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDV 216 (291)
T ss_pred HHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccch
Confidence 9999887 999999999999999999999999998865432211 2234578899999998643 36899999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||||++|+|++|+.|+........ .. . ......... .........+.+++.+||+.+|++||++.+
T Consensus 217 ~slGvi~~el~~g~~p~~~~~~~~~-~~----~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 217 WSLGITAIELGDGDPPLFDMHPVKT-LF----K-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred HHHHHHHHHHhhCCCCCCCCcHHHH-HH----H-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 9999999999999998764322111 10 0 000000000 011123457899999999999999999999
Q ss_pred HHH
Q 038647 237 VIS 239 (289)
Q Consensus 237 ll~ 239 (289)
+++
T Consensus 284 il~ 286 (291)
T cd06639 284 LLE 286 (291)
T ss_pred Hhc
Confidence 986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=246.61 Aligned_cols=224 Identities=22% Similarity=0.290 Sum_probs=167.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++........+++..+..++.|++.||.|||+.
T Consensus 41 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (284)
T cd07836 41 TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119 (284)
T ss_pred chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 456788999999999999999999999999999999999975 7888775544445689999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~el 166 (289)
+ ++||||+|+||++++++.++|+|||+++....... ......++..|++||.+.+. .++.++||||||+++|+|
T Consensus 120 ~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l 194 (284)
T cd07836 120 R---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEM 194 (284)
T ss_pred C---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 8 99999999999999999999999999876533211 12223567889999998764 578999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccC---------Ccccccccccc------CCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDG---------RAWELMDSILQ------NDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++|..||........ ........... ........... .......+..+.+++..||+.||++|
T Consensus 195 ~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 272 (284)
T cd07836 195 ITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272 (284)
T ss_pred HhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccC
Confidence 999998865443211 00000000000 00000000000 00111234678899999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
|++.++++
T Consensus 273 ~~~~~~l~ 280 (284)
T cd07836 273 ISAHDALQ 280 (284)
T ss_pred CCHHHHhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=243.11 Aligned_cols=213 Identities=25% Similarity=0.357 Sum_probs=167.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+..+.|.+|++++++++|+||+++++++.+. ..+++|+||+++++|.+++. ..+.+++..+..++.|++.||.|
T Consensus 45 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~ 121 (264)
T cd06653 45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSY 121 (264)
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998764 46889999999999999884 33457889999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
||+.+ ++|+||+|+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++|+||||++
T Consensus 122 LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 198 (264)
T cd06653 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198 (264)
T ss_pred HHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHH
Confidence 99888 999999999999999999999999999865321111 11223467889999999998889999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||........ .. ... ........+......+.+++.+||+ +|..||++.+++.
T Consensus 199 l~~l~~g~~p~~~~~~~~~-~~----~~~---------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 199 VVEMLTEKPPWAEYEAMAA-IF----KIA---------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHhCCCCCCccCHHHH-HH----HHH---------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 9999999999754321110 00 000 0001112233455789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=263.84 Aligned_cols=219 Identities=18% Similarity=0.234 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHhhCCCC------CceeeeeeEeec-CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHR------NLVRLFGCCIEH-GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~------niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
.+.+..|+++++.++|. +++++++++..+ .+.|+|||++ +++|.+++. ..+.+++..+..++.||+.||
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL 244 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVAL 244 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHH
Confidence 44567788888887654 588898988764 5789999988 778888774 345789999999999999999
Q ss_pred HHHhc-CCCCceEeeccccCceEeCCCC----------------ceEEcccccccccCCCCcccccccccccccccChhh
Q 038647 82 LYLHH-YSRLRVIHRDLKASNILLDSNM----------------NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144 (289)
Q Consensus 82 ~~lH~-~~~~~ivH~dikp~Nill~~~~----------------~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 144 (289)
.|||. .+ |+||||||+|||++.++ .+||+|||.+..... ......||+.|+|||+
T Consensus 245 ~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~ 316 (467)
T PTZ00284 245 DYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEV 316 (467)
T ss_pred HHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHH
Confidence 99997 47 99999999999998765 499999998754321 2234578999999999
Q ss_pred hhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhH-hHhHhh----hhcc----CCcccccc--------------
Q 038647 145 ALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL-LGHAWN----LWND----GRAWELMD-------------- 201 (289)
Q Consensus 145 ~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~-~~~~~~----~~~~----~~~~~~~~-------------- 201 (289)
+.+..++.++|||||||++|||++|+.||...+...... ...... .|.. .....+..
T Consensus 317 ~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (467)
T PTZ00284 317 VLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHL 396 (467)
T ss_pred hhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHH
Confidence 999999999999999999999999999987644321110 000000 0000 00000000
Q ss_pred -ccccCCC--CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 202 -SILQNDA--SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 202 -~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
....... .......+.+||..||+.||++|||++|+++
T Consensus 397 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 397 ARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000000 0001245779999999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=246.96 Aligned_cols=211 Identities=23% Similarity=0.298 Sum_probs=168.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|+|++++++++..++..++||||+++++|.+++. .+.+++..+..++.|++.||.|||+
T Consensus 59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~ 134 (292)
T cd06657 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA 134 (292)
T ss_pred hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356678999999999999999999999999999999999999999998773 2357889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 135 ~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el 209 (292)
T cd06657 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209 (292)
T ss_pred CC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 88 99999999999999999999999998876543221 12334678899999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..|+........ ........ ..... .....+..+.+++.+||+.||.+||++.++++
T Consensus 210 ~tg~~p~~~~~~~~~--~~~~~~~~---------~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 210 VDGEPPYFNEPPLKA--MKMIRDNL---------PPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HhCCCCCCCCCHHHH--HHHHHhhC---------CcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 999998764322111 11100000 00000 01123457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=252.66 Aligned_cols=219 Identities=21% Similarity=0.229 Sum_probs=164.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+++.+|+.++++++||||+++++++... ...|+||||+.+ +|.+.+.. .++...+..++.|++.|
T Consensus 57 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~a 130 (353)
T cd07850 57 THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCG 130 (353)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHH
Confidence 4456788999999999999999999988643 357999999964 77777632 27888999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+.+ ++||||||+||+++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||
T Consensus 131 L~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 204 (353)
T cd07850 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (353)
T ss_pred HHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHH
Confidence 99999988 99999999999999999999999999987543221 2234578899999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhh------------------hhccC-C------cccccccc----ccCCCCHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWN------------------LWNDG-R------AWELMDSI----LQNDASYP 211 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~------------------~~~~~-~------~~~~~~~~----~~~~~~~~ 211 (289)
|++|+|++|..||...+.... ...... .+... . ........ ........
T Consensus 205 ~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
T cd07850 205 CIMGEMIRGTVLFPGTDHIDQ--WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKL 282 (353)
T ss_pred HHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCccccccccc
Confidence 999999999999865432110 000000 00000 0 00000000 00011112
Q ss_pred HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 212 MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 283 KASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred chhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4567889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=247.59 Aligned_cols=222 Identities=22% Similarity=0.262 Sum_probs=168.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|++++|+||+++++++.+++..++|+||+++ +|.+++... ...+++..+..++.|++.||.|||+.
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~ 117 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH 117 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457888999999999999999999999999999999999975 787777532 25789999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~el 166 (289)
+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|
T Consensus 118 ~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l 192 (283)
T cd05118 118 G---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAEL 192 (283)
T ss_pred C---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987765432 112224577889999999876 789999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccC---Ccccccc-----------ccc--cCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDG---RAWELMD-----------SIL--QNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
++|+.||...+...... ......... ....... ... ........+.++.++|..||+.||.+
T Consensus 193 ~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 270 (283)
T cd05118 193 LSRRPLFPGKSEIDQLF--KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270 (283)
T ss_pred HhCCCCCCCCCHHHHHH--HHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCccc
Confidence 99998886544321100 000000000 0000000 000 00111234678899999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
||++.+++.
T Consensus 271 Rp~~~~ll~ 279 (283)
T cd05118 271 RITAEQALA 279 (283)
T ss_pred CcCHHHHhh
Confidence 999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=247.28 Aligned_cols=222 Identities=20% Similarity=0.221 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
...+.+|+.+++.++|+||+++++++.+++..|+|+||+. ++|..++.. ....+.+..+..++.|++.||.|||+.+
T Consensus 47 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 123 (291)
T cd07870 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH 123 (291)
T ss_pred cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4467899999999999999999999999999999999996 566666532 2345778888999999999999999888
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ell 167 (289)
++|+||||+||+++.++.++|+|||+++...... .......++..|+|||.+.+. .++.++||||||+++|+|+
T Consensus 124 ---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 198 (291)
T cd07870 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198 (291)
T ss_pred ---cccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987643221 112233568899999998754 5789999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCC---------ccccccccccCC---------CCHHHHHHHHHHHHcccccCCC
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGR---------AWELMDSILQND---------ASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+|..||.........+ ...+..+.... ............ ........+.+++.+|++.||+
T Consensus 199 ~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~ 277 (291)
T cd07870 199 QGQPAFPGVSDVFEQL-EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK 277 (291)
T ss_pred hCCCCCCCchhHHHHH-HHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence 9999986544321111 11111110000 000000000000 0001135778999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||+.+++.
T Consensus 278 ~R~t~~~~l~ 287 (291)
T cd07870 278 DRISAQDALL 287 (291)
T ss_pred cCcCHHHHhc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=244.47 Aligned_cols=209 Identities=21% Similarity=0.246 Sum_probs=162.6
Q ss_pred HHHHHHHHHHHh-hCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIA-KLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
...+..|..++. ..+|+|++++++++.+++..|+|+||+++++|.+++. ..+.+++..+..++.|++.||.|||+.
T Consensus 40 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~ 116 (260)
T cd05611 40 VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQR 116 (260)
T ss_pred HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344556655544 4589999999999999999999999999999999984 345688999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||+|+||+++.++.++|+|||+++.... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 117 ~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~ 187 (260)
T cd05611 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL 187 (260)
T ss_pred C---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHH
Confidence 7 99999999999999999999999999875432 22345788999999998888999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
+|..|+........ +........ ..........+..+.+++.+||+.||++||++.++.+.|
T Consensus 188 ~g~~p~~~~~~~~~------~~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 188 FGYPPFHAETPDAV------FDNILSRRI------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HCCCCCCCCCHHHH------HHHHHhccc------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 99999864432211 000100000 000111113457889999999999999999776555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=247.27 Aligned_cols=221 Identities=24% Similarity=0.246 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+|+.++++++|+||+++++++.+. +..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||+
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~ 126 (309)
T cd07845 50 PISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE 126 (309)
T ss_pred cchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567899999999999999999998765 568999999964 787777532 3568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~e 165 (289)
.+ ++||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 127 ~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 88 99999999999999999999999999987643321 1222345778999999875 467999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhc-----------cCCccccccccccCC-----CCHHHHHHHHHHHHcccccCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWN-----------DGRAWELMDSILQND-----ASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~ 229 (289)
|++|..||...+.... ......... ............... .....+..+.++|.+||+.||+
T Consensus 202 l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~ 279 (309)
T cd07845 202 LLAHKPLLPGKSEIEQ--LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPK 279 (309)
T ss_pred HHhCCCCCCCCCHHHH--HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChh
Confidence 9999998875433211 111000000 000000000000000 0011356778999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||+.+++.
T Consensus 280 ~R~t~~~il~ 289 (309)
T cd07845 280 KRATAEEALE 289 (309)
T ss_pred hCcCHHHHhc
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=245.18 Aligned_cols=212 Identities=25% Similarity=0.297 Sum_probs=173.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.....++.+|++++++++|+||+++++++.++...++|+||+++++|..++.+.. ....++++.+..++.|++.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l 119 (256)
T cd08530 40 QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119 (256)
T ss_pred HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788899999999999999999999999999999999999999999885422 235688899999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||++++
T Consensus 120 h~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~ 192 (256)
T cd08530 120 HEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLY 192 (256)
T ss_pred hhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHH
Confidence 9888 9999999999999999999999999998765431 22245788999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..|+...+.... .. .... ..........+.++.+++.+||+.+|++||++.++++
T Consensus 193 ~l~~g~~p~~~~~~~~~--~~----~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 193 EMATFAPPFEARSMQDL--RY----KVQR---------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHhCCCCCCCCCHHHH--HH----HHhc---------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 99999999865432111 00 0001 0111122245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=242.83 Aligned_cols=193 Identities=22% Similarity=0.288 Sum_probs=156.0
Q ss_pred CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCce
Q 038647 23 QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNI 102 (289)
Q Consensus 23 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Ni 102 (289)
+||||+++++.+..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~ni 140 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENV 140 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHE
Confidence 799999999999999999999999999999999843 347899999999999999999999988 99999999999
Q ss_pred EeCCCC-ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcch
Q 038647 103 LLDSNM-NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181 (289)
Q Consensus 103 ll~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~ 181 (289)
+++.++ .++|+|||+++..... ....++..|+|||++.+..++.++||||||+++|+|++|..|+........
T Consensus 141 l~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 141 LYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred EEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 999988 9999999998765432 123578899999999998999999999999999999999999874433221
Q ss_pred hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-HHHHHH
Q 038647 182 TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-MLEVIS 239 (289)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~ll~ 239 (289)
....... .. . . ........+..+.+++.+||+.||.+||+ ++++++
T Consensus 215 ~~~~~~~-~~-~--------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLK-RQ-Q--------K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHH-hh-c--------c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111100 00 0 0 00111135578899999999999999995 688874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=246.68 Aligned_cols=208 Identities=22% Similarity=0.246 Sum_probs=172.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
++..-..+|-.||..++.+.||.+-.+|++.+.+|+|+..|.||+|..+|.+.. ++.++++.+..++.+|+.||.+||.
T Consensus 227 ~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~ 305 (591)
T KOG0986|consen 227 KGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHR 305 (591)
T ss_pred hhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHh
Confidence 345556789999999999999999999999999999999999999999987643 3679999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.. ||+||+||+|||+|+.|+++|+|+|+|..+..+... ...+||.+|||||++.+..|+...|.|||||++|+|
T Consensus 306 ~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYem 379 (591)
T KOG0986|consen 306 RR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEM 379 (591)
T ss_pred cc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHH
Confidence 77 999999999999999999999999999988766543 334899999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccc--cCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSIL--QNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
+.|+.||......... .++-...+ ..+++...+++..++....|+.||++|.--+
T Consensus 380 i~G~sPFr~~KeKvk~--------------eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 380 IAGHSPFRQRKEKVKR--------------EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HcccCchhhhhhhhhH--------------HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 9999998754332110 00001111 1233445677889999999999999997543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=241.63 Aligned_cols=214 Identities=25% Similarity=0.363 Sum_probs=174.6
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
++..+.+.+|+++++.++|||++++.+.+..++..++|+||+++++|.+++.... ....+++..+..++.+++.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 119 (258)
T cd08215 40 EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH
Confidence 3567789999999999999999999999999999999999999999999886432 246789999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+.+ ++|+||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.+..++.++|+||+|++++
T Consensus 120 h~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~ 194 (258)
T cd08215 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLY 194 (258)
T ss_pred HhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHH
Confidence 9987 9999999999999999999999999998764432 1223346888999999999888999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..|+...+.... ... ..... ....+...+..+.+++.+||..+|++|||+.++++
T Consensus 195 ~l~~g~~p~~~~~~~~~--~~~----~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 195 ELCTLKHPFEGENLLEL--ALK----ILKGQ---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCCCCCCCcHHHH--HHH----HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 99999998765432211 000 00100 01111234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=242.46 Aligned_cols=210 Identities=28% Similarity=0.370 Sum_probs=172.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++|+|++++++++.+++..++|+||+++++|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~ 117 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHE 117 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 456789999999999999999999999999999999999999999999884 33678999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
.+ ++||||+|+||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|||+||+++++|
T Consensus 118 ~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l 192 (254)
T cd06627 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIEL 192 (254)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHH
Confidence 88 999999999999999999999999999876543321 2334678899999999888899999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..|+........ .+.... . .........+..+.+++.+||..+|++|||+.+++.
T Consensus 193 ~~g~~p~~~~~~~~~-----~~~~~~-~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 193 LTGNPPYYDLNPMAA-----LFRIVQ-D---------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HhCCCCCCCccHHHH-----HHHHhc-c---------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 999998764331111 111100 0 011112234568889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=245.44 Aligned_cols=224 Identities=21% Similarity=0.253 Sum_probs=163.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++++.+++..|+||||++ ++|.+++... ....+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~ 120 (294)
T PLN00009 43 GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS 120 (294)
T ss_pred cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999999999999999999996 4777766432 22346788888999999999999998
Q ss_pred CCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ 164 (289)
++ ++|+||+|+||+++. ++.+||+|||++....... .......++..|+|||.+.+. .++.++||||||+++|
T Consensus 121 ~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~ 195 (294)
T PLN00009 121 HR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFA 195 (294)
T ss_pred CC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 87 999999999999985 5679999999997653321 112233568899999998764 5799999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccC--Cc-------cccccccc--cC----CCCHHHHHHHHHHHHcccccCCC
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDG--RA-------WELMDSIL--QN----DASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~--~~----~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+|+||..||.......... ......... .. ........ .. ......+..+.+++.+||+.+|+
T Consensus 196 ~l~tg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 273 (294)
T PLN00009 196 EMVNQKPLFPGDSEIDELF--KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPS 273 (294)
T ss_pred HHHhCCCCCCCCCHHHHHH--HHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChh
Confidence 9999999886543221111 000000000 00 00000000 00 01122346788999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+||++.++++
T Consensus 274 ~Rps~~~~l~ 283 (294)
T PLN00009 274 KRITARAALE 283 (294)
T ss_pred hCcCHHHHhc
Confidence 9999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=252.74 Aligned_cols=224 Identities=20% Similarity=0.259 Sum_probs=166.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
...+.+.+|+.+|++++||||+++++++.. ...+++|+||+. ++|.+++. ..+.+++..+..++.||+.||.
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~ 121 (334)
T cd07855 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLK 121 (334)
T ss_pred cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHH
Confidence 456788899999999999999999998863 457899999995 68888884 3455899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
|||+.+ ++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||
T Consensus 122 ~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 198 (334)
T cd07855 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198 (334)
T ss_pred HHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHH
Confidence 999988 999999999999999999999999999765432211 11223468889999999865 468999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhh-----------hccCCcccccccccc-CCC-----CHHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNL-----------WNDGRAWELMDSILQ-NDA-----SYPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~ 222 (289)
|+++|+|++|+.||...+..... ...... ..........+.... ... ....+.++.+++.+
T Consensus 199 G~~l~el~~g~~pf~~~~~~~~~--~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 276 (334)
T cd07855 199 GCIFAEMLGRRQLFPGKNYVHQL--KLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ 276 (334)
T ss_pred HHHHHHHHcCCCccCCCChHHHH--HHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHH
Confidence 99999999999998654322110 000000 000000000110000 000 11235788999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.+|++||++.+++.
T Consensus 277 ~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 277 MLQFDPEERITVEQALQ 293 (334)
T ss_pred HccCChhhCcCHHHHHh
Confidence 99999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=246.73 Aligned_cols=209 Identities=29% Similarity=0.371 Sum_probs=164.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|+++++.++|+|++++++++..+...++||||+. |++.+++.. ....+++..+..++.|++.||.|||+
T Consensus 57 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~ 133 (308)
T cd06634 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS 133 (308)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999999999999999999996 577666532 23457889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl 163 (289)
.+ ++||||+|+||+++.++.++|+|||++...... ....++..|+|||.+. ...++.++|||||||++
T Consensus 134 ~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il 204 (308)
T cd06634 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (308)
T ss_pred CC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHH
Confidence 88 999999999999999999999999998754321 2245788999999985 34578999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
|+|++|..|+.......... . ... ...........+..+.+++.+||+.+|++||++.+++...
T Consensus 205 ~el~~g~~p~~~~~~~~~~~--~----~~~--------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 205 IELAERKPPLFNMNAMSALY--H----IAQ--------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHHHcCCCCCccccHHHHHH--H----Hhh--------cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 99999998865432111100 0 000 0001111223456788999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=237.03 Aligned_cols=221 Identities=22% Similarity=0.312 Sum_probs=175.5
Q ss_pred cccCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
-.....+..+|++++.+++ |+||++++++|+++...|+|||.+.||.|..++ .+...+++..+.++..+|+.||.+
T Consensus 115 ~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI---~~~~~F~E~EAs~vvkdia~aLdF 191 (463)
T KOG0607|consen 115 PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHI---QKRKHFNEREASRVVKDIASALDF 191 (463)
T ss_pred CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHH---HHhhhccHHHHHHHHHHHHHHHHH
Confidence 3445778899999999995 999999999999999999999999999999888 455679999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCc---eEEcccccccccCCCC-----cccccccccccccccChhhhh-----cCCC
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMN---PKISDFGIARLFGGDE-----LQSNTKRIVGTYGYMSPEYAL-----RGLF 150 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~-----~~~~ 150 (289)
||.+| |.|||+||+|||....+. |||+||.+..-..... ......+.+|+..|||||+.. ...|
T Consensus 192 lH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~Y 268 (463)
T KOG0607|consen 192 LHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFY 268 (463)
T ss_pred HhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccc
Confidence 99998 999999999999976655 7999998876432211 111234567889999999885 2458
Q ss_pred CCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccc-----cccccccCCCCH------HHHHHHHHH
Q 038647 151 SIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWE-----LMDSILQNDASY------PMLNRYINV 219 (289)
Q Consensus 151 ~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~------~~~~~l~~l 219 (289)
+.++|.||||+|+|-|+.|.+||.+.=..+. .|..+..-+ ++..+-.+.+.. .++.+..++
T Consensus 269 DKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdl 340 (463)
T KOG0607|consen 269 DKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDL 340 (463)
T ss_pred cccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHH
Confidence 9999999999999999999999976544332 233333322 222333333332 266788899
Q ss_pred HHcccccCCCCCCCHHHHHH
Q 038647 220 ALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~ 239 (289)
|...|..|+.+|.++.++++
T Consensus 341 isnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhccHHhhhhhhhccC
Confidence 99999999999999998876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=246.29 Aligned_cols=224 Identities=21% Similarity=0.233 Sum_probs=163.6
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCe-----EEEEEeecCCCChhhhhcCCCC--CCCCChHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGE-----KILIYEYMPNKSLDCFLFDPTK--TGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~ 79 (289)
..+.+.+|+.+++.++ ||||+++++++...+. .|+||||+++ +|.+++..... ...+++..+..++.||+.
T Consensus 43 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 121 (295)
T cd07837 43 IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121 (295)
T ss_pred CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHH
Confidence 4567889999999995 6999999999987665 8999999986 78777644221 346899999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccch
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVF 157 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diw 157 (289)
||.|||+++ ++||||+|+||+++. ++.++|+|||+++....... ......+++.|+|||++.+ ..++.++|||
T Consensus 122 ~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 196 (295)
T cd07837 122 GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIW 196 (295)
T ss_pred HHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHH
Confidence 999999888 999999999999998 88999999999876533211 1122346788999998865 4579999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC--ccc-c---c-----cc---cccCCCCHHHHHHHHHHHHcc
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR--AWE-L---M-----DS---ILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-~---~-----~~---~~~~~~~~~~~~~l~~li~~~ 223 (289)
|||+++|+|++|..||...+...... .......... ... . . .. ..........+..+.++|.+|
T Consensus 197 slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 274 (295)
T cd07837 197 SVGCIFAEMSRKQPLFPGDSELQQLL--HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKM 274 (295)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHH
Confidence 99999999999999886543221110 0000000000 000 0 0 00 000001122456788999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|..||++||++.+++.
T Consensus 275 l~~~P~~R~~~~eil~ 290 (295)
T cd07837 275 LRYDPAKRISAKAALT 290 (295)
T ss_pred ccCChhhcCCHHHHhc
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=246.99 Aligned_cols=207 Identities=28% Similarity=0.388 Sum_probs=163.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++++.++|||++++++++.++...|+||||+. |++.+++.. ....+++..+..++.|++.||.|||+
T Consensus 63 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~ 139 (313)
T cd06633 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS 139 (313)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999996 467666642 23468899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl 163 (289)
.+ ++|+||+|+||+++.++.++|+|||++..... .....|+..|+|||.+. +..++.++||||||+++
T Consensus 140 ~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil 210 (313)
T cd06633 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 210 (313)
T ss_pred CC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHH
Confidence 88 99999999999999999999999998864321 22346788999999985 35688999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..|+.......... ..... . .........+..+.+++.+||+.+|.+||++.+++.
T Consensus 211 ~el~~g~~p~~~~~~~~~~~-----~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 211 IELAERKPPLFNMNAMSALY-----HIAQN-D--------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHhCCCCCCCCChHHHHH-----HHHhc-C--------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999875432211110 00000 0 011111223457889999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=245.50 Aligned_cols=216 Identities=26% Similarity=0.381 Sum_probs=164.7
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcC--CCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD--PTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.....+.+|+.++.++. |+||+++++++..++..+++|||+.. ++.++... ......+++..+..++.+++.||+|
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 34667899999999996 99999999999999999999999854 55443211 1223578999999999999999999
Q ss_pred HhcC-CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC---CCCCcccchhH
Q 038647 84 LHHY-SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG---LFSIKSDVFSF 159 (289)
Q Consensus 84 lH~~-~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Diwsl 159 (289)
||+. + ++||||||+||+++.++.++|+|||+++....... .....|+..|+|||++.+. .++.++|||||
T Consensus 123 lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 196 (288)
T cd06616 123 LKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL 196 (288)
T ss_pred HhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHH
Confidence 9974 6 99999999999999999999999999876543221 1223578899999999876 68999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+++|+|++|..||........ ....... .. ............+..+.+++.+||+.||++|||+++|++
T Consensus 197 G~il~el~~g~~p~~~~~~~~~----~~~~~~~-~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 197 GITLYEVATGKFPYPKWNSVFD----QLTQVVK-GD-----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHHHhCCCCchhcchHHH----HHhhhcC-CC-----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999865431100 0000000 00 011111222335678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=243.65 Aligned_cols=217 Identities=20% Similarity=0.235 Sum_probs=170.4
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+++.+|+++++++ +||||+++++.+..+...++||||+++|+|.+++. ....+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~ 123 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQ 123 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999 69999999999999999999999999999998884 33568899999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC--CCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~vl~ 164 (289)
.+ ++||||+|+||+++.++.++|+|||+++........ ......|+..|+|||.+.+.. .+.++||||||++++
T Consensus 124 ~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 124 LG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199 (288)
T ss_pred CC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHH
Confidence 88 999999999999999999999999998765433211 122345788999999987655 789999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+|++|..|+...+..... .......... ....+...+..+.+++.+||+.||++|||+.++.+.|+-
T Consensus 200 el~tg~~p~~~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQ-SEISRRILKS-----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHhCCCCcccCcccchH-HHHHHHHHcc-----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999999998643322110 0000000000 011122244678899999999999999999888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=241.96 Aligned_cols=205 Identities=23% Similarity=0.260 Sum_probs=160.7
Q ss_pred HHHHHH---HHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 12 FKNEMM---LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 12 ~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
+..|.. +++..+||||+++++++.+++..++||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+.+
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~ 117 (278)
T cd05606 41 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF 117 (278)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 444444 3444579999999999999999999999999999998884 3457899999999999999999999888
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ell 167 (289)
++||||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+. .++.++||||+|+++|+|+
T Consensus 118 ---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~ 190 (278)
T cd05606 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190 (278)
T ss_pred ---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHH
Confidence 9999999999999999999999999987553221 2234689999999999754 6899999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
+|..||.............. ... .........+..+.+++.+||..+|++|| ++.++++
T Consensus 191 ~g~~p~~~~~~~~~~~~~~~---~~~----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 191 RGHSPFRQHKTKDKHEIDRM---TLT----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hCCCCCCCCCccchHHHHHH---hhc----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 99999865432211110000 000 00111122357899999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=260.54 Aligned_cols=212 Identities=26% Similarity=0.350 Sum_probs=174.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+.+|.+|+.+|.+|+|+|++++||++.+ ....+|||+++.|+|.+.|.+ ..+..+.......++.||+.|+.||..+
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk 231 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK 231 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh
Confidence 68999999999999999999999999998 688999999999999999977 4566788899999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+ +|||||...|+++.....|||+|||+.+..+.+... .......-...|+|||.+....++.++|||+|||.+|||
T Consensus 232 r---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEM 308 (1039)
T KOG0199|consen 232 R---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEM 308 (1039)
T ss_pred h---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhh
Confidence 7 999999999999999999999999999988654322 212222345689999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+| |..|+.+-...+. .+.++....-.-+...++++.+++..||..+|++|||+..|.+
T Consensus 309 FtyGEePW~G~~g~qI---------------L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 309 FTYGEEPWVGCRGIQI---------------LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred hccCCCCCCCCCHHHH---------------HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 98 4555443322211 1222222222334456789999999999999999999999974
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=242.80 Aligned_cols=217 Identities=19% Similarity=0.232 Sum_probs=161.2
Q ss_pred HHHHHHHHHhhCC-CCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 11 EFKNEMMLIAKLQ-HRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 11 ~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
...+|+.+++++. |+|++++++++.++ +..++|+||+++ +|.+++.. ....+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~ 119 (282)
T cd07831 43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRN 119 (282)
T ss_pred hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4457999999995 99999999999987 889999999974 77777643 235689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~el 166 (289)
+ ++||||+|+||+++. +.+||+|||+++....... .....++..|+|||.+.. ..++.++|||||||++|+|
T Consensus 120 ~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el 192 (282)
T cd07831 120 G---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192 (282)
T ss_pred C---ceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHH
Confidence 8 999999999999999 9999999999986643321 122457889999998754 4578999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhh-----------hhccCCccccccccccC----CCCHHHHHHHHHHHHcccccCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWN-----------LWNDGRAWELMDSILQN----DASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
++|..||...+.... ...... ................. ......+..+.+++.+||+.||++|
T Consensus 193 ~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 270 (282)
T cd07831 193 LSLFPLFPGTNELDQ--IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDER 270 (282)
T ss_pred HcCCcCCCCCCHHHH--HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccc
Confidence 999998865443211 010000 00000000000000000 0011346789999999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
|+++++++
T Consensus 271 ~~~~~~l~ 278 (282)
T cd07831 271 ITAKQALR 278 (282)
T ss_pred cCHHHHhh
Confidence 99999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=242.77 Aligned_cols=211 Identities=24% Similarity=0.346 Sum_probs=160.9
Q ss_pred HHHHHHHHHH-HhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMML-IAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..++..|+.+ ++..+||||+++++++..++..|+||||++ |+|.+++... .....+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 121 (283)
T cd06617 43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121 (283)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3455666665 566689999999999999999999999996 6787776432 234578999999999999999999998
Q ss_pred C-CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc----CCCCCcccchhHHH
Q 038647 87 Y-SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR----GLFSIKSDVFSFGV 161 (289)
Q Consensus 87 ~-~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~ 161 (289)
+ + ++||||||+||+++.++.+||+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+
T Consensus 122 ~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 195 (283)
T cd06617 122 KLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195 (283)
T ss_pred cCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHH
Confidence 6 6 9999999999999999999999999988653221 1122457888999998865 45689999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..|+............ .. ............+..+.+++.+||..+|++||++.++++
T Consensus 196 ~l~~l~~g~~p~~~~~~~~~~~~~----~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 196 TMIELATGRFPYDSWKTPFQQLKQ----VV---------EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHhCCCCCCccccCHHHHHH----HH---------hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999997543222111100 00 000000111124568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=243.52 Aligned_cols=225 Identities=22% Similarity=0.266 Sum_probs=167.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....+.+.+|++++++++|+|++++++++.+. +..++|+||+++ +|..++... ...+++..++.++.|++.||.|
T Consensus 39 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~ 115 (287)
T cd07840 39 EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQY 115 (287)
T ss_pred ccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHH
Confidence 33456789999999999999999999999988 899999999975 888877532 2468999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~v 162 (289)
||+.+ ++|+||+|+||++++++.++|+|||++........ .......++..|+|||.+.+ ..++.++||||||++
T Consensus 116 LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~ 191 (287)
T cd07840 116 LHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCI 191 (287)
T ss_pred HHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHH
Confidence 99988 99999999999999999999999999987654321 11222356788999998765 467999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhcc---CCcccc--------------ccccccCCCCHHHHHHHHHHHHcccc
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWND---GRAWEL--------------MDSILQNDASYPMLNRYINVALLCVQ 225 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~ 225 (289)
+|+|++|..|+........ .......... ...... .............+..+.+++.+||+
T Consensus 192 l~el~t~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 269 (287)
T cd07840 192 LAELFLGKPIFQGSTELEQ--LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLT 269 (287)
T ss_pred HHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcC
Confidence 9999999998865443211 1111000000 000000 00000000000025678899999999
Q ss_pred cCCCCCCCHHHHHH
Q 038647 226 ENAADRPTMLEVIS 239 (289)
Q Consensus 226 ~~p~~Rps~~~ll~ 239 (289)
.+|++||+++++++
T Consensus 270 ~~P~~Rp~~~~~l~ 283 (287)
T cd07840 270 LDPKKRISADQALQ 283 (287)
T ss_pred CChhhCcCHHHHhh
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=249.93 Aligned_cols=224 Identities=24% Similarity=0.271 Sum_probs=166.6
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
....+.+.+|+.+++.++|+||+++++++... ...|+|+||+. ++|.+++. ..+.+++..+..++.|++.|
T Consensus 45 ~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~a 120 (337)
T cd07858 45 RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRG 120 (337)
T ss_pred cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 33466788999999999999999999988654 35899999995 67888774 34568999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
|.|||+++ ++||||||+||+++.++.+||+|||+++...... .......++..|+|||.+.+ ..++.++|||||
T Consensus 121 L~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (337)
T cd07858 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV 195 (337)
T ss_pred HHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHH
Confidence 99999888 9999999999999999999999999998654321 11223457889999999875 468999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhh-----------ccCCccccccccccC------CCCHHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLW-----------NDGRAWELMDSILQN------DASYPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~ 222 (289)
|+++|+|++|..||....... ......... .........+..... ......+..+.+++.+
T Consensus 196 G~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 273 (337)
T cd07858 196 GCIFAELLGRKPLFPGKDYVH--QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEK 273 (337)
T ss_pred HHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHH
Confidence 999999999999986543211 000000000 000000011110000 0011245678999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 038647 223 CVQENAADRPTMLEVISM 240 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~~ 240 (289)
||+.+|++|||++++++.
T Consensus 274 ~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 274 MLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhcCChhhccCHHHHHcC
Confidence 999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=250.65 Aligned_cols=225 Identities=25% Similarity=0.292 Sum_probs=165.2
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.....+.+|+.+++++ +||||+++++++... ...|+||||++ ++|..++.. +.+++..+..++.||+.||.|
T Consensus 48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~ 122 (337)
T cd07852 48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKY 122 (337)
T ss_pred hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Confidence 3456788999999999 999999999998643 46899999997 588888742 267888899999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc---cccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ---SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
||+.+ ++||||+|+||+++.++.++|+|||++......... .......|+..|+|||.+.+ ..++.++|||||
T Consensus 123 LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 123 IHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred HHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 99988 999999999999999999999999999866433221 12233468889999998865 467899999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhH-hH--------hhhhccCCcccccccccc------CCCCHHHHHHHHHHHHccc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLG-HA--------WNLWNDGRAWELMDSILQ------NDASYPMLNRYINVALLCV 224 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l 224 (289)
|+++|+|++|+.||............ .. +...........++.... .......+..+.+++.+||
T Consensus 200 G~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (337)
T cd07852 200 GCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279 (337)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhc
Confidence 99999999999998654322110000 00 000000000001110000 0011114568899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 038647 225 QENAADRPTMLEVIS 239 (289)
Q Consensus 225 ~~~p~~Rps~~~ll~ 239 (289)
+.||++|||+.++++
T Consensus 280 ~~~P~~Rps~~~il~ 294 (337)
T cd07852 280 VFNPNKRLTAEEALE 294 (337)
T ss_pred cCCcccccCHHHHhh
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=254.21 Aligned_cols=220 Identities=24% Similarity=0.272 Sum_probs=168.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
.-.+...+|+++|++++|+|||+++++=++.. ...+|||||.+|+|...+.++.+...+++..++.++.+++.|
T Consensus 53 r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~a 132 (732)
T KOG4250|consen 53 RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSA 132 (732)
T ss_pred chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHH
Confidence 45678889999999999999999998876544 568999999999999999988888889999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeC--CCCc--eEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCccc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLD--SNMN--PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSD 155 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~--~~~~--vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~D 155 (289)
|.|||+++ |+||||||.||++- ++|+ .||+|||.|+....++ ...+..||..|++||.... ..|+..+|
T Consensus 133 l~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVD 206 (732)
T KOG4250|consen 133 LRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVD 206 (732)
T ss_pred HHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceee
Confidence 99999988 99999999999984 3333 5999999999887654 4667899999999999995 88999999
Q ss_pred chhHHHHHHHHHhCCCCcCCCCCcc-hhHhHhHhhhhccCCcccccccc----------c--cCCCCHHHHHHHHHHHHc
Q 038647 156 VFSFGVLVLETLSSKKNAHFYNTDS-LTLLGHAWNLWNDGRAWELMDSI----------L--QNDASYPMLNRYINVALL 222 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----------~--~~~~~~~~~~~l~~li~~ 222 (289)
.|||||++|+++||..||....... .....+....-............ + ...........+-.++..
T Consensus 207 LWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~ 286 (732)
T KOG4250|consen 207 LWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLAS 286 (732)
T ss_pred hhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHH
Confidence 9999999999999999986654442 11111111111111100000000 0 111223344566677888
Q ss_pred ccccCCCCCC
Q 038647 223 CVQENAADRP 232 (289)
Q Consensus 223 ~l~~~p~~Rp 232 (289)
+|..+|++|-
T Consensus 287 ~L~~~~~~~~ 296 (732)
T KOG4250|consen 287 MLEWNPRKRG 296 (732)
T ss_pred HHhhhHHHhC
Confidence 8899999987
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=234.39 Aligned_cols=216 Identities=23% Similarity=0.353 Sum_probs=171.5
Q ss_pred CcccCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.+++..+++...+.++...+ .|+||+++|+|..+..+.+.||.| ...++.+++. -.+++++..+-++...++.||.
T Consensus 129 ~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~ 205 (391)
T KOG0983|consen 129 GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR--IKGPIPERILGKMTVAIVKALY 205 (391)
T ss_pred CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHH
Confidence 35567788888999888885 999999999999999999999988 4466666642 3456899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSF 159 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Diwsl 159 (289)
||.+++ +|+|||+||+|||+|+.|++||+|||++..+-... ......|-+.|||||.+. ...|+.++|||||
T Consensus 206 YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 206 YLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred HHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 999866 59999999999999999999999999997654322 233346889999999997 3568999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+.++||.||+.|+.....+...+.... +... ..+... ...+..+.+++..||..|+.+||...++++
T Consensus 281 GITlveLaTg~yPy~~c~tdFe~ltkvl----n~eP------P~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 281 GITLVELATGQYPYKGCKTDFEVLTKVL----NEEP------PLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccchhhhhcccCCCCCCCccHHHHHHHH----hcCC------CCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 9999999999999987666543332111 1100 111111 115678899999999999999999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=238.95 Aligned_cols=205 Identities=24% Similarity=0.303 Sum_probs=167.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++||||+++++.+..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~ 112 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSEERARFYAAEIVLALEYLHSL 112 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 567899999999999999999999999999999999999999999999843 34688999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+...+.++|+||||+++|+++
T Consensus 113 ~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~ 187 (250)
T cd05123 113 G---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML 187 (250)
T ss_pred C---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 7 9999999999999999999999999988654332 1123346788999999999888999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
+|..||...... ..... ... .....+...+..+.+++.+||..||++||++.+
T Consensus 188 ~g~~p~~~~~~~--~~~~~---~~~-----------~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 188 TGKPPFYAEDRK--EIYEK---ILK-----------DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HCCCCCCCCCHH--HHHHH---Hhc-----------CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999998644321 11100 000 001112223578899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=240.45 Aligned_cols=212 Identities=25% Similarity=0.358 Sum_probs=168.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++.+|+.+++.++||||+++++++.+....++|+||+++++|..++... .....+++..+..++.|++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 123 (260)
T cd08222 44 NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123 (260)
T ss_pred chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH
Confidence 34556788999999999999999999999999999999999999999887532 23457899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.+ ++|+||+|+||+++. +.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+
T Consensus 124 ~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ 197 (260)
T cd08222 124 QRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197 (260)
T ss_pred HcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 888 999999999999975 5699999999876543221 1223457889999999988889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..|+....... .. .... .. .........+..+.+++.+||..||++||++.++++
T Consensus 198 l~~~~~~~~~~~~~~--~~---~~~~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 198 MCCLAHAFEGQNFLS--VV---LRIV-EG---------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHhCCCCCCCccHHH--HH---HHHH-cC---------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 999999875332111 10 0000 00 011122345578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=244.64 Aligned_cols=225 Identities=21% Similarity=0.305 Sum_probs=161.1
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecC--------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHG--------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|++++++++||||+++++++.... ..++||||+.+ +|.+++.. ....+++..+..++.|++.|
T Consensus 55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~a 131 (310)
T cd07865 55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNG 131 (310)
T ss_pred hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHH
Confidence 456678999999999999999999987654 45999999964 77777643 23468999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhcC-CCCCcccch
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALRG-LFSIKSDVF 157 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Diw 157 (289)
|.|||+++ ++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+. .++.++|||
T Consensus 132 l~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 208 (310)
T cd07865 132 LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMW 208 (310)
T ss_pred HHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhH
Confidence 99999988 999999999999999999999999999866432211 112234577889999998764 478999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchh-HhHhHhhh-----hccCCccccccccc-cCCC---------CHHHHHHHHHHHH
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLT-LLGHAWNL-----WNDGRAWELMDSIL-QNDA---------SYPMLNRYINVAL 221 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~-~~~~---------~~~~~~~l~~li~ 221 (289)
|||+++|+|++|..|+......... ........ +.........+... .... .......+.++|.
T Consensus 209 slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~ 288 (310)
T cd07865 209 GAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLID 288 (310)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHH
Confidence 9999999999999888654322110 00000000 00000000000000 0000 0001246678999
Q ss_pred cccccCCCCCCCHHHHHH
Q 038647 222 LCVQENAADRPTMLEVIS 239 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~ 239 (289)
+||..||++|||++++++
T Consensus 289 ~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 289 KLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHhcCChhhccCHHHHhc
Confidence 999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=243.21 Aligned_cols=211 Identities=25% Similarity=0.330 Sum_probs=171.7
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+..+.+.+|++++++++ ||||+++++++.+++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh 119 (280)
T cd05581 43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLH 119 (280)
T ss_pred HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44578899999999998 9999999999999999999999999999999984 3447999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc------------------cccccccccccccChhhhhc
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ------------------SNTKRIVGTYGYMSPEYALR 147 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~ 147 (289)
+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||+..+
T Consensus 120 ~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 120 SKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred HCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 988 999999999999999999999999998866433211 22234467889999999998
Q ss_pred CCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccC
Q 038647 148 GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 148 ~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 227 (289)
..++.++|+||||++++++++|..|+...+.... . .. .. ......+...+..+.+++.+||+.+
T Consensus 197 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-~~---~~-----------~~~~~~~~~~~~~~~~li~~~l~~~ 260 (280)
T cd05581 197 KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-F-QK---IL-----------KLEYSFPPNFPPDAKDLIEKLLVLD 260 (280)
T ss_pred CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-H-HH---HH-----------hcCCCCCCccCHHHHHHHHHHhcCC
Confidence 8899999999999999999999999875542111 0 00 00 0011122233568899999999999
Q ss_pred CCCCCCH----HHHHH
Q 038647 228 AADRPTM----LEVIS 239 (289)
Q Consensus 228 p~~Rps~----~~ll~ 239 (289)
|++||++ +++++
T Consensus 261 p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 261 PQDRLGVNEGYDELKA 276 (280)
T ss_pred HhhCCCcccCHHHHhc
Confidence 9999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.41 Aligned_cols=224 Identities=22% Similarity=0.271 Sum_probs=163.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
...+++.+|+.++++++||||+++++++... ...|+|+||+.+ +|..++. ...+++..+..++.|++.||
T Consensus 45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL 119 (336)
T cd07849 45 TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGL 119 (336)
T ss_pred hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHH
Confidence 3567788999999999999999999987654 358999999964 7777663 34688999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
.|||+.+ ++||||||+||+++.++.++|+|||++......... .......|+..|+|||.+.+ ..++.++|||||
T Consensus 120 ~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 196 (336)
T cd07849 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV 196 (336)
T ss_pred HHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHH
Confidence 9999988 999999999999999999999999998865432211 11223467889999998765 568999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC-----------ccccccccccC-C-----CCHHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR-----------AWELMDSILQN-D-----ASYPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~-----~~~~~~~~l~~li~~ 222 (289)
|+++|+|++|+.||....... ............. ........... . .....+..+.+++.+
T Consensus 197 Gvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (336)
T cd07849 197 GCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDK 274 (336)
T ss_pred HHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHH
Confidence 999999999999886533211 0000000000000 00000000000 0 001234678899999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 038647 223 CVQENAADRPTMLEVISM 240 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~~ 240 (289)
||+.+|++|||+.++++.
T Consensus 275 ~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 275 MLTFNPHKRITVEEALAH 292 (336)
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=240.67 Aligned_cols=213 Identities=15% Similarity=0.184 Sum_probs=155.8
Q ss_pred HHHHHHhhCCCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 14 NEMMLIAKLQHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 14 ~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
.+...+..++|+|++++++.+.... ..++++|++.. ++.+.+. .....++..+..++.|++.||.|||+++
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 146 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG- 146 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3445566778999999998766543 44678887743 5655553 2233567888999999999999999887
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCc-----ccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-----QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
++||||||+|||++.++.++|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|
T Consensus 147 --iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 147 --ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred --eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999999999987642211 11122346899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCC-CCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND-ASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+|++|..||...+.............. .....+. .....+..+.+++..|++.+|++||++.+|++.|+
T Consensus 225 el~~g~~P~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGNLIHAAKCDFI---------KRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhCCCCCCccccchHHHHHhHHHHH---------HHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 999999998765433221111100000 0000000 01122467889999999999999999999998763
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=242.83 Aligned_cols=223 Identities=23% Similarity=0.266 Sum_probs=162.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecC----------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG----------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV 77 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i 77 (289)
....+.+|++++++++||||+++++++.+.. ..++|+||+++ ++..++.. ....+++..+..++.|+
T Consensus 49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi 125 (302)
T cd07864 49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQL 125 (302)
T ss_pred chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHH
Confidence 4467889999999999999999999987654 79999999976 56666643 23468999999999999
Q ss_pred HHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccc
Q 038647 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDV 156 (289)
Q Consensus 78 ~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di 156 (289)
+.||.|||+.+ |+|+||+|+||++++++.+||+|||++......... ......++..|+|||.+.+ ..++.++||
T Consensus 126 ~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 126 LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred HHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHH
Confidence 99999999988 999999999999999999999999999865433211 1122345778999998875 457899999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC---cccc--------ccccc-----cCCCCHHHHHHHHHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR---AWEL--------MDSIL-----QNDASYPMLNRYINVA 220 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------~~~~~-----~~~~~~~~~~~l~~li 220 (289)
|||||++++|++|++|+...+... ............. .... .+... ........+..+.+++
T Consensus 202 ~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (302)
T cd07864 202 WSCGCILGELFTKKPIFQANQELA--QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLL 279 (302)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHH
Confidence 999999999999998886433211 1111111100000 0000 00000 0000112356789999
Q ss_pred HcccccCCCCCCCHHHHHH
Q 038647 221 LLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 221 ~~~l~~~p~~Rps~~~ll~ 239 (289)
..||+.||++||++++++.
T Consensus 280 ~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 280 DHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHccCChhhCCCHHHHhc
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=247.36 Aligned_cols=220 Identities=22% Similarity=0.273 Sum_probs=165.0
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
.+.+|+++++.++|+||+++++++..++..++||||+. |+|.+++. ....++++....++.|++.||.|||+.+
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~-- 139 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY-- 139 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 57899999999999999999999999999999999996 58888883 3456889999999999999999999988
Q ss_pred ceEeeccccCceEeCCCCceEEcccccccccCCCCc------------ccccccccccccccChhhhhcC-CCCCcccch
Q 038647 91 RVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL------------QSNTKRIVGTYGYMSPEYALRG-LFSIKSDVF 157 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Diw 157 (289)
++||||+|+||+++.++.++|+|||.++....... ........++..|+|||.+.+. .++.++|+|
T Consensus 140 -i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 218 (335)
T PTZ00024 140 -FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW 218 (335)
T ss_pred -eecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHH
Confidence 99999999999999999999999999986642110 1111223467889999998764 469999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCc---ccc-----cccccc------CCCCHHHHHHHHHHHHcc
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA---WEL-----MDSILQ------NDASYPMLNRYINVALLC 223 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~------~~~~~~~~~~l~~li~~~ 223 (289)
|||+++|+|++|..|+...+.... ............. ... ...... .......+..+.+++..|
T Consensus 219 slG~~l~el~tg~~p~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (335)
T PTZ00024 219 SVGCIFAELLTGKPLFPGENEIDQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296 (335)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHH
Confidence 999999999999998875543211 1111111100000 000 000000 000112346788999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|+.+|++|||+.+++.
T Consensus 297 l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 297 LKLNPLERISAKEALK 312 (335)
T ss_pred cCCCchhccCHHHHhc
Confidence 9999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=240.58 Aligned_cols=213 Identities=22% Similarity=0.246 Sum_probs=166.0
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+++.+|+++++++ +|+||+++++.+..+...|+|+||+++++|.+++. ....+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~ 123 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHK 123 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457788999999999 59999999999999999999999999999999884 34568889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC--CCCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~vl~ 164 (289)
.+ ++||||+|+||+++.++.++|+|||++........ .......|+..|+|||.+.+. .++.++||||||+++|
T Consensus 124 ~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 124 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred CC---eeccCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHH
Confidence 88 99999999999999999999999999886543221 112234688899999998753 4688999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
+|++|..|+...+.... ........... ....+......+.+++.+||+.||++|| ++++++.
T Consensus 200 ~ll~g~~p~~~~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 200 ELLTGASPFTVDGEKNS-QAEISRRILKS-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHhcCCCCCCcCCcccc-HHHHHHHhhcc-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 99999999864332211 00000000000 0111222446788999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=237.39 Aligned_cols=192 Identities=18% Similarity=0.117 Sum_probs=154.4
Q ss_pred HHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc
Q 038647 12 FKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLR 91 (289)
Q Consensus 12 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 91 (289)
+.+|...+....||||+++++++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~--- 105 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK---FLNIPEECVKRWAAEMVVALDALHREG--- 105 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 45566666777899999999999999999999999999999998843 345889999999999999999999888
Q ss_pred eEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCC
Q 038647 92 VIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171 (289)
Q Consensus 92 ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~ 171 (289)
++||||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 106 i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~ 180 (237)
T cd05576 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKT 180 (237)
T ss_pred eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcc
Confidence 999999999999999999999999987665432 122345678999999988889999999999999999999997
Q ss_pred CcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 172 NAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 172 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
++....... .. ...-..+...+..+.+++.+||+.||++||++
T Consensus 181 ~~~~~~~~~-----------~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 181 LVECHPSGI-----------NT---------HTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred hhhcCchhc-----------cc---------ccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 754221100 00 00001112245678899999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=248.21 Aligned_cols=225 Identities=25% Similarity=0.274 Sum_probs=170.6
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC-----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
....+.+.+|+.+++.++||||+++++++...+ ..|+||||++ ++|.+++. ....+++..+..++.+++.|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~ 115 (330)
T cd07834 40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRG 115 (330)
T ss_pred chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHH
Confidence 345678999999999999999999999998775 7899999997 47888884 33478999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcC-CCCCcccchh
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFS 158 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Diws 158 (289)
|.|||+.+ ++||||||.||+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++|+||
T Consensus 116 l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 192 (330)
T cd07834 116 LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS 192 (330)
T ss_pred HHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHH
Confidence 99999988 999999999999999999999999999876543210 112334578899999999887 7899999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhh-----------ccCCccccccccccC------CCCHHHHHHHHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLW-----------NDGRAWELMDSILQN------DASYPMLNRYINVAL 221 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~ 221 (289)
||+++|+|++|..||...+.... ........ ............... ......+..+.+++.
T Consensus 193 lG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 270 (330)
T cd07834 193 VGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLE 270 (330)
T ss_pred HHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHH
Confidence 99999999999999865543211 00000000 000000011100000 001124567899999
Q ss_pred cccccCCCCCCCHHHHHH
Q 038647 222 LCVQENAADRPTMLEVIS 239 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~ 239 (289)
.||+.+|++||++.++++
T Consensus 271 ~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 271 KMLVFDPKKRITADEALA 288 (330)
T ss_pred HHccCChhhCCCHHHHHh
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=243.07 Aligned_cols=223 Identities=21% Similarity=0.258 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeec--------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEH--------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|++++++++||||+++++++.+. ..+++|+||+.+ ++...+.. ....+++..+..++.|+++|
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~a 127 (311)
T cd07866 51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEG 127 (311)
T ss_pred chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHH
Confidence 45678999999999999999999987543 346999999965 56665532 33568999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc---------ccccccccccccChhhhhcC-CC
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS---------NTKRIVGTYGYMSPEYALRG-LF 150 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~-~~ 150 (289)
|.|||+++ ++|+||||+||++++++.++|+|||+++......... ......+++.|+|||.+.+. .+
T Consensus 128 l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (311)
T cd07866 128 INYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204 (311)
T ss_pred HHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCcc
Confidence 99999988 9999999999999999999999999998654322111 11233567889999988754 58
Q ss_pred CCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC---------ccccccccccCCC-------CHHHHH
Q 038647 151 SIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR---------AWELMDSILQNDA-------SYPMLN 214 (289)
Q Consensus 151 ~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-------~~~~~~ 214 (289)
+.++||||||+++|+|++|.+||...+..... ...+....... ............. ......
T Consensus 205 ~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (311)
T cd07866 205 TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL--HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGP 282 (311)
T ss_pred CchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCCh
Confidence 99999999999999999999988654432111 11111000000 0000000000000 011235
Q ss_pred HHHHHHHcccccCCCCCCCHHHHHH
Q 038647 215 RYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+.+++.+||+.||++|||+.+++.
T Consensus 283 ~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 283 EGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hHHHHHHHHcccCcccCcCHHHHhc
Confidence 7889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=234.50 Aligned_cols=202 Identities=19% Similarity=0.208 Sum_probs=169.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+.+..-..|-++|+..+||.+..+...|+.++.+|+||||..||.|.-++ +....+++.....+-..|+.||.|||+
T Consensus 210 dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs 286 (516)
T KOG0690|consen 210 DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHS 286 (516)
T ss_pred HHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhh
Confidence 34555567889999999999999999999999999999999999998888 556789999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ||+||+|.+|+|+|++|++||.|||+.+.-- .....+.+++|||.|+|||++....|..+.|.|.+||++|||
T Consensus 287 ~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEM 361 (516)
T KOG0690|consen 287 RN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEM 361 (516)
T ss_pred CC---eeeeechhhhheeccCCceEeeecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHH
Confidence 87 9999999999999999999999999998542 234457789999999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+.|+.||...+++..-.+.. .. .-..+...+++...++...|..||.+|.
T Consensus 362 mCGRLPFyn~dh~kLFeLIl------~e----------d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 362 MCGRLPFYNKDHEKLFELIL------ME----------DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HhccCcccccchhHHHHHHH------hh----------hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 99999987554432111000 00 0123334556888899999999999996
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=237.42 Aligned_cols=221 Identities=22% Similarity=0.311 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhhC---CCCCceeeeeeEeecCe-----EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKL---QHRNLVRLFGCCIEHGE-----KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|+.+++++ +|+|++++++++.+.+. .+++|||+.+ +|.+++... ....+++..+..++.|++.|
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~a 119 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRG 119 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHH
Confidence 45677888887766 59999999999998776 9999999965 788877542 22358899999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||
T Consensus 120 l~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G 193 (287)
T cd07838 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVG 193 (287)
T ss_pred HHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHH
Confidence 99999988 99999999999999999999999999887643321 1223468889999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc--------CCc--ccccccccc---CCCCHHHHHHHHHHHHcccccC
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND--------GRA--WELMDSILQ---NDASYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~ 227 (289)
+++|+|++|.+|+........ .......... ... ......... .......+..+.+++.+||+.|
T Consensus 194 ~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 271 (287)
T cd07838 194 CIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFN 271 (287)
T ss_pred HHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccC
Confidence 999999999888765432211 1001000000 000 000000000 1111234567889999999999
Q ss_pred CCCCCCHHHHHH
Q 038647 228 AADRPTMLEVIS 239 (289)
Q Consensus 228 p~~Rps~~~ll~ 239 (289)
|++||++.++++
T Consensus 272 p~~Rp~~~~il~ 283 (287)
T cd07838 272 PHKRISAFEALQ 283 (287)
T ss_pred CccCCCHHHHhc
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=250.34 Aligned_cols=231 Identities=20% Similarity=0.264 Sum_probs=189.2
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
...+.+....|-.||..++.|.||++|--|.++.++|++||-|-||.|...+ +..+.++..+...++..+++|++||
T Consensus 460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYL 536 (732)
T KOG0614|consen 460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYL 536 (732)
T ss_pred chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHH
Confidence 3456778889999999999999999999999999999999999999999999 5668899999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|.+| ||+|||||+|++++.+|.+||.|||+++..+.+. .+.+++|||.|.|||++.+...+.++|.||||+++|
T Consensus 537 H~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ 610 (732)
T KOG0614|consen 537 HRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIY 610 (732)
T ss_pred HhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHH
Confidence 9998 9999999999999999999999999999887654 466789999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
||++|.+||...+.-.. ...+++.+-.-..+..+.....++|++.+..+|.+|.- +.+|-.
T Consensus 611 ELL~G~pPFs~~dpmkt--------------Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 611 ELLTGSPPFSGVDPMKT--------------YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred HHHcCCCCCCCCchHHH--------------HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 99999999876543211 01122222223344556678889999999999999975 555543
Q ss_pred --Hhhcc------cCCCCCCCCCCccc
Q 038647 240 --MLTNE------NVILPSPLQPAFSH 258 (289)
Q Consensus 240 --~L~~~------~~~~~~~~~p~~~~ 258 (289)
++.+. ...+++|..|+..+
T Consensus 677 H~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 677 HRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred hhhhhcCChhhhhhccCCCCccccCCC
Confidence 33332 23456666665544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=238.64 Aligned_cols=225 Identities=24% Similarity=0.282 Sum_probs=168.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++|+|++++++++.+.+..++|+||++ ++|.+++.... ..+++..+..++.+++.||.|||+
T Consensus 40 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~ 116 (282)
T cd07829 40 GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS 116 (282)
T ss_pred cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345778899999999999999999999999999999999997 58999885321 468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
.+ ++||||+|+||++++++.++|+|||+++....... ......++..|+|||.+.+. .++.++||||||+++++
T Consensus 117 ~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~ 191 (282)
T cd07829 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAE 191 (282)
T ss_pred CC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHH
Confidence 88 99999999999999999999999999886543221 12223456789999999876 78999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHh---------HhHhhhhccCC-cccccccccc---CCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLL---------GHAWNLWNDGR-AWELMDSILQ---NDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~---------~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+++|..|+........... ...|..+.... .......... .......+..+.+++..||..||++||
T Consensus 192 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 271 (282)
T cd07829 192 MITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI 271 (282)
T ss_pred HHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC
Confidence 9999888765432111000 00000000000 0000000000 011112356899999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
++.+++.
T Consensus 272 ~~~~~l~ 278 (282)
T cd07829 272 SAKEALK 278 (282)
T ss_pred CHHHHhh
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=260.80 Aligned_cols=222 Identities=26% Similarity=0.401 Sum_probs=177.3
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-----C------C--CCCChHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-----K------T--GLLGWEMRV 71 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~~~~~~~~ 71 (289)
..+.+.+..|+++|+.+ +|+||+.++|++.+++..++|.||+..|+|..++++.+ . . ..+......
T Consensus 342 ~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLl 421 (609)
T KOG0200|consen 342 SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLL 421 (609)
T ss_pred cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHH
Confidence 35788999999999999 69999999999999999999999999999999997654 0 0 138888999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-ccccccccccccChhhhhcCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALRGLF 150 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~ 150 (289)
.++.||+.|++||++.. ++||||..+|||+.++..+||+|||+++......... ......-+..|||||.+....|
T Consensus 422 sfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 422 SFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred HHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence 99999999999999887 9999999999999999999999999999654433322 1111113556999999999999
Q ss_pred CCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 151 SIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 151 ~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+.++||||||+++||++| |..|++...... .+. +.++...+...+.....++.++++.||+.+|+
T Consensus 499 t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-~l~-------------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~ 564 (609)
T KOG0200|consen 499 TSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-ELL-------------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPE 564 (609)
T ss_pred cccchhhHHHHHHHHHhhCCCCCCCCCCcHH-HHH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcc
Confidence 999999999999999999 666665421111 111 11122222233344467888999999999999
Q ss_pred CCCCHHHHHHHhhcc
Q 038647 230 DRPTMLEVISMLTNE 244 (289)
Q Consensus 230 ~Rps~~~ll~~L~~~ 244 (289)
+||++.++.+.++..
T Consensus 565 ~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 565 DRPTFSECVEFFEKH 579 (609)
T ss_pred cCCCHHHHHHHHHHH
Confidence 999999999999873
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=246.91 Aligned_cols=218 Identities=23% Similarity=0.271 Sum_probs=164.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe------EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE------KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+.+|+.+++.++||||+++++++...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.|
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~a 130 (343)
T cd07851 56 IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRG 130 (343)
T ss_pred hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHH
Confidence 345778899999999999999999998876554 89999999 6689888842 468999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
|.|||+.+ ++||||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||
T Consensus 131 L~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 202 (343)
T cd07851 131 LKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred HHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence 99999888 999999999999999999999999999865332 223457888999999875 367899999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhh-----------hccCCccccccccccCC------CCHHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNL-----------WNDGRAWELMDSILQND------ASYPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~ 222 (289)
|+++|++++|+.||........ ....... +........+....... .....+..+.+++.+
T Consensus 203 Gv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~ 280 (343)
T cd07851 203 GCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK 280 (343)
T ss_pred HHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHH
Confidence 9999999999999865432211 1100000 00000000000000000 001125688999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.||++|||+.+|++
T Consensus 281 ~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 281 MLVLDPDKRITAAEALA 297 (343)
T ss_pred hCCCChhhCCCHHHHhc
Confidence 99999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=228.17 Aligned_cols=227 Identities=22% Similarity=0.291 Sum_probs=166.9
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCC--CCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPT--KTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....||+.+++.++|||++.+..+|.+ +..+++++||.+. +|.+++...+ ..+.++...+..++.||+.|+.|||+
T Consensus 72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence 345689999999999999999999987 7789999999966 7877775432 34578889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCC----CceEEcccccccccCCCCc-ccccccccccccccChhhhhcC-CCCCcccchhHH
Q 038647 87 YSRLRVIHRDLKASNILLDSN----MNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFG 160 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~----~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG 160 (289)
+. |+||||||.|||+..+ |.|||+|||+++.+.+.-. .......+-|.+|.|||.+.+. .||++.|||+.|
T Consensus 151 NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 151 NW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG 227 (438)
T ss_pred hh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHH
Confidence 98 9999999999999877 8999999999998865422 2234445678999999999986 589999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcch-------hHhHhHhhh--hccCCcccccc----------ccccCC-CCHH---------
Q 038647 161 VLVLETLSSKKNAHFYNTDSL-------TLLGHAWNL--WNDGRAWELMD----------SILQND-ASYP--------- 211 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~-------~~~~~~~~~--~~~~~~~~~~~----------~~~~~~-~~~~--------- 211 (289)
|++.||+|-.+.|........ .-+...... ......+..++ ...... .+..
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 999999998887765433211 000001111 01111111111 111000 0100
Q ss_pred -HHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 212 -MLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 212 -~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
-.+...+++.++|..||-+|.|+++.++.
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 01236789999999999999999999874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=238.48 Aligned_cols=212 Identities=24% Similarity=0.369 Sum_probs=161.1
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....+.+|+.++.+.. ||||+++++++.++...|+||||+. +++..++.. ..+.+++..+..++.|++.||.|||+
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~ 132 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKE 132 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4456777888777775 9999999999999999999999985 477766643 23478899999999999999999997
Q ss_pred -CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC----CCCcccchhHHH
Q 038647 87 -YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL----FSIKSDVFSFGV 161 (289)
Q Consensus 87 -~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~ 161 (289)
.+ ++||||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++||||||+
T Consensus 133 ~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 206 (296)
T cd06618 133 KHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI 206 (296)
T ss_pred hCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHH
Confidence 46 99999999999999999999999999876533221 12234678899999997553 789999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|+|++|..||.......... .. ..... ... . ......+.++.+++.+||+.||++||++.++++.
T Consensus 207 il~el~~g~~p~~~~~~~~~~~-~~---~~~~~-~~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 207 SLVELATGQFPYKNCKTEFEVL-TK---ILQEE-PPS-----L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHhCCCCCCcchhHHHHH-HH---HhcCC-CCC-----C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999986432221111 10 01110 000 0 0111234678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=240.47 Aligned_cols=221 Identities=23% Similarity=0.289 Sum_probs=163.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|+++++.++||||+++++++.. ++..|+|+||+ +++|..++. ...+++..+..++.|++.||.|||
T Consensus 51 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH 125 (328)
T cd07856 51 VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVH 125 (328)
T ss_pred chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356788899999999999999999999865 56789999998 568888773 245788888999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~ 164 (289)
+.+ ++||||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 126 ~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 197 (328)
T cd07856 126 SAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFA 197 (328)
T ss_pred hCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHH
Confidence 988 999999999999999999999999998754321 223456888999998866 56899999999999999
Q ss_pred HHHhCCCCcCCCCCcchhH-hHh--------HhhhhccCCccccccccccC-CCC-----HHHHHHHHHHHHcccccCCC
Q 038647 165 ETLSSKKNAHFYNTDSLTL-LGH--------AWNLWNDGRAWELMDSILQN-DAS-----YPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~l~~li~~~l~~~p~ 229 (289)
+|++|..||.......... ... .................... ..+ ...+..+.+++.+||+.+|+
T Consensus 198 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 277 (328)
T cd07856 198 EMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ 277 (328)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChh
Confidence 9999999886543211100 000 00000000000111111100 001 12346889999999999999
Q ss_pred CCCCHHHHHHH
Q 038647 230 DRPTMLEVISM 240 (289)
Q Consensus 230 ~Rps~~~ll~~ 240 (289)
+||++.+++..
T Consensus 278 ~R~t~~ell~~ 288 (328)
T cd07856 278 KRISAAEALAH 288 (328)
T ss_pred hCCCHHHHhcC
Confidence 99999999763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=237.21 Aligned_cols=222 Identities=22% Similarity=0.252 Sum_probs=164.4
Q ss_pred HHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 10 EEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 10 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
....+|+..+++++ |+|++++++++.+++..++||||+ +|+|.+++.... ...+++..+..++.|++.+|.|||+++
T Consensus 42 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~ 119 (283)
T cd07830 42 CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG 119 (283)
T ss_pred HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567999999998 999999999999999999999999 778888775422 246899999999999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~ell 167 (289)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||++.+ ..++.++|+||||+++++|+
T Consensus 120 ---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~ 193 (283)
T cd07830 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY 193 (283)
T ss_pred ---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHH
Confidence 99999999999999999999999999986543221 122457889999998854 45799999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhH-h-----hhhcc-----CCcccccccccc---CCCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 168 SSKKNAHFYNTDSLTLLGHA-W-----NLWND-----GRAWELMDSILQ---NDASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~-~-----~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
+|.+|++............. . ..|.. ............ .......+..+.+++.+||+.||++|||
T Consensus 194 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 194 TLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred hCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 99988865543211100000 0 00000 000000000000 0000112467889999999999999999
Q ss_pred HHHHHH
Q 038647 234 MLEVIS 239 (289)
Q Consensus 234 ~~~ll~ 239 (289)
++|++.
T Consensus 274 ~~ei~~ 279 (283)
T cd07830 274 ASQALQ 279 (283)
T ss_pred HHHHhh
Confidence 999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=242.33 Aligned_cols=223 Identities=22% Similarity=0.252 Sum_probs=162.1
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeec----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEH----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+.+.+|+++++++ +||||+++++.+... ...|+++||+. ++|..++. ....+++..+..++.||+.||.
T Consensus 44 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~ 119 (332)
T cd07857 44 LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLK 119 (332)
T ss_pred hHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHH
Confidence 356788999999999 599999999875432 45788999885 68888873 3456899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
|||+++ ++||||||+|||++.++.++|+|||+++........ .......|+..|+|||.+.+ ..++.++|||||
T Consensus 120 ~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl 196 (332)
T cd07857 120 YIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV 196 (332)
T ss_pred HHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence 999988 999999999999999999999999999865432211 11233468899999998865 468999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhh-----------hhccCCcccccccccc------CCCCHHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWN-----------LWNDGRAWELMDSILQ------NDASYPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~ 222 (289)
|+++|++++|..||...+... ....... ................ ..........+.+++.+
T Consensus 197 Gv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (332)
T cd07857 197 GCILAELLGRKPVFKGKDYVD--QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEK 274 (332)
T ss_pred HHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHH
Confidence 999999999999876543211 0000000 0000000000000000 00001124578899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.||++|||+.+++.
T Consensus 275 ~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 275 LLAFDPTKRISVEEALE 291 (332)
T ss_pred HccCCcccCCCHHHHhc
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=245.39 Aligned_cols=224 Identities=21% Similarity=0.227 Sum_probs=160.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec--------------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--------------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 72 (289)
...+.+.+|+++++.++||||+++++++... ...|+|+||++ ++|.+++. .+.+++..+..
T Consensus 44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~ 118 (342)
T cd07854 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARL 118 (342)
T ss_pred chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHH
Confidence 4567899999999999999999999876543 35799999996 58887773 24588999999
Q ss_pred HHHHHHHHHHHHhcCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCccc-ccccccccccccChhhhhc-CC
Q 038647 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQS-NTKRIVGTYGYMSPEYALR-GL 149 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~ 149 (289)
++.||+.||.|||+.+ ++||||||+||+++ .++.++|+|||.++......... ......++..|+|||.+.+ ..
T Consensus 119 ~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 195 (342)
T cd07854 119 FMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN 195 (342)
T ss_pred HHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccc
Confidence 9999999999999888 99999999999997 45678999999987653221111 1122357888999998764 56
Q ss_pred CCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhh----------hccCCccccccccccCCC-----CHHHHH
Q 038647 150 FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNL----------WNDGRAWELMDSILQNDA-----SYPMLN 214 (289)
Q Consensus 150 ~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~-----~~~~~~ 214 (289)
++.++|||||||++|+|++|+.||.......... ...... +................. ......
T Consensus 196 ~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (342)
T cd07854 196 YTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ-LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274 (342)
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCH
Confidence 8899999999999999999999986543221110 000000 000000000000000000 112346
Q ss_pred HHHHHHHcccccCCCCCCCHHHHHH
Q 038647 215 RYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++.+++.+||+.||++|||+.+++.
T Consensus 275 ~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 275 EALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHHHHhCCCchhccCHHHHhC
Confidence 7889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=235.38 Aligned_cols=216 Identities=24% Similarity=0.346 Sum_probs=171.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEe-ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
-.+...+|.+|-+.+.||.||++|++|. +.+..|-|+|||+|.+|+.+| +..+.+++..+..|+.||+.||.||.+
T Consensus 510 YhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNE 586 (775)
T KOG1151|consen 510 YHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNE 586 (775)
T ss_pred HHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhc
Confidence 4667789999999999999999999996 556789999999999999999 456779999999999999999999999
Q ss_pred CCCCceEeeccccCceEeC---CCCceEEcccccccccCCCCccc-----ccccccccccccChhhhhc----CCCCCcc
Q 038647 87 YSRLRVIHRDLKASNILLD---SNMNPKISDFGIARLFGGDELQS-----NTKRIVGTYGYMSPEYALR----GLFSIKS 154 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~---~~~~vkl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~----~~~~~~~ 154 (289)
. +.+|+|-||||.|||+- ..|.+||.|||+++.+....... .+....||.+|++||.+.- ...+.|.
T Consensus 587 i-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKV 665 (775)
T KOG1151|consen 587 I-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKV 665 (775)
T ss_pred c-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccce
Confidence 8 57899999999999994 45779999999999987655432 3455679999999998863 3469999
Q ss_pred cchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccC-CCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQN-DASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
||||+||++|..+.|+.||...-.... ++ ... .+++..... ...+..+.+..++|++||++-.++|..
T Consensus 666 DVWSvGVIFyQClYGrKPFGhnqsQQd-IL-------qeN---TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 666 DVWSVGVIFYQCLYGRKPFGHNQSQQD-IL-------QEN---TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred eeEeeehhhhhhhccCCCCCCchhHHH-HH-------hhh---chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh
Confidence 999999999999999999875433221 11 111 112221111 122234567889999999999999988
Q ss_pred HHHHH
Q 038647 234 MLEVI 238 (289)
Q Consensus 234 ~~~ll 238 (289)
+.++.
T Consensus 735 V~qLA 739 (775)
T KOG1151|consen 735 VQQLA 739 (775)
T ss_pred HHHHc
Confidence 87764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=243.64 Aligned_cols=219 Identities=20% Similarity=0.244 Sum_probs=161.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+.+.+|+.++++++||||+++++++... ...|++++++ +++|.+++.. ..+++..+..++.|++.||
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL 133 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGL 133 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHH
Confidence 456788999999999999999999988643 3478888887 7789887732 3588999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 160 (289)
.|||+.+ ++||||||+||+++.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++||||||
T Consensus 134 ~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG 205 (345)
T cd07877 134 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 205 (345)
T ss_pred HHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHH
Confidence 9999988 999999999999999999999999998764321 223467889999999876 5689999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHh---------HhhhhccCCcccccc---ccccC---CCCHHHHHHHHHHHHcccc
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGH---------AWNLWNDGRAWELMD---SILQN---DASYPMLNRYINVALLCVQ 225 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~ 225 (289)
|++|+|++|+.||............. ............... ..... ......+..+.+++..||+
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 285 (345)
T cd07877 206 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 285 (345)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcC
Confidence 99999999999886433221100000 000000000000000 00000 0000124578899999999
Q ss_pred cCCCCCCCHHHHHH
Q 038647 226 ENAADRPTMLEVIS 239 (289)
Q Consensus 226 ~~p~~Rps~~~ll~ 239 (289)
.||.+||++.+++.
T Consensus 286 ~dp~~R~t~~e~l~ 299 (345)
T cd07877 286 LDSDKRITAAQALA 299 (345)
T ss_pred CChhhcCCHHHHhc
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=243.64 Aligned_cols=219 Identities=21% Similarity=0.231 Sum_probs=162.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+.+.+|+.+|++++||||+++++++..+. ..++||||+ +++|..++. ...+++..+..++.|++.||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al 131 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGL 131 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999987654 458999999 778988773 24688999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 160 (289)
.|||+.+ |+||||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||
T Consensus 132 ~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 203 (343)
T cd07880 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVG 203 (343)
T ss_pred HHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHH
Confidence 9999888 999999999999999999999999998865322 223457889999999876 4588999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhH---------hHhhhhccCCccccccccccC------CCCHHHHHHHHHHHHcccc
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLG---------HAWNLWNDGRAWELMDSILQN------DASYPMLNRYINVALLCVQ 225 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~ 225 (289)
+++|++++|..||............ ..................... ......+..+.+++.+|++
T Consensus 204 ~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 283 (343)
T cd07880 204 CIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLV 283 (343)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcC
Confidence 9999999999998644321110000 000000000000000000000 0011234568899999999
Q ss_pred cCCCCCCCHHHHHH
Q 038647 226 ENAADRPTMLEVIS 239 (289)
Q Consensus 226 ~~p~~Rps~~~ll~ 239 (289)
.||++|||+.+++.
T Consensus 284 ~dP~~R~t~~~~l~ 297 (343)
T cd07880 284 LDAESRITAAEALA 297 (343)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=243.43 Aligned_cols=216 Identities=23% Similarity=0.279 Sum_probs=159.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+.+.+|+++++.++||||+++++++.... ..++|+||+.. +|..+. ...+++..+..++.|++.||
T Consensus 57 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL 130 (342)
T cd07879 57 FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGL 130 (342)
T ss_pred chhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999987543 46999999964 676655 13578899999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 160 (289)
.|||+.+ ++||||||+||+++.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++||||||
T Consensus 131 ~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 202 (342)
T cd07879 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVG 202 (342)
T ss_pred HHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHH
Confidence 9999988 999999999999999999999999998764321 223457889999999876 4689999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhh-----------ccCCccccccc---cccCCC---CHHHHHHHHHHHHcc
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLW-----------NDGRAWELMDS---ILQNDA---SYPMLNRYINVALLC 223 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~~ 223 (289)
+++|+|++|+.||...+.... ....+... ........... ...... .+..+..+.+++..|
T Consensus 203 vil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 280 (342)
T cd07879 203 CIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKM 280 (342)
T ss_pred HHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHH
Confidence 999999999999875432111 11111000 00000000000 000000 011345688999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|+.||++||++.+++.
T Consensus 281 l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 281 LELDVDKRLTATEALE 296 (342)
T ss_pred cCCChhhCcCHHHHhc
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=227.80 Aligned_cols=210 Identities=27% Similarity=0.347 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+.+|++.+++++|+|++++++++......++++||+++++|..++.. ...+++..+..++.+++.++.+||+.+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~ 107 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK---RGRLSEDEARFYARQILSALEYLHSNG 107 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 78999999999999999999999999999999999999999999998843 223889999999999999999999887
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|||+||++++++++
T Consensus 108 ---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~ 181 (244)
T smart00220 108 ---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT 181 (244)
T ss_pred ---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999998765432 2333467889999999998889999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|..|+........ .... ....... ........+.++.+++.+||..+|++||++.++++
T Consensus 182 ~~~p~~~~~~~~~-~~~~----~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 182 GKPPFPGDDQLLE-LFKK----IGKPKPP-------FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCCCCCcHHH-HHHH----HhccCCC-------CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 9988765321111 1000 0000000 00000004468899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=234.26 Aligned_cols=240 Identities=24% Similarity=0.317 Sum_probs=181.0
Q ss_pred CCCcccCHHHHHHHHHHHhhC--CCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHH
Q 038647 2 SSQSGQGLEEFKNEMMLIAKL--QHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILE 75 (289)
Q Consensus 2 ~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 75 (289)
+....+..+.|+.|-.|.+.. +|+||++++++-..+. .++||++|.+.|+|.++|. ...++|....+++.
T Consensus 239 Kifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~----~ntisw~~~cria~ 314 (534)
T KOG3653|consen 239 KIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK----ANTISWNSLCRIAE 314 (534)
T ss_pred EecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH----hccccHHHHHHHHH
Confidence 345677889999998887765 7999999999877655 7899999999999999994 35799999999999
Q ss_pred HHHHHHHHHhc------CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC
Q 038647 76 GVAQGLLYLHH------YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL 149 (289)
Q Consensus 76 ~i~~~l~~lH~------~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 149 (289)
.++.||+|||+ +.+.+|+|||||..|||+..++...|+|||++..+..+......-..+||.+|||||++.+..
T Consensus 315 SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgai 394 (534)
T KOG3653|consen 315 SMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI 394 (534)
T ss_pred HHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhc
Confidence 99999999996 234569999999999999999999999999999987666666666689999999999998753
Q ss_pred -CC-----CcccchhHHHHHHHHHhCCCCcCCCCC--cchhHh---------HhHhh-hhccCCccccccccccCCCCHH
Q 038647 150 -FS-----IKSDVFSFGVLVLETLSSKKNAHFYNT--DSLTLL---------GHAWN-LWNDGRAWELMDSILQNDASYP 211 (289)
Q Consensus 150 -~~-----~~~DiwslG~vl~elltg~~p~~~~~~--~~~~~~---------~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 211 (289)
+. .+.||||+|.|+||+++...-+..... .+..+- ...+. .........+.+.-... .
T Consensus 395 nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~ 470 (534)
T KOG3653|consen 395 NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----A 470 (534)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----c
Confidence 33 468999999999999997755432111 111110 00011 01111111111111111 2
Q ss_pred HHHHHHHHHHcccccCCCCCCCHHHHHHHhhcccCCCC
Q 038647 212 MLNRYINVALLCVQENAADRPTMLEVISMLTNENVILP 249 (289)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~~~ 249 (289)
...-+.+.+..||..||+.|.|+.=+-+.+.+.....+
T Consensus 471 ~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 471 GMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 34567889999999999999999999998888764443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=256.00 Aligned_cols=212 Identities=21% Similarity=0.224 Sum_probs=169.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....|..|-.+|..-+.+=|+.++.+|++++++|+||||++||+|-.++.+ -..+++..+..++..|+.||.-||+.
T Consensus 118 ~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~m 194 (1317)
T KOG0612|consen 118 ETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSM 194 (1317)
T ss_pred hHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhc
Confidence 346788899999999999999999999999999999999999999999943 34799999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh----c-CCCCCcccchhHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL----R-GLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~DiwslG~v 162 (289)
| +|||||||+|||+|.+|++||+|||.+-.+...... .....+|||-|++||++. + +.|++.+|.||+||+
T Consensus 195 g---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~ 270 (1317)
T KOG0612|consen 195 G---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVF 270 (1317)
T ss_pred c---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHH
Confidence 8 999999999999999999999999999887644432 345568999999999997 2 568999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC---HHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT---MLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 239 (289)
+|||+.|..||...+.. .....+...... +.=+....++....+||...+. +|+.|-. ++++-.
T Consensus 271 ~YEMlyG~TPFYadslv-----eTY~KIm~hk~~-------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 271 MYEMLYGETPFYADSLV-----ETYGKIMNHKES-------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHcCCCcchHHHHH-----HHHHHHhchhhh-------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 99999999998643321 111111111111 1111123367888899988775 7788876 777654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=249.70 Aligned_cols=221 Identities=26% Similarity=0.344 Sum_probs=182.2
Q ss_pred CCCcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 2 ~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
+.++.+..++|..|+-+|.+++|||++++++++.... +.||++|++.|+|.++++. .+..+..+..+.|+.||++||
T Consensus 735 ~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM 811 (1177)
T KOG1025|consen 735 EFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGM 811 (1177)
T ss_pred ccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHH
Confidence 4566778899999999999999999999999998776 8899999999999999975 455688999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
.|||++. +|||||-.+|+|+.+...+||.|||+++........-......-.+.|+|-|.+....|+.++|||||||
T Consensus 812 ~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGV 888 (1177)
T KOG1025|consen 812 KYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGV 888 (1177)
T ss_pred HHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhh
Confidence 9999887 9999999999999999999999999999876554333333333467899999999999999999999999
Q ss_pred HHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
.+||++| |..|+........ ..+++.-.+-..++-.+.++..++.+||..|+..||+++++...
T Consensus 889 tiWElmTFGa~Py~gi~~~eI---------------~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 889 TIWELMTFGAKPYDGIPAEEI---------------PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred hHHHHHhcCCCccCCCCHHHh---------------hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHH
Confidence 9999998 7777654433222 22222222333344456788899999999999999999999987
Q ss_pred hhc
Q 038647 241 LTN 243 (289)
Q Consensus 241 L~~ 243 (289)
+.+
T Consensus 954 fs~ 956 (1177)
T KOG1025|consen 954 FSR 956 (1177)
T ss_pred HHH
Confidence 765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=251.18 Aligned_cols=106 Identities=28% Similarity=0.445 Sum_probs=98.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+++.++||||+++++++...+..|+||||+.+++|.+++. ..+.+++..++.++.||+.||.|||.+
T Consensus 47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~---~~~~l~~~~~~~i~~qil~aL~yLH~~ 123 (669)
T cd05610 47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLHRH 123 (669)
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35788999999999999999999999999999999999999999999984 335688899999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEccccccc
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~ 119 (289)
+ |+||||||+|||++.++.+||+|||+++
T Consensus 124 g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 124 G---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred C---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7 9999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=237.42 Aligned_cols=212 Identities=22% Similarity=0.316 Sum_probs=171.7
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+.+..++.+|+.||++++||.||.+.-.|++.+.+++|||.+.|.-|+-++. .+.+.+++..-..++.||+.||.|||
T Consensus 604 ~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH 681 (888)
T KOG4236|consen 604 TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLH 681 (888)
T ss_pred CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhh
Confidence 4556889999999999999999999999999999999999996655555553 35678999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCC---CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSN---MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~---~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
.++ |+|+||||+|||+... -++||+|||+++..+..++ ..+.+|||.|+|||++.+..|...-|+||.|++
T Consensus 682 ~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVI 755 (888)
T KOG4236|consen 682 FKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVI 755 (888)
T ss_pred hcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEE
Confidence 988 9999999999999654 4589999999999876543 445689999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|--++|-.||....+-..++. .+ ........=.+++...+++|...|+..-++|.|...-+.
T Consensus 756 iYVsLSGTFPFNEdEdIndQIQ-NA-------------aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 756 IYVSLSGTFPFNEDEDINDQIQ-NA-------------AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred EEEEecccccCCCccchhHHhh-cc-------------ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 9999999988764433222111 00 001111222345678899999999999999999887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=236.91 Aligned_cols=169 Identities=22% Similarity=0.391 Sum_probs=147.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+++...+.|-.||..-..+-||++|..|++++.+|+||||++||++-.+|. .-+.+++..+..++..+..|++++|
T Consensus 670 rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVH 746 (1034)
T KOG0608|consen 670 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVH 746 (1034)
T ss_pred hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHH
Confidence 4567788899999999999999999999999999999999999999988884 4578999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEccccccccc---------CCCCc------------------------------
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF---------GGDEL------------------------------ 126 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~---------~~~~~------------------------------ 126 (289)
..| +|||||||+|||||.+|.+||.|||++.-+ ..+..
T Consensus 747 kmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h 823 (1034)
T KOG0608|consen 747 KMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQH 823 (1034)
T ss_pred hcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhh
Confidence 888 999999999999999999999999997532 11110
Q ss_pred -ccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcc
Q 038647 127 -QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180 (289)
Q Consensus 127 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~ 180 (289)
.......+||+.|+|||++....|+..+|.||.|||||||+.|+.||.......
T Consensus 824 ~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 824 QRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred hhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 001124579999999999999999999999999999999999999997665543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=224.30 Aligned_cols=218 Identities=20% Similarity=0.200 Sum_probs=162.8
Q ss_pred HHHHHHHHHHhhCC--CC----CceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 10 EEFKNEMMLIAKLQ--HR----NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 10 ~~~~~E~~~l~~l~--h~----niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+..+-|+++|+++. -| -+|++.++|.-.++.|+|+|.+ |.++.+++..+ .-.+++..++..+..|+++++++
T Consensus 130 eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~f 207 (415)
T KOG0671|consen 130 EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAF 207 (415)
T ss_pred hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHH
Confidence 44556999999994 22 3788899999999999999988 66999999653 33568889999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCC--------------------CCceEEcccccccccCCCCcccccccccccccccChh
Q 038647 84 LHHYSRLRVIHRDLKASNILLDS--------------------NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPE 143 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~--------------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE 143 (289)
||+.+ ++|.||||+||++-. +..|+|+|||.++..... ....+.|..|.|||
T Consensus 208 Lh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPE 279 (415)
T KOG0671|consen 208 LHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPE 279 (415)
T ss_pred HHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCch
Confidence 99877 999999999999821 334899999999865332 35567899999999
Q ss_pred hhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhc-----------------cC-------Ccccc
Q 038647 144 YALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWN-----------------DG-------RAWEL 199 (289)
Q Consensus 144 ~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------------~~-------~~~~~ 199 (289)
++.+-+|+..+||||+||||+||.||...|....+.. .+........ .+ ....-
T Consensus 280 ViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E--HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~ 357 (415)
T KOG0671|consen 280 VILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE--HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK 357 (415)
T ss_pred heeccCcCCccCceeeeeEEEEeeccceecccCCcHH--HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc
Confidence 9999999999999999999999999998887655322 1111111111 00 00000
Q ss_pred ccccccCC--------CCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 200 MDSILQND--------ASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 200 ~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+...... .....-..+.+|+..||.+||.+|+|+.|+++
T Consensus 358 ~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 358 SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 00000000 01113357899999999999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=242.28 Aligned_cols=212 Identities=23% Similarity=0.368 Sum_probs=175.7
Q ss_pred CcccCHHHHHHHHHHHhhC-CCCCceeeeeeEee-----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV 77 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i 77 (289)
...+.-++.+.|.++|+.. +|||++.++++|.. ++.++||||||.+|+..++++... ...+.|+.+.-++..+
T Consensus 54 ~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~ 132 (953)
T KOG0587|consen 54 PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREI 132 (953)
T ss_pred CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHH
Confidence 3455677888899999999 69999999999964 568999999999999999997655 7789999999999999
Q ss_pred HHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----CCCCC
Q 038647 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----GLFSI 152 (289)
Q Consensus 78 ~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~ 152 (289)
+.||.+||.+. ++|||||-.|||++.++.|||+|||++...... .....+..||+.|||||++.. ..|+.
T Consensus 133 lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~ 207 (953)
T KOG0587|consen 133 LRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDY 207 (953)
T ss_pred HHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCccc
Confidence 99999999876 999999999999999999999999999876543 334566789999999999973 34789
Q ss_pred cccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCC-----CCHHHHHHHHHHHHcccccC
Q 038647 153 KSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND-----ASYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 153 ~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~ 227 (289)
.+|+||||++..||.-|.+|+-....- ..+-.+.++. .+....+++.++|..||..|
T Consensus 208 R~D~WsLGITaIEladG~PPl~DmHPm------------------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd 269 (953)
T KOG0587|consen 208 RSDLWSLGITAIEMAEGAPPLCDMHPM------------------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKD 269 (953)
T ss_pred ccchhhccceeehhcCCCCCccCcchh------------------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhc
Confidence 999999999999999999986532211 1122222221 13346788999999999999
Q ss_pred CCCCCCHHHHHH
Q 038647 228 AADRPTMLEVIS 239 (289)
Q Consensus 228 p~~Rps~~~ll~ 239 (289)
.++||++.++++
T Consensus 270 ~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 270 YEQRPSTEELLK 281 (953)
T ss_pred cccCcchhhhcc
Confidence 999999999876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-33 Score=227.71 Aligned_cols=201 Identities=25% Similarity=0.337 Sum_probs=168.0
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
.++.-+.|-++|..- +-|.+++++..|++-+.+|+||||+.||+|-..+ +.-+.+.+..+..++..|+-||-+||+
T Consensus 392 Dvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~ 468 (683)
T KOG0696|consen 392 DVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHS 468 (683)
T ss_pred cccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhc
Confidence 344455677788777 6889999999999999999999999999998888 445778889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+| |++||||.+|||++..|.+||+|||+.+..-.. ...+.+++|||.|+|||++.-++|+.++|.||+||+||||
T Consensus 469 kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEm 543 (683)
T KOG0696|consen 469 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 543 (683)
T ss_pred CC---eeeeeccccceEeccCCceEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHH
Confidence 98 999999999999999999999999999854322 3457788999999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+.|++||.+.+.+.. ... +.+. ...++...+.+..++....|..+|.+|.
T Consensus 544 laGQpPFdGeDE~el--F~a------------I~eh--nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 544 LAGQPPFDGEDEDEL--FQA------------IMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HcCCCCCCCCCHHHH--HHH------------HHHc--cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 999999886554421 111 1111 1245566778888999999999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=212.19 Aligned_cols=223 Identities=20% Similarity=0.333 Sum_probs=167.0
Q ss_pred HHHHHHHHhhCCCCCceeeeeeEee--------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 12 FKNEMMLIAKLQHRNLVRLFGCCIE--------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 12 ~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
..+|+++|+.++|+|++.+++.|.. ...+|+||++|+. +|.-++.. ....++..++.+++.++..||.|
T Consensus 63 alreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~ 139 (376)
T KOG0669|consen 63 ALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYY 139 (376)
T ss_pred HHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHH
Confidence 3589999999999999999988864 2358999999965 78888843 23568899999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhcC-CCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG 160 (289)
+|... |+|||+|+.|+||+.++.+||+|||+++.+...... ......+-|.+|.+||.+.+. .|+++.|||..|
T Consensus 140 iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 140 IHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred HHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 99766 999999999999999999999999999876543322 223345668999999999874 689999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcch-hHhHhHhh-----hhccCCccccccccccCCC----C---HHH------HHHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSL-TLLGHAWN-----LWNDGRAWELMDSILQNDA----S---YPM------LNRYINVAL 221 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~~~----~---~~~------~~~l~~li~ 221 (289)
|++.+|+||.+.+........ .++....+ .|..-....+...+..... . .+. -.+..+++.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 999999999988776655422 22221111 1333222223332211100 0 011 136678999
Q ss_pred cccccCCCCCCCHHHHHHH
Q 038647 222 LCVQENAADRPTMLEVISM 240 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~~ 240 (289)
.++..||.+|+.+.+++..
T Consensus 297 ~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 297 KLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCcccCcchHhhhch
Confidence 9999999999999998864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=220.27 Aligned_cols=224 Identities=22% Similarity=0.289 Sum_probs=185.0
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhc-----CCCCCCCCChHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLF-----DPTKTGLLGWEMRVRILEGV 77 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~~~~~i 77 (289)
.++-++..|..|.-.|..+.|||+..+.+++.+ ....++++.++.-|+|..|+. +.+....++..+...++.|+
T Consensus 326 AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQl 405 (563)
T KOG1024|consen 326 ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQL 405 (563)
T ss_pred ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHH
Confidence 345567888899999999999999999999865 457888999999999999997 44555678888899999999
Q ss_pred HHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccch
Q 038647 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 78 ~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
+.|++|||.++ ++|.||..+|++|++..+|||+|-.++|..-..++.........+..||+||.+.+..|+.++|+|
T Consensus 406 a~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvW 482 (563)
T KOG1024|consen 406 AMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVW 482 (563)
T ss_pred HHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhH
Confidence 99999999988 999999999999999999999999999988777777766666778899999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||+++|||+| |+.|+...+..... ..++...+-..+.+.++++..++.-||+..|++||++.+
T Consensus 483 sfGVllWELmtlg~~PyaeIDPfEm~---------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 483 SFGVLLWELMTLGKLPYAEIDPFEME---------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred HHHHHHHHHHhcCCCCccccCHHHHH---------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 99999999998 66664432221111 111111222334456789999999999999999999999
Q ss_pred HHHHhhccc
Q 038647 237 VISMLTNEN 245 (289)
Q Consensus 237 ll~~L~~~~ 245 (289)
+..-|.+..
T Consensus 548 lv~cLseF~ 556 (563)
T KOG1024|consen 548 LVICLSEFH 556 (563)
T ss_pred HHHHHHHHH
Confidence 999988754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=221.60 Aligned_cols=233 Identities=23% Similarity=0.270 Sum_probs=174.9
Q ss_pred cccCHHHHHHHHHHHhhC--CCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKL--QHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVA 78 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~ 78 (289)
+..+.+.+.||.+|.+.+ +|+||+.+++.-..++ .++||++|.+.|+|.++|. ...++.+..+++++.++
T Consensus 243 ~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~A 318 (513)
T KOG2052|consen 243 SSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIA 318 (513)
T ss_pred cccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHh
Confidence 445678899999999887 8999999998865443 6899999999999999994 25688999999999999
Q ss_pred HHHHHHh-----cCCCCceEeeccccCceEeCCCCceEEcccccccccCCC--CcccccccccccccccChhhhhcCC--
Q 038647 79 QGLLYLH-----HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD--ELQSNTKRIVGTYGYMSPEYALRGL-- 149 (289)
Q Consensus 79 ~~l~~lH-----~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~-- 149 (289)
.||++|| .+|+..|.|||||+.|||+.+++...|+|+|+|...... ......+..+||.+|||||++...-
T Consensus 319 sGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~ 398 (513)
T KOG2052|consen 319 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINM 398 (513)
T ss_pred hhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcCh
Confidence 9999999 367788999999999999999999999999999877543 3334456678999999999997532
Q ss_pred --C--CCcccchhHHHHHHHHHhCC----------CCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHH
Q 038647 150 --F--SIKSDVFSFGVLVLETLSSK----------KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNR 215 (289)
Q Consensus 150 --~--~~~~DiwslG~vl~elltg~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (289)
+ -..+||||||.|+||+.-.. .||...-..+..+-.. ...-=..++.-.+...-...+....
T Consensus 399 ~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM----rkVVCv~~~RP~ipnrW~s~~~l~~ 474 (513)
T KOG2052|consen 399 KHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM----RKVVCVQKLRPNIPNRWKSDPALRV 474 (513)
T ss_pred hhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH----hcceeecccCCCCCcccccCHHHHH
Confidence 2 24699999999999998633 2222111111110000 0000001111122233444566788
Q ss_pred HHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 216 YINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 216 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
+.++++.||..||.-|-|+--+-+.|.+..
T Consensus 475 m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 475 MAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred HHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 899999999999999999999998888765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=199.74 Aligned_cols=221 Identities=24% Similarity=0.261 Sum_probs=168.3
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
...+|+-+|+.++|+|||+++++...++.+-+|+|||.. +|..+.. .-++.++.+....++.|++.||.++|+++
T Consensus 47 salreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn-- 121 (292)
T KOG0662|consen 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN-- 121 (292)
T ss_pred HHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh--
Confidence 467899999999999999999999999999999999954 7877763 34678999999999999999999999988
Q ss_pred ceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHHHhC
Q 038647 91 RVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~elltg 169 (289)
+.|||+||+|.+|+.+|.+|++|||+++.++-. .......+-|.+|.+|.++.+. -|+...|+||-||++.|+...
T Consensus 122 -vlhrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelana 198 (292)
T KOG0662|consen 122 -VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_pred -hhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhc
Confidence 999999999999999999999999999987543 2334445678999999999986 479999999999999999886
Q ss_pred CCCcCCCCCcchhHhHhHhhhh--ccCCcc---ccccccccCCCC---------HHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 170 KKNAHFYNTDSLTLLGHAWNLW--NDGRAW---ELMDSILQNDAS---------YPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 170 ~~p~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
..|....+....++.+..+..- ...... .+.+-.....++ +.....-++++.+.+.-+|..|.+++
T Consensus 199 grplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae 278 (292)
T KOG0662|consen 199 GRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE 278 (292)
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence 6564444444444444433321 111111 111111111111 11122346888999999999999999
Q ss_pred HHHH
Q 038647 236 EVIS 239 (289)
Q Consensus 236 ~ll~ 239 (289)
+.++
T Consensus 279 aalq 282 (292)
T KOG0662|consen 279 AALQ 282 (292)
T ss_pred HHhc
Confidence 9876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=238.76 Aligned_cols=211 Identities=21% Similarity=0.293 Sum_probs=159.8
Q ss_pred HHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 10 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
+...+|+..|+.- .|||||++++.-.+.+..||..|.|.. +|++++... .+.........+..+.|++.||++||+.
T Consensus 547 ~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl 625 (903)
T KOG1027|consen 547 DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL 625 (903)
T ss_pred HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc
Confidence 3456899999999 599999999999999999999999965 899999652 1111111134578899999999999987
Q ss_pred CCCceEeeccccCceEeCC---C--CceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 88 SRLRVIHRDLKASNILLDS---N--MNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~---~--~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
+ ||||||||+||||+. + ..++|+|||+++....+... .......||.+|+|||++....-+..+||||+||
T Consensus 626 ~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGC 702 (903)
T KOG1027|consen 626 K---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGC 702 (903)
T ss_pred c---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCc
Confidence 7 999999999999976 2 45899999999988655322 2245567999999999999988899999999999
Q ss_pred HHHHHHhC-CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSS-KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+.++| .+||...-..+..++.. ......+. ...+. ...+||.+|+..+|..||++.+|+.
T Consensus 703 vfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~~L~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 703 VFYYVLTGGSHPFGDSLERQANILTG-------NYTLVHLE------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eEEEEecCCccCCCchHHhhhhhhcC-------ccceeeec------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 99999997 67776433322221111 11000011 01111 6789999999999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-33 Score=218.83 Aligned_cols=218 Identities=23% Similarity=0.307 Sum_probs=166.0
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP--TKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
...++|..|.+...+- +.||||+++|++-.++..++.||+|. .+|+.+.... .....++++.+-++....+.||.|
T Consensus 104 keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~y 182 (361)
T KOG1006|consen 104 KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDY 182 (361)
T ss_pred HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHH
Confidence 3456777888765555 79999999999999999999999994 4776654221 234568899899999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc--CCCCCcccchhHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGV 161 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~ 161 (289)
|... ..|+|||+||+|||++..|.+||+|||++......- ....-.|-..|+|||.+.. ..|+.++||||||+
T Consensus 183 LK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 183 LKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGI 257 (361)
T ss_pred HHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcc
Confidence 9873 469999999999999999999999999987653221 1122357788999999973 45999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|||+.||..|+..++....++.... .+.. ..+.........+..+..+|..||..|-++||...++.+
T Consensus 258 TL~EvAtG~fPyr~w~svfeql~~Vv-----~gdp----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVFEQLCQVV-----IGDP----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eEeeeecCCCCcchHHHHHHHHHHHH-----cCCC----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 99999999999876654322221111 1111 112223333456678899999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=212.12 Aligned_cols=222 Identities=23% Similarity=0.235 Sum_probs=164.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....++..+|+.++..++|+||++++.+|.-. ...|+|||+|. ++|...+. -.++-+++..+++|++.
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~ 129 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLC 129 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHH
Confidence 45677889999999999999999999999643 46899999995 47877663 34667889999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
|++|||+.+ |+||||||+||++..+..+||.|||+++.-+.. -.....+.+..|.|||++.+..+.+.+||||+
T Consensus 130 ~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSv 203 (369)
T KOG0665|consen 130 GIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (369)
T ss_pred HHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhh
Confidence 999999888 999999999999999999999999999865432 22344567889999999999889999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCc-chhHh----------------HhHhhhhccCCc------cccc-ccccc--CCCCHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTD-SLTLL----------------GHAWNLWNDGRA------WELM-DSILQ--NDASYPML 213 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~-~~~~~----------------~~~~~~~~~~~~------~~~~-~~~~~--~~~~~~~~ 213 (289)
||++.||++|.-.|++...- +.... ..+......... .+.+ +.... .+.++.-.
T Consensus 204 Gci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~ 283 (369)
T KOG0665|consen 204 GCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDC 283 (369)
T ss_pred hhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccch
Confidence 99999999999887743321 11110 111111110000 0000 00000 01111123
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 214 NRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 214 ~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
..+.+++.+||..||++|.|++++|+
T Consensus 284 ~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 284 SLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHHHHhhccChhhcccHHHHhc
Confidence 45678999999999999999999987
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=251.54 Aligned_cols=198 Identities=16% Similarity=0.177 Sum_probs=140.7
Q ss_pred HhhCCC-CCceeeeeeE-------eecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 19 IAKLQH-RNLVRLFGCC-------IEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 19 l~~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
.+.++| +||++++++| .+...++.++||+ +++|.+++.. ....+++..+..++.||+.||.|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 456667 7888999988 3334677888987 6699999953 2356899999999999999999999988
Q ss_pred ceEeeccccCceEeCC-------------------CCceEEcccccccccCCCCc--------------ccccccccccc
Q 038647 91 RVIHRDLKASNILLDS-------------------NMNPKISDFGIARLFGGDEL--------------QSNTKRIVGTY 137 (289)
Q Consensus 91 ~ivH~dikp~Nill~~-------------------~~~vkl~Dfg~~~~~~~~~~--------------~~~~~~~~g~~ 137 (289)
|+||||||+|||++. ++.+|++|||+++....... ........||+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999954 44566667776654211000 00011235788
Q ss_pred cccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHH
Q 038647 138 GYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYI 217 (289)
Q Consensus 138 ~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 217 (289)
.|+|||++.+..++.++|||||||++|||++|.+|+...... . .. ... .... ...........
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~-~~----~~~--------~~~~-~~~~~~~~~~~ 242 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---M-SS----LRH--------RVLP-PQILLNWPKEA 242 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---H-HH----HHH--------hhcC-hhhhhcCHHHH
Confidence 899999999999999999999999999999988764321100 0 00 000 0000 00011123456
Q ss_pred HHHHcccccCCCCCCCHHHHHH
Q 038647 218 NVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 218 ~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7888999999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=208.31 Aligned_cols=208 Identities=19% Similarity=0.304 Sum_probs=164.8
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+.++=.+.|-.+..+- +||.+|.++..|+++..+++|.||++||+|--++ ..+..++++.+..+...|+.||.|||
T Consensus 292 edidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh 368 (593)
T KOG0695|consen 292 EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLH 368 (593)
T ss_pred ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHh
Confidence 3455566777777776 7999999999999999999999999999996666 45677999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+.| |++||||.+|+|++..|.+||.|+|..+..-.. ...+.+++|||.|.|||++.+..|....|.|+||++++|
T Consensus 369 ~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 369 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 443 (593)
T ss_pred hcC---eeeeeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHH
Confidence 988 999999999999999999999999998864322 334677899999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhH--hHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLG--HAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
|+.|+.||..-+........ ...... +++-+ ..+...+.....+++.-|..||.+|.
T Consensus 444 mmagrspfdivgm~n~d~ntedylfqvi--------lekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 444 MMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHcCCCCcceecCCCcccchhHHHHHHH--------hhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 99999999765543221111 111111 11111 11223344556778888999999985
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=239.52 Aligned_cols=182 Identities=25% Similarity=0.348 Sum_probs=133.8
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccc
Q 038647 39 EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118 (289)
Q Consensus 39 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~ 118 (289)
.+||=||||+..++.+++.++.... .....++++.+|++||.|+|++| ||||||||.|||+++++.|||+|||++
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccc
Confidence 4688899999988888884422211 46778999999999999999988 999999999999999999999999999
Q ss_pred cccC----------------CCCcccccccccccccccChhhhhcCC---CCCcccchhHHHHHHHHHhCCCCcCCCCCc
Q 038647 119 RLFG----------------GDELQSNTKRIVGTYGYMSPEYALRGL---FSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179 (289)
Q Consensus 119 ~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~vl~elltg~~p~~~~~~~ 179 (289)
.... .+..........||.-|+|||++.+.. |+.|+|+||||+|+|||+. ||......
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER 821 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER 821 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH
Confidence 8721 111122345668999999999998654 9999999999999999985 34433222
Q ss_pred chhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
. ..+ ...+.+....- .....+....-.++|+++++.||++|||+.|+|+
T Consensus 822 a-~iL----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 822 A-SIL----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred H-HHH----HhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1 111 11111111111 1122233345678999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=195.89 Aligned_cols=172 Identities=29% Similarity=0.401 Sum_probs=141.9
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+..+++.+|+.+..+. ..|.+|.++|..-.....++.||.| ..+|+.+..+. ...+.+++..+-+++..++.||.|
T Consensus 85 ~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~ 163 (282)
T KOG0984|consen 85 SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEF 163 (282)
T ss_pred hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHH
Confidence 34566777888887666 7999999999999999999999999 45888776542 346789999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc----CCCCCcccchhH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR----GLFSIKSDVFSF 159 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Diwsl 159 (289)
||+ +..++|||+||+|||++..|+||++|||++....+.- ......|-..|+|||.+.. ..|+.++|||||
T Consensus 164 L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSL 238 (282)
T KOG0984|consen 164 LHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSL 238 (282)
T ss_pred HHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhh
Confidence 998 4579999999999999999999999999997764321 1111346778999999973 468999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTL 183 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~ 183 (289)
|+.++||.+++.|++.+.....++
T Consensus 239 GItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 239 GITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred hhhhhhhhhccccccccCCHHHHH
Confidence 999999999999988776654443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-31 Score=207.98 Aligned_cols=227 Identities=20% Similarity=0.271 Sum_probs=166.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.-+++.+|+++|..++|.|++..++...-. +.+|+|+|.+ ..+|.+++ -....++...+.-+++||+.||+
T Consensus 95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLK 170 (449)
T KOG0664|consen 95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLK 170 (449)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhH
Confidence 457889999999999999999988887643 2578899998 45888887 34456888999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGV 161 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~ 161 (289)
|||+.+ |.||||||.|+|++.|-.+||+|||+++.....+ .......+-|..|.|||++.+. .|+.+.||||.||
T Consensus 171 YLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGC 246 (449)
T KOG0664|consen 171 YLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGC 246 (449)
T ss_pred HHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhH
Confidence 999888 9999999999999999999999999999765443 2234445678899999999986 5899999999999
Q ss_pred HHHHHHhCCCCcCCCCCcc-hhHhHhHhhhhcc--------CCccccccccccC---------CCCHHHHHHHHHHHHcc
Q 038647 162 LVLETLSSKKNAHFYNTDS-LTLLGHAWNLWND--------GRAWELMDSILQN---------DASYPMLNRYINVALLC 223 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~ 223 (289)
++.||+..+..|...+.-+ ..++....+.... +...-++...... .....-..+...+...+
T Consensus 247 IFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~ 326 (449)
T KOG0664|consen 247 IFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKL 326 (449)
T ss_pred HHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHH
Confidence 9999998887776655432 2222221111000 0000011100000 00011123556778889
Q ss_pred cccCCCCCCCHHHHHHHhh
Q 038647 224 VQENAADRPTMLEVISMLT 242 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~~L~ 242 (289)
+.+||++|.+.++.+..+.
T Consensus 327 l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 327 LHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hCCCCcccccHhhhccccc
Confidence 9999999999999987654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=195.59 Aligned_cols=221 Identities=17% Similarity=0.256 Sum_probs=168.4
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
-..+.+++|++||+.+. ||||++++++..+. ....+|+||..+.+...+. ..++...+..++.+++.||.|
T Consensus 74 VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdy 147 (338)
T KOG0668|consen 74 VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDY 147 (338)
T ss_pred HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhH
Confidence 34678999999999997 99999999999764 4678999999998887665 457777899999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGV 161 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~ 161 (289)
+|+.| |.|||+||.|++++. ...++|+|+|+|..+-.+.. ..-.+.+..|-.||.+.. +-|+-+-|+|||||
T Consensus 148 CHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 148 CHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 221 (338)
T ss_pred HHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHH
Confidence 99988 999999999999984 56699999999987754432 222345667889999976 45899999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc----------------------CCccccccccccCCCCHHHHHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWND----------------------GRAWELMDSILQNDASYPMLNRYINV 219 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~l~~l 219 (289)
++..|+..+.||.....+..++...+.-.-.. .............+...-.+++..++
T Consensus 222 mlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDl 301 (338)
T KOG0668|consen 222 MLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDL 301 (338)
T ss_pred HHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHH
Confidence 99999999999877666644443332221100 01111111122222222234788999
Q ss_pred HHcccccCCCCCCCHHHHHH
Q 038647 220 ALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~ 239 (289)
+.+.|..|..+|+|++|...
T Consensus 302 ldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 302 LDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHhhccccccchHHHhc
Confidence 99999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=228.28 Aligned_cols=195 Identities=15% Similarity=0.119 Sum_probs=128.4
Q ss_pred eecCeEEEEEeecCCCChhhhhcCCCCC-----------------CCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecc
Q 038647 35 IEHGEKILIYEYMPNKSLDCFLFDPTKT-----------------GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDL 97 (289)
Q Consensus 35 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~di 97 (289)
.++...++|+||+.+++|.+++...... .......+..++.||+.||.|||+++ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 4566899999999999999888542110 01123446689999999999999888 999999
Q ss_pred ccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcC----------------------CCCCcc
Q 038647 98 KASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG----------------------LFSIKS 154 (289)
Q Consensus 98 kp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~ 154 (289)
||+|||++. ++.+||+|||+++....... .......+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 57899999999986533221 123345789999999976432 234567
Q ss_pred cchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHH----------HHHHHHHHHHccc
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYP----------MLNRYINVALLCV 224 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~l~~li~~~l 224 (289)
|||||||++|||+++..+.... ...+..... .................... ......+|+.+||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLK---RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH---HHHHHHHHH---hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999876543211 001000000 00000000000000000000 1124458999999
Q ss_pred ccCCCCCCCHHHHHH
Q 038647 225 QENAADRPTMLEVIS 239 (289)
Q Consensus 225 ~~~p~~Rps~~~ll~ 239 (289)
+.||++|||+.++++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=196.97 Aligned_cols=178 Identities=38% Similarity=0.602 Sum_probs=157.0
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+.+|++.++.++|++++++++++......++++||+++++|.+++.... ..++...+..++.+++.++.+||+.+
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ 112 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG 112 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5789999999999999999999999999999999999999999999985321 46888999999999999999999988
Q ss_pred CCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~el 166 (289)
++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||..... ..+.++|+|++|++++++
T Consensus 113 ---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 113 ---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 999999999999999 89999999999986643321 12234577889999999887 889999999999999998
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
..+.+++..|++.||++||++.++++.
T Consensus 188 -----------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 477889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=194.82 Aligned_cols=167 Identities=17% Similarity=0.092 Sum_probs=124.2
Q ss_pred CChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccc
Q 038647 50 KSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129 (289)
Q Consensus 50 g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 129 (289)
|+|.+++.. ....+++..++.++.|++.||.|||+++ ||+||+++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888853 2456999999999999999999999764 999999999999999 99987654321
Q ss_pred cccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCC
Q 038647 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDAS 209 (289)
Q Consensus 130 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (289)
..|++.|+|||++.+..++.++|||||||++|||++|+.|+.............. ....... . ......
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~------~-~~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL-NGMPADD------P-RDRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH-HHhccCC------c-cccccH
Confidence 2578999999999999999999999999999999999999754332211111111 0000000 0 000111
Q ss_pred HHHHH--HHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 210 YPMLN--RYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 210 ~~~~~--~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
..... .+.+++..||..||++||++.++++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22333 689999999999999999999999977643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=218.47 Aligned_cols=223 Identities=19% Similarity=0.195 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhhCC------CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQ------HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.+.=.+|++||++|+ --|+++++-.|...+++|||||.+ ..+|.+.|++...+-.+....+..++.|+..||.
T Consensus 472 ~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALk 550 (752)
T KOG0670|consen 472 HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALK 550 (752)
T ss_pred hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHH
Confidence 444568999999996 238999999999999999999988 5689999988777767888899999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCc-eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMN-PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~-vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
.|...| |+|.||||+|||++++.+ +||||||.|...+..... ...-+..|.|||++.|.+|+...|+||.||
T Consensus 551 lLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 551 LLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGC 623 (752)
T ss_pred HHHhcC---eeecccCccceEeccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeece
Confidence 999887 999999999999997655 699999999876554322 233466899999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhH-hhhhcc---------------C--------------Ccccccc---------c
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHA-WNLWND---------------G--------------RAWELMD---------S 202 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~---------------~--------------~~~~~~~---------~ 202 (289)
.||||.||+..|++...++...+.+- .+.+.. . .....+. .
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 99999999999988777644322111 111110 0 0000000 0
Q ss_pred cc-----cCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 203 IL-----QNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 203 ~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+ .....+.....+.+|+..||..||++|.|..+.|+
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 01122335678899999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=216.95 Aligned_cols=151 Identities=25% Similarity=0.346 Sum_probs=135.5
Q ss_pred HHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeec-CCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 14 NEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYM-PNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 14 ~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
-|++||..++ |+||+|++++|++++++||+||.. ++-+|.+++ ...+.+++.....+++||+.|+++||+++
T Consensus 615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~- 690 (772)
T KOG1152|consen 615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG- 690 (772)
T ss_pred hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC-
Confidence 5999999997 999999999999999999999975 456888888 45567999999999999999999999988
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHHHHh
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~ellt 168 (289)
|||||||-+|+.++.+|-+||+|||.+.....+. ...++||..|+|||++.+..| ...-|||++|+++|.++.
T Consensus 691 --ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy 764 (772)
T KOG1152|consen 691 --IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY 764 (772)
T ss_pred --ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence 9999999999999999999999999998766554 445789999999999999988 566899999999999998
Q ss_pred CCCCcC
Q 038647 169 SKKNAH 174 (289)
Q Consensus 169 g~~p~~ 174 (289)
...|+.
T Consensus 765 kenpyy 770 (772)
T KOG1152|consen 765 KENPYY 770 (772)
T ss_pred ccCCCc
Confidence 887753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=203.36 Aligned_cols=92 Identities=25% Similarity=0.336 Sum_probs=77.5
Q ss_pred HHHHHHHHHHHhhCC-----C---CCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQ-----H---RNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEG 76 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 76 (289)
.+....||++|++++ | .+||++++.|.. +.++|+|+|++ |.+|..++..... +-++...+.+|++|
T Consensus 118 tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~q 195 (590)
T KOG1290|consen 118 TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQ 195 (590)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHH
Confidence 456678999999994 2 369999999974 56899999999 6678787765433 45788999999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEe
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILL 104 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill 104 (289)
|+.||.|||.+. +|+|.||||+|||+
T Consensus 196 vL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 196 VLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHHhc--CccccCCCcceeee
Confidence 999999999865 69999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=211.51 Aligned_cols=220 Identities=18% Similarity=0.167 Sum_probs=146.7
Q ss_pred HHHHHHHHHhhCCCCCc-----eeeeeeEee--------cCeEEEEEeecCCCChhhhhcCCCC----------------
Q 038647 11 EFKNEMMLIAKLQHRNL-----VRLFGCCIE--------HGEKILIYEYMPNKSLDCFLFDPTK---------------- 61 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------- 61 (289)
.+..|+.++.+++|.++ ++++++|.. .+..++|+||+++++|.+++.....
T Consensus 218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l 297 (507)
T PLN03224 218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI 297 (507)
T ss_pred hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence 34457778888876654 667777753 3568999999999999998853210
Q ss_pred -----CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccccccccccc
Q 038647 62 -----TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136 (289)
Q Consensus 62 -----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~ 136 (289)
...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||+++........ ......++
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~t 373 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLD 373 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCC
Confidence 123456778899999999999999887 999999999999999999999999999765432211 11122347
Q ss_pred ccccChhhhhcCCC----------------------CCcccchhHHHHHHHHHhCCC-CcCCCCCcchhHh--HhHhhhh
Q 038647 137 YGYMSPEYALRGLF----------------------SIKSDVFSFGVLVLETLSSKK-NAHFYNTDSLTLL--GHAWNLW 191 (289)
Q Consensus 137 ~~y~aPE~~~~~~~----------------------~~~~DiwslG~vl~elltg~~-p~~~~~~~~~~~~--~~~~~~~ 191 (289)
+.|+|||.+..... ..+.||||+||++++|++|.. |+.....-..... ......|
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 89999999864321 235799999999999999875 4432111000000 0000011
Q ss_pred ccCCccccccccccCCCCHHHHHHHHHHHHcccccCC---CCCCCHHHHHH
Q 038647 192 NDGRAWELMDSILQNDASYPMLNRYINVALLCVQENA---ADRPTMLEVIS 239 (289)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~ll~ 239 (289)
....... ..-...........+++.++|..+| .+|+|+.|+++
T Consensus 454 r~~~~~~-----~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 RMYKGQK-----YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HhhcccC-----CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1000000 0000111234678899999998765 78999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=189.24 Aligned_cols=214 Identities=19% Similarity=0.306 Sum_probs=158.8
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeee-EeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGC-CIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..++|.+|..-=-.+ .|.||+.-|++ |+..+.+++++||++-|+|..-+.. ..+.+....+++.|+++|+.|||
T Consensus 63 t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMH 138 (378)
T KOG1345|consen 63 TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMH 138 (378)
T ss_pred hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhh
Confidence 467888888766666 49999986654 7888889999999999999887732 34677788899999999999999
Q ss_pred cCCCCceEeeccccCceEeC--CCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-----CCCCcccchh
Q 038647 86 HYSRLRVIHRDLKASNILLD--SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-----LFSIKSDVFS 158 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~--~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Diws 158 (289)
+++ +||||||.+||||- +..+|||+|||+.+..+.. .....-+..|.+||..... ...+.+|||.
T Consensus 139 skn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wq 210 (378)
T KOG1345|consen 139 SKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQ 210 (378)
T ss_pred ccc---hhhcccccceEEEecCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchh
Confidence 988 99999999999994 3447999999999876432 2223345679999988632 2478999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
||+++|.++||..|+.-....+.... -|..|..+..... .......++.+..+.++-|..+|++|--..++.
T Consensus 211 fGIi~f~cltG~~PWQka~~~d~~Y~--~~~~w~~rk~~~~------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 211 FGIIFFYCLTGKFPWQKASIMDKPYW--EWEQWLKRKNPAL------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred eeeeeeeeecCCCcchhhhccCchHH--HHHHHhcccCccC------chhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 99999999999999885444433332 2333444333211 112233456778888999999999996555555
Q ss_pred HHh
Q 038647 239 SML 241 (289)
Q Consensus 239 ~~L 241 (289)
++.
T Consensus 283 k~r 285 (378)
T KOG1345|consen 283 KMR 285 (378)
T ss_pred HHH
Confidence 443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=211.55 Aligned_cols=213 Identities=23% Similarity=0.331 Sum_probs=168.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+.-.+.|+-+++.++|||||.+++.+...+.+++.||||.+|+|++.. .-++.+++-++...++..++||+|||+.
T Consensus 55 d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~ 131 (829)
T KOG0576|consen 55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQ 131 (829)
T ss_pred cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcC
Confidence 4455678999999999999999999999999999999999999999977 4578999999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl~ 164 (289)
+ -+|||||-.||++++.|.+|++|||.+-.++. .......+.||+.|||||+.. .+.|..++|||++|+...
T Consensus 132 g---k~hRdiKGanilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAi 206 (829)
T KOG0576|consen 132 G---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAI 206 (829)
T ss_pred C---cccccccccceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchh
Confidence 8 89999999999999999999999999877643 244566789999999999885 567999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+---++|......-+..++ .....+ ++ ..-+......+.+-++++.|+..+|.+||+++.+++
T Consensus 207 el~eLqpplfdlhpmr~l~L-mTkS~~---------qp-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 207 ELGELQPPLFDLHPMRALFL-MTKSGF---------QP-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hhhhcCCcccccchHHHHHH-hhccCC---------CC-CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 99877776432111111100 000000 00 001112224456778999999999999999987765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=185.88 Aligned_cols=161 Identities=32% Similarity=0.439 Sum_probs=140.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCC-CChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL-LGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.. ... +++..+..++.+++.++.+||+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~ 116 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK---KGGKLSEEEARFYLRQILEALEYLHS 116 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 578999999999999999999999999999999999999999999998853 223 7889999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhh-hcCCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYA-LRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~vl~e 165 (289)
.+ ++|+||+|.||+++.++.++|+|||.+........ .......++..|++||.+ ....++.++|+|+||+++++
T Consensus 117 ~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~ 192 (225)
T smart00221 117 LG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYE 192 (225)
T ss_pred CC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHH
Confidence 87 99999999999999999999999999987654320 122334677889999999 66678889999999999999
Q ss_pred HHhCCCCcCC
Q 038647 166 TLSSKKNAHF 175 (289)
Q Consensus 166 lltg~~p~~~ 175 (289)
|++|+.||..
T Consensus 193 l~~g~~pf~~ 202 (225)
T smart00221 193 LLWGPEPFSG 202 (225)
T ss_pred HHHCCCCccc
Confidence 9999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=186.84 Aligned_cols=223 Identities=23% Similarity=0.366 Sum_probs=164.1
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+...+..+|+++|..+. +.||+++.+++..++...+|+||++.-...++.. .++...+..++..++.||.++|
T Consensus 76 s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h 149 (418)
T KOG1167|consen 76 SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH 149 (418)
T ss_pred cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh
Confidence 34567889999999995 9999999999999999999999999998888883 3667889999999999999999
Q ss_pred cCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCC--------------c------------------------
Q 038647 86 HYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDE--------------L------------------------ 126 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~--------------~------------------------ 126 (289)
.+| ||||||||.|++.+. .+.-.|.|||++....... .
T Consensus 150 ~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~ 226 (418)
T KOG1167|consen 150 KNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRC 226 (418)
T ss_pred ccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceecc
Confidence 998 999999999999985 4567999999998321000 0
Q ss_pred ----ccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhh-----------
Q 038647 127 ----QSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNL----------- 190 (289)
Q Consensus 127 ----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----------- 190 (289)
........||++|.|||++.+. .-+.+.||||.|+++.-+++++.||.-...+...+. +....
T Consensus 227 ~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~-ei~tifG~~~mrk~A~ 305 (418)
T KOG1167|consen 227 NDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALA-EIATIFGSAEMRKCAA 305 (418)
T ss_pred CCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHH-HHHHHhChHHHHHHhh
Confidence 0011234599999999999864 568999999999999999999999876554421111 11111
Q ss_pred -------hccCCc---ccc------c--cccccCCC--------CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 191 -------WNDGRA---WEL------M--DSILQNDA--------SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 191 -------~~~~~~---~~~------~--~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|..... .+. + ........ ..-.+..+.+++.+|+..||.+|.|+++.|+
T Consensus 306 l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 306 LPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 110000 000 0 00000000 0112346789999999999999999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-26 Score=206.65 Aligned_cols=214 Identities=21% Similarity=0.249 Sum_probs=167.4
Q ss_pred HHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc
Q 038647 12 FKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLR 91 (289)
Q Consensus 12 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 91 (289)
+..|+.+=..++|+|++..+..+.+....+-+||||++ +|..++. ..+.+....+..++.|++.|+.|+|..|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG--- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---
Confidence 45677778888999999988888877776667999999 9998883 4457888889999999999999999998
Q ss_pred eEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhcCCCCCc-ccchhHHHHHHHHHh
Q 038647 92 VIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIK-SDVFSFGVLVLETLS 168 (289)
Q Consensus 92 ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~vl~ellt 168 (289)
+.|||+|++|+++..++.+||+|||.+......... ......+|+..|+|||++.+..|++. .||||.|+++..|++
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 999999999999999999999999999876544333 44556789999999999999999755 899999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+.|+......+........ .................+.+...++..||+.||.+|.|+++|++
T Consensus 521 ~~~~Wk~a~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSFKTNNY-------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCCccccccccccchhhhcc-------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99998776655433210000 00000000111112234567788999999999999999999986
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=177.89 Aligned_cols=217 Identities=24% Similarity=0.344 Sum_probs=161.7
Q ss_pred HhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccc
Q 038647 19 IAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLK 98 (289)
Q Consensus 19 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dik 98 (289)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ..-.+++-....+.++|+.||.|+|... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999999999999999999999999964 3445788888999999999999999754 23999999
Q ss_pred cCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-------CCCCcccchhHHHHHHHHHhCCC
Q 038647 99 ASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-------LFSIKSDVFSFGVLVLETLSSKK 171 (289)
Q Consensus 99 p~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~DiwslG~vl~elltg~~ 171 (289)
+.|++++....+||.|||+.................-..-|.|||.+... ..+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766321111111222234579999999753 14788999999999999999999
Q ss_pred CcCCCCCcch--hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcccC
Q 038647 172 NAHFYNTDSL--TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNENV 246 (289)
Q Consensus 172 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 246 (289)
||........ ........ . ......+.+.... .....+..++..||..+|++||+++.+-..++....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~----~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK----G-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh----c-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9877544422 12211111 0 0011111111000 233478899999999999999999999998887653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-24 Score=166.00 Aligned_cols=213 Identities=19% Similarity=0.296 Sum_probs=164.6
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..-.++|..|.-.|+-+.||||..+++.|....++.+|..||+-|+|...+... ..-..+..++.+++.+++.|++|||
T Consensus 228 ~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflh 306 (448)
T KOG0195|consen 228 ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLH 306 (448)
T ss_pred hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHh
Confidence 334578999999999999999999999999999999999999999999998652 3346778889999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEc--ccccccccCCCCcccccccccccccccChhhhhcCCC---CCcccchhHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKIS--DFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF---SIKSDVFSFG 160 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslG 160 (289)
+.. .-|..--++...+++|++...+|. |--++.+ .....-.|.|++||.++..+- -.++|+|||+
T Consensus 307 sle-p~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfa 376 (448)
T KOG0195|consen 307 SLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFA 376 (448)
T ss_pred hcc-hhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHH
Confidence 975 224444699999999999887664 3222211 112234789999999987653 3679999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
+++|||.|...||.....-.... .+.-..++...++.++..+.+++.-|+..||.+||.+..|+-.
T Consensus 377 illwel~trevpfadlspmecgm--------------kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpi 442 (448)
T KOG0195|consen 377 ILLWELNTREVPFADLSPMECGM--------------KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPI 442 (448)
T ss_pred HHHHHhhccccccccCCchhhhh--------------hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhh
Confidence 99999999999986544322211 1111223334556677889999999999999999999999887
Q ss_pred hhc
Q 038647 241 LTN 243 (289)
Q Consensus 241 L~~ 243 (289)
|+.
T Consensus 443 lek 445 (448)
T KOG0195|consen 443 LEK 445 (448)
T ss_pred HHH
Confidence 764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-21 Score=165.86 Aligned_cols=225 Identities=28% Similarity=0.368 Sum_probs=169.6
Q ss_pred CHHHHHHHHHHHhhCCCC-CceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHR-NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....|.+|+.+++.+.|+ +++++.+++......+++++++.++++.+++........+.......++.|++.++.|+|.
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 478899999999999988 7999999998887889999999999999776432111368889999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCccc----ccccccccccccChhhhhc---CCCCCcccchh
Q 038647 87 YSRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQS----NTKRIVGTYGYMSPEYALR---GLFSIKSDVFS 158 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~Diws 158 (289)
.+ ++|||+||+||+++..+ .+++.|||.++......... ......|+..|+|||.+.+ ...+...|+|+
T Consensus 120 ~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred CC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 88 99999999999999988 69999999998654433221 2456689999999999987 57899999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCc--chhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTD--SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
+|++++++++|..|+...... .............. .................+.+++..++..+|..|.+..+
T Consensus 197 ~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ 271 (384)
T COG0515 197 LGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271 (384)
T ss_pred HHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHH
Confidence 999999999999996555431 11111111111110 00000000000222356788999999999999999888
Q ss_pred HHHH
Q 038647 237 VISM 240 (289)
Q Consensus 237 ll~~ 240 (289)
....
T Consensus 272 ~~~~ 275 (384)
T COG0515 272 DLSH 275 (384)
T ss_pred Hhhc
Confidence 7653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-23 Score=186.10 Aligned_cols=207 Identities=18% Similarity=0.204 Sum_probs=150.3
Q ss_pred HHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceE
Q 038647 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVI 93 (289)
Q Consensus 14 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iv 93 (289)
+|++ ...++|||++.+.-+.+.+...|+|-+|..+ +|.+.+ .-++.+..-+.+.++.|++.||..+|..| |+
T Consensus 71 ~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---Vc 142 (1431)
T KOG1240|consen 71 EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VC 142 (1431)
T ss_pred HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---cc
Confidence 3444 4555899999999888888888999999955 788888 45667888888999999999999999888 99
Q ss_pred eeccccCceEeCCCCceEEcccccccccC-CCCcccccccc----cccccccChhhhhcC----------C-CCCcccch
Q 038647 94 HRDLKASNILLDSNMNPKISDFGIARLFG-GDELQSNTKRI----VGTYGYMSPEYALRG----------L-FSIKSDVF 157 (289)
Q Consensus 94 H~dikp~Nill~~~~~vkl~Dfg~~~~~~-~~~~~~~~~~~----~g~~~y~aPE~~~~~----------~-~~~~~Diw 157 (289)
|||||.+||||+.=+.+.|.||...+..- ..+.......+ ..-.+|+|||.+... . .+++-|||
T Consensus 143 HGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIF 222 (1431)
T KOG1240|consen 143 HGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIF 222 (1431)
T ss_pred ccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhh
Confidence 99999999999999999999999876542 12222222222 233579999988641 1 57899999
Q ss_pred hHHHHHHHHHhC-CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLSS-KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|+||++.||++. +++|... ++.. ++.+. .......+..-. ...+++++..|++.||++|.|+++
T Consensus 223 S~GCViaELf~Eg~PlF~LS-----QL~a-----Yr~~~-~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 223 SAGCVIAELFLEGRPLFTLS-----QLLA-----YRSGN-ADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred hhhHHHHHHHhcCCCcccHH-----HHHh-----HhccC-ccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHH
Confidence 999999999985 6666521 1110 11110 000111111111 126788999999999999999999
Q ss_pred HHHHhhc
Q 038647 237 VISMLTN 243 (289)
Q Consensus 237 ll~~L~~ 243 (289)
.|+.-++
T Consensus 288 yL~~yrG 294 (1431)
T KOG1240|consen 288 YLQKYRG 294 (1431)
T ss_pred HHHhhhc
Confidence 9987554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-20 Score=159.72 Aligned_cols=218 Identities=19% Similarity=0.222 Sum_probs=162.6
Q ss_pred HHHHHHHHHhhCCC----CCceeeeeeE-eecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 11 EFKNEMMLIAKLQH----RNLVRLFGCC-IEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 11 ~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..|..++..+.. +++.++++.. ..+..-++||+.+ |.+|.++..... .+.++..+...++.|++.+|++||
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH 139 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH 139 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH
Confidence 68889999999973 5888999998 5788899999988 889999775433 578999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCC-----CceEEccccccc--ccCCCC-----cccc-cccccccccccChhhhhcCCCCC
Q 038647 86 HYSRLRVIHRDLKASNILLDSN-----MNPKISDFGIAR--LFGGDE-----LQSN-TKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~-----~~vkl~Dfg~~~--~~~~~~-----~~~~-~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
+.| ++||||||.|+++... ..+.|.|||+++ .+.... .... ...+.||..|+++....+...+.
T Consensus 140 ~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r 216 (322)
T KOG1164|consen 140 SKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGR 216 (322)
T ss_pred hcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCC
Confidence 998 9999999999999865 458999999999 432111 1111 23456999999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCcCCCCCcch-hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 153 KSDVFSFGVLVLETLSSKKNAHFYNTDSL-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 153 ~~DiwslG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
+.|+||++.++.+++.|..|+........ ...... . ............+..+.++...+-..+...+
T Consensus 217 ~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~-------~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (322)
T KOG1164|consen 217 RDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD-------P-----RKLLTDRFGDLKPEEFAKILEYIDSLDYEDK 284 (322)
T ss_pred chhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH-------h-----hhhccccccCCChHHHHHHHHHhhccCCcCC
Confidence 99999999999999999988755443211 000000 0 0000000111223455555555566899999
Q ss_pred CCHHHHHHHhhccc
Q 038647 232 PTMLEVISMLTNEN 245 (289)
Q Consensus 232 ps~~~ll~~L~~~~ 245 (289)
|....+...|....
T Consensus 285 Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 285 PDYEKLAELLKDVF 298 (322)
T ss_pred CCHHHHHHHHHHHH
Confidence 99999998876644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-21 Score=156.80 Aligned_cols=198 Identities=20% Similarity=0.242 Sum_probs=139.7
Q ss_pred CCCCceeeeeeEee---------------------------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHH
Q 038647 23 QHRNLVRLFGCCIE---------------------------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILE 75 (289)
Q Consensus 23 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 75 (289)
+|||||.+.++|.+ +..+|+||.-++. +|..++.. ...+......++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 69999999988843 2357999987755 78888842 2355667788999
Q ss_pred HHHHHHHHHhcCCCCceEeeccccCceEeC--CC--CceEEcccccccccCCCC----cccccccccccccccChhhhhc
Q 038647 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLD--SN--MNPKISDFGIARLFGGDE----LQSNTKRIVGTYGYMSPEYALR 147 (289)
Q Consensus 76 ~i~~~l~~lH~~~~~~ivH~dikp~Nill~--~~--~~vkl~Dfg~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~ 147 (289)
|+++|+.|||.+| |.|||+|++|||+. ++ -.++|+|||.+-...... +.+......|.-..+|||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999993 33 347899999876543321 1222233457778999999874
Q ss_pred CC------CCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHH
Q 038647 148 GL------FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVAL 221 (289)
Q Consensus 148 ~~------~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 221 (289)
.+ .-.|+|.|+.|.+.||+++...||...+.-...... +.+.. + ...+...+..+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~q--------L-Palp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQ--------L-PALPSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhh--------C-CCCcccCChHHHHHHH
Confidence 22 247899999999999999999998653321111100 11100 0 1112234567888999
Q ss_pred cccccCCCCCCCHHHHHHHhh
Q 038647 222 LCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~~L~ 242 (289)
..|+.||++|++..-....|.
T Consensus 492 ~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHhcCCccccCCccHHHhHHH
Confidence 999999999999776665554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.7e-21 Score=160.93 Aligned_cols=133 Identities=17% Similarity=0.235 Sum_probs=101.3
Q ss_pred CHHHHHHHHHHHhhCCCCCcee-eeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVR-LFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.|.+|+++|++++|+|++. ++++ +..|+||||++|++|.... ..+ ...++.+++.+|.|||+
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~ 129 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHR 129 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHH
Confidence 4667999999999999999985 4432 4689999999999996321 111 14678999999999999
Q ss_pred CCCCceEeecc-ccCceEeCCCCceEEcccccccccCCCCccc------ccccccccccccChhhhhcCC------CCCc
Q 038647 87 YSRLRVIHRDL-KASNILLDSNMNPKISDFGIARLFGGDELQS------NTKRIVGTYGYMSPEYALRGL------FSIK 153 (289)
Q Consensus 87 ~~~~~ivH~di-kp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~------~~~~ 153 (289)
+| |+|||| ||+|||++.++.++|+|||+++......... ......++..|+|||.+.... .+..
T Consensus 130 ~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~ 206 (365)
T PRK09188 130 AG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLP 206 (365)
T ss_pred CC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccc
Confidence 88 999999 9999999999999999999999764332111 113456788899999986322 3344
Q ss_pred ccch
Q 038647 154 SDVF 157 (289)
Q Consensus 154 ~Diw 157 (289)
+|-|
T Consensus 207 ~dgW 210 (365)
T PRK09188 207 SRIW 210 (365)
T ss_pred cCcE
Confidence 6666
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-22 Score=169.17 Aligned_cols=124 Identities=28% Similarity=0.416 Sum_probs=108.9
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccc
Q 038647 39 EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118 (289)
Q Consensus 39 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~ 118 (289)
++|+.|++|...+|.+++.........++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 588999999999999999765555567788889999999999999 66 999999999999999999999999999
Q ss_pred cccCCCC----cccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 119 RLFGGDE----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 119 ~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
....... .........||..||+||++.+..|+.|+||||||++++||++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765443 1223455689999999999999999999999999999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=169.18 Aligned_cols=188 Identities=24% Similarity=0.265 Sum_probs=155.8
Q ss_pred HHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 11 EFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 11 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
....|-.++..++ ||.+|+++..++.+...+++.++..+|.|...+ .+...+.+.....+...++.+++++|+.+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~- 117 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG- 117 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH-
Confidence 4556788899996 999999999999999999999999999998777 34456777788889999999999999888
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhC
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg 169 (289)
++|||+|++||+++.+|.+++.|||+++..-... ..+||..|+|||++. .....+|.||||+++|+|+||
T Consensus 118 --iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg 187 (612)
T KOG0603|consen 118 --IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG 187 (612)
T ss_pred --HHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC
Confidence 9999999999999999999999999998753322 128999999999998 678999999999999999999
Q ss_pred CCCcCCCCCcchhHhHhHhhhhccCCcccccccccc--CCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 170 KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ--NDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 170 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
..||.. +.+..++. -..+........+++..++..+|.+|--.
T Consensus 188 ~~pf~~----------------------~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 188 TLPFGG----------------------DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCCCch----------------------HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 999875 11111111 12344566677888899999999999754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=138.40 Aligned_cols=147 Identities=18% Similarity=0.153 Sum_probs=112.9
Q ss_pred HHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 11 EFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 11 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
.|.+|+++|++++ |+++++++++ +..+++|||+.|.+|...+. . . ...++.|++.+|.++|.+|
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~---~------~-~~~~~~qi~~~L~~lH~~G- 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP---R------G-DLAYFRAARRLLQQLHRCG- 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh---h------h-hHHHHHHHHHHHHHHHHCc-
Confidence 6889999999995 6889999886 34799999999998865431 1 1 1357889999999999998
Q ss_pred CceEeecc-ccCceEeCCCCceEEcccccccccCCCCcc----c--c-----cccccccccccChhhhhcC-CCC-Cccc
Q 038647 90 LRVIHRDL-KASNILLDSNMNPKISDFGIARLFGGDELQ----S--N-----TKRIVGTYGYMSPEYALRG-LFS-IKSD 155 (289)
Q Consensus 90 ~~ivH~di-kp~Nill~~~~~vkl~Dfg~~~~~~~~~~~----~--~-----~~~~~g~~~y~aPE~~~~~-~~~-~~~D 155 (289)
|+|||| ||+|||++.++.++|+|||++......... . . ......++.|++|+...-. ..+ ...+
T Consensus 112 --IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~ 189 (218)
T PRK12274 112 --VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIREL 189 (218)
T ss_pred --CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHH
Confidence 999999 799999999999999999999865432210 0 0 1122357788888866532 233 6678
Q ss_pred chhHHHHHHHHHhCCCCcC
Q 038647 156 VFSFGVLVLETLSSKKNAH 174 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~ 174 (289)
.++.|+-+|.++|++.+.-
T Consensus 190 w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 190 WFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHhcchHHHHHhccCCcc
Confidence 8999999999999997643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.9e-20 Score=144.65 Aligned_cols=127 Identities=16% Similarity=0.234 Sum_probs=100.1
Q ss_pred HHHHHHHHhhCCCCCceeeeeeEeec--------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 12 FKNEMMLIAKLQHRNLVRLFGCCIEH--------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 12 ~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
|++|++.+.+++|++|..+.+++... +..++||||++|.+|.++.. +++ ....+++.++..
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~ 150 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIES 150 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHH
Confidence 68999999999999999999886643 35789999999999987641 222 346699999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+|..| ++|||++|.||+++.++ ++|+|||.......... ...+.....+..++|+|+||+.+
T Consensus 151 lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~ 212 (232)
T PRK10359 151 LHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYL 212 (232)
T ss_pred HHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEee
Confidence 99988 99999999999999988 99999998865421110 01133445567899999999987
Q ss_pred HHHH
Q 038647 164 LETL 167 (289)
Q Consensus 164 ~ell 167 (289)
..+.
T Consensus 213 ~~~~ 216 (232)
T PRK10359 213 LIYK 216 (232)
T ss_pred hHHH
Confidence 7654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-19 Score=145.44 Aligned_cols=198 Identities=16% Similarity=0.185 Sum_probs=122.8
Q ss_pred cccCHHHHHHHHHHHhhCCC----------CCceeeeeeEe---------ec--C------eEEEEEeecCCCChhhhhc
Q 038647 5 SGQGLEEFKNEMMLIAKLQH----------RNLVRLFGCCI---------EH--G------EKILIYEYMPNKSLDCFLF 57 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~---------~~--~------~~~lv~e~~~~g~L~~~l~ 57 (289)
+...++++++|.-....+.+ -.++..++... .. . +.+++|+-+ .++|..++.
T Consensus 52 ~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~ 130 (288)
T PF14531_consen 52 SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVE 130 (288)
T ss_dssp HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHH
T ss_pred chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHH
Confidence 34567888888877666533 12222233322 11 1 235677766 557877653
Q ss_pred C---CCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccc
Q 038647 58 D---PTK-TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133 (289)
Q Consensus 58 ~---~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 133 (289)
- ... ...+....+..+..|++..+++||..| ++|+||+|+|++++.+|.++|+||+.....+..... .
T Consensus 131 ~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~ 202 (288)
T PF14531_consen 131 ALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----S 202 (288)
T ss_dssp HHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----G
T ss_pred HHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----c
Confidence 1 111 122334445667799999999999998 999999999999999999999999887765432211 2
Q ss_pred cccccccChhhhhcC--------CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc
Q 038647 134 VGTYGYMSPEYALRG--------LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ 205 (289)
Q Consensus 134 ~g~~~y~aPE~~~~~--------~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (289)
..+..|.+||..... .++.+.|.|+||+++|.|++|..||........... .-
T Consensus 203 ~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f 263 (288)
T PF14531_consen 203 EFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DF 263 (288)
T ss_dssp GS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GG
T ss_pred CCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------cc
Confidence 345679999987542 478999999999999999999999875533321110 11
Q ss_pred CCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 206 NDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 206 ~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
.... ++++.+..+|..+|+.||++|
T Consensus 264 ~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 264 SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 1223 778899999999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.8e-18 Score=136.15 Aligned_cols=167 Identities=19% Similarity=0.208 Sum_probs=141.6
Q ss_pred cccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+...-++..|.+..+.| ..++|..++.+..++.+=.||+|++ |-+|+++..- =...++..++..++.|++.-++|
T Consensus 63 rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~ 139 (449)
T KOG1165|consen 63 RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEY 139 (449)
T ss_pred ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHH
Confidence 344566788898888888 4899999999999998889999988 7899887621 13469999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCC-----ceEEcccccccccCCCC-----cccccccccccccccChhhhhcCCCCCc
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNM-----NPKISDFGIARLFGGDE-----LQSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~-----~vkl~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+|+++ +|+|||||+|+||...+ .+.++|||+++.+.... .-...++..||-+||+-....+..-+.+
T Consensus 140 vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR 216 (449)
T KOG1165|consen 140 VHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR 216 (449)
T ss_pred HHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhh
Confidence 99998 99999999999997543 47899999999885433 2234566789999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCcCCCC
Q 038647 154 SDVFSFGVLVLETLSSKKNAHFYN 177 (289)
Q Consensus 154 ~DiwslG~vl~elltg~~p~~~~~ 177 (289)
.|.-|||-++++.|-|..|+.+.-
T Consensus 217 DDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 217 DDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhHHHhhhhhhhhccCCCcccccc
Confidence 999999999999999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=133.39 Aligned_cols=103 Identities=22% Similarity=0.287 Sum_probs=83.1
Q ss_pred CHHHHHHHHHHHhhC-----CCCCceeeeeeEeecC---eEE-EEEee--cCCCChhhhhcCCCCCCCCChHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL-----QHRNLVRLFGCCIEHG---EKI-LIYEY--MPNKSLDCFLFDPTKTGLLGWEMRVRILEG 76 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 76 (289)
..+.+.+|+++++.+ +||||++++++++++. .++ +|+|| +.+|+|.+++.+ +.+++. ..++.+
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~ 112 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQ 112 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc----ccccHh--HHHHHH
Confidence 467899999999999 5799999999999874 434 78999 557999999943 235554 356788
Q ss_pred HHHHH-HHHhcCCCCceEeeccccCceEeCC----CCceEEccccccc
Q 038647 77 VAQGL-LYLHHYSRLRVIHRDLKASNILLDS----NMNPKISDFGIAR 119 (289)
Q Consensus 77 i~~~l-~~lH~~~~~~ivH~dikp~Nill~~----~~~vkl~Dfg~~~ 119 (289)
++.++ .|||+++ |+||||||+||+++. +..++|+||+.+.
T Consensus 113 ~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 113 LLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 88777 9999988 999999999999974 3479999955443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-18 Score=133.20 Aligned_cols=222 Identities=14% Similarity=0.164 Sum_probs=161.9
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++..|.++...++ -..|..+..+..+..+-.+|||.+ |-+|+++..-. ...++..+++.++-|++.-++|+|
T Consensus 52 a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH 128 (341)
T KOG1163|consen 52 AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVH 128 (341)
T ss_pred CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHH
Confidence 34556788999999996 467778888888999999999988 88999987432 245889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCC-----cccccccccccccccChhhhhcCCCCCcccch
Q 038647 86 HYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDE-----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
.++ ++||||||+|+|..- ..++.++|||+++.+-... .........||.+|++-....+..-+.+.|+-
T Consensus 129 ~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDme 205 (341)
T KOG1163|consen 129 LRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDME 205 (341)
T ss_pred hhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhh
Confidence 988 999999999999964 3568999999999874332 22334566799999999888888889999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
|+|.++.++.-|..|+.........- ..+...+......+..... ..|.++.-.+.-|-..--++-|...-+
T Consensus 206 SvgYvLmYfnrG~LPWQglka~tk~Q---KyEkI~EkK~s~~ie~LC~-----G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 206 SVGYVLMYFNRGSLPWQGLKAATKKQ---KYEKISEKKMSTPIEVLCK-----GFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred hhcceeeeeecCCCcccccchhhHHH---HHHHHHHhhcCCCHHHHhC-----CCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 99999999999999987654332110 0111111111111111111 133455566666777777777776666
Q ss_pred HHHhh
Q 038647 238 ISMLT 242 (289)
Q Consensus 238 l~~L~ 242 (289)
.+...
T Consensus 278 rqlFr 282 (341)
T KOG1163|consen 278 RQLFR 282 (341)
T ss_pred HHHHH
Confidence 55444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=131.07 Aligned_cols=100 Identities=17% Similarity=0.167 Sum_probs=79.7
Q ss_pred HHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH-hcCCCCc
Q 038647 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL-HHYSRLR 91 (289)
Q Consensus 13 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~~ 91 (289)
.+|+++|.++.++++.....+ ... ..++||||++++++..... ..+.++...+..++.|++.+|.++ |+.|
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~-~~~-~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--- 138 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPI-LLK-SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR--- 138 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEE-Eec-CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 459999999988877443322 222 2389999999887755431 235688899999999999999999 6777
Q ss_pred eEeeccccCceEeCCCCceEEccccccccc
Q 038647 92 VIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 92 ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
|+||||||+||+++ ++.++|+|||++...
T Consensus 139 iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 139 LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-17 Score=150.94 Aligned_cols=151 Identities=17% Similarity=0.166 Sum_probs=126.5
Q ss_pred HHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCce
Q 038647 16 MMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRV 92 (289)
Q Consensus 16 ~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 92 (289)
.+++.+|+ -+.|..+..++.-.+..++|+||.+.|+|.++++ ..+.+++...+.+..|++..+++||..+ |
T Consensus 742 ~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---I 815 (974)
T KOG1166|consen 742 LQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---I 815 (974)
T ss_pred HHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---e
Confidence 34555555 3455566666667778899999999999999994 6678999999999999999999999988 9
Q ss_pred EeeccccCceEeC-------CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 93 IHRDLKASNILLD-------SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 93 vH~dikp~Nill~-------~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
|||||||+|+||. ++..++|+|||.+-.+..-.........++|..+-++|...|.+|+.++|.|.|+.+++-
T Consensus 816 IHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~ 895 (974)
T KOG1166|consen 816 IHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHV 895 (974)
T ss_pred ecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHH
Confidence 9999999999994 234589999999987654333345666788999999999999999999999999999999
Q ss_pred HHhCCCC
Q 038647 166 TLSSKKN 172 (289)
Q Consensus 166 lltg~~p 172 (289)
||.|+.-
T Consensus 896 mLFG~y~ 902 (974)
T KOG1166|consen 896 MLFGKYM 902 (974)
T ss_pred HHHHHHH
Confidence 9999853
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=128.51 Aligned_cols=103 Identities=19% Similarity=0.191 Sum_probs=82.2
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCC
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH-YSR 89 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~ 89 (289)
.+.+|.+.+.++.|+++.....+... ..++||||++++++..... ....++......++.|++.++.++|+ .|
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g- 138 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG- 138 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence 35689999999999987544433332 2489999998885543321 22456788899999999999999998 87
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccC
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~ 122 (289)
|+||||||+||+++ ++.++|+|||++....
T Consensus 139 --ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 139 --LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred --EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999998 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-17 Score=132.28 Aligned_cols=205 Identities=19% Similarity=0.231 Sum_probs=140.1
Q ss_pred HHHHhhCCCCCceeeeeeEeecC-----eEEEEEeecCCCChhhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 16 MMLIAKLQHRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFLFDPTK-TGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 16 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
+.-|.++-|-|||+++.|+.+.+ ...++.||+..|++..+|++... ...+......+|+-||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 44466677999999999997654 47899999999999999976433 35677788899999999999999997 5
Q ss_pred CceEeeccccCceEeCCCCceEEcccc--cccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFG--IARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg--~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
.+|+|+++..+.|++..++-+|++--. .....-..........-.+.++|.+||.-.....+..+|||+||...++|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 779999999999999999988886311 111100000011112224578899999877777889999999999999998
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+..--. .+..... .... ......+.. ...-+.++..|++-.|..||++++++-
T Consensus 277 ilEiq~t-nseS~~~---------~ee~----ia~~i~~le----n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQST-NSESKVE---------VEEN----IANVIIGLE----NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccC-CCcceee---------hhhh----hhhheeecc----CccccCcCcccccCCCCCCcchhhhhc
Confidence 7664211 1110000 0000 000000000 012245678899999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8e-18 Score=152.20 Aligned_cols=216 Identities=23% Similarity=0.264 Sum_probs=164.9
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh-
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH- 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH- 85 (289)
..++...|..+-..++ |+|++.+++...+.+..+++++|..++++...+.. ......+....-.++.|+..++.|+|
T Consensus 63 ~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~ 141 (601)
T KOG0590|consen 63 SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHP 141 (601)
T ss_pred hhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCc
Confidence 3444455777777886 99999999999999999999999999999887732 22224555667789999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCC-ceEEcccccccccCC-CCcccccccccc-cccccChhhhhcCC-CCCcccchhHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGG-DELQSNTKRIVG-TYGYMSPEYALRGL-FSIKSDVFSFGV 161 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~~-~~~~~DiwslG~ 161 (289)
..+ +.|+|+||+|.+++.++ ..+++|||++..+.. ..........+| ++.|+|||...+.. ..+..|+||.|+
T Consensus 142 ~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~ 218 (601)
T KOG0590|consen 142 ENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGI 218 (601)
T ss_pred ccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccc
Confidence 777 99999999999999999 999999999998766 444444555678 99999999999854 478899999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
++.-+++|..|+............+. ... ................+++.+++..+|..|.+.+++-
T Consensus 219 ~l~~~~~g~~p~~~~~~~~~~~~~~~-----~~~------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 219 VLSAMLTGELPWDFPSRKDGRYSSWK-----SNK------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccccCCCCccccccccccceeec-----ccc------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 99999999999776655432221111 000 0000111122335667888889999999999988864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.7e-17 Score=148.39 Aligned_cols=141 Identities=24% Similarity=0.350 Sum_probs=107.5
Q ss_pred HHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCC-------------CcccccccccccccccCh
Q 038647 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD-------------ELQSNTKRIVGTYGYMSP 142 (289)
Q Consensus 76 ~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~-------------~~~~~~~~~~g~~~y~aP 142 (289)
+++.+++|||..+ |+|||+||+|.+|+.-|.+|+.|||+++..... ...-..+..+||+.|.||
T Consensus 151 dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 3489999999988 999999999999999999999999998864211 011123455899999999
Q ss_pred hhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHc
Q 038647 143 EYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL 222 (289)
Q Consensus 143 E~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 222 (289)
|++....|..-.|.|++|+++|+.+.|..||.....+.. ...+. -+.+...+.....+.+..+++..
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~vi-----------sd~i~wpE~dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI-----------SDDIEWPEEDEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhh-----------hhhccccccCcCCCHHHHHHHHH
Confidence 999999999999999999999999999999876544321 11100 01111122233455788999999
Q ss_pred ccccCCCCCC
Q 038647 223 CVQENAADRP 232 (289)
Q Consensus 223 ~l~~~p~~Rp 232 (289)
+|+.+|..|-
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=120.80 Aligned_cols=100 Identities=20% Similarity=0.338 Sum_probs=87.6
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
.++.+|++++..++|+++.....++.+.+..++||||++|++|.+++... .. ....++.+++.+|.++|+.+
T Consensus 44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~- 115 (211)
T PRK14879 44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG- 115 (211)
T ss_pred HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC-
Confidence 46889999999999999887777777778889999999999999988421 11 77899999999999999988
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
++|||++|.||+++ ++.++|+|||.+..
T Consensus 116 --i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 116 --IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred --cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999998 78899999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=136.83 Aligned_cols=97 Identities=22% Similarity=0.335 Sum_probs=87.0
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+++.+|+++++.++|++++....++.+....++||||+++++|.+++. ....++.+++.+|.+||+.+
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g 448 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG 448 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC
Confidence 4678899999999999999988777777778899999999999998873 35678999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
++||||||+||++ .++.++|+|||+++.
T Consensus 449 ---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 449 ---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999 678899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.9e-15 Score=118.65 Aligned_cols=98 Identities=21% Similarity=0.361 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
..++.+|++++..++|+++.....++...+..++||||++|++|.+++.. ... .++.+++.+|.++|+.+
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~---~~~-------~~~~~i~~~l~~lH~~g 110 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE---GND-------ELLREIGRLVGKLHKAG 110 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhh---cHH-------HHHHHHHHHHHHHHHCC
Confidence 46788999999999988766555555666678999999999999887732 111 78999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
++|||++|.||+++ ++.++++|||++..
T Consensus 111 ---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 111 ---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-15 Score=120.02 Aligned_cols=104 Identities=25% Similarity=0.265 Sum_probs=82.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCc--eeeeeeEeecC----eEEEEEeecCC-CChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNL--VRLFGCCIEHG----EKILIYEYMPN-KSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....++.+|++++..++|+++ ++.+++..... ..++|||+++| .+|.+++.+ ..++.. .+.+++.
T Consensus 82 ~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~ 153 (239)
T PRK01723 82 LERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQ 153 (239)
T ss_pred hhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHH
Confidence 345678899999999998875 66776654332 23599999997 689888742 234443 3678999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
+|.+||+.| |+||||||.|||++.++.++|+|||.+...
T Consensus 154 ~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 154 LIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 999999998 999999999999999899999999988753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.9e-15 Score=118.39 Aligned_cols=102 Identities=16% Similarity=0.180 Sum_probs=79.4
Q ss_pred HHHHHHHHHHhhCCCCC--ceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 10 EEFKNEMMLIAKLQHRN--LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+|+.++.++.+.+ +.+++++ . ..++||||+++++|..... ....+.......++.|++.++.+||..
T Consensus 95 ~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~ 167 (237)
T smart00090 95 LWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKE 167 (237)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhc
Confidence 34678999999997532 3344432 2 3589999999988866542 223455666789999999999999976
Q ss_pred CCCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
| .++||||||+||+++ ++.++|+|||.+...
T Consensus 168 g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 G--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred C--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 5 399999999999999 888999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-13 Score=109.43 Aligned_cols=96 Identities=18% Similarity=0.225 Sum_probs=77.9
Q ss_pred HHHHHHHHHhhCCCCC--ceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 11 EFKNEMMLIAKLQHRN--LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+|..++..+.|++ +.+.++ ....++||||+++++|..+.. ......++.+++.++.++|+.+
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g 145 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG 145 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC
Confidence 4778999999998874 444443 235689999999999876541 0235678899999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccC
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~ 122 (289)
++||||+|.||++++++.++|+|||.+....
T Consensus 146 ---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 146 ---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ---CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-13 Score=102.49 Aligned_cols=102 Identities=25% Similarity=0.297 Sum_probs=87.6
Q ss_pred HHHHHHHHHHHhhCCC--CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMMLIAKLQH--RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..++.+|+.+++.++| .++++++++...++..++++||++++.+..+ +......++.+++.++.++|.
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~ 104 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQ 104 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhC
Confidence 4679999999999976 5899999998888899999999988877543 455667889999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
....+++|+|++|.||++++.+.+++.|||.+..
T Consensus 105 ~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 5334599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.7e-13 Score=118.13 Aligned_cols=148 Identities=18% Similarity=0.230 Sum_probs=114.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+...+-++.|+.++||||+++++.++..+..|+|+|-+ .-|..++.+ +.......-+.||+.||.+||..
T Consensus 52 ~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~v~~Gl~qIl~AL~FL~~d 123 (690)
T KOG1243|consen 52 VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEEVCLGLFQILAALSFLNDD 123 (690)
T ss_pred hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHHHHHHHHHHHHHHHHHhcc
Confidence 3566778899999999999999999999999999999977 346666632 33566778899999999999864
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ .++|+++.-+.|+++..|..||++|.++........ .......-..|..|+.+.... -..|.|-|||++++++
T Consensus 124 ~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ 197 (690)
T KOG1243|consen 124 C--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELF 197 (690)
T ss_pred C--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHh
Confidence 4 599999999999999999999999998865432221 111122233466776654332 4569999999999999
Q ss_pred hC
Q 038647 168 SS 169 (289)
Q Consensus 168 tg 169 (289)
.|
T Consensus 198 ng 199 (690)
T KOG1243|consen 198 NG 199 (690)
T ss_pred Cc
Confidence 98
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-13 Score=119.50 Aligned_cols=206 Identities=23% Similarity=0.271 Sum_probs=153.9
Q ss_pred HHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH----HHHHHhc
Q 038647 12 FKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ----GLLYLHH 86 (289)
Q Consensus 12 ~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~----~l~~lH~ 86 (289)
=.+|+.....++ |+|.++.+..++.++..++-+|+|. .+|..+... ....++...++..+.+... ||.++|.
T Consensus 164 k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs 240 (524)
T KOG0601|consen 164 KLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHS 240 (524)
T ss_pred ccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCC
Confidence 346777777774 9999999999999999999999994 677776642 3344777788888888888 9999998
Q ss_pred CCCCceEeeccccCceEeCCC-CceEEcccccccccCCCCcccc---cccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGGDELQSN---TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~-~~vkl~Dfg~~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
.+ ++|-|+||.||+...+ ...+++|||+...+........ .....|...|++||... ..++...|||++|.+
T Consensus 241 ~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev 316 (524)
T KOG0601|consen 241 NN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEV 316 (524)
T ss_pred Cc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhh
Confidence 87 9999999999999999 8899999999998866543322 12336788999999874 458899999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+.+..++.......-... |...+ ...+..++......++...+..+++.+|..|++.+.+..
T Consensus 317 ~l~~~l~~~~~~~g~~~~-------W~~~r--------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 317 ILEAILGSHLPSVGKNSS-------WSQLR--------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hHhhHhhcccccCCCCCC-------ccccc--------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 999999887644321111 11111 111222233233445666888999999999999888765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=95.74 Aligned_cols=97 Identities=20% Similarity=0.248 Sum_probs=70.9
Q ss_pred HHHHHHHhhCCCCC--ceeeeeeEeecCeEEEEEeecCCCChhhh-hcCCCCCCCCChHHHHHHHHHHHHHHHHHhc-CC
Q 038647 13 KNEMMLIAKLQHRN--LVRLFGCCIEHGEKILIYEYMPNKSLDCF-LFDPTKTGLLGWEMRVRILEGVAQGLLYLHH-YS 88 (289)
Q Consensus 13 ~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ 88 (289)
..|.+.+..+.+.. +.+.++. ...++||||++++.+... +.. . .. ......++.+++.++.++|. .+
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~-~~-~~~~~~~~~~~~~~l~~lh~~~~ 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD---V-RL-LEDPEELYDQILELMRKLYREAG 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhh---h-hh-cccHHHHHHHHHHHHHHHhhccC
Confidence 46677777775443 4444443 246899999998654321 211 0 01 15678899999999999998 77
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccC
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~ 122 (289)
++|+||||+||+++ ++.++|+|||.+....
T Consensus 136 ---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 136 ---LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ---cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999999 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.9e-11 Score=93.42 Aligned_cols=97 Identities=15% Similarity=0.124 Sum_probs=73.7
Q ss_pred HHHHHHhhCCC--CCceeeeeeEeecCeEEEEEeecCCCChhh-hhcCCCCCCCCChHHHHHHHHHHHHHHHHH-hcCCC
Q 038647 14 NEMMLIAKLQH--RNLVRLFGCCIEHGEKILIYEYMPNKSLDC-FLFDPTKTGLLGWEMRVRILEGVAQGLLYL-HHYSR 89 (289)
Q Consensus 14 ~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~ 89 (289)
+|++.|+++.. -++.+.+++ ..-++||||+.++.+.. .+. ...++.+....++.+++.+|..+ |..+
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g- 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN- 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence 89999999953 456666654 45679999997654421 221 12344556678889999999999 7777
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccC
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~ 122 (289)
++||||++.||+++ ++.+.|+|||.+....
T Consensus 146 --lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 --LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred --eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999996 4679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.5e-12 Score=118.55 Aligned_cols=189 Identities=23% Similarity=0.249 Sum_probs=138.8
Q ss_pred CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCce
Q 038647 23 QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNI 102 (289)
Q Consensus 23 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Ni 102 (289)
++|-++....-+.-....++|++|..+++|...+. .-+..+.+........+.+++.|||... +.|+|++|.|.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~---~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLH---NSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSL 935 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhh---cCCCcccccccchhHHHHhhhhccccch---hhcccccccch
Confidence 34666655555556678999999999999988773 3345666667778888999999999765 89999999999
Q ss_pred EeCCCCceEEcccccccccCCC-------------------------Ccc----cccccccccccccChhhhhcCCCCCc
Q 038647 103 LLDSNMNPKISDFGIARLFGGD-------------------------ELQ----SNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 103 ll~~~~~vkl~Dfg~~~~~~~~-------------------------~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+...++..++.||+.....+.- ... .......+|+.|.+||...+......
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 9999999999999843332100 000 11234568999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCC-----CHHHHHHHHHHHHcccccCC
Q 038647 154 SDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDA-----SYPMLNRYINVALLCVQENA 228 (289)
Q Consensus 154 ~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p 228 (289)
+|.|++|+++++.++|.+||....... +++.++.+.. .........+++...+..+|
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na~tpq~------------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQQ------------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCCcchhh------------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCc
Confidence 999999999999999999976544332 1122222111 22234566677888889999
Q ss_pred CCCCCHH
Q 038647 229 ADRPTML 235 (289)
Q Consensus 229 ~~Rps~~ 235 (289)
.+|-.+.
T Consensus 1078 ~qr~~a~ 1084 (1205)
T KOG0606|consen 1078 TQRLGAK 1084 (1205)
T ss_pred hhccCcc
Confidence 9998766
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.3e-11 Score=90.26 Aligned_cols=97 Identities=24% Similarity=0.159 Sum_probs=72.5
Q ss_pred HHHHHHHHHHhhCCCCCce-eeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 10 EEFKNEMMLIAKLQHRNLV-RLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
..+.+|+.+++.+.+.+++ +++.+.. ...++||||++|.++.... ......+.+++.+|..||..+
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~ 103 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED-----------FSDPENLEKIAKLLKKLHSSP 103 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc-----------ccCHHHHHHHHHHHHHHhCCC
Confidence 4578999999999765554 4554433 3457999999998875420 011345689999999999876
Q ss_pred --CCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 89 --RLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 89 --~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
...++|||++|.||+++ ++.++++||+.+..
T Consensus 104 ~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 104 LPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 22359999999999998 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-10 Score=86.27 Aligned_cols=97 Identities=24% Similarity=0.362 Sum_probs=77.9
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
.+-.+|+++|..++--.|.--.=+..+.+...|+|||.+|-.|.+.+... ...++..+-.-+.-||..|
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g- 112 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG- 112 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC-
Confidence 45568999999997555554444555666778999999999998888432 2577888889999999888
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
|+||||.++||++...+ +.++|||++..
T Consensus 113 --ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 --IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred --eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999997665 99999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.9e-11 Score=104.31 Aligned_cols=199 Identities=18% Similarity=0.153 Sum_probs=140.1
Q ss_pred HHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCce
Q 038647 14 NEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRV 92 (289)
Q Consensus 14 ~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 92 (289)
.|+-+...+ .|.+++.++..+......|+--|||.++++.... .-...+++...+++..|++.++.++|+.. +
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~ 387 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---F 387 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---h
Confidence 466667777 4899999888888888889999999999887655 22245777788999999999999999887 9
Q ss_pred EeeccccCceEeCCC-CceEEcccccccccCCCCccccccccccccccc--ChhhhhcCCCCCcccchhHHHHHHHHHhC
Q 038647 93 IHRDLKASNILLDSN-MNPKISDFGIARLFGGDELQSNTKRIVGTYGYM--SPEYALRGLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 93 vH~dikp~Nill~~~-~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DiwslG~vl~elltg 169 (289)
+|+|++|+||++..+ +..+++|||....+.... .......++. ++.......+..++|+++||.-+.+.+++
T Consensus 388 ~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~ 462 (524)
T KOG0601|consen 388 VHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITG 462 (524)
T ss_pred hcccccccceeeccchhhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccC
Confidence 999999999999876 777999999886432211 1112233444 55555567889999999999999999998
Q ss_pred CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 170 KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 170 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
...-... .....+......... .....+..+...+...++..||++.++.....
T Consensus 463 ~~ls~~~-----------------~~~~~i~~~~~p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 463 SPLSESG-----------------VQSLTIRSGDTPNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccCccc-----------------ccceeeecccccCCC--chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 7532111 111111111111111 11245556666788999999999988765443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-10 Score=101.23 Aligned_cols=104 Identities=21% Similarity=0.232 Sum_probs=73.7
Q ss_pred HHHHHHHHHhhCC----CCCceeeeeeEe-ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH-HHHHH
Q 038647 11 EFKNEMMLIAKLQ----HRNLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ-GLLYL 84 (289)
Q Consensus 11 ~~~~E~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~-~l~~l 84 (289)
+|.+|++.+.+++ |.+-+.+-.++. .....++||||++|++|.++.... ..+ . ....++..++. .+..+
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~-~~~-~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD-EAG-L---DRKALAENLARSFLNQV 273 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH-hcC-C---CHHHHHHHHHHHHHHHH
Confidence 5777888877773 333333333332 234578999999999998876321 111 1 23455566555 47888
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccC
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~ 122 (289)
|..| ++|+|++|.||+++.++.++++|||++....
T Consensus 274 ~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9887 9999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-09 Score=91.67 Aligned_cols=201 Identities=13% Similarity=0.081 Sum_probs=127.9
Q ss_pred EEEEEeecCCCC-hhhhhc---CCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEccc
Q 038647 40 KILIYEYMPNKS-LDCFLF---DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDF 115 (289)
Q Consensus 40 ~~lv~e~~~~g~-L~~~l~---~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Df 115 (289)
.-+.|..+++.- ...++. .........|....+....++.+.+.||..| .+-||++++|+|+++++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 456677665541 222221 1234456889999999999999999999998 999999999999999999999985
Q ss_pred ccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhHHHHHHHHHhC-CCCcCCCCCcch----hHhH
Q 038647 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLVLETLSS-KKNAHFYNTDSL----TLLG 185 (289)
Q Consensus 116 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~vl~elltg-~~p~~~~~~~~~----~~~~ 185 (289)
.......++. ...-.+|...|.+||.-. +..-++..|.|.||+++|+++.| ++||.+...... ....
T Consensus 162 Dsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 5444332222 223346889999999765 34457889999999999999997 888765322100 0000
Q ss_pred hHhhhhccCC-ccccccccccCCCCHHHHHHHHHHHHccccc--CCCCCCCHHHHHHHhhcccC
Q 038647 186 HAWNLWNDGR-AWELMDSILQNDASYPMLNRYINVALLCVQE--NAADRPTMLEVISMLTNENV 246 (289)
Q Consensus 186 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~~ll~~L~~~~~ 246 (289)
.....+.... ...-.........-.-.+.++..+..+|+.. ++.-|||++.++..|.....
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0000110000 0000011111111111345677788888865 46789999999988876543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-09 Score=92.84 Aligned_cols=185 Identities=18% Similarity=0.241 Sum_probs=126.8
Q ss_pred HHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCC-CChhhhhcCC------------CCCCCCChHHHHHHHHH
Q 038647 14 NEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPN-KSLDCFLFDP------------TKTGLLGWEMRVRILEG 76 (289)
Q Consensus 14 ~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~l~~~------------~~~~~~~~~~~~~~~~~ 76 (289)
.=+++++++.|+|+|++.++|.. +..+++||+|.++ ++|.++.... ..+..++++.+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 44889999999999999999873 4468999999875 5665544331 12335778999999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccc
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
+..||.++|+.| +.-+-|.+.+|+++.+.+++|...|......... . |-+. -..+-|.
T Consensus 402 LtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~--~~le---~~Qq~D~ 459 (655)
T KOG3741|consen 402 LTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------T--EPLE---SQQQNDL 459 (655)
T ss_pred HHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC--------------C--cchh---HHhhhhH
Confidence 999999999988 7779999999999999899999888776543322 0 1111 1356788
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
-.||.+++.|.||..--............ ......+.++.+++.-....++++ -++.+
T Consensus 460 ~~lG~ll~aLAt~~~ns~~~d~~~~s~~~---------------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 460 RDLGLLLLALATGTENSNRTDSTQSSHLT---------------------RITTTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred HHHHHHHHHHhhcccccccccchHHHHHH---------------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 89999999999996421000000000000 111234456667777777777776 46666
Q ss_pred HHHHhh
Q 038647 237 VISMLT 242 (289)
Q Consensus 237 ll~~L~ 242 (289)
++.++-
T Consensus 518 llp~~~ 523 (655)
T KOG3741|consen 518 LLPMIG 523 (655)
T ss_pred HHHHHH
Confidence 665443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-09 Score=90.02 Aligned_cols=106 Identities=18% Similarity=0.169 Sum_probs=81.2
Q ss_pred HHHHHHHHHhhCCCCCce--eeeeeEee-----cCeEEEEEeecCCC-ChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 11 EFKNEMMLIAKLQHRNLV--RLFGCCIE-----HGEKILIYEYMPNK-SLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv--~~~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.+.+|.+.+..+...+|. +.+++.+. ....++|+|++++. +|.+++.+.. ....+......++.+++..+.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHH
Confidence 478999999888543333 44555543 23578999999876 7888874321 234556677899999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCC-------CCceEEcccccccc
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDS-------NMNPKISDFGIARL 120 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~-------~~~vkl~Dfg~~~~ 120 (289)
-||..| |+|+|+++.|||++. +..+.++||+.++.
T Consensus 153 ~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999998 999999999999975 46789999998853
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.9e-11 Score=105.07 Aligned_cols=156 Identities=21% Similarity=0.248 Sum_probs=106.7
Q ss_pred HHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc------ccc-cccccccccccCh
Q 038647 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL------QSN-TKRIVGTYGYMSP 142 (289)
Q Consensus 70 ~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~------~~~-~~~~~g~~~y~aP 142 (289)
...=+.+++.|+.++|... .+||++|.|++|.++.++..||+.|+.+........ ... .........|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3344556679999999854 699999999999999999999999998765543211 110 0111235679999
Q ss_pred hhhhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHH
Q 038647 143 EYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVAL 221 (289)
Q Consensus 143 E~~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 221 (289)
|++.+...++++|+||+|+++|.+.. |+..+...+........ ..............++.++.+-+.
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~------------~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS------------RNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh------------hcccccccccccccCcHHHHHHHH
Confidence 99999888999999999999999994 44444333222111100 001111111222456678888888
Q ss_pred cccccCCCCCCCHHHHHH
Q 038647 222 LCVQENAADRPTMLEVIS 239 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~ 239 (289)
+++..++.-||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999998777654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-09 Score=82.61 Aligned_cols=108 Identities=24% Similarity=0.295 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCC-CChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPN-KSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.++-+.|+++|.+++--.|.--.-++.+...-.++|||++| .++.+++......... .+....++..|-+.+.-||..
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhC
Confidence 56778899999999755665445566676777899999977 4777777543333332 233478999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCc---eEEcccccccc
Q 038647 88 SRLRVIHRDLKASNILLDSNMN---PKISDFGIARL 120 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~---vkl~Dfg~~~~ 120 (289)
+ |+||||..+||++..++. +.++|||++..
T Consensus 133 d---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 133 D---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred C---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 7 999999999999965543 58999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.4e-09 Score=83.07 Aligned_cols=100 Identities=25% Similarity=0.300 Sum_probs=67.5
Q ss_pred HHHHHHHHHHHhhCCCC--CceeeeeeEeecCeEEEEEeecC--CCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH-
Q 038647 9 LEEFKNEMMLIAKLQHR--NLVRLFGCCIEHGEKILIYEYMP--NKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY- 83 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~- 83 (289)
....++|.+.|.++..- ++.+.+++- .-++||||++ |..+..+.. ..++.+....++.+++..+..
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHH
Confidence 45677899999999866 456666442 3469999998 555544331 112244567788888885555
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
+|..| ++|||+.+.||+++++ .+.|+|||.+...
T Consensus 123 ~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 123 LHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 57777 9999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.9e-09 Score=83.25 Aligned_cols=108 Identities=23% Similarity=0.219 Sum_probs=84.3
Q ss_pred CHHHHHHHHHHHhhCCCC--CceeeeeeEeecC----eEEEEEeecCCC-ChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHR--NLVRLFGCCIEHG----EKILIYEYMPNK-SLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+..+|...+..+... ...+.+++.+... ..++|+|++++. +|.+++.+. ...+......++.+++..
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHH
Confidence 345678888888888533 3445666666532 458999999874 798888431 225666788999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCC---ceEEccccccccc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNM---NPKISDFGIARLF 121 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~---~vkl~Dfg~~~~~ 121 (289)
+.-||..| |+|+|+++.|||++.++ .+.++||+.++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999998 99999999999999887 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.90 E-value=1e-08 Score=82.27 Aligned_cols=109 Identities=19% Similarity=0.287 Sum_probs=84.8
Q ss_pred CHHHHHHHHHHHhhCCCC--CceeeeeeEeecC---eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHR--NLVRLFGCCIEHG---EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
...++.+|+++++.+++. ++.+++.+...+. ..++||||++|.++...+.. ..++.+....++.+++.+|.
T Consensus 38 ~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~ 113 (223)
T cd05154 38 SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLA 113 (223)
T ss_pred ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHH
Confidence 456889999999999753 4567777776543 67899999999988765521 34677777888888888888
Q ss_pred HHhcCC-----------------------------------------------------CCceEeeccccCceEeCC--C
Q 038647 83 YLHHYS-----------------------------------------------------RLRVIHRDLKASNILLDS--N 107 (289)
Q Consensus 83 ~lH~~~-----------------------------------------------------~~~ivH~dikp~Nill~~--~ 107 (289)
.||+.. ...++|+|+++.||+++. +
T Consensus 114 ~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~ 193 (223)
T cd05154 114 ALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEP 193 (223)
T ss_pred HHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCC
Confidence 888521 245799999999999998 5
Q ss_pred CceEEcccccccc
Q 038647 108 MNPKISDFGIARL 120 (289)
Q Consensus 108 ~~vkl~Dfg~~~~ 120 (289)
+.+.|+||+.+..
T Consensus 194 ~~~~iID~e~~~~ 206 (223)
T cd05154 194 RVVAVLDWELATL 206 (223)
T ss_pred cEEEEEecccccc
Confidence 6689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.3e-09 Score=93.15 Aligned_cols=102 Identities=17% Similarity=0.202 Sum_probs=67.1
Q ss_pred HHHHHHHHHhhCC----CCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCCCC----CCChHHHHHHHHHHHHHH
Q 038647 11 EFKNEMMLIAKLQ----HRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTG----LLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 11 ~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~i~~~l 81 (289)
+|.+|+..+.+++ +.+.+.+-.++.+ ....++||||+.|+.+.++..- ...+ .+....+..++.|+
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qi---- 276 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQV---- 276 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHH----
Confidence 3556666666663 4444444444433 4457899999999999764211 1111 23333344444444
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCC----ceEEcccccccccCC
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNM----NPKISDFGIARLFGG 123 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~----~vkl~Dfg~~~~~~~ 123 (289)
...| ++|+|+||.||+++.++ .+++.|||++.....
T Consensus 277 ---f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ---FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4456 99999999999999888 899999999987643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.8e-07 Score=73.26 Aligned_cols=110 Identities=16% Similarity=0.151 Sum_probs=84.4
Q ss_pred ccCHHHHHHHHHHHhhCCCC--CceeeeeeEe-ec----CeEEEEEeecCC-CChhhhhcCCCCCCCCChHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHR--NLVRLFGCCI-EH----GEKILIYEYMPN-KSLDCFLFDPTKTGLLGWEMRVRILEGV 77 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~-~~----~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~i 77 (289)
+.+...|.+|+..|+++..- .+.++. ++. .. ..-+||+|-+.+ .+|.+++.+. .....+......++.++
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~v 137 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAV 137 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHH
Confidence 56788999999999999632 344555 332 21 246799997743 5888887432 22356777788999999
Q ss_pred HHHHHHHhcCCCCceEeeccccCceEeCCCCc--eEEcccccccc
Q 038647 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMN--PKISDFGIARL 120 (289)
Q Consensus 78 ~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~--vkl~Dfg~~~~ 120 (289)
+.++.-||+.| +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 138 a~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 138 ALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999999988 999999999999986677 89999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.3e-07 Score=73.76 Aligned_cols=98 Identities=17% Similarity=0.203 Sum_probs=73.0
Q ss_pred HHHHHHHHHHHhhCCCC--CceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMMLIAKLQHR--NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....++|.++|+++... .+.+.+++ +.-.+||||.+|-.|...- +..+....++..|++-+..+-.
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~ 220 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR 220 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH
Confidence 45668999999999755 66666654 3457999999887664322 1334455566666666666666
Q ss_pred CCCCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
.| +||||+++-||+++++|.+.++||-.+...
T Consensus 221 ~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 221 RG---IVHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cC---ccccCCchheEEEecCCCEEEEeCcccccC
Confidence 66 999999999999999999999999877643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.6e-06 Score=67.55 Aligned_cols=105 Identities=22% Similarity=0.213 Sum_probs=81.1
Q ss_pred HHHHHHHhhCCC-CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc
Q 038647 13 KNEMMLIAKLQH-RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLR 91 (289)
Q Consensus 13 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 91 (289)
..|.-+|+.+++ +++.+++|+|- .++|.||...+++......-..--..+|..+.+++.++++.+.+++......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999975 69999999994 3578999987755321000011124689999999999999999999754455
Q ss_pred eEeeccccCceEeCCCCceEEccccccccc
Q 038647 92 VIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 92 ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
+.-+|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999998766543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.3e-08 Score=84.97 Aligned_cols=148 Identities=18% Similarity=0.121 Sum_probs=110.8
Q ss_pred HHHHHHHhhCCCCC-ceeeeeeEeecCeEEEEEeecCCC-ChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 13 KNEMMLIAKLQHRN-LVRLFGCCIEHGEKILIYEYMPNK-SLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 13 ~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
.-++++|.+++||| .+..++-++.+....++++++.++ +-..... ...-.+..-+....+..-..+++++|+..
T Consensus 281 rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~-- 356 (829)
T KOG0576|consen 281 RLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY-- 356 (829)
T ss_pred HHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc--
Confidence 44789999999999 667777777778899999999887 2221111 11123444455667777788999999754
Q ss_pred ceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCC
Q 038647 91 RVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~ 170 (289)
-+|+| ||+..+ +..+.+||+....+.... ......+++.++|||+.....+....|.|++|.-..++--|.
T Consensus 357 -~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~ 427 (829)
T KOG0576|consen 357 -KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGL 427 (829)
T ss_pred -ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCC
Confidence 58888 666544 679999999987765432 345567899999999999999999999999998777777676
Q ss_pred CCc
Q 038647 171 KNA 173 (289)
Q Consensus 171 ~p~ 173 (289)
+|-
T Consensus 428 pPr 430 (829)
T KOG0576|consen 428 PPR 430 (829)
T ss_pred CCC
Confidence 664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.7e-06 Score=68.07 Aligned_cols=67 Identities=22% Similarity=0.299 Sum_probs=52.3
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccc
Q 038647 39 EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118 (289)
Q Consensus 39 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~ 118 (289)
..++||||++|..|.++. .+++ .+...+.+++..+|..| ++|||.+|.|+++++++ +++.||+..
T Consensus 117 ~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECccc
Confidence 456899999998886643 1222 24456778899999998 99999999999998554 999999876
Q ss_pred cc
Q 038647 119 RL 120 (289)
Q Consensus 119 ~~ 120 (289)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.1e-06 Score=81.44 Aligned_cols=201 Identities=20% Similarity=0.217 Sum_probs=138.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeE----EEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK----ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+...+.|+..+..+.|+|++.++.|-.+.... .+..++|..-++...+ ..-+.++.++.+.+..++.+||.
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHH
Confidence 3455566788889999999999999887654432 3445788888888877 45677889999999999999999
Q ss_pred HHhcCCCCceEeeccccC---ceEeCCCCceEEc--ccccccccCCCCcccccccccccccccChhhhhcCCCCC--ccc
Q 038647 83 YLHHYSRLRVIHRDLKAS---NILLDSNMNPKIS--DFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI--KSD 155 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~---Nill~~~~~vkl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~D 155 (289)
|+|... ..|.-+..+ +.-.+..+.+.++ ||+.++....... ......+..+.++|.......+. ..|
T Consensus 301 ~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~d 374 (1351)
T KOG1035|consen 301 YLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTD 374 (1351)
T ss_pred HHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhH
Confidence 999875 666555554 4444556667766 8888776543321 11223455678888877665544 479
Q ss_pred chhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 156 VFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
+|++|.....+..|..+...... ....+... ......+....|+..++++|+++.
T Consensus 375 L~~lgll~~~~~~~~~i~~~~~~---------------------~~~~l~~~----~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 375 LWCLGLLLLQLSQGEDISEKSAV---------------------PVSLLDVL----STSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHHHHhhhhhcCcccccccc---------------------hhhhhccc----cchhhhhhhhhhcchhhhhccchh
Confidence 99999999999887754221110 00111100 001456777889999999999999
Q ss_pred HHHHHh
Q 038647 236 EVISML 241 (289)
Q Consensus 236 ~ll~~L 241 (289)
+++...
T Consensus 430 ~ll~~~ 435 (1351)
T KOG1035|consen 430 ELLTHP 435 (1351)
T ss_pred hhhhch
Confidence 998754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.9e-06 Score=65.51 Aligned_cols=104 Identities=20% Similarity=0.151 Sum_probs=65.2
Q ss_pred HHHHHHHHHHHhhCCCCC--ceeeeeeEeecCeEEEEEeecCCCC-hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 9 LEEFKNEMMLIAKLQHRN--LVRLFGCCIEHGEKILIYEYMPNKS-LDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.....+|.++++.+..-. +.+++++....+...+|||+++|.+ +...+.. +......++.+++..+.-||
T Consensus 36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~-------~~~~~~~l~~~la~~l~~lH 108 (226)
T TIGR02172 36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISD-------NPSRLEEIAKIFAEMAKKLH 108 (226)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcC-------CHHHHHHHHHHHHHHHHHHh
Confidence 456789999999996443 4678888888888889999998863 2211110 00001111111111111111
Q ss_pred c----------------------------------------CCCCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 86 H----------------------------------------YSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 86 ~----------------------------------------~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
+ .....++|+|+.|.||++++++ +.|+||+.+..
T Consensus 109 ~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 109 STKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 1 1123478999999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.11 E-value=2e-05 Score=64.32 Aligned_cols=47 Identities=13% Similarity=0.150 Sum_probs=36.2
Q ss_pred HHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhh
Q 038647 9 LEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF 55 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 55 (289)
..++.+|+++++.+. +--+.+++++...++..++|||+++|.++...
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 346788999999984 44455788887777778999999999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.3e-05 Score=71.28 Aligned_cols=44 Identities=18% Similarity=0.490 Sum_probs=34.6
Q ss_pred HHHHHHHHHHHhhCC-CCCc--eeeeeeEeec---CeEEEEEeecCCCCh
Q 038647 9 LEEFKNEMMLIAKLQ-HRNL--VRLFGCCIEH---GEKILIYEYMPNKSL 52 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~e~~~~g~L 52 (289)
...+.+|+++|+.+. |.++ .+++.++.+. +..|+||||++|..+
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 457899999999995 6665 6788887764 467899999988654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=7e-05 Score=59.92 Aligned_cols=98 Identities=20% Similarity=0.214 Sum_probs=67.7
Q ss_pred HHHHHHHhhCC--CCCceeeeeeEeecCeEEEEEeecCCCC-hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc-CC
Q 038647 13 KNEMMLIAKLQ--HRNLVRLFGCCIEHGEKILIYEYMPNKS-LDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH-YS 88 (289)
Q Consensus 13 ~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ 88 (289)
.+|++-|+++. +-.+.+-+++.. -.|||||+.... -.=.| ..-.+..+....+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 36888888874 444455555433 469999985431 11122 11223333567778888888888876 44
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccC
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~ 122 (289)
+||+||+.-|||+. ++.+.|+|++.+....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 7889999999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00016 Score=58.69 Aligned_cols=31 Identities=26% Similarity=0.385 Sum_probs=25.9
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..++|+|+.+.|+++++++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3489999999999998766567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=8.9e-05 Score=66.44 Aligned_cols=106 Identities=17% Similarity=0.186 Sum_probs=67.6
Q ss_pred HHHHHHHHHhhCC----CCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 11 EFKNEMMLIAKLQ----HRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 11 ~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+|.+|+.-+.+++ ...-+++=.++.+ .+.-.++|||++|-.+.++..... ...+...+.....++. +..+-
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLL 282 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHH
Confidence 4667777777763 2222333334432 456789999999998888743211 2233333332222221 22222
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCC
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~ 123 (289)
..| ++|+|.+|.||+++.++.+.+.|||.......
T Consensus 283 ~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 345 99999999999999999999999999887643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=6.5e-06 Score=80.27 Aligned_cols=157 Identities=11% Similarity=-0.058 Sum_probs=113.0
Q ss_pred HHHHhhCCCCCceeeeeeEe--ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHH-HHHHHHHhcC--CCC
Q 038647 16 MMLIAKLQHRNLVRLFGCCI--EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV-AQGLLYLHHY--SRL 90 (289)
Q Consensus 16 ~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i-~~~l~~lH~~--~~~ 90 (289)
..-++...|+++.....-.. +....|.+++|+.+|.+...+.+..+......+......+++ +....-+|.. +..
T Consensus 1280 ~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~ 1359 (2724)
T KOG1826|consen 1280 RDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGN 1359 (2724)
T ss_pred hhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCc
Confidence 33445567888887665544 344678999999999999988764443222223333344444 5555554532 234
Q ss_pred ceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCC
Q 038647 91 RVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~ 170 (289)
..+|+++|+.|.+|..+-+++++++|+.+..... ....+...+++.|+.|++.+...++.++|+|..|+.+|.+..|.
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred cchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 4789999999999999999999999999843221 23355567888999999999999999999999999999998888
Q ss_pred CCcC
Q 038647 171 KNAH 174 (289)
Q Consensus 171 ~p~~ 174 (289)
.++.
T Consensus 1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred HHHH
Confidence 7643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00037 Score=56.15 Aligned_cols=113 Identities=26% Similarity=0.249 Sum_probs=59.4
Q ss_pred CHHHHHHHHHHHhhCCCC--CceeeeeeEe---ecCeEEEEEeecCCCChhh----------------hhcC---C-CCC
Q 038647 8 GLEEFKNEMMLIAKLQHR--NLVRLFGCCI---EHGEKILIYEYMPNKSLDC----------------FLFD---P-TKT 62 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~g~L~~----------------~l~~---~-~~~ 62 (289)
....+.+|+.+++.+... .+.+++.+.. .....+++|++++|..+.. .+.+ . ...
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~ 112 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF 112 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccc
Confidence 457788999999998533 3456666443 3345789999999987766 1100 0 000
Q ss_pred CCCChHH---------HHHH------------HHHHHH-HHHHHhc----CCCCceEeeccccCceEeC-CCCceEEccc
Q 038647 63 GLLGWEM---------RVRI------------LEGVAQ-GLLYLHH----YSRLRVIHRDLKASNILLD-SNMNPKISDF 115 (289)
Q Consensus 63 ~~~~~~~---------~~~~------------~~~i~~-~l~~lH~----~~~~~ivH~dikp~Nill~-~~~~vkl~Df 115 (289)
..+.... .... ...+.. .+..++. .....++|+|+.|.||+++ +++.+.|+||
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~ 192 (239)
T PF01636_consen 113 SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDF 192 (239)
T ss_dssp CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--G
T ss_pred cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEec
Confidence 1101000 0000 011111 2223321 1245699999999999999 5666689999
Q ss_pred ccccc
Q 038647 116 GIARL 120 (289)
Q Consensus 116 g~~~~ 120 (289)
+.+..
T Consensus 193 e~a~~ 197 (239)
T PF01636_consen 193 EDAGW 197 (239)
T ss_dssp TT-EE
T ss_pred ccceE
Confidence 87753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00029 Score=55.32 Aligned_cols=99 Identities=20% Similarity=0.270 Sum_probs=69.1
Q ss_pred CHHHHHHHHHHHhhCC------CCCceeeeeeEeecCeEEEEEeecCC------CChhhhhcCCCCCCCCChHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQ------HRNLVRLFGCCIEHGEKILIYEYMPN------KSLDCFLFDPTKTGLLGWEMRVRILE 75 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~~~ 75 (289)
..+++.+|+.-...+. +.+|.+++|+.+++...-+|+|...+ -+|.+++. .+.++. ...+.+.
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~ 128 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD 128 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH
Confidence 4677777877766666 88999999999999988999987632 26677773 234544 4444444
Q ss_pred HHHHHHHHHhcCCCCceEeeccccCceEeCCCC----ceEEcc-ccc
Q 038647 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM----NPKISD-FGI 117 (289)
Q Consensus 76 ~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~----~vkl~D-fg~ 117 (289)
++ ..||-+.+ |+.+|++|.||++..+. .+.|+| ||.
T Consensus 129 ~f---~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 129 EF---KRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred HH---HHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 44 45555555 99999999999996432 466776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00024 Score=63.61 Aligned_cols=103 Identities=13% Similarity=0.165 Sum_probs=63.8
Q ss_pred HHHHHHHHHhhC----CCCC------ceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 11 EFKNEMMLIAKL----QHRN------LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 11 ~~~~E~~~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
+|.+|++-..++ .|-+ |.+++..+. ....|+||||+|.-+.+.-.- ....++...+..-+.+...-
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~ 315 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLE 315 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHH
Confidence 355565554444 3555 344443332 357899999999877665321 22235555444444443333
Q ss_pred HHHHhcCCCCceEeeccccCceEeCC----CCceEEcccccccccC
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDS----NMNPKISDFGIARLFG 122 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~----~~~vkl~Dfg~~~~~~ 122 (289)
+-+.| | ++|+|=+|-||++.. +..+.+.|||+.....
T Consensus 316 qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 316 QIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 33333 4 999999999999984 6679999999987654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00046 Score=56.75 Aligned_cols=30 Identities=27% Similarity=0.346 Sum_probs=26.1
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..++|+|+.|.||++++++ +.|+||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3589999999999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00089 Score=56.32 Aligned_cols=107 Identities=23% Similarity=0.311 Sum_probs=72.7
Q ss_pred cCHHHHHHHHHHHhhCCC--CCceeeeeeEeecC--eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHH-HHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQH--RNLVRLFGCCIEHG--EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL-EGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~-~~i~~~l 81 (289)
....+..+|.++|+.+.- --+...++.|.++. ..+.||+|++|..+...+.. .... .+++ ..++..|
T Consensus 63 ~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~----~~~~----~~~~~~~l~~~L 134 (321)
T COG3173 63 ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP----ESLG----RQFALDALADFL 134 (321)
T ss_pred hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc----ccch----HHHHHHHHHHHH
Confidence 345667788888888843 23345677777766 77999999988644333210 1111 1222 3566666
Q ss_pred HHHhcCC-------------------------------------------------------CCceEeeccccCceEeCC
Q 038647 82 LYLHHYS-------------------------------------------------------RLRVIHRDLKASNILLDS 106 (289)
Q Consensus 82 ~~lH~~~-------------------------------------------------------~~~ivH~dikp~Nill~~ 106 (289)
..||+.. ...++|||+++.|++++.
T Consensus 135 a~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~ 214 (321)
T COG3173 135 AELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDP 214 (321)
T ss_pred HHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeC
Confidence 6666321 345999999999999999
Q ss_pred CCceEEccccccccc
Q 038647 107 NMNPKISDFGIARLF 121 (289)
Q Consensus 107 ~~~vkl~Dfg~~~~~ 121 (289)
.+.+-|.||+++...
T Consensus 215 ~~~~gVlDwe~~~lG 229 (321)
T COG3173 215 GRPTGVLDWELATLG 229 (321)
T ss_pred CCeeEEEeccccccC
Confidence 988999999998764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0026 Score=53.54 Aligned_cols=44 Identities=16% Similarity=0.266 Sum_probs=34.7
Q ss_pred HHHHHHHHHHHhhCCC---CCceeeeeeEee---cCeEEEEEeecCCCCh
Q 038647 9 LEEFKNEMMLIAKLQH---RNLVRLFGCCIE---HGEKILIYEYMPNKSL 52 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~~~g~L 52 (289)
...|.+|.+.|+.+.- -.+.++++++.. .+..++|||+++++++
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 4588999999999953 357788887754 3668999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.002 Score=52.11 Aligned_cols=32 Identities=25% Similarity=0.377 Sum_probs=27.3
Q ss_pred CCceEeeccccCceEeCC-CCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDS-NMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~ 120 (289)
...++|+|+.+.||+++. ++.+.|+||..+..
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 345999999999999997 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0026 Score=54.04 Aligned_cols=74 Identities=23% Similarity=0.235 Sum_probs=57.8
Q ss_pred ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEccc
Q 038647 36 EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDF 115 (289)
Q Consensus 36 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Df 115 (289)
++.+.|++|++- |+.+.. .+...++++..++.+.+..+.-+.. +.+.-|||+.-.||+|+ .|+|.|+||
T Consensus 297 e~~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred CceEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEe
Confidence 444677888865 666632 2345677888888888887777776 34699999999999999 999999999
Q ss_pred ccccc
Q 038647 116 GIARL 120 (289)
Q Consensus 116 g~~~~ 120 (289)
-++|.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99984
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0015 Score=54.90 Aligned_cols=113 Identities=21% Similarity=0.174 Sum_probs=63.2
Q ss_pred CHHHHHHHHHHHhhCCCCC--ceeeeee------EeecCeEEEEEeecCCCChhhh----hcC--------------CCC
Q 038647 8 GLEEFKNEMMLIAKLQHRN--LVRLFGC------CIEHGEKILIYEYMPNKSLDCF----LFD--------------PTK 61 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~~~g~L~~~----l~~--------------~~~ 61 (289)
..+....|++++..+.+.+ +.+++.. ...++..++|++|++|..+... ... ...
T Consensus 49 ~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~ 128 (296)
T cd05153 49 SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPG 128 (296)
T ss_pred ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCc
Confidence 4566778999888885332 3444331 2334567899999998765330 000 000
Q ss_pred C----CCCChHHH----------HHHHHHHHHHHHHHhc----CCCCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 62 T----GLLGWEMR----------VRILEGVAQGLLYLHH----YSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 62 ~----~~~~~~~~----------~~~~~~i~~~l~~lH~----~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
. ....+... ......+..++.++.. .-...+||+|+.|.|+++++++.+.|+||+.+..
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 129 ERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 0 00011000 0011112233444432 1123499999999999999887778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0017 Score=57.44 Aligned_cols=47 Identities=23% Similarity=0.299 Sum_probs=36.7
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhc
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLF 57 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~ 57 (289)
.+....+.+++.+.|+|...++++-.. .....+|+|++ +.+|++.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 345556788999999999998887653 34578899999 678988874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.015 Score=48.40 Aligned_cols=30 Identities=27% Similarity=0.534 Sum_probs=25.3
Q ss_pred ceEeeccccCceEeCCCCc-eEEcccccccc
Q 038647 91 RVIHRDLKASNILLDSNMN-PKISDFGIARL 120 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~-vkl~Dfg~~~~ 120 (289)
.++|+|+++.||++++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.016 Score=50.68 Aligned_cols=43 Identities=7% Similarity=0.067 Sum_probs=31.4
Q ss_pred cCHHHHHHHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCCCC
Q 038647 7 QGLEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPNKS 51 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~ 51 (289)
-..+++..|.+.|+.+. ..++.+++.+. .+..++||||+++..
T Consensus 72 l~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVME~L~~~~ 117 (401)
T PRK09550 72 LTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVMEDLSDHK 117 (401)
T ss_pred ccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEEecCCCcc
Confidence 35678889999999873 24567777773 355789999997643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.012 Score=50.63 Aligned_cols=32 Identities=28% Similarity=0.448 Sum_probs=27.0
Q ss_pred CCceEeeccccCceEeCC-CCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDS-NMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~ 120 (289)
...++|+|+++.||++++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 345999999999999976 46799999988764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.027 Score=44.91 Aligned_cols=48 Identities=21% Similarity=0.333 Sum_probs=38.4
Q ss_pred ccCHHHHHHHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCCCChh
Q 038647 6 GQGLEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPNKSLD 53 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 53 (289)
.+....|..|+.-|..+. .-++.+++.+..+..+.|+|+||++.+.+.
T Consensus 49 ~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 49 REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 345677888988887774 456778999999999999999999887664
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.0047 Score=51.77 Aligned_cols=95 Identities=13% Similarity=0.149 Sum_probs=65.9
Q ss_pred HHHHHHHHHhhCC-CCC-ceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 11 EFKNEMMLIAKLQ-HRN-LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 11 ~~~~E~~~l~~l~-h~n-iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
...+|+..|+.+. |.. +.+.+++ +.-++|||++.+..|.+.. .... ...++..+..-+.-|-.+|
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d---~~~ly~~lm~~Iv~la~~G 222 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVED---PPTLYDDLMGLIVRLANHG 222 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCC---hHHHHHHHHHHHHHHHHcC
Confidence 3457888888884 332 3344443 3467999999998886533 1122 2344555555566666677
Q ss_pred CCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
+||||++-=||++.+++.++++||-.....
T Consensus 223 ---lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred ---ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999765443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.014 Score=48.77 Aligned_cols=45 Identities=13% Similarity=0.210 Sum_probs=29.3
Q ss_pred ccCHHHHHHHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCCC
Q 038647 6 GQGLEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPNK 50 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 50 (289)
......|..|++-|+.|. --.+.+++++...++..++|+||++.+
T Consensus 50 ~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 50 ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 344567899999999884 445678999888877889999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.045 Score=46.83 Aligned_cols=31 Identities=23% Similarity=0.354 Sum_probs=26.6
Q ss_pred CceEeeccccCceEeCC-CCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDS-NMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~ 120 (289)
..++|.|+.+.||++++ ++.++++||..+..
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 45899999999999975 57899999998864
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.013 Score=34.21 Aligned_cols=45 Identities=31% Similarity=0.547 Sum_probs=33.1
Q ss_pred cCCCCCCCCCCccccccccCCCCCCccc-cCCCCCccccccccCCC
Q 038647 245 NVILPSPLQPAFSHVRIAENSSLPANCE-VEACTVNCLTLSAMDAR 289 (289)
Q Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~r 289 (289)
...+|.|-+|.|...+.......++... .+.|++|.+|.|.++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 3468999999998876654443232221 27899999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.029 Score=47.26 Aligned_cols=32 Identities=31% Similarity=0.370 Sum_probs=27.7
Q ss_pred CCceEeeccccCceEeCCC----CceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDSN----MNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~----~~vkl~Dfg~~~~ 120 (289)
...++|+|+.+.||+++++ +.+.++||..+..
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 4569999999999999875 7899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.16 Score=44.53 Aligned_cols=40 Identities=8% Similarity=0.021 Sum_probs=29.3
Q ss_pred CHHHHHHHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCC
Q 038647 8 GLEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPN 49 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~ 49 (289)
..++-..|++.|+.+. ..++.+++.++.+ ..+++||++++
T Consensus 77 ~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvME~L~~ 119 (418)
T PLN02756 77 TKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGMRYLEP 119 (418)
T ss_pred CccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEEeecCC
Confidence 4556666788887774 2477788888874 46788999976
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.035 Score=48.88 Aligned_cols=32 Identities=31% Similarity=0.353 Sum_probs=25.1
Q ss_pred CceEeeccccCceEeCCCCc-----eEEccccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMN-----PKISDFGIARLF 121 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~-----vkl~Dfg~~~~~ 121 (289)
..++|||+...|||++.++. ..|+||-.+...
T Consensus 268 ~VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G 304 (414)
T PF07914_consen 268 PVLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRG 304 (414)
T ss_pred cceecCCccHHheeeecCCchhHHHHHHHHHHHhhcC
Confidence 45899999999999987443 468898777654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.15 Score=43.92 Aligned_cols=101 Identities=16% Similarity=0.187 Sum_probs=68.1
Q ss_pred HHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCce
Q 038647 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRV 92 (289)
Q Consensus 13 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 92 (289)
++|++-|++++.-.|.----... . .-+|||+|+..-. +-.-....-.++...+..+-.+++.-+.-|.+.+ .+
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlL-k-~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~L 286 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILL-K-NHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RL 286 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceee-e-cceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ce
Confidence 56888888887655432111111 1 2368999994221 2211123345666678888888888888888755 59
Q ss_pred EeeccccCceEeCCCCceEEccccccccc
Q 038647 93 IHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 93 vH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
||.||+--|+|+. +|.+.++|-+.+...
T Consensus 287 VHADLSEfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 287 VHADLSEFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred eccchhhhhheEE-CCEEEEEEccccccC
Confidence 9999999999995 567999998877654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.038 Score=46.78 Aligned_cols=30 Identities=37% Similarity=0.455 Sum_probs=26.5
Q ss_pred CceEeeccccCceEeCCCCceEEccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIAR 119 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~ 119 (289)
..+||+|+++.|++++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 459999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.17 Score=39.71 Aligned_cols=86 Identities=22% Similarity=0.401 Sum_probs=58.5
Q ss_pred HHHHHHHHHHHhhCC---CCCc--eeeeeeEeec------------------CeEEEEEeecCCCChhhhhcCCCCCCCC
Q 038647 9 LEEFKNEMMLIAKLQ---HRNL--VRLFGCCIEH------------------GEKILIYEYMPNKSLDCFLFDPTKTGLL 65 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~---h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 65 (289)
..-|.+|-+...+++ +.++ |+++||+.=. -..-||.||.+... .+
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~ 165 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL 165 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc
Confidence 456888888877774 5566 8999998311 01246667664432 12
Q ss_pred ChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccc
Q 038647 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118 (289)
Q Consensus 66 ~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~ 118 (289)
.. .-+.+|..-+..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 166 ~~----~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QI----RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ch----hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 22 33456667778889887 999999999986 3588899854
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.022 Score=44.13 Aligned_cols=30 Identities=23% Similarity=0.331 Sum_probs=26.2
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
...+|+|+.|.|+++++++ ++|+||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3479999999999998877 89999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.044 Score=45.36 Aligned_cols=50 Identities=24% Similarity=0.246 Sum_probs=38.0
Q ss_pred HHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 70 ~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..+.+..+-.++.-.+.. ...+||+|+.|.|++.++.+.++|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344555555666666543 14699999999999999999999999988754
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.057 Score=45.53 Aligned_cols=39 Identities=26% Similarity=0.180 Sum_probs=27.4
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCCceEeeccccCceEeCC
Q 038647 68 EMRVRILEGVAQGLLYLHH-YSRLRVIHRDLKASNILLDS 106 (289)
Q Consensus 68 ~~~~~~~~~i~~~l~~lH~-~~~~~ivH~dikp~Nill~~ 106 (289)
+-+..++.||+.-.-.+.+ .+-...+|-||||+|||+-+
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 4567788888766544432 22345999999999999944
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.071 Score=45.07 Aligned_cols=29 Identities=28% Similarity=0.340 Sum_probs=25.0
Q ss_pred CceEeeccccCceEeCCCCceEEccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIAR 119 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~ 119 (289)
..++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 35899999999999987 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.15 Score=44.51 Aligned_cols=37 Identities=14% Similarity=0.260 Sum_probs=27.9
Q ss_pred HHHHHHHhhCCCCCc-eeeeeeEeecCeEEEEEeecCCCChh
Q 038647 13 KNEMMLIAKLQHRNL-VRLFGCCIEHGEKILIYEYMPNKSLD 53 (289)
Q Consensus 13 ~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~ 53 (289)
.+|+++++.+...++ .++++.+.. .+|.||++|.+|.
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence 679999999965544 467777753 4999999987764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.052 Score=43.14 Aligned_cols=31 Identities=35% Similarity=0.517 Sum_probs=22.1
Q ss_pred CceEeeccccCceEe-CCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILL-DSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill-~~~~~vkl~Dfg~~~~ 120 (289)
..++|.|+.+.||++ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 469999999999999 8899999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.026 Score=48.03 Aligned_cols=31 Identities=32% Similarity=0.354 Sum_probs=26.0
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
.++||+|+.|.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3599999999999998665568999998753
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.069 Score=45.26 Aligned_cols=54 Identities=22% Similarity=0.269 Sum_probs=34.5
Q ss_pred HHHHHHHHHHHHHHHHHhcC-CCCceEeeccccCceEeCCC------------------CceEEccccccccc
Q 038647 68 EMRVRILEGVAQGLLYLHHY-SRLRVIHRDLKASNILLDSN------------------MNPKISDFGIARLF 121 (289)
Q Consensus 68 ~~~~~~~~~i~~~l~~lH~~-~~~~ivH~dikp~Nill~~~------------------~~vkl~Dfg~~~~~ 121 (289)
+-+..+++||+.-.--+.+. +-...+|-||||+|||+-+. -..+|.||.+++..
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 44566777775444223222 23359999999999999432 23577788877654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.061 Score=42.78 Aligned_cols=123 Identities=15% Similarity=0.126 Sum_probs=69.9
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
.-|..+.+++++++ .|+++..= ++..+-+|.|+|-.-.. . ...++..=+.+|.-.|+. .
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~----~~N~i~agi~~L~~fH~~-~ 161 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------N----FSNFITAGIKDLMDFHSE-N 161 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------c----hhHHHHHhHHHHHHhhcc-C
Confidence 34566677777664 34554411 22234477787733211 1 011222223667777854 2
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhC
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg 169 (289)
...+|||..|+||+-|+.|.+||.|=+.... .+..|.--| -...|+++.+-+|=.-++++...
T Consensus 162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 162 QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence 4699999999999999999999999654321 111122211 12346667776776666766654
Q ss_pred C
Q 038647 170 K 170 (289)
Q Consensus 170 ~ 170 (289)
+
T Consensus 225 ~ 225 (308)
T PF07387_consen 225 Q 225 (308)
T ss_pred H
Confidence 3
|
The function of this family is unknown. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.65 E-value=0.31 Score=37.42 Aligned_cols=96 Identities=17% Similarity=0.248 Sum_probs=64.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCce-eeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLV-RLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.-...++.|+++|..+.--++- +++.|-.+ .+.|||..|-.|.+.-.. .+. +-+..+++.---|.
T Consensus 57 s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~------~~r----k~l~~vlE~a~~LD 122 (201)
T COG2112 57 SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIG------GDR----KHLLRVLEKAYKLD 122 (201)
T ss_pred cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhc------ccH----HHHHHHHHHHHHHH
Confidence 3467899999999999866665 45555433 345999998888665421 022 33445555555566
Q ss_pred cCCCCceEeecccc--CceEeCCCCceEEcccccccc
Q 038647 86 HYSRLRVIHRDLKA--SNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 86 ~~~~~~ivH~dikp--~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..| |-|+.|+- .||++ .++.+.|+||..|+.
T Consensus 123 ~~G---I~H~El~~~~k~vlv-~~~~~~iIDFd~At~ 155 (201)
T COG2112 123 RLG---IEHGELSRPWKNVLV-NDRDVYIIDFDSATF 155 (201)
T ss_pred Hhc---cchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence 556 99998864 45555 444899999998874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.61 E-value=0.11 Score=44.07 Aligned_cols=32 Identities=25% Similarity=0.347 Sum_probs=28.2
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
...+||+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999998999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 289 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-29 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-113
Identities = 83/241 (34%), Positives = 124/241 (51%), Gaps = 11/241 (4%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ + ++F E+ ++AK QH NLV L G + + L+Y YMPN SL L T
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L W MR +I +G A G+ +LH IHRD+K++NILLD KISDFG+AR
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
T RIVGT YM+PE LRG + KSD++SFGV++LE ++ + + L
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE-HREPQLL 243
Query: 184 LGHAWNLWNDGRAWE-LMDSILQNDASYPM--LNRYINVALLCVQENAADRPTMLEVISM 240
L + ++ + E +D + + + +VA C+ E RP + +V +
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 241 L 241
L
Sbjct: 301 L 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-109
Identities = 92/251 (36%), Positives = 141/251 (56%), Gaps = 6/251 (2%)
Query: 1 LSSQSGQGLE-EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP 59
L + QG E +F+ E+ +I+ HRNL+RL G C+ E++L+Y YM N S+ L +
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 60 TKTGL-LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
++ L W R RI G A+GL YLH + ++IHRD+KA+NILLD + DFG+A
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKN---AHF 175
+L + T + GT G+++PEY G S K+DVF +GV++LE ++ ++ A
Sbjct: 182 KLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 176 YNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235
N D + LL L + + L+D LQ + + + I VALLC Q + +RP M
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 236 EVISMLTNENV 246
EV+ ML + +
Sbjct: 301 EVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 5e-94
Identities = 86/243 (35%), Positives = 139/243 (57%), Gaps = 5/243 (2%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+ +S QG+EEF+ E+ ++ +H +LV L G C E E ILIY+YM N +L L+
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 61 KTGL-LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
+ + WE R+ I G A+GL YLH + +IHRD+K+ NILLD N PKI+DFGI++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 120 LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNA-HFYNT 178
+ + + GT GY+ PEY ++G + KSDV+SFGV++ E L ++
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238
+ + L A N+G+ +++D L + L ++ + A+ C+ ++ DRP+M +V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 239 SML 241
L
Sbjct: 308 WKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-74
Identities = 53/268 (19%), Positives = 100/268 (37%), Gaps = 32/268 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFL 56
Q Q + + E+ + ++H N+++ G + LI + SL FL
Sbjct: 55 FPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113
Query: 57 FDPTKTGLLGWEMRVRILEGVAQGLLYLHH-------YSRLRVIHRDLKASNILLDSNMN 109
+ W I E +A+GL YLH + + HRD+K+ N+LL +N+
Sbjct: 114 KANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 110 PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYA-----LRGLFSIKSDVFSFGVLVL 164
I+DFG+A F + +T VGT YM+PE + ++ D+++ G+++
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMD---------SILQNDASYPMLNR 215
E S A + + + ++ + + + +
Sbjct: 230 ELASRCTAADGPVDEYMLPF--EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 216 YINVALLCVQENAADRPTMLEVISMLTN 243
C +A R + V +T
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 4e-61
Identities = 55/290 (18%), Positives = 101/290 (34%), Gaps = 41/290 (14%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCF 55
S + Q K + + ++H N+ R E +L+ EY PN SL +
Sbjct: 44 FSFANRQNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY 102
Query: 56 LFDPTKTGLLGWEMRVRILEGVAQGLLYLH------HYSRLRVIHRDLKASNILLDSNMN 109
L T W R+ V +GL YLH + + + HRDL + N+L+ ++
Sbjct: 103 LSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158
Query: 110 PKISDFGIARLFGG------DELQSNTKRIVGTYGYMSPEYALRGLFSI--------KSD 155
ISDFG++ G E + VGT YM+PE L G ++ + D
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVD 217
Query: 156 VFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQN--------- 206
+++ G++ E + + + + N ++ + +
Sbjct: 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA 277
Query: 207 -DASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNENVILPSPLQPA 255
+ + C ++A R T + +I +
Sbjct: 278 WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 60/247 (24%), Positives = 108/247 (43%), Gaps = 21/247 (8%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+ F E+ ++++ H N+V+L+G C+ L+ EY SL L
Sbjct: 45 RKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAA 102
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMN-PKISDFGIARLFGGDELQ 127
+ +QG+ YLH +IHRDLK N+LL + KI DFG A ++Q
Sbjct: 103 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQ 157
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHA 187
++ G+ +M+PE +S K DVFS+G+++ E ++ +K ++
Sbjct: 158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIM 214
Query: 188 WNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNENVI 247
W + N R + P ++ C ++ + RP+M E++ ++T+
Sbjct: 215 WAVHNGTR--------PPLIKNLP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
Query: 248 LPSPLQP 254
P +P
Sbjct: 265 FPGADEP 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-51
Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 44/279 (15%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L + F E+ ++ L+H N+++ G + I EY+ +L +
Sbjct: 43 LIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD 102
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
W RV + +A G+ YLH + +IHRDL + N L+ N N ++DFG+ARL
Sbjct: 103 SQ--YPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157
Query: 121 FGGDELQSNTKR------------IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++ Q R +VG +M+PE + K DVFSFG+++ E +
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217
Query: 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPML------NRYINVALL 222
+A + MD L + + +
Sbjct: 218 ---------------RVNADPDYL----PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVR 258
Query: 223 CVQENAADRPTMLEVISMLTN--ENVILPSPLQPAFSHV 259
C + RP+ +++ L ++ PL P +
Sbjct: 259 CCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQL 297
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-50
Identities = 59/245 (24%), Positives = 108/245 (44%), Gaps = 29/245 (11%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
+ + EF E+ ++ +L+H N+V G + ++ EY+ SL L
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
L R+ + VA+G+ YLH+ ++HR+LK+ N+L+D K+ DFG++RL
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192
Query: 125 ELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
L S + GT +M+PE LR + KSDV+SFGV++ E + ++
Sbjct: 193 FLSSKSA--AGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQ------------ 237
Query: 184 LGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL-----CVQENAADRPTMLEVI 238
W + +++ ++ + R +N + C RP+ ++
Sbjct: 238 ------PWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290
Query: 239 SMLTN 243
+L
Sbjct: 291 DLLRP 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-47
Identities = 55/240 (22%), Positives = 108/240 (45%), Gaps = 19/240 (7%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
+ Q L+ FKNE+ ++ K +H N++ G I + ++ SL L
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK-- 116
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
+ + I A+G+ YLH +IHRDLK++NI L + KI DFG+A
Sbjct: 117 FEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173
Query: 125 ELQSNTKRIVGTYGYMSPE---YALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
+++ G+ +M+PE +S +SDV++FG+++ E ++ + Y ++
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---Y--SNI 228
Query: 182 TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241
+ GR L + + ++ P R + C+++ +RP+ +++ +
Sbjct: 229 NNRDQI--IEMVGRG-SLSPDLSKVRSNCP--KRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-46
Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 30/250 (12%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
Q +E + E L A L+H N++ L G C++ L+ E+ L+ L
Sbjct: 43 DEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR- 101
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD--------SNMNPKIS 113
+ ++ V +A+G+ YLH + + +IHRDLK+SNIL+ SN KI+
Sbjct: 102 ---IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158
Query: 114 DFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNA 173
DFG+AR + S G Y +M+PE +FS SDV+S+GVL+ E L+ +
Sbjct: 159 DFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV-- 212
Query: 174 HFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT 233
+ + L A+ + + A + + + + + C + RP+
Sbjct: 213 -PF--RGIDGLAVAYGVAMNKLALPIPSTCPE---------PFAKLMEDCWNPDPHSRPS 260
Query: 234 MLEVISMLTN 243
++ LT
Sbjct: 261 FTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-46
Identities = 51/249 (20%), Positives = 114/249 (45%), Gaps = 29/249 (11%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
++ + +EF+ E+ +++ L H N+V+L+G ++ E++P L L D
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAH 117
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS-----NMNPKISDFG 116
+ W +++R++ +A G+ Y+ + ++HRDL++ NI L S + K++DFG
Sbjct: 118 P--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 117 IARLFGGDELQSNTKRIVGTYGYMSPE--YALRGLFSIKSDVFSFGVLVLETLSSKKNAH 174
+++ + + ++G + +M+PE A ++ K+D +SF +++ L+ +
Sbjct: 175 LSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG--- 226
Query: 175 FYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234
++ S + + +G + + R NV LC + RP
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPP---------RLRNVIELCWSGDPKKRPHF 277
Query: 235 LEVISMLTN 243
++ L+
Sbjct: 278 SYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 7e-45
Identities = 46/248 (18%), Positives = 95/248 (38%), Gaps = 40/248 (16%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFDPTKT 62
S + +F E + H N++ + G C I +MP SL L + T
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
++ V+ +A+G+ +LH L + L + ++++D +M +IS + F
Sbjct: 107 -VVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF- 163
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRG----LFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178
+ + +++PE AL+ +D++SF VL+ E ++ +
Sbjct: 164 ------QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREV------- 209
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVAL-----LCVQENAADRPT 233
+ D E+ + P + I+ + +C+ E+ A RP
Sbjct: 210 -----------PFADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPK 257
Query: 234 MLEVISML 241
++ +L
Sbjct: 258 FDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-44
Identities = 56/263 (21%), Positives = 103/263 (39%), Gaps = 34/263 (12%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
+ L+ FK E+M + +H N+V G C+ +I ++L + D
Sbjct: 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-- 126
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
L +I + + +G+ YLH ++H+DLK+ N+ D N I+DFG+ + G
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182
Query: 125 ELQSNTKRI---VGTYGYMSPEYALRGL----------FSIKSDVFSFGVLVLETLSSKK 171
+ ++ G +++PE +R L FS SDVF+ G + E + +
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEI-IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
Query: 172 NAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231
F + + W++ + N + M ++ L C +R
Sbjct: 242 P--FKTQPAEAI------------IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
Query: 232 PTMLEVISMLTNENVILPSPLQP 254
PT +++ ML P
Sbjct: 288 PTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 58/269 (21%), Positives = 97/269 (36%), Gaps = 39/269 (14%)
Query: 5 SGQGLEEFKNE--MMLIAKLQHRNLVRLFGCCIEHGEKI----LIYEYMPNKSLDCFLFD 58
S + + + E + L+H N++ + LI Y SL +L
Sbjct: 40 SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL 99
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLH-----HYSRLRVIHRDLKASNILLDSNMNPKIS 113
T L +RI+ +A GL +LH + + HRDLK+ NIL+ N I+
Sbjct: 100 TT----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155
Query: 114 DFGIARLF--GGDELQSNTKRIVGTYGYMSPE------YALRGLFSIKSDVFSFGVLVLE 165
D G+A + ++L VGT YM+PE + D+++FG+++ E
Sbjct: 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215
Query: 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGR-AWELMD----------SILQNDASYPMLN 214
+ + ++E M +I S P L
Sbjct: 216 VARRMVSNGIVEDYKP-----PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLT 270
Query: 215 RYINVALLCVQENAADRPTMLEVISMLTN 243
+ C +N + R T L + LT
Sbjct: 271 SLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-39
Identities = 60/266 (22%), Positives = 95/266 (35%), Gaps = 37/266 (13%)
Query: 7 QGLEEFKNE--MMLIAKLQHRNLVRLFGCCIEHGEKI----LIYEYMPNKSLDCFLFDPT 60
+ E + ++H N++ I+ LI +Y N SL +L T
Sbjct: 71 TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT 130
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLH-----HYSRLRVIHRDLKASNILLDSNMNPKISDF 115
L + +++ GL +LH + + HRDLK+ NIL+ N I+D
Sbjct: 131 ----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186
Query: 116 GIARLF--GGDELQSNTKRIVGTYGYMSPE------YALRGLFSIKSDVFSFGVLVLETL 167
G+A F +E+ VGT YM PE I +D++SFG+++ E
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
Query: 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMD----------SILQNDASYPMLNRYI 217
+ L +L ++E M S +S L +
Sbjct: 247 RRCVSGGIVEEYQL----PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302
Query: 218 NVALLCVQENAADRPTMLEVISMLTN 243
+ C N A R T L V L
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-38
Identities = 54/268 (20%), Positives = 94/268 (35%), Gaps = 37/268 (13%)
Query: 5 SGQGLEEFKNE--MMLIAKLQHRNLVRLFGCCIEHGEKI----LIYEYMPNKSLDCFLFD 58
S + + E + L+H N++ + L+ +Y + SL +L
Sbjct: 74 SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 133
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLH-----HYSRLRVIHRDLKASNILLDSNMNPKIS 113
T + E +++ A GL +LH + + HRDLK+ NIL+ N I+
Sbjct: 134 YT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 114 DFGIARLF--GGDELQSNTKRIVGTYGYMSPEYALRGL-------FSIKSDVFSFGVLVL 164
D G+A D + VGT YM+PE L ++D+++ G++
Sbjct: 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQND---------ASYPMLNR 215
E + L + +D E+ + + S L
Sbjct: 249 EIARRCSIGGIHEDYQLPYYDL---VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 305
Query: 216 YINVALLCVQENAADRPTMLEVISMLTN 243
+ C N A R T L + L+
Sbjct: 306 MAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-38
Identities = 59/264 (22%), Positives = 111/264 (42%), Gaps = 43/264 (16%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFD 58
L + + L +F+ E+ ++ LQH N+V+ G C G + LI EY+P SL +L
Sbjct: 47 LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-- 104
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
+ ++ + +G+ YL R IHRDL NIL+++ KI DFG+
Sbjct: 105 QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLT 161
Query: 119 RLFGGDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171
++ D+ ++ + + +PE FS+ SDV+SFGV++ E + +
Sbjct: 162 KVLPQDKEFFKVKEPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 172 NAHFYNTDSLTLLGHA--WNLWNDGRAWELMDSILQN----------DASYPMLNRYINV 219
+ + + ++G+ + + L++ + N D Y +
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIV----FHLIELLKNNGRLPRPDGCPDEIY-------MI 264
Query: 220 ALLCVQENAADRPTMLEVISMLTN 243
C N RP+ ++ +
Sbjct: 265 MTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 43/260 (16%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKT 62
+ + L +F+ E+ ++ LQH N+V+ G C G + LI EY+P SL +L
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHK 139
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ ++ + +G+ YL R IHRDL NIL+++ KI DFG+ ++
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196
Query: 123 GDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
D+ ++ + + +PE FS+ SDV+SFGV++ E + + +
Sbjct: 197 QDKEYYKVKEPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250
Query: 176 YNTDSLTLLGHA--WNLWNDGRAWELMDSILQN----------DASYPMLNRYINVALLC 223
+ + ++G+ + L++ + N D Y + C
Sbjct: 251 PPAEFMRMIGNDKQGQMIVF----HLIELLKNNGRLPRPDGCPDEIY-------MIMTEC 299
Query: 224 VQENAADRPTMLEVISMLTN 243
N RP+ ++ +
Sbjct: 300 WNNNVNQRPSFRDLALRVDQ 319
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
EEF E ++ +++H NLV+L G C +I E+M +L +L + + + +
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVV 112
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ + ++ + YL + IHRDL A N L+ N K++DFG++RL GD ++
Sbjct: 113 LLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 130 TK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ + +PE FSIKSDV++FGVL+ E +
Sbjct: 170 AGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 5/159 (3%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
EEF E ++ +++H NLV+L G C +I E+M +L +L + + + +
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ + ++ + YL + IHR+L A N L+ N K++DFG++RL GD ++
Sbjct: 321 -LYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ +PE FSIKSDV++FGVL+ E +
Sbjct: 377 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 60/161 (37%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+F E ++ KL H LV+L+G C+E L+ E+M + L +L T+ GL E
Sbjct: 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAET 105
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--LQ 127
+ + V +G+ YL VIHRDL A N L+ N K+SDFG+ R D+
Sbjct: 106 LLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ TK V + SPE +S KSDV+SFGVL+ E S
Sbjct: 163 TGTKFPV---KWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-36
Identities = 57/256 (22%), Positives = 108/256 (42%), Gaps = 40/256 (15%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKT 62
G + + K E+ ++ L H N+V+ G C E G LI E++P+ SL +L P
Sbjct: 63 GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNK 120
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ + +++ + +G+ YL + +HRDL A N+L++S KI DFG+ +
Sbjct: 121 NKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 123 GDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
D+ ++ + + +PE ++ F I SDV+SFGV + E L+ +
Sbjct: 178 TDKEYYTVKDDRDSPVF------WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
Query: 176 YNTDSLTLLGHAWNLWNDGRAWELMDSILQN----------DASYPMLNRYINVALLCVQ 225
L ++G L++++ + D Y + C +
Sbjct: 232 PMALFLKMIGPTHGQMT---VTRLVNTLKEGKRLPCPPNCPDEVY-------QLMRKCWE 281
Query: 226 ENAADRPTMLEVISML 241
++R + +I
Sbjct: 282 FQPSNRTSFQNLIEGF 297
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 52/249 (20%), Positives = 89/249 (35%), Gaps = 39/249 (15%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
+F E ++ + H N+VRL G C + ++ E + FL T+
Sbjct: 152 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGAR 209
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
L + ++++ A G+ YL IHRDL A N L+ KISDFG++R
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
Query: 125 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLL 184
++ + +PE G +S +SDV+SFG+L+
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL--------------------- 305
Query: 185 GHAWNLWNDGR----AWELMDSILQNDASY----PML--NRYINVALLCVQENAADRPTM 234
W ++ G + + P L + + C RP+
Sbjct: 306 ---WETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSF 362
Query: 235 LEVISMLTN 243
+ L +
Sbjct: 363 STIYQELQS 371
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 58/161 (36%), Positives = 90/161 (55%), Gaps = 10/161 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+ F E L+ +LQH+ LVRL+ + I I EYM N SL FL P+ L ++
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ + +A+G+ ++ IHRDL+A+NIL+ ++ KI+DFG+ARL +E
Sbjct: 112 -LDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--- 164
Query: 130 TKRIVGTYGY--MSPEYALRGLFSIKSDVFSFGVLVLETLS 168
T R + +PE G F+IKSDV+SFG+L+ E ++
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 46/170 (27%), Positives = 89/170 (52%), Gaps = 18/170 (10%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
S + +E +E ++A + + ++ RL G C+ ++ I + MP L ++ +
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDN 113
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
+G + + +A+G+ YL R++HRDL A N+L+ + + KI+DFG+A+L G +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 125 EL---QSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
E K + +M+ E L +++ +SDV+S+GV V E ++
Sbjct: 171 EKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+EF E ++ L H LV+L+G C + +I EYM N L +L +
Sbjct: 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQ 121
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--LQ 127
+ + + V + + YL + +HRDL A N L++ K+SDFG++R DE
Sbjct: 122 LLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+K V + PE + FS KSD+++FGVL+ E S
Sbjct: 179 VGSKFPV---RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 10/161 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E F E ++ LQH LV+L + I I E+M SL FL + ++
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKL 286
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ +A+G+ ++ + IHRDL+A+NIL+ +++ KI+DFG+AR+ +E
Sbjct: 287 -IDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---Y 339
Query: 130 TKRIVGTYGY--MSPEYALRGLFSIKSDVFSFGVLVLETLS 168
T R + +PE G F+IKSDV+SFG+L++E ++
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+ F E ++ +L+H NLV+L G +E + ++ EYM SL +L ++ L G
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 290
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ ++ V + + YL +HRDL A N+L+ + K+SDFG+ + Q
Sbjct: 291 L-LKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQD 344
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
K V + +PE FS KSDV+SFG+L+ E S
Sbjct: 345 TGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-35
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 22/166 (13%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILI-YEYMPNKSLDCFLFDPTKTGLLGWE 68
+ F E ++ +L+H NLV+L G +E + I EYM SL +L ++ L G
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ ++ V + + YL +HRDL A N+L+ + K+SDFG+ + + +
Sbjct: 119 L-LKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST 170
Query: 129 NTKRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ +PE FS KSDV+SFG+L+ E S
Sbjct: 171 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+EF E + KL H LV+ +G C + ++ EY+ N L +L + L
Sbjct: 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQ 105
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--LQ 127
+ + V +G+ +L + IHRDL A N L+D ++ K+SDFG+ R D+
Sbjct: 106 LLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
TK V + +PE +S KSDV++FG+L+ E S
Sbjct: 163 VGTKFPV---KWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFD 58
L +F+ E+ ++ L +V+ G G + L+ EY+P+ L FL
Sbjct: 60 LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-- 117
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
L + + +G+ YL R +HRDL A NIL++S + KI+DFG+A
Sbjct: 118 QRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLA 174
Query: 119 RLFGGDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+L D+ ++ + + +PE +FS +SDV+SFGV++ E +
Sbjct: 175 KLLPLDKDYYVVREPGQSPIF------WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 11/170 (6%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
+ +++F E+ + L HRNL+RL+G + K+ + E P SL L
Sbjct: 58 VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ- 115
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
G R VA+G+ YL R IHRDL A N+LL + KI DFG+ R
Sbjct: 116 -GHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 122 GGDELQSNTKRIVGT---YGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++ + + + +PE FS SD + FGV + E +
Sbjct: 172 PQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 44/259 (16%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKT 62
Q +K E+ ++ L H ++++ GCC + G L+ EY+P SL +L
Sbjct: 73 GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PR 128
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+G + + + +G+ YLH IHRDL A N+LLD++ KI DFG+A+
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 123 GDE----LQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
++ + + +PE F SDV+SFGV + E L+ ++
Sbjct: 186 EGHEYYRVREDGDSPVF------WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
Query: 176 YNTDSLTLLGHA-WNLWNDGRAWELMDSILQN----------DASYPMLNRYINVALLCV 224
T L L+G A + L + + + Y ++ C
Sbjct: 240 PPTKFLELIGIAQGQMTVL----RLTELLERGERLPRPDKCPAEVY-------HLMKNCW 288
Query: 225 QENAADRPTMLEVISMLTN 243
+ A+ RPT +I +L
Sbjct: 289 ETEASFRPTFENLIPILKT 307
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 56/171 (32%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+F +E ++ + H N++RL G +++ EYM N SLD FL G
Sbjct: 95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQ 152
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
V +L GV G+ YL S L +HRDL A N+L+DSN+ K+SDFG++R+ D
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP---- 205
Query: 130 TKRIVGTYGY------------MSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+PE FS SDV+SFGV++ E L+
Sbjct: 206 -------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 16/167 (9%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
Q + + M+ I L H ++VRL G C ++ + +Y+P SL + G LG
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALG 113
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
++ + +A+G+ YL ++HR+L A N+LL S +++DFG+A L D+
Sbjct: 114 PQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 127 QSNTKRIVGTYG-----YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
Q +M+ E G ++ +SDV+S+GV V E ++
Sbjct: 171 QLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-34
Identities = 60/183 (32%), Positives = 90/183 (49%), Gaps = 28/183 (15%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-------- 56
G EEF++E ML A+LQH N+V L G + +I+ Y + L FL
Sbjct: 52 EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSD 111
Query: 57 -----FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPK 111
D T L V ++ +A G+ YL S V+H+DL N+L+ +N K
Sbjct: 112 VGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVK 168
Query: 112 ISDFGIAR-LFGGD--ELQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
ISD G+ R ++ D +L N+ R +M+PE + G FSI SD++S+GV++ E
Sbjct: 169 ISDLGLFREVYAADYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 166 TLS 168
S
Sbjct: 223 VFS 225
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 16/165 (9%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+F E ++ + H N++RL G ++ ++I EYM N +LD FL K G
Sbjct: 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQ 148
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
V +L G+A G+ YL + + +HRDL A NIL++SN+ K+SDFG++R+ D +
Sbjct: 149 LVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 130 TKRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
T G + +PE F+ SDV+SFG+++ E ++
Sbjct: 206 TTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILI-YEYMPNKSLDCFLFDPTKTGLLGWE 68
+F E ++ + H N++RL G + + ++I EYM N SLD FL
Sbjct: 91 RDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFL--RKHDAQFTVI 147
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--- 125
V +L G+A G+ YL S + +HRDL A NIL++SN+ K+SDFG+ R+ D
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 126 -LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
K + + SPE F+ SDV+S+G+++ E +S
Sbjct: 205 YTTRGGKIPI---RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-34
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 14/170 (8%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
+ +E E ++ +L + +VR+ G C + + E L+ +L +
Sbjct: 56 ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYL---QQN 111
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ + + ++ V+ G+ YL +HRDL A N+LL + KISDFG+++
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 123 GDE----LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
DE Q++ K V + +PE FS KSDV+SFGVL+ E S
Sbjct: 169 ADENYYKAQTHGKWPV---KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 58/159 (36%), Positives = 88/159 (55%), Gaps = 6/159 (3%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E F E ++ KL+H LV+L+ E I + EYM SL FL T L ++
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
V + +A G+ Y+ R+ +HRDL+A+NIL+ N+ K++DFG+ARL +E +
Sbjct: 283 -VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ +PE AL G F+IKSDV+SFG+L+ E +
Sbjct: 339 QGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-34
Identities = 46/169 (27%), Positives = 91/169 (53%), Gaps = 16/169 (9%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
S + +E +E ++A + + ++ RL G C+ ++ I + MP L ++ +
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDN 113
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
+G + + +A+G+ YL R++HRDL A N+L+ + + KI+DFG+A+L G +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 125 ELQSNTKRIVGTYG-----YMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
E + + + G +M+ E L +++ +SDV+S+GV V E ++
Sbjct: 171 EKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-34
Identities = 58/159 (36%), Positives = 88/159 (55%), Gaps = 6/159 (3%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E F E ++ KL+H LV+L+ E I + EYM SL FL T L ++
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
V + +A G+ Y+ R+ +HRDL+A+NIL+ N+ K++DFG+ARL +E +
Sbjct: 366 -VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+ +PE AL G F+IKSDV+SFG+L+ E +
Sbjct: 422 QGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 28/178 (15%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL------------- 56
++F+ E L+ LQH ++V+ +G C + I+++EYM + L+ FL
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 57 FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG 116
G LG + I +A G++YL + +HRDL N L+ +N+ KI DFG
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFG 178
Query: 117 IAR-LFGGD--ELQSNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++R ++ D + +T R +M PE + F+ +SDV+SFGV++ E +
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
EE E ++ +L + +VRL G C + + E L FL K +
Sbjct: 55 EEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSN 111
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL--- 126
+L V+ G+ YL +HRDL A N+LL + KISDFG+++ G D+
Sbjct: 112 VAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168
Query: 127 -QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+S K + + +PE FS +SDV+S+GV + E LS
Sbjct: 169 ARSAGKWPL---KWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 25/185 (13%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL---- 56
L S ++F+ E L+ LQH+++VR FG C E ++++EYM + L+ FL
Sbjct: 79 LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 57 --------FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM 108
+ G LG + + VA G++YL + L +HRDL N L+ +
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGL 195
Query: 109 NPKISDFGIARLFGGDELQSNTKRIVGTYG-----YMSPEYALRGLFSIKSDVFSFGVLV 163
KI DFG++R D ++ R VG +M PE L F+ +SDV+SFGV++
Sbjct: 196 VVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 164 LETLS 168
E +
Sbjct: 251 WEIFT 255
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 54/256 (21%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL-IYEYMPNKSLDCFLFDPTKTG 63
+ +F E +++ H N++ L G C+ L + YM + L F+ + T
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 124
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
+ + VA+G+ YL + + +HRDL A N +LD K++DFG+AR
Sbjct: 125 -PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 176
Query: 124 DELQSNTKRIVGTYG------YMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYN 177
D + G +M+ E F+ KSDV+SFGVL+ E ++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT--------- 227
Query: 178 TDSLTLLGHA--WNLWNDGRAWELMDSILQN----------DASYPMLNRYINVALLCVQ 225
G ++ +++ +LQ D Y V L C
Sbjct: 228 ------RGAPPYPDVNT----FDITVYLLQGRRLLQPEYCPDPLY-------EVMLKCWH 270
Query: 226 ENAADRPTMLEVISML 241
A RP+ E++S +
Sbjct: 271 PKAEMRPSFSELVSRI 286
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 8/167 (4%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILI-YEYMPNKSLDCFLFDPTKTG 63
Q +E F E +L+ L H N++ L G + + YM + L F+ P +
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN- 120
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
+ + VA+G+ YL + + +HRDL A N +LD + K++DFG+AR
Sbjct: 121 -PTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 124 DELQSNTKRIVGTY--GYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
E S + + + E F+ KSDV+SFGVL+ E L+
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 23/174 (13%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFL---FDPT 60
+EEF +E + H N++RL G CIE + ++I +M L +L T
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR- 119
+ + ++ + +A G+ YL S +HRDL A N +L +M ++DFG+++
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 120 LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++ GD + + +++ E +++ KSDV++FGV + E +
Sbjct: 197 IYSGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 52/271 (19%), Positives = 94/271 (34%), Gaps = 61/271 (22%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E F +++KL H++LV +G C+ E IL+ E++ SLD +L +
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILW 114
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--------KISDFGIARLF 121
++ + + +A + +L +IH ++ A NILL + K+SD GI+
Sbjct: 115 KLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 122 GGDELQSNTKRIVGTYGY-----MSPEYAL-RGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
+ + PE ++ +D +SFG + E S
Sbjct: 172 LPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS------- 213
Query: 176 YNTDSLTLLGHA--WNLWNDGRAWELMDSILQNDASY----PMLNRYINVALLCVQENAA 229
G L + + + + P N+ C+
Sbjct: 214 --------GGDKPLSALDSQ----RKLQFY---EDRHQLPAPKAAELANLINNCMDYEPD 258
Query: 230 DRPTMLEVISMLTNENVILPSPLQPAFSHVR 260
RP+ +I L + + L P SH
Sbjct: 259 HRPSFRAIIRDLNS---LFTPDLVPRGSHHH 286
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 52/255 (20%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL-IYEYMPNKSLDCFLFDPTKTG 63
+ +F E +++ H N++ L G C+ L + YM + L F+ + T
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 188
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
+ + VA+G+ +L + + +HRDL A N +LD K++DFG+AR
Sbjct: 189 -PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 124 DELQSNTKRIVGTYG-----YMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178
E S + T +M+ E F+ KSDV+SFGVL+ E ++
Sbjct: 245 KEFDSVHNK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---------- 291
Query: 179 DSLTLLGHA--WNLWNDGRAWELMDSILQN----------DASYPMLNRYINVALLCVQE 226
G ++ +++ +LQ D Y V L C
Sbjct: 292 -----RGAPPYPDVNT----FDITVYLLQGRRLLQPEYCPDPLY-------EVMLKCWHP 335
Query: 227 NAADRPTMLEVISML 241
A RP+ E++S +
Sbjct: 336 KAEMRPSFSELVSRI 350
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 13/167 (7%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILI-YEYMPNKSLDCFLFDPTKTG 63
S E+F E + + + H ++V+L G E + I E L FL +
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFL--QVRKY 111
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L + ++ L YL R +HRD+ A N+L+ SN K+ DFG++R
Sbjct: 112 SLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
Query: 124 DE--LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
S K + +M+PE F+ SDV+ FGV + E L
Sbjct: 169 STYYKASKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+F +E +++ L H ++V+L G E I I E P L +L L
Sbjct: 58 EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLT 114
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--LQ 127
V + + + YL + +HRD+ NIL+ S K+ DFG++R ++
Sbjct: 115 LVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171
Query: 128 SNTK---RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
S T+ + +MSPE F+ SDV+ F V + E LS
Sbjct: 172 SVTRLPIK------WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 22/177 (12%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-------F 57
S + EF NE ++ + ++VRL G + ++I E M L +L
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 58 DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI 117
+ +++ +A G+ YL + + +HRDL A N ++ + KI DFG+
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 118 AR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
R ++ D + K R +MSPE G+F+ SDV+SFGV++ E +
Sbjct: 185 TRDIYETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 31/265 (11%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
+ + E+ L+ +L H N+++ + IE E ++ E L + K
Sbjct: 69 DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK 128
Query: 62 TGLLGWEMRV-RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
L E V + + L ++H RV+HRD+K +N+ + + K+ D G+ R
Sbjct: 129 QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
F +++ +VGT YMSPE ++ KSD++S G L+ E + + + D
Sbjct: 186 FSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ---SPFYGDK 240
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPML--NRY----INVALLCVQENAADRPTM 234
+ L L I Q D YP L + Y + +C+ + RP +
Sbjct: 241 MNLY-------------SLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 235 LEVISMLTNENVILPSPLQPA-FSH 258
V + + S L+ H
Sbjct: 286 TYVYDVAKRMHACTASSLEHHHHHH 310
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
EE E ++ +L + +VRL G C + + E L FL K +
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSN 437
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE---- 125
+L V+ G+ YL +HR+L A N+LL + KISDFG+++ G D+
Sbjct: 438 VAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+S K + + +PE FS +SDV+S+GV + E LS
Sbjct: 495 ARSAGKWPL---KWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 23/187 (12%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF------------ 57
E+ + E+ +AKL H N+V GC ++S LF
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 58 ---DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
+ + L + + + E + +G+ Y+H ++I+RDLK SNI L KI D
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGD 165
Query: 115 FGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAH 174
FG+ D R GT YMSPE + + D+++ G+++ E L
Sbjct: 166 FGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--T 220
Query: 175 FYNTDSL 181
+ T
Sbjct: 221 AFETSKF 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 24/175 (13%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI------LIYEYMPNKSLDCFLFD---P 59
+EEF E + + H ++ +L G + K +I +M + L FL
Sbjct: 69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 60 TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
L + VR + +A G+ YL S IHRDL A N +L +M ++DFG++R
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 120 -LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++ GD + + +++ E L+++ SDV++FGV + E ++
Sbjct: 186 KIYSGDYYRQGCASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 67/281 (23%), Positives = 107/281 (38%), Gaps = 65/281 (23%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL----FDPT 60
S Q +F E ++I+K H+N+VR G ++ + ++ E M L FL P+
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD---SNMNPKISDFGI 117
+ L + + +A G YL IHRD+ A N LL KI DFG+
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 118 ARLFGGDELQSNTKRIVGTYGY-----MSPEYALRGLFSIKSDVFSFGVLVLETLSSKKN 172
AR ++ + G M PE + G+F+ K+D +SFGVL+ E S
Sbjct: 190 AR-----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---- 240
Query: 173 AHFYNTDSLTLLGHA--WNLWNDGRAWELMDSILQN----------DASYPMLNRYINVA 220
LG+ + N E+++ + Y ++
Sbjct: 241 -----------LGYMPYPSKSN----QEVLEFVTSGGRMDPPKNCPGPVYRIM------- 278
Query: 221 LLCVQENAADRPTMLEVISML----TNENVI---LPSPLQP 254
C Q DRP ++ + + +VI LP P
Sbjct: 279 TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGP 319
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 52/244 (21%), Positives = 105/244 (43%), Gaps = 29/244 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+S S + EE + E+ ++A ++H N+V+ E+G ++ +Y L + +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQ 117
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K L + + + L ++H +++HRD+K+ NI L + ++ DFGIAR+
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
+ +GT Y+SPE ++ KSD+++ G ++ E + K H + S
Sbjct: 175 LNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK---HAFEAGS 229
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVALLCVQENAADRPTMLE 236
+ L+ I+ P+ Y ++ + N DRP++
Sbjct: 230 MK---------------NLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNS 273
Query: 237 VISM 240
++
Sbjct: 274 ILEK 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 30/179 (16%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL----------- 56
+F E+ ++ KL H N++ L G C G L EY P+ +L FL
Sbjct: 69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128
Query: 57 --FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
+ L + + VA+G+ YL S+ + IHRDL A NIL+ N KI+D
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIAD 185
Query: 115 FGIARLFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
FG++R G + T R +M+ E +++ SDV+S+GVL+ E +S
Sbjct: 186 FGLSR--GQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK----ILIYEYMPNKSLDCFL 56
+ + FK E ++ LQH N+VR + + +L+ E M + +L +L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 57 FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM-NPKISDF 115
+ ++ ++ + +GL +LH +IHRDLK NI + + KI D
Sbjct: 121 ---KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
G+A L S K ++GT +M+PE + DV++FG+ +LE +S+
Sbjct: 177 GLATLKR----ASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 65/278 (23%), Positives = 104/278 (37%), Gaps = 65/278 (23%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL----FDPTKTGL 64
+F E ++I+K H+N+VR G ++ + ++ E M L FL P++
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD---SNMNPKISDFGIARLF 121
L + + +A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 178 LAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-- 232
Query: 122 GGDELQSNTKRIVGTYGY-----MSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFY 176
++ G M PE + G+F+ K+D +SFGVL+ E S
Sbjct: 233 ---DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------- 281
Query: 177 NTDSLTLLGHA--WNLWNDGRAWELMDSILQN----------DASYPMLNRYINVALLCV 224
LG+ + N E+++ + Y ++ C
Sbjct: 282 -------LGYMPYPSKSN----QEVLEFVTSGGRMDPPKNCPGPVYRIM-------TQCW 323
Query: 225 QENAADRPTMLEVISML----TNENVI---LPSPLQPA 255
Q DRP ++ + + +VI LP P
Sbjct: 324 QHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPL 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 36/191 (18%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-------- 56
S +F+ E L+A+ + N+V+L G C L++EYM L+ FL
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 149
Query: 57 -------------FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNIL 103
L ++ I VA G+ YL S + +HRDL N L
Sbjct: 150 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCL 206
Query: 104 LDSNMNPKISDFGIAR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVF 157
+ NM KI+DFG++R ++ D +++ R +M PE ++ +SDV+
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVW 260
Query: 158 SFGVLVLETLS 168
++GV++ E S
Sbjct: 261 AYGVVLWEIFS 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 55/251 (21%), Positives = 92/251 (36%), Gaps = 42/251 (16%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGE---------KILIY---EYMPNKSLDCFLF 57
E+ E+ +AKL+H +VR F +E K+ +Y + ++L ++
Sbjct: 48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107
Query: 58 DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI 117
+ + I +A+ + +LH ++HRDLK SNI + K+ DFG+
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164
Query: 118 ARLFGGDELQSNTKR----------IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
DE + VGT YMSPE +S K D+FS G+++ E L
Sbjct: 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
Query: 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQEN 227
F D R + YP + + +
Sbjct: 225 Y-----PFSTQMERVR------TLTDVRNLKFPPLF---TQKYPCEYVMVQ---DMLSPS 267
Query: 228 AADRPTMLEVI 238
+RP + +I
Sbjct: 268 PMERPEAINII 278
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 30/249 (12%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFD 58
S + + +E+ L+ +L+H N+VR + I+ L + EY L +
Sbjct: 41 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100
Query: 59 PTKTGLLGWEMRV-RILEGVAQGLLYLH--HYSRLRVIHRDLKASNILLDSNMNPKISDF 115
TK E V R++ + L H V+HRDLK +N+ LD N K+ DF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
G+AR+ D + T VGT YMSPE R ++ KSD++S G L+ E
Sbjct: 161 GLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE---------- 208
Query: 176 YNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVALLCVQENAADR 231
L L + ++ EL I + + RY + + R
Sbjct: 209 -----LCALMPPFTAFSQK---ELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHR 259
Query: 232 PTMLEVISM 240
P++ E++
Sbjct: 260 PSVEEILEN 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 36/187 (19%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-----FDPTKTG 63
L + +E ++ ++ H ++++L+G C + G +LI EY SL FL P G
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 64 LLGWEMRVRILEG----------------VAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107
G + ++QG+ YL + ++++HRDL A NIL+
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 108 MNPKISDFGIAR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
KISDFG++R ++ D ++ + +M+ E +++ +SDV+SFGV
Sbjct: 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGV 240
Query: 162 LVLETLS 168
L+ E ++
Sbjct: 241 LLWEIVT 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 21/177 (11%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGW 67
E +E+ +++ L H N+V L G C G ++I EY L FL + +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 68 EMRVRILEG---------------VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKI 112
+ + VA+G+ +L + IHRDL A NILL KI
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKI 186
Query: 113 SDFGIAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
DFG+AR + + +M+PE +++ +SDV+S+G+ + E S
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-30
Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 9/165 (5%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILI-YEYMPNKSLDCFLFDPTKTG 63
S E+F E + + + H ++V+L G E + I E L FL +
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFL--QVRKF 486
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L + ++ L YL R +HRD+ A N+L+ SN K+ DFG++R
Sbjct: 487 SLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+K + +M+PE F+ SDV+ FGV + E L
Sbjct: 544 STYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 30/181 (16%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFL---------- 56
+E+ ++ + H N+V L G C + G + +I E+ +L +L
Sbjct: 74 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 57 ---FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKIS 113
+ L E + VA+G+ +L + + IHRDL A NILL KI
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 114 DFGIAR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
DFG+AR ++ + + +M+PE +++I+SDV+SFGVL+ E
Sbjct: 191 DFGLARDIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 168 S 168
S
Sbjct: 245 S 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 17/173 (9%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL----------- 56
E +E+ +++ L QH N+V L G C G ++I EY L FL
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 57 FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG 116
+ VAQG+ +L + IHRD+ A N+LL + KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFG 209
Query: 117 IAR-LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+AR + + +M+PE +++++SDV+S+G+L+ E S
Sbjct: 210 LARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 29/180 (16%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL----------- 56
L + +EM ++ + +H+N++ L G C + G +I EY +L +L
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 57 --FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
+ + ++ V +A+G+ YL + + IHRDL A N+L+ N KI+D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 246
Query: 115 FGIAR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
FG+AR + D + T + +M+PE +++ +SDV+SFGVL+ E +
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 29/180 (16%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGW 67
L + +EM ++ + +H+N++ L G C + G +I EY +L +L G+
Sbjct: 84 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 68 EMRVRILEG-------------VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
R+ E +A+G+ YL + + IHRDL A N+L+ N KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 115 FGIAR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
FG+AR + D + T + +M+PE +++ +SDV+SFGVL+ E +
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 29/184 (15%)
Query: 5 SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ + L + +EM ++ + +H+N++ L G C + G +I EY +L +L G
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 173
Query: 64 LLGWEMRVRILEG-------------VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP 110
L E VA+G+ YL + + IHRDL A N+L+ +
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 230
Query: 111 KISDFGIAR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164
KI+DFG+AR + D + T + +M+PE +++ +SDV+SFGVL+
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLW 284
Query: 165 ETLS 168
E +
Sbjct: 285 EIFT 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ ++ + +V +G GE + E+M SLD L K G + ++ ++
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 137
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
V +GL YL + +++HRD+K SNIL++S K+ DFG++ G + S V
Sbjct: 138 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 191
Query: 135 GTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
GT YMSPE +S++SD++S G+ ++E
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 9 LEEFK-NEMMLIAKLQHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFLFDPTKTGLLG 66
LE F+ E++ A L +V L+G G + I+ E + SL + + G L
Sbjct: 93 LEVFRVEELVACAGLSSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLI---KQMGCLP 148
Query: 67 WEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFGIA-RLFGG 123
E R L +GL YLH R++H D+KA N+LL S+ + + DFG A L
Sbjct: 149 -EDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 124 DELQSNTKR--IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+S I GT +M+PE + K D++S ++L L+
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFLFDPTKT 62
+ + + E+ L L+H+N+V+ G I I+ E +P SL L
Sbjct: 58 RDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-SENGFIKIFMEQVPGGSLSALL-RSKWG 115
Query: 63 GLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFG 116
L E + ILE GL YLH +++HRD+K N+L+++ + KISDFG
Sbjct: 116 PLKDNEQTIGFYTKQILE----GLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 117 IARLFGGDELQSNTKRIVGTYGYMSPE---YALRGLFSIKSDVFSFGVLVLETLSSK 170
++ G + T+ GT YM+PE RG + +D++S G ++E + K
Sbjct: 169 TSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGK 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 47/185 (25%), Positives = 74/185 (40%), Gaps = 35/185 (18%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF---------LFDP 59
L +E+ML+A L H+ +VR + +E + + KS L+D
Sbjct: 46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL 105
Query: 60 -TKTGLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKIS 113
L ILE ++ Y+H +IHRDLK NI +D + N KI
Sbjct: 106 IHSENLNQQRDEYWRLFRQILEALS----YIH---SQGIIHRDLKPMNIFIDESRNVKIG 158
Query: 114 DFGIARLF------------GGDELQSNTKRIVGTYGYMSPE-YALRGLFSIKSDVFSFG 160
DFG+A+ N +GT Y++ E G ++ K D++S G
Sbjct: 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG 218
Query: 161 VLVLE 165
++ E
Sbjct: 219 IIFFE 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-28
Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 7/159 (4%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
L+ F+ E+ ++L H+N+V + E L+ EY+ +L ++ G L +
Sbjct: 55 LKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVD 111
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ + G+ + H +R++HRD+K NIL+DSN KI DFGIA+ L +
Sbjct: 112 TAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-T 167
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
T ++GT Y SPE A +D++S G+++ E L
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 36/187 (19%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL------FDPTK 61
E +E+ ++ +L H N+V L G C G LI+EY L +L F +
Sbjct: 92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 62 TGLLGWEMRVRILEG--------------VAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107
+ + VA+G+ +L +HRDL A N+L+
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHG 208
Query: 108 MNPKISDFGIAR-LFGGDELQSNTK-----RIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
KI DFG+AR + + +M+PE G+++IKSDV+S+G+
Sbjct: 209 KVVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGI 262
Query: 162 LVLETLS 168
L+ E S
Sbjct: 263 LLWEIFS 269
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 23 QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL-FDPTKTGLLGWEMRVRILEGVAQGL 81
V +G G+ + E M + SLD F K + ++ +I + + L
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMS 141
+LH S+L VIHRD+K SN+L+++ K+ DFGI+ D++ + G YM+
Sbjct: 123 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCKPYMA 177
Query: 142 PE----YALRGLFSIKSDVFSFGVLVLE 165
PE + +S+KSD++S G+ ++E
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 52/246 (21%), Positives = 86/246 (34%), Gaps = 38/246 (15%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP 59
+ + E+ K+ QH VRL E G L E SL
Sbjct: 92 SPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--- 147
Query: 60 TKTGLLGWEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
G E +V L L +LH ++H D+K +NI L K+ DFG+
Sbjct: 148 EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178
G + G YM+PE L+G + +DVFS G+ +LE + +
Sbjct: 205 VELGTAGA---GEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME------- 253
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVALLCVQENAADRPTM 234
L + G W+ + Q +V ++ ++ + R T
Sbjct: 254 -----------LPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATA 299
Query: 235 LEVISM 240
++++
Sbjct: 300 EALLAL 305
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 11/164 (6%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY----EYMPNKSLDCFLFDPTKTGL 64
F+ E A L H +V ++ + EY+ +L + G
Sbjct: 56 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGP 112
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
+ + + ++ Q L + H + +IHRD+K +NI++ + K+ DFGIAR
Sbjct: 113 MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 125 ELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
+ T ++GT Y+SPE A +SDV+S G ++ E L
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 23 QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL--FDPTKTGLLGWEMRVRILEGVAQG 80
+V+ +G G+ + E M + S D F ++ E+ +I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI-VGTYGY 139
L +L L++IHRD+K SNILLD + N K+ DFGI+ G + S K G Y
Sbjct: 138 LNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPY 191
Query: 140 MSPE----YALRGLFSIKSDVFSFGVLVLE 165
M+PE A R + ++SDV+S G+ + E
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 37/157 (23%), Positives = 64/157 (40%), Gaps = 9/157 (5%)
Query: 12 FKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRV 71
+ E +LQ ++V + G+ + + L L + G L V
Sbjct: 81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAV 137
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNT 130
I+ + L H HRD+K NIL+ ++ + DFGIA ++L Q
Sbjct: 138 AIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN 194
Query: 131 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
VGT YM+PE + ++D+++ ++ E L
Sbjct: 195 --TVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKT-GLLGW 67
E+ E+ + L H+++V G E + + ++ E +SL + K L
Sbjct: 86 EKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKAL-T 139
Query: 68 EMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
E R L + G YLH R RVIHRDLK N+ L+ ++ KI DFG+A D
Sbjct: 140 EPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+ + GT Y++PE + S + DV+S G +
Sbjct: 197 RKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKT-GLLGW 67
E+ E+ + L H+++V G E + + ++ E +SL + K L
Sbjct: 60 EKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALT- 113
Query: 68 EMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
E R L + G YLH R RVIHRDLK N+ L+ ++ KI DFG+A D
Sbjct: 114 EPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+ + GT Y++PE + S + DV+S G +
Sbjct: 171 RKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 204
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 17 MLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEG 76
+++ +V+ FG I + + + E M + G + + ++
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVA 132
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI-VG 135
+ + L YL + VIHRD+K SNILLD K+ DFGI+ G + K G
Sbjct: 133 IVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAKDRSAG 186
Query: 136 TYGYMSPE-----YALRGLFSIKSDVFSFGVLVLE 165
YM+PE + + I++DV+S G+ ++E
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 53/259 (20%), Positives = 94/259 (36%), Gaps = 43/259 (16%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK----ILIYEYMPNKSLDCFLFDP 59
Q EE + E + H N++RL C+ L+ + +L +
Sbjct: 65 HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL 124
Query: 60 TKTGLLGWEMRV-RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
G E ++ +L G+ +GL +H HRDLK +NILL P + D G
Sbjct: 125 KDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181
Query: 119 R-----LFGGDELQSNTKRI--VGTYGYMSPE-YALRGLFSI--KSDVFSFGVLV--LET 166
+ G + + T Y +PE ++++ I ++DV+S G ++ +
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
Query: 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVALL 222
+ F DS+ L +QN S P R+ +
Sbjct: 242 GEGPYDMVFQKGDSVAL-------------------AVQNQLSIPQSPRHSSALWQLLNS 282
Query: 223 CVQENAADRPTMLEVISML 241
+ + RP + ++S L
Sbjct: 283 MMTVDPHQRPHIPLLLSQL 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 21/183 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNL--VRLFGCCIEHGEKILIYEYMPNKSLDCFLFD 58
L Q L+ ++NE+ + KLQ + +RL+ I ++ E N L+ +L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-- 118
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
K + R + + + + +H + ++H DLK +N L+ + K+ DFGIA
Sbjct: 119 -KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPE-----------YALRGLFSIKSDVFSFGVLVLETL 167
D VGT YM PE + S KSDV+S G ++
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 168 SSK 170
K
Sbjct: 234 YGK 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 21/183 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNL--VRLFGCCIEHGEKILIYEYMPNKSLDCFLFD 58
L Q L+ ++NE+ + KLQ + +RL+ I ++ E N L+ +L
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-- 146
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
K + R + + + + +H + ++H DLK +N L+ + K+ DFGIA
Sbjct: 147 -KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA 201
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPE-----------YALRGLFSIKSDVFSFGVLVLETL 167
D VG YM PE + S KSDV+S G ++
Sbjct: 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
Query: 168 SSK 170
K
Sbjct: 262 YGK 264
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 46/162 (28%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSL-----DCFLFDPTKT 62
++FKNE+ +I +++ + G I + +++ +IYEYM N S+ F+ D T
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ ++ I++ V Y+H + + HRD+K SNIL+D N K+SDFG +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 123 GDELQSNTKRIVGTYGYMSPE-YALRGLFS-IKSDVFSFGVL 162
+++ GTY +M PE ++ ++ K D++S G+
Sbjct: 204 DKKIKG----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 21/183 (11%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNL--VRLFGCCIEHGEKILIYEYMPNKSLDCFLFD 58
L Q L+ ++NE+ + KLQ + +RL+ I ++ E N L+ +L
Sbjct: 43 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-- 99
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
K + R + + + + +H + ++H DLK +N L+ + K+ DFGIA
Sbjct: 100 -KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA 154
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPE-----------YALRGLFSIKSDVFSFGVLVLETL 167
D VGT YM PE + S KSDV+S G ++
Sbjct: 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214
Query: 168 SSK 170
K
Sbjct: 215 YGK 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 46/249 (18%), Positives = 88/249 (35%), Gaps = 30/249 (12%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
S ++ ++ + +N V + + ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
+ + I +A+ + +LH ++HRDLK SNI + K+ DFG+
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 122 GGDELQSNTK----------RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171
DE + VGT YMSPE +S K D+FS G+++ E L
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---- 270
Query: 172 NAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231
+ ++T + + D R + YP + + + + +R
Sbjct: 271 --YSFSTQMERV-----RIITDVRNLKFPLLF---TQKYPQEHMMVQ---DMLSPSPTER 317
Query: 232 PTMLEVISM 240
P ++I
Sbjct: 318 PEATDIIEN 326
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 21/161 (13%)
Query: 12 FKNEMMLIAKLQHRNLVRL--FGCCIEHGEKILIY---EYMPNKSLDCFLFDPTKTGLLG 66
E +A++ H ++V++ F + + Y EY+ +SL L
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LP 180
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
+ L + L YLH + +++ DLK NI+L K+ D G
Sbjct: 181 VAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS--- 233
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
+ GT G+ +PE R ++ +D+++ G +
Sbjct: 234 ---FGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALT 270
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-24
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDP--TKTGLLG 66
+ +NE+ + +L+H +++ L+ E + L+ E N + +
Sbjct: 56 QRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFS 110
Query: 67 WEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
E R + + G+LYLH ++HRDL SN+LL NMN KI+DFG+A
Sbjct: 111 -ENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+ T + GT Y+SPE A R ++SDV+S G +
Sbjct: 167 EKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCM 201
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
Q E NE++++ + ++ N+V + E ++ EY+ SL D
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTET 111
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
+ + Q L +LH +VIHRD+K+ NILL + + K++DFG
Sbjct: 112 CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
++ + +T +VGT +M+PE R + K D++S G++ +E
Sbjct: 169 EQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-24
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 9/162 (5%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ Q E NE++++ QH N+V ++ + E ++ E++ +L D
Sbjct: 81 RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQV 136
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L E + E V Q L YLH VIHRD+K+ +ILL + K+SDFG
Sbjct: 137 RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
D + + +VGT +M+PE R L++ + D++S G++V+E
Sbjct: 194 DVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-24
Identities = 44/157 (28%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+E+ + E+ ++++ + + +G ++ + +I EY+ S D + G L
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDET 119
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
IL + +GL YLH + IHRD+KA+N+LL + K++DFG+A +++
Sbjct: 120 QIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
NT VGT +M+PE + + K+D++S G+ +E
Sbjct: 177 NT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-24
Identities = 51/251 (20%), Positives = 92/251 (36%), Gaps = 48/251 (19%)
Query: 7 QGLEEFKNEM-MLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD--PTKT 62
+ E+ +L +H N++R F C + + + E L + K
Sbjct: 59 ECFSFADREVQLLRESDEHPNVIRYF-CTEKDRQFQYIAIELCA-----ATLQEYVEQKD 112
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL-----DSNMNPKISDFGI 117
+ +L+ GL +LH L ++HRDLK NIL+ + ISDFG+
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 118 AR-LFGGDELQSNTKRIVGTYGYMSPEY---ALRGLFSIKSDVFSFGVLVLETLSSKKNA 173
+ L G S + GT G+++PE + + D+FS G + +S
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-- 227
Query: 174 HFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL-------CVQE 226
H + G++ + +IL S L+ + ++ +
Sbjct: 228 HPF-----------------GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAM 270
Query: 227 NAADRPTMLEV 237
+ RP+ V
Sbjct: 271 DPQKRPSAKHV 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 44/261 (16%), Positives = 83/261 (31%), Gaps = 61/261 (23%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIY-EYMPNKSLDCFLFD 58
+ E+ A L QH ++VR F + +LI EY SL + +
Sbjct: 46 KPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA-WAEDDHMLIQNEYCNGGSLADAISE 104
Query: 59 PTKTGLLGWEMRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP------- 110
+ E ++ +L V +GL Y+H + ++H D+K SNI + P
Sbjct: 105 NYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEG 161
Query: 111 ------------KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS--IKSDV 156
KI D G S+ + G +++ E L+ ++ K+D+
Sbjct: 162 DEDDWASNKVMFKIGDLGHVTRI------SSPQVEEGDSRFLANE-VLQENYTHLPKADI 214
Query: 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY 216
F+ + V+ + I Q +
Sbjct: 215 FALALTVVC---------------AAGAEPLPR------NGDQWHEIRQGRLP-RIPQVL 252
Query: 217 ----INVALLCVQENAADRPT 233
+ + + + RP+
Sbjct: 253 SQEFTELLKVMIHPDPERRPS 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 13/173 (7%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDP 59
L + S + + + E+ + H N+V I E ++ +M S D L
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICT 119
Query: 60 TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
+ IL+GV + L Y+H + +HR +KAS+IL+ + +S
Sbjct: 120 HFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 120 LFGGDELQSNT-----KRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVLE 165
+ K V ++SPE + L + KSD++S G+ E
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-23
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 22/175 (12%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY---EYMPNKSLDCFLFDPTKTGLL 65
++ E ++ KL H+N+V+LF E E+ P SL L +P+ L
Sbjct: 51 VDVQMREFEVLKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLF 121
+ +L V G+ +L ++HR++K NI+ D K++DFG AR
Sbjct: 110 PESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 122 GGDELQSNTKRIVGTYGYMSPE--------YALRGLFSIKSDVFSFGVLVLETLS 168
DE + GT Y+ P+ + + D++S GV +
Sbjct: 167 EDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 45/158 (28%), Positives = 84/158 (53%), Gaps = 9/158 (5%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-DCFLFDPTKTGLLGW 67
L+E E+ ++ + ++V+ +G ++ + ++ EY S+ D + L
Sbjct: 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLRNKTLTED 125
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
E+ IL+ +GL YLH +R IHRD+KA NILL++ + K++DFG+A +
Sbjct: 126 EIAT-ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
NT ++GT +M+PE ++ +D++S G+ +E
Sbjct: 182 RNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-22
Identities = 42/176 (23%), Positives = 71/176 (40%), Gaps = 22/176 (12%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIY---EYMPNKSLDCFLFDP 59
+ ++ E ++ KL H+N+V+LF E E+ P SL L +P
Sbjct: 45 ISFLRPVDVQMREFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103
Query: 60 TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL----DSNMNPKISDF 115
+ L + +L V G+ +L ++HR++K NI+ D K++DF
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPE--------YALRGLFSIKSDVFSFGVLV 163
G AR DE + GT Y+ P+ + + D++S GV
Sbjct: 161 GAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSL-----DCFLFDPTKTG 63
++E E+ +++ H N+V + + E L+ + + S+ K+G
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI-ARLFG 122
+L IL V +GL YLH + IHRD+KA NILL + + +I+DFG+ A L
Sbjct: 117 VLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173
Query: 123 GDELQSNTKR--IVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLE 165
G ++ N R VGT +M+PE + + K+D++SFG+ +E
Sbjct: 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 1e-22
Identities = 47/165 (28%), Positives = 69/165 (41%), Gaps = 17/165 (10%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-------LIYEYMPNKSLDCFLFDPTK 61
E + E+ ++ KL H N+V + +K+ L EY L +L
Sbjct: 56 RERWCLEIQIMKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP---KISDFGIA 118
L +L ++ L YLH R+IHRDLK NI+L KI D G A
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163
+ EL VGT Y++PE + +++ D +SFG L
Sbjct: 172 KELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-22
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+ + E+ + + L+H N++RL+G ++ LI EY P ++ L K +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQ 109
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+ +A L Y H RVIHRD+K N+LL S KI+DFG +
Sbjct: 110 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD 166
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
+ GT Y+ PE + K D++S GVL E L
Sbjct: 167 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-22
Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 46/291 (15%)
Query: 4 QSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEK-------ILIYEYMPNKSLDCF 55
+ E+ + KL H N+V+ E+ L+ + L F
Sbjct: 64 NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123
Query: 56 LFDPTKTGLLGWEMRV-RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
L G L V +I + + ++H + +IHRDLK N+LL + K+ D
Sbjct: 124 LKKMESRGPL-SCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCD 181
Query: 115 FGIARLFGGDELQSNTKRI----------VGTYGYMSPE-YALRGLFSI--KSDVFSFGV 161
FG A S + + T Y +PE L F I K D+++ G
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241
Query: 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVAL 221
+ L L +++ F + L ++ + SI +D Y + + I
Sbjct: 242 I-LYLLCFRQHP-FEDGAKLRIVNGKY-------------SIPPHDTQYTVFHSLIRA-- 284
Query: 222 LCVQENAADRPTMLEVI----SMLTNENVILPSPLQPAFSHVRIAENSSLP 268
+Q N +R ++ EV+ + NV SP+ +++L
Sbjct: 285 -MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLS 334
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-22
Identities = 42/167 (25%), Positives = 87/167 (52%), Gaps = 12/167 (7%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+S + LE++ E+ ++A H +V+L G G+ ++ E+ P ++D + G
Sbjct: 55 KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRG 113
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L +++V + + + L +LH R+IHRDLKA N+L+ + +++DFG++
Sbjct: 114 LTEPQIQV-VCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFS-----IKSDVFSFGVLVLE 165
+ ++ +GT +M+PE + K+D++S G+ ++E
Sbjct: 170 TLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-21
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 18/148 (12%)
Query: 21 KLQHRNLVRLFGCCIEHGEKILIY---EYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV 77
KL H N+V+L ++ + +Y E + + + L + + +
Sbjct: 92 KLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQARFYFQDL 146
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF-GGDELQSNTKRIVGT 136
+G+ YLH ++IHRD+K SN+L+ + + KI+DFG++ F G D L SNT VGT
Sbjct: 147 IKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT---VGT 200
Query: 137 YGYMSPE--YALRGLFS-IKSDVFSFGV 161
+M+PE R +FS DV++ GV
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 3e-21
Identities = 21/167 (12%), Positives = 51/167 (30%), Gaps = 17/167 (10%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD--------PTKTGLL 65
+ ++ ++ ++ + ++ + + L + L
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
R+++ V + L LHHY ++H L+ +I+LD ++ F G
Sbjct: 209 VHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GAS 264
Query: 126 LQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLVLETL 167
S R + L + D ++ G+ +
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 5e-21
Identities = 44/194 (22%), Positives = 74/194 (38%), Gaps = 43/194 (22%)
Query: 9 LEEFKNEM-MLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-------- 58
+ E+ +L H N++R + C + + E + L D
Sbjct: 52 CDIALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELC-----NLNLQDLVESKNVS 105
Query: 59 PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS------------ 106
L + +L +A G+ +LH L++IHRDLK NIL+ +
Sbjct: 106 DENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 107 -NMNPKISDFGIARLFGGDE--LQSNTKRIVGTYGYMSPEYALRGLFSI--------KSD 155
N+ ISDFG+ + + ++N GT G+ +PE L ++ D
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL-LEESNNLQTKRRLTRSID 221
Query: 156 VFSFGVLVLETLSS 169
+FS G + LS
Sbjct: 222 IFSMGCVFYYILSK 235
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-21
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD--PT 60
+S +E+ + E+ ++ L H N++++F ++ ++ E L + +
Sbjct: 58 DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVS 113
Query: 61 KTGLLGW--EMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNP 110
E V ++ +A Y H V+H+DLK NIL +
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALA----YFH---SQHVVHKDLKPENILFQDTSPHSPI 166
Query: 111 KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
KI DFG+A LF DE GT YM+PE + + K D++S GV
Sbjct: 167 KIIDFGLAELFKSDEHS---TNAAGTALYMAPE-VFKRDVTFKCDIWSAGV 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 8e-21
Identities = 21/197 (10%), Positives = 42/197 (21%), Gaps = 39/197 (19%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCC-----------------------IEHG 38
+ S LE A+L + +
Sbjct: 99 AENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDY 158
Query: 39 EKILIYEYMPNKSLDC------FLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRV 92
MP S+D F G G + + + L +
Sbjct: 159 AVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215
Query: 93 IHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG--LF 150
+H N+ + + + D G + Y E+ F
Sbjct: 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATF 270
Query: 151 SIKSDVFSFGVLVLETL 167
+ + + G+ +
Sbjct: 271 THALNAWQLGLSIYRVW 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
QS + ++ E+ + KL+H N ++ GC + L+ EY + D L + K
Sbjct: 93 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKP 150
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
L E+ + G QGL YLH +IHRD+KA NILL K+ DFG A
Sbjct: 151 LQEVEIAA-VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----- 201
Query: 124 DELQSNTKR--IVGTYGYMSPE---YALRGLFSIKSDVFSFGVLVLE 165
VGT +M+PE G + K DV+S G+ +E
Sbjct: 202 ---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-20
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 14/160 (8%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDP-TKTGLLGW 67
+ + E+ + + L+H N++R++ ++I L+ E+ P L + K G
Sbjct: 59 HQLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDE 113
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
+ +E +A L Y H +VIHRD+K N+L+ KI+DFG + +
Sbjct: 114 QRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 128 SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
+ + GT Y+ PE K D++ GVL E L
Sbjct: 171 T----MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 45/174 (25%), Positives = 70/174 (40%), Gaps = 25/174 (14%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMP---------NKS 51
+S G E+ K E + L+H ++V L G +++E+M ++
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 52 LDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP- 110
F++ MR ILE + Y H +IHRD+K +LL S N
Sbjct: 122 DAGFVYSEAVASHY---MRQ-ILEALR----YCHD---NNIIHRDVKPHCVLLASKENSA 170
Query: 111 --KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
K+ FG+A G VGT +M+PE R + DV+ GV+
Sbjct: 171 PVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTG 63
S + E+ ++ L H N+++L+ + L+ E L FD
Sbjct: 76 STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRM 131
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARL 120
I++ V G+ YLH ++HRDLK N+LL+S + KI DFG++ +
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
F + K +GT Y++PE LR + K DV+S GV+
Sbjct: 189 FENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 28/164 (17%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF---LFDP-TKTGLL 65
KNE+ ++ +L H L+ L + E +LI E+ LFD
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF-------LSGGELFDRIAAEDYK 145
Query: 66 GWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGIA 118
E V EG+ ++H ++H D+K NI+ ++ KI DFG+A
Sbjct: 146 MSEAEVINYMRQACEGLK----HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
DE K T + +PE R +D+++ GVL
Sbjct: 199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLL 65
+ ++ FK E+ ++ L H N++RL+ ++ + L+ E L F+ +
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVF 103
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFG 122
RI++ V + Y H +L V HRDLK N L + + K+ DFG+A F
Sbjct: 104 RESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
++ + VGT Y+SP+ L GL+ + D +S GV
Sbjct: 161 PGKMM---RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGW 67
E E+ L+ +L H N+++L+ + G L+ E L FD
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSE 125
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGD 124
RI+ V G+ Y+H +++HRDLK N+LL+S + N +I DFG++ F
Sbjct: 126 VDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 125 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+ K +GT Y++PE L G + K DV+S GV+
Sbjct: 183 KKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD--PTKTGLLGW 67
E + E+ ++ L+H LV L + E ++IYE+M LF+ + +
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSE 254
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGIARLFGGDE 125
+ V + V +GL ++H +H DLK NI+ + + K+ DFG+ +
Sbjct: 255 DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163
+ K GT + +PE A +D++S GVL
Sbjct: 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-20
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTG 63
+ E+ L+ KL H N+++LF + ++ E L FD K
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRK 116
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARL 120
RI++ V G+ Y+H + ++HRDLK NILL+S + + KI DFG++
Sbjct: 117 RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
F + K +GT Y++PE LRG + K DV+S GV
Sbjct: 174 FQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-20
Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 20/169 (11%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGC-----CIEHGEKI-LIYEYMPNKSL-DCFLFDPTK 61
EE K E+ ++ K HRN+ +G +++ L+ E+ S+ D L TK
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTK 122
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
L E I + +GL +LH + +VIHRD+K N+LL N K+ DFG++
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFS-----IKSDVFSFGVLVLE 165
+ NT +GT +M+PE KSD++S G+ +E
Sbjct: 180 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 9e-20
Identities = 29/178 (16%), Positives = 59/178 (33%), Gaps = 25/178 (14%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCC--IEHGEKILIYEYMPNKSLDCF--LFD-PTK 61
+ F L+ Q + ++R+ + + +Y M + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
L R+++ V + L LHHY ++H L+ +I+LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 122 GGDELQSNTKRIVGTYGYMSPEYAL-----------RGLFSIKSDVFSFGVLVLETLS 168
G + G+ PE R L + D ++ G+++
Sbjct: 257 G------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGW 67
EE NE+ L+ L H N+++LF + L+ E+ LF+
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDE 145
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGD 124
I++ + G+ YLH ++HRD+K NILL++ +N KI DFG++ F D
Sbjct: 146 CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 125 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+ +GT Y++PE L+ ++ K DV+S GV+
Sbjct: 203 YKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 41/177 (23%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
+S + E+ L+ KL H N+++LF + ++ E LFD
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFD--- 110
Query: 62 TGLLGWEMRVRILEG--------------VAQGLLYLHHYSRLRVIHRDLKASNILLDS- 106
I++ V G+ Y+H ++HRDLK NILL+S
Sbjct: 111 ----------EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESK 157
Query: 107 --NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
+ + KI DFG++ F + K +GT Y++PE LRG + K DV+S GV
Sbjct: 158 EKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 25/171 (14%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-T 60
+S+ G EE + E+ ++ ++ H N++ L + +LI E + LFD
Sbjct: 52 ASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLA 107
Query: 61 KTGLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP----K 111
+ L E IL+GV YLH ++ H DLK NI+L P K
Sbjct: 108 QKESLS-EEEATSFIKQILDGVN----YLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 112 ISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+ DFG+A K I GT +++PE +++D++S GV+
Sbjct: 160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 30/165 (18%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF---LFD--PTKTGL 64
EE KNE+ ++ +L H NL++L+ + +L+ EY LFD ++
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYN 183
Query: 65 LGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGI 117
L E+ I EG+ ++H ++ ++H DLK NIL + KI DFG+
Sbjct: 184 LT-ELDTILFMKQICEGIR----HMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
AR + E K GT +++PE S +D++S GV+
Sbjct: 236 ARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 25/171 (14%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-T 60
+S+ G EE + E+ ++ ++ H N++ L + +LI E + LFD
Sbjct: 52 ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLA 107
Query: 61 KTGLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP----K 111
+ L E IL+GV YLH ++ H DLK NI+L P K
Sbjct: 108 QKESLS-EEEATSFIKQILDGVN----YLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 112 ISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+ DFG+A K I GT +++PE +++D++S GV+
Sbjct: 160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 34/165 (20%), Positives = 65/165 (39%), Gaps = 30/165 (18%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF---LFD--PTKTGL 64
K E+ ++ +HRN++ L E ++I+E+ +F+ T
Sbjct: 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFE 98
Query: 65 LGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGI 117
L E + + E + +LH + H D++ NI+ + + KI +FG
Sbjct: 99 LN-EREIVSYVHQVCEALQ----FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
AR + + + Y +PE + S +D++S G L
Sbjct: 151 ARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-19
Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF---LFD 58
SS+ G EE + E+ ++ +++H N++ L + +LI E LFD
Sbjct: 45 SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL-------VSGGELFD 97
Query: 59 P-TKTGLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-- 110
+ L E IL+GV YLH R+ H DLK NI+L P
Sbjct: 98 FLAEKESLT-EDEATQFLKQILDGVH----YLH---SKRIAHFDLKPENIMLLDKNVPNP 149
Query: 111 --KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
K+ DFGIA K I GT +++PE +++D++S GV+
Sbjct: 150 RIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 50/174 (28%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF---LFD 58
SS+ G E+ + E+ ++ ++QH N++ L + ILI E LFD
Sbjct: 51 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL-------VAGGELFD 103
Query: 59 P-TKTGLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-- 110
+ L E IL GV YLH L++ H DLK NI+L P
Sbjct: 104 FLAEKESLT-EEEATEFLKQILNGVY----YLH---SLQIAHFDLKPENIMLLDRNVPKP 155
Query: 111 --KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
KI DFG+A K I GT +++PE +++D++S GV+
Sbjct: 156 RIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 8e-19
Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKI--LIYEYMPN---KSLDCFLFDPTKTGLLGWEM 69
E+ L+ +L+H N++ L + H ++ L+++Y + + +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 70 RVR------ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP----KISDFGIAR 119
+ IL+G+ YLH V+HRDLK +NIL+ KI+D G AR
Sbjct: 128 GMVKSLLYQILDGIH----YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 120 LFG--GDELQSNTKRIVGTYGYMSPE 143
LF L +V T+ Y +PE
Sbjct: 181 LFNSPLKPLADLDPVVV-TFWYRAPE 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-18
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 14/161 (8%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTG 63
S + ++ + E + KLQH N+VRL E L+++ + LF+
Sbjct: 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVARE 100
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP---KISDFGIARL 120
++ + + + Y H ++HR+LK N+LL S K++DFG+A
Sbjct: 101 FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
E GT GY+SPE + +S D+++ GV
Sbjct: 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-18
Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 9/132 (6%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPN---KSLDCFLFDPTKTGLLGWEMRV 71
E+ L+ +L+H N+VRL+ + L++E+M N K +D T GL ++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK- 111
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTK 131
+ QGL + H +++HRDLK N+L++ K+ DFG+AR F G + + +
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSS 167
Query: 132 RIVGTYGYMSPE 143
+V T Y +P+
Sbjct: 168 EVV-TLWYRAPD 178
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-18
Identities = 40/134 (29%), Positives = 73/134 (54%), Gaps = 17/134 (12%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR-- 72
E+ L+ +L H N+V+L + L++E++ + L F+ TG+ ++
Sbjct: 52 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIP--LPLIKSY 108
Query: 73 ---ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+L+G+A + H + RV+HRDLK N+L+++ K++DFG+AR F G +++
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 130 TKRIVGTYGYMSPE 143
T +V T Y +PE
Sbjct: 161 THEVV-TLWYRAPE 173
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 26/138 (18%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPN--KSLDCFLFDPTKTGLLGWEMR 70
E+ L+ +L+H+N+VRL + H +K L++E+ K FD L
Sbjct: 51 EICLLKELKHKNIVRLH--DVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLD--PEI 102
Query: 71 VR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
V+ +L+G+ + H V+HRDLK N+L++ N K+++FG+AR F G
Sbjct: 103 VKSFLFQLLKGLG----FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIP 154
Query: 126 LQSNTKRIVGTYGYMSPE 143
++ + +V T Y P+
Sbjct: 155 VRCYSAEVV-TLWYRPPD 171
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 14/161 (8%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTG 63
S + ++ + E + KLQH N+VRL E L+++ + LF+
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVARE 123
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP---KISDFGIARL 120
++ + + + Y H ++HR+LK N+LL S K++DFG+A
Sbjct: 124 FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
E GT GY+SPE + +S D+++ GV
Sbjct: 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 10 EEFKNEMMLIAKLQHR-NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD---PTKTGLL 65
E +E+ ++ + ++ L E ILI EY +F P ++
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE----IFSLCLPELAEMV 128
Query: 66 GWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNPKISDFGI 117
E V ILEGV YLH + ++H DLK NILL + KI DFG+
Sbjct: 129 S-ENDVIRLIKQILEGVY----YLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+R G + I+GT Y++PE + +D+++ G++
Sbjct: 181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-18
Identities = 48/136 (35%), Positives = 78/136 (57%), Gaps = 22/136 (16%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ +L H N+V L + H E+ L++E+M K L L D KTGL + +++
Sbjct: 69 EISLLKELHHPNIVSLI--DVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQ--DSQIK 122
Query: 73 -----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
+L GVA + H + R++HRDLK N+L++S+ K++DFG+AR F G ++
Sbjct: 123 IYLYQLLRGVA----HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVR 174
Query: 128 SNTKRIVGTYGYMSPE 143
S T +V T Y +P+
Sbjct: 175 SYTHEVV-TLWYRAPD 189
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 6e-18
Identities = 43/133 (32%), Positives = 72/133 (54%), Gaps = 16/133 (12%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPN--KSLDCFLFDPTKTGLLGWEMR 70
E+ ++ +L+H N+V+L+ + H +K +L++E++ K L D + GL +
Sbjct: 50 EISILKELKHSNIVKLY--DVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAK 103
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
L + G+ Y H RV+HRDLK N+L++ KI+DFG+AR F G ++ T
Sbjct: 104 -SFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYT 158
Query: 131 KRIVGTYGYMSPE 143
IV T Y +P+
Sbjct: 159 HEIV-TLWYRAPD 170
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-18
Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-PTKTGLLG 66
L++ E+ ++ L H N+V+LF IE + + LI EY + FD G +
Sbjct: 58 LQKLFREVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMK 112
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
+ + + Y H + R++HRDLKA N+LLD++MN KI+DFG + F
Sbjct: 113 EKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVL 162
G Y +PE + + DV+S GV+
Sbjct: 170 ---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 203
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 30/166 (18%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGW 67
E E+ ++ K+ H N+++L + L+++ M L FD T+ L
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLS- 122
Query: 68 E------MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
E MR +LE + LH +L ++HRDLK NILLD +MN K++DFG +
Sbjct: 123 EKETRKIMRA-LLEVIC----ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 122 GGDELQSNTKRIVGTYGYMSPE------YALRGLFSIKSDVFSFGV 161
E + + GT Y++PE + + D++S GV
Sbjct: 175 DPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 22/171 (12%), Positives = 50/171 (29%), Gaps = 16/171 (9%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL--FDPTKTGLLGWEMR 70
M + ++ + + +L+ E +L + + T ++ +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL-----------DSNMNPKISDFGIAR 119
+ + + +H +IH D+K N +L D + + D G +
Sbjct: 175 ISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 120 LFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ T G+ E ++ + D F V L
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 44/173 (25%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E + E ++ ++ H +++ L L+++ M L FD
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FD---------- 189
Query: 69 MRVRILEG--------------VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISD 114
+ E + + + +LH ++HRDLK NILLD NM ++SD
Sbjct: 190 ---YLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD 243
Query: 115 FGIARLFGGDELQSNTKRIVGTYGYMSPE------YALRGLFSIKSDVFSFGV 161
FG + E + + GT GY++PE + + D+++ GV
Sbjct: 244 FGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-17
Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 41/169 (24%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+NE+ ++ K++H N+V L L+ + + LFD
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS----GGELFD----------- 95
Query: 70 RVRILEG--------------VAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKI 112
RILE V + YLH ++HRDLK N+L + N I
Sbjct: 96 --RILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMI 150
Query: 113 SDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
+DFG++++ + + GT GY++PE + +S D +S GV
Sbjct: 151 TDFGLSKMEQNGIMST----ACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 12/131 (9%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E+ L+ L+H N+V L I H EK L++EY+ +K L +L D + +++
Sbjct: 50 EVSLLKDLKHANIVTLH--DIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKL- 104
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKR 132
L + +GL Y H +V+HRDLK N+L++ K++DFG+AR ++
Sbjct: 105 FLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNE 160
Query: 133 IVGTYGYMSPE 143
+V T Y P+
Sbjct: 161 VV-TLWYRPPD 170
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 39/169 (23%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
++ + E + L+H N+VRL E G LI++ + L F+
Sbjct: 55 QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FE----------- 99
Query: 70 RVRILEG--------------VAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKI 112
I+ + + +L+ H + V+HR+LK N+LL S K+
Sbjct: 100 --DIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKL 154
Query: 113 SDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
+DFG+A G+ Q GT GY+SPE + + D+++ GV
Sbjct: 155 ADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 22/201 (10%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEMRV 71
E ++AK+ R +V L E + L+ M + +++ + E R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 72 RILEG-VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
+ GL +LH + +I+RDLK N+LLD + N +ISD G+A + ++
Sbjct: 292 IFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 131 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNL 190
GT G+M+PE L + D F+ GV + E ++++ F
Sbjct: 349 --YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR--GPFRARGE---------- 394
Query: 191 WNDGRAWELMDSILQNDASYP 211
EL +L+ +YP
Sbjct: 395 --KVENKELKQRVLEQAVTYP 413
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 40/169 (23%), Positives = 72/169 (42%), Gaps = 18/169 (10%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-T 60
S++ + E+ ++ KL H ++++ + + ++ E M L FD
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVV 231
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGI 117
L + + YLH +IHRDLK N+LL S + KI+DFG
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPE---YALRGLFSIKSDVFSFGVLV 163
+++ G L + + GT Y++PE ++ D +S GV++
Sbjct: 289 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 24/137 (17%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPN--KSLDCFLFDPTKTGLLGWEMRV 71
E+ L+ +L H N++ L H I L++++M + + L +
Sbjct: 62 EIKLLQELSHPNIIGLLDA-FGHKSNISLVFDFMETDLEVI----IKDNSLVLT--PSHI 114
Query: 72 R-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
+ L+G+ YLH + ++HRDLK +N+LLD N K++DFG+A+ F G
Sbjct: 115 KAYMLMTLQGLE----YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPN 166
Query: 127 QSNTKRIVGTYGYMSPE 143
++ T ++V T Y +PE
Sbjct: 167 RAYTHQVV-TRWYRAPE 182
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-17
Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWE 68
+ E+ ++ KL H ++++ + + ++ E M LFD L E
Sbjct: 60 LNVETEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLK-E 113
Query: 69 MRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARL 120
+ +L V YLH +IHRDLK N+LL S + KI+DFG +++
Sbjct: 114 ATCKLYFYQMLLAVQ----YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 121 FGGDELQSNTKRIVGTYGYMSPE---YALRGLFSIKSDVFSFGV 161
G L + + GT Y++PE ++ D +S GV
Sbjct: 167 LGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 36/156 (23%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGW 67
L + E+ ++++++H N++++ E+ L+ E + LD F F L
Sbjct: 73 LGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEP 130
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
I + + YL +IHRD+K NI++ + K+ DFG A +L
Sbjct: 131 LAS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL- 185
Query: 128 SNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVL 162
GT Y +PE + + + +++S GV
Sbjct: 186 --FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVT 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-17
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 40/169 (23%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+ + E+ ++ +L H N+++L E L+ E + LFD
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFD----------- 137
Query: 70 RVRILEG--------------VAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNPKI 112
RI+E + + + YLH ++HRDLK N+L + KI
Sbjct: 138 --RIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKI 192
Query: 113 SDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
+DFG++++ L K + GT GY +PE + + D++S G+
Sbjct: 193 ADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 25/207 (12%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLL 65
+G NE ++ K+ R +V L E + + L+ M L ++ + G
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 66 GWEMRVRILEG-VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
E R + GL LH R R+++RDLK NILLD + + +ISD G+A
Sbjct: 285 --EARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
Query: 125 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLL 184
+ K VGT GYM+PE ++ D ++ G L+ E ++ + + F
Sbjct: 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRK----- 389
Query: 185 GHAWNLWNDGRAWELMDSILQNDASYP 211
+ E+ + + Y
Sbjct: 390 -------KKIKREEVERLVKEVPEEYS 409
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 40/205 (19%), Positives = 67/205 (32%), Gaps = 48/205 (23%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYM------------- 47
+ + + +E K E+ L+ KL H N+ RL+ + L+ E
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 48 ------------PNKSLDCFLFDPTKTGLLGWEMRV------------RILEGVAQGLLY 83
+ C + R I+ + L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 84 LHHYSRLRVIHRDLKASNILLDS--NMNPKISDFGIARLFGGDELQSNT--KRIVGTYGY 139
LH + HRD+K N L + + K+ DFG+++ F GT +
Sbjct: 184 LH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 140 MSPEYALRGL---FSIKSDVFSFGV 161
++PE L + K D +S GV
Sbjct: 241 VAPE-VLNTTNESYGPKCDAWSAGV 264
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72
E ++++L H V+L+ + + Y N L L K G
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIG--------S 126
Query: 73 ILEGVAQ--------GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
E + L YLH +IHRDLK NILL+ +M+ +I+DFG A++ +
Sbjct: 127 FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 125 ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
Q+ VGT Y+SPE SD+++ G ++ + ++
Sbjct: 184 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 26/140 (18%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPN--KSL--DCFLFDPT--KTGLLGWE 68
E+ L+ +LQHRN++ L + LI+EY N K K+ L
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY--- 139
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-----KISDFGIARLFGG 123
+++ GV + H R +HRDLK N+LL + KI DFG+AR F G
Sbjct: 140 ---QLINGVN----FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-G 188
Query: 124 DELQSNTKRIVGTYGYMSPE 143
++ T I+ T Y PE
Sbjct: 189 IPIRQFTHEII-TLWYRPPE 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 38/167 (22%), Positives = 71/167 (42%), Gaps = 17/167 (10%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFG-CCIEHGEKI-LIYEYMPNKSLDCFLFDPT 60
+ G K E+ L+ +L+H+N+++L E +K+ ++ EY + + D
Sbjct: 44 RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSV 101
Query: 61 KTGLLG-WEMR---VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFG 116
+ ++++G+ YLH ++H+D+K N+LL + KIS G
Sbjct: 102 PEKRFPVCQAHGYFCQLIDGLE----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALG 154
Query: 117 IARLFGGDELQSNTKRIVGTYGYMSPEYA--LRGLFSIKSDVFSFGV 161
+A + G+ + PE A L K D++S GV
Sbjct: 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 35/129 (27%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ L+ +L+H NLV L C + L++E++ + ++ L + GL ++ + L
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQ-KYL 130
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
+ G+ + H + +IHRD+K NIL+ + K+ DFG AR + +
Sbjct: 131 FQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
Query: 135 GTYGYMSPE 143
T Y +PE
Sbjct: 187 -TRWYRAPE 194
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 38/136 (27%), Positives = 58/136 (42%), Gaps = 23/136 (16%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ GL ++H V++RDLK +NILLD + + +ISD G+A F + VGT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 137 YGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR 195
+GYM+PE +G+ S D FS G ++ + L + F
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQH-------------KTKD 398
Query: 196 AWELMDSILQNDASYP 211
E+ L P
Sbjct: 399 KHEIDRMTLTMAVELP 414
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD--PTKTGLL 65
E K E+ + L H N+V+ +G G L EY L FD G+
Sbjct: 49 PENIKKEICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMP 103
Query: 66 GWEMRV---RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ + +++ GV YLH + + HRD+K N+LLD N KISDFG+A +F
Sbjct: 104 EPDAQRFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGV 161
+ + ++ GT Y++PE R F DV+S G+
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-16
Identities = 36/129 (27%), Positives = 58/129 (44%), Gaps = 8/129 (6%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74
E+ ++ +L+H NLV L L++EY + ++ L D + G+ ++ I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVK-SIT 108
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134
Q + + H + IHRD+K NIL+ + K+ DFG ARL +
Sbjct: 109 WQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
Query: 135 GTYGYMSPE 143
T Y SPE
Sbjct: 165 -TRWYRSPE 172
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 38/148 (25%), Positives = 64/148 (43%), Gaps = 34/148 (22%)
Query: 15 EMMLIAKLQHRNLVRLFGCCIEHGEKI--------LIYEYMPNKSLDCFLFDPTKTGLLG 66
E+ ++ L+H N+V L C L++++ + L GLL
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL-----AGLLS 115
Query: 67 WEMRVRILEGVA--------QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
+ V+ GL Y+H +++HRD+KA+N+L+ + K++DFG+A
Sbjct: 116 -NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
Query: 119 RLFG---GDELQSNTKRIVGTYGYMSPE 143
R F + T R+V T Y PE
Sbjct: 172 RAFSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
VA+G+ +L + + IHRDL A NILL KI DFG+AR D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
+M+PE +++I+SDV+SFGVL+ E S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-06
Identities = 32/171 (18%), Positives = 60/171 (35%), Gaps = 28/171 (16%)
Query: 9 LEEFKNEM-MLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLG 66
+E+ +LI H N+V L G C + G + +I E+ +L +L
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------- 118
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
R + +G + + I DLK + S+ + S F
Sbjct: 119 RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV---------- 168
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV---LETLSSKKNAH 174
K + +PE + +++ + + V +E L+S+K H
Sbjct: 169 --EEKSLSDVEEEEAPEDLYKDFLTLE-HLICYSFQVAKGMEFLASRKCIH 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 22 LQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD--PTKTGLLGWEMRV---RILE 75
L H N+V+ +G G L EY L FD G+ + + +++
Sbjct: 62 LNHENVVKFYGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVG 135
GV YLH + + HRD+K N+LLD N KISDFG+A +F + + ++ G
Sbjct: 117 GVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 136 TYGYMSPEYALRGLFS-IKSDVFSFGV 161
T Y++PE R F DV+S G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGI 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 43/150 (28%), Positives = 62/150 (41%), Gaps = 15/150 (10%)
Query: 17 MLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-PTKTGLLGWEMRVRIL 74
+ A H ++RL E E L+ E P + D LFD T+ G LG
Sbjct: 90 KVGAGGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFGIARLFGGDELQSNTKRI 133
V + + H V+HRD+K NIL+D K+ DFG L +
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDF 198
Query: 134 VGTYGYMSPEYALRGLFS-IKSDVFSFGVL 162
GT Y PE+ R + + + V+S G+L
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGIL 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-15
Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-PTKTGLLG 66
+ + K E+ + +H ++++L+ I ++ EY+ L FD K G +
Sbjct: 55 VGKIKREIQNLKLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVE 109
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
R+ + + + Y H R V+HRDLK N+LLD++MN KI+DFG++ + E
Sbjct: 110 EMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVL 162
+ G+ Y +PE L++ + D++S GV+
Sbjct: 167 LRTS---CGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-15
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 24/162 (14%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-PTKTGLLG 66
+ + + E+ + +H ++++L+ I I ++ EY+ L FD K G L
Sbjct: 60 VGKIRREIQNLKLFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLD 114
Query: 67 WEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
E R IL GV Y H R V+HRDLK N+LLD++MN KI+DFG++ +
Sbjct: 115 -EKESRRLFQQILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVL 162
E + G+ Y +PE L++ + D++S GV+
Sbjct: 167 SDGEFLRTS---CGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 24/147 (16%)
Query: 10 EEFKN-EMMLIAKLQHRNLVRLFGCCIEHGEKI------LIYEYMPNKSLDCFLFDPTKT 62
+ FKN E+ ++ ++H N+V L +G+K L+ EY+P +++ K
Sbjct: 76 KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKL 134
Query: 63 GLLGWEMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFG 116
+ ++ +L + L Y+H + + HRD+K N+LLD K+ DFG
Sbjct: 135 KQTMPMLLIKLYMYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 117 IARLFGGDELQSNTKRIVGTYGYMSPE 143
A++ + N I Y Y +PE
Sbjct: 188 SAKIL--IAGEPNVSYICSRY-YRAPE 211
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 8e-15
Identities = 34/105 (32%), Positives = 60/105 (57%), Gaps = 10/105 (9%)
Query: 23 QHRNLVRLF----GCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGV 77
+H N+VRLF + K+ L++E++ ++ L +L D + E ++ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQL 129
Query: 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+GL +LH + RV+HRDLK NIL+ S+ K++DFG+AR++
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 17/154 (11%)
Query: 15 EMMLIAKLQHR--NLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-PTKTGLLGWEMR 70
E++L+ K+ ++RL E + LI E P D LFD T+ G L E+
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEELA 151
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGGDELQSN 129
V + + + H V+HRD+K NIL+D N K+ DFG L
Sbjct: 152 RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 205
Query: 130 TKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVL 162
GT Y PE+ + + V+S G+L
Sbjct: 206 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 10 EEFKN-EMMLIAKLQHRNLVRLFGCCIEHGEKI------LIYEYMP---NKSLDCFLFDP 59
+ FKN E+ ++ KL H N+VRL GEK L+ +Y+P + +
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SR 148
Query: 60 TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFGIA 118
K L +++ + + + + L Y+H + HRD+K N+LLD + K+ DFG A
Sbjct: 149 AKQTLPVIYVKLYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPE 143
+ E N I Y Y +PE
Sbjct: 205 KQLVRGE--PNVSYICSRY-YRAPE 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 40/172 (23%)
Query: 9 LEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGW 67
+ E+ + + H N+V+L + L+ E + L F+
Sbjct: 49 EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FE--------- 95
Query: 68 EMRVRILE--------------GVAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNP 110
RI + + + ++H + V+HRDLK N+L + N+
Sbjct: 96 ----RIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEI 148
Query: 111 KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
KI DFG ARL D T T Y +PE + + D++S GV+
Sbjct: 149 KIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 24/94 (25%), Positives = 44/94 (46%), Gaps = 10/94 (10%)
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDELQS 128
I+ + + +LH + HRD+K N+L + + K++DFG A+ + LQ+
Sbjct: 132 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
T Y++PE + D++S GV+
Sbjct: 189 ----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 40/153 (26%), Positives = 76/153 (49%), Gaps = 15/153 (9%)
Query: 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-PTKTGLLGWEMR 70
+ E+ + L+H ++++L+ I I ++ EY + LFD + + +
Sbjct: 57 EREISYLKLLRHPHIIKLYDV-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEG 110
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
R + + + Y H R +++HRDLK N+LLD N+N KI+DFG++ + +
Sbjct: 111 RRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 131 KRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVL 162
G+ Y +PE L++ + DV+S G++
Sbjct: 168 ---CGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-14
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 20/110 (18%)
Query: 23 QHRNLVRLF----GCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR----- 72
+H N+VRL + K+ L++E++ ++ L +L GL ++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLP--AETIKDLMRQ 128
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
L G+ +LH ++HRDLK NIL+ S K++DFG+AR++
Sbjct: 129 FLRGLD----FLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 37/147 (25%), Positives = 66/147 (44%), Gaps = 22/147 (14%)
Query: 12 FKN----EMMLIAKLQHRNLVRLFGCCIEHGEK-------ILIYEYMP---NKSLDCFLF 57
F+N M +A L H N+V+L GE+ ++ EY+P ++ +
Sbjct: 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY-- 119
Query: 58 DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFG 116
+ ++V + + + + + LH S + V HRD+K N+L++ ++ K+ DFG
Sbjct: 120 YRRQVAPPPILIKVFLFQ-LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 117 IARLFGGDELQSNTKRIVGTYGYMSPE 143
A+ E N I Y Y +PE
Sbjct: 178 SAKKLSPSE--PNVAYICSRY-YRAPE 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 36/138 (26%), Positives = 57/138 (41%), Gaps = 24/138 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L YL R+IHRD+K NILLD + + I+DF IA + + + GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 137 YGYMSPEYALRGLFSIKS---DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND 193
YM+PE + S D +S GV E L ++ ++ S +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP--YHIRSSTSSK--------- 226
Query: 194 GRAWELMDSILQNDASYP 211
E++ + +YP
Sbjct: 227 ----EIVHTFETTVVTYP 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 39/172 (22%), Positives = 63/172 (36%), Gaps = 41/172 (23%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+ E+ ++ + QH N++ L + ++ E M L D
Sbjct: 60 RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LD---------- 105
Query: 69 MRVRILE--------------GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP---- 110
+IL + + + YLH V+HRDLK SNIL
Sbjct: 106 ---KILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESI 159
Query: 111 KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
+I DFG A+ + T T +++PE R + D++S GVL
Sbjct: 160 RICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 37/135 (27%), Positives = 59/135 (43%), Gaps = 22/135 (16%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L YLH S V++RDLK N++LD + + KI+DFG+ + D T GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D + GV++ E + + FYN D
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--------------- 355
Query: 197 WELMDSILQNDASYP 211
+L + IL + +P
Sbjct: 356 -KLFELILMEEIRFP 369
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-13
Identities = 41/188 (21%), Positives = 63/188 (33%), Gaps = 50/188 (26%)
Query: 4 QSGQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
Q G E+ ++ + Q HRN++ L E L++E M S+
Sbjct: 49 QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LS---- 100
Query: 63 GLLGWEMRVRILE--------------GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM 108
I + VA L +LH + HRDLK NIL +
Sbjct: 101 ---------HIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPN 148
Query: 109 NP---KISDFGIARLFGGDELQSNTKR-----IVGTYGYMSPEYALRGLFSI------KS 154
KI DF + + S G+ YM+PE + +
Sbjct: 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE-VVEAFSEEASIYDKRC 207
Query: 155 DVFSFGVL 162
D++S GV+
Sbjct: 208 DLWSLGVI 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-13
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 26/162 (16%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFD-PTKTGLLGW 67
E + E++ L+H N+VR I + +I EY L ++ G
Sbjct: 61 ENVQREIINHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGEL----YERICNAGRFS- 114
Query: 68 EMRVR-----ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN--MNPKISDFGIARL 120
E R +L GV+ Y H +++ HRDLK N LLD + KI DFG ++
Sbjct: 115 EDEARFFFQQLLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167
Query: 121 FGGDELQSNTKRIVGTYGYMSPE-YALRGLFSIKSDVFSFGV 161
+T VGT Y++PE + +DV+S GV
Sbjct: 168 SVLHSQPKST---VGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 15 EMMLIAKLQHRNLVRLF------GCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E++L+ + H+N++ L E + L+ E M D L + L
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL--DH 163
Query: 69 MRVRILEGVAQ---GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
R+ L + Q G+ +LH +IHRDLK SNI++ S+ KI DFG+AR G
Sbjct: 164 ERMSYL--LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ + V T Y +PE L + D++S G ++ E + K
Sbjct: 219 MMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 15/94 (15%)
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLF-GGDELQS 128
I E + YLH + + HRD+K N+L S N K++DFG A+ + L +
Sbjct: 170 IGEAIQ----YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162
T Y++PE + D++S GV+
Sbjct: 223 ----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-12
Identities = 20/159 (12%), Positives = 44/159 (27%), Gaps = 37/159 (23%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
L+E + + ++++ + R+ +++ E++ SL T
Sbjct: 75 LQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVG 130
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+R ++ +A H R V S + +S G L
Sbjct: 131 A-IRAMQSLAAAADAAH---RAGVALSIDHPSRVR--------VSIDGDVVL-------- 170
Query: 129 NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
M + + D+ G + L
Sbjct: 171 ------AYPATMPDA-------NPQDDIRGIGASLYALL 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 15 EMMLIAKLQHRNLVRLF-----GCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E++L+ + H+N++ L +E + + ++ E M D L + L
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMEL--DH 126
Query: 69 MRVRILEGVAQ---GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
R+ L + Q G+ +LH S +IHRDLK SNI++ S+ KI DFG+AR G
Sbjct: 127 ERMSYL--LYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
+ + V T Y +PE L + D++S G ++ E +
Sbjct: 182 MMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L YLH V++RD+K N++LD + + KI+DFG+ + D T GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D + GV++ E + + FYN D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--------------- 211
Query: 197 WELMDSILQNDASYP 211
L + IL + +P
Sbjct: 212 -RLFELILMEEIRFP 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ L++LH +I+RDLK N+LLD + K++DFG+ + + + + T GT
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE L+ D ++ GVL+ E L A F +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH--APFEAENED--------------- 230
Query: 197 WELMDSILQNDASYP 211
+L ++IL ++ YP
Sbjct: 231 -DLFEAILNDEVVYP 244
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 41/135 (30%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A GL +L +I+RDLK N++LDS + KI+DFG+ + D + + T GT
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D ++FGVL+ E L+ + A F D
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDED--------------- 548
Query: 197 WELMDSILQNDASYP 211
EL SI++++ +YP
Sbjct: 549 -ELFQSIMEHNVAYP 562
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 5e-12
Identities = 42/135 (31%), Positives = 62/135 (45%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A L +LH L +I+RDLK NILLD + K++DFG+++ E ++ + GT
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
YM+PE R + +D +SFGVL+ E L+ F D
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQGKDRK--------------- 232
Query: 197 WELMDSILQNDASYP 211
E M IL+ P
Sbjct: 233 -ETMTMILKAKLGMP 246
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 6e-12
Identities = 34/132 (25%), Positives = 59/132 (44%), Gaps = 23/132 (17%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
L +LH + +I+RDLK NI+L+ + K++DFG+ + D ++T GT Y
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 140 MSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWEL 199
M+PE +R + D +S G L+ + L+ F + +
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA--PPFTGENRK----------------KT 229
Query: 200 MDSILQNDASYP 211
+D IL+ + P
Sbjct: 230 IDKILKCKLNLP 241
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-12
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ GL +LH +++RDLK NILLD + + KI+DFG+ + + ++NT GT
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE L ++ D +SFGVL+ E L + + F+ D
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE--------------- 224
Query: 197 WELMDSILQNDASYP 211
EL SI ++ YP
Sbjct: 225 -ELFHSIRMDNPFYP 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 31/173 (17%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMP--------NKSLDCFLFDPT 60
F+ E ++ + + L + + L+ +Y +K D
Sbjct: 119 ACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP---- 173
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
E R +A+ ++ + +L +HRD+K NIL+D N + +++DFG
Sbjct: 174 -------EEMARFY--LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKS------DVFSFGVLVLETL 167
D + VGT Y+SPE L+ + K D +S GV + E L
Sbjct: 225 LMEDGTVQ-SSVAVGTPDYISPE-ILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 41/135 (30%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A GL +L +I+RDLK N++LDS + KI+DFG+ + D + + T GT
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D ++FGVL+ E L+ + A F D
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDED--------------- 227
Query: 197 WELMDSILQNDASYP 211
EL SI++++ +YP
Sbjct: 228 -ELFQSIMEHNVAYP 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 35/135 (25%), Positives = 58/135 (42%), Gaps = 23/135 (17%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+A L YLH L +++RDLK NILLDS + ++DFG+ + ++T GT
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + + D + G ++ E L FY+ ++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL--PPFYSRNTA--------------- 245
Query: 197 WELMDSILQNDASYP 211
E+ D+IL
Sbjct: 246 -EMYDNILNKPLQLK 259
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 21/169 (12%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
F+ E ++ R + +L + + L+ EY L L +K G
Sbjct: 106 SCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPA 161
Query: 69 MRVR--ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA-RLFGGDE 125
R + E + + +H RL +HRD+K NILLD + +++DFG +L
Sbjct: 162 EMARFYLAE-IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217
Query: 126 LQSNTKRIVGTYGYMSPE-------YALRGLFSIKSDVFSFGVLVLETL 167
++S VGT Y+SPE G + + D ++ GV E
Sbjct: 218 VRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
++ L YLH +I+RDLK N+LLDS + K++D+G+ + ++T GT
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D ++ GVL+ E ++ + + F S + N +
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR--SPFDIVGS------SDNPDQNTED 268
Query: 197 WELMDSILQNDASYP 211
L IL+ P
Sbjct: 269 -YLFQVILEKQIRIP 282
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTG--LLG 66
F E ++A +V+LF + + ++ EYMP G L+
Sbjct: 114 AFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMP--------------GGDLVN 158
Query: 67 WEMRVRILEGVAQ--------GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIA 118
+ E A+ L +H + IHRD+K N+LLD + + K++DFG
Sbjct: 159 LMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
Query: 119 -RLFGGDELQSNTKRIVGTYGYMSPE----YALRGLFSIKSDVFSFGVLVLETL 167
++ ++ +T VGT Y+SPE G + + D +S GV + E L
Sbjct: 216 MKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 14/137 (10%)
Query: 15 EMMLIAKLQHRNLVRLFGCCI----EHGEKI-LIYEYMPNKSLDCFLFDPTKTG-LLGWE 68
E+ ++ +L H ++V++ I E +++ ++ E D +T L
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTEL 156
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+L + G+ Y+H S ++HRDLK +N L++ + + K+ DFG+AR E +
Sbjct: 157 HIKTLLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 129 NTKRIVGTYGYMSPEYA 145
+ I M+
Sbjct: 214 SQLPISPREDDMNLVTF 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
++ L YLH +I+RDLK N+LLDS + K++D+G+ + ++T GT
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE + D ++ GVL+ E ++ + + F S + N +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR--SPFDIVGS------SDNPDQNTED 225
Query: 197 WELMDSILQNDASYP 211
L IL+ P
Sbjct: 226 -YLFQVILEKQIRIP 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
L +LH +L +I+RD+K NILLDSN + ++DFG+++ F DE + GT Y
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 226
Query: 140 MSPEYALRGL---FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
M+P+ +RG D +S GVL+ E L+ + F
Sbjct: 227 MAPD-IVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDG------------EKNSQ 271
Query: 197 WELMDSILQNDASYP 211
E+ IL+++ YP
Sbjct: 272 AEISRRILKSEPPYP 286
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-11
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
+ YLH +I+RDLK N+L+D +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168
++PE L ++ D ++ GVL+ E +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 29/116 (25%), Positives = 53/116 (45%), Gaps = 14/116 (12%)
Query: 15 EMMLIAKLQHRNLVRLF------GCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E+ L+ ++H N++ L + + L+ +M L K LG +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGED 128
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
++ + +GL Y+H + +IHRDLK N+ ++ + KI DFG+AR +
Sbjct: 129 RIQFLVYQMLKGLRYIH--AA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 7/65 (10%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNP-KISDFGIARLFGGDELQSNTKRIVGTYG 138
+ ++H L + HRD+K N+L++S N K+ DFG A+ + + I +
Sbjct: 153 AVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF- 206
Query: 139 YMSPE 143
Y +PE
Sbjct: 207 YRAPE 211
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 18/69 (26%), Positives = 32/69 (46%), Gaps = 3/69 (4%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
G ++H +IHRDLK +N LL+ + + K+ DFG+AR ++ + +
Sbjct: 141 GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 140 MSPEYALRG 148
L+
Sbjct: 198 GPHNKNLKK 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 15 EMMLIAKLQHRNLVRLF-----GCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E+ L+ ++H N++ L +E + L+ M L + K L +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 132
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIAR 119
++ + +GL Y+H S +IHRDLK SN+ ++ + KI DFG+AR
Sbjct: 133 HVQFLIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 25/65 (38%), Positives = 35/65 (53%), Gaps = 6/65 (9%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
+ LH VIHRDLK SN+L++SN + K+ DFG+AR DE ++ G
Sbjct: 124 AVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSG 178
Query: 140 MSPEY 144
M E+
Sbjct: 179 MV-EF 182
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 29/117 (24%), Positives = 54/117 (46%), Gaps = 17/117 (14%)
Query: 15 EMMLIAKLQHRNLVRLF-----GCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E++L+ +QH N++ L + + L+ +M L E
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFS--E 125
Query: 69 MRVR-ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGD 124
+++ ++ + +GL Y+H S V+HRDLK N+ ++ + KI DFG+AR +
Sbjct: 126 EKIQYLVYQMLKGLKYIH--SA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 7e-10
Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 26/135 (19%)
Query: 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGT 136
V L YLH +I+RDLK NILLD N + KI+DFG A+ + T + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
Query: 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA 196
Y++PE ++ D +SFG+L+ E L+ FY+++++
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTM--------------- 209
Query: 197 WELMDSILQNDASYP 211
+ + IL + +P
Sbjct: 210 -KTYEKILNAELRFP 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-10
Identities = 20/64 (31%), Positives = 35/64 (54%), Gaps = 3/64 (4%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
+ YLH S ++HRD+K SNILL++ + K++DFG++R F +N +
Sbjct: 121 VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 140 MSPE 143
+ +
Sbjct: 178 ENFD 181
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-10
Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 14/135 (10%)
Query: 15 EMMLIAKLQHRNLVRLFGC----CIEHGEKI-LIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+ ++ + +H N++ + IE + + ++ + M + L+ KT L +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDH 129
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
L + +GL Y+H S V+HRDLK SN+LL++ + KI DFG+AR+ D +
Sbjct: 130 ICYFLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 130 T-KRIVGTYGYMSPE 143
V T Y +PE
Sbjct: 187 FLTEYVATRWYRAPE 201
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 24/64 (37%), Positives = 31/64 (48%), Gaps = 6/64 (9%)
Query: 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGY 139
GL LH V+HRDL NILL N + I DF +AR D +++ V Y
Sbjct: 146 GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY---VTHRWY 199
Query: 140 MSPE 143
+PE
Sbjct: 200 RAPE 203
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 26/146 (17%)
Query: 15 EMMLIAKLQHRNLVRLF--------------GCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
E+ +I +L H N+V++F G E ++ EYM + L +
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL 112
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIAR 119
+ G L E + + +GL Y+H + V+HRDLK +N+ +++ ++ KI DFG+AR
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 120 LFGGDELQSN--TKRIVGTYGYMSPE 143
+ ++ +V T Y SP
Sbjct: 170 IMDPHYSHKGHLSEGLV-TKWYRSPR 194
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 24/103 (23%)
Query: 79 QGLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTY 137
+ L Y H S ++HRD+K N+++D + ++ D+G+A Q R+ Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY 195
Query: 138 GYMSPE---------YALRGLFSIKSDVFSFGVLVLETLSSKK 171
+ PE Y+L D++S G ++ + K+
Sbjct: 196 -FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 13/100 (13%)
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP------KISDFGIARLFGGDE 125
+I + + GL Y+H R +IH D+K N+L++ +P KI+D G A + +
Sbjct: 135 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEH 191
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ + T Y SPE L + +D++S L+ E
Sbjct: 192 YTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 18/49 (36%), Positives = 25/49 (51%), Gaps = 10/49 (20%)
Query: 73 ILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIA 118
I E + YLH + + HRD+K N+L S N K++DFG A
Sbjct: 126 IGEAIQ----YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 4e-06
Identities = 56/317 (17%), Positives = 100/317 (31%), Gaps = 76/317 (23%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDC---FLFDPTKTGLLG 66
EE + ++++K +RLF + E++ + + L FL P KT
Sbjct: 49 EEIDH--IIMSKDAVSGTLRLFWTLLSKQEEM--VQKFVEEVLRINYKFLMSPIKTEQRQ 104
Query: 67 WEM-------------------------RVRILEGVAQGLLYLHHYSRLRVIHRDL---K 98
M R++ + Q LL L + +I L K
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV-LIDGVLGSGK 163
Query: 99 ---ASNILLDSNMNPKISDFGIARL-FGG-DELQSNTKRIVGTYGYMSPEYALRGLFSIK 153
A ++ L + K+ DF I L + ++ + + + P + R
Sbjct: 164 TWVALDVCLSYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR------ 216
Query: 154 SDVFSFGVLVLETLSSKKNAHFYNTD---SLTLLGHAWNLWNDGRAWELMD---SILQND 207
SD S L + ++ ++ + L +L + N AW + IL
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK----AWNAFNLSCKIL--- 269
Query: 208 ASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNENVILPSPLQPAFSHVRIAENSSL 267
+ R+ V + ++ LT + V L + R + L
Sbjct: 270 ----LTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVK---SLLLKYLDCRPQD---L 318
Query: 268 PANCEVEACTVNCLTLS 284
P E T N LS
Sbjct: 319 PR----EVLTTNPRRLS 331
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 5e-06
Identities = 16/81 (19%), Positives = 25/81 (30%), Gaps = 6/81 (7%)
Query: 42 LIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASN 101
++ E+ + +T L IL + L LR HRDL N
Sbjct: 139 IVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 102 ILLDSNMNPKISDFGIARLFG 122
+LL K+ +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSST 213
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 32/140 (22%), Positives = 52/140 (37%), Gaps = 13/140 (9%)
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTK 131
+I++ V QGL YLH ++ R+IH D+K NILL N A + +
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 132 RIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE--TLSSKKNAHFYNTDSL----TLLG 185
V T + + + L ++ + L K T L+G
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 186 HAWN----LWNDG-RAWELM 200
+N +W+ A+EL
Sbjct: 268 SGYNTPADIWSTACMAFELA 287
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGIARLFGGDELQSN 129
+ + + LL+L L +IH DLK NILL + KI DFG + G +
Sbjct: 161 KFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ- 217
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ + Y SPE L + + D++S G +++E
Sbjct: 218 ---YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 10/96 (10%)
Query: 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGIARLFGGDELQSN 129
+ + Q L LH + R+IH DLK NILL K+ DFG + + + +
Sbjct: 204 KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVYT- 258
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ + Y +PE L + + D++S G ++ E
Sbjct: 259 ---YIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 22/91 (24%), Positives = 40/91 (43%), Gaps = 19/91 (20%)
Query: 59 PTKTGL-LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKI--SDF 115
T L LG M + +LE Y+H +H D+KA+N+LL ++ +D+
Sbjct: 149 KKSTVLQLGIRM-LDVLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADY 197
Query: 116 GIARLFGGDEL-----QSNTKRIVGTYGYMS 141
G++ + + ++ K GT + S
Sbjct: 198 GLSYRYCPNGNHKQYQENPRKGHNGTIEFTS 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 19/91 (20%)
Query: 59 PTKTGL-LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKI--SDF 115
KT L L + + ILE Y+H + +H D+KASN+LL+ ++ D+
Sbjct: 150 SRKTVLQLSLRI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDY 198
Query: 116 GIARLFGGDEL-----QSNTKRIVGTYGYMS 141
G+A + + + + GT + S
Sbjct: 199 GLAYRYCPEGVHKAYAADPKRCHDGTIEFTS 229
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 289 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.54 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.42 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.9 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.57 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.41 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.98 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.83 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.32 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.27 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 86.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 85.37 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=371.64 Aligned_cols=225 Identities=25% Similarity=0.419 Sum_probs=186.7
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC----------CCCCCCChHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP----------TKTGLLGWEMRVRI 73 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~ 73 (289)
.+.+..++|.+|+++|++++|||||+++++|.+++.+|+|||||++|+|.+++... .....+++..+..+
T Consensus 54 ~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i 133 (299)
T 4asz_A 54 ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133 (299)
T ss_dssp CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHH
T ss_pred CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Confidence 34556789999999999999999999999999999999999999999999998642 22357999999999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCc
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.+
T Consensus 134 ~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k 210 (299)
T 4asz_A 134 AQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 210 (299)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch
Confidence 999999999999988 99999999999999999999999999987655443334445679999999999999999999
Q ss_pred ccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 154 SDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 154 ~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
+|||||||++|||+| |+.||...+... ..... ..+.. ...+...+.++.+++.+||+.||++||
T Consensus 211 ~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i----~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RP 275 (299)
T 4asz_A 211 SDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECI----TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRK 275 (299)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH----HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCc
Confidence 999999999999999 899987543321 11111 11111 112233557899999999999999999
Q ss_pred CHHHHHHHhhcccC
Q 038647 233 TMLEVISMLTNENV 246 (289)
Q Consensus 233 s~~~ll~~L~~~~~ 246 (289)
|+.+|++.|++...
T Consensus 276 s~~~i~~~L~~~~~ 289 (299)
T 4asz_A 276 NIKGIHTLLQNLAK 289 (299)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=366.89 Aligned_cols=228 Identities=22% Similarity=0.333 Sum_probs=176.9
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+.+..++|.+|+++|++++|||||++++++.+ +.+|+|||||++|+|.+++.. ..+.+++..+..++.||+.||.|
T Consensus 71 ~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~y 147 (307)
T 3omv_A 71 PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDY 147 (307)
T ss_dssp CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999998865 568999999999999999864 33569999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc---CCCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG 160 (289)
||+++ |+||||||+|||+++++.+||+|||+++...............||+.|+|||++.+ ..|+.++||||||
T Consensus 148 LH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~G 224 (307)
T 3omv_A 148 LHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYG 224 (307)
T ss_dssp HHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHH
T ss_pred HHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHH
Confidence 99988 99999999999999999999999999987654433334556689999999999974 3589999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
|++|||+||+.||...+...... .... .... ... ........+..+.+++.+||+.||++|||+.||++.
T Consensus 225 vvl~Elltg~~Pf~~~~~~~~~~-~~~~----~~~~----~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 225 IVLYELMTGELPYSHINNRDQII-FMVG----RGYA----SPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHSSCTTTTCCCHHHHH-HHHH----TTCC----CCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHH-HHHh----cCCC----CCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999987544322111 1111 1100 000 011223345789999999999999999999999999
Q ss_pred hhcccCC
Q 038647 241 LTNENVI 247 (289)
Q Consensus 241 L~~~~~~ 247 (289)
|+.+.-.
T Consensus 295 Le~l~~~ 301 (307)
T 3omv_A 295 IELLQHS 301 (307)
T ss_dssp HHHHHTT
T ss_pred HHHHhcc
Confidence 8876533
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=372.23 Aligned_cols=224 Identities=27% Similarity=0.438 Sum_probs=177.4
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC------------CCCCChHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK------------TGLLGWEMRV 71 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~ 71 (289)
.+.+..++|.+|+++|++++|||||+++++|.+++.+|+|||||++|+|.+++..... .+.+++.++.
T Consensus 82 ~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 161 (329)
T 4aoj_A 82 ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161 (329)
T ss_dssp CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHH
Confidence 4456678999999999999999999999999999999999999999999999865322 2468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++
T Consensus 162 ~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 238 (329)
T 4aoj_A 162 AVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238 (329)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC
Confidence 99999999999999988 999999999999999999999999999976554444444556799999999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++|||||||++|||+| |+.||....... ..... ..+. ....+...+.++.+++.+||+.||++
T Consensus 239 ~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i----~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~ 303 (329)
T 4aoj_A 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCI----TQGR---------ELERPRACPPEVYAIMRGCWQREPQQ 303 (329)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHH----HHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTT
T ss_pred ccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHH----HcCC---------CCCCcccccHHHHHHHHHHcCcChhH
Confidence 99999999999999999 899987543321 11111 1111 11122334578999999999999999
Q ss_pred CCCHHHHHHHhhccc
Q 038647 231 RPTMLEVISMLTNEN 245 (289)
Q Consensus 231 Rps~~~ll~~L~~~~ 245 (289)
|||+.||++.|+.+.
T Consensus 304 RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 304 RHSIKDVHARLQALA 318 (329)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHh
Confidence 999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=366.19 Aligned_cols=222 Identities=27% Similarity=0.384 Sum_probs=184.4
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRV 71 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~ 71 (289)
+.+..++|.+|+.+|++++|||||+++|+|.+++.+++|||||++|+|.+++..... ...+++..+.
T Consensus 69 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (308)
T 4gt4_A 69 EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148 (308)
T ss_dssp CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHH
Confidence 344578999999999999999999999999999999999999999999999964321 2468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...............||+.|+|||++.+..|+
T Consensus 149 ~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s 225 (308)
T 4gt4_A 149 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225 (308)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC
Confidence 99999999999999988 999999999999999999999999999876544434445556899999999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++|||||||++|||+| |..||...+... .... ...+.. ...+...+..+.+++.+||+.||++
T Consensus 226 ~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~----i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~ 290 (308)
T 4gt4_A 226 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEM----IRNRQV---------LPCPDDCPAWVYALMIECWNEFPSR 290 (308)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcCCC---------CCCcccchHHHHHHHHHHcCCChhH
Confidence 99999999999999998 888886544321 1111 111111 1122345578899999999999999
Q ss_pred CCCHHHHHHHhhcc
Q 038647 231 RPTMLEVISMLTNE 244 (289)
Q Consensus 231 Rps~~~ll~~L~~~ 244 (289)
|||+.||++.|+..
T Consensus 291 RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 291 RPRFKDIHSRLRAW 304 (308)
T ss_dssp SCCHHHHHHHHHTS
T ss_pred CcCHHHHHHHHHhc
Confidence 99999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=361.72 Aligned_cols=214 Identities=22% Similarity=0.261 Sum_probs=173.7
Q ss_pred HHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCce
Q 038647 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRV 92 (289)
Q Consensus 13 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 92 (289)
.+|+.+|++++|||||++++++.+++.+|||||||+||+|.+++. ..+.+++..+..++.||+.||.|||+++ |
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---I 171 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---I 171 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 579999999999999999999999999999999999999999994 3467999999999999999999999988 9
Q ss_pred EeeccccCceEeCCCC-ceEEcccccccccCCCCcc---cccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 93 IHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQ---SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 93 vH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
+||||||+|||++.++ .+||+|||+++........ ......+||+.|+|||++.+..|+.++|||||||++|||+|
T Consensus 172 iHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt 251 (336)
T 4g3f_A 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251 (336)
T ss_dssp ECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999887 6999999999876543221 12344679999999999999999999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
|+.||.......... .. ...... ....+...+..+.++|.+||+.||++|||+.||++.|....
T Consensus 252 G~~Pf~~~~~~~~~~--~i---~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 252 GCHPWTQYFRGPLCL--KI---ASEPPP--------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp SSCSSTTTCCSCCHH--HH---HHSCCG--------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCCCCCCCHHHHHH--HH---HcCCCC--------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 999987544332211 00 000000 01122345578999999999999999999999998877543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-55 Score=362.39 Aligned_cols=211 Identities=22% Similarity=0.291 Sum_probs=179.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|+++|++++|||||+++++|++++.+|+|||||+||+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 73 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH 149 (311)
T 4aw0_A 73 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 149 (311)
T ss_dssp TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999999994 4467999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++............+.+||+.|+|||++.+..|+.++|||||||++|+
T Consensus 150 ~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilye 226 (311)
T 4aw0_A 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 226 (311)
T ss_dssp HTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred HCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHH
Confidence 998 99999999999999999999999999998765444445566799999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
|++|..||...+... ..... .. .. -..+...+.++.++|.+||+.||++|||++|++
T Consensus 227 ml~G~~PF~~~~~~~--~~~~i---~~-~~----------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 227 LVAGLPPFRAGNEGL--IFAKI---IK-LE----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHSSCSSCCSSHHH--HHHHH---HH-TC----------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHhCCCCCCCCCHHH--HHHHH---Hc-CC----------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 999999987543221 11111 10 00 011223456889999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=365.40 Aligned_cols=214 Identities=22% Similarity=0.325 Sum_probs=178.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....++|.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.. .....+++..++.++.||+.||.||
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~yl 141 (350)
T 4b9d_A 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHV 141 (350)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 344578899999999999999999999999999999999999999999999854 2345678999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++..... .......+||+.|+|||++.+..|+.++|||||||++|
T Consensus 142 H~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvily 216 (350)
T 4b9d_A 142 HDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216 (350)
T ss_dssp HHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred HHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHH
Confidence 9998 999999999999999999999999999876432 12234568999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||++|+.||...+.... ... .... .. .......+.++.++|.+||+.||++|||+.|+++
T Consensus 217 emltG~~PF~~~~~~~~--~~~---i~~~-~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 217 ELCTLKHAFEAGSMKNL--VLK---IISG-SF---------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHSSCSCCCSSHHHH--HHH---HHHT-CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHCCCCCCCcCHHHH--HHH---HHcC-CC---------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999875433211 111 1110 00 1122335678999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=360.53 Aligned_cols=212 Identities=23% Similarity=0.296 Sum_probs=176.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++.+ +.+++..+..++.||+.||.|||
T Consensus 112 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH 187 (346)
T 4fih_A 112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH 187 (346)
T ss_dssp CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999999998843 46899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++||
T Consensus 188 ~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilye 262 (346)
T 4fih_A 188 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262 (346)
T ss_dssp HTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHH
Confidence 998 9999999999999999999999999998765432 22445789999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||...+... ....... ... ..-.....++.++.++|.+||+.||++|||+.|+++
T Consensus 263 ml~G~~PF~~~~~~~--~~~~i~~----~~~-------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 263 MVDGEPPYFNEPPLK--AMKMIRD----NLP-------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHSSCTTTTSCHHH--HHHHHHH----SSC-------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHCCCCCCCcCHHH--HHHHHHc----CCC-------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999986543221 1111111 000 001112235678999999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=351.07 Aligned_cols=212 Identities=23% Similarity=0.366 Sum_probs=169.6
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
+...++|.+|+++|++++|||||+++++|.+ ++.+|+|||||++|+|.+++. ..+.+++..+..++.||+.||
T Consensus 66 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL 142 (290)
T 3fpq_A 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGL 142 (290)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999975 356899999999999999994 346799999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.|||+++ .+|+||||||+|||++ .++.+||+|||+|+..... .....+||+.|+|||++.+ .|+.++||||||
T Consensus 143 ~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlG 216 (290)
T 3fpq_A 143 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 216 (290)
T ss_dssp HHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHH
Confidence 9999864 3499999999999997 4789999999999864322 2345689999999999865 699999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|||+||+.||........ .. ........... .....++++.++|.+||+.||++|||+.|+++
T Consensus 217 vilyelltg~~Pf~~~~~~~~-~~----~~i~~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 217 MCMLEMATSEYPYSECQNAAQ-IY----RRVTSGVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSSCTTTTCSSHHH-HH----HHHTTTCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCCCcHHH-HH----HHHHcCCCCCC--------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999864332211 11 11111111000 11112357899999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=360.08 Aligned_cols=222 Identities=27% Similarity=0.376 Sum_probs=181.2
Q ss_pred ccCHHHHHHHHHHHhhCCC-CCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQH-RNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMR 70 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~ 70 (289)
....++|.+|+++|++++| ||||+++++|.+ ++.+|+|||||++|+|.+++.... ....+++..+
T Consensus 108 ~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~ 187 (353)
T 4ase_A 108 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187 (353)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHH
Confidence 3456789999999999965 999999999976 457899999999999999986422 1345899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC
Q 038647 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF 150 (289)
Q Consensus 71 ~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 150 (289)
..++.||+.||.|||+++ ||||||||+|||+++++.+||+|||+++...............||+.|+|||++.+..|
T Consensus 188 ~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 188 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 999999999999999988 99999999999999999999999999997755443444556689999999999999999
Q ss_pred CCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 151 SIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 151 ~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+.++|||||||++|||+| |..||........ +... ...+. ....+...+.++.+++.+||+.||+
T Consensus 265 ~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-~~~~----i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~ 330 (353)
T 4ase_A 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRR----LKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPS 330 (353)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHH----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-HHHH----HHcCC---------CCCCCccCCHHHHHHHHHHcCcChh
Confidence 999999999999999998 8999876543321 1111 11111 1112223456889999999999999
Q ss_pred CCCCHHHHHHHhhcc
Q 038647 230 DRPTMLEVISMLTNE 244 (289)
Q Consensus 230 ~Rps~~~ll~~L~~~ 244 (289)
+|||+.||++.|+..
T Consensus 331 ~RPt~~eil~~L~~l 345 (353)
T 4ase_A 331 QRPTFSELVEHLGNL 345 (353)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=361.73 Aligned_cols=213 Identities=23% Similarity=0.295 Sum_probs=177.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.+..+.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++.. +.+++..+..++.||+.||.||
T Consensus 188 ~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~yl 263 (423)
T 4fie_A 188 KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVL 263 (423)
T ss_dssp TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999999999999999999999999999842 4589999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|
T Consensus 264 H~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvily 338 (423)
T 4fie_A 264 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 338 (423)
T ss_dssp HHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHH
Confidence 9998 9999999999999999999999999998765432 2345578999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||++|..||...+... ....... ... ..-.....++.++.+||.+||+.||++|||+.|+++
T Consensus 339 eml~G~~PF~~~~~~~--~~~~i~~----~~~-------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 339 EMVDGEPPYFNEPPLK--AMKMIRD----NLP-------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHSSCTTTTSCHHH--HHHHHHH----SCC-------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHCCCCCCCcCHHH--HHHHHHc----CCC-------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999999986543221 1111111 000 000112234578999999999999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=343.09 Aligned_cols=208 Identities=21% Similarity=0.346 Sum_probs=163.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+++.+|+++|++++|||||++++++.+++.+|+||||| +|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 54 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH 129 (275)
T 3hyh_A 54 SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCH 129 (275)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999 678988884 3467999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 130 ~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily 203 (275)
T 3hyh_A 130 RHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 203 (275)
T ss_dssp HTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHH
T ss_pred HCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHH
Confidence 998 9999999999999999999999999998764332 2345689999999999998886 58999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+||+.||...+.. ....... ... ...+...+.++.+++.+||+.||++|||++|+++
T Consensus 204 ~lltg~~PF~~~~~~--~~~~~i~----~~~----------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 204 VMLCRRLPFDDESIP--VLFKNIS----NGV----------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHSSCSSCCSSHH--HHHHHHH----HTC----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCHH--HHHHHHH----cCC----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999998653322 1111111 000 0112234578899999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=352.45 Aligned_cols=208 Identities=25% Similarity=0.267 Sum_probs=166.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
...++.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++. ..+.+++..+..++.||+.||.|||++
T Consensus 69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~ 145 (304)
T 3ubd_A 69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL 145 (304)
T ss_dssp ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34578899999999999999999999999999999999999999999994 456799999999999999999999999
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 146 ~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml 220 (304)
T 3ubd_A 146 G---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220 (304)
T ss_dssp T---CCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred C---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHH
Confidence 8 9999999999999999999999999998654322 2234568999999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH-----HHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM-----LEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~ 239 (289)
||+.||...+... ..... ... . ...+...+.++.++|.+||+.||++|||+ +|+++
T Consensus 221 tG~~PF~~~~~~~--~~~~i---~~~-~----------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 221 TGTLPFQGKDRKE--TMTMI---LKA-K----------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HSSCSSCCSSHHH--HHHHH---HHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred hCCCCCCCcCHHH--HHHHH---HcC-C----------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 9999987543321 11111 100 0 01122345789999999999999999984 66664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=338.46 Aligned_cols=211 Identities=23% Similarity=0.298 Sum_probs=159.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC------------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 73 (289)
+...+++.+|+++|++++|||||+++++|.+.+ .+|+|||||++|+|.+++.........++..++.+
T Consensus 44 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i 123 (299)
T 4g31_A 44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHH
Confidence 345678999999999999999999999997654 37999999999999999965443344556678899
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc----------cccccccccccccChh
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ----------SNTKRIVGTYGYMSPE 143 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE 143 (289)
+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......+||+.|+|||
T Consensus 124 ~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE 200 (299)
T 4g31_A 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200 (299)
T ss_dssp HHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred HHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence 999999999999998 999999999999999999999999999876543221 1123457999999999
Q ss_pred hhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCH---HHHHHHHHHH
Q 038647 144 YALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASY---PMLNRYINVA 220 (289)
Q Consensus 144 ~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li 220 (289)
++.+..|+.++|||||||++|||++ ||..... .... . ... .....+. ..++.+.+++
T Consensus 201 ~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~~---~-~~~------------~~~~~p~~~~~~~~~~~~li 260 (299)
T 4g31_A 201 QIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVRT---L-TDV------------RNLKFPPLFTQKYPCEYVMV 260 (299)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHH---H-HHH------------HTTCCCHHHHHHCHHHHHHH
T ss_pred HHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHHH---H-HHH------------hcCCCCCCCcccCHHHHHHH
Confidence 9999999999999999999999996 4432110 0000 0 001 1111111 2334667899
Q ss_pred HcccccCCCCCCCHHHHHH
Q 038647 221 LLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 221 ~~~l~~~p~~Rps~~~ll~ 239 (289)
.+||+.||++|||+.|+++
T Consensus 261 ~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 261 QDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=334.30 Aligned_cols=225 Identities=22% Similarity=0.248 Sum_probs=166.4
Q ss_pred HHHHHHHhhCCCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 13 KNEMMLIAKLQHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 13 ~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
+.|+..+.+++|||||++++++.+++ .+|||||||++|+|.+++.. ..++++.+.+++.|++.||.|||+++
T Consensus 45 e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~ 120 (303)
T 3hmm_A 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 34555667889999999999998764 58999999999999999953 45899999999999999999999761
Q ss_pred -----CCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhcC------CCCCccc
Q 038647 89 -----RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALRG------LFSIKSD 155 (289)
Q Consensus 89 -----~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~D 155 (289)
..+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|
T Consensus 121 ~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~D 200 (303)
T 3hmm_A 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp CSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred hhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHh
Confidence 124999999999999999999999999999876543321 123345799999999999764 3678999
Q ss_pred chhHHHHHHHHHhCCCCcCCCCCcchhHhH---------hHhhhhccCCccccccc-cccCCCCHHHHHHHHHHHHcccc
Q 038647 156 VFSFGVLVLETLSSKKNAHFYNTDSLTLLG---------HAWNLWNDGRAWELMDS-ILQNDASYPMLNRYINVALLCVQ 225 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 225 (289)
||||||++|||+||.+|+............ .......... ++. ........+.+..+.+++.+||+
T Consensus 201 VwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~ 276 (303)
T 3hmm_A 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWY 276 (303)
T ss_dssp HHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCC
T ss_pred hhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcc
Confidence 999999999999998876543332211100 0000000000 000 01111123456788999999999
Q ss_pred cCCCCCCCHHHHHHHhhccc
Q 038647 226 ENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 226 ~~p~~Rps~~~ll~~L~~~~ 245 (289)
.||++|||+.||++.|+++.
T Consensus 277 ~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 277 ANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred cCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=326.47 Aligned_cols=224 Identities=18% Similarity=0.219 Sum_probs=168.7
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++.+|+++|+.+ +|||||+++++|.+++++|+|||||++|+|.+++ +.+++..+..++.||+.||.|||
T Consensus 61 ~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH 134 (361)
T 4f9c_A 61 SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIH 134 (361)
T ss_dssp SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999 6999999999999999999999999999999988 24889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCC-CceEEcccccccccCCCCc--------------------------cccccccccccc
Q 038647 86 HYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGGDEL--------------------------QSNTKRIVGTYG 138 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~-~~vkl~Dfg~~~~~~~~~~--------------------------~~~~~~~~g~~~ 138 (289)
++| |+||||||+|||++.+ +.+||+|||+|+....... .......+||+.
T Consensus 135 ~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 211 (361)
T 4f9c_A 135 QFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPG 211 (361)
T ss_dssp HTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGG
T ss_pred HCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCcc
Confidence 998 9999999999999876 7999999999986543211 011234579999
Q ss_pred ccChhhhhcC-CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhh-----------hhc----------cCCc
Q 038647 139 YMSPEYALRG-LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWN-----------LWN----------DGRA 196 (289)
Q Consensus 139 y~aPE~~~~~-~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~----------~~~~ 196 (289)
|+|||++.+. .|+.++||||+||++|+|++|+.||.....+...+...... .+. ....
T Consensus 212 Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~ 291 (361)
T 4f9c_A 212 FRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDL 291 (361)
T ss_dssp GCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCH
T ss_pred ccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhh
Confidence 9999999875 58999999999999999999999986555432221111000 000 0000
Q ss_pred cccccc------------------cccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 197 WELMDS------------------ILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 197 ~~~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
...... ..........+.++.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 292 RKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000111223467889999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=332.40 Aligned_cols=225 Identities=20% Similarity=0.219 Sum_probs=170.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+++.+|+++|+.++|||||++++++.. .+.+|+|||||+ |+|.+++. ..+.+++..+..++.||+.
T Consensus 94 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~ 169 (398)
T 4b99_A 94 VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLR 169 (398)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHH
Confidence 3456788999999999999999999998764 367999999995 67988884 4567999999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCC--cccccccccccccccChhhhhcC-CCCCcccc
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE--LQSNTKRIVGTYGYMSPEYALRG-LFSIKSDV 156 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di 156 (289)
||.|||++| |+||||||+|||++.++.+||+|||+++...... ........+||+.|+|||++.+. .++.++||
T Consensus 170 al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di 246 (398)
T 4b99_A 170 GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246 (398)
T ss_dssp HHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhhe
Confidence 999999998 9999999999999999999999999998764322 12234557899999999998875 56999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC-----------ccccccccccC-CCC-----HHHHHHHHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR-----------AWELMDSILQN-DAS-----YPMLNRYINV 219 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~-----~~~~~~l~~l 219 (289)
||+||++|||++|++||...+...... .......... ........... ... ...+.++.+|
T Consensus 247 WSlG~il~ell~G~~pF~g~~~~~~l~--~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 324 (398)
T 4b99_A 247 WSVGCIFGEMLARRQLFPGKNYVHQLQ--LIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSL 324 (398)
T ss_dssp HHHHHHHHHHHHTSCSSCCSSHHHHHH--HHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHH
T ss_pred ehhHHHHHHHHHCCCCCCCCCHHHHHH--HHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHH
Confidence 999999999999999997654332111 1111000000 00000000000 000 1234678899
Q ss_pred HHcccccCCCCCCCHHHHHH
Q 038647 220 ALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~ 239 (289)
|.+||..||++|||+.|+++
T Consensus 325 l~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 325 LGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=310.31 Aligned_cols=238 Identities=37% Similarity=0.592 Sum_probs=196.4
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+.+..+.|.+|+++++.++||||+++++++.+++..++||||+++|+|.+++.... ....+++..+..++.|++.||.|
T Consensus 75 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 154 (321)
T 2qkw_B 75 SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154 (321)
T ss_dssp CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999999986533 23468999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
||+++ ++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++
T Consensus 155 lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 231 (321)
T 2qkw_B 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231 (321)
T ss_dssp HHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHH
T ss_pred hcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHH
Confidence 99988 999999999999999999999999999875433323333445689999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcc-hhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 164 LETLSSKKNAHFYNTDS-LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|+|++|+.||....... .....+..............+...........+..+.+++.+||+.||++|||+.++++.|+
T Consensus 232 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp HHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 99999999987644332 22222222333334444455555555667788899999999999999999999999999998
Q ss_pred ccc
Q 038647 243 NEN 245 (289)
Q Consensus 243 ~~~ 245 (289)
...
T Consensus 312 ~~l 314 (321)
T 2qkw_B 312 YAL 314 (321)
T ss_dssp HHH
T ss_pred HHh
Confidence 754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=338.67 Aligned_cols=213 Identities=23% Similarity=0.286 Sum_probs=175.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|+.++|||||+++++|.+++.+|+|||||+||+|.+++.+ ..+.+++..+..++.||+.||.|||+
T Consensus 196 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~ 273 (573)
T 3uto_A 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE 273 (573)
T ss_dssp HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999998853 34579999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCC--CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSN--MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~--~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
++ |+||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 274 ~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvily 347 (573)
T 3uto_A 274 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347 (573)
T ss_dssp TT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHH
T ss_pred CC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 98 9999999999999854 889999999999875432 234568999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||...+.... ..... . ... .........++.++.+||.+||+.||++|||+.|+++
T Consensus 348 eml~G~~Pf~~~~~~~~--~~~i~---~-~~~------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 348 ILLSGLSPFGGENDDET--LRNVK---S-CDW------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHSCCSSCCSSHHHH--HHHHH---T-TCC------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCcCHHHH--HHHHH---h-CCC------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999875443211 11110 0 000 0000111224568899999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=336.65 Aligned_cols=203 Identities=22% Similarity=0.226 Sum_probs=167.2
Q ss_pred HHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceE
Q 038647 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVI 93 (289)
Q Consensus 14 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iv 93 (289)
.++.+++.++|||||+++++|.+.+.+|+|||||+||+|..++. ..+.+++..+..++.||+.||.|||++| ||
T Consensus 241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---Ii 314 (689)
T 3v5w_A 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VV 314 (689)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 34677788899999999999999999999999999999999994 4567999999999999999999999988 99
Q ss_pred eeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHHhCCCC
Q 038647 94 HRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSSKKN 172 (289)
Q Consensus 94 H~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~elltg~~p 172 (289)
||||||+|||++.+|.+||+|||+++...... ..+.+||+.|+|||++.+ ..|+.++|+|||||++|||++|.+|
T Consensus 315 HRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~P 390 (689)
T 3v5w_A 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390 (689)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432 345689999999999974 5799999999999999999999999
Q ss_pred cCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 173 AHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
|...+........ ...... ....+..++.++.++|.+||+.||++|++ +.||++
T Consensus 391 F~~~~~~~~~~i~--~~i~~~-----------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 391 FRQHKTKDKHEID--RMTLTM-----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TCGGGCCCHHHHH--HHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCChHHHHHHH--HhhcCC-----------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 9754433221110 000000 01122335678999999999999999998 678765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=305.36 Aligned_cols=237 Identities=37% Similarity=0.615 Sum_probs=196.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....|.+|+++++.++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+
T Consensus 70 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 149 (326)
T 3uim_A 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 149 (326)
T ss_dssp CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34479999999999999999999999999999999999999999999987643 33468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
+...+|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 150 ~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 228 (326)
T 3uim_A 150 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228 (326)
T ss_dssp SSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHH
T ss_pred CCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHH
Confidence 8111299999999999999999999999999987653332 223345689999999999998999999999999999999
Q ss_pred HhCCCCcCCC---CCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 167 LSSKKNAHFY---NTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 167 ltg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
++|..||... .........+..............+...........+..+.+++..||+.||++|||+.+|++.|++
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 9999998632 2223333344444445555556666666667778888999999999999999999999999999997
Q ss_pred cc
Q 038647 244 EN 245 (289)
Q Consensus 244 ~~ 245 (289)
..
T Consensus 309 ~~ 310 (326)
T 3uim_A 309 DG 310 (326)
T ss_dssp SS
T ss_pred cc
Confidence 54
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=312.85 Aligned_cols=222 Identities=26% Similarity=0.392 Sum_probs=181.9
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRV 71 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~ 71 (289)
....+++.+|+++|+.+ +||||+++++++.+++.+|+||||+++|+|.+++..... ...+++..+.
T Consensus 127 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (370)
T 2psq_A 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206 (370)
T ss_dssp HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHH
Confidence 34567899999999999 899999999999999999999999999999999864321 2458899999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+..++
T Consensus 207 ~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 283 (370)
T 2psq_A 207 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283 (370)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence 99999999999999988 999999999999999999999999999876544333334445678899999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++|||||||++|+|++ |..||........ ... .... .....+...+..+.+++.+||+.||++
T Consensus 284 ~~~DvwslG~il~ellt~g~~p~~~~~~~~~--~~~----~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~ 348 (370)
T 2psq_A 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--FKL----LKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQ 348 (370)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHH----HHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH----HhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 99999999999999999 9988865433221 111 1111 011122334568999999999999999
Q ss_pred CCCHHHHHHHhhccc
Q 038647 231 RPTMLEVISMLTNEN 245 (289)
Q Consensus 231 Rps~~~ll~~L~~~~ 245 (289)
|||+.|+++.|+.+.
T Consensus 349 Rpt~~ell~~L~~il 363 (370)
T 2psq_A 349 RPTFKQLVEDLDRIL 363 (370)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=298.87 Aligned_cols=234 Identities=35% Similarity=0.505 Sum_probs=187.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.|.+|++++++++||||+++++++.+++..++||||+++++|.+++........+++..++.++.|++.||.|||
T Consensus 71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 150 (307)
T 2nru_A 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 44578899999999999999999999999999999999999999999999865444567999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.+||+|||+++...............|++.|+|||++.+ .++.++||||||+++|+
T Consensus 151 ~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~ 226 (307)
T 2nru_A 151 ENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLE 226 (307)
T ss_dssp HTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHH
T ss_pred cCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHH
Confidence 988 99999999999999999999999999987654333333344578999999998865 48999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhc-cCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWN-DGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++|..||.......... ........ .......++... .......+..+.+++..||+.||++|||+.++++.|+++
T Consensus 227 l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 227 IITGLPAVDEHREPQLLL-DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHCCCSBCTTBSSSBTT-HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHCCCCcccCcchHHHH-HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 999999987654432111 11111111 111112222222 234566788899999999999999999999999999876
Q ss_pred c
Q 038647 245 N 245 (289)
Q Consensus 245 ~ 245 (289)
.
T Consensus 305 ~ 305 (307)
T 2nru_A 305 T 305 (307)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=305.31 Aligned_cols=225 Identities=24% Similarity=0.371 Sum_probs=172.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..++|.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++........+++..++.++.|++.||.|||
T Consensus 75 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 154 (309)
T 3p86_A 75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154 (309)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999999999965333334899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ .+|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+
T Consensus 155 ~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 231 (309)
T 3p86_A 155 NRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231 (309)
T ss_dssp TSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHH
Confidence 764 239999999999999999999999999997643322 12334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
|++|..||......... .... .. ......+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 232 lltg~~Pf~~~~~~~~~--~~~~--~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 232 LATLQQPWGNLNPAQVV--AAVG--FK----------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp HHHCCCTTTTSCHHHHH--HHHH--HS----------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHH--HHHH--hc----------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999998654332111 1000 00 0011222334568899999999999999999999999999865
Q ss_pred CC
Q 038647 246 VI 247 (289)
Q Consensus 246 ~~ 247 (289)
..
T Consensus 298 ~~ 299 (309)
T 3p86_A 298 KS 299 (309)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=303.75 Aligned_cols=224 Identities=24% Similarity=0.422 Sum_probs=180.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.+..+.|.+|+++|++++||||+++++++.+++..++||||+++|+|.+++.. ..+.+++..+..++.|++.||.||
T Consensus 47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~l 124 (310)
T 3s95_A 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYL 124 (310)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 455678899999999999999999999999999999999999999999999864 245689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc------------ccccccccccccChhhhhcCCCCC
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS------------NTKRIVGTYGYMSPEYALRGLFSI 152 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~ 152 (289)
|+++ |+||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.
T Consensus 125 H~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 201 (310)
T 3s95_A 125 HSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE 201 (310)
T ss_dssp HHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCT
T ss_pred HhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCc
Confidence 9988 9999999999999999999999999998764332211 111457899999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 153 KSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 153 ~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
++||||||+++|+|++|..|+.............. ........+...+..+.+++.+||+.||++||
T Consensus 202 ~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 268 (310)
T 3s95_A 202 KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-------------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268 (310)
T ss_dssp HHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-------------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-------------hccccccCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999998765433221110000 00000111222345788999999999999999
Q ss_pred CHHHHHHHhhcccC
Q 038647 233 TMLEVISMLTNENV 246 (289)
Q Consensus 233 s~~~ll~~L~~~~~ 246 (289)
|+.++++.|+.+..
T Consensus 269 s~~~l~~~L~~l~~ 282 (310)
T 3s95_A 269 SFVKLEHWLETLRM 282 (310)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=302.49 Aligned_cols=213 Identities=24% Similarity=0.302 Sum_probs=174.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.||+.||.|||++
T Consensus 48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~ 124 (323)
T 3tki_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI 124 (323)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34678999999999999999999999999999999999999999999984 445699999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~el 166 (289)
+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|
T Consensus 125 g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 201 (323)
T 3tki_A 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201 (323)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHH
T ss_pred C---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHH
Confidence 8 99999999999999999999999999987643333333445679999999999988765 7899999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..||............+.. .. .........+..+.+++.+||+.||++|||+.|+++
T Consensus 202 l~g~~pf~~~~~~~~~~~~~~~-----~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 202 LAGELPWDQPSDSCQEYSDWKE-----KK--------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHSSCSCSSSCTTSHHHHHHHT-----TC--------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCCchHHHHHHHHhc-----cc--------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9999998765544332211110 00 000111234567889999999999999999999976
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=296.65 Aligned_cols=212 Identities=22% Similarity=0.335 Sum_probs=174.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||
T Consensus 58 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH 133 (297)
T 3fxz_A 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH 133 (297)
T ss_dssp CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999843 35889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+
T Consensus 134 ~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 208 (297)
T 3fxz_A 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208 (297)
T ss_dssp HTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHH
T ss_pred hCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHH
Confidence 988 99999999999999999999999999987654322 2344579999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||........... ...... .........+..+.+++.+||+.||++|||+.|+++
T Consensus 209 ll~g~~pf~~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 209 MIEGEPPYLNENPLRALYL-----IATNGT--------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHSSCTTTTSCHHHHHHH-----HHHHCS--------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhCCCCCCCCCHHHHHHH-----HHhCCC--------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999999865432211110 000000 001112234567899999999999999999999976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=302.40 Aligned_cols=221 Identities=29% Similarity=0.448 Sum_probs=178.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....+.|.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++.. ..+.+++..+..++.|++.||.||
T Consensus 90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~L 167 (325)
T 3kul_A 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL 167 (325)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999999999999999999853 335689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
|+++ |+||||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++
T Consensus 168 H~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 244 (325)
T 3kul_A 168 SDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244 (325)
T ss_dssp HHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHH
Confidence 9988 999999999999999999999999999876543211 122233467789999999999999999999999999
Q ss_pred HHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 164 LETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 164 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|+|++ |..||........ .... ... .........+..+.+++..||+.||++|||+.+|++.|+
T Consensus 245 ~ell~~g~~p~~~~~~~~~--~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 245 WEVLAYGERPYWNMTNRDV--ISSV----EEG---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp HHHHTTSCCTTTTSCHHHH--HHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCCCCcccCCHHHH--HHHH----HcC---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999 9998765433211 1111 000 111122334578999999999999999999999999999
Q ss_pred ccc
Q 038647 243 NEN 245 (289)
Q Consensus 243 ~~~ 245 (289)
...
T Consensus 310 ~l~ 312 (325)
T 3kul_A 310 ALI 312 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=300.92 Aligned_cols=221 Identities=25% Similarity=0.402 Sum_probs=181.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC---------------------CCC
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK---------------------TGL 64 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~ 64 (289)
....+++.+|+++|++++||||+++++++.+++..++||||+++++|.+++..... ...
T Consensus 67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (314)
T 2ivs_A 67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146 (314)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence 44568899999999999999999999999999999999999999999999865322 234
Q ss_pred CChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhh
Q 038647 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144 (289)
Q Consensus 65 ~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 144 (289)
+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||+
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES 223 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence 889999999999999999999988 99999999999999999999999999987654433333344467889999999
Q ss_pred hhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 145 ALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 145 ~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
+.+..++.++||||||+++|+|++ |..||......... . ...... ........+..+.+++.+|
T Consensus 224 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~----~~~~~~---------~~~~~~~~~~~~~~li~~~ 288 (314)
T 2ivs_A 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF--N----LLKTGH---------RMERPDNCSEEMYRLMLQC 288 (314)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--H----HHHTTC---------CCCCCTTCCHHHHHHHHHH
T ss_pred hcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H----HhhcCC---------cCCCCccCCHHHHHHHHHH
Confidence 999999999999999999999999 99988654432211 1 111111 1112223457899999999
Q ss_pred cccCCCCCCCHHHHHHHhhcc
Q 038647 224 VQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|+.||++|||+.++++.|+..
T Consensus 289 l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 289 WKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=308.47 Aligned_cols=226 Identities=26% Similarity=0.391 Sum_probs=184.5
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRV 71 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~ 71 (289)
....+++.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++..... ...+++..++
T Consensus 115 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 194 (382)
T 3tt0_A 115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence 44568899999999999 899999999999999999999999999999999865321 2458999999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++
T Consensus 195 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 195 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred HHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 99999999999999988 999999999999999999999999999876554333334445678899999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++|||||||++|+|++ |..|+....... ... ...... ........+..+.+++..||+.||++
T Consensus 272 ~~~DiwslG~il~ellt~g~~p~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~ 336 (382)
T 3tt0_A 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFK----LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQ 336 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhh
Confidence 99999999999999999 998876543221 111 111111 11112234568999999999999999
Q ss_pred CCCHHHHHHHhhcccCCCC
Q 038647 231 RPTMLEVISMLTNENVILP 249 (289)
Q Consensus 231 Rps~~~ll~~L~~~~~~~~ 249 (289)
|||+.+|++.|+.......
T Consensus 337 Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 337 RPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp SCCHHHHHHHHHHHHHHSC
T ss_pred CcCHHHHHHHHHHHHHHHh
Confidence 9999999999998754443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=303.19 Aligned_cols=225 Identities=27% Similarity=0.389 Sum_probs=180.2
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--------------------CCC
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--------------------TGL 64 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~ 64 (289)
....+.+.+|+.+|+++ +||||+++++++.+++..++||||+++|+|.+++..... ...
T Consensus 89 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (344)
T 1rjb_A 89 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168 (344)
T ss_dssp ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccccccc
Confidence 34567899999999999 899999999999999999999999999999999965322 134
Q ss_pred CChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhh
Q 038647 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144 (289)
Q Consensus 65 ~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 144 (289)
+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++................||+.|+|||+
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence 789999999999999999999988 99999999999999999999999999987654433333445567889999999
Q ss_pred hhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 145 ALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 145 ~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
+.+..++.++||||||+++|+|+| |..||.......... .. .... .....+...+..+.+++.+|
T Consensus 246 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~----~~~~---------~~~~~~~~~~~~l~~li~~~ 311 (344)
T 1rjb_A 246 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY-KL----IQNG---------FKMDQPFYATEEIYIIMQSC 311 (344)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-HH----HHTT---------CCCCCCTTCCHHHHHHHHHH
T ss_pred hccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHH-HH----HhcC---------CCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999998 999887654332111 11 1110 11112223457899999999
Q ss_pred cccCCCCCCCHHHHHHHhhcccCC
Q 038647 224 VQENAADRPTMLEVISMLTNENVI 247 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~~L~~~~~~ 247 (289)
|+.||++|||+.++++.|+.....
T Consensus 312 l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 312 WAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCCchhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999976543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=311.76 Aligned_cols=219 Identities=23% Similarity=0.322 Sum_probs=177.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..++|.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 154 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~ 231 (377)
T 3cbl_A 154 DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES 231 (377)
T ss_dssp HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4456889999999999999999999999999999999999999999999853 23458899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||
T Consensus 232 ~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el 308 (377)
T 3cbl_A 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308 (377)
T ss_dssp TT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHH
Confidence 88 999999999999999999999999999875443322222333467789999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..|+........ .. ...... ....+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 309 ~t~g~~p~~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 309 FSLGASPYPNLSNQQT--RE----FVEKGG---------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HTTSCCSSTTSCHHHH--HH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHH--HH----HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 98 8888765433211 11 111110 11112224568899999999999999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=303.05 Aligned_cols=209 Identities=25% Similarity=0.357 Sum_probs=174.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+++.+|+++|+.++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 55 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH 131 (328)
T 3fe3_A 55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCH 131 (328)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC-CcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS-IKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~vl~ 164 (289)
+++ |+||||||+||+++.++.+||+|||+++...... .....+||+.|+|||++.+..++ .++|||||||++|
T Consensus 132 ~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 205 (328)
T 3fe3_A 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 205 (328)
T ss_dssp HTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHH
T ss_pred HCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHH
Confidence 988 9999999999999999999999999998765432 23446799999999999988775 8999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||...+.... .... .. .. ...+...+..+.+++.+||+.||++|||++|+++
T Consensus 206 ell~g~~pf~~~~~~~~--~~~i---~~-~~----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 206 TLVSGSLPFDGQNLKEL--RERV---LR-GK----------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHSSCSSCCSSHHHH--HHHH---HH-CC----------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHhCCCCCCCCCHHHH--HHHH---Hh-CC----------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999875432211 1100 00 00 0112224568899999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=295.75 Aligned_cols=222 Identities=26% Similarity=0.392 Sum_probs=175.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..++|.+|+.++++++||||+++++++.+++..|+||||+++++|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 52 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH 128 (294)
T 4eqm_A 52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH 128 (294)
T ss_dssp HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999999999999999999999999999999984 3457899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+
T Consensus 129 ~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 204 (294)
T 4eqm_A 129 DMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204 (294)
T ss_dssp HTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHH
T ss_pred HCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHH
Confidence 988 99999999999999999999999999987643321 22334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-CHHHHHHHhhcc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-TMLEVISMLTNE 244 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~ll~~L~~~ 244 (289)
|++|..||.......... ..... ..... ........+..+.+++.+||+.||++|| ++.++.+.|+..
T Consensus 205 ll~g~~pf~~~~~~~~~~-----~~~~~-~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 205 MLVGEPPFNGETAVSIAI-----KHIQD-SVPNV-----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHSSCSSCSSCHHHHHH-----HHHSS-CCCCH-----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHhCCCCCCCCChHHHHH-----HHhhc-cCCCc-----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 999999987544322111 00100 00000 0011123456889999999999999998 999999999875
Q ss_pred c
Q 038647 245 N 245 (289)
Q Consensus 245 ~ 245 (289)
.
T Consensus 274 ~ 274 (294)
T 4eqm_A 274 L 274 (294)
T ss_dssp S
T ss_pred H
Confidence 4
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=301.91 Aligned_cols=228 Identities=22% Similarity=0.300 Sum_probs=175.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....+.+|+.+|++++||||+++++++.+.. .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|
T Consensus 61 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~ 136 (322)
T 3soc_A 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAY 136 (322)
T ss_dssp HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHH
Confidence 3456677999999999999999999998754 47999999999999999943 358999999999999999999
Q ss_pred HhcC----------CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-----
Q 038647 84 LHHY----------SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG----- 148 (289)
Q Consensus 84 lH~~----------~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----- 148 (289)
||+. + |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 137 LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 213 (322)
T 3soc_A 137 LHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213 (322)
T ss_dssp HTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCH
T ss_pred HHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCc
Confidence 9987 7 999999999999999999999999999877654433334456799999999999863
Q ss_pred CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHh----------HhhhhccCCccccccccccCCCCHHHHHHHHH
Q 038647 149 LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGH----------AWNLWNDGRAWELMDSILQNDASYPMLNRYIN 218 (289)
Q Consensus 149 ~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 218 (289)
.++.++|||||||++|+|++|+.||............. .............+.. .......+..+.+
T Consensus 214 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 290 (322)
T 3soc_A 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCE 290 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHH
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc---cccccchHHHHHH
Confidence 45678899999999999999999987654332111100 0000000000000000 0011234567999
Q ss_pred HHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 219 VALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 219 li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++.+||+.||++|||+.++++.|+.+.
T Consensus 291 li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 291 TIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=305.33 Aligned_cols=221 Identities=28% Similarity=0.380 Sum_probs=178.1
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecC-eEEEEEeecCCCChhhhhcCCCC-----------------------
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHG-EKILIYEYMPNKSLDCFLFDPTK----------------------- 61 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------- 61 (289)
...+.|.+|+++|+++ +||||+++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (359)
T 3vhe_A 67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence 4567899999999999 7999999999998755 48999999999999999865332
Q ss_pred ----------------------------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCc
Q 038647 62 ----------------------------------------TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASN 101 (289)
Q Consensus 62 ----------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~N 101 (289)
...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~N 223 (359)
T 3vhe_A 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 223 (359)
T ss_dssp -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhh
Confidence 122889999999999999999999988 9999999999
Q ss_pred eEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcc
Q 038647 102 ILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDS 180 (289)
Q Consensus 102 ill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~ 180 (289)
||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 224 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 303 (359)
T 3vhe_A 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303 (359)
T ss_dssp EEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence 9999999999999999987644433333445678899999999999999999999999999999998 999987654332
Q ss_pred hhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
.... . ..... ....+...+..+.+++..||+.||++|||+.++++.|+..
T Consensus 304 ~~~~-~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 304 EFCR-R----LKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HHHH-H----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-H----HHcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 2111 0 11000 1111222446789999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=301.88 Aligned_cols=220 Identities=24% Similarity=0.356 Sum_probs=176.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....++|.+|+.++++++||||+++++++.++. .++|+||+.+|+|.+++.. ..+.+++..+..++.||+.||.||
T Consensus 57 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~L 133 (327)
T 3poz_A 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133 (327)
T ss_dssp ---CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999998764 7899999999999998854 235689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|
T Consensus 134 H~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (327)
T 3poz_A 134 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210 (327)
T ss_dssp HHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHH
Confidence 9988 9999999999999999999999999998775544333334445788999999999999999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+|++ |..||.......... . . ............+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 211 ellt~g~~p~~~~~~~~~~~--~----~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 211 ELMTFGSKPYDGIPASEISS--I----L---------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp HHHTTSCCTTTTCCGGGHHH--H----H---------HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCCCccCCCHHHHHH--H----H---------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 9999 999987544332111 0 0 0111111223345688999999999999999999999999886
Q ss_pred cc
Q 038647 244 EN 245 (289)
Q Consensus 244 ~~ 245 (289)
..
T Consensus 276 ~~ 277 (327)
T 3poz_A 276 MA 277 (327)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=302.19 Aligned_cols=219 Identities=26% Similarity=0.366 Sum_probs=175.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|+.++++++||||+++++++. ++..++||||+.+|+|.+++.. ..+.+++..+..++.||+.||.|||
T Consensus 56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH 132 (325)
T 3kex_A 56 RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE 132 (325)
T ss_dssp CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHH
Confidence 345677889999999999999999999986 4578999999999999999864 2357889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+
T Consensus 133 ~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 209 (325)
T 3kex_A 133 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWE 209 (325)
T ss_dssp HTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHH
Confidence 988 99999999999999999999999999998765443333455567889999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |..||........... ..... ....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 210 l~~~g~~p~~~~~~~~~~~~------~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 210 LMTFGAEPYAGLRLAEVPDL------LEKGE---------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp HHTTSCCTTTTSCTTHHHHH------HHTTC---------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred HHhCCCCCccccCHHHHHHH------HHcCC---------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999 9999876543322110 11110 0111112334678899999999999999999999999875
Q ss_pred c
Q 038647 245 N 245 (289)
Q Consensus 245 ~ 245 (289)
.
T Consensus 275 ~ 275 (325)
T 3kex_A 275 A 275 (325)
T ss_dssp T
T ss_pred H
Confidence 4
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=299.57 Aligned_cols=211 Identities=22% Similarity=0.291 Sum_probs=172.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||++
T Consensus 58 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~ 134 (361)
T 2yab_A 58 CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTK 134 (361)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46889999999999999999999999999999999999999999999994 446799999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCC----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNM----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+ |+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++
T Consensus 135 g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp T---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred C---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 8 99999999999998877 79999999998765432 23345799999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||...+... ..... ..... .. .. ......+..+.++|.+||..||++|||+.|+++
T Consensus 209 ~~ll~g~~Pf~~~~~~~--~~~~i----~~~~~-~~-~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 209 YILLSGASPFLGDTKQE--TLANI----TAVSY-DF-DE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHSCCSSCCSSHHH--HHHHH----HTTCC-CC-CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCCCCCCHHH--HHHHH----HhcCC-CC-Cc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999986543221 11110 00000 00 00 000123467889999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=302.29 Aligned_cols=222 Identities=26% Similarity=0.385 Sum_probs=179.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC---------------------CCC
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK---------------------TGL 64 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~ 64 (289)
.+..+.|.+|++++++++||||+++++++.+++..++||||+++|+|.+++..... ...
T Consensus 91 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T 1luf_A 91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170 (343)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCC
Confidence 34567899999999999999999999999999999999999999999999864321 256
Q ss_pred CChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhh
Q 038647 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144 (289)
Q Consensus 65 ~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 144 (289)
+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||+
T Consensus 171 l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 247 (343)
T 1luf_A 171 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 247 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence 899999999999999999999988 99999999999999999999999999987644332233344567899999999
Q ss_pred hhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 145 ALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 145 ~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
+.+..++.++||||||+++|+|++ |..||........ ... ...... ...+...+..+.+++.+|
T Consensus 248 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~~l~~li~~~ 312 (343)
T 1luf_A 248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV--IYY----VRDGNI---------LACPENCPLELYNLMRLC 312 (343)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHH----HHTTCC---------CCCCTTCCHHHHHHHHHH
T ss_pred hccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH--HHH----HhCCCc---------CCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999 9888765432211 111 111111 011223456889999999
Q ss_pred cccCCCCCCCHHHHHHHhhccc
Q 038647 224 VQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
|+.||++|||+.++++.|++..
T Consensus 313 l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 313 WSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCcccCCCHHHHHHHHHHHH
Confidence 9999999999999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=296.89 Aligned_cols=222 Identities=25% Similarity=0.344 Sum_probs=181.5
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC---------------CCCCChHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK---------------TGLLGWEMR 70 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~ 70 (289)
...+.+.+|+++|+++ +||||+++++++.+++..++||||+++|+|.+++..... ...+++..+
T Consensus 68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 3468899999999999 999999999999999999999999999999999864322 225899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC
Q 038647 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF 150 (289)
Q Consensus 71 ~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 150 (289)
+.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..+
T Consensus 148 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 999999999999999988 99999999999999999999999999987755443333444567889999999999999
Q ss_pred CCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 151 SIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 151 ~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+.++||||||+++|+|++ |..||.......... ..... ..........+..+.+++.+||+.||+
T Consensus 225 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~ 290 (313)
T 1t46_A 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-KMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPL 290 (313)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH-HHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH-HHhcc-------------CCCCCCcccCCHHHHHHHHHHcCCCch
Confidence 999999999999999999 998886554332111 11100 011111223456889999999999999
Q ss_pred CCCCHHHHHHHhhccc
Q 038647 230 DRPTMLEVISMLTNEN 245 (289)
Q Consensus 230 ~Rps~~~ll~~L~~~~ 245 (289)
+|||+.++++.|++..
T Consensus 291 ~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 291 KRPTFKQIVQLIEKQI 306 (313)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=290.16 Aligned_cols=217 Identities=29% Similarity=0.452 Sum_probs=177.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ..+.+++..++.++.|++.||.|||+
T Consensus 47 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~ 124 (269)
T 4hcu_A 47 MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE 124 (269)
T ss_dssp BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999999999999999999999999999999999999854 33568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|
T Consensus 125 ~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 200 (269)
T 4hcu_A 125 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 200 (269)
T ss_dssp TT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---eecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHH
Confidence 88 999999999999999999999999999866433211 22334567789999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++ |..||........ .... ... .....+...+..+.+++..||+.||++|||+.++++.|++.
T Consensus 201 l~~g~~p~~~~~~~~~--~~~~----~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 201 FSEGKIPYENRSNSEV--VEDI----STG---------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HTTSCCTTTTCCHHHH--HHHH----HTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCHHHH--HHHH----hcC---------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 99 8888765432211 1111 000 01111222356789999999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=292.75 Aligned_cols=229 Identities=25% Similarity=0.416 Sum_probs=174.6
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.|.+|+++|++++||||+++++++.+ ..++||||+++|+|.+++........+++..++.++.|++.||.|||
T Consensus 42 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH 119 (307)
T 2eva_A 42 ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999874 48899999999999999975444445788999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCc-eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMN-PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~-vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+.+..+|+||||||+||+++.++. +||+|||++...... .....||+.|+|||++.+..++.++||||||+++|
T Consensus 120 ~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 194 (307)
T 2eva_A 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194 (307)
T ss_dssp TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHH
T ss_pred hCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHH
Confidence 832223999999999999988886 799999999765322 22346899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+|++|+.||........... +.... ... .......+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 195 el~~g~~p~~~~~~~~~~~~---~~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 195 EVITRRKPFDEIGGPAFRIM---WAVHN-GTR---------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp HHHHTCCTTTTTCSSHHHHH---HHHHT-TCC---------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHCCCCchhhCccHHHHH---HHHhc-CCC---------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999999875443322111 11111 000 111123346789999999999999999999999999987
Q ss_pred cCCCCCCCCC
Q 038647 245 NVILPSPLQP 254 (289)
Q Consensus 245 ~~~~~~~~~p 254 (289)
....+....|
T Consensus 262 ~~~~~~~~~~ 271 (307)
T 2eva_A 262 MRYFPGADEP 271 (307)
T ss_dssp GGGCCCTTSC
T ss_pred HHhccCCCCc
Confidence 6555544333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.10 Aligned_cols=222 Identities=26% Similarity=0.375 Sum_probs=178.7
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC----CCCCCChHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT----KTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~~~i~~~l 81 (289)
.+...++.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.... ....+++..++.++.||+.||
T Consensus 115 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 194 (367)
T 3l9p_A 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHH
Confidence 4456689999999999999999999999999999999999999999999986422 224588999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCC---ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchh
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNM---NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 158 (289)
.|||+++ |+||||||+|||++.++ .+||+|||+++...............||+.|+|||++.+..++.++||||
T Consensus 195 ~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws 271 (367)
T 3l9p_A 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271 (367)
T ss_dssp HHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHH
Confidence 9999998 99999999999999555 59999999998653333233344456889999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
|||++|+|++ |..||....... .... ..... ........+..+.+++..||+.||++|||+.+|
T Consensus 272 lG~il~ellt~g~~pf~~~~~~~--~~~~----i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei 336 (367)
T 3l9p_A 272 FGVLLWEIFSLGYMPYPSKSNQE--VLEF----VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 336 (367)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHH--HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9999999998 888886543221 1111 11110 111222345678999999999999999999999
Q ss_pred HHHhhccc
Q 038647 238 ISMLTNEN 245 (289)
Q Consensus 238 l~~L~~~~ 245 (289)
++.|+...
T Consensus 337 l~~l~~~~ 344 (367)
T 3l9p_A 337 LERIEYCT 344 (367)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=303.93 Aligned_cols=219 Identities=27% Similarity=0.437 Sum_probs=167.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++|.+|+++|++++||||+++++++.+++..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH 164 (373)
T 2qol_A 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLS 164 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999964 2346899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|
T Consensus 165 ~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ 241 (373)
T 2qol_A 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241 (373)
T ss_dssp HTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHH
Confidence 988 999999999999999999999999999876433211 1122224567899999999999999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+|++ |..||....... ..... .. ..........+..+.+++.+||+.||++||++.+|++.|+.
T Consensus 242 ellt~g~~P~~~~~~~~--~~~~i----~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 242 EVMSYGERPYWEMSNQD--VIKAV----DE---------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp HHHTTC-CTTTTCCHHH--HHHHH----HT---------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHH--HHHHH----Hc---------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 9998 999876443221 11111 00 01111222345789999999999999999999999999987
Q ss_pred c
Q 038647 244 E 244 (289)
Q Consensus 244 ~ 244 (289)
.
T Consensus 307 ~ 307 (373)
T 2qol_A 307 L 307 (373)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=300.10 Aligned_cols=220 Identities=24% Similarity=0.350 Sum_probs=172.6
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....+.+.+|+.++++++||||+++++++.++. .++|+||+.+|+|.+++.. ..+.+++..+..++.||+.||.||
T Consensus 57 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~L 133 (327)
T 3lzb_A 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133 (327)
T ss_dssp SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4557889999999999999999999999998765 7899999999999998854 235689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|
T Consensus 134 H~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (327)
T 3lzb_A 134 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210 (327)
T ss_dssp HHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHH
Confidence 9988 9999999999999999999999999998765443333333445688999999999999999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+|++ |..||.......... . . ............+..+.+++..||+.||++|||+.++++.|+.
T Consensus 211 ell~~g~~p~~~~~~~~~~~--~----~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 275 (327)
T 3lzb_A 211 ELMTFGSKPYDGIPASEISS--I----L---------EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp HHHTTSCCTTTTCCGGGHHH--H----H---------HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHH--H----H---------HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9999 999986544332111 0 0 0111111223345688999999999999999999999999997
Q ss_pred cc
Q 038647 244 EN 245 (289)
Q Consensus 244 ~~ 245 (289)
..
T Consensus 276 ~~ 277 (327)
T 3lzb_A 276 MA 277 (327)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=296.64 Aligned_cols=210 Identities=20% Similarity=0.229 Sum_probs=174.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|+.++||||+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 46 ~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH 122 (337)
T 1o6l_A 46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH 122 (337)
T ss_dssp TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999999999999999999999999999999999884 3457899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 123 ~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 197 (337)
T 1o6l_A 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp HTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHH
T ss_pred HCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHH
Confidence 988 9999999999999999999999999998643221 22345689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
|++|..||...+... ..... ... . ...+...+..+.+++.+||+.||++|| ++.++++
T Consensus 198 ll~g~~Pf~~~~~~~--~~~~i---~~~-~----------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 198 MMCGRLPFYNQDHER--LFELI---LME-E----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHSSCSSCCSSHHH--HHHHH---HHC-C----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhcCCCCCCCCCHHH--HHHHH---HcC-C----------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 999999986543221 11110 000 0 011223457889999999999999999 8999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=287.59 Aligned_cols=218 Identities=27% Similarity=0.389 Sum_probs=178.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~ 122 (268)
T 3sxs_A 45 MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLES 122 (268)
T ss_dssp BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999999999999999999853 23458999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.++|+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|
T Consensus 123 ~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 198 (268)
T 3sxs_A 123 HQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198 (268)
T ss_dssp TT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHH
T ss_pred CC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHH
Confidence 88 9999999999999999999999999998765443222 2334567789999999998999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..||.......... . ..... ....+...+..+.+++..||+.||++|||+.++++.|+...
T Consensus 199 ~~~g~~p~~~~~~~~~~~--~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 199 FSLGKMPYDLYTNSEVVL--K----VSQGH---------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HTTTCCTTTTSCHHHHHH--H----HHTTC---------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HcCCCCCccccChHHHHH--H----HHcCC---------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 99 998886544322111 0 00000 00111123467899999999999999999999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=288.24 Aligned_cols=216 Identities=28% Similarity=0.433 Sum_probs=168.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++. .+.+++..+..++.|++.||.|||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH 122 (271)
T 3dtc_A 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLH 122 (271)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999999999999999999999999999999883 346899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCC--------CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccch
Q 038647 86 HYSRLRVIHRDLKASNILLDS--------NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~--------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
+++..+++||||||+||+++. ++.+||+|||++....... .....|++.|+|||++.+..++.++|||
T Consensus 123 ~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 198 (271)
T 3dtc_A 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVW 198 (271)
T ss_dssp HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHH
T ss_pred hCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHH
Confidence 876444889999999999986 7789999999998654332 2234689999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
|||+++|+|++|..||.......... ..... ..........+..+.+++.+||+.||++|||+.|+
T Consensus 199 slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 264 (271)
T 3dtc_A 199 SYGVLLWELLTGEVPFRGIDGLAVAY-----GVAMN---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNI 264 (271)
T ss_dssp HHHHHHHHHHHCCCTTTTSCHHHHHH-----HHHTS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHH-----hhhcC---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 99999999999999987543221111 00100 01111222345689999999999999999999999
Q ss_pred HHHhhc
Q 038647 238 ISMLTN 243 (289)
Q Consensus 238 l~~L~~ 243 (289)
++.|+.
T Consensus 265 l~~L~~ 270 (271)
T 3dtc_A 265 LDQLTT 270 (271)
T ss_dssp HHHHHC
T ss_pred HHHHhc
Confidence 999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=301.31 Aligned_cols=233 Identities=27% Similarity=0.357 Sum_probs=179.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+..+.|.+|+++|++++||||+++++++.+. ...++||||+++|+|.+++.. ..+++..++.++.|++.||.|
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~ 149 (318)
T 3lxp_A 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAY 149 (318)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999884 678999999999999999843 348999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
||+.+ |+||||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||++
T Consensus 150 LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 150 LHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226 (318)
T ss_dssp HHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred HHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHH
Confidence 99988 999999999999999999999999999877543321 22334467888999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+|+|++|..|+..........................+............+..+.+++.+||+.||++|||+.++++.|+
T Consensus 227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 99999999987643221111000000000000011111111122223345578999999999999999999999999998
Q ss_pred ccc
Q 038647 243 NEN 245 (289)
Q Consensus 243 ~~~ 245 (289)
...
T Consensus 307 ~l~ 309 (318)
T 3lxp_A 307 TVH 309 (318)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=298.73 Aligned_cols=223 Identities=22% Similarity=0.352 Sum_probs=168.9
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeE------EEEEeecCCCChhhhhcCCC---CCCCCChHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK------ILIYEYMPNKSLDCFLFDPT---KTGLLGWEMRVRILE 75 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~ 75 (289)
.....++|.+|++++++++||||+++++++.+.+.. ++||||+++|+|.+++.... ....+++..+..++.
T Consensus 65 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~ 144 (323)
T 3qup_A 65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144 (323)
T ss_dssp -CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHH
Confidence 344578899999999999999999999999877655 99999999999999885321 122589999999999
Q ss_pred HHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCccc
Q 038647 76 GVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSD 155 (289)
Q Consensus 76 ~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 155 (289)
|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|
T Consensus 145 qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (323)
T 3qup_A 145 DIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSD 221 (323)
T ss_dssp HHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccc
Confidence 9999999999988 9999999999999999999999999998765443333333445678999999999999999999
Q ss_pred chhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 156 VFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 156 iwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|||||+++|+|++ |..||......... .. ..... ........+..+.+++.+||+.||++|||+
T Consensus 222 i~slG~il~ell~~g~~p~~~~~~~~~~--~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 286 (323)
T 3qup_A 222 VWAFGVTMWEIMTRGQTPYAGIENAEIY--NY----LIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSF 286 (323)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHH--HH----HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred hhhHHHHHHHHHhCCCCCccccChHHHH--HH----HhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCH
Confidence 9999999999999 88887654432211 10 00000 111223345689999999999999999999
Q ss_pred HHHHHHhhccc
Q 038647 235 LEVISMLTNEN 245 (289)
Q Consensus 235 ~~ll~~L~~~~ 245 (289)
.++++.|++..
T Consensus 287 ~~l~~~l~~~l 297 (323)
T 3qup_A 287 TCLRMELENIL 297 (323)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=294.67 Aligned_cols=213 Identities=20% Similarity=0.263 Sum_probs=173.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|+.++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~ 120 (321)
T 1tki_A 43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS 120 (321)
T ss_dssp HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999853 23468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCC--CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDS--NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~--~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
++ |+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|
T Consensus 121 ~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 194 (321)
T 1tki_A 121 HN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194 (321)
T ss_dssp TT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHH
T ss_pred CC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHH
Confidence 88 999999999999987 7899999999998765432 233457899999999999888999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||....... ...... ..... . .. ......+..+.+++.+||..||++|||+.|+++
T Consensus 195 ~ll~g~~pf~~~~~~~--~~~~i~---~~~~~--~-~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 195 VLLSGINPFLAETNQQ--IIENIM---NAEYT--F-DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHSSCTTCCSSHHH--HHHHHH---HTCCC--C-CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCcCCCHHH--HHHHHH---cCCCC--C-Ch----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999999986543221 111110 00000 0 00 000123568899999999999999999999997
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=292.98 Aligned_cols=211 Identities=24% Similarity=0.294 Sum_probs=172.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+|++++||||+++++++.+++..++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||++
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~ 133 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL 133 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 57889999999999999999999999999999999999999999999994 446799999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCC----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNM----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+ |+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++
T Consensus 134 ~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 207 (326)
T 2y0a_A 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207 (326)
T ss_dssp T---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred C---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHH
Confidence 8 99999999999999887 79999999998764332 22345799999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||........ ...... ... ..... .....+..+.+++.+||+.||++|||+.++++
T Consensus 208 ~~ll~g~~pf~~~~~~~~--~~~~~~---~~~--~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 208 YILLSGASPFLGDTKQET--LANVSA---VNY--EFEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHSCCSSCCSSHHHH--HHHHHH---TCC--CCCHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHCcCCCCCCCHHHH--HHHHHh---cCC--CcCcc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999865432211 111000 000 00000 00123467889999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=288.56 Aligned_cols=233 Identities=21% Similarity=0.250 Sum_probs=182.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecC--eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG--EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
...+.+.+|+++|++++||||+++++++.+.+ ..++||||+++++|.+++........+++..++.++.||+.||.||
T Consensus 49 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L 128 (319)
T 4euu_A 49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128 (319)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 45788899999999999999999999998765 7899999999999999997644444589999999999999999999
Q ss_pred hcCCCCceEeeccccCceEe----CCCCceEEcccccccccCCCCcccccccccccccccChhhhh--------cCCCCC
Q 038647 85 HHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL--------RGLFSI 152 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill----~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~ 152 (289)
|+++ |+||||||+||++ +.++.+||+|||+++...... ......||+.|+|||++. +..++.
T Consensus 129 H~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 202 (319)
T 4euu_A 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGA 202 (319)
T ss_dssp HHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCT
T ss_pred HHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCc
Confidence 9988 9999999999999 788889999999998765432 223456899999999987 467899
Q ss_pred cccchhHHHHHHHHHhCCCCcCCCCCcch--hHhHhHhhhhccCCccc----------cc-cccccCCCCHHHHHHHHHH
Q 038647 153 KSDVFSFGVLVLETLSSKKNAHFYNTDSL--TLLGHAWNLWNDGRAWE----------LM-DSILQNDASYPMLNRYINV 219 (289)
Q Consensus 153 ~~DiwslG~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~----------~~-~~~~~~~~~~~~~~~l~~l 219 (289)
++|||||||++|+|++|..||........ ................. .. ............+..+.++
T Consensus 203 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 282 (319)
T 4euu_A 203 TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282 (319)
T ss_dssp THHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHH
Confidence 99999999999999999999875443321 11111111111000000 00 0011123445678889999
Q ss_pred HHcccccCCCCCCCHHHHHHHhhccc
Q 038647 220 ALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
+..||+.||++|||++|+++...+..
T Consensus 283 l~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 283 LANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHhccCChhhhccHHHhhhccHHHh
Confidence 99999999999999999999887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.27 Aligned_cols=213 Identities=21% Similarity=0.280 Sum_probs=173.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|+.++||||+++++++.+++..|+||||+.+|+|.+.+. ..+.+++..+..++.||+.||.|||+
T Consensus 52 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~ 128 (444)
T 3soa_A 52 RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQ 128 (444)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999988884 34569999999999999999999999
Q ss_pred CCCCceEeeccccCceEeC---CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLD---SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~---~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
++ |+||||||+|||++ .++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++
T Consensus 129 ~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 129 MG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203 (444)
T ss_dssp TT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHH
Confidence 88 99999999999998 567899999999987654321 22345799999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||....... ....... ... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 204 yell~G~~Pf~~~~~~~--~~~~i~~----~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 204 YILLVGYPPFWDEDQHR--LYQQIKA----GAY------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHSSCSCCCSSHHH--HHHHHHH----TCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhCCCCCCCccHHH--HHHHHHh----CCC------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999986543221 1111100 000 0001111234568899999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=302.58 Aligned_cols=237 Identities=24% Similarity=0.320 Sum_probs=179.4
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEe--ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI--EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.....+.+.+|++++++++||||+++++++. +.+..++||||+++++|.+++.. ....+++..+..++.|++.||.
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~ 141 (327)
T 3lxl_A 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGME 141 (327)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHH
Confidence 3445678999999999999999999999986 55679999999999999999853 2345899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|||+++ |+||||||+||+++.++.+||+|||+++........ .......|+..|+|||++.+..++.++||||||+
T Consensus 142 ~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 142 YLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218 (327)
T ss_dssp HHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHH
T ss_pred HHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHH
Confidence 999988 999999999999999999999999999876543221 1233346788899999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
++|+|++|..|+..........................+............+..+.+++..||+.||++|||+.++++.|
T Consensus 219 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 219 VLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp HHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999998764332110000000000000000011111111222334567899999999999999999999999999
Q ss_pred hcccC
Q 038647 242 TNENV 246 (289)
Q Consensus 242 ~~~~~ 246 (289)
+....
T Consensus 299 ~~~~~ 303 (327)
T 3lxl_A 299 DMLWS 303 (327)
T ss_dssp HHC--
T ss_pred HHHHh
Confidence 97653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=293.79 Aligned_cols=222 Identities=16% Similarity=0.152 Sum_probs=177.2
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+++++++ +||||+++++++.+++..++||||+ +++|.+++... .+.+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~ 123 (330)
T 2izr_A 47 RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS 123 (330)
T ss_dssp SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345789999999999 9999999999999999999999999 99999998542 4579999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCc-----eEEcccccccccCCCCccc-----ccccccccccccChhhhhcCCCCCcccc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMN-----PKISDFGIARLFGGDELQS-----NTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~-----vkl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
++ |+||||||+|||++.++. +||+|||+++......... ......||+.|+|||++.+..++.++||
T Consensus 124 ~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 200 (330)
T 2izr_A 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDL 200 (330)
T ss_dssp TT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred CC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHH
Confidence 88 999999999999998887 9999999998764332211 1245679999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhH-hHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTL-LGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
||||+++|+|++|..||.......... ............ . ... ....+ .+.+++..||+.||.+||++.
T Consensus 201 ~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~----~-~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~ 270 (330)
T 2izr_A 201 EALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP----I-EVL----CENFP-EMATYLRYVRRLDFFEKPDYD 270 (330)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC----H-HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC----H-HHH----hccCh-HHHHHHHHHHhCCCCCCCCHH
Confidence 999999999999999987654332211 111000000000 0 000 00123 889999999999999999999
Q ss_pred HHHHHhhccc
Q 038647 236 EVISMLTNEN 245 (289)
Q Consensus 236 ~ll~~L~~~~ 245 (289)
+|++.|+...
T Consensus 271 ~l~~~l~~~~ 280 (330)
T 2izr_A 271 YLRKLFTDLF 280 (330)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=311.27 Aligned_cols=219 Identities=25% Similarity=0.360 Sum_probs=180.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||+
T Consensus 258 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~ 336 (495)
T 1opk_A 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK 336 (495)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45789999999999999999999999999999999999999999999999642 23468899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||
T Consensus 337 ~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el 412 (495)
T 1opk_A 337 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412 (495)
T ss_dssp TT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHH
Confidence 88 999999999999999999999999999876543222 22233467889999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..||........ ... ... ......+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 413 ~t~g~~p~~~~~~~~~--~~~----~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 413 ATYGMSPYPGIDLSQV--YEL----LEK---------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HTTSCCSSTTCCGGGH--HHH----HHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HhCCCCCCCCCCHHHH--HHH----HHc---------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 99 8888875443221 111 111 1111222334578899999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=290.71 Aligned_cols=225 Identities=23% Similarity=0.368 Sum_probs=167.0
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....+.|.+|+++|++++||||++++++. .....++||||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~l 136 (289)
T 3og7_A 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYL 136 (289)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 445678899999999999999999999965 55678999999999999998853 345689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~ 161 (289)
|+++ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++. +..++.++||||||+
T Consensus 137 H~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 213 (289)
T 3og7_A 137 HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213 (289)
T ss_dssp HHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHH
T ss_pred HhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHH
Confidence 9988 9999999999999999999999999998665433233344557899999999997 567889999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
++|+|++|..||.......... .. .......... .......+..+.+++..||+.||++|||+.++++.|
T Consensus 214 il~el~~g~~p~~~~~~~~~~~-~~----~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 214 VLYELMTGQLPYSNINNRDQII-EM----VGRGSLSPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp HHHHHHHSSCTTSSCCCHHHHH-HH----HHHTSCCCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHCCCCccccchHHHHH-HH----hcccccCcch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 9999999999987544332111 11 1111110000 111223457899999999999999999999999999
Q ss_pred hccc
Q 038647 242 TNEN 245 (289)
Q Consensus 242 ~~~~ 245 (289)
++..
T Consensus 284 ~~l~ 287 (289)
T 3og7_A 284 EELA 287 (289)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=297.32 Aligned_cols=212 Identities=22% Similarity=0.317 Sum_probs=174.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|+.++|||||++++++.+.+..|+||||+.+|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 56 ~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH 132 (384)
T 4fr4_A 56 RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQ 132 (384)
T ss_dssp TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999995 3457999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc---CCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~v 162 (289)
++| |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 133 ~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i 206 (384)
T 4fr4_A 133 NQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206 (384)
T ss_dssp HTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred HCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence 988 9999999999999999999999999998764332 2345679999999999974 458999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-HHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-MLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~ll~ 239 (289)
+|+|++|..||................ .. ....+...+..+.+++.+||+.||++||+ +.++++
T Consensus 207 l~elltG~~Pf~~~~~~~~~~~~~~~~---~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 207 AYELLRGRRPYHIRSSTSSKEIVHTFE---TT----------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHSSCSSCCCTTSCHHHHHHHHH---HC----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHhCCCCCCCCCCccHHHHHHHHh---hc----------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999987654432221111100 00 01122234578999999999999999998 777764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=300.91 Aligned_cols=221 Identities=27% Similarity=0.370 Sum_probs=178.4
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-----------CCCCCChHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-----------KTGLLGWEMRVRIL 74 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~ 74 (289)
+..+.+.+|+++|+++ +||||+++++++.+++..++||||+++|+|.+++.... ....+++..+..++
T Consensus 91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (333)
T 2i1m_A 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170 (333)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence 4567899999999999 89999999999999999999999999999999885321 13457899999999
Q ss_pred HHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcc
Q 038647 75 EGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKS 154 (289)
Q Consensus 75 ~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 154 (289)
.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++
T Consensus 171 ~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 247 (333)
T 2i1m_A 171 SQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 247 (333)
T ss_dssp HHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH
Confidence 99999999999988 999999999999999999999999999866443322233445678899999999999999999
Q ss_pred cchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 155 DVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 155 DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
||||||+++|+|++ |..||.......... .... .. .....+...+..+.+++..||+.||++|||
T Consensus 248 Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 313 (333)
T 2i1m_A 248 DVWSYGILLWEIFSLGLNPYPGILVNSKFY-KLVK----DG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPT 313 (333)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-HHHH----HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHcCCCCCCcccchhHHHH-HHHh----cC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcC
Confidence 99999999999998 888876544332111 1100 00 011112223468899999999999999999
Q ss_pred HHHHHHHhhcc
Q 038647 234 MLEVISMLTNE 244 (289)
Q Consensus 234 ~~~ll~~L~~~ 244 (289)
+.+|++.|+..
T Consensus 314 ~~~l~~~L~~~ 324 (333)
T 2i1m_A 314 FQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=298.56 Aligned_cols=213 Identities=21% Similarity=0.293 Sum_probs=172.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 69 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH 145 (362)
T 2bdw_A 69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCH 145 (362)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999998884 3457899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCC---ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNM---NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
+++ |+||||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||+
T Consensus 146 ~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 219 (362)
T 2bdw_A 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219 (362)
T ss_dssp HTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred HCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHH
Confidence 988 99999999999998654 59999999998765332 2234579999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||...... ....... .... . .........+..+.+++.+||+.||++|||+.++++
T Consensus 220 l~~ll~g~~Pf~~~~~~--~~~~~i~----~~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 220 LYILLVGYPPFWDEDQH--RLYAQIK----AGAY-D-----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHHHSSCSSCCSSHH--HHHHHHH----HTCC-C-----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCCCHH--HHHHHHH----hCCC-C-----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 99999999998654321 1111110 0000 0 000011234568899999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=290.74 Aligned_cols=213 Identities=25% Similarity=0.347 Sum_probs=174.9
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
..+..+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.||.||
T Consensus 82 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~L 157 (321)
T 2c30_A 82 KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYL 157 (321)
T ss_dssp TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999998842 4689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|
T Consensus 158 H~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 232 (321)
T 2c30_A 158 HAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232 (321)
T ss_dssp HHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHH
Confidence 9988 99999999999999999999999999987654321 233457999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||....... ..... ....... -......+..+.+++.+||+.||++|||+.++++
T Consensus 233 el~~g~~pf~~~~~~~--~~~~~----~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 233 EMVDGEPPYFSDSPVQ--AMKRL----RDSPPPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHSSCTTTTSCHHH--HHHHH----HHSSCCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCCCCCCHHH--HHHHH----hcCCCCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999986543221 11110 0000000 0111234567899999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=296.62 Aligned_cols=234 Identities=23% Similarity=0.346 Sum_probs=177.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....+++.+|+++|+.++||||+++++++.+. +..++||||+++|+|.+++.. ....+++..+..++.|++.||.|
T Consensus 64 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~ 141 (302)
T 4e5w_A 64 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDY 141 (302)
T ss_dssp -CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHH
Confidence 44678899999999999999999999999876 678999999999999999843 23468999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
||+++ |+||||||+||+++.++.+||+|||++......... .......||..|+|||++.+..++.++||||||++
T Consensus 142 lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 218 (302)
T 4e5w_A 142 LGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218 (302)
T ss_dssp HHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred hhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHH
Confidence 99988 999999999999999999999999999876543321 22334567888999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+|+|++|..|+...................................+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 219 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 219 LHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999875422110000000000000000000001111111223345578999999999999999999999999998
Q ss_pred cc
Q 038647 243 NE 244 (289)
Q Consensus 243 ~~ 244 (289)
..
T Consensus 299 ~l 300 (302)
T 4e5w_A 299 AL 300 (302)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=297.63 Aligned_cols=236 Identities=23% Similarity=0.345 Sum_probs=173.7
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+..++|.+|+++|++++||||+++++++.. ....++||||+++|+|.+++... ...+++..+..++.|++.||.
T Consensus 51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~ 128 (295)
T 3ugc_A 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGME 128 (295)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHH
Confidence 34556889999999999999999999999864 45689999999999999998542 345899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|||+++ |+||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+
T Consensus 129 ~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (295)
T 3ugc_A 129 YLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205 (295)
T ss_dssp HHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHH
Confidence 999988 999999999999999999999999999876433211 1223345677899999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhH-hhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHA-WNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|+|++|..|+.............. ............+........+...+..+.+++..||+.||++|||+.++++.
T Consensus 206 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 206 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999988654321100000000 00000000000011111112233445789999999999999999999999999
Q ss_pred hhccc
Q 038647 241 LTNEN 245 (289)
Q Consensus 241 L~~~~ 245 (289)
|+.+.
T Consensus 286 L~~l~ 290 (295)
T 3ugc_A 286 VDQIR 290 (295)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=288.11 Aligned_cols=228 Identities=25% Similarity=0.265 Sum_probs=172.1
Q ss_pred ccCHHHHHHHHHHHhh--CCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAK--LQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+.+.+|.+++.. ++||||+++++++.+ ....++||||+++|+|.+++. ...+++..+..++.|++.
T Consensus 41 ~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~ 116 (301)
T 3q4u_A 41 SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIAS 116 (301)
T ss_dssp GGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHH
T ss_pred cccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHH
Confidence 3456677788888877 789999999999754 346899999999999999993 346899999999999999
Q ss_pred HHHHHh--------cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc--ccccccccccccChhhhhcC-
Q 038647 80 GLLYLH--------HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS--NTKRIVGTYGYMSPEYALRG- 148 (289)
Q Consensus 80 ~l~~lH--------~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~- 148 (289)
||.||| +.+ |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+.
T Consensus 117 ~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (301)
T 3q4u_A 117 GLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193 (301)
T ss_dssp HHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCC
T ss_pred HHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcC
Confidence 999999 777 9999999999999999999999999998654432211 12334789999999999876
Q ss_pred -----CCCCcccchhHHHHHHHHHhC----------CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHH
Q 038647 149 -----LFSIKSDVFSFGVLVLETLSS----------KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPML 213 (289)
Q Consensus 149 -----~~~~~~DiwslG~vl~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (289)
.++.++||||||+++|+|++| ..||......................... ..........+
T Consensus 194 ~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 269 (301)
T 3q4u_A 194 QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN----IPNRWFSDPTL 269 (301)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC----CCGGGGGSHHH
T ss_pred CCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCC----CChhhccCccH
Confidence 455799999999999999999 66665433222111111111111111000 01111123467
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 214 NRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 214 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 270 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 270 TSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8899999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=290.37 Aligned_cols=209 Identities=21% Similarity=0.280 Sum_probs=167.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
..+++.+|+++|++++||||+++++++.+ ++..|+||||+++++|.+++ ..+.+++..+..++.||+.||.|||
T Consensus 79 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp --CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45789999999999999999999999987 56899999999999998865 2356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC---CCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL---FSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~v 162 (289)
+++ |+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||++
T Consensus 155 ~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~ 229 (298)
T 2zv2_A 155 YQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229 (298)
T ss_dssp HTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred HCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence 988 99999999999999999999999999987654321 223457899999999998655 3788999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||....... .... .... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 230 l~~l~~g~~pf~~~~~~~--~~~~----~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 230 LYCFVFGQCPFMDERIMC--LHSK----IKSQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHSSCSSCCSSHHH--HHHH----HHHC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHCCCCCCCccHHH--HHHH----Hhcc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999999986433211 1100 0000 0000111234568899999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=295.78 Aligned_cols=222 Identities=26% Similarity=0.395 Sum_probs=180.5
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRV 71 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~ 71 (289)
....+++.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++..... ...+++..++
T Consensus 81 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (334)
T 2pvf_A 81 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160 (334)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHH
Confidence 34567899999999999 899999999999999999999999999999999965332 2348899999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++
T Consensus 161 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 237 (334)
T 2pvf_A 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237 (334)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC
Confidence 99999999999999988 999999999999999999999999999876554333333444678899999999998999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++||||||+++|+|++ |..||....... ..... .... ........+..+.+++.+||+.||++
T Consensus 238 ~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~ 302 (334)
T 2pvf_A 238 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLL----KEGH---------RMDKPANCTNELYMMMRDCWHAVPSQ 302 (334)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--HHHHH----hcCC---------CCCCCccCCHHHHHHHHHHccCChhh
Confidence 99999999999999999 998876543221 11111 0000 01122234568899999999999999
Q ss_pred CCCHHHHHHHhhccc
Q 038647 231 RPTMLEVISMLTNEN 245 (289)
Q Consensus 231 Rps~~~ll~~L~~~~ 245 (289)
|||+.++++.|+.+.
T Consensus 303 Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 303 RPTFKQLVEDLDRIL 317 (334)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=286.32 Aligned_cols=225 Identities=23% Similarity=0.282 Sum_probs=170.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|++++++++||||+++++++.+++..++||||++++.+..+. ...+.+++..+..++.|++.||.|||
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH 118 (292)
T 3o0g_A 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCH 118 (292)
T ss_dssp TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 344578899999999999999999999999999999999999765444443 23457999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC-CCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 119 ~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 193 (292)
T 3o0g_A 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193 (292)
T ss_dssp HTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred hCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHH
Confidence 988 9999999999999999999999999998764322 2233457899999999998765 899999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCc--ccccc-------------ccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA--WELMD-------------SILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+|++|..|+.......... ............ ..... ...........+..+.+++.+||+.||+
T Consensus 194 ~l~~~~~p~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 272 (292)
T 3o0g_A 194 ELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272 (292)
T ss_dssp HHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChh
Confidence 9999988864433322211 111111111000 00000 0000111223457889999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||++|+++
T Consensus 273 ~R~t~~e~l~ 282 (292)
T 3o0g_A 273 QRISAEEALQ 282 (292)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=289.17 Aligned_cols=217 Identities=27% Similarity=0.413 Sum_probs=177.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+++.+|++++++++||||+++++++.+++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+
T Consensus 61 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~ 138 (283)
T 3gen_A 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES 138 (283)
T ss_dssp BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999999999999999999999999998542 3468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|
T Consensus 139 ~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l 214 (283)
T 3gen_A 139 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214 (283)
T ss_dssp TT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred CC---ccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 88 999999999999999999999999999876433211 12233567889999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++ |..||......... .. .... .....+...+..+.+++.+||+.||++|||+.++++.|...
T Consensus 215 ~t~g~~p~~~~~~~~~~--~~----~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 215 YSLGKMPYERFTNSETA--EH----IAQG---------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HTTTCCTTTTSCHHHHH--HH----HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCccccChhHHH--HH----Hhcc---------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 98 99988654432111 00 0000 01111122346889999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=289.29 Aligned_cols=217 Identities=23% Similarity=0.314 Sum_probs=165.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.|.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||
T Consensus 57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH 133 (281)
T 1mp8_A 57 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 133 (281)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999985 5578999999999999999853 2346899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+
T Consensus 134 ~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 209 (281)
T 1mp8_A 134 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209 (281)
T ss_dssp HTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred hCC---eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHH
Confidence 988 999999999999999999999999999876443221 1223356788999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |..||........ ... ..... ........+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 210 ll~~g~~pf~~~~~~~~--~~~----i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 210 ILMHGVKPFQGVKNNDV--IGR----IENGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHTTSCCTTTTCCGGGH--HHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCcCCHHHH--HHH----HHcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 997 8888865433221 111 00000 0112223457889999999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=295.88 Aligned_cols=214 Identities=23% Similarity=0.310 Sum_probs=171.3
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+.+++.++||||+++++++.+++..|+||||+++++|.+++.... ....+++..+..++.||+.||.|||+
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999999999999999999999999999999987774322 23458999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCc---eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMN---PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
++ |+||||||+|||++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++
T Consensus 149 ~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (351)
T 3c0i_A 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223 (351)
T ss_dssp TT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHH
Confidence 88 999999999999986655 99999999987654322 23345799999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||..... ...... .. .... .... .....+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~ll~g~~pf~~~~~---~~~~~i---~~-~~~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 224 FILLSGCLPFYGTKE---RLFEGI---IK-GKYK--MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHSSCSSCSSHH---HHHHHH---HH-TCCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHCCCCCCCcHH---HHHHHH---Hc-CCCC--CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999865321 111100 00 0000 0000 00123468899999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=298.19 Aligned_cols=229 Identities=18% Similarity=0.207 Sum_probs=172.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|+++|+.++|||||++++++.+++..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH 145 (389)
T 3gni_B 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIH 145 (389)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 445678899999999999999999999999999999999999999999998642 2356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCC-----cccccccccccccccChhhhhc--CCCCCcccchh
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE-----LQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFS 158 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Diws 158 (289)
+++ |+||||||+|||++.++.+||+|||.+....... .........||+.|+|||++.+ ..++.++||||
T Consensus 146 ~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 222 (389)
T 3gni_B 146 HMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222 (389)
T ss_dssp HTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHH
T ss_pred hCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHH
Confidence 988 9999999999999999999999999886542211 1111233478999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc----CC------------------ccccc---------cccccCC
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND----GR------------------AWELM---------DSILQND 207 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~------------------~~~~~---------~~~~~~~ 207 (289)
|||++|+|++|+.||............. ...... .. ..... .......
T Consensus 223 lG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (389)
T 3gni_B 223 VGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP 301 (389)
T ss_dssp HHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------------------------
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCc
Confidence 9999999999999987654432211100 000000 00 00000 0000001
Q ss_pred CCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 208 ASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 208 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 302 ~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 302 YHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 12224467899999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=293.32 Aligned_cols=226 Identities=15% Similarity=0.156 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+.+.+|+.+++.++||||+++++++.+ +...|+||||+ +++|.+++.. .+.+++..++.++.||+.||.||
T Consensus 92 ~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~L 167 (345)
T 2v62_A 92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYI 167 (345)
T ss_dssp CHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457788999999999999999999988 77899999999 9999999843 34799999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCC--ceEEcccccccccCCCCcc-----cccccccccccccChhhhhcCCCCCcccch
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNM--NPKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~--~vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
|+++ |+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||
T Consensus 168 H~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 244 (345)
T 2v62_A 168 HENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVE 244 (345)
T ss_dssp HHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHH
T ss_pred HhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHH
Confidence 9988 99999999999998877 9999999999876432211 112445789999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
|||+++|+|++|..||................ ...... ........ ....+..+.+++..||+.||++|||+.+|
T Consensus 245 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l 319 (345)
T 2v62_A 245 ILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN-LLDELP-QSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQAL 319 (345)
T ss_dssp HHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHH-HHHTTT-HHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHHHHhCCCCccccccccHHHHHHHHh-hccccc-HHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence 99999999999999986533332221111111 110000 00000000 01234689999999999999999999999
Q ss_pred HHHhhcccC
Q 038647 238 ISMLTNENV 246 (289)
Q Consensus 238 l~~L~~~~~ 246 (289)
++.|+....
T Consensus 320 ~~~L~~~~~ 328 (345)
T 2v62_A 320 KKILNPHGI 328 (345)
T ss_dssp HHHHCTTCC
T ss_pred HHHHhccCC
Confidence 999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=290.00 Aligned_cols=222 Identities=21% Similarity=0.249 Sum_probs=170.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|++++||||+++++++.+++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~ 138 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH 138 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457889999999999999999999999999999999999975 77777653 334589999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~el 166 (289)
+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 139 ~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 213 (311)
T 3niz_A 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEM 213 (311)
T ss_dssp T---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred C---cccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHH
Confidence 8 9999999999999999999999999998764322 12333568999999999976 5689999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCC---ccccc------ccccc--CCC-----CHHHHHHHHHHHHcccccCCCC
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGR---AWELM------DSILQ--NDA-----SYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------~~~~~--~~~-----~~~~~~~l~~li~~~l~~~p~~ 230 (289)
++|..||.......... .......... ..... ..... ... ....+.++.+++.+||+.||++
T Consensus 214 l~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 214 ITGKPLFPGVTDDDQLP--KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp HHSSCSCCCSSTTTHHH--HHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred HhCCCCCCCCChHHHHH--HHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 99999987655443211 1111111000 00000 00000 000 1113457889999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||++|+++
T Consensus 292 Rpt~~ell~ 300 (311)
T 3niz_A 292 RISARDAMN 300 (311)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=287.63 Aligned_cols=221 Identities=25% Similarity=0.271 Sum_probs=176.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeE-EEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK-ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+..+.|.+|+.++++++||||+++++++.+.+.. ++||||+.+|+|.+++.. ....+++..+..++.|++.||.||
T Consensus 63 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~L 140 (298)
T 3pls_A 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL 140 (298)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999876655 999999999999999964 345688999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc--ccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL--QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
|+++ ++||||||+||+++.++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||++
T Consensus 141 H~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 217 (298)
T 3pls_A 141 AEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVL 217 (298)
T ss_dssp HHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHH
T ss_pred HhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHH
Confidence 9988 99999999999999999999999999986543321 122334567889999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+|+|++|..|+........ ..... ... .........+..+.+++.+||+.||++|||+.++++.|+
T Consensus 218 l~~l~~g~~~~~~~~~~~~-~~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 218 LWELLTRGAPPYRHIDPFD-LTHFL----AQG---------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp HHHHHHTSCCTTTTSCGGG-HHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhCCCCCCccCCHHH-HHHHh----hcC---------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999996655432222111 11110 000 011112234568899999999999999999999999998
Q ss_pred ccc
Q 038647 243 NEN 245 (289)
Q Consensus 243 ~~~ 245 (289)
+..
T Consensus 284 ~~~ 286 (298)
T 3pls_A 284 QIV 286 (298)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=305.28 Aligned_cols=214 Identities=28% Similarity=0.383 Sum_probs=174.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecC-eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.|.+|+++|++++||||+++++++.+.+ ..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||+
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~ 307 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG 307 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 5678999999999999999999999987665 799999999999999999642 23347899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++||||||+++|||
T Consensus 308 ~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el 379 (450)
T 1k9a_A 308 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379 (450)
T ss_dssp TT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHH
T ss_pred CC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 88 999999999999999999999999999854322 1223568899999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..||......... .. ...+ .....+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 380 ~t~g~~P~~~~~~~~~~--~~----i~~~---------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 380 YSFGRVPYPRIPLKDVV--PR----VEKG---------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HTTTCCSSTTSCTTTHH--HH----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHH--HH----HHcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 98 99998755433211 11 1111 011122334578999999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=292.96 Aligned_cols=214 Identities=23% Similarity=0.290 Sum_probs=168.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC-----------------------------------------------
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG----------------------------------------------- 38 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------------------------------------------- 38 (289)
....+.+.+|+++|++++||||+++++++.+..
T Consensus 45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (332)
T 3qd2_B 45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124 (332)
T ss_dssp TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence 345688999999999999999999999986643
Q ss_pred ----------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCC
Q 038647 39 ----------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM 108 (289)
Q Consensus 39 ----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~ 108 (289)
..++|||||++|+|.+++.........++..++.++.||+.||.|||+++ |+||||||+||+++.++
T Consensus 125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 201 (332)
T 3qd2_B 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDD 201 (332)
T ss_dssp -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCC
Confidence 38999999999999999976555555667778999999999999999988 99999999999999999
Q ss_pred ceEEcccccccccCCCCcc----------cccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCC
Q 038647 109 NPKISDFGIARLFGGDELQ----------SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178 (289)
Q Consensus 109 ~vkl~Dfg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~ 178 (289)
.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-- 279 (332)
T 3qd2_B 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-- 279 (332)
T ss_dssp CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--
T ss_pred CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--
Confidence 9999999999876543211 1223457999999999999999999999999999999999987653210
Q ss_pred cchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
... ........ ........+..+.+++.+||+.||++|||+.|+++
T Consensus 280 --~~~----~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 280 --VRI----ITDVRNLK---------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp --HHH----HHHHHTTC---------CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred --HHH----HHHhhccC---------CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 000 00000000 00011223467789999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=294.99 Aligned_cols=221 Identities=25% Similarity=0.389 Sum_probs=179.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------CCCCCChHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------KTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~~~~i~~ 79 (289)
...++|.+|+++++.++||||+++++++.+++..++||||+++|+|.+++.... ....+++..++.++.||+.
T Consensus 70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 149 (322)
T 1p4o_A 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149 (322)
T ss_dssp HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999999885321 1245788999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||
T Consensus 150 ~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 150 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp HHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 999999988 99999999999999999999999999986644333333344567889999999999999999999999
Q ss_pred HHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 160 GVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 160 G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
|+++|+|++ |..|+....... .... ...... .......+..+.+++.+||+.||++|||+.+++
T Consensus 227 G~il~el~~~g~~p~~~~~~~~--~~~~----~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l 291 (322)
T 1p4o_A 227 GVVLWEIATLAEQPYQGLSNEQ--VLRF----VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291 (322)
T ss_dssp HHHHHHHHHTSCCTTTTSCHHH--HHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCCccccCCHHH--HHHH----HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 999999999 788876443221 1111 111110 111223456889999999999999999999999
Q ss_pred HHhhccc
Q 038647 239 SMLTNEN 245 (289)
Q Consensus 239 ~~L~~~~ 245 (289)
+.|++..
T Consensus 292 ~~L~~~~ 298 (322)
T 1p4o_A 292 SSIKEEM 298 (322)
T ss_dssp HHHGGGS
T ss_pred HHHHHhh
Confidence 9998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=291.58 Aligned_cols=206 Identities=24% Similarity=0.317 Sum_probs=172.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+|+.++||||+++++++.+.+.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 48 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~ 124 (318)
T 1fot_A 48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHS 124 (318)
T ss_dssp TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457788999999999999999999999999999999999999999999984 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 125 ~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 196 (318)
T 1fot_A 125 KD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 196 (318)
T ss_dssp TT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHH
T ss_pred CC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHH
Confidence 88 999999999999999999999999999875432 3345799999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
++|..||...+... ... ...... ...+...+.++.+++.+||+.||++|| +++++++
T Consensus 197 l~g~~pf~~~~~~~--~~~---~i~~~~-----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 197 LAGYTPFYDSNTMK--TYE---KILNAE-----------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHSSCTTCCSSHHH--HHH---HHHHCC-----------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HhCCCCCCCCCHHH--HHH---HHHhCC-----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 99999986543221 111 111100 011223456889999999999999999 8899885
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=287.99 Aligned_cols=219 Identities=26% Similarity=0.365 Sum_probs=180.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++... ....+++..+..++.|++.||.|||
T Consensus 50 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH 128 (288)
T 3kfa_A 50 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE 128 (288)
T ss_dssp STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999998642 3356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+
T Consensus 129 ~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 204 (288)
T 3kfa_A 129 KKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204 (288)
T ss_dssp HHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHH
Confidence 988 99999999999999999999999999987654332 22333457889999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |..|+.......... . . ............+..+.+++..||+.||++|||+.++++.|+..
T Consensus 205 ll~~g~~p~~~~~~~~~~~--~----~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 205 IATYGMSPYPGIDLSQVYE--L----L---------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHTTSCCSSTTCCGGGHHH--H----H---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHH--H----H---------hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 999 888876544332111 0 0 01111122233457899999999999999999999999998864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=295.12 Aligned_cols=204 Identities=20% Similarity=0.313 Sum_probs=170.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|+.++||||+++++++.+.+..++||||+ +|+|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 52 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~ 127 (336)
T 3h4j_B 52 MHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRH 127 (336)
T ss_dssp CSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4568999999999999999999999999999999999999 678888774 345689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLET 166 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~el 166 (289)
+ |+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..+ ++++||||||+++|+|
T Consensus 128 g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 201 (336)
T 3h4j_B 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVM 201 (336)
T ss_dssp T---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHH
T ss_pred C---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHH
Confidence 8 9999999999999999999999999998765432 2334579999999999988776 7899999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc--CCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ--NDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..||........ ...... ...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 202 l~g~~Pf~~~~~~~~------------------~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 202 LVGRLPFDDEFIPNL------------------FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHSSCSSBCSSSTTC------------------BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCccHHHH------------------HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999865332211 111110 1112234568899999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=291.59 Aligned_cols=223 Identities=22% Similarity=0.364 Sum_probs=170.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC-----eEEEEEeecCCCChhhhhcCC---CCCCCCChHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFLFDP---TKTGLLGWEMRVRILEGV 77 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~i 77 (289)
....+.|.+|+.++++++||||+++++++.+.+ ..++||||+++|+|.+++... .....+++..++.++.||
T Consensus 77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi 156 (313)
T 3brb_A 77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156 (313)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence 445678999999999999999999999998755 459999999999999987422 234568999999999999
Q ss_pred HHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccch
Q 038647 78 AQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 78 ~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
+.||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||
T Consensus 157 ~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 233 (313)
T 3brb_A 157 ALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233 (313)
T ss_dssp HHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred HHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence 99999999988 999999999999999999999999999876544333333444678899999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||+++|+|++ |..||......... ... .... ........+..+.+++.+||+.||++|||+.+
T Consensus 234 slG~il~el~~~g~~p~~~~~~~~~~--~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 298 (313)
T 3brb_A 234 AFGVTMWEIATRGMTPYPGVQNHEMY--DYL----LHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV 298 (313)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHH--HHH----HTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHhcCCCCCccCCHHHHH--HHH----HcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999999999 88887654332211 111 0000 01112234568999999999999999999999
Q ss_pred HHHHhhcccC
Q 038647 237 VISMLTNENV 246 (289)
Q Consensus 237 ll~~L~~~~~ 246 (289)
+++.|+....
T Consensus 299 l~~~L~~l~~ 308 (313)
T 3brb_A 299 LRLQLEKLLE 308 (313)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=306.54 Aligned_cols=222 Identities=28% Similarity=0.409 Sum_probs=173.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++... ....+++..+..++.||+.||.|||+
T Consensus 221 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~ 298 (452)
T 1fmk_A 221 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER 298 (452)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346789999999999999999999999876 6789999999999999999431 23458899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|
T Consensus 299 ~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el 374 (452)
T 1fmk_A 299 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374 (452)
T ss_dssp TT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHH
Confidence 88 999999999999999999999999999876433221 12233567889999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..||....... .... ...+ .....+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 375 ~t~g~~P~~~~~~~~--~~~~----i~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 375 TTKGRVPYPGMVNRE--VLDQ----VERG---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HTTTCCSSTTCCHHH--HHHH----HHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HhCCCCCCCCCCHHH--HHHH----HHcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 99 898886543221 1111 1111 011122334578899999999999999999999999999876
Q ss_pred CCCC
Q 038647 246 VILP 249 (289)
Q Consensus 246 ~~~~ 249 (289)
....
T Consensus 440 ~~~~ 443 (452)
T 1fmk_A 440 TSTE 443 (452)
T ss_dssp SCSC
T ss_pred ccCC
Confidence 4443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=306.91 Aligned_cols=219 Identities=26% Similarity=0.390 Sum_probs=177.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+++|++++||||+++++++. ++..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||+
T Consensus 225 ~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~ 302 (454)
T 1qcf_A 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ 302 (454)
T ss_dssp BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 46789999999999999999999999986 56789999999999999999532 12357888999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||
T Consensus 303 ~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 378 (454)
T 1qcf_A 303 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378 (454)
T ss_dssp TT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHH
Confidence 88 999999999999999999999999999876433211 12223467789999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..||....... ....... . .....+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 379 ~t~g~~P~~~~~~~~--~~~~i~~----~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 379 VTYGRIPYPGMSNPE--VIRALER----G---------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HTTSCCSSTTCCHHH--HHHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HhCCCCCCCCCCHHH--HHHHHHc----C---------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 99 999886543221 1111110 0 011112234578999999999999999999999999999865
Q ss_pred C
Q 038647 246 V 246 (289)
Q Consensus 246 ~ 246 (289)
.
T Consensus 444 ~ 444 (454)
T 1qcf_A 444 T 444 (454)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=298.46 Aligned_cols=209 Identities=22% Similarity=0.280 Sum_probs=169.3
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|+++|+.+ +||||+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 65 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH 141 (353)
T 3txo_A 65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLH 141 (353)
T ss_dssp TTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999998 79999999999999999999999999999999884 3457999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 142 ~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 216 (353)
T 3txo_A 142 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216 (353)
T ss_dssp HTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHH
T ss_pred HCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHH
Confidence 988 9999999999999999999999999998543221 22445689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH------HHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM------LEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~ll~ 239 (289)
|++|..||...+.... .... ... . ...+...+..+.+++.+||+.||++||++ .++++
T Consensus 217 ll~G~~Pf~~~~~~~~--~~~i---~~~-~----------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 217 MLCGHAPFEAENEDDL--FEAI---LND-E----------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHSSCSSCCSSHHHH--HHHH---HHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHhCCCCCCCCCHHHH--HHHH---HcC-C----------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 9999999875443211 1111 000 0 01122245688999999999999999998 77765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=292.02 Aligned_cols=221 Identities=28% Similarity=0.382 Sum_probs=178.2
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecC-eEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHG-EKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRV 71 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~ 71 (289)
...+.+.+|+++++++ +||||+++++++.+.+ ..++||||+++|+|.+++..... ...+++..+.
T Consensus 72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T 2xir_A 72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151 (316)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence 3567899999999999 7999999999988754 58999999999999999965332 1238899999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++
T Consensus 152 ~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (316)
T 2xir_A 152 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 228 (316)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence 99999999999999988 999999999999999999999999999876544333334455678899999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++||||||+++|+|++ |..||.......... .. ..... ........+..+.+++.+||+.||++
T Consensus 229 ~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~ 294 (316)
T 2xir_A 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-RR----LKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQ 294 (316)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH-HH----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred chhHHHHHHHHHHHHHhCCCCCCcccchhHHHH-HH----hccCc---------cCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 99999999999999998 999886554332211 11 10000 01112223467899999999999999
Q ss_pred CCCHHHHHHHhhcc
Q 038647 231 RPTMLEVISMLTNE 244 (289)
Q Consensus 231 Rps~~~ll~~L~~~ 244 (289)
|||+.++++.|+..
T Consensus 295 Rps~~ell~~L~~~ 308 (316)
T 2xir_A 295 RPTFSELVEHLGNL 308 (316)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=299.44 Aligned_cols=220 Identities=27% Similarity=0.385 Sum_probs=167.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEe-ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....++|.+|+.+|++++||||+++++++. .++..++||||+++|+|.+++.. ....+++..+..++.||+.||.||
T Consensus 131 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~L 208 (373)
T 3c1x_A 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL 208 (373)
T ss_dssp SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999865 45688999999999999999964 334688899999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc--ccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS--NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
|+++ |+||||||+|||++.++.+||+|||+++......... ......+++.|+|||++.+..++.++||||||++
T Consensus 209 H~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~i 285 (373)
T 3c1x_A 209 ASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 285 (373)
T ss_dssp HHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHH
Confidence 9988 9999999999999999999999999998664332111 1233457789999999999999999999999999
Q ss_pred HHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 163 VLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 163 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
+|+|++ |.+||.......... ... ... ....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 286 l~ellt~~~~p~~~~~~~~~~~--~~~----~~~---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 286 LWELMTRGAPPYPDVNTFDITV--YLL----QGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp HHHHHTTSCCSCTTSCSSCHHH--HHH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCcCCCCCCCCHHHHHH--HHH----cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999 566665443322111 100 000 0011222456889999999999999999999999999
Q ss_pred hccc
Q 038647 242 TNEN 245 (289)
Q Consensus 242 ~~~~ 245 (289)
+...
T Consensus 351 ~~i~ 354 (373)
T 3c1x_A 351 SAIF 354 (373)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=295.61 Aligned_cols=206 Identities=19% Similarity=0.242 Sum_probs=173.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|+.++||||+++++++.+++.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 83 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (350)
T 1rdq_E 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457789999999999999999999999999999999999999999999984 33568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 160 ~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 231 (350)
T 1rdq_E 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp TT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CC---cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHH
Confidence 88 999999999999999999999999999876432 2345799999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
++|..||...+... ..... .. .. ...+...+..+.+++.+||+.||++||+ ++++++
T Consensus 232 l~g~~Pf~~~~~~~--~~~~i---~~-~~----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 232 AAGYPPFFADQPIQ--IYEKI---VS-GK----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHSSCSSCCSSHHH--HHHHH---HH-CC----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred hhCCCCCCCCCHHH--HHHHH---Hc-CC----------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 99999986543221 11110 00 00 0112234568899999999999999998 888875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=297.13 Aligned_cols=216 Identities=19% Similarity=0.270 Sum_probs=170.9
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+..+.+.+|..+|.++ +||||+++++++.+++.+|+||||+++|+|..++. ..+.+++..+..++.||+.||.||
T Consensus 93 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~L 169 (396)
T 4dc2_A 93 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYL 169 (396)
T ss_dssp ---CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566789999999987 89999999999999999999999999999999884 345799999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|
T Consensus 170 H~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvlly 244 (396)
T 4dc2_A 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244 (396)
T ss_dssp HHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHH
Confidence 9988 999999999999999999999999999863222 12344568999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhH---hHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH------H
Q 038647 165 ETLSSKKNAHFYNTDSLTL---LGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM------L 235 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~ 235 (289)
+|++|+.||.......... ........... ....+...+..+.+++.+||+.||++||++ .
T Consensus 245 ell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 314 (396)
T 4dc2_A 245 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA 314 (396)
T ss_dssp HHHHSSCSSTTTTC------CCHHHHHHHHHHC----------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHH
T ss_pred HHHhCCCCCcccccccccchhhHHHHHHHHhcc----------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHH
Confidence 9999999996543221100 00000000000 011222345788999999999999999985 5
Q ss_pred HHHH
Q 038647 236 EVIS 239 (289)
Q Consensus 236 ~ll~ 239 (289)
|+++
T Consensus 315 ei~~ 318 (396)
T 4dc2_A 315 DIQG 318 (396)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 6654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=287.92 Aligned_cols=220 Identities=27% Similarity=0.369 Sum_probs=173.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeE-eecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCC-IEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....++|.+|+.++++++||||+++++++ ..++..++||||+++|+|.+++.. ....+++..+..++.|++.||.||
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~l 144 (298)
T 3f66_A 67 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYL 144 (298)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999985 456688999999999999999964 345688999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--cccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
|+++ ++||||||+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||++
T Consensus 145 H~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 221 (298)
T 3f66_A 145 ASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221 (298)
T ss_dssp HHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHH
Confidence 9988 999999999999999999999999999876443211 12233457789999999999999999999999999
Q ss_pred HHHHHhC-CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 163 VLETLSS-KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 163 l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
+|+|++| .+|+.......... ... ... ....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 222 l~~l~~~~~~~~~~~~~~~~~~--~~~----~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 222 LWELMTRGAPPYPDVNTFDITV--YLL----QGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp HHHHHTTSCCSSTTSCTTTHHH--HHH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCCCCccCCHHHHHH--HHh----cCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999995 45544333222111 100 000 0111122346789999999999999999999999999
Q ss_pred hccc
Q 038647 242 TNEN 245 (289)
Q Consensus 242 ~~~~ 245 (289)
++..
T Consensus 287 ~~~~ 290 (298)
T 3f66_A 287 SAIF 290 (298)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.70 Aligned_cols=212 Identities=23% Similarity=0.388 Sum_probs=175.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+.+.+|+++|+.++||||+++++++.+.+..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 58 ~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~ 134 (476)
T 2y94_A 58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHR 134 (476)
T ss_dssp TTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346789999999999999999999999999999999999999999999994 45679999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~e 165 (289)
++ |+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..+ +.++|||||||++|+
T Consensus 135 ~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 208 (476)
T 2y94_A 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208 (476)
T ss_dssp TT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHH
T ss_pred CC---CCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHH
Confidence 88 9999999999999999999999999998765432 2334579999999999998765 789999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--Hhhc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--MLTN 243 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~L~~ 243 (289)
|++|..||........ ... ..... . ..+...+..+.+++.+||+.||++|||+.++++ ++..
T Consensus 209 lltG~~Pf~~~~~~~~--~~~----i~~~~--------~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 209 LLCGTLPFDDDHVPTL--FKK----ICDGI--------F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHSSCSSCCSSSHHH--HHH----HHTTC--------C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HhhCCCCCCCCCHHHH--HHH----HhcCC--------c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 9999999875433211 111 00000 0 111223467899999999999999999999997 5554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=289.31 Aligned_cols=214 Identities=22% Similarity=0.329 Sum_probs=172.5
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.....+.|.+|++++++++||||+++++++.+++..++||||+++|+|.+++.. ....+++..+..++.||+.||.||
T Consensus 52 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~L 129 (289)
T 4fvq_A 52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL 129 (289)
T ss_dssp GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999999954 233489999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCc--------eEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCccc
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMN--------PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSD 155 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~--------vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~D 155 (289)
|+++ |+||||||+|||++.++. +||+|||++..... .....|++.|+|||++.+ ..++.++|
T Consensus 130 H~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~D 200 (289)
T 4fvq_A 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATD 200 (289)
T ss_dssp HHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHH
T ss_pred hhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhH
Confidence 9988 999999999999998887 99999999875432 223457889999999987 67999999
Q ss_pred chhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 156 VFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
|||||+++|+|++|..|+.......... .. .... ...+...+..+.+++.+||+.||++|||+.
T Consensus 201 iwslG~il~el~~g~~~~~~~~~~~~~~-~~----~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 264 (289)
T 4fvq_A 201 KWSFGTTLWEICSGGDKPLSALDSQRKL-QF----YEDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFR 264 (289)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHH-HH----HHTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHcCCCCCccccchHHHH-HH----hhcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 9999999999999665443222211111 00 0000 011111234688999999999999999999
Q ss_pred HHHHHhhccc
Q 038647 236 EVISMLTNEN 245 (289)
Q Consensus 236 ~ll~~L~~~~ 245 (289)
++++.|+...
T Consensus 265 ~ll~~l~~l~ 274 (289)
T 4fvq_A 265 AIIRDLNSLF 274 (289)
T ss_dssp HHHHHHHTCC
T ss_pred HHHHHHHHhc
Confidence 9999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=295.44 Aligned_cols=212 Identities=22% Similarity=0.250 Sum_probs=172.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+++|++++||||+++++++.+++..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++
T Consensus 91 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~ 168 (387)
T 1kob_A 91 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH 168 (387)
T ss_dssp HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456789999999999999999999999999999999999999999998853 234689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCC--CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDS--NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~--~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+ |+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+
T Consensus 169 g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 242 (387)
T 1kob_A 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242 (387)
T ss_dssp T---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHH
T ss_pred C---eeecccchHHeEEecCCCCceEEEecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHH
Confidence 8 999999999999974 5779999999998765432 1233478999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||....... ....... ... ..........+..+.+++.+||+.||++|||+.++++
T Consensus 243 lltg~~Pf~~~~~~~--~~~~i~~----~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 243 LLSGLSPFAGEDDLE--TLQNVKR----CDW------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHSCCSSCCSSHHH--HHHHHHH----CCC------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCCCCCHHH--HHHHHHh----CCC------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 999999987543221 1111100 000 0011111234578899999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=285.96 Aligned_cols=219 Identities=26% Similarity=0.375 Sum_probs=178.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+++.+|++++++++||||+++++++ +.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||
T Consensus 51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH 127 (287)
T 1u59_A 51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE 127 (287)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHH
Confidence 44678899999999999999999999999 55679999999999999999853 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ ++||||||+||+++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|
T Consensus 128 ~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 204 (287)
T 1u59_A 128 EKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 204 (287)
T ss_dssp HTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 988 999999999999999999999999999876533221 1223345688999999999889999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+|++ |..||........ ... ..... ....+...+..+.+++..||+.||++|||+.++++.|+.
T Consensus 205 ellt~g~~p~~~~~~~~~--~~~----i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 205 EALSYGQKPYKKMKGPEV--MAF----IEQGK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp HHHTTSCCTTTTCCTHHH--HHH----HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCCCCCcccCCHHHH--HHH----HhcCC---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9998 9999865443221 111 11110 111223445789999999999999999999999999987
Q ss_pred cc
Q 038647 244 EN 245 (289)
Q Consensus 244 ~~ 245 (289)
..
T Consensus 270 ~~ 271 (287)
T 1u59_A 270 CY 271 (287)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=283.66 Aligned_cols=224 Identities=13% Similarity=0.113 Sum_probs=178.3
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+++++.+ +|+|++++++++.++...++||||+ +++|.+++... ...+++..+..++.||+.||.|||+
T Consensus 48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~ 124 (298)
T 1csn_A 48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE 124 (298)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456789999999999 7999999999999999999999999 99999998532 3458999999999999999999998
Q ss_pred CCCCceEeeccccCceEeCCCCc-----eEEcccccccccCCCCcc-----cccccccccccccChhhhhcCCCCCcccc
Q 038647 87 YSRLRVIHRDLKASNILLDSNMN-----PKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~-----vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
++ |+||||||+||+++.++. +||+|||+++........ .......||+.|+|||++.+..++.++||
T Consensus 125 ~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 201 (298)
T 1csn_A 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDL 201 (298)
T ss_dssp TT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred CC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHH
Confidence 88 999999999999987766 999999999876543221 12345579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcch-hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSL-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
||||+++|+|++|+.||........ ................. .....+..+.+++..||+.||++|||+.
T Consensus 202 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~ 272 (298)
T 1csn_A 202 EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYD 272 (298)
T ss_dssp HHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHH
Confidence 9999999999999999876543321 11111110000000000 0112346889999999999999999999
Q ss_pred HHHHHhhcccC
Q 038647 236 EVISMLTNENV 246 (289)
Q Consensus 236 ~ll~~L~~~~~ 246 (289)
+|++.|++...
T Consensus 273 ~l~~~l~~~~~ 283 (298)
T 1csn_A 273 YLQGLFSKVLE 283 (298)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=285.25 Aligned_cols=223 Identities=21% Similarity=0.262 Sum_probs=168.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++++.+++..++||||+++ +|.+++.. ..+.+++..+..++.|++.||.|||+
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (288)
T 1ob3_A 42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD 118 (288)
T ss_dssp CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999999999999999999975 88888753 23568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
++ |+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 119 ~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 193 (288)
T 1ob3_A 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193 (288)
T ss_dssp TT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHH
T ss_pred CC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHH
Confidence 88 9999999999999999999999999998764321 122334689999999999764 58999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCC---ccc-----ccc-------ccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGR---AWE-----LMD-------SILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~-------~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
|++|..||........ ............ ... ..+ ...........+..+.+++.+||+.||++
T Consensus 194 l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 271 (288)
T 1ob3_A 194 MVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271 (288)
T ss_dssp HHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTT
T ss_pred HHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCccc
Confidence 9999999875443221 111111110000 000 000 00000111224568889999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||+.|+++
T Consensus 272 Rpt~~e~l~ 280 (288)
T 1ob3_A 272 RITAKQALE 280 (288)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=299.56 Aligned_cols=215 Identities=19% Similarity=0.202 Sum_probs=172.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+|..++||||++++++|.+++.+|+||||+++|+|.+++.+ ..+.+++..+..++.||+.||.|||++
T Consensus 117 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~ 194 (437)
T 4aw2_A 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQL 194 (437)
T ss_dssp TTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345589999999999999999999999999999999999999999999964 245699999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~v 162 (289)
+ |+||||||+|||++.++.+||+|||+++........ .....+||+.|+|||++. +..++.++|||||||+
T Consensus 195 g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvi 270 (437)
T 4aw2_A 195 H---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270 (437)
T ss_dssp T---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHH
T ss_pred C---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHH
Confidence 8 999999999999999999999999999876443221 233457999999999997 4568999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC--CCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD--RPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~ 239 (289)
+|||++|+.||...+..... ......... ..........+..+.++|.+||..+|++ ||+++|+++
T Consensus 271 l~elltG~~Pf~~~~~~~~~--~~i~~~~~~---------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 271 MYEMLYGETPFYAESLVETY--GKIMNHKER---------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHHSSCTTCCSSHHHHH--HHHHTHHHH---------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHHHHhCCCCCCCCChhHHH--Hhhhhcccc---------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 99999999998754432211 111000000 0000111124568899999999988888 999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=282.26 Aligned_cols=214 Identities=24% Similarity=0.318 Sum_probs=174.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++. ....+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~ 123 (276)
T 2yex_A 47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 123 (276)
T ss_dssp THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346789999999999999999999999999999999999999999999984 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~e 165 (289)
++ ++||||||+||+++.++.+||+|||++................|++.|+|||++.+..+ +.++||||||+++|+
T Consensus 124 ~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 200 (276)
T 2yex_A 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200 (276)
T ss_dssp TT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHH
T ss_pred CC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHH
Confidence 88 99999999999999999999999999986543322223345578999999999987665 789999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||............+ ..... ........+..+.+++.+||+.||++|||+.++++
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 201 MLAGELPWDQPSDSCQEYSDW-----KEKKT--------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHSSCCCSCSCTTSHHHHHH-----HTTCT--------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhCCCCCCCCchHHHHHHHh-----hhccc--------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 999999987655433222111 11000 00111234568889999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=286.64 Aligned_cols=225 Identities=22% Similarity=0.342 Sum_probs=171.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC---CCCCCCChHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP---TKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
...+.+.+|+++|++++||||+++++++.+++..++||||++ |+|.+++... .....+++..+..++.||+.||.|
T Consensus 45 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~ 123 (317)
T 2pmi_A 45 GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123 (317)
T ss_dssp CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999999999999999999997 5888877432 122458899999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~v 162 (289)
||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 124 lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 198 (317)
T 2pmi_A 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCI 198 (317)
T ss_dssp HHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred HHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHH
Confidence 99988 9999999999999999999999999998764322 12334578999999999986 468999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhcc--CCcccc------------------ccccccCCCCHHHHHHHHHHHHc
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWND--GRAWEL------------------MDSILQNDASYPMLNRYINVALL 222 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~ 222 (289)
+|+|++|..||......... ......... ...... +............+..+.+++.+
T Consensus 199 l~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 276 (317)
T 2pmi_A 199 LAEMITGKPLFPGTNDEEQL--KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG 276 (317)
T ss_dssp HHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCChHHHH--HHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHH
Confidence 99999999998765433211 111110000 000000 00000000111234688999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.||++|||+.|+++
T Consensus 277 ~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 277 LLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HSCSSGGGSCCHHHHTT
T ss_pred HCCCCcccCCCHHHHhC
Confidence 99999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.77 Aligned_cols=212 Identities=18% Similarity=0.251 Sum_probs=158.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|++++||||+++++++.+++..++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||++
T Consensus 91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~ 167 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHEN 167 (349)
T ss_dssp --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999999999999999999999999884 445689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+ |+||||||+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 168 ~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 241 (349)
T 2w4o_A 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITY 241 (349)
T ss_dssp T---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred C---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHH
Confidence 8 999999999999975 8899999999998654322 223457899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||............. . .... ..........+..+.+++.+||+.||++|||+.++++
T Consensus 242 ell~g~~pf~~~~~~~~~~~~i----~-~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 242 ILLCGFEPFYDERGDQFMFRRI----L-NCEY------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHSSCTTCCTTCHHHHHHHH----H-TTCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCcccHHHHHHH----H-hCCC------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999986544332111110 0 0000 0001111234568899999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=289.95 Aligned_cols=219 Identities=26% Similarity=0.380 Sum_probs=174.5
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMRV 71 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~ 71 (289)
....+++.+|+++|+++ +||||+++++++.+++..++||||+++|+|.+++.... ....+++..++
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (327)
T 1fvr_A 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145 (327)
T ss_dssp ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence 45667899999999999 89999999999999999999999999999999996532 23478999999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... .......+++.|+|||++.+..++
T Consensus 146 ~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~ 219 (327)
T 1fvr_A 146 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT 219 (327)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC
Confidence 99999999999999988 999999999999999999999999998743221 112233567899999999998999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++||||||+++|+|++ |..||........ . ...... .........+..+.+++.+||+.||++
T Consensus 220 ~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~ 284 (327)
T 1fvr_A 220 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--Y----EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYE 284 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H----HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGG
T ss_pred chhcchHHHHHHHHHHcCCCCCCCCCcHHHH--H----HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999999999998 9998865432211 1 111111 011122234578999999999999999
Q ss_pred CCCHHHHHHHhhccc
Q 038647 231 RPTMLEVISMLTNEN 245 (289)
Q Consensus 231 Rps~~~ll~~L~~~~ 245 (289)
|||+.++++.|....
T Consensus 285 Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 285 RPSFAQILVSLNRML 299 (327)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999988754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=295.16 Aligned_cols=213 Identities=23% Similarity=0.307 Sum_probs=173.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.|.+|+++|++++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+
T Consensus 128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~ 205 (373)
T 2x4f_A 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQ 205 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999888753 23468899999999999999999999
Q ss_pred CCCCceEeeccccCceEe--CCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILL--DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill--~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
++ |+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 206 ~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 279 (373)
T 2x4f_A 206 MY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279 (373)
T ss_dssp TT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHH
T ss_pred CC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHH
Confidence 88 9999999999999 6778899999999987654322 23346899999999999989999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||........ .... ..... . .........+..+.+++.+||+.||++|||+.|+++
T Consensus 280 elltg~~pf~~~~~~~~--~~~i---~~~~~--~-----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 280 MLLSGLSPFLGDNDAET--LNNI---LACRW--D-----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHSSCTTCCSSHHHH--HHHH---HHTCC--C-----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCHHHH--HHHH---HhccC--C-----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999875443211 1111 00000 0 000011123568899999999999999999999997
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=283.03 Aligned_cols=217 Identities=29% Similarity=0.435 Sum_probs=176.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ..+.+++..+..++.|++.||.|||++
T Consensus 46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~ 123 (267)
T 3t9t_A 46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA 123 (267)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999999999999999999999999999999999999853 235688999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 124 ~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 199 (267)
T 3t9t_A 124 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199 (267)
T ss_dssp T---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHh
Confidence 8 99999999999999999999999999987643221 1122345678899999999999999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
+ |..||....... .... ..... ....+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 200 ~~g~~p~~~~~~~~--~~~~----i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 200 SEGKIPYENRSNSE--VVED----ISTGF---------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp TTSCCTTTTCCHHH--HHHH----HHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCHHH--HHHH----HhcCC---------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9 888876433221 1111 11100 01112223568899999999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=287.66 Aligned_cols=216 Identities=26% Similarity=0.353 Sum_probs=174.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+++++.++||||+++++++ +.+..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+
T Consensus 60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~ 135 (291)
T 1xbb_A 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE 135 (291)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3468899999999999999999999999 66788999999999999999953 4568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++ ++||||||+||+++.++.+||+|||++......... .......+++.|+|||++.+..++.++||||||+++|+
T Consensus 136 ~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 212 (291)
T 1xbb_A 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212 (291)
T ss_dssp TT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred CC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHH
Confidence 88 999999999999999999999999999876543221 11222346788999999998889999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |..||........ ... ..... ....+...+..+.+++..||+.||++|||+.++++.|++.
T Consensus 213 l~~~g~~p~~~~~~~~~--~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 213 AFSYGQKPYRGMKGSEV--TAM----LEKGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHTTTCCSSTTCCHHHH--HHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCHHHH--HHH----HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999 9998865433211 111 11111 1112233457899999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=291.23 Aligned_cols=220 Identities=29% Similarity=0.445 Sum_probs=171.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.. ..+.+++..+..++.||+.||.|||
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH 164 (333)
T 1mqb_A 87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA 164 (333)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999853 2356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|
T Consensus 165 ~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 241 (333)
T 1mqb_A 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241 (333)
T ss_dssp HTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred hCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHH
Confidence 988 999999999999999999999999999876433211 1122234577899999999999999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+|++ |..||....... .... ..... ........+..+.+++.+||+.||++||++.++++.|+.
T Consensus 242 ellt~g~~pf~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 242 EVMTYGERPYWELSNHE--VMKA----INDGF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp HHHTTSCCTTTTCCHHH--HHHH----HHTTC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHcCCCCCcccCCHHH--HHHH----HHCCC---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9999 999876443221 1111 11110 011122345688999999999999999999999999987
Q ss_pred cc
Q 038647 244 EN 245 (289)
Q Consensus 244 ~~ 245 (289)
..
T Consensus 307 ~~ 308 (333)
T 1mqb_A 307 LI 308 (333)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=310.96 Aligned_cols=218 Identities=26% Similarity=0.370 Sum_probs=174.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++|.+|+++|++++|||||++++++.+ +..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||
T Consensus 377 ~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH 453 (613)
T 2ozo_A 377 KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE 453 (613)
T ss_dssp STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4568899999999999999999999999976 569999999999999999853 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+|||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|
T Consensus 454 ~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 454 EKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp HTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHH
Confidence 988 999999999999999999999999999876433211 1122234568899999999999999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
||++ |..||........ ... ...+. ....+...+..+.+++..||+.||++||++.+|++.|+.
T Consensus 531 ellt~G~~Pf~~~~~~~~--~~~----i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEV--MAF----IEQGK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp HHHTTSCCTTTTCCSHHH--HHH----HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHH--HHH----HHcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9998 9999876543321 111 11111 112223355789999999999999999999999999987
Q ss_pred c
Q 038647 244 E 244 (289)
Q Consensus 244 ~ 244 (289)
.
T Consensus 596 ~ 596 (613)
T 2ozo_A 596 C 596 (613)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=292.61 Aligned_cols=216 Identities=19% Similarity=0.273 Sum_probs=171.9
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+..+.+.+|+.+++++ +||||+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.||+.||.||
T Consensus 50 ~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~L 126 (345)
T 3a8x_A 50 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYL 126 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999998 89999999999999999999999999999999884 345689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 127 H~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 201 (345)
T 3a8x_A 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201 (345)
T ss_dssp HHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHH
Confidence 9988 9999999999999999999999999998643221 2234568999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchh---HhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH------H
Q 038647 165 ETLSSKKNAHFYNTDSLT---LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM------L 235 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~ 235 (289)
+|++|..||...+..... ............. ...+...+..+.+++.+||+.||++||++ .
T Consensus 202 ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 271 (345)
T 3a8x_A 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271 (345)
T ss_dssp HHHHSSCTTTTTTC-------CHHHHHHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHH
T ss_pred HHHhCCCCcCCcccccccccccHHHHHHHHHcCC----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHH
Confidence 999999998653322110 0000000000000 01122345688999999999999999995 5
Q ss_pred HHHH
Q 038647 236 EVIS 239 (289)
Q Consensus 236 ~ll~ 239 (289)
++++
T Consensus 272 ~i~~ 275 (345)
T 3a8x_A 272 DIQG 275 (345)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 6654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=293.07 Aligned_cols=213 Identities=23% Similarity=0.245 Sum_probs=161.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~ 135 (361)
T 3uc3_A 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSM 135 (361)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34678999999999999999999999999999999999999999999884 345689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCc--eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCc-ccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMN--PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK-SDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~--vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~vl~ 164 (289)
+ |+||||||+||+++.++. +||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|
T Consensus 136 ~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 209 (361)
T 3uc3_A 136 Q---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLY 209 (361)
T ss_dssp T---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHH
T ss_pred C---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHH
Confidence 8 999999999999987765 999999999753322 12334579999999999998887655 89999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|+.||.......... ......... ...-......+..+.+++.+||+.||++|||+.|+++
T Consensus 210 ell~g~~Pf~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 210 VMLVGAYPFEDPEEPRDYR-KTIQRILSV---------KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHSSCSCC----CCCHH-HHHHHHHTT---------CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhCCCCCCCCccHHHHH-HHHHHHhcC---------CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 9999999987644332111 000111000 0000111123468899999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=294.70 Aligned_cols=208 Identities=22% Similarity=0.275 Sum_probs=172.0
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|..+|+.+ +||||+++++++.+.+.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 59 ~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH 135 (345)
T 1xjd_A 59 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLH 135 (345)
T ss_dssp TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999987 89999999999999999999999999999999984 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 136 ~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (345)
T 1xjd_A 136 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210 (345)
T ss_dssp HTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHH
Confidence 988 9999999999999999999999999998643222 22445689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH-HHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML-EVI 238 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~ll 238 (289)
|++|..||...+... ..... ... . ...+...+..+.+++.+||+.||++||++. +++
T Consensus 211 ll~g~~Pf~~~~~~~--~~~~i---~~~-~----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 211 MLIGQSPFHGQDEEE--LFHSI---RMD-N----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHSSCSSCCSSHHH--HHHHH---HHC-C----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HhcCCCCCCCCCHHH--HHHHH---HhC-C----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 999999986543221 11111 000 0 011222456889999999999999999997 665
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=284.20 Aligned_cols=216 Identities=24% Similarity=0.352 Sum_probs=172.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+.++++++||||+++++++.++ ..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 55 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~ 131 (281)
T 3cc6_A 55 DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLES 131 (281)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999998754 56899999999999999853 23458899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|
T Consensus 132 ~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 207 (281)
T 3cc6_A 132 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 207 (281)
T ss_dssp TT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHH
Confidence 88 999999999999999999999999999876443221 12334567899999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++ |..||......... .... ... ........+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 208 lt~g~~p~~~~~~~~~~--~~~~----~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 208 LSFGKQPFFWLENKDVI--GVLE----KGD---------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HTTTCCTTTTSCGGGHH--HHHH----HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCcccCChHHHH--HHHh----cCC---------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 98 99998654333211 1100 000 0111222346789999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=294.13 Aligned_cols=220 Identities=19% Similarity=0.197 Sum_probs=153.7
Q ss_pred ccCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
......+.+|+.+++.+. ||||+++++++.+++..|+||||+++|+|.+++.. .+.+++..+..++.||+.||.||
T Consensus 46 ~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~L 122 (325)
T 3kn6_A 46 KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHM 122 (325)
T ss_dssp GGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999997 99999999999999999999999999999999843 45799999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCC---ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNM---NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|+++ |+||||||+||+++.++ .+||+|||+++...... .......||+.|+|||++.+..++.++||||||+
T Consensus 123 H~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 197 (325)
T 3kn6_A 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197 (325)
T ss_dssp HHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHH
T ss_pred HHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHH
Confidence 9988 99999999999997665 79999999998654332 1233456899999999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchh-HhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLT-LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..||......... ............... .........+..+.+++..||+.||++|||+.++++
T Consensus 198 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 198 ILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 999999999998764432110 000011111111000 000000124578899999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=289.59 Aligned_cols=209 Identities=24% Similarity=0.282 Sum_probs=163.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+|+.++||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 63 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~ 139 (327)
T 3a62_A 63 KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQ 139 (327)
T ss_dssp --------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 355678899999999999999999999999999999999999999999884 34568899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 140 ~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (327)
T 3a62_A 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214 (327)
T ss_dssp TT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred CC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHH
Confidence 88 9999999999999999999999999987643221 123345789999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
++|..||........ .... ... ....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 215 ~~g~~pf~~~~~~~~--~~~i---~~~-----------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 215 LTGAPPFTGENRKKT--IDKI---LKC-----------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHSSCSCCCSSHHHH--HHHH---HHT-----------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHCCCCCCCCCHHHH--HHHH---HhC-----------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 999999875432211 1111 000 0011223457889999999999999999 7888876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.26 Aligned_cols=229 Identities=20% Similarity=0.307 Sum_probs=172.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ....+++..++.++.|++.||.||
T Consensus 73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (310)
T 2wqm_A 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152 (310)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999999885321 245689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ ++||||||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|
T Consensus 153 H~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 227 (310)
T 2wqm_A 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227 (310)
T ss_dssp HHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred hhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHH
Confidence 9988 99999999999999999999999999886543321 123356899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+|++|..||.............. ..... ........+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 228 ~l~~g~~p~~~~~~~~~~~~~~~----~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 228 EMAALQSPFYGDKMNLYSLCKKI----EQCDY--------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp HHHHSSCTTC---CCHHHHHHHH----HTTCS--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCCCcccchhHHHHHHHh----hcccC--------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 99999999865433322211111 11100 0011123456889999999999999999999999999987
Q ss_pred cCCCCCC
Q 038647 245 NVILPSP 251 (289)
Q Consensus 245 ~~~~~~~ 251 (289)
.+....|
T Consensus 296 ~~~~~~~ 302 (310)
T 2wqm_A 296 HACTASS 302 (310)
T ss_dssp HHHHC--
T ss_pred HHhhhhh
Confidence 6544443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=290.80 Aligned_cols=219 Identities=21% Similarity=0.228 Sum_probs=167.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-------------------------
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT------------------------- 60 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------- 60 (289)
....+.+.+|+++|++++||||+++++++.+++..++||||+++|+|.+++....
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (345)
T 3hko_A 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148 (345)
T ss_dssp -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence 4567889999999999999999999999999999999999999999999884210
Q ss_pred ------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCC--ceEEcccccccccCCCC-
Q 038647 61 ------------KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM--NPKISDFGIARLFGGDE- 125 (289)
Q Consensus 61 ------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~--~vkl~Dfg~~~~~~~~~- 125 (289)
....+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||+++......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~ 225 (345)
T 3hko_A 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225 (345)
T ss_dssp HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC
T ss_pred ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCc
Confidence 0123457778899999999999999988 99999999999998776 89999999998653221
Q ss_pred -cccccccccccccccChhhhhc--CCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccc
Q 038647 126 -LQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDS 202 (289)
Q Consensus 126 -~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (289)
.........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ........
T Consensus 226 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----~~~~~~~~------ 294 (345)
T 3hko_A 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS-----QVLNKKLC------ 294 (345)
T ss_dssp C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHCCCC------
T ss_pred cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH-----HHHhcccc------
Confidence 1112344578999999999975 678999999999999999999999986544322111 11111000
Q ss_pred cccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 203 ILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 203 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.........+..+.+++..||+.||++|||+.++++
T Consensus 295 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 295 -FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp -TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred -cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000011124568899999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=292.30 Aligned_cols=214 Identities=23% Similarity=0.311 Sum_probs=164.4
Q ss_pred cccCHHHHHHHHHHHhhCCC--CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQH--RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+..+.|.+|+.+|++++| |||+++++++.+++..|+||| +.+++|.+++. ..+.+++..+..++.||+.||.
T Consensus 47 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~ 122 (343)
T 3dbq_A 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVH 122 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHH
Confidence 34556889999999999976 999999999999999999999 55889999985 3457899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----------CCCC
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----------GLFS 151 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~ 151 (289)
|||+++ |+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+ ..++
T Consensus 123 ~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 198 (343)
T 3dbq_A 123 TIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 198 (343)
T ss_dssp HHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CC
T ss_pred HHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCC
Confidence 999988 99999999999996 67899999999987654433333445679999999999975 6789
Q ss_pred CcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 152 IKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 152 ~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
.++|||||||++|+|++|+.||........... ..... ......+...+..+.+++..||+.||++|
T Consensus 199 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~l~~li~~~L~~dp~~R 265 (343)
T 3dbq_A 199 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----AIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQR 265 (343)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTS
T ss_pred chhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH----HHhcC---------CcccCCcccCCHHHHHHHHHHcCCChhHC
Confidence 999999999999999999999864332211111 11111 11111111223578899999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
||+.++++
T Consensus 266 pt~~e~l~ 273 (343)
T 3dbq_A 266 ISIPELLA 273 (343)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHHh
Confidence 99999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=280.73 Aligned_cols=212 Identities=24% Similarity=0.479 Sum_probs=171.3
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
+.|.+|++++++++||||+++++++.+.. ++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~- 142 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN- 142 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 78999999999999999999999997665 699999999999888754 3456899999999999999999999764
Q ss_pred CceEeeccccCceEeCCCCc-----eEEcccccccccCCCCcccccccccccccccChhhhh--cCCCCCcccchhHHHH
Q 038647 90 LRVIHRDLKASNILLDSNMN-----PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL--RGLFSIKSDVFSFGVL 162 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~-----vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~v 162 (289)
.+++||||||+||+++.++. +||+|||+++.... ......|++.|+|||++. ...++.++||||||++
T Consensus 143 ~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217 (287)
T ss_dssp SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHH
T ss_pred CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHH
Confidence 23999999999999988776 99999999975432 233457899999999994 4567899999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
+|+|++|..||................ ...........+..+.+++..||+.||++|||+.++++.|+
T Consensus 218 l~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 218 LYTILTGEGPFDEYSYGKIKFINMIRE------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp HHHHHHSSCTTTTCCCCHHHHHHHHHH------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCCCCccccccHHHHHHHHhc------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 999999999987655443322221111 01111122334578999999999999999999999999997
Q ss_pred c
Q 038647 243 N 243 (289)
Q Consensus 243 ~ 243 (289)
+
T Consensus 286 ~ 286 (287)
T 4f0f_A 286 E 286 (287)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=290.30 Aligned_cols=223 Identities=26% Similarity=0.379 Sum_probs=176.8
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC----CCCCChHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK----TGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~ 80 (289)
.....+++.+|+.++++++||||+++++++.+++..|+||||+++++|.+++..... ...+++..++.++.|++.|
T Consensus 73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a 152 (327)
T 2yfx_A 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152 (327)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999999999999999999865321 2458899999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccch
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVF 157 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 157 (289)
|.|||+++ |+||||||+||+++. +..+||+|||+++...............+++.|+|||++.+..++.++|||
T Consensus 153 l~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 229 (327)
T 2yfx_A 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229 (327)
T ss_dssp HHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHH
Confidence 99999988 999999999999984 446999999999865444333334445678999999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
|||+++|+|++ |..||....... .... ..... ........+..+.+++..||+.||++|||+.+
T Consensus 230 slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 294 (327)
T 2yfx_A 230 SFGVLLWEIFSLGYMPYPSKSNQE--VLEF----VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294 (327)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHH--HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHcCCCCCCCCcCHHH--HHHH----HhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 99999999998 888876543221 1111 11110 01112234568899999999999999999999
Q ss_pred HHHHhhccc
Q 038647 237 VISMLTNEN 245 (289)
Q Consensus 237 ll~~L~~~~ 245 (289)
+++.|....
T Consensus 295 ll~~l~~~~ 303 (327)
T 2yfx_A 295 ILERIEYCT 303 (327)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999988653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.45 Aligned_cols=224 Identities=14% Similarity=0.143 Sum_probs=171.9
Q ss_pred HHHHHHHHhhCCCCCceeeeeeEeec----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 12 FKNEMMLIAKLQHRNLVRLFGCCIEH----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 12 ~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
+..|+..++.++||||+++++++.+. ...|+||||+ +++|.+++.. ..+.+++..+..++.||+.||.|||++
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~ 171 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH 171 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566677788899999999999875 4589999999 9999999854 235699999999999999999999998
Q ss_pred CCCceEeeccccCceEeC--CCCceEEcccccccccCCCCcc-----cccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 88 SRLRVIHRDLKASNILLD--SNMNPKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~--~~~~vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
+ |+||||||+|||++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||
T Consensus 172 ~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 248 (364)
T 3op5_A 172 E---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248 (364)
T ss_dssp T---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred C---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHH
Confidence 8 99999999999998 8899999999999876432211 112334599999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
|++|+|++|..||.......... ......+. ......++..... ...+..+.+++..||+.||++||++.+|++.
T Consensus 249 ~~l~el~~g~~Pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 249 YCMIQWLTGHLPWEDNLKDPKYV-RDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHH-HHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHhCCCCccccccCHHHH-HHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 99999999999987543332211 11111111 1111122222111 1224688999999999999999999999999
Q ss_pred hhcccC
Q 038647 241 LTNENV 246 (289)
Q Consensus 241 L~~~~~ 246 (289)
|+....
T Consensus 324 l~~~~~ 329 (364)
T 3op5_A 324 LLQGLK 329 (364)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=290.60 Aligned_cols=201 Identities=18% Similarity=0.313 Sum_probs=169.5
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCC-ChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNK-SLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+++|++++||||+++++++.+.+..++||||+.+| +|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~ 148 (335)
T 3dls_A 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRL 148 (335)
T ss_dssp TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4567889999999999999999999999999999999999776 9999884 34569999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~e 165 (289)
++ |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||||+++|+
T Consensus 149 ~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 222 (335)
T 3dls_A 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222 (335)
T ss_dssp TT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHH
T ss_pred CC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHH
Confidence 88 9999999999999999999999999998765432 2234578999999999998776 889999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||...... ..... ..+...+..+.+++..||+.||++|||+.++++
T Consensus 223 l~~g~~pf~~~~~~--------------------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 223 LVFEENPFCELEET--------------------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp HHHSSCSCSSGGGG--------------------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCchhhHHHH--------------------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999998642110 00000 111123568899999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=284.86 Aligned_cols=211 Identities=22% Similarity=0.286 Sum_probs=172.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|++++||||+++++++.+++..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~ 134 (321)
T 2a2a_A 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK 134 (321)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 478899999999999999999999999999999999999999999999953 45689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCC----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNM----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+ |+||||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++
T Consensus 135 ~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (321)
T ss_dssp T---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred C---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHH
Confidence 8 99999999999999888 79999999998765432 12345689999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||........ ..... .... .. .... ....+..+.+++.+||+.||++|||+.++++
T Consensus 209 ~~l~~g~~pf~~~~~~~~--~~~i~----~~~~-~~-~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQET--LANIT----SVSY-DF-DEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHSCCSSCCSSHHHH--HHHHH----TTCC-CC-CHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHH--HHHHH----hccc-cc-Chhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999999865432211 11100 0000 00 0000 0123467889999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=285.61 Aligned_cols=225 Identities=20% Similarity=0.205 Sum_probs=167.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++++.+++..++||||+++++|..++. ..+.+++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~ 120 (311)
T 4agu_A 44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK 120 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346778899999999999999999999999999999999999999998874 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~e 165 (289)
++ |+||||||+||+++.++.+||+|||++........ ......|++.|+|||++.+ ..++.++||||||+++|+
T Consensus 121 ~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 195 (311)
T 4agu_A 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAE 195 (311)
T ss_dssp TT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHH
T ss_pred CC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHH
Confidence 88 99999999999999999999999999987643321 2234578999999999986 678999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHh-H--------hhhhccCCccccccc-cccCCC-----CHHHHHHHHHHHHcccccCCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLGH-A--------WNLWNDGRAWELMDS-ILQNDA-----SYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~~p~~ 230 (289)
|++|..||............. . ...+........... ...... ....+..+.+++.+||+.||++
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 275 (311)
T 4agu_A 196 LLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTE 275 (311)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhh
Confidence 999999987654332211000 0 000000000000000 000000 0124467889999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||++|+++
T Consensus 276 Rpt~~ell~ 284 (311)
T 4agu_A 276 RLTCEQLLH 284 (311)
T ss_dssp SCCHHHHHT
T ss_pred cCCHHHHhc
Confidence 999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=280.52 Aligned_cols=209 Identities=24% Similarity=0.373 Sum_probs=152.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+++.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ..+.+++..+..++.|++.||.|||++
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~ 131 (278)
T 3cok_A 54 MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSH 131 (278)
T ss_dssp CHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467899999999999999999999999999999999999999999999864 235689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 132 ~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (278)
T 3cok_A 132 G---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206 (278)
T ss_dssp T---EECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHH
T ss_pred C---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHH
Confidence 8 99999999999999999999999999987643221 123356899999999999989999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|..||.......... ..... ....+...+..+.+++.+||+.||++|||+.++++
T Consensus 207 ~g~~p~~~~~~~~~~~--------------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 207 IGRPPFDTDTVKNTLN--------------KVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HSSCSSCCCSCC-------------------CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hCCCCCCChhHHHHHH--------------HHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 9999986543321100 00000 00112224568899999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=280.58 Aligned_cols=210 Identities=21% Similarity=0.276 Sum_probs=174.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++||||+++++++.+++..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++
T Consensus 57 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (284)
T 2vgo_A 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHER 133 (284)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457899999999999999999999999999999999999999999998843 35689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.++|+|||++....... .....|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 134 ~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (284)
T 2vgo_A 134 K---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206 (284)
T ss_dssp T---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred C---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHH
Confidence 8 9999999999999999999999999987654321 23456899999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--Hhhc
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--MLTN 243 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~L~~ 243 (289)
+|..||......... .. ... .. ...+...+..+.+++.+||+.||++|||+.++++ ++..
T Consensus 207 ~g~~pf~~~~~~~~~--~~---~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 207 VGMPPFDSPSHTETH--RR---IVN-VD----------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HSSCTTCCSSHHHHH--HH---HHT-TC----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred HCCCCCCCCCHhHHH--HH---Hhc-cc----------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 999998654322111 00 000 00 0112234568899999999999999999999986 4444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.23 Aligned_cols=209 Identities=23% Similarity=0.289 Sum_probs=172.4
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|..+|..+ +||||+++++++.+.+.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH 138 (353)
T 2i0e_A 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQ 138 (353)
T ss_dssp TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4677889999999998 79999999999999999999999999999999984 3356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 139 ~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (353)
T 2i0e_A 139 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213 (353)
T ss_dssp HTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred HCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHH
Confidence 988 9999999999999999999999999998643221 22445689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
|++|..||...+... ..... ... . ...+...+..+.+++.+||+.||++||+ ++++++
T Consensus 214 ll~G~~Pf~~~~~~~--~~~~i---~~~-~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 214 MLAGQAPFEGEDEDE--LFQSI---MEH-N----------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHSSCSSCCSSHHH--HHHHH---HHC-C----------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHcCCCCCCCCCHHH--HHHHH---HhC-C----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999986543221 11111 100 0 0112234578999999999999999995 577764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=298.51 Aligned_cols=212 Identities=22% Similarity=0.222 Sum_probs=171.8
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++
T Consensus 112 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~ 187 (410)
T 3v8s_A 112 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM 187 (410)
T ss_dssp CCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 445688999999999999999999999999999999999999999998843 3588999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC----CCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL----FSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~vl 163 (289)
+ |+||||||+|||++.++.+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus 188 g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvil 263 (410)
T 3v8s_A 188 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263 (410)
T ss_dssp T---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHH
T ss_pred C---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHH
Confidence 8 99999999999999999999999999987654332 1234568999999999998765 78999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC--CCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD--RPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~ll~ 239 (289)
|+|++|..||...+.... ......... ...-......+..+.++|.+||+.+|.+ ||+++||++
T Consensus 264 yell~G~~Pf~~~~~~~~--~~~i~~~~~----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 264 YEMLVGDTPFYADSLVGT--YSKIMNHKN----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHSSCTTCCSSHHHH--HHHHHTHHH----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHhCCCCCCCCChhhH--HHHHHhccc----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 999999999875433211 111100000 0000111134578899999999999988 999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=313.10 Aligned_cols=216 Identities=25% Similarity=0.347 Sum_probs=172.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++|.+|+++|++++|||||++++++.+ +..++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~ 487 (635)
T 4fl3_A 412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE 487 (635)
T ss_dssp GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456899999999999999999999999964 56889999999999999994 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++ |+||||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++||
T Consensus 488 ~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~e 564 (635)
T 4fl3_A 488 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564 (635)
T ss_dssp TT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHH
Confidence 88 99999999999999999999999999987654321 112233356788999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |+.||........ .. ..... .....+...+..+.+++..||+.||++|||+.+|++.|+..
T Consensus 565 llt~G~~Pf~~~~~~~~--~~----~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 565 AFSYGQKPYRGMKGSEV--TA----MLEKG---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HHTTTCCSSTTCCHHHH--HH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHH--HH----HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 998 9999875443211 11 11111 11112233457899999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=302.52 Aligned_cols=210 Identities=19% Similarity=0.210 Sum_probs=163.7
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.+.+|+++|+.++||||+++++++.+++.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 189 ~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH 265 (446)
T 4ejn_A 189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLH 265 (446)
T ss_dssp ------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 3456778899999999999999999999999999999999999999999884 3457899999999999999999999
Q ss_pred c-CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 H-YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~-~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+ .+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 266 ~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 340 (446)
T 4ejn_A 266 SEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340 (446)
T ss_dssp HHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred hcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHH
Confidence 7 77 9999999999999999999999999998643222 2234467999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
+|++|..||......... ... .... ...+...+..+.+++.+||+.||++|| +++|+++
T Consensus 341 ell~g~~Pf~~~~~~~~~--~~i---~~~~-----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 341 EMMCGRLPFYNQDHEKLF--ELI---LMEE-----------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHSSCSSCCSSHHHHH--HHH---HHCC-----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHhhCCCCCCCCCHHHHH--HHH---HhCC-----------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 999999998654332111 110 0000 011223456889999999999999999 9999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=280.85 Aligned_cols=218 Identities=19% Similarity=0.313 Sum_probs=174.2
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
+....++|.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++... ....+++..+..++.|++.||.
T Consensus 47 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~ 125 (271)
T 3kmu_A 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMA 125 (271)
T ss_dssp CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHH
Confidence 345567899999999999999999999999887 7889999999999999999652 2336899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCC---cccchhH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSI---KSDVFSF 159 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Diwsl 159 (289)
|||+++ ..++||||||+||+++.++.++|.|||+..... .....||+.|+|||++.+..++. ++|||||
T Consensus 126 ~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl 197 (271)
T 3kmu_A 126 FLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197 (271)
T ss_dssp HHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred HHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence 999753 349999999999999999999999888875432 22346789999999998765544 7999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+++|+|++|..||.......... ...... .....+...+..+.+++..||+.||++|||+.++++
T Consensus 198 G~il~el~~g~~p~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 198 AVLLWELVTREVPFADLSNMEIGM-----KVALEG---------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHCSCTTTTSCHHHHHH-----HHHHSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCccccChHHHHH-----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999986543322111 011111 111122234568999999999999999999999999
Q ss_pred Hhhccc
Q 038647 240 MLTNEN 245 (289)
Q Consensus 240 ~L~~~~ 245 (289)
.|+...
T Consensus 264 ~L~~l~ 269 (271)
T 3kmu_A 264 ILEKMQ 269 (271)
T ss_dssp HHHHHC
T ss_pred HHHHhh
Confidence 998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=281.69 Aligned_cols=228 Identities=25% Similarity=0.265 Sum_probs=169.3
Q ss_pred CHHHHHHHHHHHhhC--CCCCceeeeeeEeec----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL--QHRNLVRLFGCCIEH----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
....+.+|.+++..+ +||||+++++++.+. ...++||||+++|+|.+++.. ..+++..++.++.|++.||
T Consensus 72 ~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l 147 (337)
T 3mdy_A 72 EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGL 147 (337)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHH
Confidence 445666777777766 899999999999887 789999999999999999943 3589999999999999999
Q ss_pred HHHhcC--------CCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc--ccccccccccccChhhhhcCCCC
Q 038647 82 LYLHHY--------SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS--NTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 82 ~~lH~~--------~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.|||++ + |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+...+
T Consensus 148 ~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 224 (337)
T 3mdy_A 148 CHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224 (337)
T ss_dssp HHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCT
T ss_pred HHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCC
Confidence 999987 6 9999999999999999999999999997664332211 12345799999999999887776
Q ss_pred Cc------ccchhHHHHHHHHHhCC----------CCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHH
Q 038647 152 IK------SDVFSFGVLVLETLSSK----------KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNR 215 (289)
Q Consensus 152 ~~------~DiwslG~vl~elltg~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (289)
.. +|||||||++|+|++|. .|+............ .......... .............+..
T Consensus 225 ~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~ 300 (337)
T 3mdy_A 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED-MREIVCIKKL---RPSFPNRWSSDECLRQ 300 (337)
T ss_dssp TCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH-HHHHHTTSCC---CCCCCGGGGGSHHHHH
T ss_pred ccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh-hHHHHhhhcc---CccccccchhhHHHHH
Confidence 65 99999999999999994 444332221111100 0000000000 0000000111256788
Q ss_pred HHHHHHcccccCCCCCCCHHHHHHHhhcccC
Q 038647 216 YINVALLCVQENAADRPTMLEVISMLTNENV 246 (289)
Q Consensus 216 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 246 (289)
+.+++.+||+.||++|||+.+|++.|+....
T Consensus 301 l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 301 MGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=294.81 Aligned_cols=214 Identities=22% Similarity=0.313 Sum_probs=165.3
Q ss_pred cccCHHHHHHHHHHHhhCC--CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQ--HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+..+.|.+|+++|++++ ||||+++++++..++.+|+||| +.+++|.+++.. .+.+++..+..++.||+.||.
T Consensus 94 ~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~ 169 (390)
T 2zmd_A 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVH 169 (390)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHH
Confidence 3456788999999999996 5999999999999999999999 568899999853 346888899999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----------CCCC
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----------GLFS 151 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~ 151 (289)
|||+++ |+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+ ..++
T Consensus 170 ~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 245 (390)
T 2zmd_A 170 TIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245 (390)
T ss_dssp HHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CC
T ss_pred HHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCC
Confidence 999988 99999999999995 57899999999987654433323345679999999999975 3689
Q ss_pred CcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 152 IKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 152 ~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
.++|||||||++|+|++|..||.......... ........ ....+...+..+.+++.+||+.||++|
T Consensus 246 ~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~R 312 (390)
T 2zmd_A 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQR 312 (390)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTS
T ss_pred ChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH----HHHhCccc---------cCCCCccchHHHHHHHHHHcccChhhC
Confidence 99999999999999999999986543221111 11111110 001111124578899999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
||+.|+++
T Consensus 313 ps~~ell~ 320 (390)
T 2zmd_A 313 ISIPELLA 320 (390)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=281.70 Aligned_cols=218 Identities=30% Similarity=0.431 Sum_probs=175.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.|.+|+++|++++||||+++++++.+ +..++||||+++++|.+++... ....+++..+..++.|++.||.|||+
T Consensus 50 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (279)
T 1qpc_A 50 MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE 127 (279)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356889999999999999999999999874 4689999999999999998431 12268899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ ++||||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|
T Consensus 128 ~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 203 (279)
T 1qpc_A 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203 (279)
T ss_dssp TT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHH
Confidence 88 999999999999999999999999999876543322 22334567889999999988999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++ |..||....... ..... ... .........+..+.+++..||+.||++|||+.++++.|+...
T Consensus 204 ~~~g~~p~~~~~~~~--~~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 204 VTHGRIPYPGMTNPE--VIQNL----ERG---------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp HTTTCCSSTTCCHHH--HHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCCCCCCcccCHHH--HHHHH----hcc---------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 99 888876543221 11111 110 001112234568899999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=280.06 Aligned_cols=206 Identities=25% Similarity=0.339 Sum_probs=168.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~ 128 (279)
T 3fdn_A 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK 128 (279)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46778999999999999999999999999999999999999999999884 335689999999999999999999988
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+||+++.++.++|+|||++....... .....|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 129 ~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (279)
T 3fdn_A 129 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201 (279)
T ss_dssp T---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred C---EecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHH
Confidence 8 9999999999999999999999999986543321 23457899999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|..||......... ... .. .....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 202 ~g~~p~~~~~~~~~~--~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 202 VGKPPFEANTYQETY--KRI----SR----------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HSSCTTCCSSHHHHH--HHH----HH----------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HCCCCCCCCcHHHHH--HHH----Hh----------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 999998654322111 000 00 001112224567889999999999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=288.00 Aligned_cols=209 Identities=24% Similarity=0.308 Sum_probs=173.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+++.++||||+++++++.+++..|+||||+++++|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 83 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (335)
T 2owb_A 83 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHR 159 (335)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999999884 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++||||||+++|+|
T Consensus 160 ~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 234 (335)
T 2owb_A 160 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234 (335)
T ss_dssp TT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHH
T ss_pred CC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 88 99999999999999999999999999987643221 23345689999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..||.......... . ..... .......+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~g~~pf~~~~~~~~~~--~----~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 235 LVGKPPFETSCLKETYL--R----IKKNE----------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHSSCTTCCSSHHHHHH--H----HHHTC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHCcCCCCCCCHHHHHH--H----HhcCC----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999986543221110 0 00000 0111223467889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=290.19 Aligned_cols=221 Identities=22% Similarity=0.303 Sum_probs=164.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe----EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE----KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
++..++|.+|++++++++||||+++++++..... .|+||||+++++|.+++. ..+.+++..+..++.|++.||
T Consensus 53 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l 129 (311)
T 3ork_A 53 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQAL 129 (311)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHH
Confidence 3446789999999999999999999999886543 499999999999999984 345689999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.|||+++ |+||||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||
T Consensus 130 ~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 206 (311)
T 3ork_A 130 NFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206 (311)
T ss_dssp HHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHH
T ss_pred HHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHH
Confidence 9999988 99999999999999999999999999987643321 1223345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH-H
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI-S 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll-~ 239 (289)
+++|+|++|..||.......... .......... . ......+..+.+++.+||+.||++||+..+++ .
T Consensus 207 ~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~~~~~~---~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 207 CVLYEVLTGEPPFTGDSPVSVAY-----QHVREDPIPP---S----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHH-----HHHHCCCCCH---H----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhCCCCCCCCChHHHHH-----HHhcCCCCCc---c----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 99999999999986543322111 1111100000 0 00111346789999999999999999655544 4
Q ss_pred Hhhcc
Q 038647 240 MLTNE 244 (289)
Q Consensus 240 ~L~~~ 244 (289)
.+...
T Consensus 275 ~l~~~ 279 (311)
T 3ork_A 275 DLVRV 279 (311)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.94 Aligned_cols=214 Identities=18% Similarity=0.218 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHhhC-CCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 9 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
...+.+|+.++.++ +||||+++++++.. ++.+|+||||+++|+|.+++... ....+++..+..++.||+.||.|
T Consensus 98 ~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~ 176 (400)
T 1nxk_A 98 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQY 176 (400)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHH
Confidence 35678999998555 89999999999876 66799999999999999999652 23468999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
||+++ |+||||||+|||++. ++.+||+|||+++...... .....+||+.|+|||++.+..++.++||||||
T Consensus 177 LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 250 (400)
T 1nxk_A 177 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250 (400)
T ss_dssp HHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHH
T ss_pred HHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHH
Confidence 99988 999999999999997 7889999999998654322 23345789999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchh--HhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLT--LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
|++|+|++|..||......... ..... ..... ..........+.++.++|..||+.||++|||+.+++
T Consensus 251 ~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil 320 (400)
T 1nxk_A 251 VIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 320 (400)
T ss_dssp HHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 9999999999998654432110 00000 00000 000011123457899999999999999999999999
Q ss_pred H
Q 038647 239 S 239 (289)
Q Consensus 239 ~ 239 (289)
+
T Consensus 321 ~ 321 (400)
T 1nxk_A 321 N 321 (400)
T ss_dssp H
T ss_pred c
Confidence 7
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=287.91 Aligned_cols=225 Identities=20% Similarity=0.214 Sum_probs=166.9
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+.+.+|+++|.++ +||||+++++++.+++..|+||||+++|+|.+++.. .+.+++..+..++.||+.||.||
T Consensus 51 ~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~l 127 (316)
T 2ac3_A 51 GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFL 127 (316)
T ss_dssp SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34578899999999995 799999999999999999999999999999999843 35689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCc---eEEcccccccccCCCCc-----ccccccccccccccChhhhhc-----CCCC
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMN---PKISDFGIARLFGGDEL-----QSNTKRIVGTYGYMSPEYALR-----GLFS 151 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~ 151 (289)
|+++ |+||||||+||+++.++. +||+|||++........ ........||+.|+|||++.+ ..++
T Consensus 128 H~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 204 (316)
T 2ac3_A 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204 (316)
T ss_dssp HHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHT
T ss_pred HhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCC
Confidence 9988 999999999999998776 99999999876532211 111223468999999999975 5589
Q ss_pred CcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccC--CCCH----HHHHHHHHHHHcccc
Q 038647 152 IKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQN--DASY----PMLNRYINVALLCVQ 225 (289)
Q Consensus 152 ~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~~l~~li~~~l~ 225 (289)
.++|||||||++|+|++|..||.............. ............+... ..+. ..+..+.+++.+||+
T Consensus 205 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 281 (316)
T 2ac3_A 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE---ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLV 281 (316)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred cccccHhHHHHHHHHHHCCCCCcccccccccccccc---cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhh
Confidence 999999999999999999999876543321000000 0000000000000000 0111 134678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 038647 226 ENAADRPTMLEVIS 239 (289)
Q Consensus 226 ~~p~~Rps~~~ll~ 239 (289)
.||++|||+.|+++
T Consensus 282 ~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 282 RDAKQRLSAAQVLQ 295 (316)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=278.69 Aligned_cols=208 Identities=22% Similarity=0.297 Sum_probs=171.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 47 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH 123 (277)
T 3f3z_A 47 VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH 123 (277)
T ss_dssp CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999999999999999999999999998884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEe---CCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill---~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
+++ ++||||||+||++ +.++.++|+|||++....... ......||+.|+|||++.+. ++.++||||||++
T Consensus 124 ~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~ 196 (277)
T 3f3z_A 124 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVM 196 (277)
T ss_dssp HTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHH
T ss_pred HCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHH
Confidence 988 9999999999999 788999999999998765432 23345689999999998754 8999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCH----HHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASY----PMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
+|+|++|..||......... ... .... ..... ..+..+.+++.+||+.||++|||+.+++
T Consensus 197 l~~l~~g~~p~~~~~~~~~~--~~~----~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 197 MYVLLCGYPPFSAPTDSEVM--LKI----REGT----------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp HHHHHHSSCSSCCSSHHHHH--HHH----HHCC----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHHHHHCCCCCCCCCHHHHH--HHH----HhCC----------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99999999998654332111 000 0000 00111 2346889999999999999999999997
Q ss_pred H
Q 038647 239 S 239 (289)
Q Consensus 239 ~ 239 (289)
+
T Consensus 261 ~ 261 (277)
T 3f3z_A 261 E 261 (277)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=307.61 Aligned_cols=219 Identities=28% Similarity=0.418 Sum_probs=176.4
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++|.+|+++|++++||||+++++++.+ +..|+||||+++|+|.+++... ....+++..++.++.||+.||.|||++
T Consensus 305 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~ 382 (535)
T 2h8h_A 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM 382 (535)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999999876 6789999999999999999431 224588999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+
T Consensus 383 ~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~ 458 (535)
T 2h8h_A 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458 (535)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred C---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 8 999999999999999999999999999876432211 122334678899999999999999999999999999999
Q ss_pred h-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcccC
Q 038647 168 S-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNENV 246 (289)
Q Consensus 168 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 246 (289)
+ |..||....... .... .... .........+..+.+++.+||+.||++|||+.+|++.|+....
T Consensus 459 t~g~~P~~~~~~~~--~~~~----i~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 459 TKGRVPYPGMVNRE--VLDQ----VERG---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TTTCCSSTTCCHHH--HHHH----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred hCCCCCCCCCCHHH--HHHH----HHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 9 888876543221 1111 1111 0111122345688999999999999999999999999998653
Q ss_pred C
Q 038647 247 I 247 (289)
Q Consensus 247 ~ 247 (289)
.
T Consensus 524 ~ 524 (535)
T 2h8h_A 524 S 524 (535)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=282.74 Aligned_cols=215 Identities=21% Similarity=0.301 Sum_probs=171.0
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+.+.+|+.+++.+ +||||+++++++.+++..++||||+++|+|.+++.. ...+.+++..++.++.|++.||.||
T Consensus 69 ~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~L 147 (327)
T 3lm5_A 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYL 147 (327)
T ss_dssp EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHH
Confidence 34578899999999999 579999999999999999999999999999998854 2345789999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|+++ |+||||||+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+
T Consensus 148 H~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 221 (327)
T 3lm5_A 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGI 221 (327)
T ss_dssp HHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHH
Confidence 9988 999999999999987 7899999999998764332 123457899999999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..||.......... .... . ............+..+.+++.+||+.||++|||++++++
T Consensus 222 il~~ll~g~~pf~~~~~~~~~~--~i~~-~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 222 IAYMLLTHTSPFVGEDNQETYL--NISQ-V---------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHH--HHHH-T---------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCCCCCCCCchHHHH--HHHh-c---------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 9999999999986544322111 0000 0 000111112234567899999999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=290.53 Aligned_cols=207 Identities=29% Similarity=0.391 Sum_probs=167.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..++|.+|+++|++++||||+++++++.+++..++||||+. |+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 96 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~ 172 (348)
T 1u5q_A 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS 172 (348)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345789999999999999999999999999999999999997 577776642 23568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~vl 163 (289)
++ |+||||||+|||++.++.+||+|||+++.... .....||+.|+|||++. +..++.++|||||||++
T Consensus 173 ~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il 243 (348)
T 1u5q_A 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243 (348)
T ss_dssp TT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHH
T ss_pred CC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHH
Confidence 88 99999999999999999999999999986542 23357899999999985 46789999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||......... ........ ........+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~ell~g~~p~~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 244 IELAERKPPLFNMNAMSAL-----YHIAQNES---------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHSSCTTTTSCHHHHH-----HHHHHSCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhCCCCCCCCChHHHH-----HHHHhcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 9999999998654322111 11111100 00111233567889999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=291.27 Aligned_cols=232 Identities=22% Similarity=0.260 Sum_probs=179.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecC--eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG--EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
...+.+.+|+++|++++||||+++++++.+.+ ..++||||+++|+|.+++........+++..++.++.||+.||.||
T Consensus 49 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L 128 (396)
T 4eut_A 49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128 (396)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 45688899999999999999999999998765 7899999999999999996544444599999999999999999999
Q ss_pred hcCCCCceEeeccccCceEe----CCCCceEEcccccccccCCCCcccccccccccccccChhhhhc--------CCCCC
Q 038647 85 HHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR--------GLFSI 152 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill----~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~ 152 (289)
|+++ |+||||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+ ..++.
T Consensus 129 H~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 202 (396)
T 4eut_A 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGA 202 (396)
T ss_dssp HHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHH
T ss_pred HHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCc
Confidence 9988 9999999999999 778889999999998765432 2234568999999999875 56788
Q ss_pred cccchhHHHHHHHHHhCCCCcCCCCCcch--hHhHhHhhhhccCCccc----------cc-cccccCCCCHHHHHHHHHH
Q 038647 153 KSDVFSFGVLVLETLSSKKNAHFYNTDSL--TLLGHAWNLWNDGRAWE----------LM-DSILQNDASYPMLNRYINV 219 (289)
Q Consensus 153 ~~DiwslG~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~----------~~-~~~~~~~~~~~~~~~l~~l 219 (289)
++|||||||++|+|++|..||........ ................. .. ............+..+.++
T Consensus 203 ~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~l 282 (396)
T 4eut_A 203 TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282 (396)
T ss_dssp HHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHH
Confidence 99999999999999999999875443211 11111111110000000 00 0011123345677889999
Q ss_pred HHcccccCCCCCCCHHHHHHHhhcc
Q 038647 220 ALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
+..||+.||++|||+.++++.+..+
T Consensus 283 l~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 283 LANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhhccChhhhccHHHHHHHHHHH
Confidence 9999999999999999999988764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=279.15 Aligned_cols=213 Identities=21% Similarity=0.285 Sum_probs=172.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+.+. ..+.+++..+..++.|++.||.|||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH 122 (284)
T 3kk8_A 46 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCH 122 (284)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999988874 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCc---eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMN---PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
+++ ++||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++.++||||||++
T Consensus 123 ~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 196 (284)
T 3kk8_A 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 196 (284)
T ss_dssp HTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred HCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHH
Confidence 988 999999999999986655 9999999998765432 2234578999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||........ ..... .... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 197 l~~l~~g~~pf~~~~~~~~--~~~~~----~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 197 LYILLVGYPPFWDEDQHRL--YAQIK----AGAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHHH----HTCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHCCCCCCCCchhHH--HHHHH----hccc------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999999999865432211 11100 0000 0000111233467899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=294.06 Aligned_cols=209 Identities=21% Similarity=0.222 Sum_probs=161.3
Q ss_pred cCHHHHHHHHHH-HhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMML-IAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|..+ ++.++||||+++++++.+.+.+|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH 156 (373)
T 2r5t_A 80 KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLH 156 (373)
T ss_dssp -----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345667778877 577899999999999999999999999999999999884 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+
T Consensus 157 ~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 231 (373)
T 2r5t_A 157 SLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231 (373)
T ss_dssp HTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred HCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 988 9999999999999999999999999998643221 22445689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||...+... ..... ... . .......+..+.+++.+||+.||++||++.+.++
T Consensus 232 ll~G~~Pf~~~~~~~--~~~~i---~~~-~----------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 232 MLYGLPPFYSRNTAE--MYDNI---LNK-P----------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp HHHSSCTTCCSBHHH--HHHHH---HHS-C----------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred HHcCCCCCCCCCHHH--HHHHH---Hhc-c----------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 999999986543221 11111 100 0 0112234568899999999999999999854333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.47 Aligned_cols=214 Identities=22% Similarity=0.252 Sum_probs=175.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|+.++||||+++++++.+++.+|+||||+++|+|.+++... ....+++..+..++.||+.||.|||+
T Consensus 226 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~ 304 (576)
T 2acx_A 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR 304 (576)
T ss_dssp TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999999999999999999999999999988643 23458999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 305 ~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeL 378 (576)
T 2acx_A 305 ER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378 (576)
T ss_dssp TT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHH
T ss_pred CC---EeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHH
Confidence 88 9999999999999999999999999998765432 22345799999999999998999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
++|..||........... ........ ....+...+..+.++|.+||+.||++|| ++.|+++
T Consensus 379 ltG~~PF~~~~~~~~~~~--i~~~i~~~----------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 379 IAGQSPFQQRKKKIKREE--VERLVKEV----------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHSSCSSSCSSSCCCHHH--HHHHHHHC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HhCCCCCcccccchhHHH--HHHHhhcc----------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 999999876543211100 00000000 0112233457899999999999999999 7888875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=280.36 Aligned_cols=216 Identities=23% Similarity=0.365 Sum_probs=171.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||.|||
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 139 (295)
T 2clq_A 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139 (295)
T ss_dssp C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999999865434446678889999999999999999
Q ss_pred cCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcCC--CCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~v 162 (289)
+++ ++||||||+||+++. ++.+||+|||++....... .......|++.|+|||++.+.. ++.++||||||++
T Consensus 140 ~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i 214 (295)
T 2clq_A 140 DNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214 (295)
T ss_dssp HTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHH
T ss_pred hCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHH
Confidence 988 999999999999987 8999999999998764322 1223456899999999998654 8999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||.............. .. ......+...+..+.+++.+||+.||++|||+.++++
T Consensus 215 l~~l~~g~~pf~~~~~~~~~~~~~~--~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 215 IIEMATGKPPFYELGEPQAAMFKVG--MF-----------KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHTSCTTGGGSSHHHHHHHHH--HH-----------CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCCccCCCchhHHHHhhc--cc-----------cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999865433222111100 00 0011122234568899999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=287.02 Aligned_cols=222 Identities=22% Similarity=0.291 Sum_probs=160.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|++++||||+++++++.+++..++||||+++ +|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~ 150 (329)
T 3gbz_A 75 GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150 (329)
T ss_dssp -----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456788999999999999999999999999999999999974 8988884 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEe-----CCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHH
Q 038647 87 YSRLRVIHRDLKASNILL-----DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFG 160 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill-----~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG 160 (289)
++ |+||||||+|||+ +.++.+||+|||+++...... .......||+.|+|||++.+. .++.++||||||
T Consensus 151 ~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 225 (329)
T 3gbz_A 151 RR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA 225 (329)
T ss_dssp TT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred CC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHH
Confidence 88 9999999999999 455569999999998764332 123344679999999999875 589999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhc--cCCccccc-------cc--cccCCC-----CHHHHHHHHHHHHccc
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWN--DGRAWELM-------DS--ILQNDA-----SYPMLNRYINVALLCV 224 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-------~~--~~~~~~-----~~~~~~~l~~li~~~l 224 (289)
|++|+|++|..||.......... ....... ........ .. ...... ....+..+.+++.+||
T Consensus 226 ~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 303 (329)
T 3gbz_A 226 CIWAEMLMKTPLFPGDSEIDQLF--KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML 303 (329)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHT
T ss_pred HHHHHHHHCCCCcCCCCHHHHHH--HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHc
Confidence 99999999999987654332111 1111000 00000000 00 000000 0113467889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 038647 225 QENAADRPTMLEVIS 239 (289)
Q Consensus 225 ~~~p~~Rps~~~ll~ 239 (289)
+.||++|||+.|+++
T Consensus 304 ~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 304 EMDPVKRISAKNALE 318 (329)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhC
Confidence 999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=280.30 Aligned_cols=221 Identities=23% Similarity=0.303 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHhhCC---CCCceeeeeeEeecC-----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHG-----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|+.+++.++ ||||+++++++.... ..++||||+. ++|.+++... ....+++..+..++.||+.|
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~a 132 (308)
T 3g33_A 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRG 132 (308)
T ss_dssp CHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHH
Confidence 457788888888775 999999999998765 5899999996 5999988653 23348999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+++ |+||||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||
T Consensus 133 l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 206 (308)
T 3g33_A 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG 206 (308)
T ss_dssp HHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHH
T ss_pred HHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHH
Confidence 99999988 9999999999999999999999999998664322 23445789999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc---CCcccc---ccccccC--CC-----CHHHHHHHHHHHHcccccC
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND---GRAWEL---MDSILQN--DA-----SYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~--~~-----~~~~~~~l~~li~~~l~~~ 227 (289)
|++|+|++|..||......... ......... ...... ....... .. ....+..+.+++.+||+.|
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 284 (308)
T 3g33_A 207 CIFAEMFRRKPLFCGNSEADQL--GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 284 (308)
T ss_dssp HHHHHTTTSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCC
Confidence 9999999999998765433211 111111100 000000 0000000 00 0123467889999999999
Q ss_pred CCCCCCHHHHHH
Q 038647 228 AADRPTMLEVIS 239 (289)
Q Consensus 228 p~~Rps~~~ll~ 239 (289)
|++|||+.|+++
T Consensus 285 P~~R~t~~e~l~ 296 (308)
T 3g33_A 285 PHKRISAFRALQ 296 (308)
T ss_dssp TTTSCCHHHHHT
T ss_pred CccCCCHHHHhc
Confidence 999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=285.19 Aligned_cols=227 Identities=20% Similarity=0.209 Sum_probs=175.6
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~ 80 (289)
....+.+.+|+++++.++||||+++++++.. ....++||||+++|+|.+++... .....+++..++.++.|++.|
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~ 146 (317)
T 2buj_A 67 QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146 (317)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 4457789999999999999999999999873 34789999999999999888542 134678999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-------cccccccccccccChhhhhcCC---C
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-------SNTKRIVGTYGYMSPEYALRGL---F 150 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~---~ 150 (289)
|.|||+++ |+||||||+||+++.++.+||+|||++......... .......|++.|+|||++.+.. +
T Consensus 147 L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 223 (317)
T 2buj_A 147 LEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223 (317)
T ss_dssp HHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEE
T ss_pred HHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCC
Confidence 99999988 999999999999999999999999998765321110 0112345799999999997544 6
Q ss_pred CCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 151 SIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 151 ~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
+.++||||||+++|+|++|..||............. .............+..+.+++.+||+.||++
T Consensus 224 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 224 DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-------------HHCC--CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH-------------hhccCCCCccccCCHHHHHHHHHHhhcChhh
Confidence 899999999999999999999975321111111000 0000111112234568999999999999999
Q ss_pred CCCHHHHHHHhhcccCCC
Q 038647 231 RPTMLEVISMLTNENVIL 248 (289)
Q Consensus 231 Rps~~~ll~~L~~~~~~~ 248 (289)
|||+.++++.|+......
T Consensus 291 Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 291 RPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp SCCHHHHHHHHHHTCCCC
T ss_pred CCCHHHHHHHhhhcCCCC
Confidence 999999999999876433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=280.99 Aligned_cols=218 Identities=19% Similarity=0.206 Sum_probs=167.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~ 153 (309)
T 2h34_A 77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA 153 (309)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45789999999999999999999999999999999999999999999984 335689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ |+||||||+||+++.++.+||+|||++........ .......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 154 ~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 229 (309)
T 2h34_A 154 G---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229 (309)
T ss_dssp T---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHH
T ss_pred c---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHH
Confidence 8 99999999999999999999999999986643321 1233456899999999999999999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-CHHHHHHHhhccc
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-TMLEVISMLTNEN 245 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~ll~~L~~~~ 245 (289)
+|..||....... .. ........ . ........+..+.+++.+||+.||++|| +++++++.|++..
T Consensus 230 ~g~~pf~~~~~~~--~~----~~~~~~~~-~------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 230 TGSPPYQGDQLSV--MG----AHINQAIP-R------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp HSSCSSCSCHHHH--HH----HHHHSCCC-C------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred HCCCCCCCchHHH--HH----HHhccCCC-C------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 9999986543221 10 00100000 0 0011123345788999999999999999 9999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=287.10 Aligned_cols=212 Identities=20% Similarity=0.243 Sum_probs=168.4
Q ss_pred HHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 11 EFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 11 ~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
.+.+|+++|.++ +||||+++++++.+++..|+||||+++|+|.+++. ..+.+++..+..++.||+.||.|||++|
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g- 136 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG- 136 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 456799999998 79999999999999999999999999999999884 3456899999999999999999999988
Q ss_pred CceEeeccccCceEeCCC----CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 90 LRVIHRDLKASNILLDSN----MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~----~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
|+||||||+|||+... +.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 137 --ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 212 (342)
T 2qr7_A 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYT 212 (342)
T ss_dssp --EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred --cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHH
Confidence 9999999999998543 349999999998764332 12334578999999999998889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||............. ....... ..........+..+.+++.+||+.||++|||+.++++
T Consensus 213 ll~g~~Pf~~~~~~~~~~~~~---~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 213 MLTGYTPFANGPDDTPEEILA---RIGSGKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHSSCSSCSSTTSCHHHHHH---HHHHCCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhcCCCCCCCCCcCCHHHHHH---HHccCCc------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999987543322111100 0100000 0111112235578899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=296.96 Aligned_cols=216 Identities=20% Similarity=0.257 Sum_probs=175.3
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|+++|++++||||+++++++.+.+.+|+||||++||+|..++.... ....+++..+..++.||+.||.|||
T Consensus 227 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH 306 (543)
T 3c4z_A 227 KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306 (543)
T ss_dssp TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999999886533 2457999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|+
T Consensus 307 ~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilye 381 (543)
T 3c4z_A 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381 (543)
T ss_dssp HTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHH
Confidence 988 99999999999999999999999999987654321 2334589999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH-----HHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM-----LEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~ 239 (289)
|++|..||.......... ......... ....+...+..+.+++.+||+.||++||++ .+|++
T Consensus 382 lltG~~PF~~~~~~~~~~-~~~~~i~~~-----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 382 MIAARGPFRARGEKVENK-ELKQRVLEQ-----------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHSSCSSCCTTCCCCHH-HHHHHHHHC-----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHhCCCCCCCCccchhHH-HHHHHHhhc-----------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 999999987654321110 000000000 011223345788999999999999999965 66654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.36 Aligned_cols=229 Identities=21% Similarity=0.237 Sum_probs=174.1
Q ss_pred ccCHHHHHHHHHHHhh--CCCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAK--LQHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+.+.+|+++++. ++||||+++++++.+.+ ..++||||+++|+|.+++.. ..+++..++.++.|++.
T Consensus 75 ~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~ 150 (342)
T 1b6c_B 75 SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTAS 150 (342)
T ss_dssp GGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHH
Confidence 3456788899999988 68999999999998876 89999999999999999943 35889999999999999
Q ss_pred HHHHHh--------cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc--ccccccccccccChhhhhcCC
Q 038647 80 GLLYLH--------HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS--NTKRIVGTYGYMSPEYALRGL 149 (289)
Q Consensus 80 ~l~~lH--------~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~ 149 (289)
||.||| +.+ |+||||||+||+++.++.+||+|||++.......... ......||+.|+|||++.+..
T Consensus 151 ~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (342)
T 1b6c_B 151 GLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227 (342)
T ss_dssp HHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCC
T ss_pred HHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccc
Confidence 999999 776 9999999999999999999999999998765433211 233457899999999998652
Q ss_pred ------CCCcccchhHHHHHHHHHhC----------CCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHH
Q 038647 150 ------FSIKSDVFSFGVLVLETLSS----------KKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPML 213 (289)
Q Consensus 150 ------~~~~~DiwslG~vl~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (289)
++.++||||||+++|+|++| ..||.............. ......... ............+
T Consensus 228 ~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~ 303 (342)
T 1b6c_B 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR-KVVCEQKLR---PNIPNRWQSCEAL 303 (342)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHH-HHHTTSCCC---CCCCGGGGTSHHH
T ss_pred cccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHH-HHHHHHHhC---CCCcccccchhHH
Confidence 34789999999999999999 555543322211111111 111110000 0000001123566
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 214 NRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 214 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 304 ~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 304 RVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 78999999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=283.11 Aligned_cols=220 Identities=26% Similarity=0.369 Sum_probs=175.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..++|.+|++++++++||||+++++++.++. .++|+||+++++|.+++.. ..+.+++..+..++.|++.||.|||
T Consensus 62 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH 138 (291)
T 1u46_A 62 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 138 (291)
T ss_dssp CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999998765 8899999999999998853 2356889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ ++||||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|
T Consensus 139 ~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (291)
T 1u46_A 139 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215 (291)
T ss_dssp HTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHH
Confidence 988 999999999999999999999999999876543221 1223345778899999999988999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
+|++ |..||........ ... ...... ........+..+.+++.+||+.||++|||+.++++.|++
T Consensus 216 ~l~~~g~~p~~~~~~~~~--~~~---~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 281 (291)
T 1u46_A 216 EMFTYGQEPWIGLNGSQI--LHK---IDKEGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281 (291)
T ss_dssp HHHTTSCCTTTTCCHHHH--HHH---HHTSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhCCCCCcccCCHHHH--HHH---HHccCC---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 9999 9998865432211 111 111100 011122345789999999999999999999999999987
Q ss_pred cc
Q 038647 244 EN 245 (289)
Q Consensus 244 ~~ 245 (289)
..
T Consensus 282 ~~ 283 (291)
T 1u46_A 282 AQ 283 (291)
T ss_dssp HC
T ss_pred hC
Confidence 65
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=279.50 Aligned_cols=214 Identities=22% Similarity=0.344 Sum_probs=166.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+.+.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||.||
T Consensus 61 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 140 (285)
T 3is5_A 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140 (285)
T ss_dssp CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999999999999999999999999988874321 235689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEe---CCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill---~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|+++ |+||||||+||++ +.++.+||+|||++....... ......|++.|+|||++. ..++.++||||||+
T Consensus 141 H~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~ 213 (285)
T 3is5_A 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGV 213 (285)
T ss_dssp HHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHH
T ss_pred HhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHH
Confidence 9988 9999999999999 456789999999998654332 233456899999999985 56899999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..||........... . ....... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 214 il~~ll~g~~pf~~~~~~~~~~~--~--~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 214 VMYFLLTGCLPFTGTSLEEVQQK--A--TYKEPNY---------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHH--H--HHCCCCC---------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHhCCCCCCCCCHHHHHhh--h--ccCCccc---------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999875443221110 0 0000000 0011113467889999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=281.38 Aligned_cols=209 Identities=25% Similarity=0.358 Sum_probs=171.8
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEee----------------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHH
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIE----------------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 73 (289)
+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++... ....+++..+..+
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i 127 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALEL 127 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHH
Confidence 568899999999999999999999864 45689999999999999998542 2356889999999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCc
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIK 153 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 153 (289)
+.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....|++.|+|||++.+..++.+
T Consensus 128 ~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp HHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred HHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcch
Confidence 999999999999988 99999999999999999999999999987654321 233468999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 154 SDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 154 ~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
+||||||+++|+|++|..|+.... . ....... .......+..+.+++.+||+.||++|||
T Consensus 202 ~Di~slG~il~~l~~~~~~~~~~~----~----~~~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps 261 (284)
T 2a19_B 202 VDLYALGLILAELLHVCDTAFETS----K----FFTDLRD------------GIISDIFDKKEKTLLQKLLSKKPEDRPN 261 (284)
T ss_dssp HHHHHHHHHHHHHHSCCSSHHHHH----H----HHHHHHT------------TCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhHHHHHHHHHHHhcCCcchhHH----H----HHHHhhc------------ccccccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999999998753211 0 0011111 1111223467889999999999999999
Q ss_pred HHHHHHHhhccc
Q 038647 234 MLEVISMLTNEN 245 (289)
Q Consensus 234 ~~~ll~~L~~~~ 245 (289)
+.++++.|....
T Consensus 262 ~~e~l~~l~~~~ 273 (284)
T 2a19_B 262 TSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHh
Confidence 999999998765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=287.97 Aligned_cols=225 Identities=23% Similarity=0.307 Sum_probs=167.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||+
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~ 142 (331)
T 4aaa_A 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS 142 (331)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999988763 33568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~e 165 (289)
++ |+||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+. .++.++||||||+++|+
T Consensus 143 ~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 217 (331)
T 4aaa_A 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTE 217 (331)
T ss_dssp TT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHH
T ss_pred CC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHH
Confidence 88 9999999999999999999999999998654322 122345689999999999875 78999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHh---------HhhhhccC------CccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 166 TLSSKKNAHFYNTDSLTLLGH---------AWNLWNDG------RAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~---------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
|++|..||............. ....+... ..................+..+.+++.+||+.||++
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 297 (331)
T 4aaa_A 218 MFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297 (331)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCccc
Confidence 999999987654332111000 00000000 000000000000001124578999999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||+.|+++
T Consensus 298 Rpt~~ell~ 306 (331)
T 4aaa_A 298 RPFCAELLH 306 (331)
T ss_dssp SCCGGGGGG
T ss_pred CCCHHHHhc
Confidence 999999886
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=279.74 Aligned_cols=210 Identities=22% Similarity=0.355 Sum_probs=174.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++. .+.+++..+..++.|++.||.|||
T Consensus 61 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH 136 (303)
T 3a7i_A 61 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLH 136 (303)
T ss_dssp STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999999984 246899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+
T Consensus 137 ~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 211 (303)
T 3a7i_A 137 SEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211 (303)
T ss_dssp HTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HCC---CccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 988 99999999999999999999999999987654321 2334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..|+......... .. ..... ........+..+.+++..||+.||++|||+.++++
T Consensus 212 l~~g~~p~~~~~~~~~~--~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 212 LARGEPPHSELHPMKVL--FL----IPKNN---------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHSSCTTTTSCHHHHH--HH----HHHSC---------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HccCCCCCCCcCHHHHH--HH----hhcCC---------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 99999998654322111 00 00000 01112233467899999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=287.67 Aligned_cols=216 Identities=13% Similarity=0.115 Sum_probs=176.2
Q ss_pred ccCHHHHHHHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC--CCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP--TKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~~~i~~~ 80 (289)
.....++.+|+++++.++ |+||+++++++..++..|+||||+++|+|.+++... ...+.+++..++.++.||+.|
T Consensus 105 ~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~ 184 (365)
T 3e7e_A 105 PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184 (365)
T ss_dssp SCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHH
T ss_pred CCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHH
Confidence 445678899999999997 999999999999999999999999999999998532 134679999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCC-----------CCceEEcccccccccCCCCcccccccccccccccChhhhhcCC
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDS-----------NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL 149 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~-----------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 149 (289)
|.|||+++ |+||||||+|||++. ++.+||+|||+++...............||+.|+|||++.+..
T Consensus 185 L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 261 (365)
T 3e7e_A 185 IEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261 (365)
T ss_dssp HHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC
T ss_pred HHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC
Confidence 99999988 999999999999998 8999999999997654333233345567999999999999999
Q ss_pred CCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 150 FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 150 ~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
++.++|||||||++|+|+||+.||......... ........ .....+.+++..|++.+|.
T Consensus 262 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~ 321 (365)
T 3e7e_A 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-----------------PEGLFRRL---PHLDMWNEFFHVMLNIPDC 321 (365)
T ss_dssp BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----------------ECSCCTTC---SSHHHHHHHHHHHHCCCCT
T ss_pred CCccccHHHHHHHHHHHHhCCCccccCCCCcee-----------------echhcccc---CcHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999997543221110 11111111 2256778899999999999
Q ss_pred CC-CCHHHHHHHhhcc
Q 038647 230 DR-PTMLEVISMLTNE 244 (289)
Q Consensus 230 ~R-ps~~~ll~~L~~~ 244 (289)
+| |++.++.+.|+..
T Consensus 322 ~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 322 HHLPSLDLLRQKLKKV 337 (365)
T ss_dssp TCCCCHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHH
Confidence 99 5788888777754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=289.80 Aligned_cols=235 Identities=23% Similarity=0.355 Sum_probs=175.6
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC--eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG--EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+..+.|.+|+++|++++||||+++++++...+ ..++||||+++++|.+++... ...+++..++.++.|++.||.
T Consensus 82 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~ 159 (326)
T 2w1i_A 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGME 159 (326)
T ss_dssp CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHH
Confidence 3455778999999999999999999999987644 789999999999999998542 345899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|||+++ |+||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+
T Consensus 160 ~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 236 (326)
T 2w1i_A 160 YLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236 (326)
T ss_dssp HHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred HHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHH
Confidence 999988 999999999999999999999999999876543221 1122345677899999999988999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhh-hhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWN-LWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|+|++|..|+................ ..........+............+..+.+++.+||+.||++|||+.+|++.
T Consensus 237 il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 237 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp HHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999998865321110000000000 000000000111111111223345789999999999999999999999999
Q ss_pred hhcc
Q 038647 241 LTNE 244 (289)
Q Consensus 241 L~~~ 244 (289)
|+..
T Consensus 317 L~~l 320 (326)
T 2w1i_A 317 VDQI 320 (326)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=293.42 Aligned_cols=214 Identities=19% Similarity=0.202 Sum_probs=170.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|..+|..++||||+++++++.+.+.+|+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++
T Consensus 104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~ 181 (412)
T 2vd5_A 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRL 181 (412)
T ss_dssp GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4566899999999999999999999999999999999999999999998532 24689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-------cCCCCCcccchhHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-------RGLFSIKSDVFSFG 160 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG 160 (289)
+ |+||||||+|||++.++.+||+|||+++....... ......+||+.|+|||++. +..++.++||||||
T Consensus 182 g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlG 257 (412)
T 2vd5_A 182 G---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257 (412)
T ss_dssp T---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHH
T ss_pred C---eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHh
Confidence 8 99999999999999999999999999987654322 1233457999999999997 35689999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC---CCHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR---PTMLEV 237 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~l 237 (289)
|++|||++|+.||...+.... .......... ..........+.++.++|.+||. +|.+| |+++|+
T Consensus 258 vilyelltG~~Pf~~~~~~~~--~~~i~~~~~~---------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei 325 (412)
T 2vd5_A 258 VFAYEMFYGQTPFYADSTAET--YGKIVHYKEH---------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325 (412)
T ss_dssp HHHHHHHHSSCTTCCSSHHHH--HHHHHTHHHH---------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHH--HHHHHhcccC---------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 999999999999875443211 1110000000 00001112345789999999999 99998 589998
Q ss_pred HH
Q 038647 238 IS 239 (289)
Q Consensus 238 l~ 239 (289)
++
T Consensus 326 ~~ 327 (412)
T 2vd5_A 326 RT 327 (412)
T ss_dssp HT
T ss_pred hc
Confidence 76
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=280.61 Aligned_cols=215 Identities=27% Similarity=0.382 Sum_probs=166.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec-CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...++|.+|++++++++||||+++++++.+. +..++||||+++++|.+++... ....+++..+..++.|++.||.|||
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH 134 (278)
T 1byg_A 56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE 134 (278)
T ss_dssp C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999997554 5789999999999999998531 1223788999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+
T Consensus 135 ~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (278)
T 1byg_A 135 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 206 (278)
T ss_dssp HTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHH
Confidence 988 999999999999999999999999998765432 122357889999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |..||......... . ..... .........+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 207 l~t~g~~p~~~~~~~~~~--~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 207 IYSFGRVPYPRIPLKDVV--P----RVEKG---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HHTTSCCSCTTSCGGGHH--H----HHTTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHH--H----HHhcC---------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 998 99887654332111 1 01110 01112223456889999999999999999999999999875
Q ss_pred c
Q 038647 245 N 245 (289)
Q Consensus 245 ~ 245 (289)
.
T Consensus 272 ~ 272 (278)
T 1byg_A 272 K 272 (278)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=278.77 Aligned_cols=210 Identities=24% Similarity=0.300 Sum_probs=173.7
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH 132 (294)
T 2rku_A 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLH 132 (294)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ ++||||||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+
T Consensus 133 ~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 207 (294)
T 2rku_A 133 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 207 (294)
T ss_dssp HTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHH
T ss_pred HCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHH
Confidence 988 99999999999999999999999999987643221 2233568999999999999889999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||.......... ...... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 208 l~~g~~p~~~~~~~~~~~------~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 208 LLVGKPPFETSCLKETYL------RIKKNE----------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHSSCTTCCSSHHHHHH------HHHTTC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHhCCCCCCCCCHHHHHH------HHhhcc----------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 999999986543221110 000000 0111233467889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=294.13 Aligned_cols=224 Identities=21% Similarity=0.287 Sum_probs=166.6
Q ss_pred ccCHHHHHHHHHHHhhCC-CCCceeeeeeEeecC--eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHG--EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
....+++.+|+.+|+++. ||||+++++++...+ .+|+||||++ |+|..++.. +.+++..+..++.||+.||.
T Consensus 49 ~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~ 123 (388)
T 3oz6_A 49 STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIK 123 (388)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHH
Confidence 445678889999999997 999999999997544 7899999997 588888842 46889999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCC-------------------cccccccccccccccChh
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE-------------------LQSNTKRIVGTYGYMSPE 143 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-------------------~~~~~~~~~g~~~y~aPE 143 (289)
|||+.| |+||||||+|||++.++.+||+|||+++...... .........||+.|+|||
T Consensus 124 ~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (388)
T 3oz6_A 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE 200 (388)
T ss_dssp HHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHH
T ss_pred HHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHH
Confidence 999988 9999999999999999999999999998653211 011233457999999999
Q ss_pred hhhc-CCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCc-----------ccccc---------c
Q 038647 144 YALR-GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA-----------WELMD---------S 202 (289)
Q Consensus 144 ~~~~-~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~---------~ 202 (289)
++.+ ..++.++|||||||++|+|++|.+||...+..... ............ ...+. .
T Consensus 201 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (388)
T 3oz6_A 201 ILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL--ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQ 278 (388)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC---
T ss_pred HhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccC
Confidence 9986 67899999999999999999999998765432211 111111000000 00000 0
Q ss_pred cccCC-------------CCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 203 ILQND-------------ASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 203 ~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
..... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 279 SNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp --CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 00000 00022457889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=290.41 Aligned_cols=224 Identities=25% Similarity=0.349 Sum_probs=172.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|++++||||+++++++.+++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 72 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh 148 (360)
T 3eqc_A 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 148 (360)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999984 3456899999999999999999999
Q ss_pred cC-CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HY-SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~-~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+. + |+||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+..++.++||||||+++|
T Consensus 149 ~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 221 (360)
T 3eqc_A 149 EKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221 (360)
T ss_dssp HHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHH
T ss_pred HhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHH
Confidence 85 7 999999999999999999999999998755321 223457899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHh------------------------hhhccCCcccccccc----ccCCCCHHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAW------------------------NLWNDGRAWELMDSI----LQNDASYPMLNRY 216 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 216 (289)
+|++|..||............... ............+.. .........+..+
T Consensus 222 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (360)
T 3eqc_A 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 301 (360)
T ss_dssp HHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHH
Confidence 999999998765433211100000 000000000000100 0111111235678
Q ss_pred HHHHHcccccCCCCCCCHHHHHH
Q 038647 217 INVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 217 ~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+++.+||+.||++|||+.++++
T Consensus 302 ~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 302 QDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhhcChhhCCCHHHHhh
Confidence 99999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=287.93 Aligned_cols=225 Identities=24% Similarity=0.359 Sum_probs=171.0
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.....+.|.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..+..++.||+.||.||
T Consensus 69 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~l 146 (319)
T 2y4i_B 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL 146 (319)
T ss_dssp CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 344567788999999999999999999999999999999999999999999953 234689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCC---cccccccccccccccChhhhhc---------CCCCC
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE---LQSNTKRIVGTYGYMSPEYALR---------GLFSI 152 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~ 152 (289)
|+++ ++||||||+||+++ ++.+||+|||+++...... .........|++.|+|||++.+ ..++.
T Consensus 147 H~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~ 222 (319)
T 2y4i_B 147 HAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222 (319)
T ss_dssp HHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCH
T ss_pred HhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCc
Confidence 9988 99999999999998 6799999999987653211 1122233468999999999974 35789
Q ss_pred cccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 153 KSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 153 ~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
++||||||+++|+|++|..||......... +... ..... .......+..+.+++..||+.||++||
T Consensus 223 ~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~-~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp 288 (319)
T 2y4i_B 223 HSDVFALGTIWYELHAREWPFKTQPAEAII-----WQMG-TGMKP--------NLSQIGMGKEISDILLFCWAFEQEERP 288 (319)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-----HHHH-TTCCC--------CCCCSSCCTTHHHHHHHHHCSSTTTSC
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHhc-cCCCC--------CCCcCCCCHHHHHHHHHHhcCChhhCc
Confidence 999999999999999999998654322111 0110 01000 011112345788999999999999999
Q ss_pred CHHHHHHHhhcccCCCC
Q 038647 233 TMLEVISMLTNENVILP 249 (289)
Q Consensus 233 s~~~ll~~L~~~~~~~~ 249 (289)
|+.++++.|+.......
T Consensus 289 t~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 289 TFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CHHHHHHHHTTC-----
T ss_pred CHHHHHHHHHHHHHhhc
Confidence 99999999998764443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=292.55 Aligned_cols=157 Identities=24% Similarity=0.355 Sum_probs=131.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee-----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
....+++.+|+++|+.++||||+++++++.. ...+|+||||+ +|+|.+++. ....+++..+..++.||+.|
T Consensus 93 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~a 168 (458)
T 3rp9_A 93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVG 168 (458)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999954 35799999998 568988884 34579999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-------------------------cccccccc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-------------------------SNTKRIVG 135 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-------------------------~~~~~~~g 135 (289)
|.|||+++ |+||||||+|||++.++.+||+|||+++........ ......+|
T Consensus 169 L~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 245 (458)
T 3rp9_A 169 VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245 (458)
T ss_dssp HHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------C
T ss_pred HHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcc
Confidence 99999988 999999999999999999999999999876422110 12334578
Q ss_pred cccccChhhhh-cCCCCCcccchhHHHHHHHHHhC
Q 038647 136 TYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 136 ~~~y~aPE~~~-~~~~~~~~DiwslG~vl~elltg 169 (289)
|+.|+|||++. +..++.++|||||||++|||++|
T Consensus 246 t~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99999999874 56799999999999999999993
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=275.20 Aligned_cols=211 Identities=22% Similarity=0.290 Sum_probs=169.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.|.+|++++++++||||+++++++.+++..++||||+++++|.+++. ....+++..+..++.|++.||.|||++
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~ 127 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSK 127 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 57889999999999999999999999999999999999999999999984 345689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCC----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNM----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
+ ++||||||+||+++.++ .+||+|||++....... ......|++.|+|||++.+..++.++||||||+++
T Consensus 128 ~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 201 (283)
T 3bhy_A 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201 (283)
T ss_dssp T---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred C---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHH
Confidence 8 99999999999998877 79999999998764332 12334689999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||........ ... ...... .. ... .....+..+.+++.+||+.||++|||+.++++
T Consensus 202 ~~l~~g~~p~~~~~~~~~--~~~----~~~~~~-~~-~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 202 YILLSGASPFLGETKQET--LTN----ISAVNY-DF-DEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHSSCTTCCSSHHHH--HHH----HHTTCC-CC-CHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCCCCcchHHH--HHH----hHhccc-CC-cch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 999999999865432211 110 000000 00 000 00112467889999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=282.06 Aligned_cols=225 Identities=25% Similarity=0.415 Sum_probs=161.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcC-----CCCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD-----PTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
....+++.+|+.++++++||||+++++++..++..++||||+++++|.+++.. ....+.+++..+..++.||+.|
T Consensus 54 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 133 (303)
T 2vwi_A 54 QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133 (303)
T ss_dssp ------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999998853 1134568999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc---ccccccccccccccChhhhhc-CCCCCcccc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL---QSNTKRIVGTYGYMSPEYALR-GLFSIKSDV 156 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di 156 (289)
|.|||+++ ++||||||+||+++.++.+||+|||++........ ........|++.|+|||++.+ ..++.++||
T Consensus 134 l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 210 (303)
T 2vwi_A 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADI 210 (303)
T ss_dssp HHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHH
T ss_pred HHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhH
Confidence 99999988 99999999999999999999999999986643221 112234578999999999976 568999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
||||+++|+|++|..||........... ..... .................+..+.+++.+||+.||++|||+.+
T Consensus 211 ~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 284 (303)
T 2vwi_A 211 WSFGITAIELATGAAPYHKYPPMKVLML-----TLQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284 (303)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHhCCCCCccCchhhHHHH-----HhccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999876543322110 01100 00000000111111223467899999999999999999999
Q ss_pred HHH
Q 038647 237 VIS 239 (289)
Q Consensus 237 ll~ 239 (289)
+++
T Consensus 285 ll~ 287 (303)
T 2vwi_A 285 LLR 287 (303)
T ss_dssp HHT
T ss_pred Hhh
Confidence 986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=287.06 Aligned_cols=226 Identities=14% Similarity=0.121 Sum_probs=175.8
Q ss_pred HHHHHHHHHHhhCCCCCcee---------------eeeeEee-cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHH
Q 038647 10 EEFKNEMMLIAKLQHRNLVR---------------LFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~---------------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 73 (289)
+.+.+|++++++++||||++ +++++.. ++..|+||||+ +++|.+++... ..+.+++..+..+
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i 164 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQV 164 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHH
Confidence 46899999999999999998 5677766 77899999999 99999999542 2357999999999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCC--ceEEcccccccccCCCCcc-----cccccccccccccChhhhh
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNM--NPKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYAL 146 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~--~vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~ 146 (289)
+.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.
T Consensus 165 ~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 241 (352)
T 2jii_A 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK 241 (352)
T ss_dssp HHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc
Confidence 999999999999988 99999999999999998 8999999999876432211 1123347899999999999
Q ss_pred cCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHccccc
Q 038647 147 RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQE 226 (289)
Q Consensus 147 ~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 226 (289)
+..++.++||||||+++|+|++|+.||.................. ... ....... ......+..+.+++..||+.
T Consensus 242 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~---~~~~~~~~~l~~li~~~l~~ 316 (352)
T 2jii_A 242 GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFV-DKP-GPFVGPC---GHWIRPSETLQKYLKVVMAL 316 (352)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH-HSC-CCEECTT---SCEECCCHHHHHHHHHHHTC
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhcc-CCh-hhhhhhc---cccCCCcHHHHHHHHHHHhC
Confidence 999999999999999999999999998866533322222111111 100 0010000 00112346899999999999
Q ss_pred CCCCCCCHHHHHHHhhccc
Q 038647 227 NAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 227 ~p~~Rps~~~ll~~L~~~~ 245 (289)
||++|||+.+|++.|++..
T Consensus 317 dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 317 TYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp CTTCCCCHHHHHHHHHHHH
T ss_pred ChhhCCCHHHHHHHHHHHH
Confidence 9999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=283.67 Aligned_cols=222 Identities=23% Similarity=0.291 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+.+|++++++++||||+++++++.+.+..++||||+++ +|..++.. ....+++..+..++.|++.||.|||+++
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 132 (346)
T 1ua2_A 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW 132 (346)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45788999999999999999999999999999999999976 78887753 3356888999999999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ell 167 (289)
|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 133 ---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 207 (346)
T 1ua2_A 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207 (346)
T ss_dssp ---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred ---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999999999999999998764322 123345789999999999764 5899999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCc---c---ccccccc---cCCCC-----HHHHHHHHHHHHcccccCCCCCCC
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRA---W---ELMDSIL---QNDAS-----YPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~---~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
+|.+||........ ............. . ...+... ....+ ...+..+.+++.+||+.||++|||
T Consensus 208 ~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 285 (346)
T 1ua2_A 208 LRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285 (346)
T ss_dssp HSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred HCCCCCCCCCHHHH--HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC
Confidence 99988765443211 1111111111000 0 0000000 00000 123468899999999999999999
Q ss_pred HHHHHHH
Q 038647 234 MLEVISM 240 (289)
Q Consensus 234 ~~~ll~~ 240 (289)
+.|+++.
T Consensus 286 ~~ell~h 292 (346)
T 1ua2_A 286 ATQALKM 292 (346)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=298.37 Aligned_cols=212 Identities=23% Similarity=0.304 Sum_probs=172.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|++++||||+++++++.+.+..|+||||+.+|+|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 67 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH 143 (484)
T 3nyv_A 67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMH 143 (484)
T ss_dssp SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999998884 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEe---CCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill---~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
+++ |+||||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||+
T Consensus 144 ~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i 216 (484)
T 3nyv_A 144 KNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVI 216 (484)
T ss_dssp HTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHH
T ss_pred HCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHH
Confidence 988 9999999999999 567889999999998765432 2334579999999999876 69999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||........ ..... ..... .........+..+.+++.+||+.||++|||+.++++
T Consensus 217 l~~ll~g~~pf~~~~~~~~--~~~i~----~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 217 LYILLSGCPPFNGANEYDI--LKKVE----KGKYT------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHHH----HCCCC------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHCCCCCCCCCHHHH--HHHHH----cCCCC------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 9999999999875443211 11110 00000 000011234568899999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=279.29 Aligned_cols=222 Identities=15% Similarity=0.233 Sum_probs=172.7
Q ss_pred ccCHHHHHHHHHHHhhCC-CCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
....+.+.+|+++|++++ ||||+++++++.+ ....++||||+.+++|.+++. .+++..+..++.||+.||.
T Consensus 71 ~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~ 144 (330)
T 3nsz_A 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALD 144 (330)
T ss_dssp SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHH
Confidence 345688999999999997 9999999999988 678999999999999999883 3888999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFG 160 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 160 (289)
|||+++ |+||||||+|||++.++ .+||+|||+++...... ......|+..|+|||++.+ ..++.++||||||
T Consensus 145 ~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 218 (330)
T 3nsz_A 145 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218 (330)
T ss_dssp HHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred HHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHH
Confidence 999988 99999999999999776 89999999998764432 2334568999999999987 6789999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhh--------hc--------------cCCccccccccccCCCCHHHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNL--------WN--------------DGRAWELMDSILQNDASYPMLNRYIN 218 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~ 218 (289)
|++|+|++|..||................. .. ....................+..+.+
T Consensus 219 ~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (330)
T 3nsz_A 219 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 298 (330)
T ss_dssp HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHH
T ss_pred HHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHH
Confidence 999999999999865443322111110000 00 00001111112222222335678999
Q ss_pred HHHcccccCCCCCCCHHHHHH
Q 038647 219 VALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 219 li~~~l~~~p~~Rps~~~ll~ 239 (289)
++.+||+.||++|||++|+++
T Consensus 299 li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 299 FLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.86 Aligned_cols=160 Identities=25% Similarity=0.369 Sum_probs=134.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
....+++.+|+++|++++||||+++++++... +..|+||||+. |+|.+++. ....+++..+..++.||+.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~a 141 (432)
T 3n9x_A 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLG 141 (432)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999876 57999999996 59999884 34569999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc--------------------ccccccccccccc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ--------------------SNTKRIVGTYGYM 140 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--------------------~~~~~~~g~~~y~ 140 (289)
|.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 142 L~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 218 (432)
T 3n9x_A 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218 (432)
T ss_dssp HHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTC
T ss_pred HHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCcccc
Confidence 99999998 999999999999999999999999999876433211 1234567899999
Q ss_pred Chhhh-hcCCCCCcccchhHHHHHHHHHhCCCC
Q 038647 141 SPEYA-LRGLFSIKSDVFSFGVLVLETLSSKKN 172 (289)
Q Consensus 141 aPE~~-~~~~~~~~~DiwslG~vl~elltg~~p 172 (289)
|||++ .+..++.++|||||||++|||++|..|
T Consensus 219 APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred CHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99986 456799999999999999999985444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.79 Aligned_cols=220 Identities=22% Similarity=0.220 Sum_probs=162.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+++.+|+.+|+.++||||+++++++... ..+|+||||++++ |.+.+. ..+++..+..++.||+.
T Consensus 102 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~ 175 (464)
T 3ttj_A 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLC 175 (464)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHH
Confidence 34577899999999999999999999999654 4679999999765 555552 23889999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus 176 aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 249 (464)
T 3ttj_A 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249 (464)
T ss_dssp HHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence 999999988 9999999999999999999999999998764322 2344679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc-------------------CC------ccccccccc-cCCC--CHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND-------------------GR------AWELMDSIL-QNDA--SYP 211 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~------~~~~~~~~~-~~~~--~~~ 211 (289)
||++|+|++|+.||...+..... ......... .. ......... .... ...
T Consensus 250 G~il~ell~g~~pF~g~~~~~~~--~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (464)
T 3ttj_A 250 GCIMGEMVRHKILFPGRDYIDQW--NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327 (464)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccc
Confidence 99999999999998765432110 000000000 00 000000000 0000 011
Q ss_pred HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 212 MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+..+.+++.+||+.||++|||++|+++
T Consensus 328 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 328 KASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2567899999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=285.76 Aligned_cols=229 Identities=22% Similarity=0.287 Sum_probs=165.4
Q ss_pred CHHHHHHHHHHHh--hCCCCCceeeeeeEee-----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIA--KLQHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 8 ~~~~~~~E~~~l~--~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
..+.+..|.+++. .++||||+++++++.. ....++||||+++|+|.+++.. ...++..+..++.||+.|
T Consensus 48 ~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~ 123 (336)
T 3g2f_A 48 NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRG 123 (336)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHH
Confidence 4455666666644 5899999999986543 3367899999999999999843 345888899999999999
Q ss_pred HHHHhcC---------CCCceEeeccccCceEeCCCCceEEcccccccccCCCCc------ccccccccccccccChhhh
Q 038647 81 LLYLHHY---------SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL------QSNTKRIVGTYGYMSPEYA 145 (289)
Q Consensus 81 l~~lH~~---------~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~ 145 (289)
|.|||+. + |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++
T Consensus 124 L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (336)
T 3g2f_A 124 LAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200 (336)
T ss_dssp HHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHH
T ss_pred HHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhh
Confidence 9999988 7 99999999999999999999999999987643321 1122345699999999999
Q ss_pred hc-------CCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhH------------hhhhccCCccccccccccC
Q 038647 146 LR-------GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHA------------WNLWNDGRAWELMDSILQN 206 (289)
Q Consensus 146 ~~-------~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~ 206 (289)
.+ ..++.++|||||||++|+|++|..|+.............. ............+. ..-
T Consensus 201 ~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 278 (336)
T 3g2f_A 201 EGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP--EAW 278 (336)
T ss_dssp TTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC--TTC
T ss_pred cCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC--ccc
Confidence 86 4567899999999999999999877644332211000000 00000000000000 001
Q ss_pred CCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 207 DASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 207 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
......+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 112346678999999999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.49 Aligned_cols=227 Identities=19% Similarity=0.260 Sum_probs=167.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEee--------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVA 78 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~ 78 (289)
.....+.+|+++|+.++||||+++++++.+ ++..|+||||+++ +|...+.. ....+++..+..++.||+
T Consensus 58 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~ 134 (351)
T 3mi9_A 58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLL 134 (351)
T ss_dssp SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHH
Confidence 345678899999999999999999999987 4568999999976 66666643 334689999999999999
Q ss_pred HHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc--ccccccccccccccChhhhhc-CCCCCccc
Q 038647 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL--QSNTKRIVGTYGYMSPEYALR-GLFSIKSD 155 (289)
Q Consensus 79 ~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~D 155 (289)
.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|
T Consensus 135 ~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 211 (351)
T 3mi9_A 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID 211 (351)
T ss_dssp HHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHH
T ss_pred HHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhH
Confidence 9999999988 99999999999999999999999999987643221 122344578999999999976 46899999
Q ss_pred chhHHHHHHHHHhCCCCcCCCCCcchhHh-HhHhhhhccCC-----cccccc---ccccCCCCHH-------HHHHHHHH
Q 038647 156 VFSFGVLVLETLSSKKNAHFYNTDSLTLL-GHAWNLWNDGR-----AWELMD---SILQNDASYP-------MLNRYINV 219 (289)
Q Consensus 156 iwslG~vl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~---~~~~~~~~~~-------~~~~l~~l 219 (289)
||||||++|+|++|..||........... ........... ...... .......... .+..+.++
T Consensus 212 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (351)
T 3mi9_A 212 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 291 (351)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHH
Confidence 99999999999999999876443321110 00000000000 000000 0000011110 13467899
Q ss_pred HHcccccCCCCCCCHHHHHH
Q 038647 220 ALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~ 239 (289)
+.+||+.||++|||+.|+++
T Consensus 292 i~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 292 IDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCChhhCCCHHHHhC
Confidence 99999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=281.77 Aligned_cols=221 Identities=23% Similarity=0.235 Sum_probs=169.2
Q ss_pred cCHHHHHHHHHHHhhCC-----CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQ-----HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
...+.+.+|+.+++.++ ||||+++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||
T Consensus 73 ~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL 150 (360)
T 3llt_A 73 KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKAL 150 (360)
T ss_dssp HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHH
Confidence 34567888999999997 999999999999999999999999 89999988642 234589999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCC-------------------------CCceEEcccccccccCCCCccccccccccc
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDS-------------------------NMNPKISDFGIARLFGGDELQSNTKRIVGT 136 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~-------------------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~ 136 (289)
.|||+++ |+||||||+|||++. ++.+||+|||+++..... .....||
T Consensus 151 ~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt 222 (360)
T 3llt_A 151 NYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINT 222 (360)
T ss_dssp HHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSC
T ss_pred HHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCc
Confidence 9999988 999999999999975 788999999999865332 2345789
Q ss_pred ccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC-----------ccccc-----
Q 038647 137 YGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR-----------AWELM----- 200 (289)
Q Consensus 137 ~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~----- 200 (289)
+.|+|||++.+..++.++|||||||++|+|++|+.||........ ............ .....
T Consensus 223 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 300 (360)
T 3llt_A 223 RQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH--LAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL 300 (360)
T ss_dssp GGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT
T ss_pred ccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH--HHHHHHhcCCCCHHHHhhhhhccCccccCcccc
Confidence 999999999999999999999999999999999999875443211 111111000000 00000
Q ss_pred -cccccCCCCHH---------------HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 201 -DSILQNDASYP---------------MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 201 -~~~~~~~~~~~---------------~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
........... ....+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 301 KLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp EECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred eecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 1156779999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=288.37 Aligned_cols=211 Identities=20% Similarity=0.268 Sum_probs=159.2
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+++|++++||||+++++++.. +..|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 183 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~ 258 (419)
T 3i6u_A 183 PALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN 258 (419)
T ss_dssp --CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34568999999999999999999999854 56899999999999999884 456799999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCC---ceEEcccccccccCCCCcccccccccccccccChhhhhc---CCCCCcccchhHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNM---NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFGV 161 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~ 161 (289)
+ |+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 259 ~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~ 332 (419)
T 3i6u_A 259 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332 (419)
T ss_dssp T---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHH
T ss_pred C---ccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHH
Confidence 8 99999999999997544 59999999998764322 2344679999999999863 56889999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..||........... . ...... ...... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 333 il~~lltg~~pf~~~~~~~~~~~-~----i~~~~~-~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 333 ILFICLSGYPPFSEHRTQVSLKD-Q----ITSGKY-NFIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHHHSSCSSCCCSSSCCHHH-H----HHTTCC-CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCcchHHHHH-H----HhcCCC-CCCchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99999999999875433221110 0 000000 000000 0113468899999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.27 Aligned_cols=211 Identities=24% Similarity=0.313 Sum_probs=169.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|++++||||+++++++.+.+..|+||||+.+|+|.+.+. ..+.+++..+..++.||+.||.|||+
T Consensus 63 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~ 139 (486)
T 3mwu_A 63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHK 139 (486)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457789999999999999999999999999999999999999999988884 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeC---CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLD---SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~---~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
++ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++
T Consensus 140 ~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 212 (486)
T 3mwu_A 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212 (486)
T ss_dssp TT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHH
T ss_pred CC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHH
Confidence 88 99999999999995 45679999999998764432 2334579999999999876 599999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||........ ..... ..... .........+..+.+++.+||+.||++|||+.++++
T Consensus 213 ~~ll~g~~pf~~~~~~~~--~~~i~----~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 213 YILLSGTPPFYGKNEYDI--LKRVE----TGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHSSCSSCCSSHHHH--HHHHH----HTCCC------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHH--HHHHH----hCCCC------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999999865433211 11110 00000 000011234568899999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=276.41 Aligned_cols=212 Identities=23% Similarity=0.359 Sum_probs=167.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
....+.+.+|+.+|++++||||+++++++.. +...++||||+++++|.+++. ..+.+++..+..++.|++.||
T Consensus 66 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l 142 (290)
T 1t4h_A 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGL 142 (290)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999875 456899999999999999994 335689999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.|||+.+ .+++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++.+ .++.++||||||
T Consensus 143 ~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG 216 (290)
T 1t4h_A 143 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 216 (290)
T ss_dssp HHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHH
Confidence 9999764 2499999999999997 78999999999997554322 234568999999998864 599999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|+|++|..||.......... ........... .....+..+.+++..||+.||++|||+.++++
T Consensus 217 ~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 217 MCMLEMATSEYPYSECQNAAQIY-----RRVTSGVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSSCTTTTCSSHHHHH-----HHHTTTCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCCCCCcCcHHHHH-----HHHhccCCccc--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99999999999986543322111 01111110000 11112357899999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.76 Aligned_cols=216 Identities=22% Similarity=0.235 Sum_probs=171.9
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|+++|+.+ +||||+++++++.+++..++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||
T Consensus 100 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH 176 (355)
T 1vzo_A 100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH 176 (355)
T ss_dssp SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999 699999999999999999999999999999999843 356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc--CCCCCcccchhHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGVLV 163 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~vl 163 (289)
+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 177 ~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il 252 (355)
T 1vzo_A 177 KLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252 (355)
T ss_dssp HTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHH
T ss_pred HCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence 988 99999999999999999999999999986543221 22334579999999999985 3578999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVI 238 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll 238 (289)
|+|++|..||........... ........ ....+...+..+.+++.+||+.||++|| ++.+++
T Consensus 253 ~ell~g~~pf~~~~~~~~~~~-~~~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell 320 (355)
T 1vzo_A 253 YELLTGASPFTVDGEKNSQAE-ISRRILKS-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 320 (355)
T ss_dssp HHHHHSSCTTSCTTSCCCHHH-HHHHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred HHHHHCCCCCccCCccchHHH-HHHHHhcc-----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH
Confidence 999999999875543321110 00000000 0112233456788999999999999999 999998
Q ss_pred HHh
Q 038647 239 SML 241 (289)
Q Consensus 239 ~~L 241 (289)
+..
T Consensus 321 ~h~ 323 (355)
T 1vzo_A 321 EHL 323 (355)
T ss_dssp TSG
T ss_pred cCc
Confidence 743
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=275.43 Aligned_cols=222 Identities=16% Similarity=0.169 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeE-eecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCC-IEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+++.+|+++++.++|++++..+.++ .+++..++||||+ +++|.+++.. ..+.+++..+..++.||+.||.|||++
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (296)
T 4hgt_A 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45689999999999988877666555 6778899999999 9999998853 234689999999999999999999998
Q ss_pred CCCceEeeccccCceEe---CCCCceEEcccccccccCCCCcc-----cccccccccccccChhhhhcCCCCCcccchhH
Q 038647 88 SRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill---~~~~~vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
+ |+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 125 ~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 201 (296)
T 4hgt_A 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 201 (296)
T ss_dssp T---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred C---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHH
Confidence 8 9999999999999 78899999999999876543221 12335578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcch-hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSL-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
||++|+|++|..||........ ............... .. .....+..+.+++..||+.||++|||+.+++
T Consensus 202 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 272 (296)
T 4hgt_A 202 GYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 272 (296)
T ss_dssp HHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHH
T ss_pred HHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----hh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHH
Confidence 9999999999999876443311 111110000000000 00 0011246889999999999999999999999
Q ss_pred HHhhccc
Q 038647 239 SMLTNEN 245 (289)
Q Consensus 239 ~~L~~~~ 245 (289)
+.|++..
T Consensus 273 ~~l~~~~ 279 (296)
T 4hgt_A 273 QLFRNLF 279 (296)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=296.72 Aligned_cols=211 Identities=25% Similarity=0.349 Sum_probs=170.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+.+|++++||||+++++++.+++..|+|||||++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~ 164 (504)
T 3q5i_A 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHK 164 (504)
T ss_dssp CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999988884 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCC---ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNM---NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
++ |+||||||+|||++.++ .+||+|||++....... ......||+.|+|||++. ..++.++|||||||++
T Consensus 165 ~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il 237 (504)
T 3q5i_A 165 HN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIM 237 (504)
T ss_dssp TT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHH
T ss_pred CC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHH
Confidence 88 99999999999998776 69999999998765432 233457999999999987 4689999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||........ ..... ...... .. ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~ll~g~~pf~~~~~~~~--~~~i~----~~~~~~--~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 238 YILLCGYPPFGGQNDQDI--IKKVE----KGKYYF--DF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHSSCSSCCSSHHHH--HHHHH----HCCCCC--CH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCCCCCCHHHH--HHHHH----cCCCCC--Cc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999875443211 11100 000000 00 000123468899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=296.42 Aligned_cols=212 Identities=22% Similarity=0.302 Sum_probs=169.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.+|+.++||||+++++++.+.+..|+|||||++|+|.+++. ....+++..+..++.||+.||.|||
T Consensus 77 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH 153 (494)
T 3lij_A 77 TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLH 153 (494)
T ss_dssp -CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999988874 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCC---CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSN---MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~---~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
+++ |+||||||+|||++.. +.+||+|||+++...... ......||+.|+|||++. ..++.++|||||||+
T Consensus 154 ~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~i 226 (494)
T 3lij_A 154 KHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVI 226 (494)
T ss_dssp HTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHH
T ss_pred HCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHH
Confidence 988 9999999999999764 459999999998765432 233457999999999986 569999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||........ ...... .... . ........+..+.+++.+||+.||++|||+.++++
T Consensus 227 l~~ll~g~~pf~~~~~~~~--~~~i~~----~~~~-~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 227 LFILLAGYPPFGGQTDQEI--LRKVEK----GKYT-F-----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHHHH----TCCC-C-----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCCCCCCCHHHH--HHHHHh----CCCC-C-----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 9999999999875443211 111100 0000 0 00000123468899999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=276.41 Aligned_cols=207 Identities=20% Similarity=0.300 Sum_probs=166.1
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.....++.+|+.++..+ +||||+++++++.+++..++||||+++++|.+++.... ..+.+++..+..++.||+.||.|
T Consensus 51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~ 130 (289)
T 1x8b_A 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130 (289)
T ss_dssp SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 34567889999999999 89999999999999999999999999999999985321 12568999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCC-------------------CceEEcccccccccCCCCcccccccccccccccChhh
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSN-------------------MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~-------------------~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 144 (289)
||+++ |+||||||+||+++.+ ..+||+|||.+....... ...|++.|+|||+
T Consensus 131 lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~ 201 (289)
T 1x8b_A 131 IHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEV 201 (289)
T ss_dssp HHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHH
T ss_pred HHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhH
Confidence 99988 9999999999999844 479999999998764332 2358999999999
Q ss_pred hhcC-CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 145 ALRG-LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 145 ~~~~-~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
+.+. .++.++||||||+++|+|++|.+++..... +........ ...+...+..+.+++.+|
T Consensus 202 ~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------~~~~~~~~~---------~~~~~~~~~~~~~li~~~ 263 (289)
T 1x8b_A 202 LQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---------WHEIRQGRL---------PRIPQVLSQEFTELLKVM 263 (289)
T ss_dssp HTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---------HHHHHTTCC---------CCCSSCCCHHHHHHHHHH
T ss_pred hcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---------HHHHHcCCC---------CCCCcccCHHHHHHHHHH
Confidence 9866 567899999999999999999876532210 011111111 111223456889999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|+.||++|||+.++++
T Consensus 264 l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 264 IHPDPERRPSAMALVK 279 (289)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred hCCCcccCCCHHHHhh
Confidence 9999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=280.21 Aligned_cols=221 Identities=27% Similarity=0.410 Sum_probs=171.7
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l 81 (289)
+....+.+.+|++++++++||||+++++++.+ ++..++||||+++++|.+++.... ....+++..++.++.|++.||
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 124 (279)
T 2w5a_A 45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124 (279)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence 34457789999999999999999999998854 678999999999999999885422 234589999999999999999
Q ss_pred HHHhcCC--CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 82 LYLHHYS--RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~--~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
.|||+.+ ..+++||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||
T Consensus 125 ~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (279)
T 2w5a_A 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202 (279)
T ss_dssp HHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHH
T ss_pred HHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHH
Confidence 9999764 1239999999999999999999999999998764332 11234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+++|+|++|..||....... .... ...... ...+...+..+.+++.+||+.||++|||+.+|++
T Consensus 203 G~il~~l~~g~~p~~~~~~~~--~~~~----i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 203 GCLLYELCALMPPFTAFSQKE--LAGK----IREGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHHHHHHHHSSCSSCCSSHHH--HHHH----HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCCCCcccCHHH--HHHH----Hhhccc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 999999999999987543221 1111 111110 0112234568999999999999999999999988
Q ss_pred Hhh
Q 038647 240 MLT 242 (289)
Q Consensus 240 ~L~ 242 (289)
.+.
T Consensus 268 ~~~ 270 (279)
T 2w5a_A 268 NPL 270 (279)
T ss_dssp STT
T ss_pred Chh
Confidence 553
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=273.74 Aligned_cols=224 Identities=16% Similarity=0.163 Sum_probs=173.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeE-eecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCC-IEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+++.+|+++++.++|++++..+.++ .+++..++||||+ +++|.+++.. ..+.+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~ 123 (296)
T 3uzp_A 47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS 123 (296)
T ss_dssp SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345799999999999988877655555 6677889999999 9999999853 23468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeC---CCCceEEcccccccccCCCCcc-----cccccccccccccChhhhhcCCCCCcccchh
Q 038647 87 YSRLRVIHRDLKASNILLD---SNMNPKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~---~~~~vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 158 (289)
++ |+||||||+||+++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++||||
T Consensus 124 ~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 200 (296)
T 3uzp_A 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLES 200 (296)
T ss_dssp TT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred CC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHH
Confidence 88 99999999999994 8889999999999876543321 1124457899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcch-hHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSL-TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
||+++|+|++|+.||........ ............... .. .....+..+.+++..||+.||++|||+.+|
T Consensus 201 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 271 (296)
T 3uzp_A 201 LGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp HHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred HHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----HH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence 99999999999999876433211 111110000000000 00 001234688999999999999999999999
Q ss_pred HHHhhcccC
Q 038647 238 ISMLTNENV 246 (289)
Q Consensus 238 l~~L~~~~~ 246 (289)
++.|++...
T Consensus 272 ~~~l~~~~~ 280 (296)
T 3uzp_A 272 RQLFRNLFH 280 (296)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=282.53 Aligned_cols=205 Identities=23% Similarity=0.232 Sum_probs=160.2
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...++..|+..+.++ +||||+++++++.+++..|+||||+ +++|.+++... ...+++..+..++.||+.||.|||+
T Consensus 99 ~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~ 175 (311)
T 3p1a_A 99 DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS 175 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 445566677666666 8999999999999999999999999 66888877532 3468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 176 ~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 176 QG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEV 248 (311)
T ss_dssp TT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHH
T ss_pred CC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHH
Confidence 88 9999999999999999999999999988764332 2233468999999999876 799999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|..++..... +........ ........+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~g~~~~~~~~~---------~~~~~~~~~--------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 249 ACNMELPHGGEG---------WQQLRQGYL--------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTCCCCSSHHH---------HHHHTTTCC--------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCCCCCCCccH---------HHHHhccCC--------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 999766543211 111111100 00001123468899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=276.73 Aligned_cols=212 Identities=21% Similarity=0.335 Sum_probs=173.1
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.
T Consensus 67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~ 144 (314)
T 3com_A 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM 144 (314)
T ss_dssp CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 467899999999999999999999999999999999999999999998842 235689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ell 167 (289)
+ ++||||||+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 145 ~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 219 (314)
T 3com_A 145 R---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219 (314)
T ss_dssp T---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHH
T ss_pred C---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHH
Confidence 8 9999999999999999999999999998764332 1233456899999999999989999999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|..||.......... .... ..... -......+..+.+++.+||+.||++|||+.++++
T Consensus 220 ~g~~p~~~~~~~~~~~-----~~~~-~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 220 EGKPPYADIHPMRAIF-----MIPT-NPPPT-------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HSSCTTTTSCHHHHHH-----HHHH-SCCCC-------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hCCCCCCCCChHHHHH-----HHhc-CCCcc-------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999986543221110 0000 00000 0111223568899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=285.70 Aligned_cols=219 Identities=21% Similarity=0.262 Sum_probs=169.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+++.+|+++|+.++||||+++++++...+ ..|+||||+ +++|.+++.. ..+++..+..++.||+.
T Consensus 65 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~ 139 (367)
T 1cm8_A 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLK 139 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHH
Confidence 344678899999999999999999999998653 469999999 8899998843 46889999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchh
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFS 158 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diws 158 (289)
||.|||++| |+||||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||
T Consensus 140 ~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 211 (367)
T 1cm8_A 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWS 211 (367)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHH
T ss_pred HHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHH
Confidence 999999988 999999999999999999999999999875432 233578999999999987 67999999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccC-----------Cccccccccc------cCCCCHHHHHHHHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG-----------RAWELMDSIL------QNDASYPMLNRYINVAL 221 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~------~~~~~~~~~~~l~~li~ 221 (289)
|||++|+|++|+.||...+.... ........... .....+.... ........+..+.+++.
T Consensus 212 lG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 289 (367)
T 1cm8_A 212 VGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289 (367)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 99999999999999876543211 11100000000 0000000000 00111223568899999
Q ss_pred cccccCCCCCCCHHHHHH
Q 038647 222 LCVQENAADRPTMLEVIS 239 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~ 239 (289)
+||+.||++|||+.++++
T Consensus 290 ~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 290 KMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHSCSSTTTSCCHHHHHH
T ss_pred HHccCChhHCCCHHHHhc
Confidence 999999999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=283.33 Aligned_cols=224 Identities=20% Similarity=0.266 Sum_probs=165.2
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRL 90 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 90 (289)
.+.+|+++|++++||||+++++++.+++..++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+++
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-- 120 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK-- 120 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 45679999999999999999999999999999999997 588887753 2346899999999999999999999988
Q ss_pred ceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHHhC
Q 038647 91 RVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSS 169 (289)
Q Consensus 91 ~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~elltg 169 (289)
|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 121 -ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (324)
T 3mtl_A 121 -VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197 (324)
T ss_dssp -EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred -ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654322 12334568999999999986 5689999999999999999999
Q ss_pred CCCcCCCCCcchhHhHhHhhhhccC---Cccccccc---------cccC----CCCHHHHHHHHHHHHcccccCCCCCCC
Q 038647 170 KKNAHFYNTDSLTLLGHAWNLWNDG---RAWELMDS---------ILQN----DASYPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 170 ~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
..||........ ........... ........ .... ......+..+.+++.+||+.||++|||
T Consensus 198 ~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 275 (324)
T 3mtl_A 198 RPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275 (324)
T ss_dssp SCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCHHHH--HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC
Confidence 999876543321 11111111100 00000000 0000 001123467889999999999999999
Q ss_pred HHHHHH--Hhhcc
Q 038647 234 MLEVIS--MLTNE 244 (289)
Q Consensus 234 ~~~ll~--~L~~~ 244 (289)
++|+++ ++...
T Consensus 276 ~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 276 AEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHTTSGGGGGG
T ss_pred HHHHhcChhhhhc
Confidence 999987 44443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.21 Aligned_cols=214 Identities=20% Similarity=0.285 Sum_probs=171.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 125 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHEN 125 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678999999999999999999999999999999999999999999884 345689999999999999999999998
Q ss_pred CCCceEeeccccCceEe---CCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill---~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+ ++||||||+||++ +.++.++|+|||++...... ......|++.|+|||++.+..++.++||||||+++|
T Consensus 126 ~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 198 (304)
T 2jam_A 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITY 198 (304)
T ss_dssp T---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHH
T ss_pred C---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHH
Confidence 8 9999999999999 78899999999998764332 223456899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--Hhh
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--MLT 242 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~L~ 242 (289)
+|++|..||....... ...... .... ..........+..+.+++.+||+.||++|||+.++++ ++.
T Consensus 199 ~l~~g~~pf~~~~~~~--~~~~i~----~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 199 ILLCGYPPFYEETESK--LFEKIK----EGYY------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp HHHHSSCTTTTSCHHH--HHHHHH----HCCC------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHCCCCCCCCCHHH--HHHHHH----cCCC------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 9999999986543221 111110 0000 0001112234578999999999999999999999986 444
Q ss_pred c
Q 038647 243 N 243 (289)
Q Consensus 243 ~ 243 (289)
.
T Consensus 267 ~ 267 (304)
T 2jam_A 267 G 267 (304)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=282.64 Aligned_cols=210 Identities=21% Similarity=0.321 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+.+.+|+.+++++ +||||+++++++...+..|+||||+++++|.+++. ....+++..+..++.||+.||.|||+.
T Consensus 143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~ 219 (365)
T 2y7j_A 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHAN 219 (365)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56788999999999 79999999999999999999999999999999984 345689999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc------CCCCCcccchhHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR------GLFSIKSDVFSFGV 161 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~ 161 (289)
| ++||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 220 g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 293 (365)
T 2y7j_A 220 N---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293 (365)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHH
T ss_pred C---eecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHH
Confidence 8 9999999999999999999999999998765432 2334578999999999974 35889999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..||...... ....... ..... ...... ...+..+.+++.+||+.||++|||+.++++
T Consensus 294 il~ell~g~~pf~~~~~~--~~~~~i~----~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 294 ILFTLLAGSPPFWHRRQI--LMLRMIM----EGQYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHSSCSSCCSSHH--HHHHHHH----HTCCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCCHH--HHHHHHH----hCCCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999998643221 1111100 00000 000000 012357899999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=274.86 Aligned_cols=216 Identities=19% Similarity=0.231 Sum_probs=168.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeE--eecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCC--IEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+..+.+.+|++++++++||||+++++++ .+++..++||||++++ |.+++... ..+.+++..+..++.||+.||.||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~L 125 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYL 125 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999998 4556899999999877 66665432 345789999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC--CCCcccchhHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVL 162 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~v 162 (289)
|+++ ++||||||+||+++.++.+||+|||++................|++.|+|||++.+.. ++.++||||||++
T Consensus 126 H~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i 202 (305)
T 2wtk_C 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202 (305)
T ss_dssp HHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHH
T ss_pred HHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHH
Confidence 9988 9999999999999999999999999998765433333334557899999999998654 3789999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--H
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--M 240 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~ 240 (289)
+|+|++|..||....... .... ..... .......+..+.+++.+||+.||++|||+.++++ +
T Consensus 203 l~~l~~g~~p~~~~~~~~--~~~~----i~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 203 LYNITTGLYPFEGDNIYK--LFEN----IGKGS----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHHHHHSSCSCCCSSHHH--HHHH----HHHCC----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred HHHHHhCCCCCCCchHHH--HHHH----HhcCC----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 999999999986543211 1110 00000 0111223467889999999999999999999996 4
Q ss_pred hhc
Q 038647 241 LTN 243 (289)
Q Consensus 241 L~~ 243 (289)
+..
T Consensus 267 ~~~ 269 (305)
T 2wtk_C 267 FRK 269 (305)
T ss_dssp HHS
T ss_pred ccc
Confidence 444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=280.97 Aligned_cols=222 Identities=24% Similarity=0.340 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhh------hcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF------LFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
.+.|.+|++++++++||||+++++++.+.+..++||||+++|+|.++ +.. .....+++..+..++.|++.||.
T Consensus 87 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~ 165 (348)
T 2pml_X 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFS 165 (348)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHH
Confidence 38999999999999999999999999999999999999999999998 532 22567999999999999999999
Q ss_pred HHhc-CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCC-cccchhH
Q 038647 83 YLHH-YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSI-KSDVFSF 159 (289)
Q Consensus 83 ~lH~-~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Diwsl 159 (289)
|||+ ++ ++||||||+||+++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||
T Consensus 166 ~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 238 (348)
T 2pml_X 166 YIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238 (348)
T ss_dssp HHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHH
T ss_pred HHhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHH
Confidence 9998 87 999999999999999999999999999876433 23345789999999999877 5666 9999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC--ccccccccc---cCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR--AWELMDSIL---QNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|+++|+|++|..||.......... ........... ......... ........+..+.+++.+||+.||++|||+
T Consensus 239 G~il~~l~~g~~pf~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~ 317 (348)
T 2pml_X 239 GICLYVMFYNVVPFSLKISLVELF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317 (348)
T ss_dssp HHHHHHHHHSSCSSCCSSCSHHHH-HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHH-HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH
Confidence 999999999999987654421111 11000000000 000000000 000112345788999999999999999999
Q ss_pred HHHHH
Q 038647 235 LEVIS 239 (289)
Q Consensus 235 ~~ll~ 239 (289)
.++++
T Consensus 318 ~e~l~ 322 (348)
T 2pml_X 318 EDALK 322 (348)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=292.56 Aligned_cols=205 Identities=17% Similarity=0.228 Sum_probs=158.1
Q ss_pred cccCHHHHHHHH---HHHhhCCCCCceeee-------eeEeecC-----------------eEEEEEeecCCCChhhhhc
Q 038647 5 SGQGLEEFKNEM---MLIAKLQHRNLVRLF-------GCCIEHG-----------------EKILIYEYMPNKSLDCFLF 57 (289)
Q Consensus 5 ~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~ 57 (289)
.....+.|.+|+ ++|++++|||||+++ +++.+.+ ..|+||||+ +|+|.+++.
T Consensus 113 ~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~ 191 (377)
T 3byv_A 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGE 191 (377)
T ss_dssp CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHH
T ss_pred chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHH
Confidence 344678899999 556666899999998 6665553 388999999 689999985
Q ss_pred CCC----CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccc
Q 038647 58 DPT----KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRI 133 (289)
Q Consensus 58 ~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 133 (289)
... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .....
T Consensus 192 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~ 263 (377)
T 3byv_A 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSS 263 (377)
T ss_dssp HHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECC
T ss_pred hccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCC
Confidence 321 0122335788899999999999999988 99999999999999999999999999986432 23345
Q ss_pred cccccccChhhhhcC-----------CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccc
Q 038647 134 VGTYGYMSPEYALRG-----------LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDS 202 (289)
Q Consensus 134 ~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (289)
.| +.|+|||++.+. .++.++|||||||++|+|++|..||......... ..
T Consensus 264 ~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~------------------~~ 324 (377)
T 3byv_A 264 VS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS------------------EW 324 (377)
T ss_dssp CC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS------------------GG
T ss_pred CC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch------------------hh
Confidence 67 999999999987 8999999999999999999999998643322110 01
Q ss_pred cccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 203 ILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 203 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.... ....+..+.+++.+||+.||++|||+.++++
T Consensus 325 ~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 325 IFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp GGSS--CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred hhhh--ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 1110 0123468899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=274.29 Aligned_cols=208 Identities=21% Similarity=0.352 Sum_probs=163.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+
T Consensus 53 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~ 129 (276)
T 2h6d_A 53 DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR 129 (276)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999999843 3568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~e 165 (289)
++ ++||||||+||+++.++.++|+|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+
T Consensus 130 ~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 203 (276)
T 2h6d_A 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203 (276)
T ss_dssp HC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHH
T ss_pred CC---CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHH
Confidence 88 9999999999999999999999999998764432 1233468999999999988765 689999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||....... .... ..... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 204 l~~g~~p~~~~~~~~--~~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 204 LLCGTLPFDDEHVPT--LFKK----IRGGV----------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHSSCSSCCSSHHH--HHHH----HHHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCCcHHH--HHHH----hhcCc----------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 999999986533211 1110 00000 0111223467889999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=278.56 Aligned_cols=215 Identities=20% Similarity=0.356 Sum_probs=167.6
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....+++.+|+++++.++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 56 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~l 133 (302)
T 2j7t_A 56 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFL 133 (302)
T ss_dssp --CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999999999999999999999999999999988753 234589999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSF 159 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Diwsl 159 (289)
|+++ ++||||||+||+++.++.+||+|||++...... ........|++.|+|||++. +..++.++|||||
T Consensus 134 H~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 208 (302)
T 2j7t_A 134 HSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 208 (302)
T ss_dssp HHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred hcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence 9988 999999999999999999999999987643211 11123346899999999984 5678999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+++|+|++|..|+......... . ........ ........+..+.+++.+||+.||++|||+.++++
T Consensus 209 G~il~~l~~g~~p~~~~~~~~~~--~---~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 209 GITLIEMAQIEPPHHELNPMRVL--L---KIAKSDPP--------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHH--H---HHHHSCCC--------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHhcCCCCCccCCHHHHH--H---HHhccCCc--------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999999999998754322111 0 00000000 00112234568899999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=274.53 Aligned_cols=211 Identities=20% Similarity=0.280 Sum_probs=165.0
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+++|++++||||+++++++..++ .|+||||+++++|.+++. ..+.+++..+..++.||+.||.|||++
T Consensus 58 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (322)
T 2ycf_A 58 PALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN 133 (322)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4557899999999999999999999987665 899999999999999884 446789999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCc---eEEcccccccccCCCCcccccccccccccccChhhhh---cCCCCCcccchhHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMN---PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGV 161 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~ 161 (289)
+ |+||||||+||+++.++. +||+|||+++...... ......|++.|+|||++. ...++.++||||||+
T Consensus 134 ~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 207 (322)
T 2ycf_A 134 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207 (322)
T ss_dssp T---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHH
T ss_pred C---eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHH
Confidence 8 999999999999987665 9999999998764322 123456899999999985 467899999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..||.......... ... ..... ...... ....+..+.+++.+||+.||++|||+.++++
T Consensus 208 il~~l~~g~~pf~~~~~~~~~~-~~~----~~~~~-~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 208 ILFICLSGYPPFSEHRTQVSLK-DQI----TSGKY-NFIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHSSCSSCSTTCSSCHH-HHH----HHTCC-CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCCCcccchHHHHH-HHH----HhCcc-ccCchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999999999987544332111 000 00000 000000 0113468899999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=284.47 Aligned_cols=223 Identities=20% Similarity=0.216 Sum_probs=157.6
Q ss_pred ccCHHHHHHHHHHHhhCC-CCCceeeeeeEe--------ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCI--------EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEG 76 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 76 (289)
....+.+.+|+.+++++. ||||+++++++. .....++||||+. |+|.+++......+.+++..++.++.|
T Consensus 66 ~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~q 144 (337)
T 3ll6_A 66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQ 144 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHH
Confidence 345678899999999996 999999999994 3445899999995 688888754334567999999999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc----------ccccccccccccChhhh-
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS----------NTKRIVGTYGYMSPEYA- 145 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~- 145 (289)
|+.||.|||+++ .+|+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++
T Consensus 145 i~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 145 TCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp HHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------
T ss_pred HHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 999999999753 249999999999999999999999999998765332111 11244689999999999
Q ss_pred --hcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 146 --LRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 146 --~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
.+..++.++||||||+++|+|++|..||........ .............+..+.+++..|
T Consensus 224 ~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~ 285 (337)
T 3ll6_A 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI------------------VNGKYSIPPHDTQYTVFHSLIRAM 285 (337)
T ss_dssp CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------------------CCCCTTCCSSGGGHHHHHHH
T ss_pred ccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh------------------hcCcccCCcccccchHHHHHHHHH
Confidence 566789999999999999999999999864322110 011111111112234578899999
Q ss_pred cccCCCCCCCHHHHHHHhhcccCCC
Q 038647 224 VQENAADRPTMLEVISMLTNENVIL 248 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~~L~~~~~~~ 248 (289)
|+.||++|||+.|+++.|.......
T Consensus 286 l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 286 LQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp SCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ccCChhhCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999999876443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=286.43 Aligned_cols=219 Identities=17% Similarity=0.215 Sum_probs=162.5
Q ss_pred HHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 13 KNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 13 ~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
.+|+++|+.++||||+++++++...+ .+++||||++++.+............+++..+..++.||+.||.|||+
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999996544 388999999876544333211234578999999999999999999999
Q ss_pred CCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~ 164 (289)
++ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|
T Consensus 160 ~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 233 (394)
T 4e7w_A 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233 (394)
T ss_dssp TT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred CC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence 88 99999999999998 799999999999987643322 2335689999999999765 5899999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhcc---------------CCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWND---------------GRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+|++|+.||...+...... ........ ...................+.++.+++.+||+.||+
T Consensus 234 ell~g~~pf~~~~~~~~l~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (394)
T 4e7w_A 234 ELMQGQPLFPGESGIDQLV--EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311 (394)
T ss_dssp HHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChh
Confidence 9999999987654322111 11110000 000000000000001112446899999999999999
Q ss_pred CCCCHHHHHH
Q 038647 230 DRPTMLEVIS 239 (289)
Q Consensus 230 ~Rps~~~ll~ 239 (289)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (394)
T 4e7w_A 312 ARLTAIEALC 321 (394)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.03 Aligned_cols=216 Identities=23% Similarity=0.315 Sum_probs=171.5
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.|.+|+.+|++++||||+++++++. ++..|+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 433 ~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~ 509 (656)
T 2j0j_A 433 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLES 509 (656)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34578999999999999999999999985 4578999999999999999853 23458899999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|
T Consensus 510 ~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 585 (656)
T 2j0j_A 510 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585 (656)
T ss_dssp TT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 88 999999999999999999999999999876443221 12234567899999999999999999999999999999
Q ss_pred Hh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 167 LS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 167 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
++ |..||....... ..... .... ....+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 586 lt~g~~Pf~~~~~~~--~~~~i----~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 586 LMHGVKPFQGVKNND--VIGRI----ENGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HTTSCCTTTTCCHHH--HHHHH----HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCHHH--HHHHH----HcCC---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 97 888876543221 11111 0000 0112223457889999999999999999999999998864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=278.62 Aligned_cols=213 Identities=24% Similarity=0.375 Sum_probs=163.6
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEee------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIE------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
...+.+.+|+.+++++ +||||+++++++.. .+..++||||+++|+|.+++... ....+++..+..++.||+.
T Consensus 62 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~ 140 (326)
T 2x7f_A 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILR 140 (326)
T ss_dssp STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHH
Confidence 3567899999999999 79999999999987 56899999999999999998542 2356889999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcc
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKS 154 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~ 154 (289)
||.|||+++ ++||||||+||+++.++.+||+|||++....... .......|++.|+|||++. +..++.++
T Consensus 141 ~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 215 (326)
T 2x7f_A 141 GLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215 (326)
T ss_dssp HHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTH
T ss_pred HHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccc
Confidence 999999988 9999999999999999999999999988654321 1223456899999999997 56789999
Q ss_pred cchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
||||||+++|+|++|..||.......... .... ... ........+..+.+++.+||+.||++|||+
T Consensus 216 Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 281 (326)
T 2x7f_A 216 DLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR-NPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPAT 281 (326)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHH-SCC--------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHH-----Hhhc-Ccc--------ccCCccccCHHHHHHHHHHhccChhhCCCH
Confidence 99999999999999999986443221110 0000 000 001112234688999999999999999999
Q ss_pred HHHHH
Q 038647 235 LEVIS 239 (289)
Q Consensus 235 ~~ll~ 239 (289)
.++++
T Consensus 282 ~~ll~ 286 (326)
T 2x7f_A 282 EQLMK 286 (326)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=303.45 Aligned_cols=210 Identities=23% Similarity=0.295 Sum_probs=174.2
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
....+.+..|..+|..+ +||||+++++++.+.+.+|+||||+++|+|..++. ..+.+++..+..++.||+.||.||
T Consensus 382 ~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~L 458 (674)
T 3pfq_A 382 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFL 458 (674)
T ss_dssp TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999998 79999999999999999999999999999999984 345799999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|
T Consensus 459 H~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvily 533 (674)
T 3pfq_A 459 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533 (674)
T ss_dssp HHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHH
T ss_pred HhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHH
Confidence 9988 9999999999999999999999999998643222 2244568999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCH-----HHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTM-----LEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~ 239 (289)
||++|..||...+... .... .... . ...+...+.++.++|..||+.||++||++ +||++
T Consensus 534 elltG~~Pf~~~~~~~--~~~~---i~~~-~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 534 EMLAGQAPFEGEDEDE--LFQS---IMEH-N----------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHSSCSSCCSSHHH--HHHH---HHSS-C----------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHcCCCCCCCCCHHH--HHHH---HHhC-C----------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 9999999987543321 1111 1110 0 11223456789999999999999999997 77764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=272.25 Aligned_cols=211 Identities=22% Similarity=0.295 Sum_probs=170.5
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+++|+++. ||||+++++++.+++..++||||+++++|.+++. ....+++..+..++.||+.||.|||+
T Consensus 66 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~ 142 (298)
T 1phk_A 66 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHK 142 (298)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3567889999999995 9999999999999999999999999999999984 34568999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh------cCCCCCcccchhHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL------RGLFSIKSDVFSFG 160 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG 160 (289)
++ ++||||||+||+++.++.+||+|||++....... ......|++.|+|||++. ...++.++||||||
T Consensus 143 ~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 216 (298)
T 1phk_A 143 LN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216 (298)
T ss_dssp TT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred CC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence 88 9999999999999999999999999998765432 223356899999999986 45678999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|+|++|..||....... ...... . ... ..........+..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~l~~l~~g~~p~~~~~~~~--~~~~~~---~-~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 217 VIMYTLLAGSPPFWHRKQML--MLRMIM---S-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHH--HHHHHH---H-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCcCccHHH--HHHHHh---c-CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 99999999999986543221 111100 0 000 0000111234578999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=286.24 Aligned_cols=227 Identities=23% Similarity=0.327 Sum_probs=157.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCC------CCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDP------TKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~~~~i~~~ 80 (289)
.+.+.+|+.+|++++||||+++++++.. +...|+||||+.+ +|.+++... .....+++..++.++.||+.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 4578899999999999999999999954 6789999999965 676666321 122358999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEe----CCCCceEEcccccccccCCCC-cccccccccccccccChhhhhcC-CCCCcc
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILL----DSNMNPKISDFGIARLFGGDE-LQSNTKRIVGTYGYMSPEYALRG-LFSIKS 154 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill----~~~~~vkl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~ 154 (289)
|.|||+++ |+||||||+|||+ +.++.+||+|||+++...... .........||+.|+|||++.+. .++.++
T Consensus 141 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 217 (405)
T 3rgf_A 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 217 (405)
T ss_dssp HHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHH
T ss_pred HHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchh
Confidence 99999988 9999999999999 678899999999998764321 11223456789999999999874 589999
Q ss_pred cchhHHHHHHHHHhCCCCcCCCCCcc-------hhHhHhHhhhhcc--CCccccccc----------c---ccCCC----
Q 038647 155 DVFSFGVLVLETLSSKKNAHFYNTDS-------LTLLGHAWNLWND--GRAWELMDS----------I---LQNDA---- 208 (289)
Q Consensus 155 DiwslG~vl~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~--~~~~~~~~~----------~---~~~~~---- 208 (289)
|||||||++|+|++|..||....... ............. ...+..+.. . .....
T Consensus 218 DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (405)
T 3rgf_A 218 DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK 297 (405)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHH
T ss_pred hhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhh
Confidence 99999999999999999997544321 0111111110000 000000000 0 00000
Q ss_pred -----CHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 209 -----SYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 209 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
....+..+.+|+.+||+.||++|||++|+++
T Consensus 298 ~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 298 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011357789999999999999999999997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=283.30 Aligned_cols=219 Identities=21% Similarity=0.259 Sum_probs=156.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+++.+|+++|+.++||||+++++++... ...|+|+||+ +++|.+++.. +.+++..+..++.||+.
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~ 143 (367)
T 2fst_X 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILR 143 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHH
Confidence 34567889999999999999999999998754 5689999999 7899888742 56899999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchh
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFS 158 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diws 158 (289)
||.|||++| |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||
T Consensus 144 aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 215 (367)
T 2fst_X 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 215 (367)
T ss_dssp HHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHH
T ss_pred HHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHH
Confidence 999999988 999999999999999999999999999865322 234578999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccC-----------CccccccccccC-CCC-----HHHHHHHHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG-----------RAWELMDSILQN-DAS-----YPMLNRYINVAL 221 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~-~~~-----~~~~~~l~~li~ 221 (289)
|||++|+|++|+.||...+.... ........... .....+...... ... ...+..+.+++.
T Consensus 216 lG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 293 (367)
T 2fst_X 216 VGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293 (367)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 99999999999999876543211 11111100000 000000000000 000 112467889999
Q ss_pred cccccCCCCCCCHHHHHH
Q 038647 222 LCVQENAADRPTMLEVIS 239 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~ 239 (289)
+||+.||++|||+.++++
T Consensus 294 ~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 294 KMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCcccCcCHHHHhc
Confidence 999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.83 Aligned_cols=215 Identities=10% Similarity=0.073 Sum_probs=150.3
Q ss_pred cCHHHHHHHHHHHhhC--CCCCceeee-------eeEeec-----------------CeEEEEEeecCCCChhhhhcCCC
Q 038647 7 QGLEEFKNEMMLIAKL--QHRNLVRLF-------GCCIEH-----------------GEKILIYEYMPNKSLDCFLFDPT 60 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~ 60 (289)
...+.+.+|+.+++.+ +||||++++ +++... ...|+||||++ |+|.+++...
T Consensus 104 ~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~- 181 (371)
T 3q60_A 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL- 181 (371)
T ss_dssp HHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-
T ss_pred cHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-
Confidence 4567788885544444 699988755 444433 34899999998 8999998542
Q ss_pred CCCCCChHHH------HHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccccccccc
Q 038647 61 KTGLLGWEMR------VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIV 134 (289)
Q Consensus 61 ~~~~~~~~~~------~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 134 (289)
...+++..+ ..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 182 -~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~ 252 (371)
T 3q60_A 182 -DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASS 252 (371)
T ss_dssp -HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGG
T ss_pred -ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCcc
Confidence 223455555 677899999999999988 999999999999999999999999999876432 11345
Q ss_pred ccccccChhhhhc--CCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHH
Q 038647 135 GTYGYMSPEYALR--GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPM 212 (289)
Q Consensus 135 g~~~y~aPE~~~~--~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (289)
+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.....................
T Consensus 253 ~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 325 (371)
T 3q60_A 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPL 325 (371)
T ss_dssp SCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCC
T ss_pred CCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc-------hhhhhhhhccccccchhhccCC
Confidence 6799999999987 679999999999999999999999987654321110 0000000000001111111234
Q ss_pred HHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 213 LNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 213 ~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+..+.+++.+||+.||++|||+.++++
T Consensus 326 ~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 326 PDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 578999999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=285.96 Aligned_cols=222 Identities=16% Similarity=0.181 Sum_probs=173.4
Q ss_pred CHHHHHHHHHHHhhCCC-CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQH-RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+++.+|+++++.++| +++..+..++.+++..++||||+ +++|.+++.. ..+.+++..++.++.||+.||.|||+
T Consensus 45 ~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~ 121 (483)
T 3sv0_A 45 KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHS 121 (483)
T ss_dssp SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34568999999999976 55666777778888999999999 9999999853 23568999999999999999999999
Q ss_pred CCCCceEeeccccCceEe---CCCCceEEcccccccccCCCCcc-----cccccccccccccChhhhhcCCCCCcccchh
Q 038647 87 YSRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDELQ-----SNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill---~~~~~vkl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 158 (289)
++ |+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||
T Consensus 122 ~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwS 198 (483)
T 3sv0_A 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLES 198 (483)
T ss_dssp TT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred CC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHH
Confidence 88 9999999999999 58899999999999876543321 1223567999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchh-HhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLT-LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
|||++|+|++|..||......... ........... ..+.... ...+.++.+++..||+.||++||++.+|
T Consensus 199 lGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~----~~~~~l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el 269 (483)
T 3sv0_A 199 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA----TSIEALC-----RGYPTEFASYFHYCRSLRFDDKPDYSYL 269 (483)
T ss_dssp HHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----SCHHHHH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----ccHHHHh-----cCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 999999999999998765443211 11111100000 0000000 1124688999999999999999999999
Q ss_pred HHHhhcc
Q 038647 238 ISMLTNE 244 (289)
Q Consensus 238 l~~L~~~ 244 (289)
++.|+..
T Consensus 270 ~~~L~~l 276 (483)
T 3sv0_A 270 KRLFRDL 276 (483)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998865
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.47 Aligned_cols=220 Identities=21% Similarity=0.220 Sum_probs=160.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+.+.+|+.+++.++||||+++++++...+ ..|+||||+++ +|.+++. ..+++..+..++.||+.
T Consensus 65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~ 138 (371)
T 2xrw_A 65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLC 138 (371)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHH
Confidence 345678999999999999999999999998665 78999999975 6777773 24889999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus 139 al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 212 (371)
T 2xrw_A 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212 (371)
T ss_dssp HHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence 999999988 9999999999999999999999999998654321 2234578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhc-------------------cCC------ccccccccccCCC---CHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWN-------------------DGR------AWELMDSILQNDA---SYP 211 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~------~~~~~~~~~~~~~---~~~ 211 (289)
||++|+|++|..||...+.... ......... ... ............. ...
T Consensus 213 G~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (371)
T 2xrw_A 213 GCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290 (371)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccccccc
Confidence 9999999999999876443211 000000000 000 0000000000000 112
Q ss_pred HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 212 MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+..+.+++.+||+.||++|||++|+++
T Consensus 291 ~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 291 KASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 3568899999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=275.53 Aligned_cols=214 Identities=23% Similarity=0.307 Sum_probs=163.2
Q ss_pred cccCHHHHHHHHHHHhhCC--CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQ--HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
+.+..+.+.+|++++++++ ||||+++++++.+++..++||| +.+++|.+++.. .+.+++..+..++.|++.||.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~ 141 (313)
T 3cek_A 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVH 141 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHH
Confidence 3446788999999999997 5999999999999999999999 568899999853 356889999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-----------CCCC
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-----------GLFS 151 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~ 151 (289)
|||+++ |+||||||+||++++ +.+||+|||+++...............|++.|+|||++.+ ..++
T Consensus 142 ~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 217 (313)
T 3cek_A 142 TIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 217 (313)
T ss_dssp HHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCC
T ss_pred HHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCC
Confidence 999988 999999999999964 8899999999987654332223344578999999999975 4688
Q ss_pred CcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCC
Q 038647 152 IKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADR 231 (289)
Q Consensus 152 ~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (289)
.++||||||+++|+|++|..||........... ...... .....+...+..+.+++.+||+.||++|
T Consensus 218 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~R 284 (313)
T 3cek_A 218 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----AIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQR 284 (313)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTS
T ss_pred chHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH----HHHhcc---------cccCCcccchHHHHHHHHHHccCCcccC
Confidence 999999999999999999999865433211111 111111 0011111224678999999999999999
Q ss_pred CCHHHHHH
Q 038647 232 PTMLEVIS 239 (289)
Q Consensus 232 ps~~~ll~ 239 (289)
||+.++++
T Consensus 285 ps~~ell~ 292 (313)
T 3cek_A 285 ISIPELLA 292 (313)
T ss_dssp CCHHHHHT
T ss_pred cCHHHHhc
Confidence 99999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=282.00 Aligned_cols=223 Identities=20% Similarity=0.227 Sum_probs=168.3
Q ss_pred cCHHHHHHHHHHHhhCC--------CCCceeeeeeEe----ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQ--------HRNLVRLFGCCI----EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRIL 74 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 74 (289)
...+.+.+|+++|+.++ |+||+++++++. ++...++||||+. ++|.+++.. ...+.+++..+..++
T Consensus 75 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~ 152 (397)
T 1wak_A 75 HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIK-SNYQGLPLPCVKKII 152 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHH-TTTSCCCHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHh-cccCCCCHHHHHHHH
Confidence 34678899999999995 788999999998 5568999999994 555555533 223568999999999
Q ss_pred HHHHHHHHHHhcC-CCCceEeeccccCceEeCCCC---------------------------------------------
Q 038647 75 EGVAQGLLYLHHY-SRLRVIHRDLKASNILLDSNM--------------------------------------------- 108 (289)
Q Consensus 75 ~~i~~~l~~lH~~-~~~~ivH~dikp~Nill~~~~--------------------------------------------- 108 (289)
.||+.||.|||++ + |+||||||+|||++.++
T Consensus 153 ~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (397)
T 1wak_A 153 QQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229 (397)
T ss_dssp HHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred HHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence 9999999999998 7 99999999999998775
Q ss_pred ----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcch---
Q 038647 109 ----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL--- 181 (289)
Q Consensus 109 ----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~--- 181 (289)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 230 ~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 304 (397)
T 1wak_A 230 AEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304 (397)
T ss_dssp GGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHH
T ss_pred ccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCch
Confidence 7999999999875432 2334689999999999999999999999999999999999999976543321
Q ss_pred -hHhHhHhhhhccCC---------ccccc------ccc-------------ccCCCCHHHHHHHHHHHHcccccCCCCCC
Q 038647 182 -TLLGHAWNLWNDGR---------AWELM------DSI-------------LQNDASYPMLNRYINVALLCVQENAADRP 232 (289)
Q Consensus 182 -~~~~~~~~~~~~~~---------~~~~~------~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (289)
.............. ..... ... .........+..+.+++.+||+.||++||
T Consensus 305 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 384 (397)
T 1wak_A 305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384 (397)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC
T ss_pred HHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC
Confidence 11111111000000 00000 000 01123455677899999999999999999
Q ss_pred CHHHHHH
Q 038647 233 TMLEVIS 239 (289)
Q Consensus 233 s~~~ll~ 239 (289)
|+.|+++
T Consensus 385 t~~e~l~ 391 (397)
T 1wak_A 385 TAAECLR 391 (397)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=278.14 Aligned_cols=223 Identities=21% Similarity=0.261 Sum_probs=168.6
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
...+.+.+|+++|++++||||+++++++... ...|+||||+. |+|.+++.. +.+++..+..++.||+.||
T Consensus 67 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL 141 (364)
T 3qyz_A 67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGL 141 (364)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHH
Confidence 3457899999999999999999999999765 46899999996 589888842 4589999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
.|||+++ |+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||
T Consensus 142 ~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 218 (364)
T 3qyz_A 142 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218 (364)
T ss_dssp HHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHH
T ss_pred HHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHH
Confidence 9999988 999999999999999999999999999876433211 11244578999999998765 458999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCc-----------ccccccccc-CCC-----CHHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA-----------WELMDSILQ-NDA-----SYPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-~~~-----~~~~~~~l~~li~~ 222 (289)
||++|+|++|..||.......... ........... ......... ... ....+..+.+++.+
T Consensus 219 G~il~ell~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 296 (364)
T 3qyz_A 219 GCILAEMLSNRPIFPGKHYLDQLN--HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 296 (364)
T ss_dssp HHHHHHHHHSSCSSCCSSGGGHHH--HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHH
Confidence 999999999999987654332211 11110000000 000000000 000 01234678999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.||++|||+.|+++
T Consensus 297 ~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 297 MLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCSSTTTSCCHHHHHT
T ss_pred HcCCChhhCCCHHHHhc
Confidence 99999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.47 Aligned_cols=217 Identities=20% Similarity=0.273 Sum_probs=159.7
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCC----CCChHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG----LLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~i~~~l~ 82 (289)
..+.+.+|+++|+++ +||||+++++++.+++..|+|||||. |+|.+++....... ...+..++.++.||+.||.
T Consensus 51 ~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 129 (434)
T 2rio_A 51 FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129 (434)
T ss_dssp GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHH
Confidence 456788999999987 89999999999999999999999995 69999986532211 1233456789999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCC-------------CceEEcccccccccCCCCcc--cccccccccccccChhhhhc
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSN-------------MNPKISDFGIARLFGGDELQ--SNTKRIVGTYGYMSPEYALR 147 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~-------------~~vkl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~ 147 (289)
|||+++ |+||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+
T Consensus 130 ~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp HHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred HHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 999988 9999999999999654 47999999999876543211 12234579999999999976
Q ss_pred -------CCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHH
Q 038647 148 -------GLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINV 219 (289)
Q Consensus 148 -------~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 219 (289)
..++.++|||||||++|+|++ |..||........... ..... ............+.++.++
T Consensus 207 ~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~-------~~~~~----~~~~~~~~~~~~~~~~~~l 275 (434)
T 2rio_A 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII-------RGIFS----LDEMKCLHDRSLIAEATDL 275 (434)
T ss_dssp CCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHH-------HTCCC----CCCCTTCCCHHHHHHHHHH
T ss_pred ccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHh-------cCCCC----cccccccccccchHHHHHH
Confidence 568999999999999999999 8888764332211110 00000 0001122245677899999
Q ss_pred HHcccccCCCCCCCHHHHHH
Q 038647 220 ALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~ 239 (289)
+.+||+.||++|||+.++++
T Consensus 276 i~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 276 ISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhhCChhhCCCHHHHHh
Confidence 99999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=273.32 Aligned_cols=211 Identities=24% Similarity=0.335 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+.+.++...++.++||||+++++++.+++..++||||+++ +|.+++... .....+++..+..++.|++.||.|||++
T Consensus 50 ~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (290)
T 3fme_A 50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128 (290)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 34455566668888999999999999999999999999974 777766321 2345799999999999999999999997
Q ss_pred -CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhh----hcCCCCCcccchhHHHH
Q 038647 88 -SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYA----LRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 -~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~v 162 (289)
+ ++||||||+||+++.++.+||+|||+++...... ......|++.|+|||++ .+..++.++||||||++
T Consensus 129 ~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 129 LS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp SC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred CC---eecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 7 9999999999999999999999999998664332 12334689999999996 45678999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||.............. ... .........+..+.+++.+||+.||++|||+.++++
T Consensus 203 l~~l~~g~~p~~~~~~~~~~~~~~~----~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 203 MIELAILRFPYDSWGTPFQQLKQVV----EEP---------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHTSCSSCCCSCHHHHHHHHH----HSC---------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCccccCchHHHHHHHh----ccC---------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 9999999999875443322221111 110 011111234568899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=269.36 Aligned_cols=212 Identities=24% Similarity=0.296 Sum_probs=169.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|++++++++||||+++++++.+.+..++|+||+++++|.+++.. .+.+++..+..++.||+.||.|||
T Consensus 62 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH 138 (287)
T 2wei_A 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH 138 (287)
T ss_dssp SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999999999999999999999888742 356899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCC---CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSN---MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~---~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v 162 (289)
+++ ++||||||+||+++.+ +.+||+|||++....... ......|++.|+|||++.+ .++.++||||||++
T Consensus 139 ~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~ 211 (287)
T 2wei_A 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVI 211 (287)
T ss_dssp HTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHH
T ss_pred HCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHH
Confidence 988 9999999999999754 469999999998764332 1233468999999999876 48999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||....... .... ......... .......+..+.+++.+||+.||++|||+.++++
T Consensus 212 l~~l~~g~~p~~~~~~~~--~~~~----~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 212 LYILLSGTPPFYGKNEYD--ILKR----VETGKYAFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHSSCSSCCSSHHH--HHHH----HHHCCCCCC------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHH--HHHH----HHcCCCCCC------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 999999999986543221 1111 100100000 0000123468899999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=272.86 Aligned_cols=220 Identities=19% Similarity=0.204 Sum_probs=170.1
Q ss_pred CHHHHHHHHHHHhhCCCCC------ceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRN------LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+.+.+|+++++.++|++ ++++++++.+++..++||||+ +++|.+++... ....+++..+..++.||+.||
T Consensus 54 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l 131 (339)
T 1z57_A 54 YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSV 131 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHH
Confidence 4578899999999997664 999999999999999999999 88999888542 224688999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCC-------------------CCceEEcccccccccCCCCcccccccccccccccCh
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDS-------------------NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSP 142 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~-------------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP 142 (289)
.|||+++ |+||||||+|||++. ++.+||+|||+++..... .....||+.|+||
T Consensus 132 ~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP 203 (339)
T 1z57_A 132 NFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAP 203 (339)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCH
T ss_pred HHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccCh
Confidence 9999988 999999999999987 668999999999864322 2345789999999
Q ss_pred hhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC--------cccc---------------
Q 038647 143 EYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR--------AWEL--------------- 199 (289)
Q Consensus 143 E~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--------------- 199 (289)
|++.+..++.++||||||+++|+|++|..||...+..... ........... ....
T Consensus 204 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (339)
T 1z57_A 204 EVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL--AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAG 281 (339)
T ss_dssp HHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH--HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHH
T ss_pred HHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHhhccchhHHhhcccccccccccc
Confidence 9999999999999999999999999999998765433211 11100000000 0000
Q ss_pred ------ccc-cccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 200 ------MDS-ILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 200 ------~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 000 0001122345678999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=270.29 Aligned_cols=214 Identities=23% Similarity=0.342 Sum_probs=159.8
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEee-------------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-------------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRI 73 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 73 (289)
...+.+.+|+.++++++||||+++++++.+ .+..|+||||+++|+|.+++.. ....+++..++.+
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i 121 (303)
T 1zy4_A 44 EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRL 121 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHH
Confidence 456789999999999999999999998865 4578999999999999999953 2345778899999
Q ss_pred HHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc------------ccccccccccccccC
Q 038647 74 LEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL------------QSNTKRIVGTYGYMS 141 (289)
Q Consensus 74 ~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~a 141 (289)
+.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ ........|++.|+|
T Consensus 122 ~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a 198 (303)
T 1zy4_A 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198 (303)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSC
T ss_pred HHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccC
Confidence 999999999999988 99999999999999999999999999986542210 112234568999999
Q ss_pred hhhhhcC-CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHH
Q 038647 142 PEYALRG-LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVA 220 (289)
Q Consensus 142 PE~~~~~-~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 220 (289)
||++.+. .++.++||||||+++|+|++ |+..... ..... ...... ............+..+.+++
T Consensus 199 PE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~~~~~----~~~~~~------~~~~~~~~~~~~~~~~~~li 264 (303)
T 1zy4_A 199 TEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-RVNIL----KKLRSV------SIEFPPDFDDNKMKVEKKII 264 (303)
T ss_dssp HHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHHH----HHHHST------TCCCCTTCCTTTSHHHHHHH
T ss_pred cccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-HHHHH----Hhcccc------ccccCccccccchHHHHHHH
Confidence 9999865 68999999999999999998 3321111 11110 001100 00111122233456788999
Q ss_pred HcccccCCCCCCCHHHHHH
Q 038647 221 LLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 221 ~~~l~~~p~~Rps~~~ll~ 239 (289)
.+||+.||++|||+.++++
T Consensus 265 ~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 265 RLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCcccCcCHHHHhC
Confidence 9999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.31 Aligned_cols=161 Identities=20% Similarity=0.241 Sum_probs=139.9
Q ss_pred CHHHHHHHHHHHhhC------CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL------QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+.+.+|+++++.+ +|+||+++++++...+..++||||+. ++|.+++... ....+++..+..++.||+.||
T Consensus 136 ~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL 213 (429)
T 3kvw_A 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCL 213 (429)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHH
Confidence 356788899998888 57799999999999999999999995 5888887542 234589999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCc--eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMN--PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~--vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
.|||+++ |+||||||+|||++.++. +||+|||++...... .....||+.|+|||++.+..++.++|||||
T Consensus 214 ~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 285 (429)
T 3kvw_A 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSL 285 (429)
T ss_dssp HHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred HHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhH
Confidence 9999988 999999999999999887 999999999765322 234578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCC
Q 038647 160 GVLVLETLSSKKNAHFYNT 178 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~ 178 (289)
||++|+|++|.+||.....
T Consensus 286 G~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 286 GCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp HHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHhCCCCCCCCCH
Confidence 9999999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=283.83 Aligned_cols=220 Identities=20% Similarity=0.200 Sum_probs=160.8
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEeec------CeEEEEEeecCCCChhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHH
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIEH------GEKILIYEYMPNKSLDCFLFDP-TKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+.+|+++|+.++|||||++++++... ..+++||||+++ +|.+++... .....+++..+..++.||+.||.|
T Consensus 93 ~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 171 (420)
T 1j1b_A 93 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171 (420)
T ss_dssp SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 345799999999999999999998542 247799999976 555544321 234578999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCC-CceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGV 161 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~-~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~ 161 (289)
||+++ |+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||
T Consensus 172 LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 245 (420)
T 1j1b_A 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245 (420)
T ss_dssp HHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHH
Confidence 99988 9999999999999955 5689999999987643321 2335789999999999765 7999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccC----------CccccccccccC-----CCCHHHHHHHHHHHHccccc
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG----------RAWELMDSILQN-----DASYPMLNRYINVALLCVQE 226 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~ 226 (289)
++|||++|+.||........ +. ......... ............ ......+.++.+|+.+||+.
T Consensus 246 il~ell~G~~pf~~~~~~~~-l~-~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~ 323 (420)
T 1j1b_A 246 VLAELLLGQPIFPGDSGVDQ-LV-EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323 (420)
T ss_dssp HHHHHHHSSCSSCCSSHHHH-HH-HHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHhCCCCCCCCCHHHH-HH-HHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccC
Confidence 99999999999876543211 11 111100000 000000000000 01122356889999999999
Q ss_pred CCCCCCCHHHHHH
Q 038647 227 NAADRPTMLEVIS 239 (289)
Q Consensus 227 ~p~~Rps~~~ll~ 239 (289)
||++|||+.|+++
T Consensus 324 dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 324 TPTARLTPLEACA 336 (420)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhHCCCHHHHhC
Confidence 9999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=278.85 Aligned_cols=220 Identities=21% Similarity=0.245 Sum_probs=159.5
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEee-----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+++.+|+++|++++||||+++++++.. ....|+||||+. |+|.+++.. ....+++..+..++.||+.||.|
T Consensus 73 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~ 149 (362)
T 3pg1_A 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHV 149 (362)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHH
Confidence 4889999999999999999999999954 346899999997 577777753 34568999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVL 162 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~v 162 (289)
||+++ |+||||||+||+++.++.+||+|||+++...... ......|++.|+|||++.+ ..++.++|||||||+
T Consensus 150 lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 223 (362)
T 3pg1_A 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223 (362)
T ss_dssp HHHTT---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHH
T ss_pred HHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHH
Confidence 99988 9999999999999999999999999997543322 2334568999999999987 678999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC-----------ccccccccccCC-------CCHHHHHHHHHHHHccc
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR-----------AWELMDSILQND-------ASYPMLNRYINVALLCV 224 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l 224 (289)
+|+|++|..||........ ............ ............ .....+..+.+++.+||
T Consensus 224 l~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 301 (362)
T 3pg1_A 224 MAEMFNRKALFRGSTFYNQ--LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKML 301 (362)
T ss_dssp HHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHT
T ss_pred HHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHh
Confidence 9999999999876443211 111111000000 000000000000 01122457889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 038647 225 QENAADRPTMLEVIS 239 (289)
Q Consensus 225 ~~~p~~Rps~~~ll~ 239 (289)
+.||++|||+.|+++
T Consensus 302 ~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 302 EFNPQRRISTEQALR 316 (362)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHHc
Confidence 999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=271.83 Aligned_cols=221 Identities=24% Similarity=0.312 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhhC---CCCCceeeeeeEe-----ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKL---QHRNLVRLFGCCI-----EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 9 ~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+|+.+++.+ +||||+++++++. .....++||||+. |+|.+++... ....+++..+..++.|++.|
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~ 132 (326)
T 1blx_A 55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRG 132 (326)
T ss_dssp BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHH
Confidence 34677888888777 8999999999987 5667999999997 6999888542 23458999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||++| |+||||||+||+++.++.+||+|||+++...... ......|++.|+|||++.+..++.++||||||
T Consensus 133 l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 206 (326)
T 1blx_A 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206 (326)
T ss_dssp HHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHH
T ss_pred HHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHH
Confidence 99999988 9999999999999999999999999998654321 23345789999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccC---Ccc-------ccccc---cccCCCCHHHHHHHHHHHHcccccC
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG---RAW-------ELMDS---ILQNDASYPMLNRYINVALLCVQEN 227 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-------~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~ 227 (289)
+++|+|++|..||........ ........... ... ..... ..........+..+.+++.+||+.|
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 284 (326)
T 1blx_A 207 CIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284 (326)
T ss_dssp HHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCC
Confidence 999999999999875543211 11111100000 000 00000 0000111234568899999999999
Q ss_pred CCCCCCHHHHHH
Q 038647 228 AADRPTMLEVIS 239 (289)
Q Consensus 228 p~~Rps~~~ll~ 239 (289)
|++|||+.++++
T Consensus 285 P~~Rpt~~e~l~ 296 (326)
T 1blx_A 285 PAKRISAYSALS 296 (326)
T ss_dssp TTTSCCHHHHHT
T ss_pred cccCCCHHHHhc
Confidence 999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=279.21 Aligned_cols=220 Identities=17% Similarity=0.174 Sum_probs=163.2
Q ss_pred HHHHHHHHHhhCCCCCceeeeeeEee--------------------------------------cCeEEEEEeecCCCCh
Q 038647 11 EFKNEMMLIAKLQHRNLVRLFGCCIE--------------------------------------HGEKILIYEYMPNKSL 52 (289)
Q Consensus 11 ~~~~E~~~l~~l~h~niv~~~~~~~~--------------------------------------~~~~~lv~e~~~~g~L 52 (289)
...+|+++|+.++||||+++++++.. +...++||||+++ +|
T Consensus 46 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L 124 (383)
T 3eb0_A 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124 (383)
T ss_dssp SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EH
T ss_pred hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cH
Confidence 34589999999999999999999843 3458999999974 77
Q ss_pred hhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCccccc
Q 038647 53 DCFLFDP-TKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNT 130 (289)
Q Consensus 53 ~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~ 130 (289)
.+.+... ...+.+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||+++...... ..
T Consensus 125 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~ 198 (383)
T 3eb0_A 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PS 198 (383)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CC
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CC
Confidence 6665421 23467899999999999999999999888 99999999999997 68899999999998764432 22
Q ss_pred ccccccccccChhhhhcC-CCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC--------------
Q 038647 131 KRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR-------------- 195 (289)
Q Consensus 131 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 195 (289)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... ...........
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (383)
T 3eb0_A 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL--VRIIQIMGTPTKEQMIRMNPHYTEV 276 (383)
T ss_dssp CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTC--C
T ss_pred cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhCcccccc
Confidence 335689999999999875 5899999999999999999999998764432211 11111000000
Q ss_pred -ccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 196 -AWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.............+...+..+.+++.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000011224467899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=279.08 Aligned_cols=218 Identities=21% Similarity=0.248 Sum_probs=163.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeE------EEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK------ILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+++.+|+.+++.++||||+++++++...+.. |+||||+. ++|.+++. ..+++..+..++.||+.
T Consensus 82 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~ 155 (371)
T 4exu_A 82 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLK 155 (371)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHH
Confidence 34468899999999999999999999999877655 99999996 58887772 34899999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchh
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFS 158 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diws 158 (289)
||.|||+++ |+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||
T Consensus 156 aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (371)
T 4exu_A 156 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWS 227 (371)
T ss_dssp HHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred HHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence 999999988 999999999999999999999999999865332 234568999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccC-----------CccccccccccCC-C-----CHHHHHHHHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG-----------RAWELMDSILQND-A-----SYPMLNRYINVAL 221 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~-~-----~~~~~~~l~~li~ 221 (289)
|||++|+|++|..||...+.... ........... ............. . ....+..+.+++.
T Consensus 228 lG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 305 (371)
T 4exu_A 228 VGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 305 (371)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHH
Confidence 99999999999999875442211 11110000000 0000000000000 0 0123568899999
Q ss_pred cccccCCCCCCCHHHHHH
Q 038647 222 LCVQENAADRPTMLEVIS 239 (289)
Q Consensus 222 ~~l~~~p~~Rps~~~ll~ 239 (289)
+||+.||++|||+.|+++
T Consensus 306 ~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 306 KMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHSCSCTTTSCCHHHHHT
T ss_pred HHCCCChhhcCCHHHHhc
Confidence 999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=275.12 Aligned_cols=223 Identities=23% Similarity=0.268 Sum_probs=167.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
...+++.+|+++|++++||||+++++++... ...++||||+. ++|.+++.. +.+++..+..++.|++.||
T Consensus 51 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L 125 (353)
T 2b9h_A 51 LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAV 125 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHH
Confidence 4467888999999999999999999988764 67899999996 589888843 4689999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc--------ccccccccccccChhhhhc-CCCCC
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS--------NTKRIVGTYGYMSPEYALR-GLFSI 152 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~ 152 (289)
.|||+++ |+||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+ ..++.
T Consensus 126 ~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (353)
T 2b9h_A 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR 202 (353)
T ss_dssp HHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCH
T ss_pred HHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccc
Confidence 9999988 9999999999999999999999999998764322111 1223468999999998875 67899
Q ss_pred cccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcc------------ccccccccC-CC-----CHHHHH
Q 038647 153 KSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAW------------ELMDSILQN-DA-----SYPMLN 214 (289)
Q Consensus 153 ~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~-~~-----~~~~~~ 214 (289)
++|||||||++|+|++|..||.......... ............ ......... .. ....+.
T Consensus 203 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
T 2b9h_A 203 AMDVWSCGCILAELFLRRPIFPGRDYRHQLL--LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNP 280 (353)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCH
Confidence 9999999999999999999987654321111 111111000000 000000000 00 112456
Q ss_pred HHHHHHHcccccCCCCCCCHHHHHH
Q 038647 215 RYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+.+++.+||+.||++|||+.++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 281 KGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhc
Confidence 7899999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=272.31 Aligned_cols=225 Identities=22% Similarity=0.256 Sum_probs=166.4
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEe--------------ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI--------------EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 70 (289)
+.+..+++.+|++++++++||||+++++++. +.+..++||||++ |+|.+++. .+.+++..+
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~ 122 (320)
T 2i6l_A 48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHA 122 (320)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh----cCCccHHHH
Confidence 3456788999999999999999999999873 4468899999997 69999884 256889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCc-ccccccccccccccChhhhhc-
Q 038647 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALR- 147 (289)
Q Consensus 71 ~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~- 147 (289)
..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||+++....... ........++..|+|||++.+
T Consensus 123 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (320)
T 2i6l_A 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP 199 (320)
T ss_dssp HHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT
T ss_pred HHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCc
Confidence 999999999999999988 99999999999997 567899999999987643211 112334467899999999876
Q ss_pred CCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC----------cccccccccc-CCC-----CHH
Q 038647 148 GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR----------AWELMDSILQ-NDA-----SYP 211 (289)
Q Consensus 148 ~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-~~~-----~~~ 211 (289)
..++.++||||||+++|+|++|+.||........ ............ .......... ... ...
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (320)
T 2i6l_A 200 NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG 277 (320)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTT
T ss_pred ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcch
Confidence 6789999999999999999999999875543211 111110000000 0000000000 000 012
Q ss_pred HHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 212 MLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+..+.+++.+||+.||++|||+.++++
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 278 ISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 3568899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=273.43 Aligned_cols=217 Identities=21% Similarity=0.242 Sum_probs=164.1
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe------EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE------KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+++.+|+.+++.++||||+++++++...+. .|+||||+. ++|.+++. ..+++..+..++.||+.|
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~a 138 (353)
T 3coi_A 65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKG 138 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHH
Confidence 346789999999999999999999999987654 499999997 58887773 248999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSF 159 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl 159 (289)
|.|||+++ |+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 139 l~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 210 (353)
T 3coi_A 139 LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210 (353)
T ss_dssp HHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHH
T ss_pred HHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHH
Confidence 99999988 999999999999999999999999999865322 233568999999999987 678999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccC-----------Cccccccccc------cCCCCHHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG-----------RAWELMDSIL------QNDASYPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~------~~~~~~~~~~~l~~li~~ 222 (289)
|+++|+|++|..||...+.... ........... .....+.... ........+..+.+++.+
T Consensus 211 G~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 3coi_A 211 GCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288 (353)
T ss_dssp HHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH
Confidence 9999999999999876443211 11110000000 0000000000 011122345789999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 038647 223 CVQENAADRPTMLEVIS 239 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~ 239 (289)
||+.||++|||+.++++
T Consensus 289 ~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 289 MLELDVDKRLTAAQALT 305 (353)
T ss_dssp HSCSCTTTSCCHHHHHT
T ss_pred HcCCCcccCCCHHHHhc
Confidence 99999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=281.77 Aligned_cols=213 Identities=19% Similarity=0.230 Sum_probs=157.6
Q ss_pred CHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+++|+.+ +|||||++++++.+++..|+|||||. |+|.+++.... ....+..+..++.||+.||.|||+
T Consensus 60 ~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~ 136 (432)
T 3p23_A 60 CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS 136 (432)
T ss_dssp TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHH
Confidence 344578999999999 79999999999999999999999996 58999886432 234455678999999999999999
Q ss_pred CCCCceEeeccccCceEeCC-----CCceEEcccccccccCCCCc-ccccccccccccccChhhhh---cCCCCCcccch
Q 038647 87 YSRLRVIHRDLKASNILLDS-----NMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVF 157 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~-----~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Diw 157 (289)
++ |+||||||+|||++. ...+||+|||+++....... ........||+.|+|||++. ...++.++|||
T Consensus 137 ~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Diw 213 (432)
T 3p23_A 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIF 213 (432)
T ss_dssp TT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHH
T ss_pred Cc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHH
Confidence 88 999999999999953 33578999999987653321 12234457999999999998 45678899999
Q ss_pred hHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHH
Q 038647 158 SFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236 (289)
Q Consensus 158 slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (289)
||||++|+|++ |..||........... ..... .............+.+++.+||+.||++|||+.+
T Consensus 214 SlG~il~ellt~g~~pf~~~~~~~~~~~------~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 280 (432)
T 3p23_A 214 SAGCVFYYVISEGSHPFGKSLQRQANIL------LGACS-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKH 280 (432)
T ss_dssp HHHHHHHHHHTTSCBTTBSTTTHHHHHH------TTCCC-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHHcCCCCCcchhhHHHHHHH------hccCC-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHH
Confidence 99999999999 8888753322211110 00000 0001112234566889999999999999999999
Q ss_pred HHH
Q 038647 237 VIS 239 (289)
Q Consensus 237 ll~ 239 (289)
+++
T Consensus 281 vl~ 283 (432)
T 3p23_A 281 VLK 283 (432)
T ss_dssp HHT
T ss_pred HHh
Confidence 984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=276.18 Aligned_cols=224 Identities=21% Similarity=0.218 Sum_probs=164.6
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCe-------EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE-------KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
..+++.+|++.++.++||||+++++++...+. .++||||++++.+..+.........+++..+..++.|++.|
T Consensus 62 ~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 141 (360)
T 3e3p_A 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141 (360)
T ss_dssp CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence 44567888999999999999999999976443 88999999875333222111345678899999999999999
Q ss_pred HHHHh--cCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccc
Q 038647 81 LLYLH--HYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDV 156 (289)
Q Consensus 81 l~~lH--~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di 156 (289)
|.||| +++ |+||||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++||
T Consensus 142 l~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (360)
T 3e3p_A 142 IGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDI 215 (360)
T ss_dssp HHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred HHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHH
Confidence 99999 877 999999999999996 89999999999987654321 2335689999999999765 48999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhh-----------ccCCc-ccccc------ccccCCCCHHHHHHHHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLW-----------NDGRA-WELMD------SILQNDASYPMLNRYIN 218 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~-~~~~~------~~~~~~~~~~~~~~l~~ 218 (289)
|||||++|+|++|..||........ ........ ..... ..... ...........+..+.+
T Consensus 216 ~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (360)
T 3e3p_A 216 WSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD 293 (360)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHH
Confidence 9999999999999999876443211 11111100 00000 00000 00001112224678999
Q ss_pred HHHcccccCCCCCCCHHHHHH
Q 038647 219 VALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 219 li~~~l~~~p~~Rps~~~ll~ 239 (289)
++.+||+.||++|||+.|+++
T Consensus 294 li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 294 LLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhccCccccCCHHHHhc
Confidence 999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=271.38 Aligned_cols=222 Identities=17% Similarity=0.238 Sum_probs=166.9
Q ss_pred CHHHHHHHHHHHhhCC-----------CCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQ-----------HRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVR 72 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 72 (289)
..+.+.+|++++++++ ||||+++++++...+ ..++||||+ +++|.+++... ....+++..+..
T Consensus 58 ~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ 135 (373)
T 1q8y_A 58 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQ 135 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHH
T ss_pred chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHH
Confidence 4577889999999986 899999999998654 789999999 88999988642 234588999999
Q ss_pred HHHHHHHHHHHHhcC-CCCceEeeccccCceEeC------CCCceEEcccccccccCCCCcccccccccccccccChhhh
Q 038647 73 ILEGVAQGLLYLHHY-SRLRVIHRDLKASNILLD------SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYA 145 (289)
Q Consensus 73 ~~~~i~~~l~~lH~~-~~~~ivH~dikp~Nill~------~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 145 (289)
++.||+.||.|||++ + |+||||||+|||++ ..+.+||+|||++...... .....||+.|+|||++
T Consensus 136 i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 136 ISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVL 207 (373)
T ss_dssp HHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHH
Confidence 999999999999997 8 99999999999994 4457999999999866432 2334689999999999
Q ss_pred hcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcc----hhHhHhHhhhhc------------------cCCccccccc-
Q 038647 146 LRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS----LTLLGHAWNLWN------------------DGRAWELMDS- 202 (289)
Q Consensus 146 ~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~----~~~~~~~~~~~~------------------~~~~~~~~~~- 202 (289)
.+..++.++|||||||++|+|++|..||....... ............ .......+..
T Consensus 208 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
T 1q8y_A 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287 (373)
T ss_dssp HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc
Confidence 99999999999999999999999999987554221 011111110000 0000000000
Q ss_pred ---------cccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 203 ---------ILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 203 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
..........+..+.++|.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 0011234567789999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=269.50 Aligned_cols=212 Identities=16% Similarity=0.169 Sum_probs=142.8
Q ss_pred HHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc
Q 038647 16 MMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLR 91 (289)
Q Consensus 16 ~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 91 (289)
...++.++||||+++++++.. +...++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++
T Consensus 73 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~--- 148 (336)
T 3fhr_A 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN--- 148 (336)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 334566799999999999986 45689999999999999999653 2346899999999999999999999988
Q ss_pred eEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHh
Q 038647 92 VIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLS 168 (289)
Q Consensus 92 ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ellt 168 (289)
|+||||||+||+++. ++.+||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 149 ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 224 (336)
T 3fhr_A 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 224 (336)
T ss_dssp EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999976 4559999999998654322 234568999999999988889999999999999999999
Q ss_pred CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--Hhhc
Q 038647 169 SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--MLTN 243 (289)
Q Consensus 169 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~L~~ 243 (289)
|..||........... ..... ...............+..+.+++..||+.||++|||+.++++ ++.+
T Consensus 225 g~~pf~~~~~~~~~~~--~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 225 GFPPFYSNTGQAISPG--MKRRI------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp SSCCC-----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCCCCCCccchhhhhh--HHHhh------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 9999865433211000 00000 000000011111234578899999999999999999999997 5544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=269.84 Aligned_cols=221 Identities=19% Similarity=0.176 Sum_probs=167.4
Q ss_pred cCHHHHHHHHHHHhhCCCCC------ceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRN------LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
...+.+.+|+.+++.++|++ ++.+++++...+..++||||+ +++|.+++.. .....+++..+..++.||+.|
T Consensus 58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~ 135 (355)
T 2eu9_A 58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHA 135 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHH
Confidence 34678889999999998766 899999999999999999999 5566665543 223468999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEe-------------------CCCCceEEcccccccccCCCCcccccccccccccccC
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILL-------------------DSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMS 141 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill-------------------~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 141 (289)
|.|||+++ |+||||||+|||+ +.++.+||+|||+++..... .....||+.|+|
T Consensus 136 L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~a 207 (355)
T 2eu9_A 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRP 207 (355)
T ss_dssp HHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCC
T ss_pred HHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccC
Confidence 99999988 9999999999999 56788999999999864322 233578999999
Q ss_pred hhhhhcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCC--------cccc-c------------
Q 038647 142 PEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR--------AWEL-M------------ 200 (289)
Q Consensus 142 PE~~~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~------------ 200 (289)
||++.+..++.++|||||||++|+|++|..||......... ........... .... .
T Consensus 208 PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (355)
T 2eu9_A 208 PEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL--VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD 285 (355)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHH
T ss_pred CeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHcCCCcHHHhhhccchhhhcccccccccccch
Confidence 99999999999999999999999999999998765432211 11111000000 0000 0
Q ss_pred --------cc-cccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 201 --------DS-ILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 201 --------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 286 GRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0001122334568899999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=268.72 Aligned_cols=215 Identities=25% Similarity=0.372 Sum_probs=146.6
Q ss_pred CHHHHHHHHH-HHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcC--CCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMM-LIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFD--PTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 8 ~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
..+++.+|+. +++.++||||+++++++.+++..++||||+++ +|.+++.. ......+++..+..++.|++.||.||
T Consensus 63 ~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 141 (327)
T 3aln_A 63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141 (327)
T ss_dssp HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH
Confidence 3456666766 77778999999999999999999999999975 77766632 11245789999999999999999999
Q ss_pred hcC-CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhh----hcCCCCCcccchhH
Q 038647 85 HHY-SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYA----LRGLFSIKSDVFSF 159 (289)
Q Consensus 85 H~~-~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Diwsl 159 (289)
|+. + ++||||||+||+++.++.+||+|||+++...... ......|++.|+|||++ .+..++.++|||||
T Consensus 142 H~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~sl 215 (327)
T 3aln_A 142 KENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL 215 (327)
T ss_dssp HHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHH
T ss_pred hccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHH
Confidence 997 7 9999999999999999999999999998664322 12234689999999999 45678999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+++|+|++|..||........... . ...... ...........+..+.+++.+||+.||++|||+.++++
T Consensus 216 G~il~~l~~g~~pf~~~~~~~~~~~----~-~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 216 GITLYELATGRFPYPKWNSVFDQLT----Q-VVKGDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHHHHSCCCSSCC-------C----C-CCCSCC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchHHHHHH----H-HhcCCC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 9999999999999875432111000 0 000000 00111111234568999999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=272.49 Aligned_cols=199 Identities=22% Similarity=0.302 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhhCC--CCCceeeeeeEeecCeEEEEEeecCC-CChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 9 LEEFKNEMMLIAKLQ--HRNLVRLFGCCIEHGEKILIYEYMPN-KSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+.+.+|+.++++++ ||||+++++++.+++..++|+|++.+ ++|.+++. ..+.+++..+..++.||+.||.|||
T Consensus 90 ~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH 166 (320)
T 3a99_A 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCH 166 (320)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356788999999996 59999999999999999999999976 89999884 3457899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLV 163 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl 163 (289)
+++ |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++
T Consensus 167 ~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 239 (320)
T 3a99_A 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239 (320)
T ss_dssp HTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred HCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHH
Confidence 988 99999999999998 78899999999998765332 233568999999999987765 7889999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||..... . .... .......+..+.+++.+||+.||++|||+.++++
T Consensus 240 ~el~~g~~pf~~~~~----~-------~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 240 YDMVCGDIPFEHDEE----I-------IRGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHSSCSCCSHHH----H-------HHCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCCCCChhh----h-------hccc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999754211 0 0000 0011123468899999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=270.63 Aligned_cols=200 Identities=22% Similarity=0.338 Sum_probs=160.7
Q ss_pred CHHHHHHHHHHHhhC----CCCCceeeeeeEeecCeEEEEEee-cCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL----QHRNLVRLFGCCIEHGEKILIYEY-MPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
....+.+|+.++.++ +||||+++++++.+.+..++|+|| +.+++|.+++.. .+.+++..+..++.||+.||.
T Consensus 77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~ 153 (312)
T 2iwi_A 77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQ 153 (312)
T ss_dssp --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHH
Confidence 345667899999999 899999999999999999999999 789999999843 456899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFG 160 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG 160 (289)
|||+++ |+||||||+||+++ .++.+||+|||+++...... .....|+..|+|||++.+..+ +.++||||||
T Consensus 154 ~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 226 (312)
T 2iwi_A 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLG 226 (312)
T ss_dssp HHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHH
T ss_pred HHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHH
Confidence 999988 99999999999998 88999999999998765432 234568999999999987766 4589999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+++|+|++|..||..... . ... ........+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~il~~l~~g~~pf~~~~~----~-------~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 227 ILLYDMVCGDIPFERDQE----I-------LEA-----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHHHSSCSCCSHHH----H-------HHT-----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCChHH----H-------hhh-----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999753210 0 000 00111234567899999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=266.41 Aligned_cols=163 Identities=24% Similarity=0.310 Sum_probs=137.7
Q ss_pred CHHHHHHHHHHHhhCC-CC-----CceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQ-HR-----NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+++.+|+++++.++ |+ +|+++++++...+..|+||||+. |+|.+++... ..+.+++..+..++.|++.||
T Consensus 93 ~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al 170 (382)
T 2vx3_A 93 FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTAL 170 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHH
Confidence 4577888999999885 55 49999999999999999999996 5898888543 224589999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeC--CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLD--SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~--~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
.|||.+ ..+|+||||||+|||++ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp HHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred HHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 999952 12399999999999994 5778999999999876432 234578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCC
Q 038647 160 GVLVLETLSSKKNAHFYNT 178 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~ 178 (289)
||++|+|++|..||...+.
T Consensus 245 G~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 245 GCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp HHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHhCCCCCCCCCH
Confidence 9999999999999876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=286.73 Aligned_cols=225 Identities=22% Similarity=0.236 Sum_probs=169.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....++|.+|+++|++++||||+++++++.. ++..++||||+++|+|.+++........+++..+..++.|++.
T Consensus 53 ~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~ 132 (676)
T 3qa8_A 53 PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132 (676)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHH
Confidence 4457789999999999999999999999765 6788999999999999999976555557899999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCc---eEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccc
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMN---PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
||.|||+.+ |+||||||+||+++.++. +||+|||++....... ......|++.|+|||++.+..++.++||
T Consensus 133 aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDI 206 (676)
T 3qa8_A 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDY 206 (676)
T ss_dssp HHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHH
T ss_pred HHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHH
Confidence 999999988 999999999999987665 8999999998765432 2234578999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhH------hHhHhhhhccCCc-cccccc-cccCCCCHHHHHHHHHHHHcccccCC
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTL------LGHAWNLWNDGRA-WELMDS-ILQNDASYPMLNRYINVALLCVQENA 228 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p 228 (289)
||||+++|+|++|..||........-. ............. ...... ..........+..+.+++..||..||
T Consensus 207 wSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP 286 (676)
T 3qa8_A 207 WSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ 286 (676)
T ss_dssp HHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSC
T ss_pred HHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCH
Confidence 999999999999999986532110000 0000000000000 000000 01122344577899999999999999
Q ss_pred CCCCCHHH
Q 038647 229 ADRPTMLE 236 (289)
Q Consensus 229 ~~Rps~~~ 236 (289)
++|||+.+
T Consensus 287 ~kRPTa~e 294 (676)
T 3qa8_A 287 RQRGTDPQ 294 (676)
T ss_dssp C---CCTT
T ss_pred hhCcCHHH
Confidence 99999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=263.56 Aligned_cols=210 Identities=22% Similarity=0.343 Sum_probs=153.3
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC-
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY- 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 87 (289)
.+.+..+..+++.++||||+++++++.+++..++||||+ ++.+..+... ..+.+++..+..++.|++.||.|||++
T Consensus 68 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (318)
T 2dyl_A 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH 144 (318)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 344555566788889999999999999999999999999 5556555431 235689999999999999999999985
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchhHHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVL 162 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~v 162 (289)
+ ++||||||+||+++.++.+||+|||++....... ......|++.|+|||++. +..++.++||||||++
T Consensus 145 ~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 145 G---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp C---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred C---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 7 9999999999999999999999999997654322 123346899999999994 4568999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||........... .. .... .. .. ......+..+.+++.+||+.||++|||+.++++
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~-~~---~~~~-~~-----~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDFEVLT-KV---LQEE-PP-----LL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHH-HH---HHSC-CC-----CC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCCCCCccHHHHH-HH---hccC-CC-----CC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999999999875433221111 11 1000 00 00 001123468899999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=285.58 Aligned_cols=200 Identities=20% Similarity=0.282 Sum_probs=160.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCe-----EEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGE-----KILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
.+..+.|.+|+++|++++||||+++++++.+.+. .|+||||+++++|.+++.. .+++..++.++.||+.|
T Consensus 120 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~a 194 (681)
T 2pzi_A 120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPA 194 (681)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999988765 7999999999999887632 68999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
|.|||+++ |+||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.+.. +.++||||||
T Consensus 195 L~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG 263 (681)
T 2pzi_A 195 LSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVG 263 (681)
T ss_dssp HHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHH
T ss_pred HHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhH
Confidence 99999988 9999999999999875 8999999999876432 3456899999999997654 8999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-CHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-TMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~ll~ 239 (289)
|++|+|++|..|+....... ..........+..+.+++.+||+.||++|| +++++..
T Consensus 264 ~~l~~l~~g~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 264 RTLAALTLDLPTRNGRYVDG----------------------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp HHHHHHHSCCCEETTEECSS----------------------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhCCCCCccccccc----------------------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 99999999988765321110 001111122346788999999999999999 5666666
Q ss_pred Hhhc
Q 038647 240 MLTN 243 (289)
Q Consensus 240 ~L~~ 243 (289)
.|..
T Consensus 322 ~l~~ 325 (681)
T 2pzi_A 322 QLTG 325 (681)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=250.80 Aligned_cols=189 Identities=18% Similarity=0.236 Sum_probs=148.9
Q ss_pred HHHHHHHHHHH-hhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLI-AKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 9 ~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
...+.+|+.++ +..+||||+++++++.+ +...++||||+++|+|.+++... ....+++..+..++.|++.||.|
T Consensus 54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~ 132 (299)
T 3m2w_A 54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQY 132 (299)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHH
Confidence 35678999998 55589999999999987 77899999999999999998652 23468999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
||+++ |+||||||+||+++. ++.+||+|||++.... +..++.++||||||
T Consensus 133 lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG 185 (299)
T 3m2w_A 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLG 185 (299)
T ss_dssp HHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHH
T ss_pred HHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHH
Confidence 99988 999999999999998 7889999999986532 23467899999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccC--CCC----HHHHHHHHHHHHcccccCCCCCCCH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQN--DAS----YPMLNRYINVALLCVQENAADRPTM 234 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~~p~~Rps~ 234 (289)
|++|+|++|..||......... . ......... ... ...+..+.+++.+||+.||++|||+
T Consensus 186 ~il~el~tg~~pf~~~~~~~~~----------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~ 251 (299)
T 3m2w_A 186 VIMYILLCGYPPFYSNHGLAIS----------P----GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 251 (299)
T ss_dssp HHHHHHHHSSCSCCC-----------------C----CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHHHCCCCCCCCcchhhh----------H----HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCH
Confidence 9999999999998644322100 0 000000000 111 1235689999999999999999999
Q ss_pred HHHHH
Q 038647 235 LEVIS 239 (289)
Q Consensus 235 ~~ll~ 239 (289)
.|+++
T Consensus 252 ~e~l~ 256 (299)
T 3m2w_A 252 TEFMN 256 (299)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=249.85 Aligned_cols=192 Identities=11% Similarity=0.052 Sum_probs=151.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..+.|.+|+.++++++||||+++++++.+++..|+||||+++++|.+++.. + .....+..++.|++.||.|||
T Consensus 72 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH 146 (286)
T 3uqc_A 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAH 146 (286)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999999832 2 345568899999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++| |+||||||+|||++.++.+||++++ |++ .++.++|||||||++|+
T Consensus 147 ~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~e 194 (286)
T 3uqc_A 147 RAG---VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYA 194 (286)
T ss_dssp HTT---CCCCCCSGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHH
T ss_pred HCC---CccCCCCcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHH
Confidence 998 9999999999999999999998543 222 36899999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc--CCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ--NDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
|++|+.||...+........ . ........ .......+..+.+++.+||+.||++| |+.|+++.|+.
T Consensus 195 lltg~~Pf~~~~~~~~~~~~-----~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 195 LLVNRWPLPEAGVRSGLAPA-----E------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp HHHSEECSCCCSBCCCSEEC-----C------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred HHHCCCCCCcCCcchhhHHH-----H------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 99999998764432110000 0 00000000 00111245678999999999999999 99999999998
Q ss_pred ccC
Q 038647 244 ENV 246 (289)
Q Consensus 244 ~~~ 246 (289)
...
T Consensus 263 ~~~ 265 (286)
T 3uqc_A 263 ATA 265 (286)
T ss_dssp HHC
T ss_pred Hhc
Confidence 653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=256.92 Aligned_cols=202 Identities=17% Similarity=0.204 Sum_probs=149.4
Q ss_pred cCHHHHHHHHHHHhhCCC-CCceeee---------------------eeEee-----cCeEEEEEeecCCCChhhhhcC-
Q 038647 7 QGLEEFKNEMMLIAKLQH-RNLVRLF---------------------GCCIE-----HGEKILIYEYMPNKSLDCFLFD- 58 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h-~niv~~~---------------------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~- 58 (289)
...+.|.+|+.+++.++| +|...+. .++.. ....+++|+++ +++|.+++..
T Consensus 120 ~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l 198 (413)
T 3dzo_A 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 198 (413)
T ss_dssp -CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHh
Confidence 457889999999999987 3221111 11111 22456777766 6789888731
Q ss_pred ---CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccc
Q 038647 59 ---PTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVG 135 (289)
Q Consensus 59 ---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g 135 (289)
....+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....|
T Consensus 199 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g 270 (413)
T 3dzo_A 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG 270 (413)
T ss_dssp HHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC
T ss_pred hcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC
Confidence 123456788899999999999999999988 999999999999999999999999998865322 334567
Q ss_pred cccccChhhh----------hcCCCCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCcccccccccc
Q 038647 136 TYGYMSPEYA----------LRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQ 205 (289)
Q Consensus 136 ~~~y~aPE~~----------~~~~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (289)
+.|+|||++ .+..++.++|||||||++|+|++|+.||........ ......
T Consensus 271 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~------------------~~~~~~ 331 (413)
T 3dzo_A 271 -RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG------------------SEWIFR 331 (413)
T ss_dssp -TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC------------------SGGGGS
T ss_pred -CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh------------------HHHHHh
Confidence 999999999 455688999999999999999999999865432211 111111
Q ss_pred CCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 206 NDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 206 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
.. ...+..+.+++.+||+.||++|||+.+++
T Consensus 332 ~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 332 SC--KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred hc--ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 11 12346899999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.19 Aligned_cols=206 Identities=12% Similarity=0.073 Sum_probs=151.4
Q ss_pred cccCHHHHHHHHHHHhhCC---------CCCcee-----------------eeeeEee-------------cCeEEEEEe
Q 038647 5 SGQGLEEFKNEMMLIAKLQ---------HRNLVR-----------------LFGCCIE-------------HGEKILIYE 45 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~---------h~niv~-----------------~~~~~~~-------------~~~~~lv~e 45 (289)
.....+.+.+|+.+|+.++ |||||+ +++++.+ ++..|+|||
T Consensus 63 ~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E 142 (336)
T 2vuw_A 63 HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142 (336)
T ss_dssp CCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEE
T ss_pred cchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEE
Confidence 3455689999999999996 555554 4444443 678999999
Q ss_pred ecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh-cCCCCceEeeccccCceEeCCCC----------------
Q 038647 46 YMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH-HYSRLRVIHRDLKASNILLDSNM---------------- 108 (289)
Q Consensus 46 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~~ivH~dikp~Nill~~~~---------------- 108 (289)
|+++|++.+.+.+ +.+++..+..++.||+.||.||| +++ |+||||||+|||++.++
T Consensus 143 ~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~ 215 (336)
T 2vuw_A 143 FEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215 (336)
T ss_dssp EECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEE
T ss_pred ecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCcccccc
Confidence 9999976665522 46899999999999999999999 888 99999999999999887
Q ss_pred ----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHH-HHHHHhCCCCcCCCCCcchhH
Q 038647 109 ----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVL-VLETLSSKKNAHFYNTDSLTL 183 (289)
Q Consensus 109 ----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~v-l~elltg~~p~~~~~~~~~~~ 183 (289)
.+||+|||+++..... ...||+.|+|||++.+.. +.++||||||++ .+++++|..||...... ...
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-~~~ 286 (336)
T 2vuw_A 216 SCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-HYL 286 (336)
T ss_dssp CTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-HHH
T ss_pred CCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-hHH
Confidence 8999999999876432 347999999999998776 899999998777 77788898886421000 000
Q ss_pred hHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 184 LGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
.. ....... .............+.++.+++.+||+.| |++|++
T Consensus 287 ~~---~~~~~~~----~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 287 TD---KMLKQMT----FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HH---HHHHTCC----CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred HH---hhhhhhc----cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 00 0000000 0000011112346788999999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=263.63 Aligned_cols=153 Identities=18% Similarity=0.166 Sum_probs=117.2
Q ss_pred cCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...++|.+|+++|+++ +|+||+++++++++++..||||||++|++|.+++.+ .+.++.. +++.||+.||.|+|
T Consensus 283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH 356 (569)
T 4azs_A 283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALE 356 (569)
T ss_dssp HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHH
Confidence 3467899999999999 799999999999999999999999999999999953 4556654 57899999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++| ||||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+. +..++|+|++|+++++
T Consensus 357 ~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~ 430 (569)
T 4azs_A 357 KQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFN 430 (569)
T ss_dssp HTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CC
T ss_pred HCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhh
Confidence 998 9999999999999999999999999998764432 234557899999999999764 6778999999999888
Q ss_pred HHhCCC
Q 038647 166 TLSSKK 171 (289)
Q Consensus 166 lltg~~ 171 (289)
+.++..
T Consensus 431 l~~~~~ 436 (569)
T 4azs_A 431 LPQPWS 436 (569)
T ss_dssp CCTTHH
T ss_pred hccccc
Confidence 876554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-27 Score=211.96 Aligned_cols=148 Identities=19% Similarity=0.217 Sum_probs=126.5
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.++|.+|+++|++++||||+++..++.+.+..|+||||+++++|.+++.. +..++.|++.||.|||+++
T Consensus 383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g 451 (540)
T 3en9_A 383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND 451 (540)
T ss_dssp HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc
Confidence 56689999999999999999777777778888999999999999999843 4589999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCccc-----ccccccccccccChhhhhc--CCCCCcccchhHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS-----NTKRIVGTYGYMSPEYALR--GLFSIKSDVFSFGV 161 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~ 161 (289)
|+||||||+|||++. .+||+|||+++......... ......||+.|+|||++.. ..|+..+|+|+..+
T Consensus 452 ---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl 526 (540)
T 3en9_A 452 ---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL 526 (540)
T ss_dssp ---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred ---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence 999999999999998 99999999999875432211 1245689999999999987 66888999999999
Q ss_pred HHHHHHhCCCC
Q 038647 162 LVLETLSSKKN 172 (289)
Q Consensus 162 vl~elltg~~p 172 (289)
-..+-+.++.+
T Consensus 527 ~~l~~v~~r~r 537 (540)
T 3en9_A 527 ELMKDVERRAR 537 (540)
T ss_dssp HHHHHHHTCSC
T ss_pred HHHHHHHhccc
Confidence 88887776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=155.84 Aligned_cols=107 Identities=20% Similarity=0.165 Sum_probs=88.9
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
....+.+|+.+|++++ | +++.+++.. +..|+||||+++|+|.+ +. . .....++.|++.||.|||++
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---~------~~~~~i~~qi~~~l~~lH~~ 212 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---V------ENPDEVLDMILEEVAKFYHR 212 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---C------SCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---h------hhHHHHHHHHHHHHHHHHHC
Confidence 4567999999999999 5 677776654 45699999999999988 41 1 23457999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR 147 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 147 (289)
| |+||||||+|||++ ++.+||+|||+++. +..+.|||.+.+
T Consensus 213 g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 213 G---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp T---EECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred C---CEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 8 99999999999999 99999999999863 335788998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.7e-16 Score=128.45 Aligned_cols=97 Identities=16% Similarity=0.173 Sum_probs=77.0
Q ss_pred HHHHHHHHHHhhCCCCCc--eeeeeeEeecCeEEEEEeecCC-C----ChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 10 EEFKNEMMLIAKLQHRNL--VRLFGCCIEHGEKILIYEYMPN-K----SLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
..+.+|+++|++++|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHH
Confidence 478999999999988864 333332 357899999942 4 56554421 235567899999999999
Q ss_pred HHh-cCCCCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 83 YLH-HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 83 ~lH-~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
||| +.+ |+||||||+|||++. .++|+|||++...
T Consensus 185 ~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 185 RLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999 888 999999999999988 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.8e-13 Score=116.65 Aligned_cols=95 Identities=14% Similarity=0.151 Sum_probs=68.6
Q ss_pred HHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCce
Q 038647 13 KNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRV 92 (289)
Q Consensus 13 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 92 (289)
.+|...|.++.+.++. +...+... ..++||||++|++|.++.. .+....++.|++.+|.+||..| |
T Consensus 161 ~kE~~nL~rL~~~gv~-vp~p~~~~-~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---I 226 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFP-VPEPIAQS-RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---L 226 (397)
T ss_dssp HHHHHHHHHHHHTTCS-CCCEEEEE-TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHHhcCCC-CCeeeecc-CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---C
Confidence 3566666666544432 22222222 2379999999988876541 1234578899999999999988 9
Q ss_pred EeeccccCceEeCCCC----------ceEEccccccccc
Q 038647 93 IHRDLKASNILLDSNM----------NPKISDFGIARLF 121 (289)
Q Consensus 93 vH~dikp~Nill~~~~----------~vkl~Dfg~~~~~ 121 (289)
|||||||.|||+++++ .+.|+||+.+...
T Consensus 227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999999998776 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=4.7e-11 Score=97.41 Aligned_cols=104 Identities=16% Similarity=0.109 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..++.+|+++|+.+. +..+.++++++.+.+..|+||||++|.+|.+.+. +......++.+++.+|..||+.
T Consensus 53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~ 124 (263)
T 3tm0_A 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSI 124 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCC
Confidence 456999999999994 6778899999999999999999999999977541 1123457889999999999981
Q ss_pred C--------------------------------------------------------CCceEeeccccCceEeCCCCceE
Q 038647 88 S--------------------------------------------------------RLRVIHRDLKASNILLDSNMNPK 111 (289)
Q Consensus 88 ~--------------------------------------------------------~~~ivH~dikp~Nill~~~~~vk 111 (289)
. ...++|||++|.||+++++..+.
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~ 204 (263)
T 3tm0_A 125 DISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSG 204 (263)
T ss_dssp CCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEE
T ss_pred CcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEE
Confidence 1 13499999999999998765567
Q ss_pred Ecccccccc
Q 038647 112 ISDFGIARL 120 (289)
Q Consensus 112 l~Dfg~~~~ 120 (289)
|+||+.+..
T Consensus 205 lIDwe~a~~ 213 (263)
T 3tm0_A 205 FIDLGRSGR 213 (263)
T ss_dssp ECCCTTCEE
T ss_pred EEEchhccc
Confidence 999997753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.1e-09 Score=93.38 Aligned_cols=108 Identities=14% Similarity=0.263 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHhhCC--CCCceeeeeeEeec---CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQ--HRNLVRLFGCCIEH---GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
..++.+|+.+|+.+. +..+.+++.++.+. +..|+||||++|..+.+.. ...++......++.+++..|..
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~ 154 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAA 154 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHH
Confidence 457889999999997 45578889888776 4589999999998875422 1236778888999999999999
Q ss_pred HhcCC-------------------------------------------------------CCceEeeccccCceEeCCCC
Q 038647 84 LHHYS-------------------------------------------------------RLRVIHRDLKASNILLDSNM 108 (289)
Q Consensus 84 lH~~~-------------------------------------------------------~~~ivH~dikp~Nill~~~~ 108 (289)
||... ...++|||+++.||+++.++
T Consensus 155 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~ 234 (359)
T 3dxp_A 155 MHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE 234 (359)
T ss_dssp HHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS
T ss_pred HhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC
Confidence 99731 24699999999999998765
Q ss_pred c--eEEccccccccc
Q 038647 109 N--PKISDFGIARLF 121 (289)
Q Consensus 109 ~--vkl~Dfg~~~~~ 121 (289)
. +.|+||+.+...
T Consensus 235 ~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 235 PRVLAVLDWELSTLG 249 (359)
T ss_dssp SCEEEECCCTTCEEE
T ss_pred CcEEEEECccccccC
Confidence 3 689999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=6.9e-10 Score=90.15 Aligned_cols=101 Identities=21% Similarity=0.265 Sum_probs=77.5
Q ss_pred HHHHHHHHHHHhhCCCCC--ceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMMLIAKLQHRN--LVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+|+.+|+.+.+.+ +.+++++..+++..++||||++|.+|. .. . .. ...++.+++..|..||.
T Consensus 57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~ 125 (264)
T 1nd4_A 57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHT 125 (264)
T ss_dssp TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTT
T ss_pred chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhC
Confidence 356889999999996444 456888888888899999999998884 21 1 11 23677888888888886
Q ss_pred CC-------------------------------------------------------CCceEeeccccCceEeCCCCceE
Q 038647 87 YS-------------------------------------------------------RLRVIHRDLKASNILLDSNMNPK 111 (289)
Q Consensus 87 ~~-------------------------------------------------------~~~ivH~dikp~Nill~~~~~vk 111 (289)
.. ...++|||++|.||++++++.+.
T Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~ 205 (264)
T 1nd4_A 126 LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSG 205 (264)
T ss_dssp SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEE
T ss_pred CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEE
Confidence 43 12399999999999998776667
Q ss_pred Ecccccccc
Q 038647 112 ISDFGIARL 120 (289)
Q Consensus 112 l~Dfg~~~~ 120 (289)
|+||+.+..
T Consensus 206 liD~~~a~~ 214 (264)
T 1nd4_A 206 FIDCGRLGV 214 (264)
T ss_dssp ECCCTTCEE
T ss_pred EEcchhccc
Confidence 999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=5.8e-10 Score=93.00 Aligned_cols=159 Identities=18% Similarity=0.195 Sum_probs=101.7
Q ss_pred CHHHHHHHHHHHhhCC-CCC--ceeeeeeEeecC---eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQ-HRN--LVRLFGCCIEHG---EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
....+.+|+++|+.+. +.. +.+++.....++ ..|+||++++|.+|..... ..++.+....++.+++..|
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~l 127 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFL 127 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHH
Confidence 4578999999999883 333 334554443333 3589999999988865331 2356777788888888888
Q ss_pred HHHhcCC-------------------------------------------------------CCceEeeccccCceEeCC
Q 038647 82 LYLHHYS-------------------------------------------------------RLRVIHRDLKASNILLDS 106 (289)
Q Consensus 82 ~~lH~~~-------------------------------------------------------~~~ivH~dikp~Nill~~ 106 (289)
..||... ...++|+|++|.||++++
T Consensus 128 a~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~ 207 (304)
T 3sg8_A 128 SELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDT 207 (304)
T ss_dssp HHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEET
T ss_pred HHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeC
Confidence 8888521 134899999999999988
Q ss_pred --CCceEEcccccccccCCCCccccccc------------ccccccccC-hhhhhcCCCCCcccchhHHHHHHHHHhCCC
Q 038647 107 --NMNPKISDFGIARLFGGDELQSNTKR------------IVGTYGYMS-PEYALRGLFSIKSDVFSFGVLVLETLSSKK 171 (289)
Q Consensus 107 --~~~vkl~Dfg~~~~~~~~~~~~~~~~------------~~g~~~y~a-PE~~~~~~~~~~~DiwslG~vl~elltg~~ 171 (289)
+..+.|+||+.+.............. +........ |+..... ....+.|++|.+++.+.+|..
T Consensus 208 ~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~ 285 (304)
T 3sg8_A 208 EKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYM 285 (304)
T ss_dssp TTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCH
T ss_pred CCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCH
Confidence 55678999998875432110000000 000001112 2222111 223578999999999999987
Q ss_pred Cc
Q 038647 172 NA 173 (289)
Q Consensus 172 p~ 173 (289)
++
T Consensus 286 ~~ 287 (304)
T 3sg8_A 286 DW 287 (304)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=3.1e-07 Score=74.92 Aligned_cols=105 Identities=19% Similarity=0.167 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
...+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.++.+.... .......++.+++..|..||..
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~ 135 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSI 135 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTS
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCC
Confidence 457889999999884 33466889999999999999999999888765421 1233456777788888888843
Q ss_pred C-------------------------------------------------------CCceEeeccccCceEeCCCCceEE
Q 038647 88 S-------------------------------------------------------RLRVIHRDLKASNILLDSNMNPKI 112 (289)
Q Consensus 88 ~-------------------------------------------------------~~~ivH~dikp~Nill~~~~~vkl 112 (289)
. ...++|||+.+.||+++.++.+-|
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~v 215 (272)
T 4gkh_A 136 PVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGC 215 (272)
T ss_dssp CGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEE
T ss_pred CcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEE
Confidence 2 123899999999999998777779
Q ss_pred cccccccc
Q 038647 113 SDFGIARL 120 (289)
Q Consensus 113 ~Dfg~~~~ 120 (289)
+||+.+..
T Consensus 216 iDwe~a~~ 223 (272)
T 4gkh_A 216 IDVGRVGI 223 (272)
T ss_dssp CCCTTCEE
T ss_pred EECccccc
Confidence 99998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.4e-06 Score=72.52 Aligned_cols=109 Identities=22% Similarity=0.256 Sum_probs=76.9
Q ss_pred CHHHHHHHHHHHhhCCCC---CceeeeeeEe-ecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKLQHR---NLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
....+.+|+++|+.+.+. .+.+++.+.. ..+..++||||++|..+..... ..++......++.+++..|..
T Consensus 52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~ 126 (306)
T 3tdw_A 52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNE 126 (306)
T ss_dssp HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHH
Confidence 457899999999999643 2456666664 4556789999999988866321 123455556666666666666
Q ss_pred HhcCC---------------------------------------------------------CCceEeeccccCceEeCC
Q 038647 84 LHHYS---------------------------------------------------------RLRVIHRDLKASNILLDS 106 (289)
Q Consensus 84 lH~~~---------------------------------------------------------~~~ivH~dikp~Nill~~ 106 (289)
||+.. ...++|+|+++.||+++.
T Consensus 127 LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~ 206 (306)
T 3tdw_A 127 LSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNL 206 (306)
T ss_dssp HHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECT
T ss_pred HhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEec
Confidence 66432 224699999999999987
Q ss_pred ---CCc-eEEccccccccc
Q 038647 107 ---NMN-PKISDFGIARLF 121 (289)
Q Consensus 107 ---~~~-vkl~Dfg~~~~~ 121 (289)
++. +.|+||+.+...
T Consensus 207 ~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 207 NSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp TCSSCCEEEECCCTTCEEE
T ss_pred CCCCCceEEEEehhhcCCC
Confidence 455 489999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.17 E-value=3.5e-06 Score=65.29 Aligned_cols=102 Identities=13% Similarity=0.020 Sum_probs=66.7
Q ss_pred CChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccc
Q 038647 50 KSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129 (289)
Q Consensus 50 g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 129 (289)
-+|.++|. ..+.+++++++|.+|+|.+.+|..+-... . -..+-+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 37888885 34578999999999999999988872111 0 12344567999999999998874 1110
Q ss_pred cccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCC
Q 038647 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKK 171 (289)
Q Consensus 130 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~ 171 (289)
.....+.|||... ...+.+.=|||||+++|..+--..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122466787653 345677889999999999986444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=9.7e-06 Score=68.78 Aligned_cols=45 Identities=9% Similarity=0.073 Sum_probs=34.2
Q ss_pred HHHHHHHHHHhhCC-C--CCceeeeeeEeec---CeEEEEEeecCCCChhh
Q 038647 10 EEFKNEMMLIAKLQ-H--RNLVRLFGCCIEH---GEKILIYEYMPNKSLDC 54 (289)
Q Consensus 10 ~~~~~E~~~l~~l~-h--~niv~~~~~~~~~---~~~~lv~e~~~~g~L~~ 54 (289)
..+.+|+.+|+.+. + -.+.+++.++.+. +..++||||++|..+.+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 56889999999884 3 3466788877665 35789999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00033 Score=58.68 Aligned_cols=31 Identities=23% Similarity=0.304 Sum_probs=27.4
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..++|||+++.||+++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4599999999999998888899999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00054 Score=56.88 Aligned_cols=45 Identities=20% Similarity=0.230 Sum_probs=37.2
Q ss_pred CHHHHHHHHHHHhhCC---CCCceeeeeeEeecCeEEEEEeecCCCCh
Q 038647 8 GLEEFKNEMMLIAKLQ---HRNLVRLFGCCIEHGEKILIYEYMPNKSL 52 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~L 52 (289)
....|.+|+..|+.+. ...+.+++.+....+..++||||+++..+
T Consensus 71 ~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 71 YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3567899999999984 35677889888888889999999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00075 Score=57.58 Aligned_cols=109 Identities=23% Similarity=0.266 Sum_probs=67.7
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhh-hc----------------CC--CCCCCCC-
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF-LF----------------DP--TKTGLLG- 66 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~----------------~~--~~~~~~~- 66 (289)
....+.+|.++++.+. +.-..++++.+.++ +|+||++|.+|..- +. .. ...+...
T Consensus 96 ~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~ 171 (379)
T 3feg_A 96 GVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHW 171 (379)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 4667789999999884 43345677766543 99999988665321 10 00 0011121
Q ss_pred -hHHHHHHHHHHHH-------------------HHHHHh----c-CCCCceEeeccccCceEeCCC----CceEEccccc
Q 038647 67 -WEMRVRILEGVAQ-------------------GLLYLH----H-YSRLRVIHRDLKASNILLDSN----MNPKISDFGI 117 (289)
Q Consensus 67 -~~~~~~~~~~i~~-------------------~l~~lH----~-~~~~~ivH~dikp~Nill~~~----~~vkl~Dfg~ 117 (289)
+.++.+|..++.. .+..|. . .....++|+|+.+.||+++.+ +.+.|+||..
T Consensus 172 l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~ 251 (379)
T 3feg_A 172 LFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEY 251 (379)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTT
T ss_pred HHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEeccc
Confidence 3455555544422 122222 1 123569999999999999876 6899999998
Q ss_pred ccc
Q 038647 118 ARL 120 (289)
Q Consensus 118 ~~~ 120 (289)
+..
T Consensus 252 a~~ 254 (379)
T 3feg_A 252 SSY 254 (379)
T ss_dssp CEE
T ss_pred CCc
Confidence 764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00095 Score=55.84 Aligned_cols=33 Identities=30% Similarity=0.408 Sum_probs=28.0
Q ss_pred CCceEeeccccCceEeCCC----CceEEccccccccc
Q 038647 89 RLRVIHRDLKASNILLDSN----MNPKISDFGIARLF 121 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~----~~vkl~Dfg~~~~~ 121 (289)
...++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3469999999999999874 67899999988754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0017 Score=55.73 Aligned_cols=31 Identities=26% Similarity=0.284 Sum_probs=26.1
Q ss_pred CceEeeccccCceEeCCCCceEEccccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
..++|||+.+.||+++.+ .++++||..+...
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 459999999999999876 4899999877653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0026 Score=52.32 Aligned_cols=32 Identities=25% Similarity=0.249 Sum_probs=26.2
Q ss_pred CCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
...++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 345899999999999 55667899999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0022 Score=55.68 Aligned_cols=39 Identities=26% Similarity=0.508 Sum_probs=27.3
Q ss_pred HHHHHHHHHHhhCCCCCc-eeeeeeEeecCeEEEEEeecCCCCh
Q 038647 10 EEFKNEMMLIAKLQHRNL-VRLFGCCIEHGEKILIYEYMPNKSL 52 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L 52 (289)
+.+.+|+.+++.+...++ .++++.+.++ +|+||++|.+|
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~g----~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSGG----RLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETTE----EEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCCC----EEEEEeCCccc
Confidence 667789999999853333 5677665432 89999986544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.013 Score=50.70 Aligned_cols=32 Identities=16% Similarity=0.258 Sum_probs=27.7
Q ss_pred CCceEeeccccCceEeCCCCceEEccccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
...++|||+++.|||++.++ ++|+||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 34599999999999998776 999999988754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.41 E-value=0.07 Score=43.36 Aligned_cols=24 Identities=29% Similarity=0.331 Sum_probs=20.2
Q ss_pred CceEeeccccCceEeCCCCceEEcc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISD 114 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~D 114 (289)
..++|+|+.+.|++++.++. .+.|
T Consensus 188 p~LvHGDlw~gNvl~~~~g~-~~iD 211 (288)
T 3f7w_A 188 PARIHGDLWNGNVLWQDDGA-VVID 211 (288)
T ss_dssp CEEECSCCSGGGEEEETTEE-EECS
T ss_pred CeeeecCCCCCcEEEcCCCe-EEEe
Confidence 46999999999999998874 4666
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.11 E-value=0.018 Score=49.42 Aligned_cols=31 Identities=26% Similarity=0.385 Sum_probs=26.0
Q ss_pred CceEeeccccCceEe------CCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILL------DSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill------~~~~~vkl~Dfg~~~~ 120 (289)
..++|+|+.+.||++ +++..+.++||..+..
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 347899999999999 4567799999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.98 E-value=0.08 Score=43.78 Aligned_cols=30 Identities=33% Similarity=0.429 Sum_probs=25.5
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
...++|||+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34589999999999998 4 899999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.83 E-value=0.022 Score=47.11 Aligned_cols=31 Identities=29% Similarity=0.292 Sum_probs=26.1
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..++|+|+++.||++++++.+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4599999999999998776568999987753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.32 E-value=0.36 Score=37.41 Aligned_cols=113 Identities=9% Similarity=0.038 Sum_probs=74.7
Q ss_pred CCCCceeeeeeEeecCeEEEEEeecCCC-ChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH-HHhcCCCCceEeeccccC
Q 038647 23 QHRNLVRLFGCCIEHGEKILIYEYMPNK-SLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL-YLHHYSRLRVIHRDLKAS 100 (289)
Q Consensus 23 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~~ivH~dikp~ 100 (289)
.||++ -..+-.+++.+.+.++.-+++ ++.. + ...+...+++++.+|+.... +++. -+|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 47777 334446677777777754333 3332 3 24677888999999877776 4442 678899999
Q ss_pred ceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCc
Q 038647 101 NILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNA 173 (289)
Q Consensus 101 Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~ 173 (289)
|++++.++.+++.-.|+-..+... =..+|.+ .-.+=|++..++.++..|
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP~--------------e~~ee~f----------l~qyKali~all~~K~~F 162 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPPD--------------EWDDERL----------LREVKATVLALTEGEYRF 162 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSSC--------------SCCHHHH----------HHHHHHHHHHHTTCSSCH
T ss_pred eEEEeCCCcEEEEEcCCcccCCCC--------------CCCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence 999999999999988765432111 1233333 235677888888877654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.05 E-value=0.12 Score=45.24 Aligned_cols=36 Identities=19% Similarity=0.305 Sum_probs=25.9
Q ss_pred HHHHHHHhhCCCCCc-eeeeeeEeecCeEEEEEeecCCCCh
Q 038647 13 KNEMMLIAKLQHRNL-VRLFGCCIEHGEKILIYEYMPNKSL 52 (289)
Q Consensus 13 ~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L 52 (289)
.+|..+++.+...++ .++++.+.. . +|+||++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~~--G--~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFTN--G--RIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEETT--E--EEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeCC--e--EEEEeeCCccC
Confidence 689999999965555 467777632 2 49999987554
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.93 E-value=0.36 Score=37.24 Aligned_cols=115 Identities=10% Similarity=0.057 Sum_probs=77.5
Q ss_pred CCCCceeeeeeEeecCeEEEEEeecC-CCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCc
Q 038647 23 QHRNLVRLFGCCIEHGEKILIYEYMP-NKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASN 101 (289)
Q Consensus 23 ~h~niv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~N 101 (289)
.||+.+.. .+-.+.+.+.+.++.-+ ..++.. + ...+...+++++.+|+....+++. -+|--++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 58888866 56666677666666443 223333 2 346788899999999888865543 5788899999
Q ss_pred eEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHHHhCCCCcC
Q 038647 102 ILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAH 174 (289)
Q Consensus 102 ill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~elltg~~p~~ 174 (289)
++++.++.+++.-.|+-..+... =..+|.+ .-.+=|++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPL--------------PVSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCC--------------CCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCCC--------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999987764332111 0122322 3357788889998876653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.85 E-value=0.089 Score=43.95 Aligned_cols=31 Identities=26% Similarity=0.374 Sum_probs=27.5
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.27 E-value=0.07 Score=45.08 Aligned_cols=30 Identities=23% Similarity=0.438 Sum_probs=25.0
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
..++|+|+++.||++++++ +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4599999999999997655 89999987764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=86.05 E-value=0.05 Score=47.95 Aligned_cols=32 Identities=22% Similarity=0.096 Sum_probs=25.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH 37 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 37 (289)
.++.++|..|++++.+++|+|+|++.|||...
T Consensus 320 ~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 320 GQGSETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp -----CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred cccHHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 45678999999999999999999999997653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=85.37 E-value=0.39 Score=41.44 Aligned_cols=31 Identities=26% Similarity=0.498 Sum_probs=26.9
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
...++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 345999999999999 7788899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 289 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-59
Identities = 52/244 (21%), Positives = 111/244 (45%), Gaps = 19/244 (7%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+++ + Q L+ FKNE+ ++ K +H N++ G + ++ ++ SL L
Sbjct: 40 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI-- 96
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ I AQG+ YLH +IHRDLK++NI L ++ KI DFG+A +
Sbjct: 97 IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLETLSSKKNAHFYN 177
+++ G+ +M+PE + +S +SDV++FG+++ E ++ + + N
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSN 211
Query: 178 TDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237
++ + + G + + N + C+++ +RP ++
Sbjct: 212 INNRDQI---IFMVGRGYLSPDLSKVRSN-----CPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 238 ISML 241
++ +
Sbjct: 264 LASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-52
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
Q + F E L+ +LQH+ LVRL+ + +I EYM N SL FL P+
Sbjct: 46 KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI 104
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
L + + +A+G+ ++ IHRDL+A+NIL+ ++ KI+DFG+ARL
Sbjct: 105 KL-TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
+E + + +PE G F+IKSDV+SFG+L+ E ++ + + T+
Sbjct: 161 DNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-- 217
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241
G D+ + + LC +E DRPT + S+L
Sbjct: 218 ---EVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-52
Identities = 64/239 (26%), Positives = 104/239 (43%), Gaps = 20/239 (8%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
+ E+F E ++ KL H LV+L+G C+E L++E+M + L +L +
Sbjct: 38 REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QR 95
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
GL E + + V +G + + VIHRDL A N L+ N K+SDFG+ R
Sbjct: 96 GLFAAETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
D+ +++ + SPE +S KSDV+SFGVL+ E S K + ++S
Sbjct: 153 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-- 209
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241
+ + + L L + + C +E DRP ++ L
Sbjct: 210 -----EVVEDISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 1e-51
Identities = 62/256 (24%), Positives = 116/256 (45%), Gaps = 31/256 (12%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
S + + +F +E ++ + H N++ L G + ++I E+M N SLD FL
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--N 121
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
G V +L G+A G+ YL +HRDL A NIL++SN+ K+SDFG++R
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 122 GGDELQSNTKRIVG---TYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178
D +G + +PE F+ SDV+S+G+++ E
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE------------- 225
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLN---RYINVALLCVQENAADRPTML 235
++ + + D +++++I Q+ P ++ + L C Q++ RP
Sbjct: 226 ----VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 236 EVISMLTNENVILPSP 251
++++ L ++ +P
Sbjct: 282 QIVNTLDK---MIRNP 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-51
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 20/241 (8%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
+ +EF E ++ L H LV+L+G C + +I EYM N L +L +
Sbjct: 37 KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MR 94
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ + + + V + + YL + +HRDL A N L++ K+SDFG++R
Sbjct: 95 HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
DE S+ + PE + FS KSD+++FGVL+ E S K
Sbjct: 152 DDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK----------- 199
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242
+ + + E + L+ + + + C E A +RPT ++S +
Sbjct: 200 ---MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
Query: 243 N 243
+
Sbjct: 257 D 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 7e-51
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 20/253 (7%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
E F E ++ KL+H LV+L+ ++ EYM SL FL T
Sbjct: 50 KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG- 107
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
L V + +A G+ Y+ +HRDL+A+NIL+ N+ K++DFG+ARL
Sbjct: 108 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 164
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
+E + + +PE AL G F+IKSDV+SFG+L+ E + +
Sbjct: 165 DNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR----------- 212
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242
+ + + ++ + ++ C ++ +RPT + + L
Sbjct: 213 ---VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 243 NENVILPSPLQPA 255
+ QP
Sbjct: 270 DYFTSTEPQYQPG 282
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-50
Identities = 58/253 (22%), Positives = 94/253 (37%), Gaps = 21/253 (8%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
EE E ++ +L + +VRL G C + +L+ E L FL K +
Sbjct: 51 ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIP 107
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
+L V+ G+ YL +HRDL A N+LL + KISDFG+++ G D+
Sbjct: 108 VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164
Query: 127 QSNTKR-IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLG 185
+ + +PE FS +SDV+S+GV + E LS +
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-------------- 210
Query: 186 HAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNEN 245
+ ++ + + + C DRP L V +
Sbjct: 211 KPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
Query: 246 VILPSPLQPAFSH 258
L S ++ H
Sbjct: 271 YSLASKVEGHHHH 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-50
Identities = 52/266 (19%), Positives = 93/266 (34%), Gaps = 28/266 (10%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI----LIYEYMPNKSLDCFL 56
SS+ + + E+ L+H N++ + L+ +Y + SL +L
Sbjct: 34 FSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92
Query: 57 FDPTKTGLLGWEMRVRILEGVAQGLLYLHH-----YSRLRVIHRDLKASNILLDSNMNPK 111
+ E +++ A GL +LH + + HRDLK+ NIL+ N
Sbjct: 93 ----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148
Query: 112 ISDFGIARLF--GGDELQSNTKRIVGTYGYMSPEYALRGL------FSIKSDVFSFGVLV 163
I+D G+A D + VGT YM+PE + ++D+++ G++
Sbjct: 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208
Query: 164 LETLSSKKNAHFYNTDS-----LTLLGHAWNLWNDGRAWELMD-SILQNDASYPMLNRYI 217
E + L + + + +I S L
Sbjct: 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268
Query: 218 NVALLCVQENAADRPTMLEVISMLTN 243
+ C N A R T L + L+
Sbjct: 269 KIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-50
Identities = 56/258 (21%), Positives = 105/258 (40%), Gaps = 37/258 (14%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+ E+ ++ + +V +G GE + E+M SLD L K G + ++
Sbjct: 49 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQI 105
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
++ V +GL YL + +++HRD+K SNIL++S K+ DFG++ S
Sbjct: 106 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSM 159
Query: 130 TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK------------------- 170
VGT YMSPE +S++SD++S G+ ++E +
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 171 -----KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVAL 221
+ T L + + +EL+D I+ + +
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 222 LCVQENAADRPTMLEVIS 239
C+ +N A+R + +++
Sbjct: 280 KCLIKNPAERADLKQLMV 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (417), Expect = 5e-50
Identities = 58/239 (24%), Positives = 107/239 (44%), Gaps = 19/239 (7%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
+ +EEF E ++ +++H NLV+L G C +I E+M +L +L + +
Sbjct: 51 KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR- 109
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ + + + ++ + YL + IHRDL A N L+ N K++DFG++RL
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
GD ++ + +PE FSIKSDV++FGVL+ E + +
Sbjct: 167 GDTYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------- 215
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241
+ + + +EL++ + + + + C Q N +DRP+ E+
Sbjct: 216 ----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-50
Identities = 53/243 (21%), Positives = 93/243 (38%), Gaps = 22/243 (9%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
+ +E E ++ +L + +VR+ G C E +L+ E L+ +L +
Sbjct: 45 EANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---Q 100
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
+ + + ++ V+ G+ YL +HRDL A N+LL + KISDFG+++
Sbjct: 101 NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157
Query: 122 GGD-ELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
D + +PE FS KSDV+SFGVL+ E S +
Sbjct: 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ--------- 208
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
+ +++ + ++ LC + +RP V
Sbjct: 209 -----KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 263
Query: 241 LTN 243
L N
Sbjct: 264 LRN 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-49
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI-LIYEYMPNKSLDCFLFDPTKT 62
++ + F E ++ +L+H NLV+L G +E + ++ EYM SL +L ++
Sbjct: 39 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 98
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+LG + ++ V + + YL +HRDL A N+L+ + K+SDFG+ +
Sbjct: 99 -VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--- 151
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
E S + +PE FS KSDV+SFG+L+ E S + Y L
Sbjct: 152 --EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLK 207
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241
G + D V C +AA RP+ L++ L
Sbjct: 208 ---DVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-49
Identities = 60/257 (23%), Positives = 102/257 (39%), Gaps = 37/257 (14%)
Query: 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT----- 62
E +E+ ++ +L H N+V L G C G LI+EY L +L +
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 63 ---------------GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107
+L +E + VA+G+ +L +HRDL A N+L+
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHG 200
Query: 108 MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
KI DFG+AR D +M+PE G+++IKSDV+S+G+L+ E
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQEN 227
S N + + D ++L+ + + D + + C +
Sbjct: 261 SLGVNPY-------------PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307
Query: 228 AADRPTMLEVISMLTNE 244
+ RP+ + S L +
Sbjct: 308 SRKRPSFPNLTSFLGCQ 324
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 9e-49
Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 38/260 (14%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
S +F+ E L+A+ + N+V+L G C L++EYM L+ FL +
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113
Query: 63 GL---------------------LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASN 101
+ L ++ I VA G+ YL + +HRDL N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170
Query: 102 ILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161
L+ NM KI+DFG++R + +M PE ++ +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVAL 221
++ E S ++ DG ++ N+
Sbjct: 231 VLWEIFSYGLQPYYGMAHE-----EVIYYVRDGNILACPENCPL---------ELYNLMR 276
Query: 222 LCVQENAADRPTMLEVISML 241
LC + ADRP+ + +L
Sbjct: 277 LCWSKLPADRPSFCSIHRIL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-48
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 32/248 (12%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKIL--IYEYMPNKSLDCFLFD 58
S + + +E+ L+ +L+H N+VR + I+ L + EY L +
Sbjct: 39 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98
Query: 59 PTKT-GLLGWEMRVRILEGVAQGLLYLH--HYSRLRVIHRDLKASNILLDSNMNPKISDF 115
TK L E +R++ + L H V+HRDLK +N+ LD N K+ DF
Sbjct: 99 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
G+AR+ D S K VGT YMSPE R ++ KSD++S G L+ E
Sbjct: 159 GLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE---------- 206
Query: 176 YNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYI-----NVALLCVQENAAD 230
L + EL I + + + + +
Sbjct: 207 --------LCALMPPFTAFSQKELAGKIREGK--FRRIPYRYSDELNEIITRMLNLKDYH 256
Query: 231 RPTMLEVI 238
RP++ E++
Sbjct: 257 RPSVEEIL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 59/275 (21%), Positives = 117/275 (42%), Gaps = 34/275 (12%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
+ S + +E +E ++A + + ++ RL G C+ LI + MP L ++ +
Sbjct: 49 ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HK 105
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+G + + +A+G+ YL R++HRDL A N+L+ + + KI+DFG+A+L G
Sbjct: 106 DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
+E + + + +M+ E L +++ +SDV+S+GV V E ++
Sbjct: 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----------- 211
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242
++ +++ + + + C +A RP E+I +
Sbjct: 212 ---KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
Query: 243 --------------NENVILPSPLQPAFSHVRIAE 263
+E + LPSP F + E
Sbjct: 269 KMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDE 303
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-48
Identities = 55/241 (22%), Positives = 109/241 (45%), Gaps = 20/241 (8%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
+ + + +F E ++ + H N++RL G ++ ++I EYM N + F K
Sbjct: 46 AGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREK 103
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
G V +L G+A G+ + + + +HRDL A NIL++SN+ K+SDFG++R+
Sbjct: 104 DGEFSVLQLVGMLRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160
Query: 122 GGDELQSNT-KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
D + T + +PE F+ SDV+SFG+++ E ++ +
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--------- 211
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
+ ++ + ++ + + + + C Q+ A RP +++S+
Sbjct: 212 -----RPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
Query: 241 L 241
L
Sbjct: 267 L 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-48
Identities = 51/243 (20%), Positives = 104/243 (42%), Gaps = 27/243 (11%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK----ILIYEYMPNKSLDCFLF 57
+ + FK E ++ LQH N+VR + + +L+ E M + +L +L
Sbjct: 45 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104
Query: 58 DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFG 116
+ ++ ++ + +GL +LH + +IHRDLK NI + + KI D G
Sbjct: 105 ---RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLG 160
Query: 117 IARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFY 176
+A L S K ++GT +M+PE + DV++FG+ +LE +S+ +
Sbjct: 161 LATLKRA----SFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YS 213
Query: 177 NTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLE 236
+ + + G D + + + C+++N +R ++ +
Sbjct: 214 ECQNAAQI---YRRVTSGVKPASFDKVAIPEV--------KEIIEGCIRQNKDERYSIKD 262
Query: 237 VIS 239
+++
Sbjct: 263 LLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 5e-48
Identities = 67/274 (24%), Positives = 104/274 (37%), Gaps = 41/274 (14%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
QS + ++ E+ + KL+H N ++ GC + L+ EY + D
Sbjct: 52 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---H 108
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
L + G QGL YLH +IHRD+KA NILL K+ DFG A +
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 122 GGDELQSNTKRIVGTYGYMSPEYAL---RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178
+ VGT +M+PE L G + K DV+S G+ +E K
Sbjct: 166 ------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP------- 212
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVALLCVQENAADRPTM 234
+ A + I QN++ + N C+Q+ DRPT
Sbjct: 213 -----------PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 261
Query: 235 LEVISM--LTNE--NVILPSPLQPAFSHVRIAEN 264
++ + E ++ +Q VR +N
Sbjct: 262 EVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-48
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 20/238 (8%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
++ E K E+ + L H N+V+ +G E + L EY L +
Sbjct: 41 KRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PD 97
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
+ R + G++YLH + + HRD+K N+LLD N KISDFG+A +F
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
+ + ++ GT Y++PE R F + DV+S G+++ L+ + +DS
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC 213
Query: 182 TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
W+ +DS +L++ + EN + R T+ ++
Sbjct: 214 QEYSDWKEKKTYLNPWKKIDSAPLA-----LLHK-------ILVENPSARITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 8e-48
Identities = 56/258 (21%), Positives = 100/258 (38%), Gaps = 32/258 (12%)
Query: 3 SQSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
S E +E+ +++ L H N+V L G C G ++I EY L FL
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 62 TGL---------------LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS 106
+ + L E + VA+G+ +L IHRDL A NILL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH 180
Query: 107 NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166
KI DFG+AR D +M+PE +++ +SDV+S+G+ + E
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQE 226
S + + + D + ++++ + + ++ C
Sbjct: 241 FSLGSSPY-------------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287
Query: 227 NAADRPTMLEVISMLTNE 244
+ RPT +++ ++ +
Sbjct: 288 DPLKRPTFKQIVQLIEKQ 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-47
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 28/240 (11%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEH-GEKILIYEYMPNKSLDCFLFDPTKTGLLGW 67
+ +F E +++ H N++ L G C+ G +++ YM + L F +T
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTV 129
Query: 68 EMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ 127
+ + VA+G+ + + +HRDL A N +LD K++DFG+AR E
Sbjct: 130 KDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 128 SNTKR--IVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLG 185
S + +M+ E F+ KSDV+SFGVL+ E ++
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-------------- 232
Query: 186 HAWNLWNDGRAWELMDSILQNDASYP---MLNRYINVALLCVQENAADRPTMLEVISMLT 242
+ D +++ +LQ + V L C A RP+ E++S ++
Sbjct: 233 ---PPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-47
Identities = 46/249 (18%), Positives = 102/249 (40%), Gaps = 35/249 (14%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+ ++S + LE++ E+ ++A H N+V+L ++ E+ ++D + +
Sbjct: 45 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-- 102
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
L + + L YLH ++IHRDLKA NIL + + K++DFG++
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
+ ++ +GT +M+PE + + K+DV+S G+ ++E +
Sbjct: 160 NTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---- 213
Query: 176 YNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL-----CVQENAAD 230
++ ++ I +++ + C+++N
Sbjct: 214 --------------PHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 231 RPTMLEVIS 239
R T +++
Sbjct: 260 RWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-47
Identities = 60/244 (24%), Positives = 92/244 (37%), Gaps = 28/244 (11%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ +++F E+ + L HRNL+RL+G + ++ E P SL L G
Sbjct: 50 SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQG 106
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG- 122
R VA+G+ YL R IHRDL A N+LL + KI DFG+ R
Sbjct: 107 HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
D+ + + + +PE FS SD + FGV + E
Sbjct: 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE----------------- 206
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY----INVALLCVQENAADRPTMLEVI 238
+ + W +++ I + P NV + C DRPT + +
Sbjct: 207 MFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
Query: 239 SMLT 242
L
Sbjct: 267 DFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 6e-47
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 30/238 (12%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ + + E+ + + L+H N++RL+G + LI EY P ++ L K
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLS 101
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
+ + +A L Y H RVIHRD+K N+LL S KI+DFG +
Sbjct: 102 KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
+ GT Y+ PE + K D++S GVL E L K
Sbjct: 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------- 201
Query: 184 LGHAWNLWNDGRAWELMDSILQNDASYP--MLNRYINVALLCVQENAADRPTMLEVIS 239
+ E I + + ++P + ++ ++ N + RP + EV+
Sbjct: 202 -----PPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 7e-46
Identities = 61/279 (21%), Positives = 109/279 (39%), Gaps = 38/279 (13%)
Query: 5 SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFL------- 56
S +F E+ ++ KL H N++ L G C G L EY P+ +L FL
Sbjct: 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 109
Query: 57 ------FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP 110
+ L + + VA+G+ YL + IHRDL A NIL+ N
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166
Query: 111 KISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
KI+DFG++R E+ +M+ E +++ SDV+S+GVL+ E +S
Sbjct: 167 KIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
Query: 171 KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230
+ +E + + + + ++ C +E +
Sbjct: 224 G--------------TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 269
Query: 231 RPTMLEVISMLTN----ENVILPSPLQPAFSHVRIAENS 265
RP+ +++ L + + L F++ I ++
Sbjct: 270 RPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-45
Identities = 58/263 (22%), Positives = 108/263 (41%), Gaps = 26/263 (9%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLF----- 57
+ S + EF NE ++ + ++VRL G + ++I E M L +L
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 58 --DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDF 115
+ +++ +A G+ YL+ + +HRDL A N ++ + KI DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHF 175
G+ R + + + +MSPE G+F+ SDV+SFGV++ E + + +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 176 YNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235
++ +G + D+ + +C Q N RP+ L
Sbjct: 238 GLSNE-----QVLRFVMEGGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFL 283
Query: 236 EVISMLTNENVILPSPLQPAFSH 258
E+IS + E + P + +F +
Sbjct: 284 EIISSIKEE--MEPGFREVSFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-43
Identities = 48/244 (19%), Positives = 95/244 (38%), Gaps = 32/244 (13%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
++ Q E NE++++ + ++ N+V + E ++ EY+ SL + +
Sbjct: 53 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ Q L +LH +VIHRD+K+ NILL + + K++DFG
Sbjct: 113 MD----EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
+ QS +VGT +M+PE R + K D++S G++ +E + +
Sbjct: 166 ITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--------- 214
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL-----CVQENAADRPTML 235
+ + + I N ++ C+ + R +
Sbjct: 215 ---------PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAK 265
Query: 236 EVIS 239
E++
Sbjct: 266 ELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-42
Identities = 60/256 (23%), Positives = 94/256 (36%), Gaps = 30/256 (11%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILI-YEYMPNKSLDCFLF--- 57
+ + +LI H N+V L G C + G +++ E+ +L +L
Sbjct: 54 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 113
Query: 58 ----------DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107
+ L E + VA+G+ +L + IHRDL A NILL
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 170
Query: 108 MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
KI DFG+AR D +M+PE +++I+SDV+SFGVL+ E
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQEN 227
S + + + + +G D L C
Sbjct: 231 SLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGE 277
Query: 228 AADRPTMLEVISMLTN 243
+ RPT E++ L N
Sbjct: 278 PSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-42
Identities = 45/235 (19%), Positives = 91/235 (38%), Gaps = 26/235 (11%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
+ E ++++L H V+L+ + + Y N L ++ K G
Sbjct: 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFD 106
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
A+ + L + +IHRDLK NILL+ +M+ +I+DFG A++ +
Sbjct: 107 ETCTRFY---TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGH 186
Q+ VGT Y+SPE SD+++ G ++ + ++
Sbjct: 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL---------------- 207
Query: 187 AWNLWNDGRAWELMDSILQNDASYP--MLNRYINVALLCVQENAADRPTMLEVIS 239
+ G + + I++ + +P + ++ + +A R E+
Sbjct: 208 --PPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-42
Identities = 49/241 (20%), Positives = 88/241 (36%), Gaps = 21/241 (8%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKT 62
S E+F E + + + H ++V+L G E+ +I E L F +
Sbjct: 46 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGEL--RSFLQVRK 102
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
L + ++ L YL R +HRD+ A N+L+ SN K+ DFG++R
Sbjct: 103 YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
+ + +M+PE F+ SDV+ FGV + E L ++
Sbjct: 160 DSTYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-- 216
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242
+G + + ++ C + + RP E+ + L+
Sbjct: 217 ---DVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYDPSRRPRFTELKAQLS 264
Query: 243 N 243
Sbjct: 265 T 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-42
Identities = 60/254 (23%), Positives = 104/254 (40%), Gaps = 31/254 (12%)
Query: 2 SSQSGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
S + + L + +EM ++ + +H+N++ L G C + G +I EY +L +L
Sbjct: 55 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 114
Query: 61 KTGL-------------LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN 107
GL L + V VA+G+ YL + IHRDL A N+L+ +
Sbjct: 115 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED 171
Query: 108 MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETL 167
KI+DFG+AR + T +M+PE +++ +SDV+SFGVL+ E
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 168 SSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQEN 227
+ + ++L+ + D N + C
Sbjct: 232 TLGG--------------SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV 277
Query: 228 AADRPTMLEVISML 241
+ RPT +++ L
Sbjct: 278 PSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (350), Expect = 2e-39
Identities = 51/274 (18%), Positives = 100/274 (36%), Gaps = 36/274 (13%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+ + E + E+ ++ L+H LV L + E ++IYE+M L + D
Sbjct: 59 VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-- 116
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGIA 118
+ + + V + V +GL ++H +H DLK NI+ + + K+ DFG+
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178
+ + K GT + +PE A +D++S GVL LS
Sbjct: 174 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL-------- 222
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY------INVALLCVQENAADRP 232
+ + E + ++ D + + + + R
Sbjct: 223 ----------SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM 272
Query: 233 TMLEVISM--LTNENVILPSPLQPAFSHVRIAEN 264
T+ + + LT N P+ + +I ++
Sbjct: 273 TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (340), Expect = 5e-38
Identities = 44/247 (17%), Positives = 90/247 (36%), Gaps = 34/247 (13%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
+++ KNE+ ++ +L H L+ L + E +LI E++ L +
Sbjct: 62 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--A 119
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGIA 118
+ + + + +GL ++H ++H D+K NI+ ++ KI DFG+A
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
Query: 119 RLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNT 178
DE+ K T + +PE R +D+++ GVL LS
Sbjct: 177 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS------- 226
Query: 179 DSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY------INVALLCVQENAADRP 232
+ E + ++ + D + + +Q+ R
Sbjct: 227 -----------PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 275
Query: 233 TMLEVIS 239
T+ + +
Sbjct: 276 TVHDALE 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (324), Expect = 5e-36
Identities = 48/235 (20%), Positives = 95/235 (40%), Gaps = 31/235 (13%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ +E +E ++++ + H ++R++G + + +I +Y+ LF +
Sbjct: 43 VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKS 98
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
+ A+ L L + +I+RDLK NILLD N + KI+DFG A+
Sbjct: 99 QRFPNPVAKFY--AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---- 152
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
+ T + GT Y++PE ++ D +SFG+L+ E L+
Sbjct: 153 -YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT------------ 199
Query: 184 LGHAWNLWNDGRAWELMDSILQNDASYP--MLNRYINVALLCVQENAADRPTMLE 236
+ D + + IL + +P ++ + + + R L+
Sbjct: 200 ------PFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 9e-35
Identities = 45/241 (18%), Positives = 92/241 (38%), Gaps = 34/241 (14%)
Query: 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
G K E+ ++ +HRN++ L E ++I+E++ + + T
Sbjct: 41 KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFE 98
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP--KISDFGIARLFG 122
L V + V + L +LH + H D++ NI+ + + KI +FG AR
Sbjct: 99 LNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
+ N + + Y +PE + S +D++S G LV LS
Sbjct: 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------------ 200
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPM-LNRYINVALL-----CVQENAADRPTMLE 236
N + +++++I+ + ++ + I++ + + + R T E
Sbjct: 201 ------NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 237 V 237
Sbjct: 255 A 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (310), Expect = 2e-34
Identities = 50/252 (19%), Positives = 94/252 (37%), Gaps = 36/252 (14%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI----LIYEYMPNKSLDCFLF 57
++ F+ E A L H +V ++ ++ EY+ +L +
Sbjct: 44 LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH 103
Query: 58 DPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGI 117
G + + + ++ A L+ + +IHRD+K +NI++ + K+ DFGI
Sbjct: 104 ---TEGPMTPKRAIEVI---ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 157
Query: 118 ARLFG-GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFY 176
AR + T ++GT Y+SPE A +SDV+S G ++ E L+ +
Sbjct: 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------ 211
Query: 177 NTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNR------YINVALLCVQENAAD 230
+ + ++ D P V L + +N +
Sbjct: 212 ------------PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259
Query: 231 RP-TMLEVISML 241
R T E+ + L
Sbjct: 260 RYQTAAEMRADL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (309), Expect = 3e-34
Identities = 47/243 (19%), Positives = 96/243 (39%), Gaps = 40/243 (16%)
Query: 10 EEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
E E+ ++ K+ H N+++L + L+++ M L +L T+ L +
Sbjct: 54 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEK 110
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
+I+ + + + LH +L ++HRDLK NILLD +MN K++DFG + E
Sbjct: 111 ETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--- 164
Query: 129 NTKRIVGTYGYMSPEYAL------RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
+ + GT Y++PE + + D++S GV++ L+
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------------ 212
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYPMLNR------YINVALLCVQENAADRPTMLE 236
+ + ++ I+ + + ++ + R T E
Sbjct: 213 ------PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266
Query: 237 VIS 239
++
Sbjct: 267 ALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 6e-34
Identities = 48/239 (20%), Positives = 90/239 (37%), Gaps = 36/239 (15%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+NE+ ++ K++H N+V L G LI + + L + + G
Sbjct: 52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERD 108
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILL---DSNMNPKISDFGIARLFGGDEL 126
R++ V + YLH ++HRDLK N+L D + ISDFG++++ +
Sbjct: 109 ASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGH 186
GT GY++PE + +S D +S GV+ L
Sbjct: 166 ---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP--------------- 207
Query: 187 AWNLWNDGRAWELMDSILQNDASYPMLNR------YINVALLCVQENAADRPTMLEVIS 239
+ D +L + IL+ + + + ++++ R T + +
Sbjct: 208 ---PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-34
Identities = 55/250 (22%), Positives = 98/250 (39%), Gaps = 24/250 (9%)
Query: 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+ E+ ++ + +H N++ + + + Y+ + L+ KT L +
Sbjct: 50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND 109
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS 128
L + +GL Y+H V+HRDLK SN+LL++ + KI DFG+AR+ D +
Sbjct: 110 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 129 NT-KRIVGTYGYMSPEYALRGLFSIKS-DVFSFGVLVLETLSSKKNAHFYNTDSLTLLGH 186
V T Y +PE L KS D++S G ++ E LS++ F L L H
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNH 224
Query: 187 AWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL-----------------CVQENAA 229
+ +L I +Y + + N + N
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284
Query: 230 DRPTMLEVIS 239
R + + ++
Sbjct: 285 KRIEVEQALA 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (306), Expect = 5e-33
Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 18/207 (8%)
Query: 11 EFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMR 70
+ + L++ +V + + I + M L L + G+
Sbjct: 53 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADM 109
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
+ GL ++H+ V++RDLK +NILLD + + +ISD G+A F +
Sbjct: 110 RFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKP 162
Query: 131 KRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWN 189
VGT+GYM+PE +G+ + +D FS G ++ + L + T +
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
Query: 190 LWN-------DGRAWELMDSILQNDAS 209
L++ +LQ D +
Sbjct: 223 TMAVELPDSFSPELRSLLEGLLQRDVN 249
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 6e-33
Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 29/235 (12%)
Query: 7 QGLEEFKNE-MMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLL 65
+E E +L +H L +F + EY+ L +
Sbjct: 44 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKF 100
Query: 66 GWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE 125
+ GL +LH +++RDLK NILLD + + KI+DFG+ + +
Sbjct: 101 DLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157
Query: 126 LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLG 185
++NT GT Y++PE L ++ D +SFGVL+ E L +
Sbjct: 158 AKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--------------- 200
Query: 186 HAWNLWNDGRAWELMDSILQNDASYP--MLNRYINVALLCVQENAADRPTMLEVI 238
+ ++ EL SI ++ YP + ++ + R + I
Sbjct: 201 ---SPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 2e-31
Identities = 39/243 (16%), Positives = 76/243 (31%), Gaps = 23/243 (9%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK-ILIYEYMPNKSLDCFLFDPTKTGLLGWE 68
+ E + +Q + C G+ +++ E + D F F + +
Sbjct: 47 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLK 103
Query: 69 MRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNIL---LDSNMNPKISDFGIARLFGGDE 125
+ + + + + Y+H IHRD+K N L I DFG+A+ +
Sbjct: 104 TVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160
Query: 126 LQSN-----TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
+ K + GT Y S L S + D+ S G +++ +
Sbjct: 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240
+ ++ I YP + + C D+P + +
Sbjct: 221 K------RQKYERISEKKMSTPIEVLCKGYP--SEFATYLNFCRSLRFDDKPDYSYLRQL 272
Query: 241 LTN 243
N
Sbjct: 273 FRN 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-31
Identities = 52/242 (21%), Positives = 95/242 (39%), Gaps = 24/242 (9%)
Query: 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDC---FLFDPTKTGLLGWEMR 70
+ + +H N+VRLF C + + +D D + E
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118
Query: 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNT 130
++ + +GL +LH RV+HRDLK NIL+ S+ K++DFG+AR++ Q
Sbjct: 119 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMAL 172
Query: 131 KRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNL 190
+V T Y +PE L+ ++ D++S G + E K F + + LG ++
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSSDVDQLGKILDV 230
Query: 191 WNDGRAWELMDSILQNDASYPMLNRY-------------INVALLCVQENAADRPTMLEV 237
+ + ++ + ++ L C+ N A R +
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
Query: 238 IS 239
+S
Sbjct: 291 LS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-31
Identities = 51/242 (21%), Positives = 95/242 (39%), Gaps = 25/242 (10%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
SS+ G E+ + E+ ++ ++QH N++ L + ILI E + L F +
Sbjct: 50 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF---LAE 106
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP----KISDFGI 117
L E L+ + G +++ L++ H DLK NI+L P KI DFG+
Sbjct: 107 KESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 118 ARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYN 177
A K I GT +++PE +++D++S GV+ LS
Sbjct: 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 178 TDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237
A N + + ++ ++ + R + ++ R T+ +
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKD-----FIRR-------LLVKDPKKRMTIQDS 268
Query: 238 IS 239
+
Sbjct: 269 LQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 8e-31
Identities = 60/286 (20%), Positives = 100/286 (34%), Gaps = 33/286 (11%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEK------ILIYEYMPNKSLDCFLFDPTKTG 63
E+ ++ KL H N+VRL GEK L+ +Y+P
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFG 122
L + + + L Y+H + HRD+K N+LLD + K+ DFG A+
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTDS- 180
E + + + Y +PE ++ DV+S G ++ E L + +
Sbjct: 175 RGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
Query: 181 ----LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRY--------INVALLCVQENA 228
+ +LG + ++P + I + ++
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 229 ADRPTMLEV-----ISMLTNENVILPS-PLQPAFSHVRIAENSSLP 268
R T LE L + NV LP+ PA + E SS P
Sbjct: 292 TARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-30
Identities = 54/262 (20%), Positives = 92/262 (35%), Gaps = 27/262 (10%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
E+ L+ +L H N++ L L++++M D + + +L
Sbjct: 45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSH 101
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSN 129
+ QGL YLH + ++HRDLK +N+LLD N K++DFG+A+ FG
Sbjct: 102 IKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156
Query: 130 TKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAW 188
V T Y +PE ++ + D+++ G ++ E L L L +
Sbjct: 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV--PFLPGDSDLDQLTRIF 214
Query: 189 NLWNDGRAWELMDSILQNDASYPMLNRYINVALL--------------CVQENAADRPTM 234
+ D D I + + N R T
Sbjct: 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
Query: 235 LEVISM--LTNENVILPSPLQP 254
+ + M +N P P
Sbjct: 275 TQALKMKYFSNRPGPTPGCQLP 296
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 5e-30
Identities = 49/253 (19%), Positives = 92/253 (36%), Gaps = 21/253 (8%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L +++ E+ L+ +L H N+V+L + L++E++ D +
Sbjct: 37 LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDAS 94
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
+ + L Q L L RV+HRDLK N+L+++ K++DFG+AR
Sbjct: 95 ALTGIPLPLIKSYL---FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151
Query: 121 FGGDELQSNTKRIVGTYGYMSPE-YALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
FG V T Y +PE +S D++S G + E ++ + +
Sbjct: 152 FGVPVRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL-------------CVQE 226
D W + S+ S+P R ++ +
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY 269
Query: 227 NAADRPTMLEVIS 239
+ R + ++
Sbjct: 270 DPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 6e-30
Identities = 49/252 (19%), Positives = 90/252 (35%), Gaps = 39/252 (15%)
Query: 7 QGLEEFKNEMMLIAKLQ--HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
E++L+ K+ ++RL +LI E T+ G
Sbjct: 49 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGA 106
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN-MNPKISDFGIARLFGG 123
L E+ V + + + H+ V+HRD+K NIL+D N K+ DFG L
Sbjct: 107 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK- 162
Query: 124 DELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLT 182
+ GT Y PE+ + V+S G+L+ + +
Sbjct: 163 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------ 207
Query: 183 LLGHAWNLWNDGRAWELMDSILQNDASYP--MLNRYINVALLCVQENAADRPTMLEVISM 240
+E + I++ + + + ++ C+ +DRPT E+ +
Sbjct: 208 ------------IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 241 LTNENVILPSPL 252
++V+LP
Sbjct: 256 PWMQDVLLPQET 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (279), Expect = 9e-30
Identities = 46/253 (18%), Positives = 95/253 (37%), Gaps = 22/253 (8%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L + E+ ++ +L+H N+V+L+ +L++E++
Sbjct: 36 LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--- 92
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
G L L + G+ Y H RV+HRDLK N+L++ KI+DFG+AR
Sbjct: 93 CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARA 149
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
FG + + T Y +P+ + +S D++S G + E ++ +
Sbjct: 150 FGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL-------------CVQE 226
+ + + W + + + D ++ + + L ++
Sbjct: 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267
Query: 227 NAADRPTMLEVIS 239
+ R T + +
Sbjct: 268 DPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 6e-29
Identities = 31/251 (12%), Positives = 72/251 (28%), Gaps = 37/251 (14%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEM 69
+ ++E L + + G ++ + SL+ L + +
Sbjct: 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKT 102
Query: 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP-----KISDFGIARLFGGD 124
+ + + +H +++RD+K N L+ + + DFG+ + +
Sbjct: 103 VAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159
Query: 125 ELQSN-----TKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
+ + K + GT YMS L S + D+ + G + + L
Sbjct: 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS--------- 210
Query: 180 SLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNR-------YINVALLCVQENAADRP 232
W + + I + S P+ + P
Sbjct: 211 ------LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264
Query: 233 TMLEVISMLTN 243
+ + +
Sbjct: 265 DYDYLQGLFSK 275
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 7e-29
Identities = 46/210 (21%), Positives = 77/210 (36%), Gaps = 16/210 (7%)
Query: 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTG 63
+ + E ++ +H L L H + EY L L
Sbjct: 44 IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF- 102
Query: 64 LLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGG 123
E R R A+ + L + V++RD+K N++LD + + KI+DFG+ +
Sbjct: 103 ---TEERARFY--GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 124 DELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTL 183
D + K GT Y++PE + D + GV++ E + + FYN D L
Sbjct: 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL--PFYNQDHERL 213
Query: 184 LGHAWNL------WNDGRAWELMDSILQND 207
A L+ +L+ D
Sbjct: 214 FELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-28
Identities = 49/253 (19%), Positives = 90/253 (35%), Gaps = 21/253 (8%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT 60
L E+ L+ +L+H+N+VRL + L++E+ F
Sbjct: 37 LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN- 95
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
G + + Q L L V+HRDLK N+L++ N K+++FG+AR
Sbjct: 96 -----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDS 180
F G ++ + +V + L+S D++S G + E ++ + N
Sbjct: 151 F-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 181 LTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL--------------CVQE 226
L L + L + YPM ++ + ++
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269
Query: 227 NAADRPTMLEVIS 239
N R + E +
Sbjct: 270 NPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 43/266 (16%), Positives = 92/266 (34%), Gaps = 33/266 (12%)
Query: 1 LSSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKI--------LIYEYMPNKSL 52
+ ++ E+ ++ L+H N+V L C L++++ +
Sbjct: 45 MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104
Query: 53 DCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKI 112
K R++ L L++ R +++HRD+KA+N+L+ + K+
Sbjct: 105 GLLSNVLVK---FTLSEIKRVM---QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 158
Query: 113 SDFGIARLFGGDELQSNTKR--IVGTYGYMSPEYALRG-LFSIKSDVFSFGVLVLETLS- 168
+DFG+AR F + + V T Y PE L + D++ G ++ E +
Sbjct: 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
Query: 169 -----SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALL- 222
H S +W + +EL + + + + +
Sbjct: 219 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD 278
Query: 223 ---------CVQENAADRPTMLEVIS 239
+ + A R + ++
Sbjct: 279 PYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 4e-27
Identities = 41/238 (17%), Positives = 83/238 (34%), Gaps = 23/238 (9%)
Query: 10 EEFKNEMMLIAKL-QHRNLVRLFGCC----IEHGEKILIYEYMPNKSLDCFLFDPTKTGL 64
+ + E+ L + Q ++VR+ +++ E + L + D
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNP---KISDFGIARLF 121
I++ + + + YLH + + HRD+K N+L S K++DFG A+
Sbjct: 109 -TEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL 181
+ T Y++PE + D++S GV++ L FY+ L
Sbjct: 165 TSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFYSNHGL 219
Query: 182 TLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239
+ G+ N + + ++ R T+ E ++
Sbjct: 220 AISPGMKTRIRMGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (260), Expect = 1e-26
Identities = 42/207 (20%), Positives = 82/207 (39%), Gaps = 19/207 (9%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLG 66
+ +E NE ++ + LV+L ++ ++ EY+ + L + G
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFS 139
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL 126
+ YLH L +I+RDLK N+L+D +++DFG A+
Sbjct: 140 EPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----- 191
Query: 127 QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGH 186
+ T + GT ++PE L ++ D ++ GVL+ E + F+ + +
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFADQPIQIYEK 249
Query: 187 AWNLWND------GRAWELMDSILQND 207
+ +L+ ++LQ D
Sbjct: 250 IVSGKVRFPSHFSSDLKDLLRNLLQVD 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 8e-25
Identities = 49/255 (19%), Positives = 94/255 (36%), Gaps = 25/255 (9%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYE-YMPNKSLDCFLFDPT 60
QS + E+ L+ ++H N++ L + Y+ + L
Sbjct: 54 PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM 113
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K LG + ++ + +GL Y+H +IHRDLK N+ ++ + KI DFG+AR
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 169
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
+ S V T Y +PE L + ++ D++S G ++ E ++ K +
Sbjct: 170 ----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 180 SL---------TLLGHAWNLWNDGRAWELMDSILQNDA-SYPMLNRYINVALL-----CV 224
T A M + + + + + + + +
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285
Query: 225 QENAADRPTMLEVIS 239
+A R T E ++
Sbjct: 286 VLDAEQRVTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 1e-23
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 10/171 (5%)
Query: 3 SQSGQGLEEFKNEMMLIAKLQHR-NLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK 61
Q + E + E ++ ++ LV L + LI +Y+ L L +
Sbjct: 66 VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER 125
Query: 62 TGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLF 121
++ V + +L L H +L +I+RD+K NILLDSN + ++DFG+++ F
Sbjct: 126 FTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 122 GGDELQSNTKRIVGTYGYMSPEYALRGL--FSIKSDVFSFGVLVLETLSSK 170
DE GT YM+P+ G D +S GVL+ E L+
Sbjct: 180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (224), Expect = 1e-21
Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 18/175 (10%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI------EHGEKILIYEYMPNKSLDCF 55
Q+ + E++L+ + H+N++ L E + L+ E M
Sbjct: 53 PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 112
Query: 56 LFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDF 115
+ E +L + G+ +LH +IHRDLK SNI++ S+ KI DF
Sbjct: 113 QMELD------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
G+AR G + V T Y +PE L + D++S G ++ E + K
Sbjct: 164 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 90.3 bits (223), Expect = 2e-21
Identities = 28/166 (16%), Positives = 70/166 (42%), Gaps = 17/166 (10%)
Query: 10 EEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEK--ILIYEYMPNKSLDCFLFDPTKTGLLG 66
++ K E+ ++ L+ N++ L + + L++E++ N L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLT 127
Query: 67 WEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDE 125
+ + + L Y H + ++HRD+K N+++D + ++ D+G+A + +
Sbjct: 128 DYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 126 LQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSSK 170
+ V + + PE + ++ D++S G ++ + K
Sbjct: 185 EYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.9 bits (206), Expect = 4e-19
Identities = 32/175 (18%), Positives = 64/175 (36%), Gaps = 16/175 (9%)
Query: 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCF-------------L 56
E ++E+ L+ ++ + + H K+L + + L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 57 FDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSN-MNPKISDF 115
+ + +I + + GL Y+H R +IH D+K N+L++ +
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 116 GIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLETLSSK 170
IA L + + T Y SPE L + +D++S L+ E ++
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 6e-19
Identities = 55/279 (19%), Positives = 102/279 (36%), Gaps = 33/279 (11%)
Query: 2 SSQSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCI-EHGEKILIYEYMPNKSLDCFLFDPT 60
QS + E+ L+ ++H N++ L + Y+ + L +
Sbjct: 54 PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 113
Query: 61 KTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARL 120
K L + ++ + +GL Y+H +IHRDLK SN+ ++ + KI DFG+AR
Sbjct: 114 KCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170
Query: 121 FGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVLETLSSKKNAHFYNTD 179
V T Y +PE L + ++ D++S G ++ E L+ + F TD
Sbjct: 171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTD 223
Query: 180 SLTLL-----------GHAWNLWNDGRAWELMDSILQNDASYPMLNRYINV-----ALL- 222
+ L + A + S+ Q N +I LL
Sbjct: 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLE 282
Query: 223 -CVQENAADRPTMLEVISM--LTNENVILPSPLQPAFSH 258
+ ++ R T + ++ + P+ +
Sbjct: 283 KMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQ 321
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.9 bits (178), Expect = 4e-16
Identities = 27/163 (16%), Positives = 55/163 (33%), Gaps = 23/163 (14%)
Query: 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCI----EHGEKILIYEYMPNKSLDCFLFDPTKT 62
G F + A+ + R L +L G + ++ E + K L
Sbjct: 48 YGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------- 100
Query: 63 GLLGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFG 122
E +L+ + + + +H ++H DL N+L+ I DF + G
Sbjct: 101 ---RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
Query: 123 GDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165
+ + +R V + + + D+ S +L+
Sbjct: 154 EEGWREILERDVR-----NIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 289 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.71 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=346.81 Aligned_cols=214 Identities=24% Similarity=0.306 Sum_probs=175.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
+..++|.+|+++|++++|||||++++++.+++..|+|||||++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 45 ~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~ 121 (271)
T d1nvra_ 45 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121 (271)
T ss_dssp ----CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 445789999999999999999999999999999999999999999999984 45679999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLVLE 165 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl~e 165 (289)
++ |+||||||+|||+++++.+||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+
T Consensus 122 ~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilye 198 (271)
T d1nvra_ 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 198 (271)
T ss_dssp TT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHH
T ss_pred cC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHH
Confidence 88 99999999999999999999999999987654433334455789999999999998876 678999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+.||.............. .. ..........+.++.+++.+||+.||++|||++|+++
T Consensus 199 ml~G~~pf~~~~~~~~~~~~~~-----~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 199 MLAGELPWDQPSDSCQEYSDWK-----EK--------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHSSCSCSSSSTTSHHHHHHH-----TT--------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhCCCCCCCCChHHHHHHHHh-----cC--------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999999976554432221111 00 0001112234568889999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=347.97 Aligned_cols=228 Identities=22% Similarity=0.331 Sum_probs=176.0
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+++..+.|.+|+++|++++|||||++++++.+ +.+++|||||++|+|.+++.. ..+.+++..+..++.||+.||.|
T Consensus 43 ~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~y 119 (276)
T d1uwha_ 43 PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDY 119 (276)
T ss_dssp CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHH
Confidence 356678899999999999999999999998754 568999999999999999854 23568999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc---CCCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG 160 (289)
||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||
T Consensus 120 LH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~G 196 (276)
T d1uwha_ 120 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196 (276)
T ss_dssp HHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHH
T ss_pred HhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhH
Confidence 99988 99999999999999999999999999987654443344456689999999999974 3589999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
|++|||+||+.||.......... ........... . .......++.+.+++.+||+.||++|||+.+|++.
T Consensus 197 v~l~el~tg~~Pf~~~~~~~~~~-~~~~~~~~~p~----~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 197 IVLYELMTGQLPYSNINNRDQII-FMVGRGYLSPD----L-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHSSCTTTTCCCHHHHH-HHHHHTSCCCC----G-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHH-HHHhcCCCCCc----c-----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999987543322111 11111100000 0 01122345689999999999999999999999999
Q ss_pred hhcccCC
Q 038647 241 LTNENVI 247 (289)
Q Consensus 241 L~~~~~~ 247 (289)
|+.+...
T Consensus 267 Le~l~~~ 273 (276)
T d1uwha_ 267 IELLARS 273 (276)
T ss_dssp HHHHHHT
T ss_pred HHHHHHc
Confidence 9876533
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-52 Score=346.48 Aligned_cols=220 Identities=25% Similarity=0.422 Sum_probs=170.7
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.+..++|.+|+++|++++|||||++++++.+++.+++|||||++|+|.+++.. ..+.+++..+..++.||+.||.||
T Consensus 67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yL 144 (299)
T d1jpaa_ 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYL 144 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 445678899999999999999999999999999999999999999999998853 345689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc---ccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS---NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
|+++ |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||
T Consensus 145 H~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gv 221 (299)
T d1jpaa_ 145 ADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGI 221 (299)
T ss_dssp HHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred hhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchH
Confidence 9988 9999999999999999999999999998765432221 122245789999999999999999999999999
Q ss_pred HHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHH
Q 038647 162 LVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISM 240 (289)
Q Consensus 162 vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 240 (289)
++|||+| |..||....... ..... ..+ .....+...+..+.+++.+||+.||++|||+.||++.
T Consensus 222 vl~el~t~g~~Pf~~~~~~~--~~~~i----~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 222 VMWEVMSYGERPYWDMTNQD--VINAI----EQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTTSCCTTTTCCHHH--HHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHH--HHHHH----HcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999998 888876543221 11111 111 1112233456789999999999999999999999999
Q ss_pred hhcc
Q 038647 241 LTNE 244 (289)
Q Consensus 241 L~~~ 244 (289)
|+.+
T Consensus 287 L~~~ 290 (299)
T d1jpaa_ 287 LDKM 290 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=339.47 Aligned_cols=207 Identities=25% Similarity=0.327 Sum_probs=175.0
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|++++|||||++++++.+++..|+|||||++|+|.+++. ..+.+++..+..++.||+.||.|||+
T Consensus 48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~ 124 (263)
T d2j4za1 48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS 124 (263)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999999984 34579999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 125 ~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 197 (263)
T d2j4za1 125 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 197 (263)
T ss_dssp TT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CC---eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHH
Confidence 88 9999999999999999999999999998664332 3346799999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+.||...+... .... ..... ...+...++++.+++.+||+.||++|||++|+++
T Consensus 198 l~G~~Pf~~~~~~~--~~~~----i~~~~----------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 198 LVGKPPFEANTYQE--TYKR----ISRVE----------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHSSCTTCCSSHHH--HHHH----HHTTC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcCCCCCCCCCHHH--HHHH----HHcCC----------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 99999986543221 1111 10100 0112234578899999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=348.69 Aligned_cols=220 Identities=27% Similarity=0.415 Sum_probs=179.2
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC--------------------CCC
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK--------------------TGL 64 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~ 64 (289)
....+.|.+|+.+|+++ +|||||++++++.+.+.+|+|||||++|+|.+++..... ...
T Consensus 81 ~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (325)
T d1rjba_ 81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160 (325)
T ss_dssp ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCC
Confidence 44567899999999998 899999999999999999999999999999999865321 245
Q ss_pred CChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhh
Q 038647 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144 (289)
Q Consensus 65 ~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 144 (289)
+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||+
T Consensus 161 l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 237 (325)
T d1rjba_ 161 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHH
Confidence 889999999999999999999988 99999999999999999999999999987654443333445678999999999
Q ss_pred hhcCCCCCcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 145 ALRGLFSIKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 145 ~~~~~~~~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
+.+..++.++|||||||++|||+| |..||........ +... .... .....+...+.++.++|.+|
T Consensus 238 l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~-~~~~----~~~~---------~~~~~p~~~~~~l~~li~~c 303 (325)
T d1rjba_ 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-FYKL----IQNG---------FKMDQPFYATEEIYIIMQSC 303 (325)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHH----HHTT---------CCCCCCTTCCHHHHHHHHHH
T ss_pred HcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH-HHHH----HhcC---------CCCCCCCcCCHHHHHHHHHH
Confidence 999999999999999999999998 8998875443321 1111 1111 11122233457899999999
Q ss_pred cccCCCCCCCHHHHHHHhh
Q 038647 224 VQENAADRPTMLEVISMLT 242 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~~L~ 242 (289)
|+.||++|||++||++.|.
T Consensus 304 l~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 304 WAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCSSGGGSCCHHHHHHHHH
T ss_pred cCCChhHCcCHHHHHHHHh
Confidence 9999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-51 Score=340.32 Aligned_cols=222 Identities=26% Similarity=0.361 Sum_probs=181.2
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....++|.+|+++|++++|||||++++++.+++..++|||||++|+|.+++.. .....+++..+..++.||+.||.||
T Consensus 53 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yL 131 (287)
T d1opja_ 53 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL 131 (287)
T ss_dssp TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999998854 2345789999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++........ ......|++.|+|||++.+..++.++|||||||++|
T Consensus 132 H~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ 207 (287)
T d1opja_ 132 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 207 (287)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred HHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHH
Confidence 9988 999999999999999999999999999876544322 233346889999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
||++|..|+........ ... ..... .....+...+.++.+++.+||+.||++|||+.+|++.|+..
T Consensus 208 ell~~~~p~~~~~~~~~-~~~----~i~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 208 EIATYGMSPYPGIDLSQ-VYE----LLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHTTSCCSSTTCCHHH-HHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHhCCCCCCCcchHHH-HHH----HHhcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99997776543322211 111 11111 11122233457899999999999999999999999998865
Q ss_pred c
Q 038647 245 N 245 (289)
Q Consensus 245 ~ 245 (289)
.
T Consensus 274 ~ 274 (287)
T d1opja_ 274 F 274 (287)
T ss_dssp T
T ss_pred H
Confidence 3
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=339.93 Aligned_cols=212 Identities=22% Similarity=0.330 Sum_probs=175.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|++++|||||++++++.+++.+|+|||||++|+|.+++.+ +.+++..+..++.||+.||.|||
T Consensus 58 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH 133 (293)
T d1yhwa1 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH 133 (293)
T ss_dssp CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998742 46899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
++| |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 134 ~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilye 208 (293)
T d1yhwa1 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208 (293)
T ss_dssp HTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHH
T ss_pred HCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHH
Confidence 988 9999999999999999999999999998765432 22344579999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||...+...... ....... ..-..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 209 mltG~~Pf~~~~~~~~~~-----~~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 209 MIEGEPPYLNENPLRALY-----LIATNGT--------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHSSCTTTTSCHHHHHH-----HHHHHCS--------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhhCCCCCCCCCHHHHHH-----HHHhCCC--------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999986543221111 1111000 001112334578999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=336.26 Aligned_cols=219 Identities=29% Similarity=0.440 Sum_probs=167.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++|.+|+++|++++|||||++++++.+++..++||||+++|+|.+++.. ....++++.+..++.||+.||.|||
T Consensus 41 ~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH 118 (263)
T d1sm2a_ 41 AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE 118 (263)
T ss_dssp SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhh
Confidence 44568899999999999999999999999999999999999999999998853 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++||
T Consensus 119 ~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~e 194 (263)
T d1sm2a_ 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 194 (263)
T ss_dssp HTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccc---eeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHH
Confidence 988 999999999999999999999999999876543322 2334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|+|+..|+...... ......... . .....+...+.++.+++.+||+.||++|||+++|++.|+++
T Consensus 195 l~t~~~~~~~~~~~-~~~~~~i~~----~---------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 195 VFSEGKIPYENRSN-SEVVEDIST----G---------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp HHTTSCCTTCSCCH-HHHHHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHCCCCCCCCCCH-HHHHHHHHh----c---------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 99965443322211 111111111 1 00111222346889999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=337.38 Aligned_cols=219 Identities=26% Similarity=0.373 Sum_probs=179.4
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
++...++|.+|+++|++++|||||++++++.+ +.+|+|||||++|+|.+++.. ..+.+++..+..++.||+.||.||
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yl 125 (285)
T d1u59a_ 49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL 125 (285)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999865 468999999999999998743 345689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
|+++ |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++
T Consensus 126 H~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l 202 (285)
T d1u59a_ 126 EEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 202 (285)
T ss_dssp HHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHH
Confidence 9988 99999999999999999999999999997754332 2223345689999999999999999999999999999
Q ss_pred HHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 164 LETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 164 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|||+| |..||....... .... ...+. ....+...+.++.+++.+||+.||++|||+.+|++.|+
T Consensus 203 ~E~lt~G~~Pf~~~~~~~--~~~~----i~~~~---------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 203 WEALSYGQKPYKKMKGPE--VMAF----IEQGK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp HHHHTTSCCTTTTCCTHH--HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHH--HHHH----HHcCC---------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99998 899987544321 1111 11111 11222345578999999999999999999999999887
Q ss_pred cc
Q 038647 243 NE 244 (289)
Q Consensus 243 ~~ 244 (289)
..
T Consensus 268 ~~ 269 (285)
T d1u59a_ 268 AC 269 (285)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=342.33 Aligned_cols=212 Identities=22% Similarity=0.288 Sum_probs=173.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|++++|||||++++++.+++.+|+|||||++|+|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH 125 (288)
T d1uu3a_ 49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125 (288)
T ss_dssp TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhc
Confidence 3467889999999999999999999999999999999999999999999884 4467999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+
T Consensus 126 ~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilye 202 (288)
T d1uu3a_ 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202 (288)
T ss_dssp HTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred ccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHH
Confidence 988 99999999999999999999999999998765443444455689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|..||...+... .... .. ... ...+...+.++.++|.+||+.||++|||++|+++
T Consensus 203 ll~g~~Pf~~~~~~~--~~~~---i~-~~~----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 203 LVAGLPPFRAGNEYL--IFQK---II-KLE----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHSSCSSCCSSHHH--HHHH---HH-TTC----------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HhhCCCCCCCcCHHH--HHHH---HH-cCC----------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 999999987543221 1111 00 000 0112234568899999999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=339.32 Aligned_cols=216 Identities=25% Similarity=0.347 Sum_probs=175.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+...++|.+|+++|++++|||||++++++.+ +..++|||||++|+|.+++. ....+++..+..++.||+.||.|||
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH 124 (277)
T d1xbba_ 49 PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE 124 (277)
T ss_dssp CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHH
Confidence 4456789999999999999999999999965 46789999999999999984 3456999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|
T Consensus 125 ~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ 201 (277)
T d1xbba_ 125 ESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 201 (277)
T ss_dssp HTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhh
Confidence 988 99999999999999999999999999987654322 22234457899999999999999999999999999999
Q ss_pred HHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 165 ETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 165 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
||+| |+.||....... .... ...+. ....+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus 202 ellt~g~~Pf~~~~~~~--~~~~----i~~~~---------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 202 EAFSYGQKPYRGMKGSE--VTAM----LEKGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp HHHTTTCCSSTTCCHHH--HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHhhCCCCCCCCCCHHH--HHHH----HHcCC---------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 9998 899987543221 1111 11111 111223345789999999999999999999999998875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=338.72 Aligned_cols=216 Identities=22% Similarity=0.338 Sum_probs=175.5
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+.+..++|.+|+++|++++|||||++++++.+++.+|+|||||++|+|.+++.+ ..+.+++..+..++.||+.||.|
T Consensus 48 ~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~y 125 (288)
T d2jfla1 48 KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNY 125 (288)
T ss_dssp SSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHH
Confidence 3456778999999999999999999999999999999999999999999998743 23569999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhh-----cCCCCCcccchh
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYAL-----RGLFSIKSDVFS 158 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Diws 158 (289)
||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++. +..|+.++||||
T Consensus 126 lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwS 200 (288)
T d2jfla1 126 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200 (288)
T ss_dssp HHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHH
T ss_pred HHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHH
Confidence 99998 999999999999999999999999999764322 11233467999999999984 456899999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
|||++|+|++|+.||...+..... .. ..... . ..-..+...+.++.+++.+||+.||++|||+.|++
T Consensus 201 lGvilyemltg~~Pf~~~~~~~~~--~~---i~~~~-~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 201 LGITLIEMAEIEPPHHELNPMRVL--LK---IAKSE-P-------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp HHHHHHHHHHSSCTTTTSCGGGHH--HH---HHHSC-C-------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHHHHHHHhhCCCCCCCCCHHHHH--HH---HHcCC-C-------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 999999999999998754432211 11 11100 0 00111233457899999999999999999999997
Q ss_pred H
Q 038647 239 S 239 (289)
Q Consensus 239 ~ 239 (289)
+
T Consensus 268 ~ 268 (288)
T d2jfla1 268 Q 268 (288)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=342.51 Aligned_cols=224 Identities=25% Similarity=0.351 Sum_probs=174.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+...+++.+|+++|++++|||||+++++|.+++.+|+|||||++|+|.+++. ..+.+++..+..++.|++.||.|||
T Consensus 45 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH 121 (322)
T d1s9ja_ 45 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 121 (322)
T ss_dssp TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3446789999999999999999999999999999999999999999999984 3457999999999999999999999
Q ss_pred cC-CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HY-SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~-~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
++ + |+||||||+|||++.++.+||+|||+|+..... .....+||+.|+|||++.+..|+.++||||+||++|
T Consensus 122 ~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ 194 (322)
T d1s9ja_ 122 EKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 194 (322)
T ss_dssp HHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHH
T ss_pred HhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHH
Confidence 74 7 999999999999999999999999999865322 234568999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhcc------------------------CCcccccccccc----CCCCHHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWND------------------------GRAWELMDSILQ----NDASYPMLNRY 216 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~----~~~~~~~~~~l 216 (289)
||++|+.||...+................ ....+....... .......+.++
T Consensus 195 ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 274 (322)
T d1s9ja_ 195 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274 (322)
T ss_dssp HHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHH
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHH
Confidence 99999999976554322111000000000 000000000000 00011134678
Q ss_pred HHHHHcccccCCCCCCCHHHHHH
Q 038647 217 INVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 217 ~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.+++.+||+.||++|||++|+++
T Consensus 275 ~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 275 QDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHhh
Confidence 99999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=337.10 Aligned_cols=218 Identities=28% Similarity=0.424 Sum_probs=164.3
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCC-CCCCCChHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPT-KTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l 81 (289)
++...+.|.+|+++|++++|||||++++++.+ ++.+|+|||||++|+|.+++.+.. ..+.+++..++.++.||+.||
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al 122 (269)
T d2java1 43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122 (269)
T ss_dssp CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence 44557789999999999999999999999864 557899999999999999885422 345799999999999999999
Q ss_pred HHHhcCC--CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 82 LYLHHYS--RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 82 ~~lH~~~--~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
.|||+++ ..+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||
T Consensus 123 ~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp HHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 9999854 1349999999999999999999999999998765432 12344679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
||++|+|+||+.||...+... .... ...... ...+...+.++.+++.+||+.||++|||+.|+++
T Consensus 201 Gvilyel~tg~~Pf~~~~~~~--~~~~----i~~~~~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 201 GCLLYELCALMPPFTAFSQKE--LAGK----IREGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHSSCSCCCSSHHH--HHHH----HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhhCCCCCCCCCHHH--HHHH----HHcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999999999986543221 1111 111111 1112234568999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=331.50 Aligned_cols=212 Identities=23% Similarity=0.368 Sum_probs=168.7
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
+...++|.+|+++|++++|||||++++++.+ +..+|+|||||++|+|.+++. ..+.+++..+..++.||+.||
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl 125 (270)
T d1t4ha_ 49 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGL 125 (270)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999875 346899999999999999984 346789999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeC-CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLD-SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.|||+++ .+|+||||||+|||++ +++.+||+|||+++..... ......||+.|+|||++.+ .++.++||||||
T Consensus 126 ~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlG 199 (270)
T d1t4ha_ 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 199 (270)
T ss_dssp HHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHH
Confidence 9999764 3499999999999996 5789999999999864332 2345679999999999865 599999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+|++|+.||........ .... ......... .....++++.+++.+||+.||++|||+.|+++
T Consensus 200 vilyel~~g~~Pf~~~~~~~~-~~~~----i~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 200 MCMLEMATSEYPYSECQNAAQ-IYRR----VTSGVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHSSCTTTTCSSHHH-HHHH----HTTTCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCcccHHH-HHHH----HHcCCCCcc--------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 999999999999864432211 1111 111111000 11112357889999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=332.46 Aligned_cols=218 Identities=30% Similarity=0.440 Sum_probs=174.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.|.+|+++|++++|||||++++++.+ +..++||||+++|+|.+++... ....+++..+..++.||+.||.|||
T Consensus 49 ~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH 126 (272)
T d1qpca_ 49 SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE 126 (272)
T ss_dssp SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998765 5679999999999999877432 2235899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||+++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++||
T Consensus 127 ~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~e 202 (272)
T d1qpca_ 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 202 (272)
T ss_dssp HTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred hCC---cccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHH
Confidence 988 999999999999999999999999999987544322 2334578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
|+||..|+....... ..... ..... ....+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus 203 llt~~~~~~~~~~~~-~~~~~----i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 203 IVTHGRIPYPGMTNP-EVIQN----LERGY---------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHTTTCCSSTTCCHH-HHHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHH-HHHHH----HHhcC---------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 999765543322221 11111 11110 111122345688999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=332.48 Aligned_cols=221 Identities=29% Similarity=0.450 Sum_probs=172.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+...++|.+|+++|++++|||||++++++.+.+..++|||||.+|++.+++.. ..+.+++..+..++.||+.||.|||
T Consensus 50 ~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH 127 (283)
T d1mqba_ 50 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA 127 (283)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcc
Confidence 34567899999999999999999999999999999999999999999887753 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 128 ~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~ 204 (283)
T d1mqba_ 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 204 (283)
T ss_dssp HTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred ccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHH
Confidence 988 999999999999999999999999999876443221 1233346899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
||++|..|+....... ..... ...+ .....+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 205 el~t~~~~~~~~~~~~-~~~~~----i~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 205 EVMTYGERPYWELSNH-EVMKA----INDG---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHTTSCCTTTTCCHH-HHHHH----HHTT---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHhCCCCccccCCHH-HHHHH----Hhcc---------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 9999766654332221 11111 1111 11122333557899999999999999999999999999865
Q ss_pred c
Q 038647 245 N 245 (289)
Q Consensus 245 ~ 245 (289)
.
T Consensus 271 ~ 271 (283)
T d1mqba_ 271 I 271 (283)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-50 Score=337.78 Aligned_cols=208 Identities=29% Similarity=0.403 Sum_probs=171.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+..++|.+|+++|++++|||||++++++.+++..|+|||||.+|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 56 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH 132 (309)
T d1u5ra_ 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH 132 (309)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999977663 3457999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc---CCCCCcccchhHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR---GLFSIKSDVFSFGVL 162 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~v 162 (289)
++| |+||||||+|||++.++.+||+|||+++.... .....||+.|+|||++.+ ..|+.++|||||||+
T Consensus 133 ~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvi 203 (309)
T d1u5ra_ 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203 (309)
T ss_dssp HTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHH
T ss_pred hCC---EeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHH
Confidence 988 99999999999999999999999999986533 234579999999999964 458999999999999
Q ss_pred HHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 163 VLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 163 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|+|++|..||........ . ....... .........+..+.+++.+||+.||++|||+.|+++
T Consensus 204 lyel~~g~~Pf~~~~~~~~--~---~~i~~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 204 CIELAERKPPLFNMNAMSA--L---YHIAQNE---------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHSSCTTTTSCHHHH--H---HHHHHSC---------CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCCCHHHH--H---HHHHhCC---------CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 9999999999864432211 1 1111110 001112234568999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-50 Score=334.20 Aligned_cols=211 Identities=21% Similarity=0.273 Sum_probs=159.7
Q ss_pred CHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 8 GLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
..+.+.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++. ..+.+++..+..++.||+.||.|||++
T Consensus 50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~ 126 (307)
T d1a06a_ 50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL 126 (307)
T ss_dssp -----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhc
Confidence 34678899999999999999999999999999999999999999999994 346799999999999999999999998
Q ss_pred CCCceEeeccccCceEeC---CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 88 SRLRVIHRDLKASNILLD---SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~---~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+ |+||||||+||++. +++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|
T Consensus 127 ~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvily 200 (307)
T d1a06a_ 127 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200 (307)
T ss_dssp T---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred e---eeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHH
Confidence 8 99999999999994 57889999999998664332 234467999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+|++|..||........ .... .... ...........+.++.+++.+||+.||++|||+.|+++
T Consensus 201 ell~g~~Pf~~~~~~~~--~~~i---~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 201 ILLCGYPPFYDENDAKL--FEQI---LKAE-------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHSSCSCCCSSHHHH--HHHH---HTTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCHHHH--HHHH---hccC-------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99999999865432211 1110 1000 00111122335578999999999999999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=324.16 Aligned_cols=217 Identities=27% Similarity=0.407 Sum_probs=179.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....++|.+|++++++++|||||++++++.+++.+++||||+++|+|..++.. ....+++..+.+++.|+++||.|||
T Consensus 40 ~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH 117 (258)
T d1k2pa_ 40 SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE 117 (258)
T ss_dssp SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHh
Confidence 34568899999999999999999999999999999999999999999988753 3456889999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++||
T Consensus 118 ~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~e 193 (258)
T d1k2pa_ 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 193 (258)
T ss_dssp HTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHh
Confidence 988 999999999999999999999999999876544322 2334568999999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTN 243 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 243 (289)
|+| |+.||........ .... .... ....+...+..+.+++.+||+.||++|||+.+|++.|..
T Consensus 194 l~t~g~~Pf~~~~~~~~--~~~i----~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 194 IYSLGKMPYERFTNSET--AEHI----AQGL---------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTSCCTTTTSCHHHH--HHHH----HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHhcCCCCCCCCCHHHH--HHHH----HhCC---------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 998 7888765543221 1111 1110 111122334688999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=328.95 Aligned_cols=225 Identities=28% Similarity=0.404 Sum_probs=173.8
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+....+.|.+|+.+|++++|||||++++++.+ +..++||||+++|+|..++... ..+.+++..+..++.||+.||.||
T Consensus 52 ~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~L 129 (285)
T d1fmka3 52 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV 129 (285)
T ss_dssp TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHH
Confidence 34456889999999999999999999999865 5678999999999999887431 234689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|
T Consensus 130 H~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~ 205 (285)
T d1fmka3 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 205 (285)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHH
Confidence 9988 99999999999999999999999999987644332 2233457899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
||++|..|+........ ..... ... .........+.++.+++.+||+.||++|||+.+|+++|+..
T Consensus 206 el~t~~~p~~~~~~~~~-~~~~i----~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 206 ELTTKGRVPYPGMVNRE-VLDQV----ERG---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp HHHTTTCCSSTTCCHHH-HHHHH----HTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHHhCCCCCCCCCCHHH-HHHHH----Hhc---------CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 99997766544333221 11111 111 11122334457899999999999999999999999999876
Q ss_pred cCCCC
Q 038647 245 NVILP 249 (289)
Q Consensus 245 ~~~~~ 249 (289)
-...+
T Consensus 272 ~~~~~ 276 (285)
T d1fmka3 272 FTSTE 276 (285)
T ss_dssp TSCSC
T ss_pred hcCCC
Confidence 54443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.9e-49 Score=334.65 Aligned_cols=218 Identities=22% Similarity=0.248 Sum_probs=177.2
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|++++|||||+++++|.+++.+|+|||||++|+|.+++.. ....+++..+..++.||+.||.|||+
T Consensus 68 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~ 145 (352)
T d1koba_ 68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE 145 (352)
T ss_dssp HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999887743 34469999999999999999999999
Q ss_pred CCCCceEeeccccCceEeC--CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLD--SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~--~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
+| |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 146 ~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 219 (352)
T d1koba_ 146 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 219 (352)
T ss_dssp TT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHH
T ss_pred CC---eeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHH
Confidence 88 99999999999997 67899999999998875432 234457899999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--Hhh
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--MLT 242 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~L~ 242 (289)
+|+||..||........ .... .... ...........+.++.++|.+||+.||.+|||+.|+++ +++
T Consensus 220 elltG~~Pf~~~~~~~~--~~~i---~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~ 287 (352)
T d1koba_ 220 VLLSGLSPFAGEDDLET--LQNV---KRCD-------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287 (352)
T ss_dssp HHHHSCCSSCCSSHHHH--HHHH---HHCC-------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred HHHhCCCCCCCCCHHHH--HHHH---HhCC-------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 99999999865433211 1110 0000 00111122335678899999999999999999999987 355
Q ss_pred cc
Q 038647 243 NE 244 (289)
Q Consensus 243 ~~ 244 (289)
..
T Consensus 288 ~~ 289 (352)
T d1koba_ 288 GD 289 (352)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-49 Score=333.70 Aligned_cols=214 Identities=22% Similarity=0.283 Sum_probs=175.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+++|++++|||||++++++.+++.+|+|||||++|+|.+++.. ..+.+++..+..++.||+.||.|||
T Consensus 64 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH 141 (350)
T d1koaa2 64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH 141 (350)
T ss_dssp HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998853 3456999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeC--CCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLD--SNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~--~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
++| |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++
T Consensus 142 ~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvil 215 (350)
T d1koaa2 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 215 (350)
T ss_dssp HTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHH
T ss_pred hcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHH
Confidence 998 99999999999995 46789999999998765432 23446799999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|..||...+... ...... .... .........++.++.++|.+||+.||++|||++|+++
T Consensus 216 yell~G~~Pf~~~~~~~--~~~~i~---~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 216 YILLSGLSPFGGENDDE--TLRNVK---SCDW-------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHSSCSSCCSSHHH--HHHHHH---HTCC-------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCCHHH--HHHHHH---hCCC-------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999986543221 111110 0000 0001111234568899999999999999999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=329.69 Aligned_cols=210 Identities=20% Similarity=0.215 Sum_probs=176.3
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+++.+|+.+|++++|||||++++++.+++.+|+|||||++|+|..++. ..+.+++..+..++.||+.||.|||
T Consensus 46 ~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH 122 (337)
T d1o6la_ 46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH 122 (337)
T ss_dssp TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhh
Confidence 3467889999999999999999999999999999999999999999999884 4567899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++||
T Consensus 123 ~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilye 197 (337)
T d1o6la_ 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp HTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHH
T ss_pred hcC---ccccccCHHHeEecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHH
Confidence 998 9999999999999999999999999998654322 22445689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
|++|..||...+.... ... ..... -..+...+.++.++|.+||+.||++||+ +.|+++
T Consensus 198 ml~G~~pf~~~~~~~~--~~~----i~~~~----------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 198 MMCGRLPFYNQDHERL--FEL----ILMEE----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHSSCSSCCSSHHHH--HHH----HHHCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHCCCCCCCcCHHHH--HHH----HhcCC----------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 9999999876543221 111 00000 1122234578899999999999999995 888876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=324.30 Aligned_cols=213 Identities=24% Similarity=0.304 Sum_probs=173.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.|.+|+++|++++|||||++++++.+++.+|+|||||++|+|.+++. ..+.+++..++.++.|++.||.|||
T Consensus 54 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH 130 (293)
T d1jksa_ 54 GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH 130 (293)
T ss_dssp SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhh
Confidence 3457889999999999999999999999999999999999999999999984 3457999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCC----ceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNM----NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~----~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
+++ |+||||||+||+++.++ .+|++|||+++...... ......||+.|+|||++.+..++.++|||||||
T Consensus 131 ~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGv 204 (293)
T d1jksa_ 131 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 204 (293)
T ss_dssp HTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred hcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhH
Confidence 988 99999999999998776 49999999998765432 233457899999999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|..||...+.... ... .. .... .... ......+..+.++|.+||+.||++|||++|+++
T Consensus 205 ilyell~g~~Pf~~~~~~~~--~~~---i~-~~~~-~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 205 ITYILLSGASPFLGDTKQET--LAN---VS-AVNY-EFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHSSCSSCCSSHHHH--HHH---HH-TTCC-CCCH-----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCCCCCHHHH--HHH---HH-hcCC-CCCc-----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999875432211 110 00 0000 0000 000123467889999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=325.06 Aligned_cols=217 Identities=23% Similarity=0.311 Sum_probs=166.5
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.|.+|+++|++++|||||++++++. ++.+|+||||+++|+|.+++.. ..+.+++..+..++.||+.||.|||
T Consensus 49 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH 125 (273)
T d1mp8a_ 49 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 125 (273)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhc
Confidence 445678999999999999999999999996 4678999999999999987743 3456899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++||
T Consensus 126 ~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e 201 (273)
T d1mp8a_ 126 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 201 (273)
T ss_dssp HTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred ccC---eeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHH
Confidence 988 999999999999999999999999999876543322 2334568999999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|++ |.+|+........ ... ...+.. ...+...+..+.++|.+||+.||++|||+.||++.|+..
T Consensus 202 ~lt~g~~P~~~~~~~~~--~~~----i~~~~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 202 ILMHGVKPFQGVKNNDV--IGR----IENGER---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp HHTTSCCTTTTCCGGGH--HHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCHHHH--HHH----HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 998 7888765443321 111 111111 112234557899999999999999999999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=329.98 Aligned_cols=220 Identities=24% Similarity=0.370 Sum_probs=174.3
Q ss_pred CcccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 4 QSGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 4 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+.+..++|.+|+++|++++|||||++++++.++ ..++++||+.+|+|.+++.. ....+++..+..++.||+.||.|
T Consensus 50 ~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~y 126 (317)
T d1xkka_ 50 TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 126 (317)
T ss_dssp ---CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999875 56788899999999887753 34578999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++
T Consensus 127 LH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 127 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203 (317)
T ss_dssp HHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHH
Confidence 99988 999999999999999999999999999987654444334445789999999999999999999999999999
Q ss_pred HHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 164 LETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 164 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|||+| |..||........ .... ..+ .....+...+..+.+++.+||+.||++|||+.||++.|.
T Consensus 204 ~el~t~g~~p~~~~~~~~~--~~~i----~~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEI--SSIL----EKG---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGH--HHHH----HHT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHH--HHHH----HcC---------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 99998 7777765433221 1111 111 111222334578899999999999999999999999887
Q ss_pred cc
Q 038647 243 NE 244 (289)
Q Consensus 243 ~~ 244 (289)
..
T Consensus 269 ~~ 270 (317)
T d1xkka_ 269 KM 270 (317)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=326.23 Aligned_cols=221 Identities=26% Similarity=0.381 Sum_probs=177.9
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC---------------------CCCC
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT---------------------KTGL 64 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~ 64 (289)
.+..++|.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++.... ....
T Consensus 57 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (301)
T d1lufa_ 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136 (301)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCC
Confidence 3456789999999999999999999999999999999999999999999885321 1234
Q ss_pred CChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhh
Q 038647 65 LGWEMRVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEY 144 (289)
Q Consensus 65 ~~~~~~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 144 (289)
+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...............|++.|+|||.
T Consensus 137 l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~ 213 (301)
T d1lufa_ 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence 888999999999999999999988 99999999999999999999999999987654443344455678899999999
Q ss_pred hhcCCCCCcccchhHHHHHHHHHhCCC-CcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcc
Q 038647 145 ALRGLFSIKSDVFSFGVLVLETLSSKK-NAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLC 223 (289)
Q Consensus 145 ~~~~~~~~~~DiwslG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 223 (289)
+.+..++.++|||||||++|||++|.. ||...... ..... ...+.. ...+...+.++.+++..|
T Consensus 214 ~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~--e~~~~----v~~~~~---------~~~p~~~~~~~~~li~~c 278 (301)
T d1lufa_ 214 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE--EVIYY----VRDGNI---------LACPENCPLELYNLMRLC 278 (301)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHH----HHTTCC---------CCCCTTCCHHHHHHHHHH
T ss_pred HccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH--HHHHH----HHcCCC---------CCCCccchHHHHHHHHHH
Confidence 999999999999999999999999964 55443222 11111 111111 111223456889999999
Q ss_pred cccCCCCCCCHHHHHHHhhcc
Q 038647 224 VQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|+.||++|||+.||+++|+++
T Consensus 279 l~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 279 WSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TCSSGGGSCCHHHHHHHHHHT
T ss_pred cCCChhHCcCHHHHHHHHHHh
Confidence 999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=322.00 Aligned_cols=219 Identities=26% Similarity=0.372 Sum_probs=174.6
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
+.+..++|.+|+++|++++|||||++++++.++ ..++|||||++|++.+++.. ..+.+++..+..++.||+.||.||
T Consensus 51 ~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 51 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp -CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHh
Confidence 345578999999999999999999999999764 67899999999999887753 345699999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcc-cccccccccccccChhhhhcCCCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQ-SNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl 163 (289)
|+++ |+||||||+||+++.++.+||+|||+++........ .......|+..|+|||++.+..++.++||||||+++
T Consensus 128 H~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil 204 (273)
T d1u46a_ 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204 (273)
T ss_dssp HHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred hhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHH
Confidence 9988 999999999999999999999999999987544322 223344678899999999999999999999999999
Q ss_pred HHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhh
Q 038647 164 LETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLT 242 (289)
Q Consensus 164 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 242 (289)
|||+| |..||...+.... .. ....... ........+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 205 ~emlt~G~~Pf~~~~~~~~--~~---~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 205 WEMFTYGQEPWIGLNGSQI--LH---KIDKEGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp HHHHTTSCCTTTTCCHHHH--HH---HHHTSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCCCCCCcCHHHH--HH---HHHhCCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99998 8988764433221 11 1111111 11122234568999999999999999999999999987
Q ss_pred c
Q 038647 243 N 243 (289)
Q Consensus 243 ~ 243 (289)
+
T Consensus 271 ~ 271 (273)
T d1u46a_ 271 E 271 (273)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-48 Score=325.56 Aligned_cols=207 Identities=24% Similarity=0.313 Sum_probs=174.0
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
....+.+.+|+.+|++++|||||++++++.+++.+|+|||||+||+|..++. ....+++..+..++.||+.||.|||
T Consensus 45 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH 121 (316)
T d1fota_ 45 LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH 121 (316)
T ss_dssp TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhc
Confidence 3457889999999999999999999999999999999999999999998884 4456788999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 122 ~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilye 193 (316)
T d1fota_ 122 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193 (316)
T ss_dssp TTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHH
T ss_pred cCc---EEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHH
Confidence 988 999999999999999999999999999876432 334689999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 166 TLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 166 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
|++|+.||...+.... ... .... ....+...+.++.+++.+||..||.+|+ |++++++
T Consensus 194 mltG~~Pf~~~~~~~~--~~~---i~~~-----------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 194 MLAGYTPFYDSNTMKT--YEK---ILNA-----------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHSSCTTCCSSHHHH--HHH---HHHC-----------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhCCCCCCCcCHHHH--HHH---HHcC-----------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 9999999875432211 110 0000 0112223457889999999999999996 8999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=319.89 Aligned_cols=214 Identities=28% Similarity=0.394 Sum_probs=166.4
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...++|.+|+++|++++|||||++++++.+ ++.+|+||||+++|+|.+++.+. ....+++..++.++.||+.||.|||
T Consensus 42 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH 120 (262)
T d1byga_ 42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE 120 (262)
T ss_dssp C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc
Confidence 456889999999999999999999999865 46789999999999999998532 2235899999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLE 165 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~e 165 (289)
+++ |+||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..+++++||||||+++||
T Consensus 121 ~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~e 192 (262)
T d1byga_ 121 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 192 (262)
T ss_dssp HTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cCc---eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHH
Confidence 988 999999999999999999999999999865432 233467889999999999999999999999999999
Q ss_pred HHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHhhcc
Q 038647 166 TLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISMLTNE 244 (289)
Q Consensus 166 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 244 (289)
|+| |.+|+......+. .... ..+ .....+...+.++.+++.+||+.||++|||+.+|+++|+.+
T Consensus 193 l~t~~~~p~~~~~~~~~--~~~i----~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 193 IYSFGRVPYPRIPLKDV--VPRV----EKG---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHTTSCCSCTTSCGGGH--HHHH----TTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHCCCCCCCCCCHHHH--HHHH----HcC---------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 998 6776654433221 1111 111 11122333456889999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=322.71 Aligned_cols=222 Identities=27% Similarity=0.398 Sum_probs=183.9
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCC-------------CCCCChHHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTK-------------TGLLGWEMRV 71 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~ 71 (289)
.....++.+|+..+.++ +|||||+++++|.+++..++|||||++|+|.+++..... ...+++.++.
T Consensus 59 ~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 138 (299)
T d1fgka_ 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHH
Confidence 34568899999999999 799999999999999999999999999999999965432 2468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCC
Q 038647 72 RILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFS 151 (289)
Q Consensus 72 ~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 151 (289)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............|++.|+|||.+.+..++
T Consensus 139 ~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence 99999999999999988 999999999999999999999999999977655444445566789999999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 152 IKSDVFSFGVLVLETLS-SKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 152 ~~~DiwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
.++||||||+++|||++ |.+||....... .. .....+. ....+...+.++.+++.+||+.||++
T Consensus 216 ~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~~----~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~ 280 (299)
T d1fgka_ 216 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LF----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQ 280 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH----HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred chhhhHHhHHHHHHhccCCCCCCCCCCHHH--HH----HHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhH
Confidence 99999999999999998 677765433221 11 1111111 11222234568999999999999999
Q ss_pred CCCHHHHHHHhhccc
Q 038647 231 RPTMLEVISMLTNEN 245 (289)
Q Consensus 231 Rps~~~ll~~L~~~~ 245 (289)
|||+.||++.|+++.
T Consensus 281 Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 281 RPTFKQLVEDLDRIV 295 (299)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHh
Confidence 999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=321.08 Aligned_cols=221 Identities=21% Similarity=0.250 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
.+.+.+|+++|++++|||||++++++.+++.+|+||||+.++++..+. .....+++..+..++.||+.||.|||+++
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~ 120 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc
Confidence 467899999999999999999999999999999999999988777666 34567899999999999999999999988
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETL 167 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~ell 167 (289)
|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 121 ---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 195 (299)
T d1ua2a_ 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 195 (299)
T ss_dssp ---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred ---eecccCCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHH
Confidence 9999999999999999999999999998764432 22334579999999999875 46799999999999999999
Q ss_pred hCCCCcCCCCCcchhHhHhHhhhhcc---CCcccc---cccc---ccCCCC-----HHHHHHHHHHHHcccccCCCCCCC
Q 038647 168 SSKKNAHFYNTDSLTLLGHAWNLWND---GRAWEL---MDSI---LQNDAS-----YPMLNRYINVALLCVQENAADRPT 233 (289)
Q Consensus 168 tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~---~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps 233 (289)
+|.+||......+. .......... ...... .... ...... ...+.++.+++.+||+.||++|||
T Consensus 196 ~g~~pf~~~~~~~~--l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s 273 (299)
T d1ua2a_ 196 LRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273 (299)
T ss_dssp HSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred hCcCCCCCCCHHHH--HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC
Confidence 99998875443221 1111111100 000000 0000 000001 123468899999999999999999
Q ss_pred HHHHHH
Q 038647 234 MLEVIS 239 (289)
Q Consensus 234 ~~~ll~ 239 (289)
++|+++
T Consensus 274 a~e~L~ 279 (299)
T d1ua2a_ 274 ATQALK 279 (299)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=321.54 Aligned_cols=220 Identities=26% Similarity=0.375 Sum_probs=174.9
Q ss_pred cccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-------------CCCCCCChHHH
Q 038647 5 SGQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-------------TKTGLLGWEMR 70 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~ 70 (289)
+.+..++|.+|+++|+++ +|||||++++++.+++.+++||||+++|+|.+++... .....+++..+
T Consensus 50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (309)
T d1fvra_ 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129 (309)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence 445677899999999999 7999999999999999999999999999999998653 23467999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC
Q 038647 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF 150 (289)
Q Consensus 71 ~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 150 (289)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..+
T Consensus 130 ~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~ 203 (309)
T d1fvra_ 130 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY 203 (309)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCC
Confidence 999999999999999988 9999999999999999999999999998653221 2234468999999999999999
Q ss_pred CCcccchhHHHHHHHHHhCCC-CcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 151 SIKSDVFSFGVLVLETLSSKK-NAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 151 ~~~~DiwslG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+.++|||||||++|||++|.. |+...+.. ...... ..+. ....+...+.++.++|.+||+.||+
T Consensus 204 ~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i----~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~ 268 (309)
T d1fvra_ 204 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL----PQGY---------RLEKPLNCDDEVYDLMRQCWREKPY 268 (309)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHG----GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred CccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHH----HhcC---------CCCCCccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999765 45433211 111111 1111 1122233557899999999999999
Q ss_pred CCCCHHHHHHHhhccc
Q 038647 230 DRPTMLEVISMLTNEN 245 (289)
Q Consensus 230 ~Rps~~~ll~~L~~~~ 245 (289)
+|||+.||++.|+.+.
T Consensus 269 ~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 269 ERPSFAQILVSLNRML 284 (309)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHH
Confidence 9999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=322.99 Aligned_cols=222 Identities=27% Similarity=0.372 Sum_probs=170.6
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeec-CeEEEEEeecCCCChhhhhcCCC-------------CCCCCChHHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEH-GEKILIYEYMPNKSLDCFLFDPT-------------KTGLLGWEMR 70 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~ 70 (289)
....+.+.+|+.++.++ +|+|||.+++++.+. +.+++|||||++|+|.+++.... ....+++..+
T Consensus 57 ~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (299)
T d1ywna1 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHH
T ss_pred cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHH
Confidence 34567888999999888 699999999987654 56899999999999999985422 1345889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC
Q 038647 71 VRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF 150 (289)
Q Consensus 71 ~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 150 (289)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+
T Consensus 137 ~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 137 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 999999999999999988 99999999999999999999999999987655444444555689999999999999999
Q ss_pred CCcccchhHHHHHHHHHhCC-CCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 151 SIKSDVFSFGVLVLETLSSK-KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 151 ~~~~DiwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
+.++|||||||++|||+||. +||........ .... ...+.. ...+...+.++.+++.+||+.||+
T Consensus 214 ~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~~~----~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1ywna1 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRR----LKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPS 279 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHHH----HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HHHH----HhcCCC---------CCCCccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999975 45554333221 1111 111111 112223456889999999999999
Q ss_pred CCCCHHHHHHHhhcc
Q 038647 230 DRPTMLEVISMLTNE 244 (289)
Q Consensus 230 ~Rps~~~ll~~L~~~ 244 (289)
+|||+.||++.|+++
T Consensus 280 ~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 280 QRPTFSELVEHLGNL 294 (299)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=319.34 Aligned_cols=222 Identities=26% Similarity=0.355 Sum_probs=177.5
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEee-cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE-HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
+....++|.+|+++|++++|||||++++++.+ ++..++|||||++|+|.+++.. ....+++..+..++.|++.||.|
T Consensus 68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~ 145 (311)
T d1r0pa_ 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKF 145 (311)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhh
Confidence 45567889999999999999999999999876 4589999999999999998864 34457788899999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCccc--ccccccccccccChhhhhcCCCCCcccchhHHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQS--NTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGV 161 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 161 (289)
||+.+ |+||||||+|||+++++.+||+|||+++......... ......||+.|+|||.+.+..++.++||||||+
T Consensus 146 lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGi 222 (311)
T d1r0pa_ 146 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222 (311)
T ss_dssp HHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred hcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHH
Confidence 99988 9999999999999999999999999998765432221 223356899999999999999999999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHHHh
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVISML 241 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 241 (289)
++|||+||..|+....... ....... .+.. ...+...+..+.+++.+||+.||++|||+.||++.|
T Consensus 223 vl~El~t~~~p~~~~~~~~-~~~~~i~----~g~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 223 LLWELMTRGAPPYPDVNTF-DITVYLL----QGRR---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp HHHHHHTTSCCSCC-------CHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCHH-HHHHHHH----cCCC---------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999888765433221 1111111 1110 111223456889999999999999999999999999
Q ss_pred hccc
Q 038647 242 TNEN 245 (289)
Q Consensus 242 ~~~~ 245 (289)
+.+.
T Consensus 289 ~~i~ 292 (311)
T d1r0pa_ 289 SAIF 292 (311)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-47 Score=324.59 Aligned_cols=206 Identities=19% Similarity=0.232 Sum_probs=173.9
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+.+.+|+++|+.++|||||++++++.+.+..++||||+.+|+|..++. ..+.+++..+..++.||+.||.|||+
T Consensus 83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~ 159 (350)
T d1rdqe_ 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456789999999999999999999999999999999999999999999884 34579999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 87 YSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
++ |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 160 ~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyem 231 (350)
T d1rdqe_ 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp TT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHH
Confidence 88 999999999999999999999999999876432 3346799999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-----CHHHHHH
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-----TMLEVIS 239 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~ 239 (289)
+||..||...+... ..... ... . ...+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 232 ltG~~Pf~~~~~~~--~~~~i---~~~-~----------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 232 AAGYPPFFADQPIQ--IYEKI---VSG-K----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHSSCSSCCSSHHH--HHHHH---HHC-C----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HhCCCCCCCcCHHH--HHHHH---hcC-C----------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 99999986543221 11111 000 0 011223457899999999999999994 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-47 Score=314.21 Aligned_cols=210 Identities=21% Similarity=0.290 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+++.+|+.+|++++ |||||++++++.+++..|+|||||++|+|.+++. ..+.+++..+..++.||+.||.|||++
T Consensus 53 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~ 129 (277)
T d1phka_ 53 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKL 129 (277)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 457899999999997 9999999999999999999999999999999994 456799999999999999999999998
Q ss_pred CCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc------CCCCCcccchhHHH
Q 038647 88 SRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR------GLFSIKSDVFSFGV 161 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~ 161 (289)
+ |+||||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||
T Consensus 130 ~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGv 203 (277)
T d1phka_ 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203 (277)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred C---CcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccch
Confidence 8 99999999999999999999999999987654322 234579999999999963 34688999999999
Q ss_pred HHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 162 LVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 162 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
++|+|++|+.||........ ... .... .. ..........++++.+++.+||+.||++|||++|+++
T Consensus 204 ilyeml~g~~Pf~~~~~~~~--~~~---i~~~-~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 204 IMYTLLAGSPPFWHRKQMLM--LRM---IMSG-NY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHSSCSSCCSSHHHH--HHH---HHHT-CC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhhhhccCCCCCCCCCHHHH--HHH---HHhC-CC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99999999999875442211 111 1111 00 0111122345678999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=320.90 Aligned_cols=223 Identities=24% Similarity=0.325 Sum_probs=180.5
Q ss_pred ccCHHHHHHHHHHHhhC-CCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCC---------------CCCCCChHH
Q 038647 6 GQGLEEFKNEMMLIAKL-QHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPT---------------KTGLLGWEM 69 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~ 69 (289)
.....+|.+|+.+++.+ +|||||++++++.+++..++|||||++|+|.+++.... ....+++..
T Consensus 67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (311)
T d1t46a_ 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146 (311)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence 34566899999999999 69999999999999999999999999999999986432 233688999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC
Q 038647 70 RVRILEGVAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL 149 (289)
Q Consensus 70 ~~~~~~~i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 149 (289)
+..++.||+.||.|||+++ ++||||||+||+++.++.+|++|||+++...............||+.|+|||++.+..
T Consensus 147 ~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence 9999999999999999988 9999999999999999999999999999876554444455678999999999999999
Q ss_pred CCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCC
Q 038647 150 FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 150 ~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (289)
++.++|||||||++|||+|++.|+.........+..... .......+...+..+.+||.+||+.||+
T Consensus 224 ~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~-------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~ 290 (311)
T d1t46a_ 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPL 290 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------------cCCCCCCcccccHHHHHHHHHHcCCChh
Confidence 999999999999999999955444333222222111111 1111122233457899999999999999
Q ss_pred CCCCHHHHHHHhhcc
Q 038647 230 DRPTMLEVISMLTNE 244 (289)
Q Consensus 230 ~Rps~~~ll~~L~~~ 244 (289)
+|||+.+|+++|++.
T Consensus 291 ~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 291 KRPTFKQIVQLIEKQ 305 (311)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHh
Confidence 999999999999853
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.1e-48 Score=317.46 Aligned_cols=220 Identities=23% Similarity=0.324 Sum_probs=169.4
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
++..++|.+|+++|+.++|||||++++++.+.+ .+|+|||||+||+|.+++. ..+.+++..+..++.||+.||
T Consensus 48 ~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al 124 (277)
T d1o6ya_ 48 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQAL 124 (277)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHH
Confidence 445678999999999999999999999998654 3899999999999998884 446799999999999999999
Q ss_pred HHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCC-cccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 82 LYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDE-LQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 82 ~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
.|||++| |+||||||+|||++.++.++++|||.+....... .........||+.|+|||++.+..+++++||||||
T Consensus 125 ~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlG 201 (277)
T d1o6ya_ 125 NFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 201 (277)
T ss_dssp HHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccch
Confidence 9999988 9999999999999999999999999987654322 12234456799999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCC-CHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRP-TMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~ll~ 239 (289)
|++|+|+||+.||...+.... .......... .........+.++.++|.+||+.||++|| |++++++
T Consensus 202 vilyelltG~~Pf~~~~~~~~-----~~~~~~~~~~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 202 CVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPI-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp HHHHHHHHSSCSCCCSSHHHH-----HHHHHHCCCC-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhCCCCCCCcCHHHH-----HHHHHhcCCC-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 999999999999875432211 1111111110 00111123457899999999999999999 8999988
Q ss_pred Hhhc
Q 038647 240 MLTN 243 (289)
Q Consensus 240 ~L~~ 243 (289)
.|..
T Consensus 270 ~l~r 273 (277)
T d1o6ya_ 270 DLVR 273 (277)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.4e-47 Score=321.82 Aligned_cols=203 Identities=22% Similarity=0.238 Sum_probs=166.5
Q ss_pred HHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceE
Q 038647 14 NEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSRLRVI 93 (289)
Q Consensus 14 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iv 93 (289)
+|+++++.++|||||++++++.+++.+|+|||||++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---ii 129 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VV 129 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 44777888899999999999999999999999999999999984 3467889999999999999999999998 99
Q ss_pred eeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHHHHHHhCCCC
Q 038647 94 HRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLVLETLSSKKN 172 (289)
Q Consensus 94 H~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl~elltg~~p 172 (289)
||||||+|||++.++.+||+|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.|
T Consensus 130 HrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~P 205 (364)
T d1omwa3 130 YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205 (364)
T ss_dssp CCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432 334579999999999974 5689999999999999999999999
Q ss_pred cCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHHH
Q 038647 173 AHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVIS 239 (289)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll~ 239 (289)
|............. ... . .....+...+.++.++|.+||+.||++||| ++|+++
T Consensus 206 f~~~~~~~~~~~~~--~~~-~----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 206 FRQHKTKDKHEIDR--MTL-T----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCSSCSSCHHHHHH--HSS-S----------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCHHHHHHHHH--hcc-c----------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 87654432211100 000 0 001112234578999999999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=312.68 Aligned_cols=231 Identities=19% Similarity=0.263 Sum_probs=173.1
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
++..+++.+|+++|++++|||||++++++.+++.+|+||||+.++.+..... ...+.+++..+..++.||+.||.|||
T Consensus 42 ~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH 119 (298)
T d1gz8a_ 42 EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCH 119 (298)
T ss_dssp --CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh
Confidence 4457889999999999999999999999999999999999997654544332 23456999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC-CCCcccchhHHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLVL 164 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~vl~ 164 (289)
+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.... ++.++|||||||++|
T Consensus 120 ~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily 194 (298)
T d1gz8a_ 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFA 194 (298)
T ss_dssp HTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred cCC---EEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhh
Confidence 988 9999999999999999999999999998765432 2234457999999999987765 589999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhcc--CCccccccc-------ccc-CCC-----CHHHHHHHHHHHHcccccCCC
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWND--GRAWELMDS-------ILQ-NDA-----SYPMLNRYINVALLCVQENAA 229 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-------~~~-~~~-----~~~~~~~l~~li~~~l~~~p~ 229 (289)
+|++|+.||...+...... ........ ......... ... ... ....+.++.+++.+||+.||+
T Consensus 195 ~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 272 (298)
T d1gz8a_ 195 EMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272 (298)
T ss_dssp HHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTT
T ss_pred HHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChh
Confidence 9999999987544322111 11110000 000000000 000 000 112346789999999999999
Q ss_pred CCCCHHHHHH--Hhhccc
Q 038647 230 DRPTMLEVIS--MLTNEN 245 (289)
Q Consensus 230 ~Rps~~~ll~--~L~~~~ 245 (289)
+|||+.|+++ ++++.+
T Consensus 273 ~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 273 KRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TSCCHHHHHTSGGGTTCC
T ss_pred HCcCHHHHhCCHhhccCC
Confidence 9999999997 355443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=320.17 Aligned_cols=216 Identities=18% Similarity=0.194 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHhhC-CCCCceeeeeeEee----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKL-QHRNLVRLFGCCIE----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLY 83 (289)
Q Consensus 9 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 83 (289)
.+.+.+|++++.++ +|||||+++++|.+ +..+|+|||||+||+|.+++.+. ....+++..+..++.||+.||.|
T Consensus 48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~y 126 (335)
T d2ozaa1 48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQY 126 (335)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHH
Confidence 35788999997665 89999999999976 46799999999999999999642 23469999999999999999999
Q ss_pred HhcCCCCceEeeccccCceEeCC---CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHH
Q 038647 84 LHHYSRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFG 160 (289)
Q Consensus 84 lH~~~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 160 (289)
||++| |+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..|+.++||||||
T Consensus 127 lH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlG 200 (335)
T d2ozaa1 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200 (335)
T ss_dssp HHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHH
T ss_pred HHHcC---CccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhc
Confidence 99988 999999999999985 4579999999998765432 23445799999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|++|+|+||+.||...+....... ........ ............+.++.++|.+||+.||++|||+.|+++
T Consensus 201 vily~lltg~~Pf~~~~~~~~~~~--~~~~i~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 201 VIMYILLCGYPPFYSNHGLAISPG--MKTRIRMG------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHHHHTTSSCSCEETTCC----------CCCSC------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHhhCCCCCCCCCHHHHHHH--HHHHHhcC------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999999999875443221000 00000000 000001111234578999999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=315.95 Aligned_cols=215 Identities=20% Similarity=0.259 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 038647 9 LEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYS 88 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 88 (289)
...+.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.. ....+++.++..++.||+.||.|||++|
T Consensus 45 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~ 122 (321)
T d1tkia_ 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN 122 (321)
T ss_dssp HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 45688999999999999999999999999999999999999999999843 2346899999999999999999999988
Q ss_pred CCceEeeccccCceEeCCC--CceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHHHH
Q 038647 89 RLRVIHRDLKASNILLDSN--MNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVLET 166 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~--~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~el 166 (289)
|+||||||+|||++.+ ..+||+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|+|
T Consensus 123 ---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~l 196 (321)
T d1tkia_ 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp ---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHH
T ss_pred ---CCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHH
Confidence 9999999999999854 479999999998764432 23345789999999999999999999999999999999
Q ss_pred HhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH--Hhhc
Q 038647 167 LSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS--MLTN 243 (289)
Q Consensus 167 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~--~L~~ 243 (289)
++|..||...+.... ... ....... .... .....+.++.+++.+||..||++|||+.|+++ ++.+
T Consensus 197 l~G~~Pf~~~~~~~~--~~~---i~~~~~~--~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 197 LSGINPFLAETNQQI--IEN---IMNAEYT--FDEE-----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHSSCTTCCSSHHHH--HHH---HHHTCCC--CCHH-----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HhCCCCCCCCCHHHH--HHH---HHhCCCC--CChh-----hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 999999875443211 110 0000000 0000 00123467899999999999999999999997 4543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=314.33 Aligned_cols=221 Identities=25% Similarity=0.384 Sum_probs=179.8
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCC-------CCCCCCChHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDP-------TKTGLLGWEMRVRILEGVA 78 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~~~~i~ 78 (289)
.+....|.+|++++++++|||||++++++..++..++||||+++|+|.+++... .....+++..+..++.|++
T Consensus 64 ~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia 143 (308)
T d1p4oa_ 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143 (308)
T ss_dssp HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHH
Confidence 345567999999999999999999999999999999999999999999987431 1223578899999999999
Q ss_pred HHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchh
Q 038647 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158 (289)
Q Consensus 79 ~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 158 (289)
.||.|||+++ |+||||||+|||+++++++||+|||+++...............||+.|+|||.+.+..++.++||||
T Consensus 144 ~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S 220 (308)
T d1p4oa_ 144 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 220 (308)
T ss_dssp HHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCccccccc
Confidence 9999999988 9999999999999999999999999998775554444455557899999999999999999999999
Q ss_pred HHHHHHHHHhCC-CCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHH
Q 038647 159 FGVLVLETLSSK-KNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEV 237 (289)
Q Consensus 159 lG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (289)
||+++|||+||. .|+...+... ..... ..+.. ...+...+..+.+++.+||+.||++|||+.+|
T Consensus 221 ~G~il~El~t~~~~p~~~~~~~~--~~~~i----~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 221 FGVVLWEIATLAEQPYQGLSNEQ--VLRFV----MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp HHHHHHHHHHTSCCTTTTSCHHH--HHHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HhCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999985 5554332221 11111 11111 11122345689999999999999999999999
Q ss_pred HHHhhcc
Q 038647 238 ISMLTNE 244 (289)
Q Consensus 238 l~~L~~~ 244 (289)
++.|+..
T Consensus 286 l~~L~~~ 292 (308)
T d1p4oa_ 286 ISSIKEE 292 (308)
T ss_dssp HHHHGGG
T ss_pred HHHHHHh
Confidence 9999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=317.56 Aligned_cols=210 Identities=21% Similarity=0.268 Sum_probs=173.2
Q ss_pred ccCHHHHHHHHHHHh-hCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIA-KLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+..+.+.+|..++. .++|||||++++++.+++.+|+|||||++|+|.+++. ..+.+++..+..++.||+.||.||
T Consensus 43 ~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~yl 119 (320)
T d1xjda_ 43 DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119 (320)
T ss_dssp TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 345677888888876 6899999999999999999999999999999999994 445689999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhHHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSFGVLVL 164 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~vl~ 164 (289)
|+++ |+||||||+|||+++++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 120 H~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 194 (320)
T d1xjda_ 120 HSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 194 (320)
T ss_dssp HHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HhCC---eeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHH
Confidence 9988 9999999999999999999999999998654332 2234467999999999999999999999999999999
Q ss_pred HHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH-HHHH
Q 038647 165 ETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML-EVIS 239 (289)
Q Consensus 165 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~ll~ 239 (289)
+|++|+.||...+.... ..... ... ...+...+.++.++|.+||+.||++|||+. ++++
T Consensus 195 emltG~~PF~~~~~~~~--~~~i~----~~~----------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 195 EMLIGQSPFHGQDEEEL--FHSIR----MDN----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHSSCSSCCSSHHHH--HHHHH----HCC----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHhCCCCCCCCCHHHH--HHHHH----cCC----------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 99999999875443221 11110 000 011223457899999999999999999995 6754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=309.64 Aligned_cols=230 Identities=21% Similarity=0.231 Sum_probs=167.7
Q ss_pred CHHHHHHHHH--HHhhCCCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMM--LIAKLQHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGL 81 (289)
Q Consensus 8 ~~~~~~~E~~--~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 81 (289)
..+++.+|.+ .+.+++|||||++++++.+.+ .+|+|||||++|+|.+++.+ ..+++..+..++.|++.||
T Consensus 38 ~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl 113 (303)
T d1vjya_ 38 EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGL 113 (303)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHH
Confidence 3445555544 556789999999999998754 58999999999999999953 3588999999999999999
Q ss_pred HHHhcCC-----CCceEeeccccCceEeCCCCceEEcccccccccCCCCc--ccccccccccccccChhhhhcCC-----
Q 038647 82 LYLHHYS-----RLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL--QSNTKRIVGTYGYMSPEYALRGL----- 149 (289)
Q Consensus 82 ~~lH~~~-----~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~----- 149 (289)
.|+|+.. ..+|+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+..
T Consensus 114 ~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 193 (303)
T d1vjya_ 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193 (303)
T ss_dssp HHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCH
T ss_pred HHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCC
Confidence 9999631 23499999999999999999999999999987644322 12234567999999999997643
Q ss_pred -CCCcccchhHHHHHHHHHhCCCCcCCCCCcchhHhH---------hHhhhhccCCcccccccc-ccCCCCHHHHHHHHH
Q 038647 150 -FSIKSDVFSFGVLVLETLSSKKNAHFYNTDSLTLLG---------HAWNLWNDGRAWELMDSI-LQNDASYPMLNRYIN 218 (289)
Q Consensus 150 -~~~~~DiwslG~vl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 218 (289)
++.++|||||||++|||+||..|+............ .......... .+.. ............+.+
T Consensus 194 ~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~ 269 (303)
T d1vjya_ 194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAK 269 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHH
T ss_pred CcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHH
Confidence 577899999999999999998876543332211100 0000000000 0000 011112235567899
Q ss_pred HHHcccccCCCCCCCHHHHHHHhhccc
Q 038647 219 VALLCVQENAADRPTMLEVISMLTNEN 245 (289)
Q Consensus 219 li~~~l~~~p~~Rps~~~ll~~L~~~~ 245 (289)
++.+||+.||++|||+.||++.|+++.
T Consensus 270 li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 270 IMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=306.97 Aligned_cols=199 Identities=22% Similarity=0.296 Sum_probs=164.0
Q ss_pred HHHHHHHHHHHhhCC--CCCceeeeeeEeecCeEEEEEeecCC-CChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 9 LEEFKNEMMLIAKLQ--HRNLVRLFGCCIEHGEKILIYEYMPN-KSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
.+++.+|+.+|++++ |||||++++++.+++..|+||||+.+ +++.+++. ..+.++++.++.++.||+.||.|||
T Consensus 51 ~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH 127 (273)
T d1xwsa_ 51 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCH 127 (273)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345779999999997 89999999999999999999999976 57777773 3467999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCC-CCceEEcccccccccCCCCcccccccccccccccChhhhhcCCC-CCcccchhHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDS-NMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLF-SIKSDVFSFGVLV 163 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~vl 163 (289)
+++ |+||||||+|||++. ++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++
T Consensus 128 ~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvil 200 (273)
T d1xwsa_ 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200 (273)
T ss_dssp HTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred HCC---CccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeee
Confidence 988 999999999999985 478999999999865432 2334679999999999987765 6779999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
|+|++|+.||..... . .... .......+.++.+++.+||+.||++|||++|+++
T Consensus 201 yell~g~~Pf~~~~~----i-------~~~~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 201 YDMVCGDIPFEHDEE----I-------IRGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHSSCSCCSHHH----H-------HHCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHhhCCCCCCCchH----H-------hhcc-----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 999999999864210 0 0000 0111224578999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.8e-45 Score=302.24 Aligned_cols=225 Identities=19% Similarity=0.263 Sum_probs=170.8
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
++...++|.+|+.+|++++|||||++++++.+++..++++||+.++++..+. ...+.+++..+..++.||+.||.||
T Consensus 40 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~L 116 (286)
T d1ob3a_ 40 DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYC 116 (286)
T ss_dssp GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHh
Confidence 4455789999999999999999999999999999999999999888777666 3456799999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~vl 163 (289)
|+.+ |+||||||+|||++.++.+||+|||.+........ ......+++.|+|||.+.+. .++.++|||||||++
T Consensus 117 H~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l 191 (286)
T d1ob3a_ 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191 (286)
T ss_dssp HHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred ccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHH
Confidence 9988 99999999999999999999999999987654322 23344689999999999754 579999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCC---------c------cccccccccCCCCHHHHHHHHHHHHcccccCC
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGR---------A------WELMDSILQNDASYPMLNRYINVALLCVQENA 228 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 228 (289)
|||++|+.||...+.... ............ . ................+..+.+++.+||+.||
T Consensus 192 ~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 269 (286)
T d1ob3a_ 192 AEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269 (286)
T ss_dssp HHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCCh
Confidence 999999999875443221 111111100000 0 00000000011122245688999999999999
Q ss_pred CCCCCHHHHHH
Q 038647 229 ADRPTMLEVIS 239 (289)
Q Consensus 229 ~~Rps~~~ll~ 239 (289)
++|||++|+++
T Consensus 270 ~~R~s~~ell~ 280 (286)
T d1ob3a_ 270 NQRITAKQALE 280 (286)
T ss_dssp TTSCCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=303.58 Aligned_cols=222 Identities=24% Similarity=0.314 Sum_probs=166.8
Q ss_pred CHHHHHHHHHHHhhC---CCCCceeeeeeEee-----cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 038647 8 GLEEFKNEMMLIAKL---QHRNLVRLFGCCIE-----HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQ 79 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~ 79 (289)
....+.+|+.+|+.+ +||||++++++|.. +...+++|||+.++++..... .....+++..+..++.|++.
T Consensus 50 ~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~ 127 (305)
T d1blxa_ 50 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLR 127 (305)
T ss_dssp CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHH
Confidence 345677888887766 79999999999863 347899999999887755443 34456899999999999999
Q ss_pred HHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 80 GLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 80 ~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..++.++||||+
T Consensus 128 aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp HHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhch
Confidence 999999988 999999999999999999999999998765332 23445689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhh--------hccCCc-c-cccccc---ccCCCCHHHHHHHHHHHHccccc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNL--------WNDGRA-W-ELMDSI---LQNDASYPMLNRYINVALLCVQE 226 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~-~-~~~~~~---~~~~~~~~~~~~l~~li~~~l~~ 226 (289)
||++|||++|+.||...+.... ....... +..... . ...... .........++.+.+|+.+||+.
T Consensus 202 G~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 279 (305)
T d1blxa_ 202 GCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 279 (305)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcC
Confidence 9999999999999875543221 1111110 000000 0 000000 00011122456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 038647 227 NAADRPTMLEVIS 239 (289)
Q Consensus 227 ~p~~Rps~~~ll~ 239 (289)
||++|||+.|+++
T Consensus 280 dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 280 NPAKRISAYSALS 292 (305)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=301.60 Aligned_cols=222 Identities=20% Similarity=0.182 Sum_probs=163.4
Q ss_pred HHHHHHHHhhCCCCCceeeeeeEee------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 12 FKNEMMLIAKLQHRNLVRLFGCCIE------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 12 ~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
+.+|+++|++++||||++++++|.. ..++|+|||||+++.+..+.........+++..+..++.||+.||.|||
T Consensus 60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4589999999999999999999854 3358999999987654443322234557999999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCcccccccccccccccChhhhhc-CCCCCcccchhHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALR-GLFSIKSDVFSFGVLV 163 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~vl 163 (289)
++| |+||||||+|||++.++ .+||+|||+++....... .....|++.|+|||.+.+ ..++.++||||+||++
T Consensus 140 ~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213 (350)
T ss_dssp TTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred hcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEE
Confidence 988 99999999999999775 899999999987654332 334578999999999875 5789999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhH---------hHhhhhccC----CccccccccccCCCCHHHHHHHHHHHHcccccCCCC
Q 038647 164 LETLSSKKNAHFYNTDSLTLLG---------HAWNLWNDG----RAWELMDSILQNDASYPMLNRYINVALLCVQENAAD 230 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (289)
|||++|..||............ ..+...... ..................+.++.+|+.+||+.||++
T Consensus 214 ~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 293 (350)
T d1q5ka_ 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293 (350)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred EehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhH
Confidence 9999999998765432211000 000000000 000000000011112234567899999999999999
Q ss_pred CCCHHHHHH
Q 038647 231 RPTMLEVIS 239 (289)
Q Consensus 231 Rps~~~ll~ 239 (289)
|||+.|+++
T Consensus 294 R~ta~e~L~ 302 (350)
T d1q5ka_ 294 RLTPLEACA 302 (350)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=293.72 Aligned_cols=227 Identities=19% Similarity=0.247 Sum_probs=167.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEee--------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE--------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEG 76 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 76 (289)
.+...+++.+|+++|++++||||+++++++.. ++..|+||||+.++++..+. .....+++..++.++.|
T Consensus 49 ~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~q 125 (318)
T d3blha1 49 KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQM 125 (318)
T ss_dssp TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHH
Confidence 34567789999999999999999999999855 45689999999888776555 34456889999999999
Q ss_pred HHHHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc--ccccccccccccccChhhhhcC-CCCCc
Q 038647 77 VAQGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL--QSNTKRIVGTYGYMSPEYALRG-LFSIK 153 (289)
Q Consensus 77 i~~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~ 153 (289)
++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+. .++.+
T Consensus 126 il~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k 202 (318)
T d3blha1 126 LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 202 (318)
T ss_dssp HHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTH
T ss_pred HHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcH
Confidence 999999999988 99999999999999999999999999987653321 1223345799999999999765 68999
Q ss_pred ccchhHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhh---ccC--------CccccccccccCCCCHH-------HHHH
Q 038647 154 SDVFSFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLW---NDG--------RAWELMDSILQNDASYP-------MLNR 215 (289)
Q Consensus 154 ~DiwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~~-------~~~~ 215 (289)
+|||||||++|+|++|+.||........ ........ ... ................. ....
T Consensus 203 ~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (318)
T d3blha1 203 IDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 280 (318)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHH
T ss_pred HHcccCCceeeeHhhCCCCCCCCCHHHH--HHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHH
Confidence 9999999999999999999865432211 11111111 000 00000011111111111 1246
Q ss_pred HHHHHHcccccCCCCCCCHHHHHH
Q 038647 216 YINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 216 l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+.+++.+||+.||++|||++|+++
T Consensus 281 ~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 281 ALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCChhHCcCHHHHHc
Confidence 678999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=299.69 Aligned_cols=224 Identities=21% Similarity=0.238 Sum_probs=170.5
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecC------eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG------EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVA 78 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~ 78 (289)
++...+.+.+|+++|++++|||||+++++|...+ .+|+||||+ +++|..+.. .+.+++..+..++.||+
T Consensus 57 ~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~ 131 (346)
T d1cm8a_ 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQML 131 (346)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHH
Confidence 3445778999999999999999999999998654 579999999 667777663 35699999999999999
Q ss_pred HHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccch
Q 038647 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVF 157 (289)
Q Consensus 79 ~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Diw 157 (289)
.||.|||++| |+||||||+|||++.++.+|++|||+++..... .....||+.|+|||++.+. .++.++|||
T Consensus 132 ~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 203 (346)
T d1cm8a_ 132 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIW 203 (346)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHH
T ss_pred HHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhh
Confidence 9999999998 999999999999999999999999999876432 3345789999999999864 579999999
Q ss_pred hHHHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhcc--------CC----------ccccccccccCCCCHHHHHHHHHH
Q 038647 158 SFGVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWND--------GR----------AWELMDSILQNDASYPMLNRYINV 219 (289)
Q Consensus 158 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~----------~~~~~~~~~~~~~~~~~~~~l~~l 219 (289)
|+||++|+|++|..||...+...... ........ .. ......... .......+..+.+|
T Consensus 204 SlGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dl 280 (346)
T d1cm8a_ 204 SVGCIMAEMITGKTLFKGSDHLDQLK--EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNL 280 (346)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHH
T ss_pred cchHHHHHHHHCcCCCCCCChHHHHH--HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHH
Confidence 99999999999999987654321110 00000000 00 000000000 00111234578899
Q ss_pred HHcccccCCCCCCCHHHHHH--Hhhcc
Q 038647 220 ALLCVQENAADRPTMLEVIS--MLTNE 244 (289)
Q Consensus 220 i~~~l~~~p~~Rps~~~ll~--~L~~~ 244 (289)
+.+||..||++|||+.|+++ ++++.
T Consensus 281 i~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 281 LEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 99999999999999999997 35543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-42 Score=292.43 Aligned_cols=222 Identities=15% Similarity=0.234 Sum_probs=170.2
Q ss_pred ccCHHHHHHHHHHHhhCC-CCCceeeeeeEee--cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIE--HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
....+++.+|+++|+.++ ||||++++++|.. ...+++|||||.+++|..+. +.+++..+..++.||+.||.
T Consensus 70 ~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~ 143 (328)
T d3bqca1 70 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALD 143 (328)
T ss_dssp SSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 445788999999999995 9999999999974 45699999999999997764 35899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCC-ceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNM-NPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSFG 160 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG 160 (289)
|||++| |+||||||+|||++.++ .+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+|
T Consensus 144 ~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 217 (328)
T d3bqca1 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 217 (328)
T ss_dssp HHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred HHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhh
Confidence 999998 99999999999998654 68999999998765432 23445789999999998865 579999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHh-----------hhhccC-----------CccccccccccCCCCHHHHHHHHH
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAW-----------NLWNDG-----------RAWELMDSILQNDASYPMLNRYIN 218 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~ 218 (289)
|++|++++|+.||............... ...... ..................+.++.+
T Consensus 218 ~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 297 (328)
T d3bqca1 218 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297 (328)
T ss_dssp HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHH
T ss_pred hhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHH
Confidence 9999999999998765543221111000 000000 000111111222222335578899
Q ss_pred HHHcccccCCCCCCCHHHHHH
Q 038647 219 VALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 219 li~~~l~~~p~~Rps~~~ll~ 239 (289)
||.+||+.||++|||++|+++
T Consensus 298 li~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 298 FLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=294.20 Aligned_cols=214 Identities=21% Similarity=0.238 Sum_probs=171.6
Q ss_pred cCHHHHHHHHHHHhhCCC-CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 038647 7 QGLEEFKNEMMLIAKLQH-RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLH 85 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 85 (289)
...+.+.+|+++|++++| |||+++++++.+....++||||+.+|+|.+++. ..+.+++..+..++.||+.||.|+|
T Consensus 70 ~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH 146 (322)
T d1vzoa_ 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLH 146 (322)
T ss_dssp SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhh
Confidence 346788999999999966 899999999999999999999999999999884 4456788999999999999999999
Q ss_pred cCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC--CCCCcccchhHHHHH
Q 038647 86 HYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG--LFSIKSDVFSFGVLV 163 (289)
Q Consensus 86 ~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~vl 163 (289)
+++ |+||||||+||+++.++.+||+|||+++....... .......|++.|+|||.+.+. .++.++|||||||++
T Consensus 147 ~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iL 222 (322)
T d1vzoa_ 147 KLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 222 (322)
T ss_dssp HTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHH
T ss_pred cCC---EEeccCCccceeecCCCCEEEeeccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHH
Confidence 988 99999999999999999999999999987644332 223446799999999999764 468899999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCC-----HHHHH
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPT-----MLEVI 238 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~ll 238 (289)
|+|++|..||...+.......... ..... ....+...+.++.+++.+||+.||++||| ++|++
T Consensus 223 yelltG~~PF~~~~~~~~~~~i~~-~~~~~-----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 223 YELLTGASPFTVDGEKNSQAEISR-RILKS-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp HHHHHSSCTTSCTTSCCCHHHHHH-HHHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHH-hcccC-----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 999999999876554432111110 00000 01112235678999999999999999994 88887
Q ss_pred H
Q 038647 239 S 239 (289)
Q Consensus 239 ~ 239 (289)
+
T Consensus 291 ~ 291 (322)
T d1vzoa_ 291 E 291 (322)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=286.53 Aligned_cols=226 Identities=22% Similarity=0.230 Sum_probs=174.1
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYL 84 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 84 (289)
.+...+++.+|+.+|+.++||||+++++++.+....++|++++.+++|..++. ..+.+++..+..++.|++.||+||
T Consensus 41 ~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~l 117 (292)
T d1unla_ 41 DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFC 117 (292)
T ss_dssp STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHh
Confidence 34457899999999999999999999999999999999999999999888774 446788999999999999999999
Q ss_pred hcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCC-CCCcccchhHHHHH
Q 038647 85 HHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGL-FSIKSDVFSFGVLV 163 (289)
Q Consensus 85 H~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~vl 163 (289)
|+++ |+||||||+|||++.++.+||+|||.++....... ......+++.|+|||++.+.. ++.++|||||||++
T Consensus 118 H~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il 192 (292)
T d1unla_ 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192 (292)
T ss_dssp HHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred hcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHH
Confidence 9988 99999999999999999999999999987654322 223345778899999998665 69999999999999
Q ss_pred HHHHhCCCCcCCCCCcchhHhHhHhhhhccC---Cc------------cccccccccCCCCHHHHHHHHHHHHcccccCC
Q 038647 164 LETLSSKKNAHFYNTDSLTLLGHAWNLWNDG---RA------------WELMDSILQNDASYPMLNRYINVALLCVQENA 228 (289)
Q Consensus 164 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 228 (289)
|+|++|+.||........... ......... .. ................+..+.+++.+||+.||
T Consensus 193 ~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 271 (292)
T d1unla_ 193 AELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp HHHTTTSCCSCCCSSHHHHHH-HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred HHHhhCCCCCCCCCCHHHHHH-HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCCh
Confidence 999999998754433322211 111111110 00 00000001111122345678899999999999
Q ss_pred CCCCCHHHHHH
Q 038647 229 ADRPTMLEVIS 239 (289)
Q Consensus 229 ~~Rps~~~ll~ 239 (289)
.+|||++|+++
T Consensus 272 ~~R~sa~e~L~ 282 (292)
T d1unla_ 272 VQRISAEEALQ 282 (292)
T ss_dssp GGSCCHHHHTT
T ss_pred hHCcCHHHHhc
Confidence 99999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=296.61 Aligned_cols=224 Identities=20% Similarity=0.236 Sum_probs=165.7
Q ss_pred cCHHHHHHHHHHHhhCCCCCceeeeeeEeecC----eEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 038647 7 QGLEEFKNEMMLIAKLQHRNLVRLFGCCIEHG----EKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLL 82 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~ 82 (289)
...+++.+|+++|++++||||+++++++.... ..+++++|+.+|+|.+++.. ..+++..++.++.||+.||.
T Consensus 48 ~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~ 123 (345)
T d1pmea_ 48 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLK 123 (345)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHH
Confidence 44678999999999999999999999997643 23444556679999999842 35899999999999999999
Q ss_pred HHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCc-ccccccccccccccChhhhh-cCCCCCcccchhHH
Q 038647 83 YLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDEL-QSNTKRIVGTYGYMSPEYAL-RGLFSIKSDVFSFG 160 (289)
Q Consensus 83 ~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG 160 (289)
|||++| |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++. +..++.++||||+|
T Consensus 124 yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG 200 (345)
T d1pmea_ 124 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHH
T ss_pred HHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccC
Confidence 999998 99999999999999999999999999987643322 12234567899999999985 45679999999999
Q ss_pred HHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccCCc-----------ccccccccc-CCC-----CHHHHHHHHHHHHcc
Q 038647 161 VLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDGRA-----------WELMDSILQ-NDA-----SYPMLNRYINVALLC 223 (289)
Q Consensus 161 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-~~~-----~~~~~~~l~~li~~~ 223 (289)
|++|+|++|..||........... .......... ......... ... ....+.++.+++.+|
T Consensus 201 ~il~eml~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 278 (345)
T d1pmea_ 201 CILAEMLSNRPIFPGKHYLDQLNH--ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278 (345)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHH
T ss_pred ceehHHhhCCCCCCCCCHHHHHHH--HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHH
Confidence 999999999999865443211110 0000000000 000000000 000 112235788999999
Q ss_pred cccCCCCCCCHHHHHH
Q 038647 224 VQENAADRPTMLEVIS 239 (289)
Q Consensus 224 l~~~p~~Rps~~~ll~ 239 (289)
|+.||++|||+.|+++
T Consensus 279 L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 279 LTFNPHKRIEVEQALA 294 (345)
T ss_dssp SCSSTTTSCCHHHHHT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-42 Score=284.24 Aligned_cols=221 Identities=16% Similarity=0.145 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHhhCCCCCce-eeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 038647 9 LEEFKNEMMLIAKLQHRNLV-RLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHY 87 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 87 (289)
.+++.+|+++++.++|+|++ .+.+++.+++..++||||+. +++...+.. ..+.+++..+..++.|++.||+|||++
T Consensus 46 ~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (299)
T d1ckia_ 46 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK 122 (299)
T ss_dssp SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 45688999999999876655 55666678889999999994 556555532 345789999999999999999999999
Q ss_pred CCCceEeeccccCceEeCC---CCceEEcccccccccCCCCc-----ccccccccccccccChhhhhcCCCCCcccchhH
Q 038647 88 SRLRVIHRDLKASNILLDS---NMNPKISDFGIARLFGGDEL-----QSNTKRIVGTYGYMSPEYALRGLFSIKSDVFSF 159 (289)
Q Consensus 88 ~~~~ivH~dikp~Nill~~---~~~vkl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 159 (289)
+ |+||||||+|||++. +..++|+|||+++....... ........||+.|+|||++.+..++.++|||||
T Consensus 123 ~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 199 (299)
T d1ckia_ 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199 (299)
T ss_dssp T---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHH
T ss_pred C---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEec
Confidence 8 999999999999864 45699999999998754322 122345679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhh-hhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHH
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWN-LWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTMLEVI 238 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 238 (289)
||++|||++|..||................ ....... .......+.++.+++..||+.||++||++.++.
T Consensus 200 G~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 200 GYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred CHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh---------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 999999999999987654432211110000 0000000 000112346789999999999999999999998
Q ss_pred HHhhcc
Q 038647 239 SMLTNE 244 (289)
Q Consensus 239 ~~L~~~ 244 (289)
+.|+..
T Consensus 271 ~~l~~~ 276 (299)
T d1ckia_ 271 QLFRNL 276 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-41 Score=278.86 Aligned_cols=222 Identities=13% Similarity=0.118 Sum_probs=173.4
Q ss_pred CHHHHHHHHHHHhhCCC-CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQH-RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
..+.+.+|+++++.++| +|++.+++++.++...++||||+ +++|.+++.. ....++...+..++.|++.||.|||+
T Consensus 43 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~ 119 (293)
T d1csna_ 43 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE 119 (293)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999964 89999999999999999999999 7899888753 33468999999999999999999999
Q ss_pred CCCCceEeeccccCceEeCC-----CCceEEcccccccccCCCCc-----ccccccccccccccChhhhhcCCCCCcccc
Q 038647 87 YSRLRVIHRDLKASNILLDS-----NMNPKISDFGIARLFGGDEL-----QSNTKRIVGTYGYMSPEYALRGLFSIKSDV 156 (289)
Q Consensus 87 ~~~~~ivH~dikp~Nill~~-----~~~vkl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 156 (289)
+| |+||||||+|||++. ++.+||+|||+++....... ........||+.|+|||++.+..++.++||
T Consensus 120 ~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~Di 196 (293)
T d1csna_ 120 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDL 196 (293)
T ss_dssp TT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred CC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHH
Confidence 88 999999999999974 57799999999987643321 122345679999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCcCCCCCcchhH-hHhHhhhhccCCccccccccccCCCCHHHHHHHHHHHHcccccCCCCCCCHH
Q 038647 157 FSFGVLVLETLSSKKNAHFYNTDSLTL-LGHAWNLWNDGRAWELMDSILQNDASYPMLNRYINVALLCVQENAADRPTML 235 (289)
Q Consensus 157 wslG~vl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (289)
||||+++|||+||..||.......... ............. ... ....++++.+++..|++.+|++||+++
T Consensus 197 wSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----~~l-----~~~~p~~l~~ii~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 197 EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL----REL-----CAGFPEEFYKYMHYARNLAFDATPDYD 267 (293)
T ss_dssp HHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH----HHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred HHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh----HHh-----cCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 999999999999999997654432211 1111100000000 000 112346788999999999999999999
Q ss_pred HHHHHhhcc
Q 038647 236 EVISMLTNE 244 (289)
Q Consensus 236 ~ll~~L~~~ 244 (289)
.+.+.|++.
T Consensus 268 ~l~~~l~~~ 276 (293)
T d1csna_ 268 YLQGLFSKV 276 (293)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 988877754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=288.38 Aligned_cols=223 Identities=22% Similarity=0.192 Sum_probs=161.5
Q ss_pred cccCHHHHHHHHHHHhhCCCCCceeeeeeEee------cCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHH
Q 038647 5 SGQGLEEFKNEMMLIAKLQHRNLVRLFGCCIE------HGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVA 78 (289)
Q Consensus 5 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~ 78 (289)
+++..+++.+|+.+|++++|||||+++++|.. ..++|+|||||.++++..+. ..+++..++.++.||+
T Consensus 56 ~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil 129 (355)
T d2b1pa1 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQML 129 (355)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHH
Confidence 34567789999999999999999999999963 46899999999776555432 3588999999999999
Q ss_pred HHHHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcCCCCCcccchh
Q 038647 79 QGLLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRGLFSIKSDVFS 158 (289)
Q Consensus 79 ~~l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 158 (289)
.||.|||++| |+||||||+|||++.++.++++|||+++...... ......+|+.|+|||++.+..++.++||||
T Consensus 130 ~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwS 203 (355)
T d2b1pa1 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWS 203 (355)
T ss_dssp HHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHH
T ss_pred HHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCccccc
Confidence 9999999998 9999999999999999999999999988664432 234457899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCcCCCCCcchhHhH---------hHh--------hhhccC------CccccccccccCCC---CHHH
Q 038647 159 FGVLVLETLSSKKNAHFYNTDSLTLLG---------HAW--------NLWNDG------RAWELMDSILQNDA---SYPM 212 (289)
Q Consensus 159 lG~vl~elltg~~p~~~~~~~~~~~~~---------~~~--------~~~~~~------~~~~~~~~~~~~~~---~~~~ 212 (289)
+||++++|++|+.||...+........ ..+ ...... .............. ....
T Consensus 204 lG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (355)
T d2b1pa1 204 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283 (355)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred ccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccC
Confidence 999999999999998755422110000 000 000000 00001111111111 1235
Q ss_pred HHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 213 LNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 213 ~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
+.++.+|+.+||+.||++|||++|+++
T Consensus 284 s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 284 ASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 678899999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=291.44 Aligned_cols=226 Identities=19% Similarity=0.238 Sum_probs=165.2
Q ss_pred ccCHHHHHHHHHHHhhCCCCCceeeeeeEeec-----CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 038647 6 GQGLEEFKNEMMLIAKLQHRNLVRLFGCCIEH-----GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQG 80 (289)
Q Consensus 6 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 80 (289)
....+++.+|+++|++++|||||++++++... ...++|++|+.+|+|.+++. .+.+++..+..++.||+.|
T Consensus 58 ~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~a 133 (348)
T d2gfsa1 58 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRG 133 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHH
Confidence 34567889999999999999999999998643 34466677788999999883 2469999999999999999
Q ss_pred HHHHhcCCCCceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChhhhhcC-CCCCcccchhH
Q 038647 81 LLYLHHYSRLRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG-LFSIKSDVFSF 159 (289)
Q Consensus 81 l~~lH~~~~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Diwsl 159 (289)
|.|||++| |+||||||+|||++.++.+|++|||++..... ......|++.|+|||+..+. .++.++|||||
T Consensus 134 L~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl 205 (348)
T d2gfsa1 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205 (348)
T ss_dssp HHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred HHHHHhCC---CcccccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhh
Confidence 99999998 99999999999999999999999999876532 23445789999999998765 46899999999
Q ss_pred HHHHHHHHhCCCCcCCCCCcchhHhHhHhhhhccC-----------Ccccccccccc-CCCC-----HHHHHHHHHHHHc
Q 038647 160 GVLVLETLSSKKNAHFYNTDSLTLLGHAWNLWNDG-----------RAWELMDSILQ-NDAS-----YPMLNRYINVALL 222 (289)
Q Consensus 160 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~ 222 (289)
||++|+|++|..||...+....... ........ ........... .... ...+..+.++|.+
T Consensus 206 Gv~l~~ll~g~~pF~~~~~~~~~~~--i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 283 (348)
T d2gfsa1 206 GCIMAELLTGRTLFPGTDHIDQLKL--ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283 (348)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHH
Confidence 9999999999999875543211110 00000000 00000000000 0000 1234678899999
Q ss_pred ccccCCCCCCCHHHHHH--Hhhccc
Q 038647 223 CVQENAADRPTMLEVIS--MLTNEN 245 (289)
Q Consensus 223 ~l~~~p~~Rps~~~ll~--~L~~~~ 245 (289)
||+.||++|||+.|+++ ++.+..
T Consensus 284 mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 284 MLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HCcCChhhCcCHHHHhcCHhhCCCC
Confidence 99999999999999997 555443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-35 Score=251.80 Aligned_cols=223 Identities=17% Similarity=0.185 Sum_probs=158.5
Q ss_pred HHHHHHHHHHHhhCC-----------CCCceeeeeeEeec--CeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHH
Q 038647 9 LEEFKNEMMLIAKLQ-----------HRNLVRLFGCCIEH--GEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILE 75 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 75 (289)
.+.+.+|+++|+.++ |+||+++++++... ...+++++++..+..............+++..+..++.
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 132 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence 467889999999886 47899999988653 46677777765554333322224456788999999999
Q ss_pred HHHHHHHHHhc-CCCCceEeeccccCceEeCCCCc------eEEcccccccccCCCCcccccccccccccccChhhhhcC
Q 038647 76 GVAQGLLYLHH-YSRLRVIHRDLKASNILLDSNMN------PKISDFGIARLFGGDELQSNTKRIVGTYGYMSPEYALRG 148 (289)
Q Consensus 76 ~i~~~l~~lH~-~~~~~ivH~dikp~Nill~~~~~------vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 148 (289)
||+.||.|||+ .| |+||||||+|||++.++. ++++|||.+..... ......||+.|+|||++.+.
T Consensus 133 qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 133 QLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp HHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTC
T ss_pred HHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhcccc
Confidence 99999999997 66 999999999999986553 89999999876532 22345799999999999999
Q ss_pred CCCCcccchhHHHHHHHHHhCCCCcCCCCCcch-----hHhHhHhhh-----------------hccCCcccccccc---
Q 038647 149 LFSIKSDVFSFGVLVLETLSSKKNAHFYNTDSL-----TLLGHAWNL-----------------WNDGRAWELMDSI--- 203 (289)
Q Consensus 149 ~~~~~~DiwslG~vl~elltg~~p~~~~~~~~~-----~~~~~~~~~-----------------~~~~~~~~~~~~~--- 203 (289)
.++.++||||+||++++|++|+.||........ ......... +............
T Consensus 205 ~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
T d1q8ya_ 205 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284 (362)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC
T ss_pred CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC
Confidence 999999999999999999999999865433210 010000000 0000000000000
Q ss_pred -------ccCCCCHHHHHHHHHHHHcccccCCCCCCCHHHHHH
Q 038647 204 -------LQNDASYPMLNRYINVALLCVQENAADRPTMLEVIS 239 (289)
Q Consensus 204 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 239 (289)
.........+..+.+++.+||+.||.+|||++|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp CHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred chhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112234556788999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.75 E-value=3.4e-19 Score=137.25 Aligned_cols=126 Identities=17% Similarity=0.207 Sum_probs=92.9
Q ss_pred HHHHHHHHHHhhCCCCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 038647 10 EEFKNEMMLIAKLQHRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHHYSR 89 (289)
Q Consensus 10 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 89 (289)
..+.+|...|.++.|.++++.+++.. .++||||+++..+.+ ++......++.|++.+|.|||++|
T Consensus 59 ~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g- 123 (191)
T d1zara2 59 RSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG- 123 (191)
T ss_dssp HHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC-
Confidence 45567899999999999998876532 379999998866543 233446689999999999999988
Q ss_pred CceEeeccccCceEeCCCCceEEcccccccccCCCCcccccccccccccccChh-----hhhcCCCCCcccchhHHHHH
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLFGGDELQSNTKRIVGTYGYMSPE-----YALRGLFSIKSDVFSFGVLV 163 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~DiwslG~vl 163 (289)
|+||||||+|||+++++ ++|+|||++......... .|.... .+....|+.++|+||+.--+
T Consensus 124 --iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 124 --IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp --EECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred --EEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999999999998654 899999999765422110 111111 11245678999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=3.1e-07 Score=72.57 Aligned_cols=105 Identities=17% Similarity=0.119 Sum_probs=76.2
Q ss_pred CHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 8 GLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 8 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
....+.+|..++..+. +--+.+++.+..+++..++||++++|.++...... ......++.+++..+..||+
T Consensus 52 ~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~ 123 (263)
T d1j7la_ 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHT
T ss_pred chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhc
Confidence 3446788999988874 43466788888889999999999999888654411 11233456666667777774
Q ss_pred CC--------------------------------------------------------CCceEeeccccCceEeCCCCce
Q 038647 87 YS--------------------------------------------------------RLRVIHRDLKASNILLDSNMNP 110 (289)
Q Consensus 87 ~~--------------------------------------------------------~~~ivH~dikp~Nill~~~~~v 110 (289)
.. ...++|+|+.|.||++++++.+
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~ 203 (263)
T d1j7la_ 124 IDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVS 203 (263)
T ss_dssp SCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEE
T ss_pred cCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceE
Confidence 21 1238999999999999887666
Q ss_pred EEcccccccc
Q 038647 111 KISDFGIARL 120 (289)
Q Consensus 111 kl~Dfg~~~~ 120 (289)
-|+||+.+..
T Consensus 204 ~lIDwe~a~~ 213 (263)
T d1j7la_ 204 GFIDLGRSGR 213 (263)
T ss_dssp EECCCTTCEE
T ss_pred EEeechhccc
Confidence 7999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=1.7e-06 Score=67.77 Aligned_cols=101 Identities=21% Similarity=0.240 Sum_probs=69.4
Q ss_pred HHHHHHHHHHHhhCCC--CCceeeeeeEeecCeEEEEEeecCCCChhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 038647 9 LEEFKNEMMLIAKLQH--RNLVRLFGCCIEHGEKILIYEYMPNKSLDCFLFDPTKTGLLGWEMRVRILEGVAQGLLYLHH 86 (289)
Q Consensus 9 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 86 (289)
...+..|+..|+.+.. -.+.+++.+..+++..++||++++|.++.... ... ...+.++...|..||.
T Consensus 48 ~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--------~~~---~~~~~~l~~~la~LH~ 116 (255)
T d1nd4a_ 48 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--------LAP---AEKVSIMADAMRRLHT 116 (255)
T ss_dssp TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--------CCH---HHHHHHHHHHHHHHTT
T ss_pred HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--------ccH---HHHHHHHHHHHHHHcc
Confidence 3457889988888743 23567888888888999999999887664321 111 1223344455555553
Q ss_pred CC-------------------------------------------------------CCceEeeccccCceEeCCCCceE
Q 038647 87 YS-------------------------------------------------------RLRVIHRDLKASNILLDSNMNPK 111 (289)
Q Consensus 87 ~~-------------------------------------------------------~~~ivH~dikp~Nill~~~~~vk 111 (289)
.. ...++|+|+.|.||+++.+..+-
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~ 196 (255)
T d1nd4a_ 117 LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSG 196 (255)
T ss_dssp SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEE
T ss_pred CChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEE
Confidence 11 23389999999999998876678
Q ss_pred Ecccccccc
Q 038647 112 ISDFGIARL 120 (289)
Q Consensus 112 l~Dfg~~~~ 120 (289)
|+||+.+..
T Consensus 197 iID~~~~~~ 205 (255)
T d1nd4a_ 197 FIDCGRLGV 205 (255)
T ss_dssp ECCCTTCEE
T ss_pred EEEchhccc
Confidence 999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.22 E-value=0.00035 Score=58.00 Aligned_cols=31 Identities=26% Similarity=0.253 Sum_probs=26.3
Q ss_pred CceEeeccccCceEeCCCCceEEccccccccc
Q 038647 90 LRVIHRDLKASNILLDSNMNPKISDFGIARLF 121 (289)
Q Consensus 90 ~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~~ 121 (289)
..++|||+.+.|||+++++ ++|+||..+...
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 3599999999999998765 899999887653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.80 E-value=0.0011 Score=54.88 Aligned_cols=42 Identities=19% Similarity=0.299 Sum_probs=30.0
Q ss_pred cCHHHHHHHHHHHhhCC-CCCceeeeeeEeecCeEEEEEeecCCCCh
Q 038647 7 QGLEEFKNEMMLIAKLQ-HRNLVRLFGCCIEHGEKILIYEYMPNKSL 52 (289)
Q Consensus 7 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 52 (289)
...-...+|..+++.+. +.-..++++++.+ .+|+||++|..+
T Consensus 86 ~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 86 ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 34456778999999995 5444578887754 478999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.09 E-value=0.069 Score=42.32 Aligned_cols=30 Identities=33% Similarity=0.410 Sum_probs=23.9
Q ss_pred CCceEeeccccCceEeCCCCceEEcccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIARL 120 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~~ 120 (289)
...+||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3458999999999999743 45889997763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.71 E-value=0.0049 Score=49.00 Aligned_cols=31 Identities=29% Similarity=0.314 Sum_probs=27.0
Q ss_pred CCceEeeccccCceEeCCCCceEEccccccc
Q 038647 89 RLRVIHRDLKASNILLDSNMNPKISDFGIAR 119 (289)
Q Consensus 89 ~~~ivH~dikp~Nill~~~~~vkl~Dfg~~~ 119 (289)
..++||+|+.++|++++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3459999999999999988777899999875
|